text,title,id,project_number,terms,administration,organization,mechanism,year,funding,score
"DNA PATTERN IDENTIFICATION AND ANALYSIS   DESCRIPTION (Investigator's Abstract): We wi11 continue the development of                                                                                 computer methods for analyzing gene regulation. We will further enhance methods      to identify regulatory sites from the promoter regions of co-regulated genes.        Included in the improvements will be better ways of identifying multiple             transcription factors that act coordinately to regulate gene expression.                                                                                                  We will also study the evolution of regulatory networks in bacteria. By              comparing the homologous regulons in several bacterial species we can study the      gain and loss of gene from common regulatory pa ways, the rates at which             binding sites specificities change, and the duplication and divergence of            regulatory proteins and the genes they regulate.                                                                                                                          We wil1 continue the development and enhancement of methods to predict RNA           structures, especially comparative-based methods that attempt to find common         structure, for collections of sequences These methods will be applied to             several types of sequences including: {\em in vitro} selection product;              structural RNA families; mRNA motifs involved in post-transcriptional                regulation of gene expression.                                                                                                                                            Each of these projects will be enhanced through collaborations with other            groups, primarily experimentalists, who are interested in the application of         our methods to their biological problems.                                                                                                                                 n/a",DNA PATTERN IDENTIFICATION AND ANALYSIS,6627387,R01HG000249,"['DNA', ' DNA binding protein', ' RNA', ' artificial intelligence', ' bacterial genetics', ' binding sites', ' biomedical automation', ' computer assisted sequence analysis', ' computer system design /evaluation', ' gene expression', ' mathematical model', ' method development', ' nucleic acid sequence', ' nucleic acid structure', ' posttranscriptional RNA processing', ' protein sequence', ' regulatory gene']",NHGRI,WASHINGTON UNIVERSITY,R01,2003,269500,0.05216936378773235
"DNA PATTERN IDENTIFICATION AND ANALYSIS   DESCRIPTION (Investigator's Abstract): We wi11 continue the development of                                                                                 computer methods for analyzing gene regulation. We will further enhance methods      to identify regulatory sites from the promoter regions of co-regulated genes.        Included in the improvements will be better ways of identifying multiple             transcription factors that act coordinately to regulate gene expression.                                                                                                  We will also study the evolution of regulatory networks in bacteria. By              comparing the homologous regulons in several bacterial species we can study the      gain and loss of gene from common regulatory pa ways, the rates at which             binding sites specificities change, and the duplication and divergence of            regulatory proteins and the genes they regulate.                                                                                                                          We wil1 continue the development and enhancement of methods to predict RNA           structures, especially comparative-based methods that attempt to find common         structure, for collections of sequences These methods will be applied to             several types of sequences including: {\em in vitro} selection product;              structural RNA families; mRNA motifs involved in post-transcriptional                regulation of gene expression.                                                                                                                                            Each of these projects will be enhanced through collaborations with other            groups, primarily experimentalists, who are interested in the application of         our methods to their biological problems.                                                                                                                                 n/a",DNA PATTERN IDENTIFICATION AND ANALYSIS,6490431,R01HG000249,"['DNA', ' DNA binding protein', ' RNA', ' artificial intelligence', ' bacterial genetics', ' binding sites', ' biomedical automation', ' computer assisted sequence analysis', ' computer system design /evaluation', ' gene expression', ' mathematical model', ' method development', ' nucleic acid sequence', ' nucleic acid structure', ' posttranscriptional RNA processing', ' protein sequence', ' regulatory gene']",NHGRI,WASHINGTON UNIVERSITY,R01,2002,269500,0.05216936378773235
"DNA PATTERN IDENTIFICATION AND ANALYSIS   DESCRIPTION (Investigator's Abstract): We wi11 continue the development of                                                                                 computer methods for analyzing gene regulation. We will further enhance methods      to identify regulatory sites from the promoter regions of co-regulated genes.        Included in the improvements will be better ways of identifying multiple             transcription factors that act coordinately to regulate gene expression.                                                                                                  We will also study the evolution of regulatory networks in bacteria. By              comparing the homologous regulons in several bacterial species we can study the      gain and loss of gene from common regulatory pa ways, the rates at which             binding sites specificities change, and the duplication and divergence of            regulatory proteins and the genes they regulate.                                                                                                                          We wil1 continue the development and enhancement of methods to predict RNA           structures, especially comparative-based methods that attempt to find common         structure, for collections of sequences These methods will be applied to             several types of sequences including: {\em in vitro} selection product;              structural RNA families; mRNA motifs involved in post-transcriptional                regulation of gene expression.                                                                                                                                            Each of these projects will be enhanced through collaborations with other            groups, primarily experimentalists, who are interested in the application of         our methods to their biological problems.                                                                                                                                 n/a",DNA PATTERN IDENTIFICATION AND ANALYSIS,6291580,R01HG000249,"['DNA', ' DNA binding protein', ' RNA', ' artificial intelligence', ' bacterial genetics', ' binding sites', ' biomedical automation', ' computer assisted sequence analysis', ' computer system design /evaluation', ' gene expression', ' mathematical model', ' method development', ' nucleic acid sequence', ' nucleic acid structure', ' posttranscriptional RNA processing', ' protein sequence', ' regulatory gene']",NHGRI,WASHINGTON UNIVERSITY,R01,2001,261800,0.05216936378773235
"Genetic variation and regulatory networks:  Mechanisms and complexity The focus of the proposed research is to understand the effect of sequence variation on the function of molecular networks. We will develop computational algorithms that integrate genotype, gene expression and phenotype data to construct models that describe how sequence variation perturbs the regulatory network, alters signal processing and is manifested in cellular phenotypes. Our approach is based on Bayesian networks, a framework we pioneered for the reconstruction of molecular networks from high-throughput data. We recently applied this framework to develop the Geronemo algorithm which we applied to yeast and uncovered a novel relationship between the sequence specific RNA factor PUF3 and P-Bodies, as well as a Single Nucleotide Polymorphism (SNP) in MKT1 that modulates this relationship. Both novel findings were experimentally validated subsequent to their discovery. Our approach is based on the complementary duality between genetic sequence and functional genomics. A significant influence of genotype on phenotype is induced by fine tuned perturbations to the complex regulatory network that governs a cell's activity. Variation in the expression of a single gene is more tractable and can be used as an intermediary to help associate genetic factors to the more complex downstream changes in phenotype in a hierarchical fashion. Conversely, DNA sequence polymorphisms are effective perturb-agens which provide a rich source of variation to help uncover regulatory relations in the molecular network as well as direct their causality. We will develop our methods using a large collection of highly variable yeast strains, for which we have generated robust quantitative growth curves under numerous environmental conditions. The methodologies piloted in yeast will be extended to genotype and gene expression data derived from tumor samples to attempt to elucidate the multiple genetic factors that drive their proliferation. These tools will be made publicly available, including a friendly graphical user interface and visualization. n/a",Genetic variation and regulatory networks:  Mechanisms and complexity,7937675,DP2OD002414,"['Active Learning', 'Address', 'Affect', 'Algorithms', 'Amino Acid Sequence', 'Animal Model', 'Apoptosis', 'Area', 'Arginine', 'Arts', 'Atlases', 'Automobile Driving', 'B-Lymphocytes', 'Behavior', 'Binding', 'Biochemical Process', 'Biochemistry', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Models', 'Biological Process', 'Biological Sciences', 'Biology', 'Budgets', 'CD4 Positive T Lymphocytes', 'Cancer Center', 'Cancer Etiology', 'Carbon', 'Categories', 'Cell physiology', 'Cells', 'Cessation of life', 'Chromosome abnormality', 'Chromosomes', 'Classification', 'Clinical', 'Code', 'Collaborations', 'Collection', 'Communities', 'Complex', 'Computational Biology', 'Computational Technique', 'Computational algorithm', 'Computer Analysis', 'Computing Methodologies', 'Cues', 'Cyclic AMP-Dependent Protein Kinases', 'Cytoplasm', 'DNA Sequence', 'DNA Sequence Analysis', 'DNA-Protein Interaction', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Decision Trees', 'Dependency', 'Detection', 'Development', 'Diabetes Mellitus', 'Diagnostic', 'Dimensions', 'Disease', 'Distant', 'Doctor of Philosophy', 'Double Effect', 'Drops', 'ERBB2 gene', 'Ensure', 'Environment', 'Environmental Risk Factor', 'Enzymes', 'Ethanol', 'Etiology', 'Event', 'Evolution', 'Exhibits', 'Experimental Designs', 'Experimental Genetics', 'Face', 'Faculty', 'Feedback', 'Figs - dietary', 'Flow Cytometry', 'Fluorescence Microscopy', 'Foundations', 'Fungal Genome', 'Future', 'Gene Deletion', 'Gene Dosage', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Genes', 'Genetic', 'Genetic Epistasis', 'Genetic Markers', 'Genetic Models', 'Genetic Polymorphism', 'Genetic Predisposition to Disease', 'Genetic Transcription', 'Genetic Translation', 'Genetic Variation', 'Genets', 'Genome', 'Genomic Instability', 'Genomics', 'Genotype', 'Glean', 'Glioblastoma', 'Glucose', 'Goals', 'Grant', 'Growth', 'Heart', 'Heating', 'Heritability', 'Human', 'Humidity', 'Hybridization Array', 'Image', 'Imagery', 'Immunity', 'Individual', 'Institutes', 'Investigation', 'Knowledge', 'Label', 'Language', 'Lead', 'Learning', 'Left', 'Letters', 'Life', 'Link', 'Logic', 'Lung', 'MAPK14 gene', 'MYCN gene', 'Machine Learning', 'Malignant - descriptor', 'Malignant Neoplasms', 'Malignant neoplasm of ovary', 'Mammals', 'Maps', 'Measurement', 'Measures', 'Mediating', 'Membrane', 'Memorial Sloan-Kettering Cancer Center', 'Messenger RNA', 'Metabolic', 'Metabolic Pathway', 'Metabolism', 'Methionine Metabolism Pathway', 'Methodology', 'Methods', 'Methylation', 'Mission', 'Mitochondria', 'Mitogen-Activated Protein Kinase Kinases', 'Modeling', 'Molecular', 'Molecular Biology', 'Molecular Profiling', 'Mus', 'Mutation', 'Nature', 'Needles', 'Neuroblastoma', 'Nitrogen', 'Noise', 'Normal Cell', 'Nuclear', 'Nutrient', 'Optics', 'Oranges', 'Organism', 'Output', 'Paper', 'Parents', 'Pathway Analysis', 'Pathway interactions', 'Pattern', 'Peptide Sequence Determination', 'Performance', 'Pharmaceutical Preparations', 'Phase', 'Phenotype', 'Phosphatidylinositol 4,5-Diphosphate', 'Phosphorylation', 'Physical condensation', 'Physiology', 'Plants', 'Play', 'Point Mutation', 'Population', 'Population Genetics', 'Positioning Attribute', 'Post-Transcriptional Regulation', 'Postdoctoral Fellow', 'Probability', 'Procedures', 'Process', 'Proliferating', 'Protein Binding', 'Proteins', 'Protocols documentation', 'Proxy', 'Publications', 'Published Comment', 'Publishing', 'Quantitative Trait Loci', 'RNA', 'RNA-Binding Proteins', 'Raffinose', 'Recruitment Activity', 'Regulation', 'Regulator Genes', 'Regulatory Pathway', 'Relative (related person)', 'Repression', 'Reproducibility', 'Research', 'Research Design', 'Research Personnel', 'Risk', 'Role', 'Saccharomyces cerevisiae', 'Sampling', 'Scanning', 'Science', 'Seminal', 'Series', 'Signal Pathway', 'Signal Transduction', 'Signaling Molecule', 'Signaling Protein', 'Single Nucleotide Polymorphism', 'Sirolimus', 'Site', 'Small Interfering RNA', 'Sodium Chloride', 'Solutions', 'Sorting - Cell Movement', 'Source', 'Speed', 'Spottings', 'Starvation', 'Statistical Models', 'Stimulus', 'Stress', 'Structure', 'Sucrose', 'Sum', 'Suspension substance', 'Suspensions', 'System', 'T-Lymphocyte', 'TOP2A gene', 'Techniques', 'Technology', 'Temperature', 'Testing', 'Therapeutic', 'Time', 'Training', 'Transcript', 'Translation Initiation', 'Treatment Protocols', 'Tumor-Derived', 'Universities', 'Untranslated Regions', 'Up-Regulation', 'Upper arm', 'Validation', 'Variant', 'Visual', 'Work', 'Yeasts', 'base', 'biological systems', 'cancer cell', 'cancer genome', 'cancer genomics', 'chromatin modification', 'combinatorial', 'comparative', 'comparative genomic hybridization', 'computer based statistical methods', 'computer framework', 'computerized data processing', 'computerized tools', 'cost', 'data integration', 'density', 'design', 'disease phenotype', 'empowered', 'evaporation', 'fitness', 'flexibility', 'functional genomics', 'gene function', 'genetic analysis', 'genetic linkage analysis', 'genetic variant', 'genome wide association study', 'genome-wide', 'graphical user interface', 'improved', 'innovation', 'inorganic phosphate', 'insight', 'interdisciplinary approach', 'interest', 'leukemia', 'loss of function', 'mRNA Expression', 'mRNA Transcript Degradation', 'mRNA decapping', 'malignant breast neoplasm', 'medical schools', 'member', 'method development', 'molecular domain', 'mutant', 'novel', 'novel strategies', 'outcome forecast', 'pressure', 'prognostic', 'programs', 'promoter', 'protein B', 'protein expression', 'prototype', 'reconstruction', 'research study', 'response', 'segregation', 'skills', 'statistics', 'success', 'sugar', 'symposium', 'tool', 'trait', 'transcription factor', 'tumor', 'tumor growth', 'tumor progression', 'tumorigenesis', 'user-friendly', 'yeast genetics']",OD,COLUMBIA UNIV NEW YORK MORNINGSIDE,DP2,2009,89960,0.08263960561404457
"Genetic variation and regulatory networks:  Mechanisms and complexity The focus of the proposed research is to understand the effect of sequence variation on the function of molecular networks. We will develop computational algorithms that integrate genotype, gene expression and phenotype data to construct models that describe how sequence variation perturbs the regulatory network, alters signal processing and is manifested in cellular phenotypes. Our approach is based on Bayesian networks, a framework we pioneered for the reconstruction of molecular networks from high-throughput data. We recently applied this framework to develop the Geronemo algorithm which we applied to yeast and uncovered a novel relationship between the sequence specific RNA factor PUF3 and P-Bodies, as well as a Single Nucleotide Polymorphism (SNP) in MKT1 that modulates this relationship. Both novel findings were experimentally validated subsequent to their discovery. Our approach is based on the complementary duality between genetic sequence and functional genomics. A significant influence of genotype on phenotype is induced by fine tuned perturbations to the complex regulatory network that governs a cell's activity. Variation in the expression of a single gene is more tractable and can be used as an intermediary to help associate genetic factors to the more complex downstream changes in phenotype in a hierarchical fashion. Conversely, DNA sequence polymorphisms are effective perturb-agens which provide a rich source of variation to help uncover regulatory relations in the molecular network as well as direct their causality. We will develop our methods using a large collection of highly variable yeast strains, for which we have generated robust quantitative growth curves under numerous environmental conditions. The methodologies piloted in yeast will be extended to genotype and gene expression data derived from tumor samples to attempt to elucidate the multiple genetic factors that drive their proliferation. These tools will be made publicly available, including a friendly graphical user interface and visualization. n/a",Genetic variation and regulatory networks:  Mechanisms and complexity,7431104,DP2OD002414,"['Active Learning', 'Address', 'Affect', 'Algorithms', 'Amino Acid Sequence', 'Animal Model', 'Apoptosis', 'Area', 'Arginine', 'Arts', 'Atlases', 'Automobile Driving', 'B-Lymphocytes', 'Behavior', 'Binding', 'Biochemical Process', 'Biochemistry', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Models', 'Biological Process', 'Biological Sciences', 'Biology', 'Budgets', 'CD4 Positive T Lymphocytes', 'Cancer Center', 'Cancer Etiology', 'Carbon', 'Categories', 'Cell physiology', 'Cells', 'Cessation of life', 'Chromatin', 'Chromosome abnormality', 'Chromosomes', 'Classification', 'Clinical', 'Code', 'Collaborations', 'Collection', 'Communities', 'Compatible', 'Complex', 'Computational Biology', 'Computational Technique', 'Computational algorithm', 'Computer Analysis', 'Computing Methodologies', 'Condition', 'Cues', 'Cyclic AMP-Dependent Protein Kinases', 'Cytoplasm', 'DNA Sequence', 'DNA Sequence Analysis', 'DNA-Protein Interaction', 'Data', 'Data Analyses', 'Data Set', 'Data Sources', 'Decision Trees', 'Dependency', 'Detection', 'Development', 'Diabetes Mellitus', 'Diagnostic', 'Dimensions', 'Disease', 'Disease regression', 'Distant', 'Doctor of Philosophy', 'Double Effect', 'Drops', 'ERBB2 gene', 'Ensure', 'Environment', 'Environmental Risk Factor', 'Enzymes', 'Ethanol', 'Etiology', 'Event', 'Evolution', 'Exhibits', 'Experimental Designs', 'Experimental Genetics', 'Face', 'Facility Construction Funding Category', 'Faculty', 'Feedback', 'Figs - dietary', 'Flow Cytometry', 'Fluorescence Microscopy', 'Foundations', 'Fungal Genome', 'Future', 'Gene Deletion', 'Gene Dosage', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Genes', 'Genetic', 'Genetic Epistasis', 'Genetic Markers', 'Genetic Models', 'Genetic Polymorphism', 'Genetic Predisposition to Disease', 'Genetic Transcription', 'Genetic Translation', 'Genetic Variation', 'Genets', 'Genome', 'Genomic Instability', 'Genomics', 'Genotype', 'Glean', 'Glioblastoma', 'Glucose', 'Goals', 'Grant', 'Green Fluorescent Proteins', 'Growth', 'Heart', 'Heating', 'Heritability', 'Human', 'Humidity', 'Hybridization Array', 'Image', 'Imagery', 'Immunity', 'Individual', 'Institutes', 'Investigation', 'Knowledge', 'Label', 'Language', 'Lead', 'Learning', 'Left', 'Letters', 'Life', 'Link', 'Localized', 'Logic', 'Lung', 'MAPK14 gene', 'MYCN gene', 'Machine Learning', 'Malignant - descriptor', 'Malignant Neoplasms', 'Malignant neoplasm of ovary', 'Mammals', 'Maps', 'Measurement', 'Measures', 'Mediating', 'Membrane', 'Memorial Sloan-Kettering Cancer Center', 'Messenger RNA', 'Metabolic', 'Metabolic Pathway', 'Metabolism', 'Methionine Metabolism Pathway', 'Methodology', 'Methods', 'Methylation', 'Mission', 'Mitochondria', 'Mitogen-Activated Protein Kinase Kinases', 'Modeling', 'Modification', 'Molecular', 'Molecular Biology', 'Molecular Profiling', 'Mus', 'Mutation', 'Nature', 'Needles', 'Neuroblastoma', 'Nitrogen', 'Noise', 'Normal Cell', 'Nuclear', 'Numbers', 'Nutrient', 'Oleate', 'Optics', 'Oranges', 'Organism', 'Output', 'Paper', 'Parents', 'Pathway Analysis', 'Pathway interactions', 'Pattern', 'Peptide Sequence Determination', 'Performance', 'Personal Satisfaction', 'Pharmaceutical Preparations', 'Phase', 'Phenotype', 'Phosphatidylinositol 4,5-Diphosphate', 'Phosphorylation', 'Physical condensation', 'Physiology', 'Plants', 'Play', 'Point Mutation', 'Population', 'Population Genetics', 'Positioning Attribute', 'Post-Transcriptional Regulation', 'Postdoctoral Fellow', 'Probability', 'Procedures', 'Process', 'Proliferating', 'Protein Binding', 'Proteins', 'Protocols documentation', 'Proxy', 'Publications', 'Published Comment', 'Publishing', 'Quantitative Trait Loci', 'RNA', 'RNA-Binding Proteins', 'Raffinose', 'Range', 'Rate', 'Recruitment Activity', 'Regulation', 'Regulator Genes', 'Regulatory Pathway', 'Relative (related person)', 'Repression', 'Reproducibility', 'Research', 'Research Design', 'Research Personnel', 'Risk', 'Role', 'Saccharomyces cerevisiae', 'Sampling', 'Scanning', 'Science', 'Score', 'Seminal', 'Series', 'Signal Pathway', 'Signal Transduction', 'Signaling Molecule', 'Signaling Protein', 'Single Nucleotide Polymorphism', 'Sirolimus', 'Site', 'Small Interfering RNA', 'Sodium Chloride', 'Solutions', 'Sorting - Cell Movement', 'Source', 'Speed', 'Spottings', 'Starvation', 'Statistical Models', 'Stimulus', 'Stress', 'Structure', 'Sucrose', 'Sum', 'Suspension substance', 'Suspensions', 'System', 'T-Lymphocyte', 'TOP2A gene', 'Techniques', 'Technology', 'Temperature', 'Testing', 'Therapeutic', 'Time', 'Training', 'Transcript', 'Translation Initiation', 'Treatment Protocols', 'Tumor-Derived', 'Universities', 'Untranslated Regions', 'Up-Regulation', 'Upper arm', 'Validation', 'Variant', 'Visual', 'Work', 'Yeasts', 'base', 'cancer cell', 'cancer genome', 'cancer genomics', 'combinatorial', 'comparative', 'comparative genomic hybridization', 'computer based statistical methods', 'computer framework', 'computerized data processing', 'computerized tools', 'concept', 'cost', 'data integration', 'density', 'design', 'disease phenotype', 'evaporation', 'fitness', 'functional genomics', 'gene function', 'genetic analysis', 'genetic linkage analysis', 'genetic variant', 'graphical user interface', 'improved', 'innovation', 'inorganic phosphate', 'insight', 'interdisciplinary approach', 'interest', 'leukemia', 'loss of function', 'mRNA Expression', 'mRNA Transcript Degradation', 'mRNA decapping', 'malignant breast neoplasm', 'medical schools', 'member', 'method development', 'molecular domain', 'mutant', 'novel', 'novel strategies', 'outcome forecast', 'pressure', 'prognostic', 'programs', 'promoter', 'protein B', 'protein expression', 'prototype', 'reconstruction', 'research study', 'response', 'segregation', 'skills', 'statistics', 'success', 'sugar', 'symposium', 'tool', 'trait', 'transcription factor', 'tumor', 'tumor growth', 'tumor progression', 'tumorigenesis', 'user-friendly', 'yeast genetics']",OD,COLUMBIA UNIV NEW YORK MORNINGSIDE,DP2,2007,2415000,0.08263960561404457
"Computational Analysis of Gene Expression Pattern Images    DESCRIPTION (provided by applicant): The overarching goal of the proposed project is to develop computational methods and practical bioinformatics resources for data-driven, integrative analysis of expression images and sequence data to discover functional, genetic, and regulatory interactions between genes and genomic elements. Fast growing collections of spatial and temporal gene expression patterns in the model organism, Drosophila melanogaster, are providing unprecedented opportunities for understanding the spatiotemporal regulation of expression not only for fruit fly genes, but also human genes that show extensive evolutionary similarity and functional conservation. These expression patterns are the first links between a gene's primary sequence and its influence on the phenotype, and their overlaps provide initial clues to functional, genetic, or regulatory interactions. Therefore, our primary framework for translating large volumes of images into functional knowledge is to discover and analyze co- expressed (and, thus, potentially co-regulated) genes. To date, our efforts have led to the development and establishment of a unique and innovative image-based framework (FlyExpress) to carry out high-throughput analyses of these large datasets, because the standard practice of manually inspecting images is no longer feasible owing to the sheer volume of available images. We are now poised to address a growing and urgent need to develop computational tools and data-integration methods that enable effective harnessing of fast- growing image and sequence data as well as foster enhanced engagement of the research community in building the FlyExpress knowledgebase. Therefore, we plan to (a) develop a new software tool to enable effective expression image analysis while advancing community collaborations, (b) translate knowledge of spatiotemporal expression overlap into the discovery of regulatory motifs by developing novel methods for integrative analysis of image and sequence data, and (c) evolve FlyExpress into a comprehensive knowledge- base of embryonic expression images in order to generate better predictions and integrative analysis across heterogeneous image sources. These developments will enable investigators to effectively generate and evaluate their gene interaction hypotheses based on overlaps in expression patterns by using all relevant biological information. The software tool and web system, including the source code, will always be freely available. The computational algorithms, statistical methods, and bioinformatics technologies developed in this project will be reconfigurable and adaptable for application in constructing similar frameworks for organizing expression pattern data from other species and life history stages. The FlyExpress system will fulfill the day-to-day needs of basic and applied researchers as well as students in many areas of molecular biology crucial in basic biomedicine, including computational genomics, molecular genetics, developmental biology, genetics, and evolution.        Investigations of model organisms are critical for understanding spatiotemporal regulation of gene expression that result in alternative cell fates in a developing embryo and establish the cellular precursors of adult tissues and organs. The proposed project will produce urgently needed computational methods and practical bioinformatics resources that enable scientists to carry out integrative data-driven analysis of expression pattern images to discover functional, genetic, and regulatory interactions between genes and genomic elements. The proposed advances would lead to a more effective translation of gene expression (image) and genomics (sequence) data into the functional knowledge of human and other animal genes.         ",Computational Analysis of Gene Expression Pattern Images,8523190,R01HG002516,"['Address', 'Adult', 'Animal Model', 'Animals', 'Architecture', 'Area', 'Binding', 'Bioinformatics', 'Biological', 'Cells', 'Collaborations', 'Collection', 'Communities', 'Computational algorithm', 'Computer Analysis', 'Computer software', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Defect', 'Development', 'Developmental Biology', 'Drosophila genus', 'Drosophila melanogaster', 'Education', 'Elements', 'Embryo', 'Embryonic Development', 'Experimental Genetics', 'Fostering', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Goals', 'Human', 'Image', 'Image Analysis', 'Individual', 'Informatics', 'Institution', 'Internet', 'Investigation', 'Journals', 'Knowledge', 'Laboratories', 'Lead', 'Learning', 'Link', 'Malignant Neoplasms', 'Methods', 'Mining', 'Molecular Biology', 'Molecular Genetics', 'Organ', 'Pattern', 'Peer Review', 'Phenotype', 'Plug-in', 'Probability', 'Process', 'Publishing', 'Regulation', 'Research', 'Research Personnel', 'Resources', 'Scientist', 'Software Tools', 'Source', 'Source Code', 'Staging', 'Statistical Methods', 'Students', 'System', 'Technology', 'Testing', 'Tissues', 'Training Activity', 'Translating', 'Translations', 'Work', 'base', 'computerized tools', 'data integration', 'flexibility', 'functional genomics', 'gene interaction', 'genetic evolution', 'genome sequencing', 'human disease', 'innovation', 'knowledge base', 'life history', 'novel', 'programs', 'research study', 'spatiotemporal', 'text searching', 'tool', 'transcription factor']",NHGRI,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R01,2013,580221,0.1223083985110201
"Computational Analysis of Gene Expression Pattern Images    DESCRIPTION (provided by applicant): The overarching goal of the proposed project is to develop computational methods and practical bioinformatics resources for data-driven, integrative analysis of expression images and sequence data to discover functional, genetic, and regulatory interactions between genes and genomic elements. Fast growing collections of spatial and temporal gene expression patterns in the model organism, Drosophila melanogaster, are providing unprecedented opportunities for understanding the spatiotemporal regulation of expression not only for fruit fly genes, but also human genes that show extensive evolutionary similarity and functional conservation. These expression patterns are the first links between a gene's primary sequence and its influence on the phenotype, and their overlaps provide initial clues to functional, genetic, or regulatory interactions. Therefore, our primary framework for translating large volumes of images into functional knowledge is to discover and analyze co- expressed (and, thus, potentially co-regulated) genes. To date, our efforts have led to the development and establishment of a unique and innovative image-based framework (FlyExpress) to carry out high-throughput analyses of these large datasets, because the standard practice of manually inspecting images is no longer feasible owing to the sheer volume of available images. We are now poised to address a growing and urgent need to develop computational tools and data-integration methods that enable effective harnessing of fast- growing image and sequence data as well as foster enhanced engagement of the research community in building the FlyExpress knowledgebase. Therefore, we plan to (a) develop a new software tool to enable effective expression image analysis while advancing community collaborations, (b) translate knowledge of spatiotemporal expression overlap into the discovery of regulatory motifs by developing novel methods for integrative analysis of image and sequence data, and (c) evolve FlyExpress into a comprehensive knowledge- base of embryonic expression images in order to generate better predictions and integrative analysis across heterogeneous image sources. These developments will enable investigators to effectively generate and evaluate their gene interaction hypotheses based on overlaps in expression patterns by using all relevant biological information. The software tool and web system, including the source code, will always be freely available. The computational algorithms, statistical methods, and bioinformatics technologies developed in this project will be reconfigurable and adaptable for application in constructing similar frameworks for organizing expression pattern data from other species and life history stages. The FlyExpress system will fulfill the day-to-day needs of basic and applied researchers as well as students in many areas of molecular biology crucial in basic biomedicine, including computational genomics, molecular genetics, developmental biology, genetics, and evolution.        Investigations of model organisms are critical for understanding spatiotemporal regulation of gene expression that result in alternative cell fates in a developing embryo and establish the cellular precursors of adult tissues and organs. The proposed project will produce urgently needed computational methods and practical bioinformatics resources that enable scientists to carry out integrative data-driven analysis of expression pattern images to discover functional, genetic, and regulatory interactions between genes and genomic elements. The proposed advances would lead to a more effective translation of gene expression (image) and genomics (sequence) data into the functional knowledge of human and other animal genes.         ",Computational Analysis of Gene Expression Pattern Images,8286161,R01HG002516,"['Address', 'Adult', 'Animal Model', 'Animals', 'Architecture', 'Area', 'Binding', 'Bioinformatics', 'Biological', 'Cells', 'Collaborations', 'Collection', 'Communities', 'Computational algorithm', 'Computer Analysis', 'Computer software', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Defect', 'Development', 'Developmental Biology', 'Drosophila genus', 'Drosophila melanogaster', 'Education', 'Elements', 'Embryo', 'Embryonic Development', 'Experimental Genetics', 'Fostering', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Goals', 'Human', 'Image', 'Image Analysis', 'Individual', 'Informatics', 'Institution', 'Internet', 'Investigation', 'Journals', 'Knowledge', 'Laboratories', 'Lead', 'Learning', 'Link', 'Malignant Neoplasms', 'Methods', 'Mining', 'Molecular Biology', 'Molecular Genetics', 'Organ', 'Pattern', 'Peer Review', 'Phenotype', 'Plug-in', 'Probability', 'Process', 'Publishing', 'Regulation', 'Research', 'Research Personnel', 'Resources', 'Scientist', 'Software Tools', 'Source', 'Source Code', 'Staging', 'Statistical Methods', 'Students', 'System', 'Technology', 'Testing', 'Tissues', 'Training Activity', 'Translating', 'Translations', 'Work', 'base', 'computerized tools', 'data integration', 'flexibility', 'functional genomics', 'gene interaction', 'genetic evolution', 'genome sequencing', 'human disease', 'innovation', 'knowledge base', 'life history', 'novel', 'programs', 'research study', 'spatiotemporal', 'text searching', 'tool', 'transcription factor']",NHGRI,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R01,2012,601206,0.1223083985110201
"Computational Analysis of Gene Expression Pattern Images    DESCRIPTION (provided by applicant): The overarching goal of the proposed project is to develop computational methods and practical bioinformatics resources for data-driven, integrative analysis of expression images and sequence data to discover functional, genetic, and regulatory interactions between genes and genomic elements. Fast growing collections of spatial and temporal gene expression patterns in the model organism, Drosophila melanogaster, are providing unprecedented opportunities for understanding the spatiotemporal regulation of expression not only for fruit fly genes, but also human genes that show extensive evolutionary similarity and functional conservation. These expression patterns are the first links between a gene's primary sequence and its influence on the phenotype, and their overlaps provide initial clues to functional, genetic, or regulatory interactions. Therefore, our primary framework for translating large volumes of images into functional knowledge is to discover and analyze co- expressed (and, thus, potentially co-regulated) genes. To date, our efforts have led to the development and establishment of a unique and innovative image-based framework (FlyExpress) to carry out high-throughput analyses of these large datasets, because the standard practice of manually inspecting images is no longer feasible owing to the sheer volume of available images. We are now poised to address a growing and urgent need to develop computational tools and data-integration methods that enable effective harnessing of fast- growing image and sequence data as well as foster enhanced engagement of the research community in building the FlyExpress knowledgebase. Therefore, we plan to (a) develop a new software tool to enable effective expression image analysis while advancing community collaborations, (b) translate knowledge of spatiotemporal expression overlap into the discovery of regulatory motifs by developing novel methods for integrative analysis of image and sequence data, and (c) evolve FlyExpress into a comprehensive knowledge- base of embryonic expression images in order to generate better predictions and integrative analysis across heterogeneous image sources. These developments will enable investigators to effectively generate and evaluate their gene interaction hypotheses based on overlaps in expression patterns by using all relevant biological information. The software tool and web system, including the source code, will always be freely available. The computational algorithms, statistical methods, and bioinformatics technologies developed in this project will be reconfigurable and adaptable for application in constructing similar frameworks for organizing expression pattern data from other species and life history stages. The FlyExpress system will fulfill the day-to-day needs of basic and applied researchers as well as students in many areas of molecular biology crucial in basic biomedicine, including computational genomics, molecular genetics, developmental biology, genetics, and evolution.      PUBLIC HEALTH RELEVANCE: Investigations of model organisms are critical for understanding spatiotemporal regulation of gene expression that result in alternative cell fates in a developing embryo and establish the cellular precursors of adult tissues and organs. The proposed project will produce urgently needed computational methods and practical bioinformatics resources that enable scientists to carry out integrative data-driven analysis of expression pattern images to discover functional, genetic, and regulatory interactions between genes and genomic elements. The proposed advances would lead to a more effective translation of gene expression (image) and genomics (sequence) data into the functional knowledge of human and other animal genes.           Investigations of model organisms are critical for understanding spatiotemporal regulation of gene expression that result in alternative cell fates in a developing embryo and establish the cellular precursors of adult tissues and organs. The proposed project will produce urgently needed computational methods and practical bioinformatics resources that enable scientists to carry out integrative data-driven analysis of expression pattern images to discover functional, genetic, and regulatory interactions between genes and genomic elements. The proposed advances would lead to a more effective translation of gene expression (image) and genomics (sequence) data into the functional knowledge of human and other animal genes.         ",Computational Analysis of Gene Expression Pattern Images,8119155,R01HG002516,"['Address', 'Adult', 'Animal Model', 'Animals', 'Architecture', 'Area', 'Binding', 'Bioinformatics', 'Biological', 'Cells', 'Collaborations', 'Collection', 'Communities', 'Computational algorithm', 'Computer Analysis', 'Computer software', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Defect', 'Development', 'Developmental Biology', 'Drosophila genus', 'Drosophila melanogaster', 'Education', 'Elements', 'Embryo', 'Embryonic Development', 'Experimental Genetics', 'Fostering', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Goals', 'Human', 'Image', 'Image Analysis', 'Individual', 'Informatics', 'Institution', 'Internet', 'Investigation', 'Journals', 'Knowledge', 'Laboratories', 'Lead', 'Learning', 'Link', 'Malignant Neoplasms', 'Methods', 'Mining', 'Molecular Biology', 'Molecular Genetics', 'Organ', 'Pattern', 'Peer Review', 'Phenotype', 'Plug-in', 'Probability', 'Process', 'Publishing', 'Regulation', 'Research', 'Research Personnel', 'Resources', 'Scientist', 'Software Tools', 'Source', 'Source Code', 'Staging', 'Statistical Methods', 'Students', 'System', 'Technology', 'Testing', 'Tissues', 'Training Activity', 'Translating', 'Translations', 'Work', 'base', 'computerized tools', 'data integration', 'flexibility', 'functional genomics', 'gene interaction', 'genetic evolution', 'genome sequencing', 'human disease', 'innovation', 'knowledge base', 'life history', 'novel', 'programs', 'research study', 'spatiotemporal', 'text searching', 'tool', 'transcription factor']",NHGRI,ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,R01,2011,600000,0.12294520184723652
"Decoding Gene Expression Control Using Conditional Clustering by Dynamics    DESCRIPTION (provided by applicant): Microarray technology enables investigators to simultaneously measure the expression of thousands of genes and holds the promise to cast new light onto the regulatory mechanisms of the genome. A main avenue of experimental investigation, leveraging on this technology, is based on the temporal dissection of cellular mechanisms. Temporal experiments offer the possibility of observing these mechanisms in action and to break down the genome into sets of genes involved in the same processes. The overall goal of this project is to develop an unsupervised approach and an integrated software environment to automatically discover regulatory mechanisms from temporal microarray experiments. The hypothesis underpinning our approach is that complex interaction patterns can be identified through analysis of conditional rather than marginal gene expression profiles. This novel approach also provides principled guidance to experimental design and sampling strategies, and it naturally extends to a large class of statistical models, able to capture a wider range of dynamic behaviors and experimental designs. We plan to develop a comprehensive framework to design and analyze microarray data collected through temporal experiments. This framework will be used to specify and answer the critical design questions of sample size and sampling frequency determination. Using this framework, we will develop a new model-based approach and an iterative search algorithm, called Conditional Clustering, to identify different patterns of behavior determined by a set of genes through the analysis of the behavior of a gene given a set of other genes, rather than the behavior of each gene in isolation. We will implement this design and analysis framework in a computer program that will be distributed over the Internet.This project brings together researchers in artificial intelligence, theoretical statistics and experimental design with a long track record of methodological contributions to bioinformatics to develop a novel methodological approach to a critical question at the forefront of genomic research.         n/a",Decoding Gene Expression Control Using Conditional Clustering by Dynamics,7350919,R01HG003354,"['Algorithms', 'Artificial Intelligence', 'Bayesian Method', 'Behavior', 'Behavioral', 'Bioinformatics', 'Class', 'Cluster Analysis', 'Complex', 'Computer software', 'Data', 'Development', 'Dissection', 'Environment', 'Experimental Designs', 'Experimental Models', 'Foundations', 'Frequencies', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Research', 'Genome', 'Genomics', 'Goals', 'Haplotypes', 'Internet', 'Investigation', 'Journals', 'Light', 'Measures', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular Profiling', 'Names', 'Numbers', 'One-Step dentin bonding system', 'Paper', 'Pattern', 'Process', 'Publishing', 'Range', 'Research', 'Research Personnel', 'Sample Size', 'Sampling', 'Series', 'Statistical Models', 'System', 'Technology', 'Time', 'To specify', 'Today', 'analytical method', 'analytical tool', 'base', 'computer program', 'design', 'functional genomics', 'gene interaction', 'genome-wide analysis', 'insight', 'novel', 'novel strategies', 'programs', 'reconstruction', 'research study', 'size', 'software development', 'statistics']",NHGRI,BOSTON CHILDREN'S HOSPITAL,R01,2008,298801,0.07264639658968514
"Decoding Gene Expression Control Using Conditional Clustering by Dynamics    DESCRIPTION (provided by applicant): Microarray technology enables investigators to simultaneously measure the expression of thousands of genes and holds the promise to cast new light onto the regulatory mechanisms of the genome. A main avenue of experimental investigation, leveraging on this technology, is based on the temporal dissection of cellular mechanisms. Temporal experiments offer the possibility of observing these mechanisms in action and to break down the genome into sets of genes involved in the same processes. The overall goal of this project is to develop an unsupervised approach and an integrated software environment to automatically discover regulatory mechanisms from temporal microarray experiments. The hypothesis underpinning our approach is that complex interaction patterns can be identified through analysis of conditional rather than marginal gene expression profiles. This novel approach also provides principled guidance to experimental design and sampling strategies, and it naturally extends to a large class of statistical models, able to capture a wider range of dynamic behaviors and experimental designs. We plan to develop a comprehensive framework to design and analyze microarray data collected through temporal experiments. This framework will be used to specify and answer the critical design questions of sample size and sampling frequency determination. Using this framework, we will develop a new model-based approach and an iterative search algorithm, called Conditional Clustering, to identify different patterns of behavior determined by a set of genes through the analysis of the behavior of a gene given a set of other genes, rather than the behavior of each gene in isolation. We will implement this design and analysis framework in a computer program that will be distributed over the Internet.This project brings together researchers in artificial intelligence, theoretical statistics and experimental design with a long track record of methodological contributions to bioinformatics to develop a novel methodological approach to a critical question at the forefront of genomic research.         n/a",Decoding Gene Expression Control Using Conditional Clustering by Dynamics,7176152,R01HG003354,"['Algorithms', 'Artificial Intelligence', 'Bayesian Method', 'Behavior', 'Behavioral', 'Bioinformatics', 'Class', 'Cluster Analysis', 'Complex', 'Computer software', 'Data', 'Development', 'Dissection', 'Environment', 'Experimental Designs', 'Experimental Models', 'Foundations', 'Frequencies', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Research', 'Genome', 'Genomics', 'Goals', 'Haplotypes', 'Internet', 'Investigation', 'Journals', 'Light', 'Measures', 'Methods', 'Microarray Analysis', 'Modeling', 'Molecular Profiling', 'Names', 'Numbers', 'One-Step dentin bonding system', 'Paper', 'Pattern', 'Process', 'Publishing', 'Range', 'Research', 'Research Personnel', 'Sample Size', 'Sampling', 'Series', 'Statistical Models', 'System', 'Technology', 'Time', 'To specify', 'Today', 'analytical method', 'analytical tool', 'base', 'computer program', 'design', 'functional genomics', 'gene interaction', 'genome-wide analysis', 'insight', 'novel', 'novel strategies', 'programs', 'reconstruction', 'research study', 'size', 'software development', 'statistics']",NHGRI,CHILDREN'S HOSPITAL CORPORATION,R01,2007,305165,0.07264639658968514
"Decoding Gene Expression Control Using Conditional Clustering by Dyanamics    DESCRIPTION (provided by applicant): Microarray technology enables investigators to simultaneously measure the expression of thousands of genes and holds the promise to cast new light onto the regulatory mechanisms of the genome. A main avenue of experimental investigation, leveraging on this technology, is based on the temporal dissection of cellular mechanisms. Temporal experiments offer the possibility of observing these mechanisms in action and to break down the genome into sets of genes involved in the same processes. The overall goal of this project is to develop an unsupervised approach and an integrated software environment to automatically discover regulatory mechanisms from temporal microarray experiments. The hypothesis underpinning our approach is that complex interaction patterns can be identified through analysis of conditional rather than marginal gene expression profiles. This novel approach also provides principled guidance to experimental design and sampling strategies, and it naturally extends to a large class of statistical models, able to capture a wider range of dynamic behaviors and experimental designs. We plan to develop a comprehensive framework to design and analyze microarray data collected through temporal experiments. This framework will be used to specify and answer the critical design questions of sample size and sampling frequency determination. Using this framework, we will develop a new model-based approach and an iterative search algorithm, called Conditional Clustering, to identify different patterns of behavior determined by a set of genes through the analysis of the behavior of a gene given a set of other genes, rather than the behavior of each gene in isolation. We will implement this design and analysis framework in a computer program that will be distributed over the Internet.This project brings together researchers in artificial intelligence, theoretical statistics and experimental design with a long track record of methodological contributions to bioinformatics to develop a novel methodological approach to a critical question at the forefront of genomic research.         n/a",Decoding Gene Expression Control Using Conditional Clustering by Dyanamics,7033620,R01HG003354,"['behavior', 'computer program /software', 'experimental designs', 'gene expression', 'genes', 'genome', 'mathematical model', 'model']",NHGRI,CHILDREN'S HOSPITAL BOSTON,R01,2006,325000,0.07264639658968514
"Locating Regulatory Elements in Genomes    DESCRIPTION (provided by applicant): Understanding regulatory networks controlling gene expression is one of the fundamental problems of modern biology. The proposed research focuses on the methods of locating regulatory elements in DNA. We have developed a new maximum likelihood method based on the physical DNA dependent binding probability of a transcription factor (TF) that correctly incorporates the protein concentration dependent saturation effect. The advantage of keeping the saturation effect is that the method automatically provides a score threshold for classifying candidate sites into binders and non-binders. Most conventional methods, based on the information score, merely provide a relative ordering of candidate sequences. The principled choice of a threshold is extremely useful for dealing with the highly variable sites typical of global regulatory factors. The simplest of our algorithms reduces to a one-class support vector machine. This classifier will be applied to detect large regulons in E. coli, as well as in phages, with special attention to targets of sigma factors. We also develop classifiers for regulatory targets that go beyond pure sequence analysis and combine it with information from additional sources, like microarray expression data or sequence similarity between phylogenetically closely related species. The proposed computational effort will be complemented by experiments verifying the predictions as well as providing in vitro and in vivo data needed to make predictions. Experimental efforts will involve a high throughput low stringency SELEX method applied to global transcriptional regulators from E. coli. It will also involve chromatin immunoprecipitation and beta- galactosidase assays performed in S. Cerevisiae that test the ability of bioinformatic algorithms to predict functionality of TF binding sites. A special feature of this proposal is the analysis of the effect of the rest of the promoter on the regulatory potential of a site. We apply the lessons learnt in simple organisms to the elucidation of distinctive specificity of different NFkB proteins involved in immunity, inflammation and cancer. Mutation, over-expression and amplification of genes encoding transcription factors play an important role in many diseases from diabetes to cancer. Understanding how a factor targets genes is crucial for discovering the pathways whose malfunction leads to the symptoms. This is an achievable goal, given the right way to analyze the plethora of genome-wide data available to us.           n/a",Locating Regulatory Elements in Genomes,7392219,R01HG003470,"['Affinity', 'Algorithms', 'Attention', 'Bacteriophages', 'Binding', 'Binding Sites', 'Biogenesis', 'Bioinformatics', 'Biological Assay', 'Biology', 'Class', 'Complement', 'Complex', 'Computer Analysis', 'DNA', 'Data', 'Data Analyses', 'Detection', 'Development', 'Diabetes Mellitus', 'Disease', 'Early identification', 'Electrophoretic Mobility Shift Assay', 'Escherichia coli', 'Evolution', 'Gene Amplification', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Goals', 'Immunity', 'In Vitro', 'Inflammation', 'Learning', 'Machine Learning', 'Malignant Neoplasms', 'Mating Types', 'Methods', 'Modeling', 'Mutation', 'Organism', 'Pathway interactions', 'Phylogenetic Analysis', 'Play', 'Probability', 'Protein Overexpression', 'Proteins', 'Regulatory Element', 'Regulon', 'Relative (related person)', 'Research', 'Research Personnel', 'Rest', 'Ribosomes', 'Role', 'Saccharomyces cerevisiae', 'Score', 'Sequence Analysis', 'Shock', 'Sigma Factor', 'Site', 'Source', 'Specificity', 'Symptoms', 'Testing', 'Work', 'base', 'beta-Galactosidase', 'chromatin immunoprecipitation', 'combinatorial', 'improved', 'in vivo', 'programs', 'promoter', 'research study', 'response', 'transcription factor']",NHGRI,"RUTGERS, THE STATE UNIV OF N.J.",R01,2008,294338,0.04638328134950756
"Locating Regulatory Elements in Genomes    DESCRIPTION (provided by applicant): Understanding regulatory networks controlling gene expression is one of the fundamental problems of modern biology. The proposed research focuses on the methods of locating regulatory elements in DNA. We have developed a new maximum likelihood method based on the physical DNA dependent binding probability of a transcription factor (TF) that correctly incorporates the protein concentration dependent saturation effect. The advantage of keeping the saturation effect is that the method automatically provides a score threshold for classifying candidate sites into binders and non-binders. Most conventional methods, based on the information score, merely provide a relative ordering of candidate sequences. The principled choice of a threshold is extremely useful for dealing with the highly variable sites typical of global regulatory factors. The simplest of our algorithms reduces to a one-class support vector machine. This classifier will be applied to detect large regulons in E. coli, as well as in phages, with special attention to targets of sigma factors. We also develop classifiers for regulatory targets that go beyond pure sequence analysis and combine it with information from additional sources, like microarray expression data or sequence similarity between phylogenetically closely related species. The proposed computational effort will be complemented by experiments verifying the predictions as well as providing in vitro and in vivo data needed to make predictions. Experimental efforts will involve a high throughput low stringency SELEX method applied to global transcriptional regulators from E. coli. It will also involve chromatin immunoprecipitation and beta- galactosidase assays performed in S. Cerevisiae that test the ability of bioinformatic algorithms to predict functionality of TF binding sites. A special feature of this proposal is the analysis of the effect of the rest of the promoter on the regulatory potential of a site. We apply the lessons learnt in simple organisms to the elucidation of distinctive specificity of different NFkB proteins involved in immunity, inflammation and cancer. Mutation, over-expression and amplification of genes encoding transcription factors play an important role in many diseases from diabetes to cancer. Understanding how a factor targets genes is crucial for discovering the pathways whose malfunction leads to the symptoms. This is an achievable goal, given the right way to analyze the plethora of genome-wide data available to us.           n/a",Locating Regulatory Elements in Genomes,7221303,R01HG003470,"['Affinity', 'Algorithms', 'Attention', 'Bacteriophages', 'Binding', 'Binding Sites', 'Biogenesis', 'Bioinformatics', 'Biological Assay', 'Biology', 'Class', 'Complement', 'Complex', 'Computer Analysis', 'DNA', 'Data', 'Data Analyses', 'Detection', 'Development', 'Diabetes Mellitus', 'Disease', 'Early identification', 'Electrophoretic Mobility Shift Assay', 'Escherichia coli', 'Evolution', 'Gene Amplification', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Goals', 'Immunity', 'In Vitro', 'Inflammation', 'Learning', 'Machine Learning', 'Malignant Neoplasms', 'Mating Types', 'Methods', 'Modeling', 'Mutation', 'Organism', 'Pathway interactions', 'Phylogenetic Analysis', 'Play', 'Probability', 'Protein Overexpression', 'Proteins', 'Regulatory Element', 'Regulon', 'Relative (related person)', 'Research', 'Research Personnel', 'Rest', 'Ribosomes', 'Role', 'Saccharomyces cerevisiae', 'Score', 'Sequence Analysis', 'Shock', 'Sigma Factor', 'Site', 'Source', 'Specificity', 'Symptoms', 'Testing', 'Work', 'base', 'beta-Galactosidase', 'chromatin immunoprecipitation', 'combinatorial', 'improved', 'in vivo', 'programs', 'promoter', 'research study', 'response', 'transcription factor']",NHGRI,RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,R01,2007,299796,0.04638328134950756
"Locating Regulatory Elements in Genomes    DESCRIPTION (provided by applicant): Understanding regulatory networks controlling gene expression is one of the fundamental problems of modern biology. The proposed research focuses on the methods of locating regulatory elements in DNA. We have developed a new maximum likelihood method based on the physical DNA dependent binding probability of a transcription factor (TF) that correctly incorporates the protein concentration dependent saturation effect. The advantage of keeping the saturation effect is that the method automatically provides a score threshold for classifying candidate sites into binders and non-binders. Most conventional methods, based on the information score, merely provide a relative ordering of candidate sequences. The principled choice of a threshold is extremely useful for dealing with the highly variable sites typical of global regulatory factors. The simplest of our algorithms reduces to a one-class support vector machine. This classifier will be applied to detect large regulons in E. coli, as well as in phages, with special attention to targets of sigma factors. We also develop classifiers for regulatory targets that go beyond pure sequence analysis and combine it with information from additional sources, like microarray expression data or sequence similarity between phylogenetically closely related species. The proposed computational effort will be complemented by experiments verifying the predictions as well as providing in vitro and in vivo data needed to make predictions. Experimental efforts will involve a high throughput low stringency SELEX method applied to global transcriptional regulators from E. coli. It will also involve chromatin immunoprecipitation and beta- galactosidase assays performed in S. Cerevisiae that test the ability of bioinformatic algorithms to predict functionality of TF binding sites. A special feature of this proposal is the analysis of the effect of the rest of the promoter on the regulatory potential of a site. We apply the lessons learnt in simple organisms to the elucidation of distinctive specificity of different NFkB proteins involved in immunity, inflammation and cancer. Mutation, over-expression and amplification of genes encoding transcription factors play an important role in many diseases from diabetes to cancer. Understanding how a factor targets genes is crucial for discovering the pathways whose malfunction leads to the symptoms. This is an achievable goal, given the right way to analyze the plethora of genome-wide data available to us.           n/a",Locating Regulatory Elements in Genomes,7096896,R01HG003470,"['DNA', 'binding sites', 'bioinformatics', 'gene expression', 'genes', 'genome', 'neoplasm /cancer', 'proteins', 'transcription factor']",NHGRI,RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,R01,2006,302050,0.04638328134950756
"Towards a cognitive framework for understanding cellular behavior Abstract Free-living cells display strong genome-wide transcriptional responses to changes in individual environmental parameters such as oxygen and temperature. Such transcriptional dynamics are thought to be the basis of a homeostatic response that attempts to reverse the immediate intracellular consequences resulting from the specific change in the environment. I present an alternative interpretation where transcriptional responses reflect a multifaceted behavioral program in response to global changes in the environment that are anticipated to follow the perturbation. This results from the fact that native microbial habitats are highly structured, giving rise to strong correlations between environmental parameters. Over geological timescales, such correlations can be internalized through an ""associative learning"" process that shapes the connectivity and dynamics of regulatory networks. Such internal models should allow microbes to predict the future trajectory of the environment based on immediate sensory information. We have seen evidence of this anticipatory behavior in responses of the bacterium Escherichia coli to changes in temperature and oxygen that correspond to transitions between the outside environment and the mammalian gastrointestinal tract. These internal representations seem to reflect a true associative learning paradigm, since they show plasticity upon exposure to novel environments. These phenomena increasingly demand that we interpret microbial behaviors from a cognitive perspective, much as we do for understanding animal behaviors. I propose a multi-faceted research program aimed at 1) establishing that these phenomena, indeed, represent cognitive modeling of microbial habitats, 2) revealing the underlying network mechanisms, and 3) exploring associative learning of novel environments through laboratory experimental evolution. The proposed work establishes deep connections between the disparate fields of microbial ecology, regulatory network evolution, and behavior. In so doing, it challenges the dominance of the century-old notion of homeostasis, with fundamental implications for how we understand and control microbial behavior, especially in the context of disease. n/a",Towards a cognitive framework for understanding cellular behavior,7555864,DP1OD003787,"['Acidity', 'Acids', 'Adaptive Behaviors', 'Address', 'Aerobic', 'Affect', 'Affinity', 'Amino Acid Sequence', 'Animal Behavior', 'Antibiotics', 'Architecture', 'Area', 'Arts', 'Association Learning', 'Award', 'Bacteria', 'Bacterial Genome', 'Bacteroides fragilis', 'Base Pairing', 'Basic Science', 'Beer', 'Behavior', 'Behavioral', 'Binding', 'Binding Sites', 'Biochemical', 'Biological Neural Networks', 'Biology', 'Blood', 'Carbon', 'Cell Respiration', 'Cells', 'Characteristics', 'Chemicals', 'Chemotaxis', 'Circadian Rhythms', 'Cognitive', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'Condition', 'Coupling', 'Cyanobacterium', 'Cytochromes', 'DNA-Protein Interaction', 'Data', 'Dependency', 'Depth', 'Dimensions', 'Discipline', 'Disease', 'Dreams', 'Drops', 'Ecology', 'Ecosystem', 'Employee Strikes', 'Engineering', 'Enterobacteriaceae', 'Enterococcus faecalis', 'Environment', 'Enzymes', 'Escherichia coli', 'Event', 'Evolution', 'Exposure to', 'Figs - dietary', 'Funding Mechanisms', 'Future', 'Gastrointestinal tract structure', 'Gene Expression', 'Generations', 'Genes', 'Genetic', 'Genets', 'Genome', 'Genomics', 'Global Change', 'Growth', 'Habitats', 'Hand', 'Head', 'Heat-Shock Response', 'Homeostasis', 'Homo', 'Human', 'Hybridization Array', 'Individual', 'Industry', 'Ingestion', 'Knowledge', 'Label', 'Laboratories', 'Lead', 'Learning', 'Life', 'Life Style', 'Logic', 'Lung', 'Machine Learning', 'Maps', 'Marines', 'Measurement', 'Measures', 'Mediating', 'Medicine', 'Metabolism', 'Methods', 'Microbe', 'Microbial Physiology', 'Microbiology', 'Modeling', 'Molecular', 'Monitor', 'Morbidity - disease rate', 'Movement', 'Mutation', 'Mutation Detection', 'Natural Selections', 'Nature', 'Nervous system structure', 'Neurons', 'New York', 'Nitrogen', 'Numbers', 'Nutrient', 'Nutritional', 'Oral cavity', 'Organism', 'Osmolar Concentration', 'Output', 'Oxidases', 'Oxygen', 'Pathogenesis', 'Pathway interactions', 'Peptide Sequence Determination', 'Perception', 'Phage Display', 'Phase', 'Phenotype', 'Photons', 'Physiologic pulse', 'Physiological', 'Play', 'Population', 'Predisposition', 'Preparation', 'Process', 'Proteins', 'Pseudomonas aeruginosa', 'Psychological Manipulation', 'Psychology', 'Pulse taking', 'Range', 'Rate', 'Recurrence', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Regulatory Pathway', 'Repression', 'Research', 'Research Activity', 'Research Infrastructure', 'Resistance', 'Resolution', 'Respiration', 'Respiratory System', 'Respiratory tract structure', 'Role', 'Rotation', 'Salts', 'Science', 'Second Messenger Systems', 'Sensory', 'Series', 'Shapes', 'Signal Transduction', 'Signaling Protein', 'Site', 'Source', 'Specificity', 'Speed', 'Standards of Weights and Measures', 'Statistical Models', 'Stimulus', 'Stomach', 'Stream', 'Stress', 'Structure', 'Surveys', 'Synaptic plasticity', 'System', 'Systems Biology', 'Technology', 'Temperature', 'Thinking', 'Time', 'Transcriptional Regulation', 'Variant', 'Vibrio cholerae', 'Work', 'Yeasts', 'abstracting', 'base', 'classical conditioning', 'cognitive neuroscience', 'combinatorial', 'cost', 'crosslink', 'cystic fibrosis patients', 'cytochrome c oxidase', 'day', 'density', 'design', 'electron donor', 'enteric pathogen', 'experience', 'fascinate', 'fitness', 'follow-up', 'genetic regulatory protein', 'genome-wide analysis', 'improved', 'in vivo', 'innovation', 'insight', 'interest', 'life history', 'microbial', 'microbial disease', 'mortality', 'mutant', 'novel', 'null mutation', 'predictive modeling', 'pressure', 'programs', 'quorum sensing', 'relating to nervous system', 'research study', 'respiratory', 'response', 'second messenger', 'sensor', 'technology development', 'transcription factor']",OD,PRINCETON UNIVERSITY,DP1,2008,805000,-0.014751359400217892
"KNOWLEDGE BASED BIOLOGICAL MODELING INFORMATION SYSTEM DESCRIPTION (Taken from the application abstract):  Gene expression              databases will take on growing importance as the complexities of development     and differentiation, and normal versus diseased states are studied in            greater detail.  Vast amounts of sequence data are now available for the         study of gene expression, along with an anticipated surge in high-throughput     data on differential gene expression.  Much of the key information remains       in the primary literature inaccessible for computational analysis.  The goal     of the proposed project is to provide in a single integrated system, the         information management, analysis, and visualization tools containing these       data sources.  Such a system requires the representation of gene expression      encompassing spatial, temporal and quantitative dimensions; the collection       and encoding of information from online resources and the primary                literature; the integration of analysis methodologies tailored to the study      of gene expression; and the availability of interfaces able to query and         visualize the data in human comprehensible form.  The prototype system,          EpoDB, focuses on erythropoiesis, but will generalize to the study of gene       expression along any pathway of differentiation.  This research will enhance     and extend the existing information management technology through                integration of a declarative constraint language into the representation         language, development of an integrity constraint system to facilitate            synchronization with external databases, and implementation of a query           language and optimizer.  Schemas and controlled vocabularies will be             tailored to represent DNA and chromosomal features relating to gene              regulation, temporal events describing expression levels during development      and differentiation, and descriptions of gene control processes, pathways        and networks.  The foundation for EpoDB will be extracted from online            resources (GenBank, TRANSFAC, MedLine, etc.), restructured and analyzed to       remove errors.  Data relevant to gene expression during erythropoiesis will      be entered from the literature by trained annotators.  Improved versions of      data entry editing tools will be developed to improve quality control, ease      of annotation, and allow annotation by external users through Web                interfaces.  Incorporated into EpoDB will also be results of data analysis       such as transcriptional regulatory patterns discovered by statistical            techniques, by pattern matching techniques, and by classification                hierarchies of genes and patterns.  EpoDB will be accessible through query       interfaces and visualization tools built for the WWW using the evolving          bioTk system.  Data and the system tools will be distributed on a regular        basis.                                                                            n/a",KNOWLEDGE BASED BIOLOGICAL MODELING INFORMATION SYSTEM,2797084,R01RR004026,"['artificial intelligence', ' cell differentiation', ' computer assisted sequence analysis', ' computer system design /evaluation', ' data collection methodology /evaluation', ' erythropoiesis', ' gene expression', ' genetic regulatory element', ' information retrieval', ' information system analysis', ' information systems', ' nucleic acid sequence', ' vocabulary development for information system']",NCRR,UNIVERSITY OF PENNSYLVANIA,R01,1998,375398,0.030110465113126855
"A Data Analysis Center for integration of fly and worm modENCODE datasets    DESCRIPTION (provided by applicant):  The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human. We foresee four central roles for the DAC, and have organized our aims around them. Aim 1: We will provide common computational guidelines for data processing in fly and worm, a common computational infrastructure and pipeline for common analysis and statistical tasks. Aim 2: We will facilitate and carry out element-specific integrative analyses to identify diverse classes of functional elements based on combinations of relevant datasets coming from multiple groups. This includes (a) enhancers, promoters, insulators, and other regions of regulatory importance, (b) protein-coding and non-coding genes, (c) regulatory networks of transcription factor and microRNA targeting, and (d) sequence features predictive of diverse classes of functional elements. Aim 3: We will carry out exploratory data analyses across different data types to discover potentially novel correlations and insights relating diverse classes of elements. In particular we will apply dimensionality reduction techniques to coordinate-based genome-wide genomic and epigenomic datasets, we will apply clustering and bi-clustering methods to identify functionally related sets of genes and modules, and we will analyze structural and dynamic properties of discovered networks. Aim 4: We will carry out comparative analyses across the two model organisms, and also with yeast and human. We will provide an ortholog resource between the species, compare regulatory relationships and dynamics for orthologous cell lines and developmental points, and carry over biological knowledge across model organisms and human. To achieve these four aims, we will work closely with members of the consortium, the modENCODE Analysis Working Group (AWG), consisting of all Principal Investigators and analysis groups, and the Data Coordination Center (DCC), responsible for all data sharing within the consortium and with the larger worm and fly communities.      PUBLIC HEALTH RELEVANCE:  The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human.           Narrative The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human.",A Data Analysis Center for integration of fly and worm modENCODE datasets,8327885,RC2HG005639,"['Animal Model', 'Animals', 'Beryllium', 'Binding', 'Biological', 'Biology', 'Biomedical Research', 'Boundary Elements', 'Caenorhabditis elegans', 'Cataloging', 'Catalogs', 'Cell Line', 'Chromatin', 'Code', 'Communities', 'DNA', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Elements', 'Embryonic Development', 'Enhancers', 'Functional RNA', 'Galaxy', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Guidelines', 'Health', 'Histones', 'Human', 'Human Genome', 'Hypersensitivity', 'Indium', 'Knowledge', 'Logic', 'Machine Learning', 'Measures', 'Messenger RNA', 'Methodology', 'Methods', 'MicroRNAs', 'Nucleic Acid Regulatory Sequences', 'Orthologous Gene', 'Polymerase', 'Post-Transcriptional Regulation', 'Principal Component Analysis', 'Principal Investigator', 'Property', 'Proteins', 'Reading', 'Recurrence', 'Regulatory Element', 'Replication Initiation', 'Research Infrastructure', 'Resolution', 'Resources', 'Role', 'Site', 'System', 'Techniques', 'Testing', 'Tissues', 'Transcriptional Regulation', 'Ursidae Family', 'Variant', 'Work', 'Yeasts', 'base', 'chromatin immunoprecipitation', 'combinatorial', 'comparative', 'computer infrastructure', 'computerized data processing', 'computerized tools', 'cost', 'data exchange', 'data integration', 'data modeling', 'data sharing', 'epigenomics', 'file format', 'fly', 'gene function', 'genome-wide', 'insight', 'markov model', 'member', 'next generation', 'novel', 'promoter', 'public health relevance', 'research study', 'sequence learning', 'task analysis', 'transcription factor', 'working group']",NHGRI,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,RC2,2011,1296550,0.09280475156490915
"A Data Analysis Center for integration of fly and worm modENCODE datasets    DESCRIPTION (provided by applicant):  The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human. We foresee four central roles for the DAC, and have organized our aims around them. Aim 1: We will provide common computational guidelines for data processing in fly and worm, a common computational infrastructure and pipeline for common analysis and statistical tasks. Aim 2: We will facilitate and carry out element-specific integrative analyses to identify diverse classes of functional elements based on combinations of relevant datasets coming from multiple groups. This includes (a) enhancers, promoters, insulators, and other regions of regulatory importance, (b) protein-coding and non-coding genes, (c) regulatory networks of transcription factor and microRNA targeting, and (d) sequence features predictive of diverse classes of functional elements. Aim 3: We will carry out exploratory data analyses across different data types to discover potentially novel correlations and insights relating diverse classes of elements. In particular we will apply dimensionality reduction techniques to coordinate-based genome-wide genomic and epigenomic datasets, we will apply clustering and bi-clustering methods to identify functionally related sets of genes and modules, and we will analyze structural and dynamic properties of discovered networks. Aim 4: We will carry out comparative analyses across the two model organisms, and also with yeast and human. We will provide an ortholog resource between the species, compare regulatory relationships and dynamics for orthologous cell lines and developmental points, and carry over biological knowledge across model organisms and human. To achieve these four aims, we will work closely with members of the consortium, the modENCODE Analysis Working Group (AWG), consisting of all Principal Investigators and analysis groups, and the Data Coordination Center (DCC), responsible for all data sharing within the consortium and with the larger worm and fly communities.      PUBLIC HEALTH RELEVANCE:  The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human.           Narrative The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human.",A Data Analysis Center for integration of fly and worm modENCODE datasets,7943875,RC2HG005639,"['Animal Model', 'Animals', 'Binding', 'Biological', 'Biology', 'Biomedical Research', 'Boundary Elements', 'Caenorhabditis elegans', 'Cataloging', 'Catalogs', 'Cell Line', 'Chromatin', 'Code', 'Communities', 'DNA', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Elements', 'Embryonic Development', 'Enhancers', 'Functional RNA', 'Galaxy', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Guidelines', 'Health', 'Histones', 'Human', 'Human Genome', 'Hypersensitivity', 'Indium', 'Knowledge', 'Logic', 'Machine Learning', 'Measures', 'Methodology', 'Methods', 'Nucleic Acid Regulatory Sequences', 'Orthologous Gene', 'Polymerase', 'Post-Transcriptional Regulation', 'Principal Component Analysis', 'Principal Investigator', 'Process', 'Property', 'Proteins', 'Reading', 'Recurrence', 'Regulation', 'Regulatory Element', 'Replication Initiation', 'Research Infrastructure', 'Resolution', 'Resources', 'Role', 'Site', 'System', 'Techniques', 'Testing', 'Tissues', 'Transcriptional Regulation', 'Ursidae Family', 'Variant', 'Work', 'Yeasts', 'base', 'chromatin immunoprecipitation', 'combinatorial', 'comparative', 'computer infrastructure', 'computerized data processing', 'computerized tools', 'cost', 'data exchange', 'data integration', 'data modeling', 'data sharing', 'epigenomics', 'file format', 'fly', 'gene function', 'genome-wide', 'insight', 'markov model', 'member', 'next generation', 'novel', 'promoter', 'public health relevance', 'research study', 'sequence learning', 'task analysis', 'transcription factor', 'working group']",NHGRI,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,RC2,2010,1316360,0.09280475156490915
"A Data Analysis Center for integration of fly and worm modENCODE datasets    DESCRIPTION (provided by applicant):  The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human. We foresee four central roles for the DAC, and have organized our aims around them. Aim 1: We will provide common computational guidelines for data processing in fly and worm, a common computational infrastructure and pipeline for common analysis and statistical tasks. Aim 2: We will facilitate and carry out element-specific integrative analyses to identify diverse classes of functional elements based on combinations of relevant datasets coming from multiple groups. This includes (a) enhancers, promoters, insulators, and other regions of regulatory importance, (b) protein-coding and non-coding genes, (c) regulatory networks of transcription factor and microRNA targeting, and (d) sequence features predictive of diverse classes of functional elements. Aim 3: We will carry out exploratory data analyses across different data types to discover potentially novel correlations and insights relating diverse classes of elements. In particular we will apply dimensionality reduction techniques to coordinate-based genome-wide genomic and epigenomic datasets, we will apply clustering and bi-clustering methods to identify functionally related sets of genes and modules, and we will analyze structural and dynamic properties of discovered networks. Aim 4: We will carry out comparative analyses across the two model organisms, and also with yeast and human. We will provide an ortholog resource between the species, compare regulatory relationships and dynamics for orthologous cell lines and developmental points, and carry over biological knowledge across model organisms and human. To achieve these four aims, we will work closely with members of the consortium, the modENCODE Analysis Working Group (AWG), consisting of all Principal Investigators and analysis groups, and the Data Coordination Center (DCC), responsible for all data sharing within the consortium and with the larger worm and fly communities.      PUBLIC HEALTH RELEVANCE:  The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human.           Narrative The aims of the ENCODE (Encyclopedia of DNA Elements) and modENCODE (model organism ENCODE) projects are to apply high-throughput, cost-efficient approaches to generate a catalog of functional elements in the human, worm, and fly genomes, which will serve as the basis for biomedical research advances. By their smaller genome size, powerful genetics, and ease of experimentation, D. melanogaster and C. elegans can help guide the study of functional elements in the human genome, reveal new insights into global gene regulation and embryo development, and enable experimental studies of gene function and regulation which are not accessible in mammalian systems. This proposal aims to enhance the value of these datasets by creating a Data Analysis Center (DAC) to support, facilitate, and enhance integrative analyses of the modENCODE consortium in fly and worm, to achieve a high-resolution annotation of all their functional elements, and to reveal new insights into the biology and gene regulation of animal genomes including the human.",A Data Analysis Center for integration of fly and worm modENCODE datasets,7854989,RC2HG005639,"['Animal Model', 'Animals', 'Binding', 'Biological', 'Biology', 'Biomedical Research', 'Boundary Elements', 'Caenorhabditis elegans', 'Cataloging', 'Catalogs', 'Cell Line', 'Chromatin', 'Classification', 'Code', 'Communities', 'DNA', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Elements', 'Embryonic Development', 'Enhancers', 'Functional RNA', 'Galaxy', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Guidelines', 'Health', 'Histones', 'Human', 'Human Genome', 'Hypersensitivity', 'Indium', 'Knowledge', 'Logic', 'Machine Learning', 'Measures', 'Methodology', 'Methods', 'Nucleic Acid Regulatory Sequences', 'Orthologous Gene', 'Polymerase', 'Post-Transcriptional Regulation', 'Principal Component Analysis', 'Principal Investigator', 'Process', 'Property', 'Proteins', 'Reading', 'Recurrence', 'Regulation', 'Regulatory Element', 'Replication Initiation', 'Research Infrastructure', 'Resolution', 'Resources', 'Role', 'Site', 'System', 'Techniques', 'Testing', 'Tissues', 'Transcriptional Regulation', 'Ursidae Family', 'Variant', 'Work', 'Yeasts', 'base', 'chromatin immunoprecipitation', 'combinatorial', 'comparative', 'computer infrastructure', 'computerized data processing', 'computerized tools', 'cost', 'data exchange', 'data integration', 'data modeling', 'data sharing', 'epigenomics', 'file format', 'fly', 'gene function', 'genome-wide', 'insight', 'markov model', 'member', 'next generation', 'novel', 'promoter', 'public health relevance', 'research study', 'sequence learning', 'task analysis', 'transcription factor', 'working group']",NHGRI,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,RC2,2009,1473507,0.09280475156490915
"Predict transcriptional enhancers using epigenetic signatures    DESCRIPTION (provided by applicant): Activation of eukaryotic gene transcription involves the coordination of a multitude of transcription factors and cofactors on regulatory DNA sequences such as promoters and enhancers and on the chromatin structure containing these elements. Therefore, identification of these regulatory DNA elements is of utmost importance for understanding gene regulation in both healthy and diseased cells. Previous studies have demonstrated many characteristic epigenetic modifications occur at regulatory DNA elements, e.g., high levels of histone acetylation at gene promoters and at many enhancers. In addition, it is known that many regulatory elements carry these epigenetic modifications only in specific cell/tissue types or according to environmental conditions. In recent years, a vast amount of genome-wide histone modification data has been generated using chromatin immunoprecipitation coupled with microarray chip (ChIP-chip) or with next-generation sequencing technologies (ChIP-Seq). Currently, there is a pressing need for computational methods to analyze genome-wide histone modification data in order to identify functional DNA elements.  The goal of the proposed research is to develop a novel computational method to identify transcriptional regulatory elements on the basis of their epigenetic characteristics. In the field of machine learning, it is well established that meaningful statistical features extracted from raw data can elude more relevant information and increase the prediction accuracy of a classifier. We hypothesize that by introducing efficient data transformation and feature extraction procedures before classification, we can increase the overall prediction accuracy of our method for identifying transcriptional regulatory elements. We propose to test the aforementioned hypothesis by pursuing the following three aims: (1) We will adopt well-established measures from signal processing to design and test a set of statistical features that could give us a better representation of signals in histone modification data. (2) We will evaluate the performance of several commonly used statistical classifiers in predicting enhancers. We will then develop a software tool combining the most informative features from Aim 1 with the optimal classifier. (3) We will apply our computational method to predict novel enhancers in mouse embryonic stem cell and human T cell using genome-wide histone modification maps in these two cell types. We will use both computational and experimental approaches to evaluate the accuracy of our predictions. Although in this project we focus on enhancers, the approach we develop can be readily extended to discover other types of functional DNA elements using histone modification data in different organisms and cell types. )      PUBLIC HEALTH RELEVANCE: Transcriptional enhancers play an essential role in establishing tissue and developmental stage specific gene expression patterns that are essential for understanding development, cellular responses to environmental and genetic perturbations as well as the molecular basis of many diseases. The proposed research will lead to the development of a novel computational tool to discover enhancer elements using genome-wide chromatin signatures. Successful completion of the project will also uncover novel enhancers in two biomedically important cell types, embryonic stem cell and T lymphocyte, which could generate new insights into the regulatory networks controlling stem cell phenotype and T cell development and activation.              Narrative: Transcriptional enhancers play an essential role in establishing tissue and developmental stage specific gene expression patterns that are essential for understanding development, cellular responses to environmental and genetic perturbations as well as the molecular basis of many diseases. The proposed research will lead to the development of a novel computational tool to discover enhancer elements using genome-wide chromatin signatures. Successful completion of the project will also uncover novel enhancers in two biomedically important cell types, embryonic stem cell and T lymphocyte, which could generate new insights into the regulatory networks controlling stem cell phenotype and T cell development and activation.",Predict transcriptional enhancers using epigenetic signatures,8079671,R21HG005948,"['Adopted', 'Beryllium', 'CD4 Positive T Lymphocytes', 'Cells', 'Characteristics', 'Chromatin', 'Chromatin Structure', 'Classification', 'Computer software', 'Computing Methodologies', 'Coupled', 'DNA', 'DNA Sequence', 'DNA Sequence Analysis', 'Data', 'Data Analyses', 'Development', 'Disease', 'Elements', 'Enhancers', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Enhancer Element', 'Genetic Transcription', 'Goals', 'Histocompatibility Testing', 'Histone Acetylation', 'Lead', 'Machine Learning', 'Maps', 'Measures', 'Methods', 'Modification', 'Molecular', 'Mus', 'Organism', 'Pattern', 'Performance', 'Phenotype', 'Play', 'Procedures', 'Publishing', 'Regulator Genes', 'Regulatory Element', 'Research', 'Role', 'Signal Transduction', 'Software Tools', 'Staging', 'Stem cells', 'T-Cell Development', 'T-Lymphocyte', 'Technology', 'Testing', 'Tissues', 'Training', 'Untranslated RNA', 'base', 'cell type', 'cellular development', 'chromatin immunoprecipitation', 'chromatin modification', 'cofactor', 'computerized data processing', 'computerized tools', 'design', 'embryonic stem cell', 'genome-wide', 'histone modification', 'human embryonic stem cell', 'insight', 'next generation', 'novel', 'promoter', 'public health relevance', 'response', 'transcription factor']",NHGRI,UNIVERSITY OF IOWA,R21,2011,150000,0.08757715310799422
"Predict transcriptional enhancers using epigenetic signatures    DESCRIPTION (provided by applicant): Activation of eukaryotic gene transcription involves the coordination of a multitude of transcription factors and cofactors on regulatory DNA sequences such as promoters and enhancers and on the chromatin structure containing these elements. Therefore, identification of these regulatory DNA elements is of utmost importance for understanding gene regulation in both healthy and diseased cells. Previous studies have demonstrated many characteristic epigenetic modifications occur at regulatory DNA elements, e.g., high levels of histone acetylation at gene promoters and at many enhancers. In addition, it is known that many regulatory elements carry these epigenetic modifications only in specific cell/tissue types or according to environmental conditions. In recent years, a vast amount of genome-wide histone modification data has been generated using chromatin immunoprecipitation coupled with microarray chip (ChIP-chip) or with next-generation sequencing technologies (ChIP-Seq). Currently, there is a pressing need for computational methods to analyze genome-wide histone modification data in order to identify functional DNA elements.  The goal of the proposed research is to develop a novel computational method to identify transcriptional regulatory elements on the basis of their epigenetic characteristics. In the field of machine learning, it is well established that meaningful statistical features extracted from raw data can elude more relevant information and increase the prediction accuracy of a classifier. We hypothesize that by introducing efficient data transformation and feature extraction procedures before classification, we can increase the overall prediction accuracy of our method for identifying transcriptional regulatory elements. We propose to test the aforementioned hypothesis by pursuing the following three aims: (1) We will adopt well-established measures from signal processing to design and test a set of statistical features that could give us a better representation of signals in histone modification data. (2) We will evaluate the performance of several commonly used statistical classifiers in predicting enhancers. We will then develop a software tool combining the most informative features from Aim 1 with the optimal classifier. (3) We will apply our computational method to predict novel enhancers in mouse embryonic stem cell and human T cell using genome-wide histone modification maps in these two cell types. We will use both computational and experimental approaches to evaluate the accuracy of our predictions. Although in this project we focus on enhancers, the approach we develop can be readily extended to discover other types of functional DNA elements using histone modification data in different organisms and cell types. )      PUBLIC HEALTH RELEVANCE: Transcriptional enhancers play an essential role in establishing tissue and developmental stage specific gene expression patterns that are essential for understanding development, cellular responses to environmental and genetic perturbations as well as the molecular basis of many diseases. The proposed research will lead to the development of a novel computational tool to discover enhancer elements using genome-wide chromatin signatures. Successful completion of the project will also uncover novel enhancers in two biomedically important cell types, embryonic stem cell and T lymphocyte, which could generate new insights into the regulatory networks controlling stem cell phenotype and T cell development and activation.              Narrative: Transcriptional enhancers play an essential role in establishing tissue and developmental stage specific gene expression patterns that are essential for understanding development, cellular responses to environmental and genetic perturbations as well as the molecular basis of many diseases. The proposed research will lead to the development of a novel computational tool to discover enhancer elements using genome-wide chromatin signatures. Successful completion of the project will also uncover novel enhancers in two biomedically important cell types, embryonic stem cell and T lymphocyte, which could generate new insights into the regulatory networks controlling stem cell phenotype and T cell development and activation.",Predict transcriptional enhancers using epigenetic signatures,7872279,R21HG005948,"['Adopted', 'Be++ element', 'Beryllium', 'CD4 Positive T Lymphocytes', 'Cells', 'Characteristics', 'Chromatin', 'Chromatin Structure', 'Classification', 'Computer software', 'Computing Methodologies', 'Coupled', 'DNA', 'DNA Sequence', 'DNA Sequence Analysis', 'Data', 'Data Analyses', 'Development', 'Disease', 'Elements', 'Enhancers', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Enhancer Element', 'Genetic Transcription', 'Goals', 'Histocompatibility Testing', 'Histone Acetylation', 'Lead', 'Machine Learning', 'Maps', 'Measures', 'Methods', 'Modification', 'Molecular', 'Mus', 'Organism', 'Pattern', 'Performance', 'Phenotype', 'Play', 'Procedures', 'Publishing', 'Regulator Genes', 'Regulatory Element', 'Research', 'Role', 'Signal Transduction', 'Software Tools', 'Staging', 'Stem cells', 'T-Cell Development', 'T-Lymphocyte', 'Technology', 'Testing', 'Tissues', 'Training', 'Untranslated RNA', 'base', 'cell type', 'cellular development', 'chromatin immunoprecipitation', 'chromatin modification', 'cofactor', 'computerized data processing', 'computerized tools', 'design', 'embryonic stem cell', 'genome-wide', 'histone modification', 'human embryonic stem cell', 'insight', 'next generation', 'novel', 'promoter', 'public health relevance', 'response', 'transcription factor']",NHGRI,UNIVERSITY OF IOWA,R21,2010,262500,0.08757715310799422
"Functional activity and inter-organismal interactions in the human microbiome    DESCRIPTION (provided by applicant): High-throughput sequencing has provided a tool capable of observing the human microbiome, but characterizing the biological roles and metabolic potential of these microbial communities remains a significant challenge. Increasing evidence points to the functional activity of gene products, rather than community taxonomic composition, as the most robust descriptor of the microflora's relationship with its host and as a potential point of intervention in modulating human health. Existing computational tools for exploring a newly sequenced metagenome rely heavily on sequence homology and do not yet leverage information from the thousands of publicly available functional experimental results. Likewise, no previous methods have provided genome-scale computational tools for biological hypothesis generation regarding specific molecular interactions among the microflora and with a human host. This proposal aims to develop computational methodology to interpret the functional activity of microfloral communities: 1. Integrate functional information from taxonomic, metagenomic, and metatranscriptomic datasets. We will develop methodology to unify these three representations of microbiome composition by incorporating  information from large scale functional genomic data collections. 2. Identify genomic predictors of inter-species functional activity, including host/microflora interactions and points of community-wide regulatory feedback. We will computationally screen microbiome assays for molecular interactions and regulatory motifs spanning multiple organisms in the community. 3. Implement these technologies as publicly available, accessible, and interpretable tools. We will provide freely available, open source, downloadable and web-based implementations of this methodology for use  by the bioinformatic and biological communities. As high-throughput sequencing becomes more widely used to study microbial communities in the human microbiome and in the environment, computational tools will be necessary to summarize their global functional activity and systems-level regulatory interactions. In the long term, by providing methodology to understand the human microbiome at the molecular level, we hope to enable its future use as a diagnostic indicator and as a point of intervention to improve human health.      PUBLIC HEALTH RELEVANCE: DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.              2 Project Narrative DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.",Functional activity and inter-organismal interactions in the human microbiome,8310258,R01HG005969,"['Behavior', 'Binding', 'Bioinformatics', 'Biological', 'Biological Assay', 'Cells', 'Communities', 'Complement', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Data', 'Data Collection', 'Data Set', 'Databases', 'Descriptor', 'Diagnostic', 'Disease', 'Environment', 'Feedback', 'Future', 'Gene Expression', 'Generations', 'Genes', 'Genome', 'Genomics', 'Health', 'Human', 'Human Microbiome', 'Human body', 'Individual', 'Internet', 'Intervention', 'Machine Learning', 'Maps', 'Mentors', 'Metabolic', 'Metagenomics', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Online Systems', 'Organism', 'Pathway Analysis', 'Pathway interactions', 'Process', 'Proteins', 'Recombinant DNA', 'Research Personnel', 'Resources', 'Role', 'Sequence Homology', 'Signaling Molecule', 'System', 'Systems Biology', 'Taxon', 'Techniques', 'Technology', 'Testing', 'Tissues', 'base', 'computerized tools', 'functional genomics', 'improved', 'member', 'metagenome', 'metagenomic sequencing', 'microbial', 'microbial community', 'microbiome', 'microorganism', 'novel', 'open source', 'public health relevance', 'repository', 'tool', 'transcriptomics']",NHGRI,HARVARD SCHOOL OF PUBLIC HEALTH,R01,2012,367520,0.018712741222674027
"Functional activity and inter-organismal interactions in the human microbiome    DESCRIPTION (provided by applicant): High-throughput sequencing has provided a tool capable of observing the human microbiome, but characterizing the biological roles and metabolic potential of these microbial communities remains a significant challenge. Increasing evidence points to the functional activity of gene products, rather than community taxonomic composition, as the most robust descriptor of the microflora's relationship with its host and as a potential point of intervention in modulating human health. Existing computational tools for exploring a newly sequenced metagenome rely heavily on sequence homology and do not yet leverage information from the thousands of publicly available functional experimental results. Likewise, no previous methods have provided genome-scale computational tools for biological hypothesis generation regarding specific molecular interactions among the microflora and with a human host. This proposal aims to develop computational methodology to interpret the functional activity of microfloral communities: 1. Integrate functional information from taxonomic, metagenomic, and metatranscriptomic datasets. We will develop methodology to unify these three representations of microbiome composition by incorporating  information from large scale functional genomic data collections. 2. Identify genomic predictors of inter-species functional activity, including host/microflora interactions and points of community-wide regulatory feedback. We will computationally screen microbiome assays for molecular interactions and regulatory motifs spanning multiple organisms in the community. 3. Implement these technologies as publicly available, accessible, and interpretable tools. We will provide freely available, open source, downloadable and web-based implementations of this methodology for use  by the bioinformatic and biological communities. As high-throughput sequencing becomes more widely used to study microbial communities in the human microbiome and in the environment, computational tools will be necessary to summarize their global functional activity and systems-level regulatory interactions. In the long term, by providing methodology to understand the human microbiome at the molecular level, we hope to enable its future use as a diagnostic indicator and as a point of intervention to improve human health.      PUBLIC HEALTH RELEVANCE: DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.              2 Project Narrative DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.",Functional activity and inter-organismal interactions in the human microbiome,8537085,R01HG005969,"['Behavior', 'Binding', 'Bioinformatics', 'Biological', 'Biological Assay', 'Cells', 'Communities', 'Complement', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Data', 'Data Collection', 'Data Set', 'Databases', 'Descriptor', 'Diagnostic', 'Disease', 'Environment', 'Feedback', 'Future', 'Gene Expression', 'Generations', 'Genes', 'Genome', 'Genomics', 'Health', 'Human', 'Human Microbiome', 'Human body', 'Individual', 'Internet', 'Intervention', 'Machine Learning', 'Maps', 'Mentors', 'Metabolic', 'Metagenomics', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Online Systems', 'Organism', 'Pathway Analysis', 'Pathway interactions', 'Process', 'Proteins', 'Recombinant DNA', 'Research Personnel', 'Resources', 'Role', 'Sequence Homology', 'Signaling Molecule', 'System', 'Systems Biology', 'Taxon', 'Techniques', 'Technology', 'Testing', 'Tissues', 'base', 'computerized tools', 'functional genomics', 'improved', 'member', 'metagenome', 'metagenomic sequencing', 'microbial', 'microbial community', 'microbiome', 'microorganism', 'novel', 'open source', 'public health relevance', 'repository', 'tool', 'transcriptomics']",NHGRI,HARVARD SCHOOL OF PUBLIC HEALTH,R01,2012,139853,0.018712741222674027
"Functional activity and inter-organismal interactions in the human microbiome    DESCRIPTION (provided by applicant): High-throughput sequencing has provided a tool capable of observing the human microbiome, but characterizing the biological roles and metabolic potential of these microbial communities remains a significant challenge. Increasing evidence points to the functional activity of gene products, rather than community taxonomic composition, as the most robust descriptor of the microflora's relationship with its host and as a potential point of intervention in modulating human health. Existing computational tools for exploring a newly sequenced metagenome rely heavily on sequence homology and do not yet leverage information from the thousands of publicly available functional experimental results. Likewise, no previous methods have provided genome-scale computational tools for biological hypothesis generation regarding specific molecular interactions among the microflora and with a human host. This proposal aims to develop computational methodology to interpret the functional activity of microfloral communities: 1. Integrate functional information from taxonomic, metagenomic, and metatranscriptomic datasets. We will develop methodology to unify these three representations of microbiome composition by incorporating  information from large scale functional genomic data collections. 2. Identify genomic predictors of inter-species functional activity, including host/microflora interactions and points of community-wide regulatory feedback. We will computationally screen microbiome assays for molecular interactions and regulatory motifs spanning multiple organisms in the community. 3. Implement these technologies as publicly available, accessible, and interpretable tools. We will provide freely available, open source, downloadable and web-based implementations of this methodology for use  by the bioinformatic and biological communities. As high-throughput sequencing becomes more widely used to study microbial communities in the human microbiome and in the environment, computational tools will be necessary to summarize their global functional activity and systems-level regulatory interactions. In the long term, by providing methodology to understand the human microbiome at the molecular level, we hope to enable its future use as a diagnostic indicator and as a point of intervention to improve human health.      PUBLIC HEALTH RELEVANCE: DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.              2 Project Narrative DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.",Functional activity and inter-organismal interactions in the human microbiome,8150462,R01HG005969,"['Behavior', 'Binding', 'Bioinformatics', 'Biological', 'Biological Assay', 'Cells', 'Communities', 'Complement', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Data', 'Data Collection', 'Data Set', 'Databases', 'Descriptor', 'Diagnostic', 'Disease', 'Environment', 'Feedback', 'Future', 'Gene Expression', 'Generations', 'Genes', 'Genome', 'Genomics', 'Health', 'Human', 'Human Microbiome', 'Human body', 'Individual', 'Internet', 'Intervention', 'Machine Learning', 'Maps', 'Mentors', 'Metabolic', 'Metagenomics', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Online Systems', 'Organism', 'Pathway Analysis', 'Pathway interactions', 'Process', 'Proteins', 'Recombinant DNA', 'Research Personnel', 'Resources', 'Role', 'Sequence Homology', 'Signaling Molecule', 'System', 'Systems Biology', 'Taxon', 'Techniques', 'Technology', 'Testing', 'Tissues', 'base', 'computerized tools', 'functional genomics', 'improved', 'member', 'metagenomic sequencing', 'microbial', 'microbial community', 'microbiome', 'microorganism', 'novel', 'open source', 'public health relevance', 'repository', 'tool', 'transcriptomics']",NHGRI,HARVARD SCHOOL OF PUBLIC HEALTH,R01,2011,407746,0.018712741222674027
"Functional activity and inter-organismal interactions in the human microbiome    DESCRIPTION (provided by applicant): High-throughput sequencing has provided a tool capable of observing the human microbiome, but characterizing the biological roles and metabolic potential of these microbial communities remains a significant challenge. Increasing evidence points to the functional activity of gene products, rather than community taxonomic composition, as the most robust descriptor of the microflora's relationship with its host and as a potential point of intervention in modulating human health. Existing computational tools for exploring a newly sequenced metagenome rely heavily on sequence homology and do not yet leverage information from the thousands of publicly available functional experimental results. Likewise, no previous methods have provided genome-scale computational tools for biological hypothesis generation regarding specific molecular interactions among the microflora and with a human host. This proposal aims to develop computational methodology to interpret the functional activity of microfloral communities: 1. Integrate functional information from taxonomic, metagenomic, and metatranscriptomic datasets. We will develop methodology to unify these three representations of microbiome composition by incorporating  information from large scale functional genomic data collections. 2. Identify genomic predictors of inter-species functional activity, including host/microflora interactions and points of community-wide regulatory feedback. We will computationally screen microbiome assays for molecular interactions and regulatory motifs spanning multiple organisms in the community. 3. Implement these technologies as publicly available, accessible, and interpretable tools. We will provide freely available, open source, downloadable and web-based implementations of this methodology for use  by the bioinformatic and biological communities. As high-throughput sequencing becomes more widely used to study microbial communities in the human microbiome and in the environment, computational tools will be necessary to summarize their global functional activity and systems-level regulatory interactions. In the long term, by providing methodology to understand the human microbiome at the molecular level, we hope to enable its future use as a diagnostic indicator and as a point of intervention to improve human health.      PUBLIC HEALTH RELEVANCE: DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.              2 Project Narrative DNA sequencing technology has recently allowed us to examine the microorganisms naturally residing in and on the human body, many of which are beneficial and some of which can be harmful. Although we can now gather data on the cellular behavior of these microbes and on their interactions with human beings, computational tools are needed to interpret this information. By developing new software to study these communities of microorganisms, we hope to eventually be able to detect when they may be causing disease and modify their composition to improve human health.",Functional activity and inter-organismal interactions in the human microbiome,8020799,R01HG005969,"['Behavior', 'Binding', 'Bioinformatics', 'Biological', 'Biological Assay', 'Cells', 'Communities', 'Complement', 'Computer software', 'Computing Methodologies', 'DNA Sequence', 'Data', 'Data Collection', 'Data Set', 'Databases', 'Descriptor', 'Diagnostic', 'Disease', 'Environment', 'Feedback', 'Future', 'Gene Expression', 'Generations', 'Genes', 'Genome', 'Genomics', 'Health', 'Human', 'Human Microbiome', 'Human body', 'Individual', 'Internet', 'Intervention', 'Machine Learning', 'Maps', 'Mentors', 'Metabolic', 'Metagenomics', 'Methodology', 'Methods', 'Microbe', 'Modeling', 'Molecular', 'Online Systems', 'Organism', 'Pathway Analysis', 'Pathway interactions', 'Process', 'Proteins', 'Recombinant DNA', 'Research Personnel', 'Resources', 'Role', 'Sequence Homology', 'Signaling Molecule', 'System', 'Systems Biology', 'Taxon', 'Techniques', 'Technology', 'Testing', 'Tissues', 'base', 'computerized tools', 'functional genomics', 'improved', 'member', 'metagenomic sequencing', 'microbial', 'microbial community', 'microbiome', 'microorganism', 'novel', 'open source', 'public health relevance', 'repository', 'tool', 'transcriptomics']",NHGRI,HARVARD SCHOOL OF PUBLIC HEALTH,R01,2010,408559,0.018712741222674027
"Integrative analysis tools to dissect cell-type specific transcriptional programs DESCRIPTION (provided by applicant): How cell-type specific gene expression programs are established and maintained is a fundamental question in molecular biology. In mammalian cells, hundreds of sequence-specific transcription factors have been catalogued, and they bind the regulatory regions of their target genes in cell-type specific and combinatorial occupancy patterns. Moreover, the developmental programs that generate different cell lineages are accompanied by complex chromatin remodeling. Increasing evidence suggests that the regulatory regions of cell-type specific genes may often be established and sometimes ""poised"" by chromatin marks at earlier stages in development. However, the detailed characterization of gene regulatory regions-including their initial establishment in earlier progenitor cells, the dynamics of their chromatin state, and the combinatorial control of gene transcriptional output by multiple transcription factors-has only been studied for a handful of developmentally important genes.  The goal of this project is to develop new integrative computational methods that exploit massive next- generation sequencing data sets to fundamentally advance our understanding of cell-type specific transcriptional programs. We will develop integrative computational analysis methods for (1) learning the sequence and chromatin determinants of transcription factor binding from ChIP-seq and DNase-seq; (2) mapping the landscape of chromatin accessibility of all regulatory regions in the human and mouse genomes using DNase-seq across all available cell types, dissecting the poising of their chromatin state in earlier progenitor cells, and extracting the sequence code governing their gain and loss in differentiation; and (3) modeling cell-type specific gene expression programs as a function of chromatin state, transcription factor binding, and regulatory sequence analysis. We will couple our computational methods development with targeted experimental validation, including both locus-specific and genome-wide assays. Understanding gene regulation is fundamental to the study of normal cellular processes as well as disease. In this project, we develop computational methods to exploit multiple sources of large-scale genomics data enabled by next-generation sequencing technology in order to provide new tools for studying gene regulation in mammalian cells.",Integrative analysis tools to dissect cell-type specific transcriptional programs,8628862,R01HG006798,"['Algorithms', 'Binding', 'Binding Sites', 'Biological Assay', 'Case Study', 'Cataloging', 'Catalogs', 'Cell Extracts', 'Cell Line', 'Cell Lineage', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Remodeling Factor', 'Code', 'Computer Analysis', 'Computer Simulation', 'Computing Methodologies', 'DNA', 'DNA Methylation', 'DNA Sequence', 'Data', 'Data Set', 'Deoxyribonucleases', 'Development', 'Disease', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Transcription', 'Genomics', 'Goals', 'Hematopoietic', 'Histocompatibility Testing', 'Histones', 'Human', 'Human Genome', 'Lasso', 'Learning', 'Libraries', 'Machine Learning', 'Mammalian Cell', 'Maps', 'Methods', 'Methylation', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Profiling', 'Mus', 'Nucleic Acid Regulatory Sequences', 'Output', 'Pattern', 'Reading', 'Relative (related person)', 'Role', 'Sequence Analysis', 'Site', 'Source', 'Staging', 'Stem cells', 'Technology', 'Tissues', 'Training', 'Validation', 'Work', 'base', 'bisulfite', 'cell type', 'combinatorial', 'computerized tools', 'data modeling', 'epigenomics', 'genome-wide', 'histone modification', 'improved', 'method development', 'mouse genome', 'multitask', 'next generation sequencing', 'preference', 'programs', 'promoter', 'repository', 'role model', 'sequence learning', 'tool', 'transcription factor', 'transcriptome sequencing', 'transcriptomics']",NHGRI,SLOAN-KETTERING INST CAN RESEARCH,R01,2014,520701,0.09801572843210504
"Integrative analysis tools to dissect cell-type specific transcriptional programs DESCRIPTION (provided by applicant): How cell-type specific gene expression programs are established and maintained is a fundamental question in molecular biology. In mammalian cells, hundreds of sequence-specific transcription factors have been catalogued, and they bind the regulatory regions of their target genes in cell-type specific and combinatorial occupancy patterns. Moreover, the developmental programs that generate different cell lineages are accompanied by complex chromatin remodeling. Increasing evidence suggests that the regulatory regions of cell-type specific genes may often be established and sometimes ""poised"" by chromatin marks at earlier stages in development. However, the detailed characterization of gene regulatory regions-including their initial establishment in earlier progenitor cells, the dynamics of their chromatin state, and the combinatorial control of gene transcriptional output by multiple transcription factors-has only been studied for a handful of developmentally important genes.  The goal of this project is to develop new integrative computational methods that exploit massive next- generation sequencing data sets to fundamentally advance our understanding of cell-type specific transcriptional programs. We will develop integrative computational analysis methods for (1) learning the sequence and chromatin determinants of transcription factor binding from ChIP-seq and DNase-seq; (2) mapping the landscape of chromatin accessibility of all regulatory regions in the human and mouse genomes using DNase-seq across all available cell types, dissecting the poising of their chromatin state in earlier progenitor cells, and extracting the sequence code governing their gain and loss in differentiation; and (3) modeling cell-type specific gene expression programs as a function of chromatin state, transcription factor binding, and regulatory sequence analysis. We will couple our computational methods development with targeted experimental validation, including both locus-specific and genome-wide assays. Understanding gene regulation is fundamental to the study of normal cellular processes as well as disease. In this project, we develop computational methods to exploit multiple sources of large-scale genomics data enabled by next-generation sequencing technology in order to provide new tools for studying gene regulation in mammalian cells.",Integrative analysis tools to dissect cell-type specific transcriptional programs,8463019,R01HG006798,"['Algorithms', 'Binding', 'Binding Sites', 'Biological Assay', 'Case Study', 'Cataloging', 'Catalogs', 'Cell Extracts', 'Cell Line', 'Cell Lineage', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Remodeling Factor', 'Code', 'Computer Analysis', 'Computer Simulation', 'Computing Methodologies', 'DNA', 'DNA Methylation', 'DNA Sequence', 'Data', 'Data Set', 'Deoxyribonucleases', 'Development', 'Disease', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Transcription', 'Genomics', 'Goals', 'Hematopoietic', 'Histocompatibility Testing', 'Histones', 'Human', 'Human Genome', 'Lasso', 'Learning', 'Libraries', 'Machine Learning', 'Mammalian Cell', 'Maps', 'Methods', 'Methylation', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Profiling', 'Mus', 'Nucleic Acid Regulatory Sequences', 'Output', 'Pattern', 'Reading', 'Relative (related person)', 'Role', 'Sequence Analysis', 'Site', 'Source', 'Staging', 'Stem cells', 'Technology', 'Tissues', 'Training', 'Validation', 'Work', 'base', 'bisulfite', 'cell type', 'combinatorial', 'computerized tools', 'data modeling', 'epigenomics', 'genome-wide', 'histone modification', 'improved', 'method development', 'mouse genome', 'multitask', 'next generation sequencing', 'preference', 'programs', 'promoter', 'repository', 'role model', 'sequence learning', 'tool', 'transcription factor', 'transcriptome sequencing', 'transcriptomics']",NHGRI,SLOAN-KETTERING INST CAN RESEARCH,R01,2013,493524,0.09801572843210504
"Integrative analysis tools to dissect cell-type specific transcriptional programs DESCRIPTION (provided by applicant): How cell-type specific gene expression programs are established and maintained is a fundamental question in molecular biology. In mammalian cells, hundreds of sequence-specific transcription factors have been catalogued, and they bind the regulatory regions of their target genes in cell-type specific and combinatorial occupancy patterns. Moreover, the developmental programs that generate different cell lineages are accompanied by complex chromatin remodeling. Increasing evidence suggests that the regulatory regions of cell-type specific genes may often be established and sometimes ""poised"" by chromatin marks at earlier stages in development. However, the detailed characterization of gene regulatory regions-including their initial establishment in earlier progenitor cells, the dynamics of their chromatin state, and the combinatorial control of gene transcriptional output by multiple transcription factors-has only been studied for a handful of developmentally important genes.  The goal of this project is to develop new integrative computational methods that exploit massive next- generation sequencing data sets to fundamentally advance our understanding of cell-type specific transcriptional programs. We will develop integrative computational analysis methods for (1) learning the sequence and chromatin determinants of transcription factor binding from ChIP-seq and DNase-seq; (2) mapping the landscape of chromatin accessibility of all regulatory regions in the human and mouse genomes using DNase-seq across all available cell types, dissecting the poising of their chromatin state in earlier progenitor cells, and extracting the sequence code governing their gain and loss in differentiation; and (3) modeling cell-type specific gene expression programs as a function of chromatin state, transcription factor binding, and regulatory sequence analysis. We will couple our computational methods development with targeted experimental validation, including both locus-specific and genome-wide assays. Understanding gene regulation is fundamental to the study of normal cellular processes as well as disease. In this project, we develop computational methods to exploit multiple sources of large-scale genomics data enabled by next-generation sequencing technology in order to provide new tools for studying gene regulation in mammalian cells.",Integrative analysis tools to dissect cell-type specific transcriptional programs,8311335,R01HG006798,"['Algorithms', 'Binding', 'Binding Sites', 'Biological Assay', 'Case Study', 'Cataloging', 'Catalogs', 'Cell Extracts', 'Cell Line', 'Cell Lineage', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Remodeling Factor', 'Code', 'Computer Analysis', 'Computer Simulation', 'Computing Methodologies', 'DNA', 'DNA Methylation', 'DNA Sequence', 'Data', 'Data Set', 'Deoxyribonucleases', 'Development', 'Disease', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Transcription', 'Genomics', 'Goals', 'Hematopoietic', 'Histocompatibility Testing', 'Histones', 'Human', 'Human Genome', 'Lasso', 'Learning', 'Libraries', 'Machine Learning', 'Mammalian Cell', 'Maps', 'Methods', 'Methylation', 'MicroRNAs', 'Modeling', 'Molecular Biology', 'Molecular Profiling', 'Mus', 'Nucleic Acid Regulatory Sequences', 'Output', 'Pattern', 'RNA', 'Reading', 'Relative (related person)', 'Role', 'Sequence Analysis', 'Site', 'Source', 'Staging', 'Stem cells', 'Technology', 'Tissues', 'Training', 'Validation', 'Work', 'base', 'bisulfite', 'cell type', 'combinatorial', 'computerized tools', 'data modeling', 'epigenomics', 'genome-wide', 'histone modification', 'improved', 'method development', 'mouse genome', 'multitask', 'next generation', 'preference', 'programs', 'promoter', 'repository', 'role model', 'sequence learning', 'tool', 'transcription factor', 'transcriptomics']",NHGRI,SLOAN-KETTERING INST CAN RESEARCH,R01,2012,556291,0.09801572843210504
"Statistical and Computational Tools for Next-generation ChIP-seq Applications     DESCRIPTION (provided by applicant): ChIP-seq is a powerful technology to map genome-wide protein-DNA interactions (PDIs). It is increasingly used by scientists worldwide to study how gene activities are controlled in normal cells and why they are disrupted in diseases. Applying ChIP-seq to study gene regulation faces three major challenges: (1) how to analyze large ChIP-seq data sets to discover dynamic changes of gene regulation across different biological contexts, (2) how to infer global regulatory programs under the practical constraint that it is not feasible to conduct ChIP-seq for all transcription factors (TFs), and (3) how to analyze allele-specific events given the small amount of data at heterozygote SNPs which cause low statistical power.  This study investigates novel statistical and computational solutions to address the challenges above. First, a new method will be developed to discover and characterize dynamic changes of gene regulation across different biological contexts. This method, Generalized Differential Principal Component Analysis (dPCA/GDPCA), integrates unsupervised pattern discovery, dimension reduction and statistical inference into a single statistical framework. It provides a systematic solution to analyze quantitative and curve shape changes in large ChIP-seq data sets involving multiple proteins. It is expected to have a wide range of applications. Second, a computational framework will be developed to predict global gene regulation dynamics, i.e., dynamic changes of downstream regulatory events of all TFs for which DNA binding motif information is available. The analysis integrates the dynamic changes of histone modification ChIP-seq, DNase-seq, and FAIRE-seq data with DNA sequences, public ChIP-seq, and public gene expression data. It will provide a practical, affordable, and reasonably accurate solution to utilizing ChIP-seq to study many TFs simultaneously. A systematic benchmark study will also be con- ducted to evaluate the impact of technologies, data types and analytical methods on prediction performance. This benchmark study will provide guidelines for designing informative future experiments. Third, a method for detecting allele-specific protein-DNA binding (ASB) will be developed. The method is able to integrate information from multiple ChIP-seq data sets and completely phased genome sequences to significantly improve the statistical power of ASB inference. Various sources of biases will also be handled.  Guidelines and new analytical tools generated by this study will allow one to design informative ChIP-seq experiments in the future such that by collecting one set of ChIP-seq data, one can not only identify locations of PDIs, but also infer global dynamic changes of TF binding sites across different biological contexts, and, if genotype data are available, robustly analyze allele-specific gene regulation. This will make ChIP-seq a low-cost high-reward experiment that serves multiple purposes. By significantly expanding the utility and increasing the power of ChIP-seq, our computational infrastructure is expected to have a major impact on advancing future studies of gene regulation and dissections of regulatory mechanisms behind human diseases.          ChIP-seq is a powerful technology to analyze how genes' activities are controlled in normal cells and diseases. This proposal develops statistical and computational tools urgently needed by scientists to analyze large and complex ChIP-seq data sets. By allowing one to examine dynamic changes of global gene regulatory programs across different biological contexts, the new computational technologies developed in this proposal are expected to have a major impact on advancing future studies of regulatory mechanisms behind human diseases.            ",Statistical and Computational Tools for Next-generation ChIP-seq Applications,8666661,R01HG006841,"['Accounting', 'Address', 'Alleles', 'Antibodies', 'Benchmarking', 'Binding', 'Binding Sites', 'Biological', 'ChIP-seq', 'Complex', 'Coupled', 'Couples', 'DNA Binding', 'DNA Sequence', 'DNA-Binding Proteins', 'DNA-Protein Interaction', 'Data', 'Data Analyses', 'Data Set', 'Deoxyribonucleases', 'Dimensions', 'Disease', 'Dissection', 'Event', 'Experimental Designs', 'Face', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genome', 'Genomics', 'Genotype', 'Global Change', 'Grant', 'Guidelines', 'Heterozygote', 'High-Throughput Nucleotide Sequencing', 'Human', 'Location', 'Maps', 'Methods', 'Normal Cell', 'Pattern', 'Performance', 'Phase', 'Principal Component Analysis', 'Protein Dynamics', 'Proteins', 'Public Domains', 'Reading', 'Regulator Genes', 'Research Infrastructure', 'Research Personnel', 'Resources', 'Sampling', 'Scientist', 'Shapes', 'Site', 'Software Tools', 'Solutions', 'Source', 'Technology', 'Transcription Factor 3', 'Vision', 'analytical method', 'analytical tool', 'chromatin immunoprecipitation', 'chromatin modification', 'computer framework', 'computer infrastructure', 'computerized tools', 'cost', 'design', 'follow-up', 'functional genomics', 'genome sequencing', 'genome-wide', 'high reward', 'histone modification', 'human disease', 'improved', 'innovation', 'method development', 'new technology', 'next generation', 'novel', 'novel strategies', 'programs', 'research study', 'tool', 'transcription factor', 'user friendly software']",NHGRI,JOHNS HOPKINS UNIVERSITY,R01,2014,317520,0.07098428328623475
"Statistical and Computational Tools for Next-generation ChIP-seq Applications     DESCRIPTION (provided by applicant): ChIP-seq is a powerful technology to map genome-wide protein-DNA interactions (PDIs). It is increasingly used by scientists worldwide to study how gene activities are controlled in normal cells and why they are disrupted in diseases. Applying ChIP-seq to study gene regulation faces three major challenges: (1) how to analyze large ChIP-seq data sets to discover dynamic changes of gene regulation across different biological contexts, (2) how to infer global regulatory programs under the practical constraint that it is not feasible to conduct ChIP-seq for all transcription factors (TFs), and (3) how to analyze allele-specific events given the small amount of data at heterozygote SNPs which cause low statistical power.  This study investigates novel statistical and computational solutions to address the challenges above. First, a new method will be developed to discover and characterize dynamic changes of gene regulation across different biological contexts. This method, Generalized Differential Principal Component Analysis (dPCA/GDPCA), integrates unsupervised pattern discovery, dimension reduction and statistical inference into a single statistical framework. It provides a systematic solution to analyze quantitative and curve shape changes in large ChIP-seq data sets involving multiple proteins. It is expected to have a wide range of applications. Second, a computational framework will be developed to predict global gene regulation dynamics, i.e., dynamic changes of downstream regulatory events of all TFs for which DNA binding motif information is available. The analysis integrates the dynamic changes of histone modification ChIP-seq, DNase-seq, and FAIRE-seq data with DNA sequences, public ChIP-seq, and public gene expression data. It will provide a practical, affordable, and reasonably accurate solution to utilizing ChIP-seq to study many TFs simultaneously. A systematic benchmark study will also be con- ducted to evaluate the impact of technologies, data types and analytical methods on prediction performance. This benchmark study will provide guidelines for designing informative future experiments. Third, a method for detecting allele-specific protein-DNA binding (ASB) will be developed. The method is able to integrate information from multiple ChIP-seq data sets and completely phased genome sequences to significantly improve the statistical power of ASB inference. Various sources of biases will also be handled.  Guidelines and new analytical tools generated by this study will allow one to design informative ChIP-seq experiments in the future such that by collecting one set of ChIP-seq data, one can not only identify locations of PDIs, but also infer global dynamic changes of TF binding sites across different biological contexts, and, if genotype data are available, robustly analyze allele-specific gene regulation. This will make ChIP-seq a low-cost high-reward experiment that serves multiple purposes. By significantly expanding the utility and increasing the power of ChIP-seq, our computational infrastructure is expected to have a major impact on advancing future studies of gene regulation and dissections of regulatory mechanisms behind human diseases.          ChIP-seq is a powerful technology to analyze how genes' activities are controlled in normal cells and diseases. This proposal develops statistical and computational tools urgently needed by scientists to analyze large and complex ChIP-seq data sets. By allowing one to examine dynamic changes of global gene regulatory programs across different biological contexts, the new computational technologies developed in this proposal are expected to have a major impact on advancing future studies of regulatory mechanisms behind human diseases.            ",Statistical and Computational Tools for Next-generation ChIP-seq Applications,8543753,R01HG006841,"['Accounting', 'Address', 'Alleles', 'Antibodies', 'Benchmarking', 'Binding', 'Binding Sites', 'Biological', 'ChIP-seq', 'Complex', 'Coupled', 'Couples', 'DNA Binding', 'DNA Sequence', 'DNA-Binding Proteins', 'DNA-Protein Interaction', 'Data', 'Data Analyses', 'Data Set', 'Deoxyribonucleases', 'Dimensions', 'Disease', 'Dissection', 'Event', 'Experimental Designs', 'Face', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genome', 'Genomics', 'Genotype', 'Global Change', 'Grant', 'Guidelines', 'Heterozygote', 'Human', 'Location', 'Maps', 'Methods', 'Normal Cell', 'Pattern', 'Performance', 'Phase', 'Principal Component Analysis', 'Protein Dynamics', 'Proteins', 'Public Domains', 'Reading', 'Regulator Genes', 'Research Infrastructure', 'Research Personnel', 'Resources', 'Sampling', 'Scientist', 'Shapes', 'Site', 'Software Tools', 'Solutions', 'Source', 'Technology', 'Transcription Factor 3', 'Vision', 'analytical method', 'analytical tool', 'chromatin immunoprecipitation', 'chromatin modification', 'computer framework', 'computer infrastructure', 'computerized tools', 'cost', 'design', 'follow-up', 'functional genomics', 'genome sequencing', 'genome-wide', 'high reward', 'histone modification', 'human disease', 'improved', 'innovation', 'method development', 'new technology', 'next generation', 'novel', 'novel strategies', 'programs', 'research study', 'tool', 'transcription factor', 'user friendly software']",NHGRI,JOHNS HOPKINS UNIVERSITY,R01,2013,309420,0.07098428328623475
"Statistical and Computational Tools for Next-generation ChIP-seq Applications     DESCRIPTION (provided by applicant): ChIP-seq is a powerful technology to map genome-wide protein-DNA interactions (PDIs). It is increasingly used by scientists worldwide to study how gene activities are controlled in normal cells and why they are disrupted in diseases. Applying ChIP-seq to study gene regulation faces three major challenges: (1) how to analyze large ChIP-seq data sets to discover dynamic changes of gene regulation across different biological contexts, (2) how to infer global regulatory programs under the practical constraint that it is not feasible to conduct ChIP-seq for all transcription factors (TFs), and (3) how to analyze allele-specific events given the small amount of data at heterozygote SNPs which cause low statistical power.  This study investigates novel statistical and computational solutions to address the challenges above. First, a new method will be developed to discover and characterize dynamic changes of gene regulation across different biological contexts. This method, Generalized Differential Principal Component Analysis (dPCA/GDPCA), integrates unsupervised pattern discovery, dimension reduction and statistical inference into a single statistical framework. It provides a systematic solution to analyze quantitative and curve shape changes in large ChIP-seq data sets involving multiple proteins. It is expected to have a wide range of applications. Second, a computational framework will be developed to predict global gene regulation dynamics, i.e., dynamic changes of downstream regulatory events of all TFs for which DNA binding motif information is available. The analysis integrates the dynamic changes of histone modification ChIP-seq, DNase-seq, and FAIRE-seq data with DNA sequences, public ChIP-seq, and public gene expression data. It will provide a practical, affordable, and reasonably accurate solution to utilizing ChIP-seq to study many TFs simultaneously. A systematic benchmark study will also be con- ducted to evaluate the impact of technologies, data types and analytical methods on prediction performance. This benchmark study will provide guidelines for designing informative future experiments. Third, a method for detecting allele-specific protein-DNA binding (ASB) will be developed. The method is able to integrate information from multiple ChIP-seq data sets and completely phased genome sequences to significantly improve the statistical power of ASB inference. Various sources of biases will also be handled.  Guidelines and new analytical tools generated by this study will allow one to design informative ChIP-seq experiments in the future such that by collecting one set of ChIP-seq data, one can not only identify locations of PDIs, but also infer global dynamic changes of TF binding sites across different biological contexts, and, if genotype data are available, robustly analyze allele-specific gene regulation. This will make ChIP-seq a low-cost high-reward experiment that serves multiple purposes. By significantly expanding the utility and increasing the power of ChIP-seq, our computational infrastructure is expected to have a major impact on advancing future studies of gene regulation and dissections of regulatory mechanisms behind human diseases.        PUBLIC HEALTH RELEVANCE: ChIP-seq is a powerful technology to analyze how genes' activities are controlled in normal cells and diseases. This proposal develops statistical and computational tools urgently needed by scientists to analyze large and complex ChIP-seq data sets. By allowing one to examine dynamic changes of global gene regulatory programs across different biological contexts, the new computational technologies developed in this proposal are expected to have a major impact on advancing future studies of regulatory mechanisms behind human diseases.              ChIP-seq is a powerful technology to analyze how genes' activities are controlled in normal cells and diseases. This proposal develops statistical and computational tools urgently needed by scientists to analyze large and complex ChIP-seq data sets. By allowing one to examine dynamic changes of global gene regulatory programs across different biological contexts, the new computational technologies developed in this proposal are expected to have a major impact on advancing future studies of regulatory mechanisms behind human diseases.            ",Statistical and Computational Tools for Next-generation ChIP-seq Applications,8342445,R01HG006841,"['Accounting', 'Address', 'Alleles', 'Antibodies', 'Benchmarking', 'Binding', 'Binding Sites', 'Biological', 'Complex', 'Coupled', 'Couples', 'DNA Binding', 'DNA Sequence', 'DNA-Binding Proteins', 'DNA-Protein Interaction', 'Data', 'Data Analyses', 'Data Set', 'Deoxyribonucleases', 'Dimensions', 'Disease', 'Dissection', 'Event', 'Experimental Designs', 'Face', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genome', 'Genomics', 'Genotype', 'Global Change', 'Grant', 'Guidelines', 'Heterozygote', 'Human', 'Location', 'Maps', 'Methods', 'Normal Cell', 'Pattern', 'Performance', 'Phase', 'Principal Component Analysis', 'Protein Dynamics', 'Proteins', 'Public Domains', 'Reading', 'Regulator Genes', 'Research Infrastructure', 'Research Personnel', 'Resources', 'Sampling', 'Scientist', 'Shapes', 'Site', 'Software Tools', 'Solutions', 'Source', 'Technology', 'Transcription Factor 3', 'Vision', 'analytical method', 'analytical tool', 'chromatin immunoprecipitation', 'chromatin modification', 'computer framework', 'computer infrastructure', 'computerized tools', 'cost', 'design', 'follow-up', 'functional genomics', 'genome sequencing', 'genome-wide', 'high reward', 'histone modification', 'human disease', 'improved', 'innovation', 'method development', 'new technology', 'next generation', 'novel', 'novel strategies', 'programs', 'research study', 'tool', 'transcription factor', 'user friendly software']",NHGRI,JOHNS HOPKINS UNIVERSITY,R01,2012,324000,0.08474460392601448
"Mechanisms of Transcriptional Control Revealed by Nascent Transcript Sequencing Large consortium efforts have collected hundreds of genome-wide datasets that have delineated myriad regulatory regions, transcription factor binding sites and large numbers of coding and non-coding transcripts. Even with this massive amount of data, it remains a significant challenge to determine how the mapped elements function together in regulatory networks. This is due in large part to our inability to accurately and quantitatively detect all forms of nascent transcription, the instantaneous output of transcriptional regulation. Moreover, our understanding of global gene regulation is restricted by a lack of computational tools that seamlessly integrate genome-wide datasets. The overall goal of this proposal is to maximize the impact of nascent transcriptome studies and enable facile integration with other functional genomic data. My group developed native elongating transcript sequencing (NET-seq), that enables the strand-specific nucleotide-resolution mapping of RNA polymerase density, highlighting all transcriptional activity regardless of transcript half-lives and revealing precise positions of Pol II pausing where regulatory control is applied. Here, we will develop a new version of NET-seq  NET-seq 2.0  that enables the routine, scalable and flexible application to diverse human cell types (or any eukaryotic system). Moreover, we will increase the potential of NET-seq analysis by developing two innovative bioinformatics strategies to seamlessly integrate NET-seq data with other genome-wide datasets that will have applications beyond NET-seq studies. To demonstrate the broad utility of our integrated approach, we will study regulatory networks and cell differentiation for which instantaneous nascent transcriptional analysis will be highly impactful. In Aim 1, our goal is to make NET-seq easier, cheaper, and more flexible. Our improvements will reduce background and increase usable reads, dramatically reduce cell input requirements (100-1000-fold), enable dense, region-specific RNA transcription analyses, and enable quantitative comparisons between samples and conditions. In Aim 2, we will determine transcription kinetics through integrating NET-seq with metabolic RNA labeling (TT-seq) data which report local synthesis rates. This integrative approach yields a rich transcriptional phenotype that we will use to develop gene regulatory network models. In Aim 3, we will create new computational algorithms that circumvent the need to determine each molecular event separately, and instead infer the status of unmapped events using information-rich datasets, such as NET-seq. We will use integrative deep neural networks (`deep-learning') that use available genome-wide datasets to predict unavailable datasets from data already on hand. We will apply this approach to study erythropoiesis using a well- defined primary human hematopoietic differentiation system by a time series NET-seq and DNase-seq analysis. These data will inform deep neural network models to predict ChIP-seq data for myriad transcription factors and chromatin marks to investigate key regulatory events without additional expense. The proposed research is relevant to public health, because discovery of regulatory mechanisms in transcription at high resolution is ultimately expected to significantly impact our understanding of most human disease. As such, the proposed research is relevant to the part of the NIH's mission that seeks to develop fundamental knowledge to inform our diagnosis and treatment of human disease.",Mechanisms of Transcriptional Control Revealed by Nascent Transcript Sequencing,9932470,R01HG007173,"['Binding Sites', 'Bioinformatics', 'Cell Differentiation process', 'Cells', 'ChIP-seq', 'Chromatin', 'Code', 'Communities', 'Computational algorithm', 'Consumption', 'DNA-Directed RNA Polymerase', 'DNase I hypersensitive sites sequencing', 'Data', 'Data Set', 'Detection', 'Diagnosis', 'Elements', 'Embryonic Development', 'Enhancers', 'Erythropoiesis', 'Eukaryotic Cell', 'Event', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Goals', 'Hand', 'Human', 'Investigation', 'KDM1A gene', 'Kinetics', 'Knowledge', 'Label', 'Maps', 'Measures', 'Mediating', 'Messenger RNA', 'Metabolic', 'Methods', 'Mission', 'Molecular', 'Neural Network Simulation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Output', 'Phenotype', 'Play', 'Polymerase', 'Positioning Attribute', 'Process', 'Protocols documentation', 'Public Health', 'RNA', 'RNA Polymerase II', 'RNA purification', 'Regulator Genes', 'Reporting', 'Research', 'Resolution', 'Ribonucleases', 'Ribosomal RNA', 'Role', 'Sampling', 'Science', 'Series', 'Small Nuclear RNA', 'Small Nucleolar RNA', 'Speed', 'System', 'Testing', 'Time', 'Transcript', 'Transcriptional Regulation', 'United States National Institutes of Health', 'Untranslated RNA', 'cell type', 'computerized tools', 'deep learning', 'deep neural network', 'density', 'flexibility', 'functional genomics', 'genome-wide', 'genomic data', 'hematopoietic differentiation', 'human disease', 'improved', 'innovation', 'network models', 'novel', 'promoter', 'transcription factor', 'transcriptome', 'virtual']",NHGRI,HARVARD MEDICAL SCHOOL,R01,2020,517318,0.04352006570212006
"Mechanisms of Transcriptional Control Revealed by Nascent Transcript Sequencing Large consortium efforts have collected hundreds of genome-wide datasets that have delineated myriad regulatory regions, transcription factor binding sites and large numbers of coding and non-coding transcripts. Even with this massive amount of data, it remains a significant challenge to determine how the mapped elements function together in regulatory networks. This is due in large part to our inability to accurately and quantitatively detect all forms of nascent transcription, the instantaneous output of transcriptional regulation. Moreover, our understanding of global gene regulation is restricted by a lack of computational tools that seamlessly integrate genome-wide datasets. The overall goal of this proposal is to maximize the impact of nascent transcriptome studies and enable facile integration with other functional genomic data. My group developed native elongating transcript sequencing (NET-seq), that enables the strand-specific nucleotide-resolution mapping of RNA polymerase density, highlighting all transcriptional activity regardless of transcript half-lives and revealing precise positions of Pol II pausing where regulatory control is applied. Here, we will develop a new version of NET-seq  NET-seq 2.0  that enables the routine, scalable and flexible application to diverse human cell types (or any eukaryotic system). Moreover, we will increase the potential of NET-seq analysis by developing two innovative bioinformatics strategies to seamlessly integrate NET-seq data with other genome-wide datasets that will have applications beyond NET-seq studies. To demonstrate the broad utility of our integrated approach, we will study regulatory networks and cell differentiation for which instantaneous nascent transcriptional analysis will be highly impactful. In Aim 1, our goal is to make NET-seq easier, cheaper, and more flexible. Our improvements will reduce background and increase usable reads, dramatically reduce cell input requirements (100-1000-fold), enable dense, region-specific RNA transcription analyses, and enable quantitative comparisons between samples and conditions. In Aim 2, we will determine transcription kinetics through integrating NET-seq with metabolic RNA labeling (TT-seq) data which report local synthesis rates. This integrative approach yields a rich transcriptional phenotype that we will use to develop gene regulatory network models. In Aim 3, we will create new computational algorithms that circumvent the need to determine each molecular event separately, and instead infer the status of unmapped events using information-rich datasets, such as NET-seq. We will use integrative deep neural networks (`deep-learning') that use available genome-wide datasets to predict unavailable datasets from data already on hand. We will apply this approach to study erythropoiesis using a well- defined primary human hematopoietic differentiation system by a time series NET-seq and DNase-seq analysis. These data will inform deep neural network models to predict ChIP-seq data for myriad transcription factors and chromatin marks to investigate key regulatory events without additional expense. The proposed research is relevant to public health, because discovery of regulatory mechanisms in transcription at high resolution is ultimately expected to significantly impact our understanding of most human disease. As such, the proposed research is relevant to the part of the NIH's mission that seeks to develop fundamental knowledge to inform our diagnosis and treatment of human disease.",Mechanisms of Transcriptional Control Revealed by Nascent Transcript Sequencing,9762140,R01HG007173,"['Binding Sites', 'Bioinformatics', 'Cell Differentiation process', 'Cells', 'ChIP-seq', 'Chromatin', 'Code', 'Communities', 'Computational algorithm', 'Consumption', 'DNA-Directed RNA Polymerase', 'DNase I hypersensitive sites sequencing', 'Data', 'Data Set', 'Detection', 'Diagnosis', 'Elements', 'Embryonic Development', 'Enhancers', 'Erythropoiesis', 'Eukaryotic Cell', 'Event', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Goals', 'Hand', 'Human', 'Investigation', 'KDM1A gene', 'Kinetics', 'Knowledge', 'Label', 'Maps', 'Measures', 'Mediating', 'Messenger RNA', 'Metabolic', 'Methods', 'Mission', 'Molecular', 'Neural Network Simulation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Output', 'Phenotype', 'Play', 'Polymerase', 'Positioning Attribute', 'Process', 'Protocols documentation', 'Public Health', 'RNA', 'RNA Polymerase II', 'RNA purification', 'Regulator Genes', 'Reporting', 'Research', 'Resolution', 'Ribonucleases', 'Ribosomal RNA', 'Role', 'Sampling', 'Science', 'Series', 'Small Nuclear RNA', 'Small Nucleolar RNA', 'Speed', 'System', 'Testing', 'Time', 'Transcript', 'Transcriptional Regulation', 'United States National Institutes of Health', 'Untranslated RNA', 'cell type', 'computerized tools', 'deep learning', 'deep neural network', 'density', 'flexibility', 'functional genomics', 'genome-wide', 'genomic data', 'hematopoietic differentiation', 'human disease', 'improved', 'innovation', 'network models', 'novel', 'promoter', 'transcription factor', 'transcriptome', 'virtual']",NHGRI,HARVARD MEDICAL SCHOOL,R01,2019,513500,0.04352006570212006
"Mechanisms of Transcriptional Control Revealed by Nascent Transcript Sequencing Large consortium efforts have collected hundreds of genome-wide datasets that have delineated myriad regulatory regions, transcription factor binding sites and large numbers of coding and non-coding transcripts. Even with this massive amount of data, it remains a significant challenge to determine how the mapped elements function together in regulatory networks. This is due in large part to our inability to accurately and quantitatively detect all forms of nascent transcription, the instantaneous output of transcriptional regulation. Moreover, our understanding of global gene regulation is restricted by a lack of computational tools that seamlessly integrate genome-wide datasets. The overall goal of this proposal is to maximize the impact of nascent transcriptome studies and enable facile integration with other functional genomic data. My group developed native elongating transcript sequencing (NET-seq), that enables the strand-specific nucleotide-resolution mapping of RNA polymerase density, highlighting all transcriptional activity regardless of transcript half-lives and revealing precise positions of Pol II pausing where regulatory control is applied. Here, we will develop a new version of NET-seq  NET-seq 2.0  that enables the routine, scalable and flexible application to diverse human cell types (or any eukaryotic system). Moreover, we will increase the potential of NET-seq analysis by developing two innovative bioinformatics strategies to seamlessly integrate NET-seq data with other genome-wide datasets that will have applications beyond NET-seq studies. To demonstrate the broad utility of our integrated approach, we will study regulatory networks and cell differentiation for which instantaneous nascent transcriptional analysis will be highly impactful. In Aim 1, our goal is to make NET-seq easier, cheaper, and more flexible. Our improvements will reduce background and increase usable reads, dramatically reduce cell input requirements (100-1000-fold), enable dense, region-specific RNA transcription analyses, and enable quantitative comparisons between samples and conditions. In Aim 2, we will determine transcription kinetics through integrating NET-seq with metabolic RNA labeling (TT-seq) data which report local synthesis rates. This integrative approach yields a rich transcriptional phenotype that we will use to develop gene regulatory network models. In Aim 3, we will create new computational algorithms that circumvent the need to determine each molecular event separately, and instead infer the status of unmapped events using information-rich datasets, such as NET-seq. We will use integrative deep neural networks (`deep-learning') that use available genome-wide datasets to predict unavailable datasets from data already on hand. We will apply this approach to study erythropoiesis using a well- defined primary human hematopoietic differentiation system by a time series NET-seq and DNase-seq analysis. These data will inform deep neural network models to predict ChIP-seq data for myriad transcription factors and chromatin marks to investigate key regulatory events without additional expense. The proposed research is relevant to public health, because discovery of regulatory mechanisms in transcription at high resolution is ultimately expected to significantly impact our understanding of most human disease. As such, the proposed research is relevant to the part of the NIH's mission that seeks to develop fundamental knowledge to inform our diagnosis and treatment of human disease.",Mechanisms of Transcriptional Control Revealed by Nascent Transcript Sequencing,9521770,R01HG007173,"['Binding Sites', 'Bioinformatics', 'Cell Differentiation process', 'Cells', 'ChIP-seq', 'Chromatin', 'Code', 'Communities', 'Computational algorithm', 'DNA-Directed RNA Polymerase', 'DNase I hypersensitive sites sequencing', 'Data', 'Data Set', 'Detection', 'Diagnosis', 'Elements', 'Embryonic Development', 'Enhancers', 'Erythropoiesis', 'Eukaryotic Cell', 'Event', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Goals', 'Hand', 'Hematopoietic', 'Human', 'Investigation', 'KDM1A gene', 'Kinetics', 'Knowledge', 'Label', 'Maps', 'Measures', 'Mediating', 'Messenger RNA', 'Metabolic', 'Methods', 'Mission', 'Molecular', 'Neural Network Simulation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Output', 'Phenotype', 'Play', 'Polymerase', 'Positioning Attribute', 'Process', 'Protocols documentation', 'Public Health', 'RNA', 'RNA Polymerase II', 'RNA purification', 'Regulator Genes', 'Reporting', 'Research', 'Resolution', 'Ribonucleases', 'Ribosomal RNA', 'Role', 'Sampling', 'Science', 'Series', 'Small Nuclear RNA', 'Small Nucleolar RNA', 'Speed', 'System', 'Testing', 'Time', 'Transcript', 'Transcriptional Regulation', 'United States National Institutes of Health', 'Untranslated RNA', 'cell type', 'computerized tools', 'deep learning', 'deep neural network', 'density', 'flexibility', 'functional genomics', 'genome-wide', 'genomic data', 'human disease', 'improved', 'innovation', 'network models', 'novel', 'promoter', 'transcription factor', 'transcriptome', 'virtual']",NHGRI,HARVARD MEDICAL SCHOOL,R01,2018,592501,0.04352006570212006
"Global Discovery and Validation of Functional Regulatory Elements Understanding of regulatory elements in the human genome is a key step in our ability to understand complex biological and disease systems. Regulatory elements are much more difficult to identify than genes and likely account for more variation among individuals than actual coding differences in genes. Identifying and studying elements, including promoters, enhancers, silencers, and insulators, will lead to new therapeutic strategies as the complex regulatory networks are revealed. Up to now the characterization and validation of truly functional regulatory elements has been a low throughput endeavor as each regulatory site is cloned into a reporter assay and tested. This proposal produces a novel method that performs one of the most common validation assays, transient transfections, in a high-throughput manner by combining it with an innovative sorting and sequencing system. This system, which has been shown to be practical and feasible, will allow for rapid and thorough identification of the method of action of regulatory elements throughout the human genome.  The candidate's background in both computer science and molecular biology ranging from undergraduate to graduate school and post-doctoral work provides a complete background that should allow for implementation and extension of the described experiment in the post-doctoral environment. The nature of the science and the data produced should allow continuation and extension of the work as a new faculty member. Stanford and the Snyder lab provide an outstanding environment for a strong program allowing development of the candidate and preparation for transition to a long-term independent research career. As part of this program, the candidate will combine a mentoring committee with continuing education via available online courses.  The end result of both phases of the program will be scientific results that can be extended into useful and important medically and scientifically relevant areas as they relate to regulation of expression in humans. The innovative methods described will allow the candidate to pursue various lines of endeavor well past the end of this funding program. In turn the candidate will be positioned at the end of the program to function as an independent principle investigator and valuable collaborator. This project seeks to extend current assays demonstrating function of genomic regions into an equivalent genome-wide assay. Identification of the effect of these regions on gene expression will lead to a better understanding of the complex regulatory `code' dictating our cellular processes. In turn, this improved understanding will bring forth new potential targets to approach incorrect regulation leading to disease.",Global Discovery and Validation of Functional Regulatory Elements,9478475,R00HG007356,"['Area', 'Basic Science', 'Binding', 'Biological', 'Biological Assay', 'Cell physiology', 'Cells', 'Classification', 'Code', 'Complex', 'Continuing Education', 'DNA Sequence', 'Data', 'Development', 'Disease', 'Elements', 'Enhancers', 'Environment', 'Faculty', 'Funding', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Enhancer Element', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Genome', 'Individual', 'LIF gene', 'Libraries', 'Machine Learning', 'Measures', 'Medical', 'Mentors', 'Methods', 'Molecular Biology', 'Nature', 'Nucleic Acid Regulatory Sequences', 'Pattern', 'Phase', 'Population', 'Positioning Attribute', 'Postdoctoral Fellow', 'Preparation', 'Proteins', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Research Personnel', 'Schools', 'Science', 'Site', 'Sorting - Cell Movement', 'System', 'Techniques', 'Testing', 'Trans-Activators', 'Transfection', 'Validation', 'Variant', 'Work', 'base', 'career', 'cell type', 'chromatin immunoprecipitation', 'combinatorial', 'computer science', 'cost', 'design', 'experimental study', 'genome-wide', 'histone modification', 'improved', 'innovation', 'insight', 'knock-down', 'member', 'novel', 'novel therapeutic intervention', 'online course', 'programs', 'promoter', 'tool', 'transcription factor', 'undergraduate student', 'whole genome']",NHGRI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R00,2017,50000,0.15271155048390797
"Global Discovery and Validation of Functional Regulatory Elements Understanding of regulatory elements in the human genome is a key step in our ability to understand complex biological and disease systems. Regulatory elements are much more difficult to identify than genes and likely account for more variation among individuals than actual coding differences in genes. Identifying and studying elements, including promoters, enhancers, silencers, and insulators, will lead to new therapeutic strategies as the complex regulatory networks are revealed. Up to now the characterization and validation of truly functional regulatory elements has been a low throughput endeavor as each regulatory site is cloned into a reporter assay and tested. This proposal produces a novel method that performs one of the most common validation assays, transient transfections, in a high-throughput manner by combining it with an innovative sorting and sequencing system. This system, which has been shown to be practical and feasible, will allow for rapid and thorough identification of the method of action of regulatory elements throughout the human genome.  The candidate's background in both computer science and molecular biology ranging from undergraduate to graduate school and post-doctoral work provides a complete background that should allow for implementation and extension of the described experiment in the post-doctoral environment. The nature of the science and the data produced should allow continuation and extension of the work as a new faculty member. Stanford and the Snyder lab provide an outstanding environment for a strong program allowing development of the candidate and preparation for transition to a long-term independent research career. As part of this program, the candidate will combine a mentoring committee with continuing education via available online courses.  The end result of both phases of the program will be scientific results that can be extended into useful and important medically and scientifically relevant areas as they relate to regulation of expression in humans. The innovative methods described will allow the candidate to pursue various lines of endeavor well past the end of this funding program. In turn the candidate will be positioned at the end of the program to function as an independent principle investigator and valuable collaborator. This project seeks to extend current assays demonstrating function of genomic regions into an equivalent genome-wide assay. Identification of the effect of these regions on gene expression will lead to a better understanding of the complex regulatory `code' dictating our cellular processes. In turn, this improved understanding will bring forth new potential targets to approach incorrect regulation leading to disease.",Global Discovery and Validation of Functional Regulatory Elements,9130618,R00HG007356,"['Accounting', 'Area', 'Basic Science', 'Beryllium', 'Binding', 'Biological', 'Biological Assay', 'Cell Separation', 'Cell physiology', 'Cells', 'Classification', 'Code', 'Complex', 'Continuing Education', 'DNA Sequence', 'Data', 'Data Science', 'Development', 'Disease', 'Elements', 'Enhancers', 'Environment', 'Faculty', 'Funding', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Enhancer Element', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Genome', 'Individual', 'Lead', 'Libraries', 'Machine Learning', 'Measures', 'Mentors', 'Methods', 'Molecular Biology', 'Nature', 'Nucleic Acid Regulatory Sequences', 'Pattern', 'Phase', 'Population', 'Positioning Attribute', 'Postdoctoral Fellow', 'Preparation', 'Proteins', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Research Personnel', 'Schools', 'Site', 'Sorting - Cell Movement', 'System', 'Techniques', 'Testing', 'Trans-Activators', 'Transfection', 'Validation', 'Variant', 'Work', 'base', 'career', 'cell type', 'chromatin immunoprecipitation', 'combinatorial', 'computer science', 'design', 'genome-wide', 'histone modification', 'improved', 'innovation', 'insight', 'knock-down', 'member', 'novel', 'novel therapeutic intervention', 'online course', 'programs', 'promoter', 'research study', 'tool', 'transcription factor', 'whole genome']",NHGRI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R00,2016,234887,0.15271155048390797
"Global Discovery and Validation of Functional Regulatory Elements Understanding of regulatory elements in the human genome is a key step in our ability to understand complex biological and disease systems. Regulatory elements are much more difficult to identify than genes and likely account for more variation among individuals than actual coding differences in genes. Identifying and studying elements, including promoters, enhancers, silencers, and insulators, will lead to new therapeutic strategies as the complex regulatory networks are revealed. Up to now the characterization and validation of truly functional regulatory elements has been a low throughput endeavor as each regulatory site is cloned into a reporter assay and tested. This proposal produces a novel method that performs one of the most common validation assays, transient transfections, in a high-throughput manner by combining it with an innovative sorting and sequencing system. This system, which has been shown to be practical and feasible, will allow for rapid and thorough identification of the method of action of regulatory elements throughout the human genome.  The candidate's background in both computer science and molecular biology ranging from undergraduate to graduate school and post-doctoral work provides a complete background that should allow for implementation and extension of the described experiment in the post-doctoral environment. The nature of the science and the data produced should allow continuation and extension of the work as a new faculty member. Stanford and the Snyder lab provide an outstanding environment for a strong program allowing development of the candidate and preparation for transition to a long-term independent research career. As part of this program, the candidate will combine a mentoring committee with continuing education via available online courses.  The end result of both phases of the program will be scientific results that can be extended into useful and important medically and scientifically relevant areas as they relate to regulation of expression in humans. The innovative methods described will allow the candidate to pursue various lines of endeavor well past the end of this funding program. In turn the candidate will be positioned at the end of the program to function as an independent principle investigator and valuable collaborator. This project seeks to extend current assays demonstrating function of genomic regions into an equivalent genome-wide assay. Identification of the effect of these regions on gene expression will lead to a better understanding of the complex regulatory `code' dictating our cellular processes. In turn, this improved understanding will bring forth new potential targets to approach incorrect regulation leading to disease.",Global Discovery and Validation of Functional Regulatory Elements,8916174,R00HG007356,"['Accounting', 'Area', 'Basic Science', 'Beryllium', 'Binding', 'Biological', 'Biological Assay', 'Cell Separation', 'Cell physiology', 'Cells', 'Classification', 'Code', 'Complex', 'Continuing Education', 'DNA Sequence', 'Data', 'Development', 'Disease', 'Elements', 'Enhancers', 'Environment', 'Faculty', 'Funding', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Enhancer Element', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Genome', 'Individual', 'Lead', 'Libraries', 'Machine Learning', 'Measures', 'Mentors', 'Methods', 'Molecular Biology', 'Nature', 'Nucleic Acid Regulatory Sequences', 'Pattern', 'Phase', 'Population', 'Positioning Attribute', 'Postdoctoral Fellow', 'Preparation', 'Proteins', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Research Personnel', 'Schools', 'Science', 'Site', 'Sorting - Cell Movement', 'System', 'Techniques', 'Testing', 'Trans-Activators', 'Transfection', 'Validation', 'Variant', 'Work', 'base', 'career', 'cell type', 'chromatin immunoprecipitation', 'combinatorial', 'computer science', 'design', 'genome-wide', 'histone modification', 'improved', 'innovation', 'insight', 'member', 'novel', 'novel therapeutics', 'programs', 'promoter', 'research study', 'tool', 'transcription factor']",NHGRI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R00,2015,242017,0.15271155048390797
"Global Discovery and Validation of Functional Regulatory Elements Understanding of regulatory elements in the human genome is a key step in our ability to understand complex biological and disease systems. Regulatory elements are much more difficult to identify than genes and likely account for more variation among individuals than actual coding differences in genes. Identifying and studying elements, including promoters, enhancers, silencers, and insulators, will lead to new therapeutic strategies as the complex regulatory networks are revealed. Up to now the characterization and validation of truly functional regulatory elements has been a low throughput endeavor as each regulatory site is cloned into a reporter assay and tested. This proposal produces a novel method that performs one of the most common validation assays, transient transfections, in a high-throughput manner by combining it with an innovative sorting and sequencing system. This system, which has been shown to be practical and feasible, will allow for rapid and thorough identification of the method of action of regulatory elements throughout the human genome.  The candidate's background in both computer science and molecular biology ranging from undergraduate to graduate school and post-doctoral work provides a complete background that should allow for implementation and extension of the described experiment in the post-doctoral environment. The nature of the science and the data produced should allow continuation and extension of the work as a new faculty member. Stanford and the Snyder lab provide an outstanding environment for a strong program allowing development of the candidate and preparation for transition to a long-term independent research career. As part of this program, the candidate will combine a mentoring committee with continuing education via available online courses.  The end result of both phases of the program will be scientific results that can be extended into useful and important medically and scientifically relevant areas as they relate to regulation of expression in humans. The innovative methods described will allow the candidate to pursue various lines of endeavor well past the end of this funding program. In turn the candidate will be positioned at the end of the program to function as an independent principle investigator and valuable collaborator. This project seeks to extend current assays demonstrating function of genomic regions into an equivalent genome-wide assay. Identification of the effect of these regions on gene expression will lead to a better understanding of the complex regulatory `code' dictating our cellular processes. In turn, this improved understanding will bring forth new potential targets to approach incorrect regulation leading to disease.",Global Discovery and Validation of Functional Regulatory Elements,8898931,R00HG007356,"['Accounting', 'Area', 'Basic Science', 'Beryllium', 'Binding', 'Biological', 'Biological Assay', 'Cell Separation', 'Cell physiology', 'Cells', 'Classification', 'Code', 'Complex', 'Continuing Education', 'DNA Sequence', 'Data', 'Development', 'Disease', 'Elements', 'Enhancers', 'Environment', 'Faculty', 'Funding', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Enhancer Element', 'Genome', 'Genomics', 'Goals', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Genome', 'Individual', 'Lead', 'Libraries', 'Machine Learning', 'Measures', 'Mentors', 'Methods', 'Molecular Biology', 'Nature', 'Nucleic Acid Regulatory Sequences', 'Pattern', 'Phase', 'Population', 'Positioning Attribute', 'Postdoctoral Fellow', 'Preparation', 'Proteins', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Research Personnel', 'Schools', 'Science', 'Site', 'Sorting - Cell Movement', 'System', 'Techniques', 'Testing', 'Trans-Activators', 'Transfection', 'Validation', 'Variant', 'Work', 'base', 'career', 'cell type', 'chromatin immunoprecipitation', 'combinatorial', 'computer science', 'design', 'genome-wide', 'histone modification', 'improved', 'innovation', 'insight', 'member', 'novel', 'novel therapeutics', 'programs', 'promoter', 'research study', 'tool', 'transcription factor']",NHGRI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R00,2014,248822,0.15271155048390797
"Global Discovery and Validation of Functional Regulatory Elements     DESCRIPTION (provided by applicant):  Understanding of regulatory elements in the human genome is a key step in our ability to understand complex biological and disease systems. Regulatory elements are much more difficult to identify than genes and likely account for more variation among individuals than actual coding differences in genes. Identifying and studying elements, including promoters, enhancers, silencers, and insulators, will lead to new therapeutic strategies as the complex regulatory networks are revealed. Up to now the characterization and validation of truly functional regulatory elements has been a low throughput endeavor as each regulatory site is cloned into a reporter assay and tested. This proposal produces a novel method that performs one of the most common validation assays, transient transfections, in a high-throughput manner by combining it with an innovative sorting and sequencing system. This system, which has been shown to be practical and feasible, will allow for rapid and thorough identification of the method of action of regulatory elements throughout the human genome.  The candidate's background in both computer science and molecular biology ranging from undergraduate to graduate school and post-doctoral work provides a complete background that should allow for implementation and extension of the described experiment in the post-doctoral environment. The nature of the science and the data produced should allow continuation and extension of the work as a new faculty member. Stanford and the Snyder lab provide an outstanding environment for a strong program allowing development of the candidate and preparation for transition to a long-term independent research career. As part of this program, the candidate will combine a mentoring committee with continuing education via available online courses.  The end result of both phases of the program will be scientific results that can be extended into useful and important medically and scientifically relevant areas as they relate to regulation of expression in humans. The innovative methods described will allow the candidate to pursue various lines of endeavor well past the end of this funding program. In turn the candidate will be positioned at the end of the program to function as an independent principle investigator and valuable collaborator.         PUBLIC HEALTH RELEVANCE: This project seeks to extend current assays demonstrating function of genomic regions into an equivalent genome-wide assay. Identification of the effect of these regions on gene expression will lead to a better understanding of the complex regulatory 'code' dictating our cellular processes. In turn, this improved understanding will bring forth new potential targets to approach incorrect regulation leading to disease.                ",Global Discovery and Validation of Functional Regulatory Elements,8564428,K99HG007356,"['Accounting', 'Area', 'Basic Science', 'Beryllium', 'Binding', 'Biological', 'Biological Assay', 'Cell Separation', 'Cell physiology', 'Cells', 'Classification', 'Code', 'Complex', 'Continuing Education', 'DNA Sequence', 'Data', 'Development', 'Disease', 'Elements', 'Enhancers', 'Environment', 'Faculty', 'Funding', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Enhancer Element', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Individual', 'Lead', 'Libraries', 'Machine Learning', 'Measures', 'Mentors', 'Methods', 'Molecular Biology', 'Nature', 'Nucleic Acid Regulatory Sequences', 'Pattern', 'Phase', 'Population', 'Positioning Attribute', 'Postdoctoral Fellow', 'Preparation', 'Proteins', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Research Personnel', 'Schools', 'Science', 'Site', 'Sorting - Cell Movement', 'System', 'Techniques', 'Testing', 'Trans-Activators', 'Transfection', 'Validation', 'Variant', 'Work', 'base', 'career', 'cell type', 'chromatin immunoprecipitation', 'combinatorial', 'computer science', 'design', 'genome-wide', 'histone modification', 'improved', 'innovation', 'insight', 'member', 'novel', 'novel therapeutics', 'programs', 'promoter', 'public health relevance', 'research study', 'tool', 'transcription factor']",NHGRI,STANFORD UNIVERSITY,K99,2013,94346,0.15271155048390797
"""Ribonomics"" of Gene Regulation to predict Innate Immune Responses DESCRIPTION (provided by applicant): The expression of genes involves a sequence of enzymatic events, such as transcription, mRNA processing, mRNA decay, and translation, that are subject to gene regulatory networks (GRNs) of protein-nucleic acid interactions. It is well appreciated that the control of transcription via regulatory networks that regulate enhancer and promoter activities are not the sole determinant of what gene products result, but that exon skipping is pervasive and post-transcriptional mechanisms such as mRNA splicing and decay determine the kinetics of mRNA induction and abundance. Indeed, in our preliminary studies of the macrophage response to pathogens, we find that a majority of induced gene expression events result in mRNAs that deviate substantially from those predicted by the genome-browser, and that mRNA decay is controlled by both protein- nucleic acid and miRNA regulatory networks. The proposed Center for the ""Ribonomics"" of Gene Regulation leverages and pioneers Next Gen Sequencing and computational modeling approaches to develop a predictive model for which mRNA isoforms are expressed and at what level given a given promoter activity and transcription initiation rate. We will develop generally applicable tools in conjunction with or in depth and quantitative experimental analysis of the macrophage response to pathogen-associated endotoxin, which results in the dramatic up regulation of more than 1000 genes. Strikingly, our preliminary data identified more than 900 exon skipping events in addition to numerous cases of alternative 5' or 3' splice site use, emphasizing the essential contribution of post-initiation events. Further, these splice patterns are dependent on the macrophage subtype-specific chromatin landscape and are altered by inducible splice factors in primed or tolerated states. Thus we will leverage the well-described macrophage biology and associated experimental model systems, to examine the role of gene structure and sequence (Aim 1), the role of chromatin modifications (Aim 2), and of trans-acting splicing factors (Aim 3) in determining the identity of mature mRNAs and their associated synthesis rates, before adding the stimulus-responsive regulatory networks that confer mRNA half-life control and thus determine the abundance of each mRNA isoform (Aim 4). PUBLIC HEALTH RELEVANCE:  The proposed Center for the Ribonomics of Gene Regulation leverages and pioneers Next Gen Sequencing and computational modeling approaches to develop gene regulatory network (GRN) models that predict which of many alternative mRNA isoforms are actually expressed and at what level. We will leverage the dramatic innate immune transcriptomic response and well-described macrophage biology and associated experimental model systems, to examine the role of gene structure and sequence (Aim 1), the role of chromatin modifications (Aim 2), and of trans-acting splicing factors (Aim 3) in determining the identity of mature mRNAs and their associated synthesis rates, before adding the stimulus-responsive regulatory networks that determine mRNA abundance via mRNA half-life control (Aim 4).","""Ribonomics"" of Gene Regulation to predict Innate Immune Responses",9178030,U01HG007912,"['3&apos', ' Splice Site', 'Affect', 'Biological Models', 'Biological Phenomena', 'Biology', 'Cells', 'Chromatin', 'Chromatin Modeling', 'Complement', 'Computer Simulation', 'Cytoplasm', 'DNA Methylation', 'DNA Polymerase II', 'Data', 'Data Set', 'Degradation Pathway', 'Endotoxins', 'Enhancers', 'Environment', 'Event', 'Exons', 'Experimental Models', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Genes', 'Genetic Transcription', 'Genomic approach', 'Genomics', 'Half-Life', 'Immune', 'Inflammatory', 'Innate Immune Response', 'Introns', 'Kinetics', 'Machine Learning', 'Measures', 'Mediating', 'Messenger RNA', 'MicroRNAs', 'Modeling', 'Nucleic Acids', 'Nucleoplasm', 'Pattern', 'Phase', 'Production', 'Protein Isoforms', 'Proteins', 'RNA', 'RNA Splicing', 'RNA-Binding Proteins', 'Recording of previous events', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resolution', 'Role', 'Stimulus', 'Systems Biology', 'Testing', 'Time', 'Transcription Initiation', 'Transcriptional Regulation', 'Translations', 'Up-Regulation', 'Yeasts', 'analytical tool', 'base', 'cell type', 'chromatin modification', 'crosslinking and immunoprecipitation sequencing', 'epigenome', 'exon skipping', 'experimental analysis', 'gene product', 'genome browser', 'histone modification', 'mRNA Decay', 'mRNA Transcript Degradation', 'macrophage', 'mutant', 'network models', 'next generation sequencing', 'novel', 'pathogen', 'predictive modeling', 'promoter', 'public health relevance', 'response', 'tool', 'transcription factor', 'transcriptomics']",NHGRI,UNIVERSITY OF CALIFORNIA LOS ANGELES,U01,2017,1897108,0.13801420589839283
"""Ribonomics"" of Gene Regulation to predict Innate Immune Responses DESCRIPTION (provided by applicant): The expression of genes involves a sequence of enzymatic events, such as transcription, mRNA processing, mRNA decay, and translation, that are subject to gene regulatory networks (GRNs) of protein-nucleic acid interactions. It is well appreciated that the control of transcription via regulatory networks that regulate enhancer and promoter activities are not the sole determinant of what gene products result, but that exon skipping is pervasive and post-transcriptional mechanisms such as mRNA splicing and decay determine the kinetics of mRNA induction and abundance. Indeed, in our preliminary studies of the macrophage response to pathogens, we find that a majority of induced gene expression events result in mRNAs that deviate substantially from those predicted by the genome-browser, and that mRNA decay is controlled by both protein- nucleic acid and miRNA regulatory networks. The proposed Center for the ""Ribonomics"" of Gene Regulation leverages and pioneers Next Gen Sequencing and computational modeling approaches to develop a predictive model for which mRNA isoforms are expressed and at what level given a given promoter activity and transcription initiation rate. We will develop generally applicable tools in conjunction with or in depth and quantitative experimental analysis of the macrophage response to pathogen-associated endotoxin, which results in the dramatic up regulation of more than 1000 genes. Strikingly, our preliminary data identified more than 900 exon skipping events in addition to numerous cases of alternative 5' or 3' splice site use, emphasizing the essential contribution of post-initiation events. Further, these splice patterns are dependent on the macrophage subtype-specific chromatin landscape and are altered by inducible splice factors in primed or tolerated states. Thus we will leverage the well-described macrophage biology and associated experimental model systems, to examine the role of gene structure and sequence (Aim 1), the role of chromatin modifications (Aim 2), and of trans-acting splicing factors (Aim 3) in determining the identity of mature mRNAs and their associated synthesis rates, before adding the stimulus-responsive regulatory networks that confer mRNA half-life control and thus determine the abundance of each mRNA isoform (Aim 4). PUBLIC HEALTH RELEVANCE:  The proposed Center for the Ribonomics of Gene Regulation leverages and pioneers Next Gen Sequencing and computational modeling approaches to develop gene regulatory network (GRN) models that predict which of many alternative mRNA isoforms are actually expressed and at what level. We will leverage the dramatic innate immune transcriptomic response and well-described macrophage biology and associated experimental model systems, to examine the role of gene structure and sequence (Aim 1), the role of chromatin modifications (Aim 2), and of trans-acting splicing factors (Aim 3) in determining the identity of mature mRNAs and their associated synthesis rates, before adding the stimulus-responsive regulatory networks that determine mRNA abundance via mRNA half-life control (Aim 4).","""Ribonomics"" of Gene Regulation to predict Innate Immune Responses",8991718,U01HG007912,"['3&apos', ' Splice Site', 'Accounting', 'Affect', 'Biological Models', 'Biological Phenomena', 'Biology', 'Cells', 'Chromatin', 'Chromatin Modeling', 'Clip', 'Complement', 'Computer Simulation', 'Cytoplasm', 'DNA Methylation', 'DNA Polymerase II', 'Data', 'Data Set', 'Degradation Pathway', 'Endotoxins', 'Enhancers', 'Environment', 'Event', 'Exons', 'Experimental Models', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Genes', 'Genetic Transcription', 'Genomic approach', 'Genomics', 'Half-Life', 'Health', 'Immune', 'Immune Response Genes', 'Immune response', 'Inflammatory', 'Introns', 'Kinetics', 'Machine Learning', 'Measures', 'Mediating', 'Messenger RNA', 'MicroRNAs', 'Modeling', 'Nucleic Acids', 'Nucleoplasm', 'Pattern', 'Phase', 'Process', 'Production', 'Protein Isoforms', 'Proteins', 'RNA', 'RNA Splicing', 'RNA-Binding Proteins', 'Recording of previous events', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resolution', 'Role', 'Stimulus', 'Systems Biology', 'Testing', 'Time', 'Transcription Initiation', 'Translations', 'Up-Regulation', 'Yeasts', 'analytical tool', 'base', 'cell type', 'chromatin modification', 'epigenome', 'exon skipping', 'experimental analysis', 'gene product', 'genome browser', 'histone modification', 'mRNA Decay', 'mRNA Transcript Degradation', 'macrophage', 'mutant', 'network models', 'next generation sequencing', 'novel', 'pathogen', 'predictive modeling', 'programs', 'promoter', 'response', 'tool', 'transcription factor', 'transcriptomics']",NHGRI,UNIVERSITY OF CALIFORNIA LOS ANGELES,U01,2016,1939552,0.13801420589839283
"""Ribonomics"" of Gene Regulation to predict Innate Immune Responses     DESCRIPTION (provided by applicant): The expression of genes involves a sequence of enzymatic events, such as transcription, mRNA processing, mRNA decay, and translation, that are subject to gene regulatory networks (GRNs) of protein-nucleic acid interactions. It is well appreciated that the control of transcription via regulatory networks that regulate enhancer and promoter activities are not the sole determinant of what gene products result, but that exon skipping is pervasive and post-transcriptional mechanisms such as mRNA splicing and decay determine the kinetics of mRNA induction and abundance. Indeed, in our preliminary studies of the macrophage response to pathogens, we find that a majority of induced gene expression events result in mRNAs that deviate substantially from those predicted by the genome-browser, and that mRNA decay is controlled by both protein- nucleic acid and miRNA regulatory networks. The proposed Center for the ""Ribonomics"" of Gene Regulation leverages and pioneers Next Gen Sequencing and computational modeling approaches to develop a predictive model for which mRNA isoforms are expressed and at what level given a given promoter activity and transcription initiation rate. We will develop generally applicable tools in conjunction with or in depth and quantitative experimental analysis of the macrophage response to pathogen-associated endotoxin, which results in the dramatic up regulation of more than 1000 genes. Strikingly, our preliminary data identified more than 900 exon skipping events in addition to numerous cases of alternative 5' or 3' splice site use, emphasizing the essential contribution of post-initiation events. Further, these splice patterns are dependent on the macrophage subtype-specific chromatin landscape and are altered by inducible splice factors in primed or tolerated states. Thus we will leverage the well-described macrophage biology and associated experimental model systems, to examine the role of gene structure and sequence (Aim 1), the role of chromatin modifications (Aim 2), and of trans-acting splicing factors (Aim 3) in determining the identity of mature mRNAs and their associated synthesis rates, before adding the stimulus-responsive regulatory networks that confer mRNA half-life control and thus determine the abundance of each mRNA isoform (Aim 4).         PUBLIC HEALTH RELEVANCE:  The proposed Center for the Ribonomics of Gene Regulation leverages and pioneers Next Gen Sequencing and computational modeling approaches to develop gene regulatory network (GRN) models that predict which of many alternative mRNA isoforms are actually expressed and at what level. We will leverage the dramatic innate immune transcriptomic response and well-described macrophage biology and associated experimental model systems, to examine the role of gene structure and sequence (Aim 1), the role of chromatin modifications (Aim 2), and of trans-acting splicing factors (Aim 3) in determining the identity of mature mRNAs and their associated synthesis rates, before adding the stimulus-responsive regulatory networks that determine mRNA abundance via mRNA half-life control (Aim 4).                ","""Ribonomics"" of Gene Regulation to predict Innate Immune Responses",8771101,U01HG007912,"['3&apos', ' Splice Site', 'Accounting', 'Affect', 'Biological Models', 'Biological Phenomena', 'Biology', 'Cells', 'Chromatin', 'Chromatin Modeling', 'Clip', 'Complement', 'Computer Simulation', 'Cytoplasm', 'DNA Methylation', 'DNA Polymerase II', 'Data', 'Data Set', 'Degradation Pathway', 'Endotoxins', 'Enhancers', 'Environment', 'Event', 'Exons', 'Experimental Models', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic approach', 'Genomics', 'Half-Life', 'Immune', 'Immune Response Genes', 'Immune response', 'Inflammatory', 'Introns', 'Kinetics', 'Machine Learning', 'Measures', 'Mediating', 'Messenger RNA', 'MicroRNAs', 'Modeling', 'Nucleic Acids', 'Nucleoplasm', 'Pattern', 'Phase', 'Process', 'Production', 'Protein Isoforms', 'Proteins', 'RNA', 'RNA Splicing', 'RNA-Binding Proteins', 'Recording of previous events', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resolution', 'Role', 'Stimulus', 'Systems Biology', 'Testing', 'Time', 'Transcription Initiation', 'Translations', 'Up-Regulation', 'Yeasts', 'analytical tool', 'base', 'cell type', 'chromatin modification', 'epigenome', 'exon skipping', 'experimental analysis', 'histone modification', 'mRNA Decay', 'mRNA Transcript Degradation', 'macrophage', 'mutant', 'network models', 'next generation sequencing', 'novel', 'pathogen', 'predictive modeling', 'programs', 'promoter', 'public health relevance', 'response', 'tool', 'transcription factor', 'transcriptomics']",NHGRI,UNIVERSITY OF CALIFORNIA LOS ANGELES,U01,2015,1979328,0.13801420589839283
"High-throughput methods for elucidating the control of chromatin accessibility     DESCRIPTION (provided by applicant): We will develop the first validated predictive model of how transcription factors dynamically determine genome-wide chromatin accessibility that is generalizable across biological systems. We will accomplish this goal with three specific aims. We will develop novel Genome Syntax to Regulation (GSR) models that accurately learn a genomic regulatory vocabulary and predict how phrases in this vocabulary control chromatin accessibility (Aim 1). As part of this aim we will identify transcription factor binding motifs tha are in the discovered regulatory vocabulary. We will validate and refine the causality of these models by testing whether they accurately predict the chromatin accessibility of thousands of synthetic DNA ""phrases"" that have been engineered into specific genomic locations and measured in the context of transcription factor gain-of-function and loss-of-function studies. The phrases will be designed to elucidate both the factors and grammar that control chromatin opening in several distinct cellular states (Aim 2). We will use our predictive models to assign importance scores to individual genome bases and to predict how selected factors alter chromatin accessibility genome wide (Aim 3). We will test the ability of our importance scores to identify regulatory SNPs in the context of human genome-wide association study (GWAS) data, and we will validate model predictions of changes in whole genome chromatin accessibility in response to ectopic factor expression. Through computational modeling of the effect of such ectopic factor expression, we will develop a predictive understanding of how transcription factors alter chromatin state, laying the groundwork for a novel regenerative medicine paradigm of predictive cellular programming. PUBLIC HEALTH RELEVANCE: Access to the information in our genomes is regulated by a cell much like doors in a building can regulate access to rooms that contain instructions. The control over which doors are open in a cell regulates which instructions are accessible in a cell-type specific way. We will understand the code that controls the doors to our genome, and improve human health by understanding what genome changes interfere with door control and demonstrating that we can program cells to open and close their doors to create cells that might be able to serve as replacements for damaged cells in our bodies.",High-throughput methods for elucidating the control of chromatin accessibility,9066734,R01HG008363,"['Access to Information', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Proteins', 'Cells', 'Chromatin', 'Chromatin Modeling', 'Code', 'Computer Simulation', 'Controlled Vocabulary', 'DNA', 'DNA Library', 'DNA Sequence', 'DNase I hypersensitive sites sequencing', 'Data', 'Ectopic Expression', 'Engineering', 'Enhancers', 'Etiology', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Health', 'Human', 'Human Genome', 'Individual', 'Instruction', 'Knock-out', 'Learning', 'Libraries', 'Location', 'Machine Learning', 'Maps', 'Measures', 'Methods', 'Modeling', 'Oligonucleotides', 'Pancreas', 'Proteins', 'Regenerative Medicine', 'Regulation', 'Regulatory Element', 'Resolution', 'Role', 'Testing', 'Time', 'Variant', 'Vocabulary', 'Work', 'base', 'biological systems', 'cell injury', 'cell type', 'combinatorial', 'design', 'embryonic stem cell', 'gain of function', 'genetic regulatory protein', 'genome editing', 'genome sequencing', 'genome wide association study', 'genome-wide', 'improved', 'loss of function', 'novel', 'overexpression', 'phrases', 'predictive modeling', 'programs', 'promoter', 'relating to nervous system', 'response', 'stem cell differentiation', 'syntax', 'synthetic construct', 'transcription factor', 'whole genome']",NHGRI,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R01,2016,748525,0.06286484210223102
"High-throughput methods for elucidating the control of chromatin accessibility     DESCRIPTION (provided by applicant): We will develop the first validated predictive model of how transcription factors dynamically determine genome-wide chromatin accessibility that is generalizable across biological systems. We will accomplish this goal with three specific aims. We will develop novel Genome Syntax to Regulation (GSR) models that accurately learn a genomic regulatory vocabulary and predict how phrases in this vocabulary control chromatin accessibility (Aim 1). As part of this aim we will identify transcription factor binding motifs tha are in the discovered regulatory vocabulary. We will validate and refine the causality of these models by testing whether they accurately predict the chromatin accessibility of thousands of synthetic DNA ""phrases"" that have been engineered into specific genomic locations and measured in the context of transcription factor gain-of-function and loss-of-function studies. The phrases will be designed to elucidate both the factors and grammar that control chromatin opening in several distinct cellular states (Aim 2). We will use our predictive models to assign importance scores to individual genome bases and to predict how selected factors alter chromatin accessibility genome wide (Aim 3). We will test the ability of our importance scores to identify regulatory SNPs in the context of human genome-wide association study (GWAS) data, and we will validate model predictions of changes in whole genome chromatin accessibility in response to ectopic factor expression. Through computational modeling of the effect of such ectopic factor expression, we will develop a predictive understanding of how transcription factors alter chromatin state, laying the groundwork for a novel regenerative medicine paradigm of predictive cellular programming. PUBLIC HEALTH RELEVANCE: Access to the information in our genomes is regulated by a cell much like doors in a building can regulate access to rooms that contain instructions. The control over which doors are open in a cell regulates which instructions are accessible in a cell-type specific way. We will understand the code that controls the doors to our genome, and improve human health by understanding what genome changes interfere with door control and demonstrating that we can program cells to open and close their doors to create cells that might be able to serve as replacements for damaged cells in our bodies.",High-throughput methods for elucidating the control of chromatin accessibility,9267524,R01HG008363,"['Access to Information', 'Alpha Cell', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Proteins', 'Biological', 'Cell Differentiation process', 'Cells', 'Chromatin', 'Chromatin Modeling', 'Code', 'Computer Simulation', 'Controlled Vocabulary', 'DNA', 'DNA Library', 'DNA Sequence', 'DNase I hypersensitive sites sequencing', 'Data', 'Ectopic Expression', 'Engineering', 'Enhancers', 'Etiology', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Health', 'Human', 'Human Genome', 'Individual', 'Instruction', 'Knock-out', 'Learning', 'Libraries', 'Location', 'Machine Learning', 'Maps', 'Measures', 'Methods', 'Modeling', 'Oligonucleotides', 'Pancreas', 'Proteins', 'Regenerative Medicine', 'Regulation', 'Regulatory Element', 'Resolution', 'Role', 'Testing', 'Time', 'Variant', 'Vocabulary', 'Work', 'base', 'biological systems', 'cell injury', 'cell type', 'combinatorial', 'design', 'embryonic stem cell', 'gain of function', 'genetic regulatory protein', 'genome editing', 'genome wide association study', 'genome-wide', 'high dimensionality', 'improved', 'loss of function', 'novel', 'overexpression', 'phrases', 'predictive modeling', 'programs', 'promoter', 'public health relevance', 'relating to nervous system', 'response', 'syntax', 'synthetic construct', 'transcription factor', 'whole genome']",NHGRI,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R01,2017,748525,0.06286484210223102
"High-throughput methods for elucidating the control of chromatin accessibility     DESCRIPTION (provided by applicant): We will develop the first validated predictive model of how transcription factors dynamically determine genome-wide chromatin accessibility that is generalizable across biological systems. We will accomplish this goal with three specific aims. We will develop novel Genome Syntax to Regulation (GSR) models that accurately learn a genomic regulatory vocabulary and predict how phrases in this vocabulary control chromatin accessibility (Aim 1). As part of this aim we will identify transcription factor binding motifs tha are in the discovered regulatory vocabulary. We will validate and refine the causality of these models by testing whether they accurately predict the chromatin accessibility of thousands of synthetic DNA ""phrases"" that have been engineered into specific genomic locations and measured in the context of transcription factor gain-of-function and loss-of-function studies. The phrases will be designed to elucidate both the factors and grammar that control chromatin opening in several distinct cellular states (Aim 2). We will use our predictive models to assign importance scores to individual genome bases and to predict how selected factors alter chromatin accessibility genome wide (Aim 3). We will test the ability of our importance scores to identify regulatory SNPs in the context of human genome-wide association study (GWAS) data, and we will validate model predictions of changes in whole genome chromatin accessibility in response to ectopic factor expression. Through computational modeling of the effect of such ectopic factor expression, we will develop a predictive understanding of how transcription factors alter chromatin state, laying the groundwork for a novel regenerative medicine paradigm of predictive cellular programming.         PUBLIC HEALTH RELEVANCE: Access to the information in our genomes is regulated by a cell much like doors in a building can regulate access to rooms that contain instructions. The control over which doors are open in a cell regulates which instructions are accessible in a cell-type specific way. We will understand the code that controls the doors to our genome, and improve human health by understanding what genome changes interfere with door control and demonstrating that we can program cells to open and close their doors to create cells that might be able to serve as replacements for damaged cells in our bodies.            ",High-throughput methods for elucidating the control of chromatin accessibility,8861021,R01HG008363,"['Access to Information', 'Base Pairing', 'Base Sequence', 'Binding', 'Binding Proteins', 'Cells', 'Chromatin', 'Chromatin Modeling', 'Code', 'Computer Simulation', 'Controlled Vocabulary', 'DNA', 'DNA Library', 'DNA Sequence', 'DNase I hypersensitive sites sequencing', 'Data', 'Ectopic Expression', 'Engineering', 'Enhancers', 'Etiology', 'Genome', 'Genomics', 'Genotype', 'Goals', 'Health', 'Human', 'Human Genome', 'Individual', 'Instruction', 'Knock-out', 'Learning', 'Libraries', 'Location', 'Machine Learning', 'Maps', 'Measures', 'Methods', 'Modeling', 'Oligonucleotides', 'Pancreas', 'Proteins', 'Regenerative Medicine', 'Regulation', 'Regulatory Element', 'Resolution', 'Role', 'Testing', 'Time', 'Variant', 'Vocabulary', 'Work', 'base', 'biological systems', 'cell injury', 'cell type', 'combinatorial', 'design', 'embryonic stem cell', 'gain of function', 'genetic regulatory protein', 'genome editing', 'genome sequencing', 'genome wide association study', 'genome-wide', 'improved', 'loss of function', 'novel', 'phrases', 'predictive modeling', 'programs', 'promoter', 'public health relevance', 'relating to nervous system', 'response', 'stem cell differentiation', 'syntax', 'synthetic construct', 'transcription factor']",NHGRI,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R01,2015,762851,0.06286484210223102
"Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences The proportion of the human genome that underlies gene regulation dwarfs the proportion that encodes proteins. However, we remain poorly equipped for identifying which genetic variants compromise gene regulatory function in ways that may contribute to risk for both rare and common human diseases. Understanding how non-coding sequences regulate gene expression, as well as being able to predict the functional consequences of genetic variation for gene regulation, are paramount challenges for the field. Here, we propose to combine synthetic biology, massively parallel functional assays, and machine learning to profoundly advance our understanding of the `regulatory code' of the human genome. While challenging, the task of unravelling complex codes from large amounts of empirical data is not without precedent. For example, over the past decade, computer scientists working in natural language processing have made immense progress, driven in large part by a combination of algorithmic and computational improvements and enormously larger training datasets than were available to the previous generations of scientists working in this area. Inspired by the revolutionizing impact of big data for traditional problems in machine learning, we propose to model gene regulatory phenomena using training datasets with several orders of magnitude more examples than naturally exist in the human genome. We predict that the models learned from massive numbers of synthetic examples will strongly outperform models learned from the small number of natural examples. We will demonstrate our approach by developing comprehensive, quantitative, and predictive models for alternative splicing and alternative polyadenylation, two widespread regulatory mechanisms by which a single gene can code for multiple transcripts and proteins. However, we anticipate that this basic paradigm  specifically, the massively parallel measurement of the functional behavior of extremely large numbers of synthetic sequences followed by quantitative modeling of sequence-function relationships  can be generalized to advance our understanding of diverse forms of gene regulation. This research seeks to develop predictive models of alternative splicing and polyadenylation by learning from millions of synthetic constructs, orders of magnitude more than the number of endogenous examples. These models will be applied for understanding the consequences of genetic variation in humans and how this variation can lead to disease.",Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences,9869019,R01HG009136,"['Adopted', 'Algorithms', 'Alternative Splicing', 'Area', 'Basic Science', 'Behavior', 'Big Data', 'Biological Assay', 'Biological Phenomena', 'CRISPR/Cas technology', 'Clinical Medicine', 'Code', 'Complex', 'Computers', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Dependence', 'Disease', 'Dwarfism', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genetic Variation', 'Genome', 'Genomics', 'Haplotypes', 'Human', 'Human Genome', 'Lead', 'Learning', 'Libraries', 'Machine Learning', 'Measurement', 'Measures', 'Mediating', 'Mendelian disorder', 'Modeling', 'Mutation', 'Natural Language Processing', 'Polyadenylation', 'Protein Isoforms', 'Proteins', 'Publishing', 'Quantitative Trait Loci', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulator Genes', 'Reporter', 'Research', 'Risk', 'Scientist', 'Shapes', 'Single Nucleotide Polymorphism', 'Specific qualifier value', 'Testing', 'Training', 'Transcript', 'Untranslated RNA', 'Validation', 'Variant', 'Work', 'base', 'causal variant', 'clinically relevant', 'disease-causing mutation', 'exon skipping', 'experimental study', 'genetic variant', 'human disease', 'knock-down', 'novel strategies', 'predictive modeling', 'repaired', 'synthetic biology', 'synthetic construct']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2020,573285,0.09415043942008518
"Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences The proportion of the human genome that underlies gene regulation dwarfs the proportion that encodes proteins. However, we remain poorly equipped for identifying which genetic variants compromise gene regulatory function in ways that may contribute to risk for both rare and common human diseases. Understanding how non-coding sequences regulate gene expression, as well as being able to predict the functional consequences of genetic variation for gene regulation, are paramount challenges for the field. Here, we propose to combine synthetic biology, massively parallel functional assays, and machine learning to profoundly advance our understanding of the `regulatory code' of the human genome. While challenging, the task of unravelling complex codes from large amounts of empirical data is not without precedent. For example, over the past decade, computer scientists working in natural language processing have made immense progress, driven in large part by a combination of algorithmic and computational improvements and enormously larger training datasets than were available to the previous generations of scientists working in this area. Inspired by the revolutionizing impact of big data for traditional problems in machine learning, we propose to model gene regulatory phenomena using training datasets with several orders of magnitude more examples than naturally exist in the human genome. We predict that the models learned from massive numbers of synthetic examples will strongly outperform models learned from the small number of natural examples. We will demonstrate our approach by developing comprehensive, quantitative, and predictive models for alternative splicing and alternative polyadenylation, two widespread regulatory mechanisms by which a single gene can code for multiple transcripts and proteins. However, we anticipate that this basic paradigm  specifically, the massively parallel measurement of the functional behavior of extremely large numbers of synthetic sequences followed by quantitative modeling of sequence-function relationships  can be generalized to advance our understanding of diverse forms of gene regulation. This research seeks to develop predictive models of alternative splicing and polyadenylation by learning from millions of synthetic constructs, orders of magnitude more than the number of endogenous examples. These models will be applied for understanding the consequences of genetic variation in humans and how this variation can lead to disease.",Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences,9637415,R01HG009136,"['Adopted', 'Algorithms', 'Alternative Splicing', 'Area', 'Basic Science', 'Behavior', 'Big Data', 'Biological Assay', 'Biological Phenomena', 'CRISPR/Cas technology', 'Clinical Medicine', 'Code', 'Complex', 'Computers', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Dependence', 'Disease', 'Dwarfism', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genetic Variation', 'Genome', 'Genomics', 'Haplotypes', 'Human', 'Human Genome', 'Lead', 'Learning', 'Libraries', 'Machine Learning', 'Measurement', 'Measures', 'Mediating', 'Mendelian disorder', 'Modeling', 'Mutation', 'Natural Language Processing', 'Nucleotides', 'Polyadenylation', 'Protein Isoforms', 'Proteins', 'Publishing', 'Quantitative Trait Loci', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulator Genes', 'Reporter', 'Research', 'Risk', 'Scientist', 'Shapes', 'Specific qualifier value', 'Testing', 'Training', 'Transcript', 'Untranslated RNA', 'Validation', 'Variant', 'Work', 'base', 'causal variant', 'clinically relevant', 'disease-causing mutation', 'exon skipping', 'experimental study', 'genetic variant', 'human disease', 'knock-down', 'novel strategies', 'predictive modeling', 'repaired', 'synthetic biology', 'synthetic construct']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2019,582191,0.09415043942008518
"Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences The proportion of the human genome that underlies gene regulation dwarfs the proportion that encodes proteins. However, we remain poorly equipped for identifying which genetic variants compromise gene regulatory function in ways that may contribute to risk for both rare and common human diseases. Understanding how non-coding sequences regulate gene expression, as well as being able to predict the functional consequences of genetic variation for gene regulation, are paramount challenges for the field. Here, we propose to combine synthetic biology, massively parallel functional assays, and machine learning to profoundly advance our understanding of the `regulatory code' of the human genome. While challenging, the task of unravelling complex codes from large amounts of empirical data is not without precedent. For example, over the past decade, computer scientists working in natural language processing have made immense progress, driven in large part by a combination of algorithmic and computational improvements and enormously larger training datasets than were available to the previous generations of scientists working in this area. Inspired by the revolutionizing impact of big data for traditional problems in machine learning, we propose to model gene regulatory phenomena using training datasets with several orders of magnitude more examples than naturally exist in the human genome. We predict that the models learned from massive numbers of synthetic examples will strongly outperform models learned from the small number of natural examples. We will demonstrate our approach by developing comprehensive, quantitative, and predictive models for alternative splicing and alternative polyadenylation, two widespread regulatory mechanisms by which a single gene can code for multiple transcripts and proteins. However, we anticipate that this basic paradigm  specifically, the massively parallel measurement of the functional behavior of extremely large numbers of synthetic sequences followed by quantitative modeling of sequence-function relationships  can be generalized to advance our understanding of diverse forms of gene regulation. This research seeks to develop predictive models of alternative splicing and polyadenylation by learning from millions of synthetic constructs, orders of magnitude more than the number of endogenous examples. These models will be applied for understanding the consequences of genetic variation in humans and how this variation can lead to disease.",Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences,9475243,R01HG009136,"['Adopted', 'Algorithms', 'Alternative Splicing', 'Area', 'Basic Science', 'Behavior', 'Big Data', 'Biological Assay', 'Biological Phenomena', 'CRISPR/Cas technology', 'Clinical Medicine', 'Code', 'Complex', 'Computers', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Dependence', 'Disease', 'Dwarfism', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genetic Variation', 'Genome', 'Genomics', 'Haplotypes', 'Human', 'Human Genome', 'Lead', 'Learning', 'Libraries', 'Machine Learning', 'Measurement', 'Measures', 'Mediating', 'Mendelian disorder', 'Modeling', 'Mutation', 'Natural Language Processing', 'Nucleotides', 'Polyadenylation', 'Protein Isoforms', 'Proteins', 'Publishing', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulator Genes', 'Reporter', 'Research', 'Risk', 'Scientist', 'Shapes', 'Specific qualifier value', 'Testing', 'Training', 'Transcript', 'Untranslated RNA', 'Validation', 'Variant', 'Work', 'base', 'clinically relevant', 'disease-causing mutation', 'exon skipping', 'experimental study', 'genetic variant', 'human disease', 'knock-down', 'novel strategies', 'predictive modeling', 'repaired', 'synthetic biology', 'synthetic construct']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2018,590281,0.09415043942008518
"Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences The proportion of the human genome that underlies gene regulation dwarfs the proportion that encodes proteins. However, we remain poorly equipped for identifying which genetic variants compromise gene regulatory function in ways that may contribute to risk for both rare and common human diseases. Understanding how non-coding sequences regulate gene expression, as well as being able to predict the functional consequences of genetic variation for gene regulation, are paramount challenges for the field. Here, we propose to combine synthetic biology, massively parallel functional assays, and machine learning to profoundly advance our understanding of the `regulatory code' of the human genome. While challenging, the task of unravelling complex codes from large amounts of empirical data is not without precedent. For example, over the past decade, computer scientists working in natural language processing have made immense progress, driven in large part by a combination of algorithmic and computational improvements and enormously larger training datasets than were available to the previous generations of scientists working in this area. Inspired by the revolutionizing impact of big data for traditional problems in machine learning, we propose to model gene regulatory phenomena using training datasets with several orders of magnitude more examples than naturally exist in the human genome. We predict that the models learned from massive numbers of synthetic examples will strongly outperform models learned from the small number of natural examples. We will demonstrate our approach by developing comprehensive, quantitative, and predictive models for alternative splicing and alternative polyadenylation, two widespread regulatory mechanisms by which a single gene can code for multiple transcripts and proteins. However, we anticipate that this basic paradigm  specifically, the massively parallel measurement of the functional behavior of extremely large numbers of synthetic sequences followed by quantitative modeling of sequence-function relationships  can be generalized to advance our understanding of diverse forms of gene regulation. This research seeks to develop predictive models of alternative splicing and polyadenylation by learning from millions of synthetic constructs, orders of magnitude more than the number of endogenous examples. These models will be applied for understanding the consequences of genetic variation in humans and how this variation can lead to disease.",Predictive Modeling of Alternative Splicing and Polyadenylation from Millions of Random Sequences,9306648,R01HG009136,"['Adopted', 'Algorithms', 'Alternative Splicing', 'Area', 'Basic Science', 'Behavior', 'Big Data', 'Biological Assay', 'Biological Phenomena', 'CRISPR/Cas technology', 'Clinical Medicine', 'Code', 'Complex', 'Computers', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Dependency', 'Disease', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genetic Variation', 'Genome', 'Genomics', 'Haplotypes', 'Human', 'Human Genome', 'Lead', 'Learning', 'Libraries', 'Machine Learning', 'Measurement', 'Measures', 'Mediating', 'Mendelian disorder', 'Modeling', 'Mutation', 'Natural Language Processing', 'Nucleotides', 'Polyadenylation', 'Protein Isoforms', 'Proteins', 'Publishing', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulator Genes', 'Reporter', 'Research', 'Risk', 'Scientist', 'Shapes', 'Specific qualifier value', 'Testing', 'Training', 'Transcript', 'Untranslated RNA', 'Validation', 'Variant', 'Work', 'base', 'clinically relevant', 'data modeling', 'disease-causing mutation', 'exon skipping', 'experimental study', 'genetic variant', 'human disease', 'knock-down', 'novel strategies', 'predictive modeling', 'repaired', 'synthetic biology', 'synthetic construct']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2017,596615,0.09415043942008518
"RegulomeDB: A Resource for the Human Regulome PROJECT SUMMARY The Human RegulomeDB project provides an essential resource that facilitates medical research and exploratory investigations of gene regulation. The majority of sequence variation identified in genome sequencing projects and disease association studies (GWAS) lie within the 98% of the human genome that is non-exomic. RegulomeDB is a unique web accessible resource that provides integrated knowledge of the wealth of existing information concerning regulatory elements that lie within non-exomic regions. The unique feature of this resource is its ability to comprehensively annotate, integrate and display the experimentally defined functional and biochemical regulatory elements of the human genome. Information generated from individual laboratories and consortia concerning potential regulatory regions such as that affecting gene expression, transcription factor binding, chromatin modification and DNA methylation will be collected from the literature, and integrated into a common database and displayed at nucleotide resolution. The information can be readily accessed via a web accessible interface and related to sequence variations identified from large scale projects (e.g. db SNPs, 1000 genome project, GWAS studies). Researchers will be able to compare variants identified from personal genomes and large scale sequencing projects as well as GWAS studies to the wealth of information in RegulomeDB, and thereby rapidly gain knowledge of non-exomic information. Given the wealth of DNA sequencing project that are emerging, we expect this unique resource to have wide impact in the biomedical community. RELEVANCE TO PUBLIC HEALTH, PROJECT NARRATIVE The regulation of gene expression controls the determination of cell types, and aberrant gene expression can cause diseases such as cancer. RegulomeDB will enable researchers, clinicians, and sophisticated computer programs to relate DNA variants that lie in previously poorly understood regions of the human genome to possible functions thereby helping us understand the genetic basis of human variation and disease.",RegulomeDB: A Resource for the Human Regulome,10024325,U24HG009293,"['Adopted', 'Affect', 'Algorithms', 'Alleles', 'Back', 'Binding', 'Biochemical', 'ChIP-seq', 'Chromatin', 'Communities', 'Computer software', 'Country', 'DNA', 'DNA Methylation', 'DNA sequencing', 'DNA-Protein Interaction', 'Data', 'Data Set', 'Data Sources', 'Databases', 'Development', 'Disease', 'Documentation', 'Electronic Mail', 'Elements', 'Follow-Up Studies', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Human Resources', 'Individual', 'Investigation', 'Knowledge', 'Laboratories', 'Large-Scale Sequencing', 'Literature', 'Maintenance', 'Malignant Neoplasms', 'Medical Research', 'Methods', 'Modeling', 'Modernization', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Process', 'Production', 'Public Health', 'Publishing', 'Pythons', 'Quality Control', 'Regulatory Element', 'Research', 'Research Personnel', 'Resolution', 'Resources', 'Sampling', 'Scoring Method', 'Site', 'Source', 'Structure', 'System', 'Techniques', 'Tissues', 'Training', 'Untranslated RNA', 'Update', 'Variant', 'Work', 'analysis pipeline', 'base', 'cell determination', 'cell type', 'chromatin modification', 'computer program', 'data integration', 'data wrangling', 'de novo mutation', 'epigenome', 'experimental study', 'functional genomics', 'gene function', 'genome annotation', 'genome sequencing', 'genome wide association study', 'genome-wide', 'genomic data', 'heuristics', 'improved', 'meetings', 'outreach', 'random forest', 'social media', 'tool', 'transcription factor', 'web platform', 'web site', 'web-accessible', 'whole genome']",NHGRI,STANFORD UNIVERSITY,U24,2020,697414,0.04417725117295533
"RegulomeDB: A Resource for the Human Regulome PROJECT SUMMARY The Human RegulomeDB project provides an essential resource that facilitates medical research and exploratory investigations of gene regulation. The majority of sequence variation identified in genome sequencing projects and disease association studies (GWAS) lie within the 98% of the human genome that is non-exomic. RegulomeDB is a unique web accessible resource that provides integrated knowledge of the wealth of existing information concerning regulatory elements that lie within non-exomic regions. The unique feature of this resource is its ability to comprehensively annotate, integrate and display the experimentally defined functional and biochemical regulatory elements of the human genome. Information generated from individual laboratories and consortia concerning potential regulatory regions such as that affecting gene expression, transcription factor binding, chromatin modification and DNA methylation will be collected from the literature, and integrated into a common database and displayed at nucleotide resolution. The information can be readily accessed via a web accessible interface and related to sequence variations identified from large scale projects (e.g. db SNPs, 1000 genome project, GWAS studies). Researchers will be able to compare variants identified from personal genomes and large scale sequencing projects as well as GWAS studies to the wealth of information in RegulomeDB, and thereby rapidly gain knowledge of non-exomic information. Given the wealth of DNA sequencing project that are emerging, we expect this unique resource to have wide impact in the biomedical community. RELEVANCE TO PUBLIC HEALTH, PROJECT NARRATIVE The regulation of gene expression controls the determination of cell types, and aberrant gene expression can cause diseases such as cancer. RegulomeDB will enable researchers, clinicians, and sophisticated computer programs to relate DNA variants that lie in previously poorly understood regions of the human genome to possible functions thereby helping us understand the genetic basis of human variation and disease.",RegulomeDB: A Resource for the Human Regulome,9626410,U41HG009293,"['Affect', 'Binding', 'Biochemical', 'Biological Assay', 'Cells', 'ChIP-seq', 'Classification', 'Communities', 'Computer software', 'DNA', 'DNA Methylation', 'DNA sequencing', 'Data', 'Data Quality', 'Data Set', 'Databases', 'Disease', 'Documentation', 'Electronic Mail', 'Elements', 'Gene Expression', 'Gene Expression Regulation', 'Genetic', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Human Resources', 'Individual', 'Internet', 'Investigation', 'Knowledge', 'Laboratories', 'Large-Scale Sequencing', 'Literature', 'Machine Learning', 'Malignant Neoplasms', 'Medical Research', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Process', 'Public Health', 'Publishing', 'Regulatory Element', 'Research', 'Research Personnel', 'Resolution', 'Resource Informatics', 'Resources', 'Sampling', 'Scoring Method', 'Source', 'Technology', 'Testing', 'Training', 'Variant', 'Visualization software', 'base', 'cell determination', 'cell type', 'chromatin modification', 'cloud based', 'computer program', 'gene function', 'genome annotation', 'genome sequencing', 'genome wide association study', 'genome-wide', 'genomic data', 'improved', 'indexing', 'meetings', 'outreach', 'social media', 'tool', 'transcription factor', 'web site', 'web-accessible', 'whole genome']",NHGRI,STANFORD UNIVERSITY,U41,2019,734201,0.04417725117295533
"RegulomeDB: A Resource for the Human Regulome PROJECT SUMMARY The Human RegulomeDB project provides an essential resource that facilitates medical research and exploratory investigations of gene regulation. The majority of sequence variation identified in genome sequencing projects and disease association studies (GWAS) lie within the 98% of the human genome that is non-exomic. RegulomeDB is a unique web accessible resource that provides integrated knowledge of the wealth of existing information concerning regulatory elements that lie within non-exomic regions. The unique feature of this resource is its ability to comprehensively annotate, integrate and display the experimentally defined functional and biochemical regulatory elements of the human genome. Information generated from individual laboratories and consortia concerning potential regulatory regions such as that affecting gene expression, transcription factor binding, chromatin modification and DNA methylation will be collected from the literature, and integrated into a common database and displayed at nucleotide resolution. The information can be readily accessed via a web accessible interface and related to sequence variations identified from large scale projects (e.g. db SNPs, 1000 genome project, GWAS studies). Researchers will be able to compare variants identified from personal genomes and large scale sequencing projects as well as GWAS studies to the wealth of information in RegulomeDB, and thereby rapidly gain knowledge of non-exomic information. Given the wealth of DNA sequencing project that are emerging, we expect this unique resource to have wide impact in the biomedical community. RELEVANCE TO PUBLIC HEALTH, PROJECT NARRATIVE The regulation of gene expression controls the determination of cell types, and aberrant gene expression can cause diseases such as cancer. RegulomeDB will enable researchers, clinicians, and sophisticated computer programs to relate DNA variants that lie in previously poorly understood regions of the human genome to possible functions thereby helping us understand the genetic basis of human variation and disease.",RegulomeDB: A Resource for the Human Regulome,9420648,U41HG009293,"['Affect', 'Binding', 'Biochemical', 'Biological Assay', 'Cells', 'ChIP-seq', 'Classification', 'Communities', 'Computer software', 'DNA', 'DNA Methylation', 'DNA sequencing', 'Data', 'Data Quality', 'Data Set', 'Databases', 'Disease', 'Documentation', 'Electronic Mail', 'Elements', 'Gene Expression', 'Gene Expression Regulation', 'Genetic', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Human Resources', 'Individual', 'Internet', 'Investigation', 'Knowledge', 'Laboratories', 'Large-Scale Sequencing', 'Literature', 'Machine Learning', 'Malignant Neoplasms', 'Medical Research', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Process', 'Public Health', 'Publishing', 'Regulatory Element', 'Research', 'Research Personnel', 'Resolution', 'Resource Informatics', 'Resources', 'Sampling', 'Scoring Method', 'Source', 'Technology', 'Testing', 'Training', 'Variant', 'Visualization software', 'base', 'cell determination', 'cell type', 'chromatin modification', 'cloud based', 'computer program', 'gene function', 'genome annotation', 'genome sequencing', 'genome wide association study', 'genome-wide', 'improved', 'indexing', 'meetings', 'outreach', 'social media', 'tool', 'transcription factor', 'web site', 'web-accessible', 'whole genome']",NHGRI,STANFORD UNIVERSITY,U41,2018,733299,0.04417725117295533
"RegulomeDB: A Resource for the Human Regulome PROJECT SUMMARY The Human RegulomeDB project provides an essential resource that facilitates medical research and exploratory investigations of gene regulation. The majority of sequence variation identified in genome sequencing projects and disease association studies (GWAS) lie within the 98% of the human genome that is non-exomic. RegulomeDB is a unique web accessible resource that provides integrated knowledge of the wealth of existing information concerning regulatory elements that lie within non-exomic regions. The unique feature of this resource is its ability to comprehensively annotate, integrate and display the experimentally defined functional and biochemical regulatory elements of the human genome. Information generated from individual laboratories and consortia concerning potential regulatory regions such as that affecting gene expression, transcription factor binding, chromatin modification and DNA methylation will be collected from the literature, and integrated into a common database and displayed at nucleotide resolution. The information can be readily accessed via a web accessible interface and related to sequence variations identified from large scale projects (e.g. db SNPs, 1000 genome project, GWAS studies). Researchers will be able to compare variants identified from personal genomes and large scale sequencing projects as well as GWAS studies to the wealth of information in RegulomeDB, and thereby rapidly gain knowledge of non-exomic information. Given the wealth of DNA sequencing project that are emerging, we expect this unique resource to have wide impact in the biomedical community. RELEVANCE TO PUBLIC HEALTH, PROJECT NARRATIVE The regulation of gene expression controls the determination of cell types, and aberrant gene expression can cause diseases such as cancer. RegulomeDB will enable researchers, clinicians, and sophisticated computer programs to relate DNA variants that lie in previously poorly understood regions of the human genome to possible functions thereby helping us understand the genetic basis of human variation and disease.",RegulomeDB: A Resource for the Human Regulome,9209087,U41HG009293,"['Affect', 'Binding', 'Biochemical', 'Biological Assay', 'Cells', 'ChIP-seq', 'Classification', 'Communities', 'Computer software', 'DNA', 'DNA Methylation', 'DNA sequencing', 'Data', 'Data Quality', 'Data Set', 'Databases', 'Disease', 'Documentation', 'Electronic Mail', 'Elements', 'Gene Expression', 'Gene Expression Regulation', 'Genetic', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Human Resources', 'Individual', 'Internet', 'Investigation', 'Knowledge', 'Laboratories', 'Large-Scale Sequencing', 'Literature', 'Machine Learning', 'Malignant Neoplasms', 'Medical Research', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Process', 'Public Health', 'Publishing', 'Regulatory Element', 'Research', 'Research Personnel', 'Resolution', 'Resource Informatics', 'Resources', 'Sampling', 'Scoring Method', 'Source', 'Technology', 'Testing', 'Training', 'Variant', 'Visualization software', 'base', 'cell determination', 'cell type', 'chromatin modification', 'cloud based', 'computer program', 'gene function', 'genome annotation', 'genome sequencing', 'genome wide association study', 'genome-wide', 'improved', 'indexing', 'meetings', 'outreach', 'social media', 'tool', 'transcription factor', 'web site', 'web-accessible', 'whole genome']",NHGRI,STANFORD UNIVERSITY,U41,2017,782177,0.04417725117295533
"Mapping RNA polymerase in tissue samples with ChRO-seq. PROJECT ABSTRACT Deciphering how complex programs of gene expression and regulation contribute to human disease is one of the major challenges facing the field of genomics. Over the past decade, a wealth of new high-throughput genomics tools have revolutionized how we identify active genomic regions and appear poised to make great strides in understanding the mechanisms of disease. Yet the application of most of these technologies has been limited to established cell lines. Currently, approaches being developed to comprehensively map functional elements across the genome involve combining data from several different genome-wide experimental assays, making them expensive and impractical to use in clinical isolates of limited quantity or even to analyze new cell lines. Compounding these technical difficulties, gene expression is a complex and highly tissue dependent biological process, and many important applications will require the direct interrogation of clinical isolates or other similarly limited sources of sample. Thus, efficient new tools that map the repertoire of functional elements across the genome are likely to transform the biomedical and clinical sciences.  We propose to develop Chromatin Run-On and Sequencing (ChRO-seq) and a suite of computational tools for mapping transcription directly in limited tissue samples. Our approach uses a single genome-wide molecular assay to efficiently identify the location of promoters and enhancers, transcription factor binding sites, gene and lincRNA boundaries, transcription levels, and impute certain histone modifications. Preliminary ChRO-seq data reveals patterns of transcription that are virtually identical to those using Precision Run on and Sequencing in cultured cells, but can easily be applied in solid tissue samples. We applied our preliminary ChRO-seq technology to several primary tumors, revealing new insights into how transcriptional regulation underlies cancer development and progression, and providing a key proof-of-concept motivating further technology development. We anticipate that ChRO-seq and the computational methods proposed will enable the efficient discovery of functional elements in virtually any cell sample. In addition, ChRO-seq has the unique advantage that it can be applied in limited tissue samples and clinical isolates even after the degradation of mRNA. PROJECT NARRATIVE We propose to develop a suite of molecular and computational technologies that allow researchers to directly measure transcriptional regulation of genes, enhancers, and lincRNAs in limited clinical isolates. These technologies are anticipated to have a major impact on the biomedical sciences, enabling the genome-wide interrogation of transcription during virtually any disease process for the first time.",Mapping RNA polymerase in tissue samples with ChRO-seq.,9420630,R01HG009309,"['Archives', 'Binding', 'Binding Sites', 'Biological', 'Biological Assay', 'Biological Process', 'Cell Line', 'Cells', 'ChIP-seq', 'Chromatin', 'Clinical', 'Clinical Sciences', 'Code', 'Complex', 'Computing Methodologies', 'Cultured Cells', 'DNA Sequence', 'DNA-Directed RNA Polymerase', 'Data', 'Deoxyribonuclease I', 'Detection', 'Development', 'Disease', 'Elements', 'Enhancers', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'Gold', 'Hypersensitivity', 'Location', 'Malignant Neoplasms', 'Maps', 'Measures', 'Methods', 'Molecular', 'Molecular Computations', 'Nuclear', 'Outcome', 'Pattern', 'Performance', 'Population', 'Primary Neoplasm', 'Process', 'Protocols documentation', 'RNA', 'RNA Polymerase I', 'Regulatory Element', 'Research', 'Research Personnel', 'Resolution', 'Running', 'Sampling', 'Science', 'Signal Transduction', 'Site', 'Solid', 'Source', 'Specimen', 'Speed', 'Technology', 'Time', 'Tissue Sample', 'Tissues', 'Transcriptional Regulation', 'Untranslated RNA', 'computerized tools', 'deep learning', 'established cell line', 'experimental study', 'genome-wide', 'genomic tools', 'histone modification', 'human disease', 'improved', 'innovation', 'insight', 'mRNA Transcript Degradation', 'next generation', 'novel', 'predictive tools', 'programs', 'promoter', 'scale up', 'technology development', 'tool', 'transcription factor', 'virtual']",NHGRI,CORNELL UNIVERSITY,R01,2018,387500,0.01685679892161978
"Mapping RNA polymerase in tissue samples with ChRO-seq. PROJECT ABSTRACT Deciphering how complex programs of gene expression and regulation contribute to human disease is one of the major challenges facing the field of genomics. Over the past decade, a wealth of new high-throughput genomics tools have revolutionized how we identify active genomic regions and appear poised to make great strides in understanding the mechanisms of disease. Yet the application of most of these technologies has been limited to established cell lines. Currently, approaches being developed to comprehensively map functional elements across the genome involve combining data from several different genome-wide experimental assays, making them expensive and impractical to use in clinical isolates of limited quantity or even to analyze new cell lines. Compounding these technical difficulties, gene expression is a complex and highly tissue dependent biological process, and many important applications will require the direct interrogation of clinical isolates or other similarly limited sources of sample. Thus, efficient new tools that map the repertoire of functional elements across the genome are likely to transform the biomedical and clinical sciences.  We propose to develop Chromatin Run-On and Sequencing (ChRO-seq) and a suite of computational tools for mapping transcription directly in limited tissue samples. Our approach uses a single genome-wide molecular assay to efficiently identify the location of promoters and enhancers, transcription factor binding sites, gene and lincRNA boundaries, transcription levels, and impute certain histone modifications. Preliminary ChRO-seq data reveals patterns of transcription that are virtually identical to those using Precision Run on and Sequencing in cultured cells, but can easily be applied in solid tissue samples. We applied our preliminary ChRO-seq technology to several primary tumors, revealing new insights into how transcriptional regulation underlies cancer development and progression, and providing a key proof-of-concept motivating further technology development. We anticipate that ChRO-seq and the computational methods proposed will enable the efficient discovery of functional elements in virtually any cell sample. In addition, ChRO-seq has the unique advantage that it can be applied in limited tissue samples and clinical isolates even after the degradation of mRNA. PROJECT NARRATIVE We propose to develop a suite of molecular and computational technologies that allow researchers to directly measure transcriptional regulation of genes, enhancers, and lincRNAs in limited clinical isolates. These technologies are anticipated to have a major impact on the biomedical sciences, enabling the genome-wide interrogation of transcription during virtually any disease process for the first time.",Mapping RNA polymerase in tissue samples with ChRO-seq.,9850271,R01HG009309,"['Archives', 'Binding', 'Binding Sites', 'Biological', 'Biological Assay', 'Biological Process', 'Cell Line', 'Cells', 'ChIP-seq', 'Chromatin', 'Clinical', 'Clinical Sciences', 'Code', 'Complex', 'Computing Methodologies', 'Consumption', 'Cultured Cells', 'DNA Sequence', 'DNA-Directed RNA Polymerase', 'Data', 'Deoxyribonuclease I', 'Detection', 'Development', 'Disease', 'Elements', 'Enhancers', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'Gold', 'Hypersensitivity', 'Location', 'Malignant Neoplasms', 'Maps', 'Measures', 'Methods', 'Molecular', 'Molecular Computations', 'Nuclear', 'Outcome', 'Pattern', 'Performance', 'Population', 'Primary Neoplasm', 'Process', 'Protocols documentation', 'RNA', 'RNA Polymerase I', 'Regulatory Element', 'Research', 'Research Personnel', 'Resolution', 'Running', 'Sampling', 'Science', 'Signal Transduction', 'Site', 'Solid', 'Source', 'Specimen', 'Speed', 'Technology', 'Time', 'Tissue Sample', 'Tissues', 'Transcriptional Regulation', 'Untranslated RNA', 'computational suite', 'computerized tools', 'deep learning', 'established cell line', 'experimental study', 'genome-wide', 'genomic tools', 'histone modification', 'human disease', 'improved', 'innovation', 'insight', 'mRNA Transcript Degradation', 'next generation', 'novel', 'predictive tools', 'programs', 'promoter', 'scale up', 'technology development', 'tool', 'transcription factor', 'virtual']",NHGRI,CORNELL UNIVERSITY,R01,2020,387500,0.01685679892161978
"Mapping RNA polymerase in tissue samples with ChRO-seq. PROJECT ABSTRACT Deciphering how complex programs of gene expression and regulation contribute to human disease is one of the major challenges facing the field of genomics. Over the past decade, a wealth of new high-throughput genomics tools have revolutionized how we identify active genomic regions and appear poised to make great strides in understanding the mechanisms of disease. Yet the application of most of these technologies has been limited to established cell lines. Currently, approaches being developed to comprehensively map functional elements across the genome involve combining data from several different genome-wide experimental assays, making them expensive and impractical to use in clinical isolates of limited quantity or even to analyze new cell lines. Compounding these technical difficulties, gene expression is a complex and highly tissue dependent biological process, and many important applications will require the direct interrogation of clinical isolates or other similarly limited sources of sample. Thus, efficient new tools that map the repertoire of functional elements across the genome are likely to transform the biomedical and clinical sciences.  We propose to develop Chromatin Run-On and Sequencing (ChRO-seq) and a suite of computational tools for mapping transcription directly in limited tissue samples. Our approach uses a single genome-wide molecular assay to efficiently identify the location of promoters and enhancers, transcription factor binding sites, gene and lincRNA boundaries, transcription levels, and impute certain histone modifications. Preliminary ChRO-seq data reveals patterns of transcription that are virtually identical to those using Precision Run on and Sequencing in cultured cells, but can easily be applied in solid tissue samples. We applied our preliminary ChRO-seq technology to several primary tumors, revealing new insights into how transcriptional regulation underlies cancer development and progression, and providing a key proof-of-concept motivating further technology development. We anticipate that ChRO-seq and the computational methods proposed will enable the efficient discovery of functional elements in virtually any cell sample. In addition, ChRO-seq has the unique advantage that it can be applied in limited tissue samples and clinical isolates even after the degradation of mRNA. PROJECT NARRATIVE We propose to develop a suite of molecular and computational technologies that allow researchers to directly measure transcriptional regulation of genes, enhancers, and lincRNAs in limited clinical isolates. These technologies are anticipated to have a major impact on the biomedical sciences, enabling the genome-wide interrogation of transcription during virtually any disease process for the first time.",Mapping RNA polymerase in tissue samples with ChRO-seq.,9637410,R01HG009309,"['Archives', 'Binding', 'Binding Sites', 'Biological', 'Biological Assay', 'Biological Process', 'Cell Line', 'Cells', 'ChIP-seq', 'Chromatin', 'Clinical', 'Clinical Sciences', 'Code', 'Complex', 'Computing Methodologies', 'Consumption', 'Cultured Cells', 'DNA Sequence', 'DNA-Directed RNA Polymerase', 'Data', 'Deoxyribonuclease I', 'Detection', 'Development', 'Disease', 'Elements', 'Enhancers', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'Gold', 'Hypersensitivity', 'Location', 'Malignant Neoplasms', 'Maps', 'Measures', 'Methods', 'Molecular', 'Molecular Computations', 'Nuclear', 'Outcome', 'Pattern', 'Performance', 'Population', 'Primary Neoplasm', 'Process', 'Protocols documentation', 'RNA', 'RNA Polymerase I', 'Regulatory Element', 'Research', 'Research Personnel', 'Resolution', 'Running', 'Sampling', 'Science', 'Signal Transduction', 'Site', 'Solid', 'Source', 'Specimen', 'Speed', 'Technology', 'Time', 'Tissue Sample', 'Tissues', 'Transcriptional Regulation', 'Untranslated RNA', 'computational suite', 'computerized tools', 'deep learning', 'established cell line', 'experimental study', 'genome-wide', 'genomic tools', 'histone modification', 'human disease', 'improved', 'innovation', 'insight', 'mRNA Transcript Degradation', 'next generation', 'novel', 'predictive tools', 'programs', 'promoter', 'scale up', 'technology development', 'tool', 'transcription factor', 'virtual']",NHGRI,CORNELL UNIVERSITY,R01,2019,387500,0.01685679892161978
"Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D Project Summary Most of the 1000s of sequencing experiments generated by ENCODE provide 1D readouts of the epigenetic landscape or transcriptional output of a 3D genome. New chromosome conformation capture (3C) technologies  in particular Hi-C and ChIA-PET  have begun to provide insight into the hierarchical 3D organization of the genome: the partition of chromosomes into open and closed compartments; the existence of structural subunits defined as topologically associated domains (TADs); and the presence of regulatory and structural DNA loops within TADs. New experimental evidence using CRISPR/Cas-mediated genome editing suggests that disruption of local 3D structure can alter regulation of neighboring genes, and there have been early efforts to use data on 3D DNA looping to predict the impact of non-coding SNPs from GWAS studies. The goal of this proposal is to develop new integrative computational methods to interpret large-scale ENCODE 1D epigenomic and transcriptomic resources in light of the underlying 3D architecture of the genome. Members of our team have pioneered powerful methods to infer local chromatin states from a 1D viewpoint through the Segway suite. We have also analyzed the 1D organization of chromatin accessible elements and their lineage dynamics to define the concept of regulatory complexity, and we presented a gene regulation model to predict gene expression changes in differentiation from the DNA content of active enhancers. Here we will build on these efforts to learn chromatin state and gene regulation models that incorporate information on hierarchical 3D genomic architecture, enabling us to predict how individual structural/regulatory elements contribute to 3D DNA looping and to gene expression. Mechanistic predictions will be experimentally validated in their native cell-type specific chromatin context using state-of-the-art genome editing, exploiting computational and experimental CRISPR/Cas tools developed by our team. Project Narrative This project develops advanced computational methods for integrating information on the 3D structure of the human genome with large-scale genomics data sets generated by the ENCODE project to gain insight into cell-type specific chromatin state and gene regulation. These studies have broad relevance for understanding the regulation of gene expression in human cells and the disruption of gene expression programs in disease.","Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D",9855022,U01HG009395,"['3-Dimensional', 'ATAC-seq', 'Architecture', 'Atlases', 'Cells', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Chromatin Loop', 'Chromosomes', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'DNA Structure', 'DNase I hypersensitive sites sequencing', 'Data', 'Disease', 'Elements', 'Encyclopedias', 'Enhancers', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomics', 'Goals', 'Guide RNA', 'Human', 'Human Genome', 'Hybrids', 'Individual', 'Learning', 'Light', 'Link', 'Mediating', 'Methods', 'Modeling', 'Output', 'Peptide Signal Sequences', 'Ploidies', 'Published Comment', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Resolution', 'Resources', 'Specificity', 'Statistical Data Interpretation', 'Structural Models', 'Structure', 'Technology', 'Training', 'Untranslated RNA', 'base', 'cell type', 'chromosome conformation capture', 'computerized tools', 'deep learning', 'density', 'epigenomics', 'experimental study', 'genome annotation', 'genome editing', 'genome wide association study', 'genomic data', 'histone modification', 'insight', 'learning strategy', 'member', 'next generation', 'predictive modeling', 'programs', 'sequence learning', 'supervised learning', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'transcription factor', 'transcriptomics', 'unsupervised learning']",NHGRI,SLOAN-KETTERING INST CAN RESEARCH,U01,2020,742538,0.026106444922985448
"Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D Project Summary Most of the 1000s of sequencing experiments generated by ENCODE provide 1D readouts of the epigenetic landscape or transcriptional output of a 3D genome. New chromosome conformation capture (3C) technologies  in particular Hi-C and ChIA-PET  have begun to provide insight into the hierarchical 3D organization of the genome: the partition of chromosomes into open and closed compartments; the existence of structural subunits defined as topologically associated domains (TADs); and the presence of regulatory and structural DNA loops within TADs. New experimental evidence using CRISPR/Cas-mediated genome editing suggests that disruption of local 3D structure can alter regulation of neighboring genes, and there have been early efforts to use data on 3D DNA looping to predict the impact of non-coding SNPs from GWAS studies. The goal of this proposal is to develop new integrative computational methods to interpret large-scale ENCODE 1D epigenomic and transcriptomic resources in light of the underlying 3D architecture of the genome. Members of our team have pioneered powerful methods to infer local chromatin states from a 1D viewpoint through the Segway suite. We have also analyzed the 1D organization of chromatin accessible elements and their lineage dynamics to define the concept of regulatory complexity, and we presented a gene regulation model to predict gene expression changes in differentiation from the DNA content of active enhancers. Here we will build on these efforts to learn chromatin state and gene regulation models that incorporate information on hierarchical 3D genomic architecture, enabling us to predict how individual structural/regulatory elements contribute to 3D DNA looping and to gene expression. Mechanistic predictions will be experimentally validated in their native cell-type specific chromatin context using state-of-the-art genome editing, exploiting computational and experimental CRISPR/Cas tools developed by our team. Project Narrative This project develops advanced computational methods for integrating information on the 3D structure of the human genome with large-scale genomics data sets generated by the ENCODE project to gain insight into cell-type specific chromatin state and gene regulation. These studies have broad relevance for understanding the regulation of gene expression in human cells and the disruption of gene expression programs in disease.","Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D",9629973,U01HG009395,"['3-Dimensional', 'ATAC-seq', 'Architecture', 'Atlases', 'Cells', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Chromatin Loop', 'Chromosomes', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'DNA Structure', 'DNase I hypersensitive sites sequencing', 'Data', 'Disease', 'Elements', 'Encyclopedias', 'Enhancers', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomics', 'Goals', 'Guide RNA', 'Human', 'Human Genome', 'Hybrids', 'Individual', 'Learning', 'Light', 'Link', 'Mediating', 'Methods', 'Modeling', 'Output', 'Peptide Signal Sequences', 'Ploidies', 'Published Comment', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Resolution', 'Resources', 'Specificity', 'Statistical Data Interpretation', 'Structural Models', 'Structure', 'Technology', 'Training', 'Untranslated RNA', 'base', 'cell type', 'chromosome conformation capture', 'computerized tools', 'deep learning', 'density', 'epigenomics', 'experimental study', 'genome annotation', 'genome editing', 'genome wide association study', 'genomic data', 'histone modification', 'insight', 'learning strategy', 'member', 'next generation', 'predictive modeling', 'programs', 'sequence learning', 'supervised learning', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'transcription factor', 'transcriptomics', 'unsupervised learning']",NHGRI,SLOAN-KETTERING INST CAN RESEARCH,U01,2019,742538,0.026106444922985448
"Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D Project Summary Most of the 1000s of sequencing experiments generated by ENCODE provide 1D readouts of the epigenetic landscape or transcriptional output of a 3D genome. New chromosome conformation capture (3C) technologies  in particular Hi-C and ChIA-PET  have begun to provide insight into the hierarchical 3D organization of the genome: the partition of chromosomes into open and closed compartments; the existence of structural subunits defined as topologically associated domains (TADs); and the presence of regulatory and structural DNA loops within TADs. New experimental evidence using CRISPR/Cas-mediated genome editing suggests that disruption of local 3D structure can alter regulation of neighboring genes, and there have been early efforts to use data on 3D DNA looping to predict the impact of non-coding SNPs from GWAS studies. The goal of this proposal is to develop new integrative computational methods to interpret large-scale ENCODE 1D epigenomic and transcriptomic resources in light of the underlying 3D architecture of the genome. Members of our team have pioneered powerful methods to infer local chromatin states from a 1D viewpoint through the Segway suite. We have also analyzed the 1D organization of chromatin accessible elements and their lineage dynamics to define the concept of regulatory complexity, and we presented a gene regulation model to predict gene expression changes in differentiation from the DNA content of active enhancers. Here we will build on these efforts to learn chromatin state and gene regulation models that incorporate information on hierarchical 3D genomic architecture, enabling us to predict how individual structural/regulatory elements contribute to 3D DNA looping and to gene expression. Mechanistic predictions will be experimentally validated in their native cell-type specific chromatin context using state-of-the-art genome editing, exploiting computational and experimental CRISPR/Cas tools developed by our team. Project Narrative This project develops advanced computational methods for integrating information on the 3D structure of the human genome with large-scale genomics data sets generated by the ENCODE project to gain insight into cell-type specific chromatin state and gene regulation. These studies have broad relevance for understanding the regulation of gene expression in human cells and the disruption of gene expression programs in disease.","Encoding genomic architecture in the encyclopedia: linking DNA elements, chromatin state, and gene expression in 3D",9420631,U01HG009395,"['ATAC-seq', 'Architecture', 'Atlases', 'Cells', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Chromatin Loop', 'Chromosomes', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'DNase I hypersensitive sites sequencing', 'Data', 'Data Set', 'Disease', 'Elements', 'Encyclopedias', 'Enhancers', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomics', 'Goals', 'Guide RNA', 'Human', 'Human Genome', 'Hybrids', 'Individual', 'Learning', 'Light', 'Link', 'Mediating', 'Methods', 'Modeling', 'Output', 'Peptide Signal Sequences', 'Ploidies', 'Published Comment', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Resolution', 'Resources', 'Specificity', 'Statistical Data Interpretation', 'Structure', 'Supervision', 'Technology', 'Training', 'Untranslated RNA', 'base', 'cell type', 'chromosome conformation capture', 'computerized tools', 'deep learning', 'density', 'epigenomics', 'experimental study', 'genome annotation', 'genome editing', 'genome wide association study', 'genomic data', 'histone modification', 'insight', 'learning strategy', 'member', 'next generation', 'predictive modeling', 'programs', 'sequence learning', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'transcription factor', 'transcriptomics']",NHGRI,SLOAN-KETTERING INST CAN RESEARCH,U01,2018,717318,0.026106444922985448
"Decoding the regulatory architecture of the human genome across cell types, individuals and disease PROJECT DESCRIPTION While accurate annotations of protein-coding regions in the human genome have been available for many years, annotation and interpretation of regulatory sequences has lagged far behind. This is becausein contrast to protein-coding sequencesthe rules that govern links from genome sequence to regulatory function are fuzzy, complex, and highly context-specific. Our limited understanding of regulatory regions presents a fundamental challenge for the identification and interpretation of disease variation, especially in the context of personal genome interpretation. Work from ENCODE and other groups has started to close this gap through experimental work, including high-resolution maps of regulatory sites in a variety of cell types, and modeling of the cell-type specific mappings from genome sequence to regulatory function. In this project we will develop a suite of new tools that uses these diverse new data sets to tackle these problems. We will implement and apply powerful new machine learning methods (based on deep learning) to interpret the genomic, context-specific encoding of regulatory information, and to identify genetic variants that impact the encoded information. We will build models using data from a variety of sources including ENCODE, Roadmap Epigenomics, GTEx, regulatory variation in the HapMap cell lines, as well as from disease cohorts. Validation experiments will be performed using a new high-complexity CRISPR/Cas9 system developed by our team. We will develop software tools and analytical results that can be widely used for genome interpretation, especially in analysis of personal genomes. By the end of this study we expect to have: (1) developed powerful new computational models for predicting regulatory function in a wide variety of cell types, at unprecedented resolution; (2) implemented novel validation screens in native chromatin at extremely high throughput; and (3) developed new tools for interpreting common and rare regulatory variation, with particular focus on identification of high-impact regulatory mutations in personal genomes. We are committed to timely release of software, data and analysis and are committed to working with the ENCODE Consortium to increase the impact of data and analyses from all study sites. PROJECT NARRATIVE The purpose of this project is to develop powerful new computational methods to understand and predict the identity and function of gene regulatory sequences in diverse cell types. We will use these new methods to help us interpret common and rare genetic variation, and to identify variants that may contribute to disease. Outputs from the project will include new methods, software and functional validation data.","Decoding the regulatory architecture of the human genome across cell types, individuals and disease",9851890,U01HG009431,"['Affect', 'Architecture', 'Binding', 'Biological Assay', 'CRISPR screen', 'CRISPR/Cas technology', 'Cell Line', 'Cell model', 'Cells', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Code', 'Complement', 'Complex', 'Computer Analysis', 'Computer Models', 'Computer software', 'Computing Methodologies', 'Custom', 'DNA', 'DNA Sequence', 'DNA Sequence Alteration', 'Data', 'Data Analyses', 'Data Set', 'Disease', 'Elements', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genome Mappings', 'Genomics', 'Genotype-Tissue Expression Project', 'Human Genome', 'Individual', 'K-562', 'Libraries', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modernization', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Open Reading Frames', 'Output', 'Phenotype', 'Proteins', 'Quantitative Trait Loci', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Repression', 'Research Personnel', 'Resolution', 'Sampling', 'Scoring Method', 'Shapes', 'Site', 'Software Tools', 'Source', 'System', 'Testing', 'The Sun', 'Time', 'Tissues', 'Training', 'Trans-Activators', 'Untranslated RNA', 'Validation', 'Variant', 'Work', 'base', 'cell type', 'cohort', 'deep learning', 'epigenome', 'epigenomics', 'experimental study', 'expression vector', 'gene function', 'genetic variant', 'genome wide association study', 'genome-wide', 'genomic data', 'induced pluripotent stem cell', 'innovation', 'insertion/deletion mutation', 'large scale data', 'lymphoblastoid cell line', 'machine learning method', 'molecular phenotype', 'novel', 'personalized genomic medicine', 'predictive modeling', 'programs', 'software development', 'tool', 'trait', 'transcription factor', 'transcriptome sequencing']",NHGRI,STANFORD UNIVERSITY,U01,2020,620335,0.12114678715264923
"Decoding the regulatory architecture of the human genome across cell types, individuals and disease PROJECT DESCRIPTION While accurate annotations of protein-coding regions in the human genome have been available for many years, annotation and interpretation of regulatory sequences has lagged far behind. This is becausein contrast to protein-coding sequencesthe rules that govern links from genome sequence to regulatory function are fuzzy, complex, and highly context-specific. Our limited understanding of regulatory regions presents a fundamental challenge for the identification and interpretation of disease variation, especially in the context of personal genome interpretation. Work from ENCODE and other groups has started to close this gap through experimental work, including high-resolution maps of regulatory sites in a variety of cell types, and modeling of the cell-type specific mappings from genome sequence to regulatory function. In this project we will develop a suite of new tools that uses these diverse new data sets to tackle these problems. We will implement and apply powerful new machine learning methods (based on deep learning) to interpret the genomic, context-specific encoding of regulatory information, and to identify genetic variants that impact the encoded information. We will build models using data from a variety of sources including ENCODE, Roadmap Epigenomics, GTEx, regulatory variation in the HapMap cell lines, as well as from disease cohorts. Validation experiments will be performed using a new high-complexity CRISPR/Cas9 system developed by our team. We will develop software tools and analytical results that can be widely used for genome interpretation, especially in analysis of personal genomes. By the end of this study we expect to have: (1) developed powerful new computational models for predicting regulatory function in a wide variety of cell types, at unprecedented resolution; (2) implemented novel validation screens in native chromatin at extremely high throughput; and (3) developed new tools for interpreting common and rare regulatory variation, with particular focus on identification of high-impact regulatory mutations in personal genomes. We are committed to timely release of software, data and analysis and are committed to working with the ENCODE Consortium to increase the impact of data and analyses from all study sites. PROJECT NARRATIVE The purpose of this project is to develop powerful new computational methods to understand and predict the identity and function of gene regulatory sequences in diverse cell types. We will use these new methods to help us interpret common and rare genetic variation, and to identify variants that may contribute to disease. Outputs from the project will include new methods, software and functional validation data.","Decoding the regulatory architecture of the human genome across cell types, individuals and disease",9625746,U01HG009431,"['Affect', 'Architecture', 'Binding', 'Biological Assay', 'CRISPR screen', 'CRISPR/Cas technology', 'Cell Line', 'Cell model', 'Cells', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Code', 'Complement', 'Complex', 'Computer Analysis', 'Computer Simulation', 'Computer software', 'Computing Methodologies', 'Custom', 'DNA', 'DNA Sequence', 'DNA Sequence Alteration', 'Data', 'Data Analyses', 'Data Set', 'Disease', 'Elements', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genome Mappings', 'Genomics', 'Genotype-Tissue Expression Project', 'Human Genome', 'Individual', 'K-562', 'Libraries', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modernization', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Open Reading Frames', 'Output', 'Phenotype', 'Proteins', 'Quantitative Trait Loci', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Repression', 'Research Personnel', 'Resolution', 'Sampling', 'Scoring Method', 'Shapes', 'Site', 'Software Tools', 'Source', 'System', 'Testing', 'The Sun', 'Time', 'Tissues', 'Training', 'Trans-Activators', 'Untranslated RNA', 'Validation', 'Variant', 'Work', 'base', 'cell type', 'cohort', 'deep learning', 'epigenome', 'epigenomics', 'experimental study', 'expression vector', 'gene function', 'genetic variant', 'genome wide association study', 'genome-wide', 'genomic data', 'induced pluripotent stem cell', 'innovation', 'insertion/deletion mutation', 'learning strategy', 'lymphoblastoid cell line', 'molecular phenotype', 'novel', 'personalized genomic medicine', 'predictive modeling', 'programs', 'software development', 'tool', 'trait', 'transcription factor', 'transcriptome sequencing']",NHGRI,STANFORD UNIVERSITY,U01,2019,620335,0.12114678715264923
"Decoding the regulatory architecture of the human genome across cell types, individuals and disease PROJECT DESCRIPTION While accurate annotations of protein-coding regions in the human genome have been available for many years, annotation and interpretation of regulatory sequences has lagged far behind. This is becausein contrast to protein-coding sequencesthe rules that govern links from genome sequence to regulatory function are fuzzy, complex, and highly context-specific. Our limited understanding of regulatory regions presents a fundamental challenge for the identification and interpretation of disease variation, especially in the context of personal genome interpretation. Work from ENCODE and other groups has started to close this gap through experimental work, including high-resolution maps of regulatory sites in a variety of cell types, and modeling of the cell-type specific mappings from genome sequence to regulatory function. In this project we will develop a suite of new tools that uses these diverse new data sets to tackle these problems. We will implement and apply powerful new machine learning methods (based on deep learning) to interpret the genomic, context-specific encoding of regulatory information, and to identify genetic variants that impact the encoded information. We will build models using data from a variety of sources including ENCODE, Roadmap Epigenomics, GTEx, regulatory variation in the HapMap cell lines, as well as from disease cohorts. Validation experiments will be performed using a new high-complexity CRISPR/Cas9 system developed by our team. We will develop software tools and analytical results that can be widely used for genome interpretation, especially in analysis of personal genomes. By the end of this study we expect to have: (1) developed powerful new computational models for predicting regulatory function in a wide variety of cell types, at unprecedented resolution; (2) implemented novel validation screens in native chromatin at extremely high throughput; and (3) developed new tools for interpreting common and rare regulatory variation, with particular focus on identification of high-impact regulatory mutations in personal genomes. We are committed to timely release of software, data and analysis and are committed to working with the ENCODE Consortium to increase the impact of data and analyses from all study sites. PROJECT NARRATIVE The purpose of this project is to develop powerful new computational methods to understand and predict the identity and function of gene regulatory sequences in diverse cell types. We will use these new methods to help us interpret common and rare genetic variation, and to identify variants that may contribute to disease. Outputs from the project will include new methods, software and functional validation data.","Decoding the regulatory architecture of the human genome across cell types, individuals and disease",9420632,U01HG009431,"['Affect', 'Architecture', 'Binding', 'Biological Assay', 'CRISPR screen', 'CRISPR/Cas technology', 'Cell Line', 'Cell model', 'Cells', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Code', 'Complement', 'Complex', 'Computer Analysis', 'Computer Simulation', 'Computer software', 'Computing Methodologies', 'Custom', 'DNA', 'DNA Sequence', 'DNA Sequence Alteration', 'Data', 'Data Analyses', 'Data Set', 'Disease', 'Elements', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genome Mappings', 'Genomics', 'Genotype-Tissue Expression Project', 'Human Genome', 'Individual', 'K-562', 'Libraries', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modernization', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Open Reading Frames', 'Output', 'Phenotype', 'Proteins', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Repression', 'Research Personnel', 'Resolution', 'Sampling', 'Scoring Method', 'Shapes', 'Site', 'Software Tools', 'Source', 'System', 'Testing', 'The Sun', 'Time', 'Tissues', 'Training', 'Trans-Activators', 'Untranslated RNA', 'Validation', 'Variant', 'Work', 'base', 'cell type', 'cohort', 'deep learning', 'epigenome', 'epigenomics', 'experimental study', 'expression vector', 'gene function', 'genetic variant', 'genome wide association study', 'genome-wide', 'genomic data', 'induced pluripotent stem cell', 'innovation', 'insertion/deletion mutation', 'learning strategy', 'lymphoblastoid cell line', 'molecular phenotype', 'novel', 'personalized genomic medicine', 'predictive modeling', 'programs', 'software development', 'tool', 'trait', 'transcription factor', 'transcriptome sequencing']",NHGRI,STANFORD UNIVERSITY,U01,2018,620335,0.12114678715264923
"Decoding the regulatory architecture of the human genome across cell types, individuals and disease PROJECT DESCRIPTION While accurate annotations of protein-coding regions in the human genome have been available for many years, annotation and interpretation of regulatory sequences has lagged far behind. This is becausein contrast to protein-coding sequencesthe rules that govern links from genome sequence to regulatory function are fuzzy, complex, and highly context-specific. Our limited understanding of regulatory regions presents a fundamental challenge for the identification and interpretation of disease variation, especially in the context of personal genome interpretation. Work from ENCODE and other groups has started to close this gap through experimental work, including high-resolution maps of regulatory sites in a variety of cell types, and modeling of the cell-type specific mappings from genome sequence to regulatory function. In this project we will develop a suite of new tools that uses these diverse new data sets to tackle these problems. We will implement and apply powerful new machine learning methods (based on deep learning) to interpret the genomic, context-specific encoding of regulatory information, and to identify genetic variants that impact the encoded information. We will build models using data from a variety of sources including ENCODE, Roadmap Epigenomics, GTEx, regulatory variation in the HapMap cell lines, as well as from disease cohorts. Validation experiments will be performed using a new high-complexity CRISPR/Cas9 system developed by our team. We will develop software tools and analytical results that can be widely used for genome interpretation, especially in analysis of personal genomes. By the end of this study we expect to have: (1) developed powerful new computational models for predicting regulatory function in a wide variety of cell types, at unprecedented resolution; (2) implemented novel validation screens in native chromatin at extremely high throughput; and (3) developed new tools for interpreting common and rare regulatory variation, with particular focus on identification of high-impact regulatory mutations in personal genomes. We are committed to timely release of software, data and analysis and are committed to working with the ENCODE Consortium to increase the impact of data and analyses from all study sites. PROJECT NARRATIVE The purpose of this project is to develop powerful new computational methods to understand and predict the identity and function of gene regulatory sequences in diverse cell types. We will use these new methods to help us interpret common and rare genetic variation, and to identify variants that may contribute to disease. Outputs from the project will include new methods, software and functional validation data.","Decoding the regulatory architecture of the human genome across cell types, individuals and disease",9247598,U01HG009431,"['Affect', 'Architecture', 'Binding', 'Biological Assay', 'CRISPR screen', 'CRISPR/Cas technology', 'Cell Line', 'Cell model', 'Cells', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Code', 'Complement', 'Complex', 'Computer Analysis', 'Computer Simulation', 'Computer software', 'Computing Methodologies', 'Custom', 'DNA', 'DNA Sequence', 'DNA Sequence Alteration', 'Data', 'Data Analyses', 'Data Set', 'Disease', 'Elements', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genome Mappings', 'Genomics', 'Genotype-Tissue Expression Project', 'Human Genome', 'Individual', 'K-562', 'Learning', 'Libraries', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modernization', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Open Reading Frames', 'Output', 'Phenotype', 'Proteins', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Repression', 'Research Personnel', 'Resolution', 'Sampling', 'Scoring Method', 'Shapes', 'Site', 'Software Tools', 'Source', 'System', 'Testing', 'The Sun', 'Time', 'Tissues', 'Training', 'Trans-Activators', 'Validation', 'Variant', 'Work', 'base', 'cell type', 'cohort', 'epigenome', 'epigenomics', 'experimental study', 'expression vector', 'gene function', 'genetic variant', 'genome wide association study', 'genome-wide', 'genomic data', 'induced pluripotent stem cell', 'innovation', 'insertion/deletion mutation', 'learning strategy', 'lymphoblastoid cell line', 'molecular phenotype', 'novel', 'personalized genomic medicine', 'predictive modeling', 'programs', 'software development', 'tool', 'trait', 'transcription factor', 'transcriptome sequencing']",NHGRI,STANFORD UNIVERSITY,U01,2017,620335,0.12114678715264923
"Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation Project Summary The ENCODE project has generated comprehensive maps of cis-regulatory elements (CREs) controlling the transcription of genes within the human genome. These maps have been crucial in our efforts to understand sequence variants linked to human traits and disease, as the majority of these variants are non- coding regulatory changes rather than amino acid substitutions. However, even though we know the locations of thousands of CREs, our understanding of how they operate is derived from a relatively small set of well- described examples. Therefore, we plan to directly characterize the function of ENCODE CREs at a genome- wide scale in multiple cell-types. This will transition the field of functional genomics from a simple map of regulatory elements towards a deep understanding of the fundamental rules governing regulatory logic down to the basepair resolution. Achieving this will dramatically expand ENCODE's utility by strengthening our ability to interpret the effects of natural human variation on gene regulation. We propose to directly measure regulatory activity of over 3% of the genome, pursuing loci highlighted as important by ENCODE and other functional data. We will first apply computational methods to identify the most biologically informative CREs, representing a diversity of regulatory logic and architecture, and will use machine learning techniques to prioritize functional variants for characterization relevant to common and rare human diseases, traits, and adaptation. Of these we will select 200,000 CREs and 300,000 variants, representing 100 Mb of genomic sequence, and characterize them using the massively parallel reporter assay (MPRA) to understand each element's regulatory activity. Then, to complement data from the MPRA, we will characterize additional 1 Mb regions across 10 loci using CRISPR-based non-coding screens to build a comprehensive picture of these loci. This strategy leverages the throughput and flexibility of MPRA while maintaining the connectivity of regulatory logic in the CRISPR-based screens, which perturb elements within their endogenous genomic context. This will help us judge the accuracy and completeness of ENCODE, while also providing data from both approaches to address a wide-variety of research questions. These methods are difficult to apply to disease relevant primary cells at full scale, but we will use the results of our MPRA and CRISPR screens to inform our models and better predict the fundamental rules of regulatory logic. We will then construct smaller, targeted libraries to test disease-specific variants in primary cells and use assays specific for each of three autoimmune diseases: type 1 diabetes, inflammatory bowel disease, and lupus. This approach will inform the research community on the rules governing the activity of the CREs mapped by the ENCODE project, and will simultaneously provide concrete information about the function of hundreds of thousands of sequence variants relevant for human traits, health, and disease. Project Narrative In our proposal we seek to extend the efforts by the ENCODE consortium and others who have made significant strides towards mapping the regulatory landscape of the human genome. We will apply large-scale functional characterization methods to directly test over 3% of the human genome for cis-regulatory activity. In doing so, we will create a resource that will improve our ability to pinpoint regulatory elements in our genome, increase our understanding of how they function, and aid in our ability to link genetic variation to human health and disease.",Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation,9952404,UM1HG009435,"['Address', 'Amino Acid Substitution', 'Architecture', 'Autoimmune Diseases', 'Benchmarking', 'Biochemical', 'Biological', 'Biological Assay', 'Bypass', 'CRISPR interference', 'CRISPR screen', 'CRISPR/Cas technology', 'Catalogs', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Complement', 'Complex', 'Computational Technique', 'Computing Methodologies', 'Data', 'Data Set', 'Disease', 'Dissection', 'Elements', 'Foundations', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genomic Segment', 'Genomics', 'Health', 'HepG2', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Inflammatory Bowel Diseases', 'Insulin-Dependent Diabetes Mellitus', 'K-562', 'Learning', 'Libraries', 'Link', 'Location', 'Logic', 'Lupus', 'Machine Learning', 'Maps', 'Measures', 'Mechanics', 'Medical', 'Methods', 'Modeling', 'Regulatory Element', 'Reporter', 'Research', 'Resolution', 'Resources', 'System', 'Systemic Lupus Erythematosus', 'Techniques', 'Testing', 'Untranslated RNA', 'Variant', 'Work', 'base', 'biological systems', 'cell type', 'computerized tools', 'design', 'experimental study', 'flexibility', 'functional genomics', 'genome-wide', 'human disease', 'improved', 'interest', 'tool', 'trait']",NHGRI,"BROAD INSTITUTE, INC.",UM1,2020,1496387,0.05854709309862032
"Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation Project Summary The ENCODE project has generated comprehensive maps of cis-regulatory elements (CREs) controlling the transcription of genes within the human genome. These maps have been crucial in our efforts to understand sequence variants linked to human traits and disease, as the majority of these variants are non- coding regulatory changes rather than amino acid substitutions. However, even though we know the locations of thousands of CREs, our understanding of how they operate is derived from a relatively small set of well- described examples. Therefore, we plan to directly characterize the function of ENCODE CREs at a genome- wide scale in multiple cell-types. This will transition the field of functional genomics from a simple map of regulatory elements towards a deep understanding of the fundamental rules governing regulatory logic down to the basepair resolution. Achieving this will dramatically expand ENCODE's utility by strengthening our ability to interpret the effects of natural human variation on gene regulation. We propose to directly measure regulatory activity of over 3% of the genome, pursuing loci highlighted as important by ENCODE and other functional data. We will first apply computational methods to identify the most biologically informative CREs, representing a diversity of regulatory logic and architecture, and will use machine learning techniques to prioritize functional variants for characterization relevant to common and rare human diseases, traits, and adaptation. Of these we will select 200,000 CREs and 300,000 variants, representing 100 Mb of genomic sequence, and characterize them using the massively parallel reporter assay (MPRA) to understand each element's regulatory activity. Then, to complement data from the MPRA, we will characterize additional 1 Mb regions across 10 loci using CRISPR-based non-coding screens to build a comprehensive picture of these loci. This strategy leverages the throughput and flexibility of MPRA while maintaining the connectivity of regulatory logic in the CRISPR-based screens, which perturb elements within their endogenous genomic context. This will help us judge the accuracy and completeness of ENCODE, while also providing data from both approaches to address a wide-variety of research questions. These methods are difficult to apply to disease relevant primary cells at full scale, but we will use the results of our MPRA and CRISPR screens to inform our models and better predict the fundamental rules of regulatory logic. We will then construct smaller, targeted libraries to test disease-specific variants in primary cells and use assays specific for each of three autoimmune diseases: type 1 diabetes, inflammatory bowel disease, and lupus. This approach will inform the research community on the rules governing the activity of the CREs mapped by the ENCODE project, and will simultaneously provide concrete information about the function of hundreds of thousands of sequence variants relevant for human traits, health, and disease. Project Narrative In our proposal we seek to extend the efforts by the ENCODE consortium and others who have made significant strides towards mapping the regulatory landscape of the human genome. We will apply large-scale functional characterization methods to directly test over 3% of the human genome for cis-regulatory activity. In doing so, we will create a resource that will improve our ability to pinpoint regulatory elements in our genome, increase our understanding of how they function, and aid in our ability to link genetic variation to human health and disease.",Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation,9766882,UM1HG009435,"['Address', 'Amino Acid Substitution', 'Architecture', 'Autoimmune Diseases', 'Benchmarking', 'Biochemical', 'Biological', 'Biological Assay', 'Bypass', 'CRISPR interference', 'CRISPR screen', 'CRISPR/Cas technology', 'Catalogs', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Complement', 'Complex', 'Computational Technique', 'Computing Methodologies', 'Data', 'Data Set', 'Disease', 'Dissection', 'Elements', 'Foundations', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genomic Segment', 'Genomics', 'Health', 'HepG2', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Inflammatory Bowel Diseases', 'Insulin-Dependent Diabetes Mellitus', 'K-562', 'Learning', 'Libraries', 'Link', 'Location', 'Logic', 'Lupus', 'Machine Learning', 'Maps', 'Measures', 'Mechanics', 'Medical', 'Methods', 'Modeling', 'Regulatory Element', 'Reporter', 'Research', 'Resolution', 'Resources', 'System', 'Systemic Lupus Erythematosus', 'Techniques', 'Testing', 'Untranslated RNA', 'Variant', 'Work', 'base', 'biological systems', 'cell type', 'computerized tools', 'design', 'experimental study', 'flexibility', 'functional genomics', 'genome-wide', 'human disease', 'improved', 'interest', 'tool', 'trait']",NHGRI,"BROAD INSTITUTE, INC.",UM1,2019,1497668,0.05854709309862032
"Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation Project Summary The ENCODE project has generated comprehensive maps of cis-regulatory elements (CREs) controlling the transcription of genes within the human genome. These maps have been crucial in our efforts to understand sequence variants linked to human traits and disease, as the majority of these variants are non- coding regulatory changes rather than amino acid substitutions. However, even though we know the locations of thousands of CREs, our understanding of how they operate is derived from a relatively small set of well- described examples. Therefore, we plan to directly characterize the function of ENCODE CREs at a genome- wide scale in multiple cell-types. This will transition the field of functional genomics from a simple map of regulatory elements towards a deep understanding of the fundamental rules governing regulatory logic down to the basepair resolution. Achieving this will dramatically expand ENCODE's utility by strengthening our ability to interpret the effects of natural human variation on gene regulation. We propose to directly measure regulatory activity of over 3% of the genome, pursuing loci highlighted as important by ENCODE and other functional data. We will first apply computational methods to identify the most biologically informative CREs, representing a diversity of regulatory logic and architecture, and will use machine learning techniques to prioritize functional variants for characterization relevant to common and rare human diseases, traits, and adaptation. Of these we will select 200,000 CREs and 300,000 variants, representing 100 Mb of genomic sequence, and characterize them using the massively parallel reporter assay (MPRA) to understand each element's regulatory activity. Then, to complement data from the MPRA, we will characterize additional 1 Mb regions across 10 loci using CRISPR-based non-coding screens to build a comprehensive picture of these loci. This strategy leverages the throughput and flexibility of MPRA while maintaining the connectivity of regulatory logic in the CRISPR-based screens, which perturb elements within their endogenous genomic context. This will help us judge the accuracy and completeness of ENCODE, while also providing data from both approaches to address a wide-variety of research questions. These methods are difficult to apply to disease relevant primary cells at full scale, but we will use the results of our MPRA and CRISPR screens to inform our models and better predict the fundamental rules of regulatory logic. We will then construct smaller, targeted libraries to test disease-specific variants in primary cells and use assays specific for each of three autoimmune diseases: type 1 diabetes, inflammatory bowel disease, and lupus. This approach will inform the research community on the rules governing the activity of the CREs mapped by the ENCODE project, and will simultaneously provide concrete information about the function of hundreds of thousands of sequence variants relevant for human traits, health, and disease. Project Narrative In our proposal we seek to extend the efforts by the ENCODE consortium and others who have made significant strides towards mapping the regulatory landscape of the human genome. We will apply large-scale functional characterization methods to directly test over 3% of the human genome for cis-regulatory activity. In doing so, we will create a resource that will improve our ability to pinpoint regulatory elements in our genome, increase our understanding of how they function, and aid in our ability to link genetic variation to human health and disease.",Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation,9696513,UM1HG009435,"['Address', 'Amino Acid Substitution', 'Architecture', 'Autoimmune Diseases', 'Benchmarking', 'Biochemical', 'Biological', 'Biological Assay', 'Bypass', 'CRISPR interference', 'CRISPR screen', 'CRISPR/Cas technology', 'Catalogs', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Complement', 'Complex', 'Computational Technique', 'Computing Methodologies', 'Data', 'Data Set', 'Disease', 'Dissection', 'Elements', 'Foundations', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genomic Segment', 'Genomics', 'Health', 'HepG2', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Inflammatory Bowel Diseases', 'Insulin-Dependent Diabetes Mellitus', 'K-562', 'Learning', 'Libraries', 'Link', 'Location', 'Logic', 'Lupus', 'Machine Learning', 'Maps', 'Measures', 'Mechanics', 'Medical', 'Methods', 'Modeling', 'Regulatory Element', 'Reporter', 'Research', 'Resolution', 'Resources', 'System', 'Systemic Lupus Erythematosus', 'Techniques', 'Testing', 'Untranslated RNA', 'Variant', 'Work', 'base', 'biological systems', 'cell type', 'computerized tools', 'design', 'experimental study', 'flexibility', 'functional genomics', 'genome-wide', 'human disease', 'improved', 'interest', 'tool', 'trait']",NHGRI,"BROAD INSTITUTE, INC.",UM1,2018,933353,0.05854709309862032
"Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation Project Summary The ENCODE project has generated comprehensive maps of cis-regulatory elements (CREs) controlling the transcription of genes within the human genome. These maps have been crucial in our efforts to understand sequence variants linked to human traits and disease, as the majority of these variants are non- coding regulatory changes rather than amino acid substitutions. However, even though we know the locations of thousands of CREs, our understanding of how they operate is derived from a relatively small set of well- described examples. Therefore, we plan to directly characterize the function of ENCODE CREs at a genome- wide scale in multiple cell-types. This will transition the field of functional genomics from a simple map of regulatory elements towards a deep understanding of the fundamental rules governing regulatory logic down to the basepair resolution. Achieving this will dramatically expand ENCODE's utility by strengthening our ability to interpret the effects of natural human variation on gene regulation. We propose to directly measure regulatory activity of over 3% of the genome, pursuing loci highlighted as important by ENCODE and other functional data. We will first apply computational methods to identify the most biologically informative CREs, representing a diversity of regulatory logic and architecture, and will use machine learning techniques to prioritize functional variants for characterization relevant to common and rare human diseases, traits, and adaptation. Of these we will select 200,000 CREs and 300,000 variants, representing 100 Mb of genomic sequence, and characterize them using the massively parallel reporter assay (MPRA) to understand each element's regulatory activity. Then, to complement data from the MPRA, we will characterize additional 1 Mb regions across 10 loci using CRISPR-based non-coding screens to build a comprehensive picture of these loci. This strategy leverages the throughput and flexibility of MPRA while maintaining the connectivity of regulatory logic in the CRISPR-based screens, which perturb elements within their endogenous genomic context. This will help us judge the accuracy and completeness of ENCODE, while also providing data from both approaches to address a wide-variety of research questions. These methods are difficult to apply to disease relevant primary cells at full scale, but we will use the results of our MPRA and CRISPR screens to inform our models and better predict the fundamental rules of regulatory logic. We will then construct smaller, targeted libraries to test disease-specific variants in primary cells and use assays specific for each of three autoimmune diseases: type 1 diabetes, inflammatory bowel disease, and lupus. This approach will inform the research community on the rules governing the activity of the CREs mapped by the ENCODE project, and will simultaneously provide concrete information about the function of hundreds of thousands of sequence variants relevant for human traits, health, and disease. Project Narrative In our proposal we seek to extend the efforts by the ENCODE consortium and others who have made significant strides towards mapping the regulatory landscape of the human genome. We will apply large-scale functional characterization methods to directly test over 3% of the human genome for cis-regulatory activity. In doing so, we will create a resource that will improve our ability to pinpoint regulatory elements in our genome, increase our understanding of how they function, and aid in our ability to link genetic variation to human health and disease.",Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation,9564177,UM1HG009435,"['Address', 'Amino Acid Substitution', 'Architecture', 'Autoimmune Diseases', 'Benchmarking', 'Biochemical', 'Biological', 'Biological Assay', 'Bypass', 'CRISPR interference', 'CRISPR screen', 'CRISPR/Cas technology', 'Catalogs', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Complement', 'Complex', 'Computational Technique', 'Computing Methodologies', 'Data', 'Data Set', 'Disease', 'Dissection', 'Elements', 'Foundations', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genomic Segment', 'Genomics', 'Health', 'HepG2', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Inflammatory Bowel Diseases', 'Insulin-Dependent Diabetes Mellitus', 'K-562', 'Learning', 'Libraries', 'Link', 'Location', 'Logic', 'Lupus', 'Machine Learning', 'Maps', 'Measures', 'Mechanics', 'Medical', 'Methods', 'Modeling', 'Regulatory Element', 'Reporter', 'Research', 'Resolution', 'Resources', 'System', 'Systemic Lupus Erythematosus', 'Techniques', 'Testing', 'Untranslated RNA', 'Variant', 'Work', 'base', 'biological systems', 'cell type', 'computerized tools', 'design', 'experimental study', 'flexibility', 'functional genomics', 'genome-wide', 'human disease', 'improved', 'interest', 'tool', 'trait']",NHGRI,"BROAD INSTITUTE, INC.",UM1,2018,500000,0.05854709309862032
"Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation Project Summary The ENCODE project has generated comprehensive maps of cis-regulatory elements (CREs) controlling the transcription of genes within the human genome. These maps have been crucial in our efforts to understand sequence variants linked to human traits and disease, as the majority of these variants are non- coding regulatory changes rather than amino acid substitutions. However, even though we know the locations of thousands of CREs, our understanding of how they operate is derived from a relatively small set of well- described examples. Therefore, we plan to directly characterize the function of ENCODE CREs at a genome- wide scale in multiple cell-types. This will transition the field of functional genomics from a simple map of regulatory elements towards a deep understanding of the fundamental rules governing regulatory logic down to the basepair resolution. Achieving this will dramatically expand ENCODE's utility by strengthening our ability to interpret the effects of natural human variation on gene regulation. We propose to directly measure regulatory activity of over 3% of the genome, pursuing loci highlighted as important by ENCODE and other functional data. We will first apply computational methods to identify the most biologically informative CREs, representing a diversity of regulatory logic and architecture, and will use machine learning techniques to prioritize functional variants for characterization relevant to common and rare human diseases, traits, and adaptation. Of these we will select 200,000 CREs and 300,000 variants, representing 100 Mb of genomic sequence, and characterize them using the massively parallel reporter assay (MPRA) to understand each element's regulatory activity. Then, to complement data from the MPRA, we will characterize additional 1 Mb regions across 10 loci using CRISPR-based non-coding screens to build a comprehensive picture of these loci. This strategy leverages the throughput and flexibility of MPRA while maintaining the connectivity of regulatory logic in the CRISPR-based screens, which perturb elements within their endogenous genomic context. This will help us judge the accuracy and completeness of ENCODE, while also providing data from both approaches to address a wide-variety of research questions. These methods are difficult to apply to disease relevant primary cells at full scale, but we will use the results of our MPRA and CRISPR screens to inform our models and better predict the fundamental rules of regulatory logic. We will then construct smaller, targeted libraries to test disease-specific variants in primary cells and use assays specific for each of three autoimmune diseases: type 1 diabetes, inflammatory bowel disease, and lupus. This approach will inform the research community on the rules governing the activity of the CREs mapped by the ENCODE project, and will simultaneously provide concrete information about the function of hundreds of thousands of sequence variants relevant for human traits, health, and disease. Project Narrative In our proposal we seek to extend the efforts by the ENCODE consortium and others who have made significant strides towards mapping the regulatory landscape of the human genome. We will apply large-scale functional characterization methods to directly test over 3% of the human genome for cis-regulatory activity. In doing so, we will create a resource that will improve our ability to pinpoint regulatory elements in our genome, increase our understanding of how they function, and aid in our ability to link genetic variation to human health and disease.",Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation,9247640,UM1HG009435,"['Address', 'Amino Acid Substitution', 'Architecture', 'Autoimmune Diseases', 'Benchmarking', 'Biochemical', 'Biological', 'Biological Assay', 'Bypass', 'CRISPR interference', 'CRISPR screen', 'CRISPR/Cas technology', 'Catalogs', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Complement', 'Complex', 'Computational Technique', 'Computing Methodologies', 'Data', 'Data Set', 'Disease', 'Dissection', 'Elements', 'Foundations', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genomic Segment', 'Genomics', 'Health', 'HepG2', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Inflammatory Bowel Diseases', 'Insulin-Dependent Diabetes Mellitus', 'K-562', 'Learning', 'Libraries', 'Link', 'Location', 'Logic', 'Lupus', 'Machine Learning', 'Maps', 'Measures', 'Mechanics', 'Medical', 'Methods', 'Modeling', 'Regulatory Element', 'Reporter', 'Research', 'Resolution', 'Resources', 'System', 'Systemic Lupus Erythematosus', 'Techniques', 'Testing', 'Untranslated RNA', 'Variant', 'Work', 'base', 'biological systems', 'cell type', 'computerized tools', 'design', 'experimental study', 'flexibility', 'functional genomics', 'genome-wide', 'human disease', 'improved', 'interest', 'tool', 'trait']",NHGRI,"BROAD INSTITUTE, INC.",UM1,2017,654000,0.05854709309862032
"EDAC: ENCODE Data Analysis Center PROJECT SUMMARY The goal of the Encyclopedia of DNA Elements (ENCODE) project is to catalog all functional elements in the human genome through the integration and analysis of high-throughput data. We propose to continue the ENCODE Data Analysis Center (EDAC, DAC) which will provide support and leadership in analyzing and integrating data from the ENCODE project as well as work closely with other ENCODE groups including the Data Coordination Center. Our proposed DAC team (Zhiping Weng, Mark Gerstein, Manolis Kellis, Roderic Guigo, Rafael Irizarry, X. Shirley Liu, Anshul Kundaje, and William Noble) has expertise across a wide range of fields including transcriptional regulation, epigenetics, evolution, genomics and proteomics, regulatory RNA, biophysics, and computational biology, where they are the leaders in machine learning, statistical genetics, networks, and gene annotation. These investigators also have a history of successfully working collaboratively in large consortia, particularly with other ENCODE groups. Their publication records demonstrate their synergistic approach to producing high-impact science and useful resources that benefit the broader biomedical communities. The proposed DAC will pursue the following four aims: Aim 1. Analyze and integrate data and metadata from a broad range of functional genomics projects; Aim 2. Serve as an informatics resource by supporting the activities of the ENCODE Analysis Working Group; Aim 3. Create high-quality Encyclopedias of DNA elements in the human and mouse genomes; Aim 4. Assess quality and utility of the ENCODE data and provide feedback to NHGRI and the Consortium. RELEVANCE The goal of the Encyclopedia of DNA Elements (ENCODE) project is a highly collaborative effort aiming to develop a comprehensive list of functional elements in the human genome. This proposal creates a data analysis center to provide support and computational prowess for this effort in collaboration with other ENCODE groups. This comprehensive list will be of use to the wider research community and will aid in understanding human biology particularly in the context of disease, ultimately leading to improvements in human health.",EDAC: ENCODE Data Analysis Center,9420662,U24HG009446,"['ATAC-seq', 'Alleles', 'Binding', 'Biochemical', 'Biological', 'Biological Assay', 'Biophysics', 'Catalogs', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Communities', 'Computational Biology', 'Computing Methodologies', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Collection', 'Data Coordinating Center', 'Data Element', 'Data Set', 'Deoxyribonucleases', 'Development', 'Disease', 'Elements', 'Encyclopedia of DNA Elements', 'Encyclopedias', 'Enhancers', 'Epigenetic Process', 'Event', 'Evolution', 'Feedback', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Goals', 'Guidelines', 'Health', 'Human', 'Human Biology', 'Human Genome', 'Intuition', 'Leadership', 'Location', 'Machine Learning', 'Manuscripts', 'Measures', 'Metadata', 'Methods', 'Mus', 'National Human Genome Research Institute', 'Nucleotides', 'Pathway Analysis', 'Process', 'Proteomics', 'Publications', 'RNA', 'RNA-Binding Proteins', 'Recording of previous events', 'Records', 'Reporting', 'Reproducibility', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resolution', 'Resource Informatics', 'Resources', 'Science', 'Signal Transduction', 'Standardization', 'Subgroup', 'Techniques', 'The Cancer Genome Atlas', 'Transcriptional Regulation', 'Variant', 'Work', 'Writing', 'base', 'bisulfite sequencing', 'cell type', 'comparative', 'computerized data processing', 'data exchange', 'data integration', 'experience', 'experimental study', 'functional genomics', 'genetic variant', 'genome wide association study', 'high throughput analysis', 'histone modification', 'insight', 'member', 'mouse genome', 'novel', 'symposium', 'transcription factor', 'transcriptome sequencing', 'whole genome', 'working group']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U24,2018,2000000,0.0014389202589342434
"EDAC: ENCODE Data Analysis Center PROJECT SUMMARY The goal of the Encyclopedia of DNA Elements (ENCODE) project is to catalog all functional elements in the human genome through the integration and analysis of high-throughput data. We propose to continue the ENCODE Data Analysis Center (EDAC, DAC) which will provide support and leadership in analyzing and integrating data from the ENCODE project as well as work closely with other ENCODE groups including the Data Coordination Center. Our proposed DAC team (Zhiping Weng, Mark Gerstein, Manolis Kellis, Roderic Guigo, Rafael Irizarry, X. Shirley Liu, Anshul Kundaje, and William Noble) has expertise across a wide range of fields including transcriptional regulation, epigenetics, evolution, genomics and proteomics, regulatory RNA, biophysics, and computational biology, where they are the leaders in machine learning, statistical genetics, networks, and gene annotation. These investigators also have a history of successfully working collaboratively in large consortia, particularly with other ENCODE groups. Their publication records demonstrate their synergistic approach to producing high-impact science and useful resources that benefit the broader biomedical communities. The proposed DAC will pursue the following four aims: Aim 1. Analyze and integrate data and metadata from a broad range of functional genomics projects; Aim 2. Serve as an informatics resource by supporting the activities of the ENCODE Analysis Working Group; Aim 3. Create high-quality Encyclopedias of DNA elements in the human and mouse genomes; Aim 4. Assess quality and utility of the ENCODE data and provide feedback to NHGRI and the Consortium. RELEVANCE The goal of the Encyclopedia of DNA Elements (ENCODE) project is a highly collaborative effort aiming to develop a comprehensive list of functional elements in the human genome. This proposal creates a data analysis center to provide support and computational prowess for this effort in collaboration with other ENCODE groups. This comprehensive list will be of use to the wider research community and will aid in understanding human biology particularly in the context of disease, ultimately leading to improvements in human health.",EDAC: ENCODE Data Analysis Center,9248178,U24HG009446,"['ATAC-seq', 'Alleles', 'Alpha Cell', 'Binding', 'Biochemical', 'Biological', 'Biological Assay', 'Biophysics', 'Catalogs', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Communities', 'Computational Biology', 'Computing Methodologies', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Collection', 'Data Coordinating Center', 'Data Element', 'Data Set', 'Deoxyribonucleases', 'Development', 'Disease', 'Elements', 'Encyclopedia of DNA Elements', 'Encyclopedias', 'Enhancers', 'Epigenetic Process', 'Event', 'Evolution', 'Feedback', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Goals', 'Guidelines', 'Health', 'Human', 'Human Biology', 'Human Genome', 'Intuition', 'Leadership', 'Location', 'Machine Learning', 'Manuscripts', 'Measures', 'Metadata', 'Methods', 'Mus', 'National Human Genome Research Institute', 'Nucleotides', 'Pathway Analysis', 'Process', 'Proteomics', 'Publications', 'RNA', 'RNA-Binding Proteins', 'Recording of previous events', 'Records', 'Reporting', 'Reproducibility', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resolution', 'Resource Informatics', 'Resources', 'Science', 'Signal Transduction', 'Standardization', 'Subgroup', 'Techniques', 'The Cancer Genome Atlas', 'Transcriptional Regulation', 'Variant', 'Work', 'Writing', 'base', 'bisulfite sequencing', 'cell type', 'comparative', 'computerized data processing', 'data exchange', 'data integration', 'experience', 'experimental study', 'functional genomics', 'genetic variant', 'genome wide association study', 'high throughput analysis', 'histone modification', 'insight', 'member', 'mouse genome', 'novel', 'symposium', 'transcription factor', 'transcriptome sequencing', 'whole genome', 'working group']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U24,2017,2000000,0.0014389202589342434
"EDAC: ENCODE Data Analysis Center PROJECT SUMMARY The goal of the Encyclopedia of DNA Elements (ENCODE) project is to catalog all functional elements in the human genome through the integration and analysis of high-throughput data. We propose to continue the ENCODE Data Analysis Center (EDAC, DAC) which will provide support and leadership in analyzing and integrating data from the ENCODE project as well as work closely with other ENCODE groups including the Data Coordination Center. Our proposed DAC team (Zhiping Weng, Mark Gerstein, Manolis Kellis, Roderic Guigo, Rafael Irizarry, X. Shirley Liu, Anshul Kundaje, and William Noble) has expertise across a wide range of fields including transcriptional regulation, epigenetics, evolution, genomics and proteomics, regulatory RNA, biophysics, and computational biology, where they are the leaders in machine learning, statistical genetics, networks, and gene annotation. These investigators also have a history of successfully working collaboratively in large consortia, particularly with other ENCODE groups. Their publication records demonstrate their synergistic approach to producing high-impact science and useful resources that benefit the broader biomedical communities. The proposed DAC will pursue the following four aims: Aim 1. Analyze and integrate data and metadata from a broad range of functional genomics projects; Aim 2. Serve as an informatics resource by supporting the activities of the ENCODE Analysis Working Group; Aim 3. Create high-quality Encyclopedias of DNA elements in the human and mouse genomes; Aim 4. Assess quality and utility of the ENCODE data and provide feedback to NHGRI and the Consortium. RELEVANCE The goal of the Encyclopedia of DNA Elements (ENCODE) project is a highly collaborative effort aiming to develop a comprehensive list of functional elements in the human genome. This proposal creates a data analysis center to provide support and computational prowess for this effort in collaboration with other ENCODE groups. This comprehensive list will be of use to the wider research community and will aid in understanding human biology particularly in the context of disease, ultimately leading to improvements in human health.",EDAC: ENCODE Data Analysis Center,9858390,U24HG009446,"['ATAC-seq', 'Alleles', 'Binding', 'Biochemical', 'Biological', 'Biological Assay', 'Biophysics', 'Catalogs', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Communities', 'Computational Biology', 'Computing Methodologies', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Collection', 'Data Coordinating Center', 'Data Element', 'Data Set', 'Deoxyribonucleases', 'Development', 'Disease', 'Elements', 'Encyclopedia of DNA Elements', 'Encyclopedias', 'Enhancers', 'Epigenetic Process', 'Event', 'Evolution', 'Feedback', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Goals', 'Guidelines', 'Health', 'Human', 'Human Biology', 'Human Genome', 'Intuition', 'Leadership', 'Location', 'Machine Learning', 'Manuscripts', 'Measures', 'Metadata', 'Methods', 'Mus', 'National Human Genome Research Institute', 'Nucleotides', 'Pathway Analysis', 'Process', 'Proteomics', 'Publications', 'RNA', 'RNA-Binding Proteins', 'Recording of previous events', 'Records', 'Reporting', 'Reproducibility', 'Research', 'Research Personnel', 'Resolution', 'Resource Informatics', 'Resources', 'Science', 'Signal Transduction', 'Subgroup', 'Techniques', 'The Cancer Genome Atlas', 'Transcriptional Regulation', 'Variant', 'Work', 'Writing', 'analysis pipeline', 'base', 'bisulfite sequencing', 'cell type', 'comparative', 'computerized data processing', 'data exchange', 'data infrastructure', 'data integration', 'data standards', 'experience', 'experimental study', 'functional genomics', 'genetic variant', 'genome wide association study', 'high throughput analysis', 'histone modification', 'insight', 'large scale data', 'member', 'mouse genome', 'multiple data types', 'novel', 'symposium', 'transcription factor', 'transcriptome sequencing', 'whole genome', 'working group']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U24,2020,2000000,0.0014389202589342434
"EDAC: ENCODE Data Analysis Center PROJECT SUMMARY The goal of the Encyclopedia of DNA Elements (ENCODE) project is to catalog all functional elements in the human genome through the integration and analysis of high-throughput data. We propose to continue the ENCODE Data Analysis Center (EDAC, DAC) which will provide support and leadership in analyzing and integrating data from the ENCODE project as well as work closely with other ENCODE groups including the Data Coordination Center. Our proposed DAC team (Zhiping Weng, Mark Gerstein, Manolis Kellis, Roderic Guigo, Rafael Irizarry, X. Shirley Liu, Anshul Kundaje, and William Noble) has expertise across a wide range of fields including transcriptional regulation, epigenetics, evolution, genomics and proteomics, regulatory RNA, biophysics, and computational biology, where they are the leaders in machine learning, statistical genetics, networks, and gene annotation. These investigators also have a history of successfully working collaboratively in large consortia, particularly with other ENCODE groups. Their publication records demonstrate their synergistic approach to producing high-impact science and useful resources that benefit the broader biomedical communities. The proposed DAC will pursue the following four aims: Aim 1. Analyze and integrate data and metadata from a broad range of functional genomics projects; Aim 2. Serve as an informatics resource by supporting the activities of the ENCODE Analysis Working Group; Aim 3. Create high-quality Encyclopedias of DNA elements in the human and mouse genomes; Aim 4. Assess quality and utility of the ENCODE data and provide feedback to NHGRI and the Consortium. RELEVANCE The goal of the Encyclopedia of DNA Elements (ENCODE) project is a highly collaborative effort aiming to develop a comprehensive list of functional elements in the human genome. This proposal creates a data analysis center to provide support and computational prowess for this effort in collaboration with other ENCODE groups. This comprehensive list will be of use to the wider research community and will aid in understanding human biology particularly in the context of disease, ultimately leading to improvements in human health.",EDAC: ENCODE Data Analysis Center,9626416,U24HG009446,"['ATAC-seq', 'Alleles', 'Binding', 'Biochemical', 'Biological', 'Biological Assay', 'Biophysics', 'Catalogs', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Communities', 'Computational Biology', 'Computing Methodologies', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Collection', 'Data Coordinating Center', 'Data Element', 'Data Set', 'Deoxyribonucleases', 'Development', 'Disease', 'Elements', 'Encyclopedia of DNA Elements', 'Encyclopedias', 'Enhancers', 'Epigenetic Process', 'Event', 'Evolution', 'Feedback', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Goals', 'Guidelines', 'Health', 'Human', 'Human Biology', 'Human Genome', 'Infrastructure', 'Intuition', 'Leadership', 'Location', 'Machine Learning', 'Manuscripts', 'Measures', 'Metadata', 'Methods', 'Mus', 'National Human Genome Research Institute', 'Nucleotides', 'Pathway Analysis', 'Process', 'Proteomics', 'Publications', 'RNA', 'RNA-Binding Proteins', 'Recording of previous events', 'Records', 'Reporting', 'Reproducibility', 'Research', 'Research Personnel', 'Resolution', 'Resource Informatics', 'Resources', 'Science', 'Signal Transduction', 'Standardization', 'Subgroup', 'Techniques', 'The Cancer Genome Atlas', 'Transcriptional Regulation', 'Variant', 'Work', 'Writing', 'analysis pipeline', 'base', 'bisulfite sequencing', 'cell type', 'comparative', 'computerized data processing', 'data exchange', 'data integration', 'experience', 'experimental study', 'functional genomics', 'genetic variant', 'genome wide association study', 'high throughput analysis', 'histone modification', 'insight', 'member', 'mouse genome', 'novel', 'symposium', 'transcription factor', 'transcriptome sequencing', 'whole genome', 'working group']",NHGRI,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U24,2019,2000000,0.0014389202589342434
"Metadata applications on informed content to facilitate biorepository data regulation and sharing ABSTRACT Biorepositories are critical to enabling modern molecular-based research that will drive the development of a new generation of targeted diagnostics and therapies as well as personalized medicine to improve clinical outcomes for patients. The use of data and biospecimen resources collected during research are constrained by the informed consent that research participants give to research teams, research protocol documents, and the constraints imposed on the research by the IRB itself. Currently there is a lack of a common model of consent that limits how easily data (and research specimens) from multiple research projects, or multiple institutions can be combined for large-scale retrospective studies. Manually examining and reconciling potentially millions of informed consent forms from different biobanks becomes an expensive and possibly irreconcilable problem. The application of suitable metadata in support of the complex set of regulatory, legal, privacy and security requirement processes and information flows involved in regulated research is a field in an early phases of development. The complicated legal and technical requirements involved in the processes challenge our ability to effectively build information systems that support sharing of research data, specimens and other research artifacts at scale. Additionally, much of the regulatory processes involved in research are still based on paper-based workflows. We posit that by developing suitable machine-based metadata representation of regulatory processes focusing on informed consents and the associated documents would enhance the ability of regulatory bodies such as Institutional Review Boards to 1) review proposals in a more streamlined fashion, 2) have the potential to provide a more comprehensive understanding of risk along multiple axes, and 3) provide a formal and computable basis for data sharing and information release policies. More specifically we will focus on three specific aims: 1) Develop standard-conforming metadata representations of informed consent; 2) Develop NLP-based automatic annotation tool for informed consent documents; and 3) Evaluate the metadata-ontology-based approach for semantically representing the domain and demonstrate its capacity for answering competency questions. Our proposed approach is novel for the following reasons: 1) it provides the first metadata ontology, to the best of our knowledge, to represent the informed consent space while considering the US common rules; 2) it combines natural language processing technologies with ontology-based approaches for semantic annotation as well as ontology enrichment; and 3) it engages stakeholders in the ontology development and evaluation process and uses competency questions to verify the coverage of the ontology. PROJECT NARRATIVE The application of suitable metadata in support of the complex set of regulatory, legal, privacy and security requirement processes and information flows involved in regulated research is a field in an early phases of development. The complicated legal and technical requirements involved in the processes challenge our ability to effectively build information systems that support sharing of research data, specimens and other research artifacts at scale. In response to RFA-CA-15-017, this proposed project will develop suitable machine-based metadata representation and automatic annotation of regulatory processes focusing on informed consents and the associated documents. The proposed approach will presumably enhance the ability of regulatory bodies such as Institutional Review Boards to (a) review proposals in a more streamlined fashion, (b) have the potential to provide a more comprehensive understanding of risk along multiple axes, and (c) provide a formal and computable basis for data sharing and information release policies.",Metadata applications on informed content to facilitate biorepository data regulation and sharing,9534738,U01HG009454,"['Address', 'Adherence', 'Automated Annotation', 'Charge', 'Classification', 'Clinical', 'Communities', 'Competence', 'Complex', 'Consent', 'Consent Forms', 'Data', 'Data Element', 'Decision Making', 'Derivation procedure', 'Development', 'Diagnostic', 'Elements', 'Ensure', 'Ethics', 'Evaluation', 'Future', 'Generations', 'Guidelines', 'Heterogeneity', 'Human', 'Individual', 'Information Systems', 'Informed Consent', 'Institution', 'Institutional Review Boards', 'Knowledge', 'Legal', 'Manuals', 'Measures', 'Metadata', 'Methods', 'Modeling', 'Modernization', 'Molecular', 'Morphologic artifacts', 'Natural Language Processing', 'Ontology', 'Paper', 'Participant', 'Patient-Focused Outcomes', 'Phase', 'Policies', 'Privacy', 'Process', 'Protocols documentation', 'Readability', 'Regulation', 'Research', 'Research Project Grants', 'Resources', 'Retrospective Studies', 'Rights', 'Risk', 'Science', 'Security', 'Semantics', 'Specimen', 'Support System', 'Techniques', 'Technology', 'Terminology', 'Text', 'Trust', 'Work', 'annotation  system', 'base', 'biobank', 'common rule', 'data integration', 'data modeling', 'data sharing', 'human subject', 'improved', 'knowledge base', 'novel', 'ontology development', 'personalized medicine', 'repository', 'response', 'stem', 'tool', 'translational pipeline']",NHGRI,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,U01,2018,431097,-0.055962242944275375
"Metadata applications on informed content to facilitate biorepository data regulation and sharing ABSTRACT Biorepositories are critical to enabling modern molecular-based research that will drive the development of a new generation of targeted diagnostics and therapies as well as personalized medicine to improve clinical outcomes for patients. The use of data and biospecimen resources collected during research are constrained by the informed consent that research participants give to research teams, research protocol documents, and the constraints imposed on the research by the IRB itself. Currently there is a lack of a common model of consent that limits how easily data (and research specimens) from multiple research projects, or multiple institutions can be combined for large-scale retrospective studies. Manually examining and reconciling potentially millions of informed consent forms from different biobanks becomes an expensive and possibly irreconcilable problem. The application of suitable metadata in support of the complex set of regulatory, legal, privacy and security requirement processes and information flows involved in regulated research is a field in an early phases of development. The complicated legal and technical requirements involved in the processes challenge our ability to effectively build information systems that support sharing of research data, specimens and other research artifacts at scale. Additionally, much of the regulatory processes involved in research are still based on paper-based workflows. We posit that by developing suitable machine-based metadata representation of regulatory processes focusing on informed consents and the associated documents would enhance the ability of regulatory bodies such as Institutional Review Boards to 1) review proposals in a more streamlined fashion, 2) have the potential to provide a more comprehensive understanding of risk along multiple axes, and 3) provide a formal and computable basis for data sharing and information release policies. More specifically we will focus on three specific aims: 1) Develop standard-conforming metadata representations of informed consent; 2) Develop NLP-based automatic annotation tool for informed consent documents; and 3) Evaluate the metadata-ontology-based approach for semantically representing the domain and demonstrate its capacity for answering competency questions. Our proposed approach is novel for the following reasons: 1) it provides the first metadata ontology, to the best of our knowledge, to represent the informed consent space while considering the US common rules; 2) it combines natural language processing technologies with ontology-based approaches for semantic annotation as well as ontology enrichment; and 3) it engages stakeholders in the ontology development and evaluation process and uses competency questions to verify the coverage of the ontology. PROJECT NARRATIVE The application of suitable metadata in support of the complex set of regulatory, legal, privacy and security requirement processes and information flows involved in regulated research is a field in an early phases of development. The complicated legal and technical requirements involved in the processes challenge our ability to effectively build information systems that support sharing of research data, specimens and other research artifacts at scale. In response to RFA-CA-15-017, this proposed project will develop suitable machine-based metadata representation and automatic annotation of regulatory processes focusing on informed consents and the associated documents. The proposed approach will presumably enhance the ability of regulatory bodies such as Institutional Review Boards to (a) review proposals in a more streamlined fashion, (b) have the potential to provide a more comprehensive understanding of risk along multiple axes, and (c) provide a formal and computable basis for data sharing and information release policies.",Metadata applications on informed content to facilitate biorepository data regulation and sharing,9360131,U01HG009454,"['Address', 'Adherence', 'Automated Annotation', 'Charge', 'Classification', 'Clinical', 'Communities', 'Competence', 'Complex', 'Consent', 'Consent Forms', 'Data', 'Data Element', 'Decision Making', 'Derivation procedure', 'Development', 'Diagnostic', 'Elements', 'Ensure', 'Ethics', 'Evaluation', 'Future', 'Generations', 'Guidelines', 'Heterogeneity', 'Human', 'Individual', 'Information Systems', 'Informed Consent', 'Institution', 'Institutional Review Boards', 'Knowledge', 'Legal', 'Manuals', 'Measures', 'Metadata', 'Methods', 'Modeling', 'Modernization', 'Molecular', 'Morphologic artifacts', 'Natural Language Processing', 'Ontology', 'Paper', 'Participant', 'Patient-Focused Outcomes', 'Phase', 'Policies', 'Privacy', 'Process', 'Protocols documentation', 'Readability', 'Regulation', 'Research', 'Research Project Grants', 'Resources', 'Retrospective Studies', 'Rights', 'Risk', 'Science', 'Security', 'Semantics', 'Specimen', 'Support System', 'Techniques', 'Technology', 'Terminology', 'Text', 'Trust', 'Work', 'annotation  system', 'base', 'biobank', 'common rule', 'data integration', 'data modeling', 'data sharing', 'human subject', 'improved', 'knowledge base', 'novel', 'permissiveness', 'personalized medicine', 'repository', 'response', 'stem', 'tool', 'translational pipeline']",NHGRI,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,U01,2017,456710,-0.055962242944275375
"Metadata applications on informed content to facilitate biorepository data regulation and sharing ABSTRACT Biorepositories are critical to enabling modern molecular-based research that will drive the development of a new generation of targeted diagnostics and therapies as well as personalized medicine to improve clinical outcomes for patients. The use of data and biospecimen resources collected during research are constrained by the informed consent that research participants give to research teams, research protocol documents, and the constraints imposed on the research by the IRB itself. Currently there is a lack of a common model of consent that limits how easily data (and research specimens) from multiple research projects, or multiple institutions can be combined for large-scale retrospective studies. Manually examining and reconciling potentially millions of informed consent forms from different biobanks becomes an expensive and possibly irreconcilable problem. The application of suitable metadata in support of the complex set of regulatory, legal, privacy and security requirement processes and information flows involved in regulated research is a field in an early phases of development. The complicated legal and technical requirements involved in the processes challenge our ability to effectively build information systems that support sharing of research data, specimens and other research artifacts at scale. Additionally, much of the regulatory processes involved in research are still based on paper-based workflows. We posit that by developing suitable machine-based metadata representation of regulatory processes focusing on informed consents and the associated documents would enhance the ability of regulatory bodies such as Institutional Review Boards to 1) review proposals in a more streamlined fashion, 2) have the potential to provide a more comprehensive understanding of risk along multiple axes, and 3) provide a formal and computable basis for data sharing and information release policies. More specifically we will focus on three specific aims: 1) Develop standard-conforming metadata representations of informed consent; 2) Develop NLP-based automatic annotation tool for informed consent documents; and 3) Evaluate the metadata-ontology-based approach for semantically representing the domain and demonstrate its capacity for answering competency questions. Our proposed approach is novel for the following reasons: 1) it provides the first metadata ontology, to the best of our knowledge, to represent the informed consent space while considering the US common rules; 2) it combines natural language processing technologies with ontology-based approaches for semantic annotation as well as ontology enrichment; and 3) it engages stakeholders in the ontology development and evaluation process and uses competency questions to verify the coverage of the ontology. PROJECT NARRATIVE The application of suitable metadata in support of the complex set of regulatory, legal, privacy and security requirement processes and information flows involved in regulated research is a field in an early phases of development. The complicated legal and technical requirements involved in the processes challenge our ability to effectively build information systems that support sharing of research data, specimens and other research artifacts at scale. In response to RFA-CA-15-017, this proposed project will develop suitable machine-based metadata representation and automatic annotation of regulatory processes focusing on informed consents and the associated documents. The proposed approach will presumably enhance the ability of regulatory bodies such as Institutional Review Boards to (a) review proposals in a more streamlined fashion, (b) have the potential to provide a more comprehensive understanding of risk along multiple axes, and (c) provide a formal and computable basis for data sharing and information release policies.",Metadata applications on informed content to facilitate biorepository data regulation and sharing,9161167,U01HG009454,"['Address', 'Adherence', 'Automated Annotation', 'Charge', 'Classification', 'Clinical', 'Communities', 'Complex', 'Consent', 'Consent Forms', 'Data', 'Data Element', 'Decision Making', 'Derivation procedure', 'Development', 'Diagnostic', 'Elements', 'Ensure', 'Ethics', 'Evaluation', 'Future', 'Generations', 'Guidelines', 'Heterogeneity', 'Human', 'Individual', 'Information Systems', 'Informed Consent', 'Institution', 'Institutional Review Boards', 'Knowledge', 'Legal', 'Maps', 'Measures', 'Metadata', 'Methods', 'Modeling', 'Molecular', 'Morphologic artifacts', 'Natural Language Processing', 'Ontology', 'Paper', 'Participant', 'Patient-Focused Outcomes', 'Phase', 'Policies', 'Privacy', 'Process', 'Protocols documentation', 'Regulation', 'Research', 'Research Project Grants', 'Resources', 'Retrospective Studies', 'Rights', 'Risk', 'Science', 'Security', 'Semantics', 'Specimen', 'Support System', 'System', 'Techniques', 'Technology', 'Terminology', 'Text', 'Trust', 'Work', 'base', 'biobank', 'common rule', 'data integration', 'data modeling', 'data sharing', 'human subject', 'improved', 'information processing', 'knowledge base', 'novel', 'personalized medicine', 'repository', 'response', 'stem', 'tool']",NHGRI,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,U01,2016,471848,-0.055962242944275375
"Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming PROJECT SUMMARY The deluge of sequencing-based functional genomic data profiling the transcriptome, regulome and epigenome in hundreds of diverse cellular contexts has spurred the development of powerful computational methods to learn integrative models of gene regulation. However, models learned on data from static cellular contexts only reveal correlative regulatory relationships. There is a paucity of tractable model systems and experiments profiling dynamic cellular processes and a corresponding lack of computational methods that can learn putative causal mechanisms controlling the precise timing and temporal order of changes in genomic chromatin state and gene expression. Here, we propose novel machine learning methods to learn dynamic models of transcription regulation in the context of cellular reprogramming. In Aim 1, we propose deep learning frameworks with new interpretation engines that can integrate dynamic chromatin accessibility and gene expression data to reveal networks of cis regulatory elements, transcription factor binding complexes and cascades of trans-acting regulatory factors that control cell fate. In Aim2, we will apply our modeling framework to investigate early dynamics of nuclear reprogramming of human fibroblasts to pluripotency. We will leverage a powerful heterokaryon cell fusion model system to generate global chromatin and gene expression profiles over a two day timecourse. In Aim 3, we perform perturbation experiments using RNAi and CRISPR/Cas9 technologies to validate hypotheses generated by our models and test the effectiveness of predicted pluripotency factors and regulatory elements in inducing reprogramming. The validation experiments will be further used to iteratively refine the computational models. We will integrate the time-course data generated in our model system with data from large reference compendia of functional genomic data such as the Encyclopedia of DNA Elements (ENCODE) and The Roadmap Epigenomics Project. Our analyses will reveal molecular mechanisms crucial to early and transient stages of nuclear reprogramming, providing novel contributions to our fundamental knowledge of regenerative medicine. Finally, the proposed end-to-end integrative framework is highly generalizable and will be of broad utility to learn dynamic models of transcriptional regulation from time-course datasets in other model systems. NARRATIVE Understanding how cells precisely control the timing and order of gene expression changes during dynamic cellular processes remains a challenge. Here, we propose the development of novel machine learning methods based on deep neural networks to decipher dynamic regulatory networks controlling cell fate decisions. We will generate genome-wide temporal profiles of chromatin state and gene expression during nuclear reprogramming, learn integrative models of dynamic gene regulation and perform experiments to validate biological hypotheses generated by the model.",Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming,9722284,R01HG009674,"['3-Dimensional', 'ATAC-seq', 'Back', 'Binding', 'Biological', 'Biological Models', 'CRISPR/Cas technology', 'Cell Differentiation process', 'Cell Fate Control', 'Cell Nucleus', 'Cell fusion', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'DNA Sequence', 'Data', 'Data Set', 'Development', 'Effectiveness', 'Encyclopedia of DNA Elements', 'Event', 'Expression Profiling', 'Fibroblasts', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Order', 'Gene Silencing', 'Generations', 'Genes', 'Genetic Transcription', 'Genomics', 'Human', 'Knock-out', 'Knowledge', 'Learning', 'Machine Learning', 'Maps', 'Methods', 'Modeling', 'Molecular', 'Mus', 'Pattern', 'Pluripotent Stem Cells', 'RNA Interference', 'Regenerative Medicine', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Series', 'System', 'Testing', 'Time', 'Training', 'Transcription Factor 3', 'Transcriptional Regulation', 'Validation', 'base', 'c-myc Genes', 'combinatorial', 'deep learning', 'deep neural network', 'embryonic stem cell', 'epigenome', 'epigenomics', 'experimental study', 'feeding', 'functional genomics', 'genetic regulatory protein', 'genome editing', 'genome-wide', 'genomic data', 'heterokaryon', 'induced pluripotent stem cell', 'innovation', 'learning strategy', 'loss of function', 'novel', 'nuclear reprogramming', 'pluripotency', 'transcription factor', 'transcriptome', 'transcriptome sequencing']",NHGRI,STANFORD UNIVERSITY,R01,2019,703311,0.15771487259146247
"Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming PROJECT SUMMARY The deluge of sequencing-based functional genomic data profiling the transcriptome, regulome and epigenome in hundreds of diverse cellular contexts has spurred the development of powerful computational methods to learn integrative models of gene regulation. However, models learned on data from static cellular contexts only reveal correlative regulatory relationships. There is a paucity of tractable model systems and experiments profiling dynamic cellular processes and a corresponding lack of computational methods that can learn putative causal mechanisms controlling the precise timing and temporal order of changes in genomic chromatin state and gene expression. Here, we propose novel machine learning methods to learn dynamic models of transcription regulation in the context of cellular reprogramming. In Aim 1, we propose deep learning frameworks with new interpretation engines that can integrate dynamic chromatin accessibility and gene expression data to reveal networks of cis regulatory elements, transcription factor binding complexes and cascades of trans-acting regulatory factors that control cell fate. In Aim2, we will apply our modeling framework to investigate early dynamics of nuclear reprogramming of human fibroblasts to pluripotency. We will leverage a powerful heterokaryon cell fusion model system to generate global chromatin and gene expression profiles over a two day timecourse. In Aim 3, we perform perturbation experiments using RNAi and CRISPR/Cas9 technologies to validate hypotheses generated by our models and test the effectiveness of predicted pluripotency factors and regulatory elements in inducing reprogramming. The validation experiments will be further used to iteratively refine the computational models. We will integrate the time-course data generated in our model system with data from large reference compendia of functional genomic data such as the Encyclopedia of DNA Elements (ENCODE) and The Roadmap Epigenomics Project. Our analyses will reveal molecular mechanisms crucial to early and transient stages of nuclear reprogramming, providing novel contributions to our fundamental knowledge of regenerative medicine. Finally, the proposed end-to-end integrative framework is highly generalizable and will be of broad utility to learn dynamic models of transcriptional regulation from time-course datasets in other model systems. NARRATIVE Understanding how cells precisely control the timing and order of gene expression changes during dynamic cellular processes remains a challenge. Here, we propose the development of novel machine learning methods based on deep neural networks to decipher dynamic regulatory networks controlling cell fate decisions. We will generate genome-wide temporal profiles of chromatin state and gene expression during nuclear reprogramming, learn integrative models of dynamic gene regulation and perform experiments to validate biological hypotheses generated by the model.",Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming,9542357,R01HG009674,"['ATAC-seq', 'Back', 'Binding', 'Biological', 'Biological Models', 'CRISPR/Cas technology', 'Cell Differentiation process', 'Cell Fate Control', 'Cell Nucleus', 'Cell fusion', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'DNA Sequence', 'Data', 'Data Set', 'Development', 'Effectiveness', 'Encyclopedia of DNA Elements', 'Event', 'Expression Profiling', 'Fibroblasts', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Order', 'Gene Silencing', 'Gene Targeting', 'Generations', 'Genes', 'Genetic Transcription', 'Genomics', 'Human', 'Knock-out', 'Knowledge', 'Learning', 'Machine Learning', 'Maps', 'Methods', 'Modeling', 'Molecular', 'Mus', 'Pattern', 'Pluripotent Stem Cells', 'RNA Interference', 'Regenerative Medicine', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Series', 'System', 'Testing', 'Time', 'Training', 'Transcription Factor 3', 'Transcriptional Regulation', 'Validation', 'base', 'c-myc Genes', 'combinatorial', 'deep learning', 'deep neural network', 'embryonic stem cell', 'epigenome', 'epigenomics', 'experimental study', 'feeding', 'functional genomics', 'genetic regulatory protein', 'genome editing', 'genome-wide', 'genomic data', 'heterokaryon', 'induced pluripotent stem cell', 'innovation', 'learning strategy', 'loss of function', 'novel', 'nuclear reprogramming', 'pluripotency', 'transcription factor', 'transcriptome', 'transcriptome sequencing']",NHGRI,STANFORD UNIVERSITY,R01,2018,702694,0.15771487259146247
"Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming PROJECT SUMMARY The deluge of sequencing-based functional genomic data profiling the transcriptome, regulome and epigenome in hundreds of diverse cellular contexts has spurred the development of powerful computational methods to learn integrative models of gene regulation. However, models learned on data from static cellular contexts only reveal correlative regulatory relationships. There is a paucity of tractable model systems and experiments profiling dynamic cellular processes and a corresponding lack of computational methods that can learn putative causal mechanisms controlling the precise timing and temporal order of changes in genomic chromatin state and gene expression. Here, we propose novel machine learning methods to learn dynamic models of transcription regulation in the context of cellular reprogramming. In Aim 1, we propose deep learning frameworks with new interpretation engines that can integrate dynamic chromatin accessibility and gene expression data to reveal networks of cis regulatory elements, transcription factor binding complexes and cascades of trans-acting regulatory factors that control cell fate. In Aim2, we will apply our modeling framework to investigate early dynamics of nuclear reprogramming of human fibroblasts to pluripotency. We will leverage a powerful heterokaryon cell fusion model system to generate global chromatin and gene expression profiles over a two day timecourse. In Aim 3, we perform perturbation experiments using RNAi and CRISPR/Cas9 technologies to validate hypotheses generated by our models and test the effectiveness of predicted pluripotency factors and regulatory elements in inducing reprogramming. The validation experiments will be further used to iteratively refine the computational models. We will integrate the time-course data generated in our model system with data from large reference compendia of functional genomic data such as the Encyclopedia of DNA Elements (ENCODE) and The Roadmap Epigenomics Project. Our analyses will reveal molecular mechanisms crucial to early and transient stages of nuclear reprogramming, providing novel contributions to our fundamental knowledge of regenerative medicine. Finally, the proposed end-to-end integrative framework is highly generalizable and will be of broad utility to learn dynamic models of transcriptional regulation from time-course datasets in other model systems. NARRATIVE Understanding how cells precisely control the timing and order of gene expression changes during dynamic cellular processes remains a challenge. Here, we propose the development of novel machine learning methods based on deep neural networks to decipher dynamic regulatory networks controlling cell fate decisions. We will generate genome-wide temporal profiles of chromatin state and gene expression during nuclear reprogramming, learn integrative models of dynamic gene regulation and perform experiments to validate biological hypotheses generated by the model.",Learning Regulatory Drivers of Chromatin and Expression Dynamics during Nuclear Reprogramming,9368022,R01HG009674,"['ATAC-seq', 'Back', 'Binding', 'Biological', 'Biological Models', 'Biological Neural Networks', 'CRISPR/Cas technology', 'Cell Differentiation process', 'Cell Fate Control', 'Cell Nucleus', 'Cell fusion', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'DNA Sequence', 'Data', 'Data Set', 'Development', 'Effectiveness', 'Encyclopedia of DNA Elements', 'Event', 'Fibroblasts', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Order', 'Gene Silencing', 'Gene Targeting', 'Generations', 'Genes', 'Genetic Transcription', 'Genomics', 'Human', 'Knock-out', 'Knowledge', 'Learning', 'Machine Learning', 'Maps', 'Methods', 'Modeling', 'Molecular', 'Molecular Profiling', 'Mus', 'Pattern', 'Pluripotent Stem Cells', 'RNA Interference', 'Regenerative Medicine', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Series', 'System', 'Technology', 'Testing', 'Time', 'Training', 'Transcription Factor 3', 'Transcriptional Regulation', 'Validation', 'base', 'c-myc Genes', 'combinatorial', 'embryonic stem cell', 'epigenome', 'epigenomics', 'experimental study', 'feeding', 'functional genomics', 'genetic regulatory protein', 'genome editing', 'genome-wide', 'genomic data', 'heterokaryon', 'induced pluripotent stem cell', 'innovation', 'learning strategy', 'loss of function', 'novel', 'nuclear reprogramming', 'pluripotency', 'transcription factor', 'transcriptome', 'transcriptome sequencing']",NHGRI,STANFORD UNIVERSITY,R01,2017,694416,0.15771487259146247
"A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics The leading and trailing untranslated regions (UTRs) of an mRNA, along with the coding sequence (CDS), control protein production by modulating translation and mRNA stability. However, although we have identified a vast number of regulatory features in these regions, we are still far from being able to predict, for example, whether and how a sequence variant affects the levels of protein being made. Here, we propose to combine high-throughput experimental characterization of protein expression in synthetic libraries with machine learning to create predictive models of translation and mRNA stability, addressing an urgent need. Recent progress in machine vision, voice recognition and other fields of computer science has been driven by the availability of enormous data sets on which to train models. Machine learning approaches have also had remarkable impact in biology, but biological data sets often are comparatively small, limiting the quality of models that can be learned. For example, there are only around 20,000 genes in the human genome, a restrictively small set of examples for training a predictive model that captures the full extent of the genomes regulatory code. In this proposal, we aim to overcome this data size limitation by training predictive models of protein expression on data from millions of synthetic constructs -- a data set several orders of magnitude larger than the number of genes in the genome. Specifically, we will create libraries of in vitro transcribed mRNA with targeted variation in the UTRs and CDS and will assay protein expression of each library member by performing high-throughput polysome profiling, ribosome profiling, and mRNA stability assays. We will then use neural network approaches to learn predictive models of the relationship between mRNA sequence and levels of protein production. We will apply our models to three applications of practical importance: first, we expect to uncover novel biology, for example identifying regulatory sequence elements and interactions between them. Second, we will validate our models through the de novo design and experimental testing of sequences that result in higher levels or protein production than any of the millions of randomly generated members of the original library or than the endogenous UTR sequences currently used in biotechnology. Such stable and highly translating mRNA constructs would be of particular value for the field or mRNA therapeutics. Third, we will predict the functional consequences of genetic variation in UTRs on protein production and we will validate these predictions experimentally. We are far from understanding which genetic variants compromise gene regulatory function in ways that may contribute to disease, making such a comprehensive and quantitative analysis of variants valuable. This research project aims to use machine learning to build predictive models of translation and mRNA stability. Models are trained on data obtained by measuring protein production for millions of synthetic RNA constructs. Models will then be applied for understanding the consequences of genetic variation in humans and for the design of mRNA therapeutics.",A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics,9421497,R01HG009892,"['3&apos', ' Untranslated Regions', '5&apos', ' Untranslated Regions', 'Address', 'Affect', 'Alternative Splicing', 'Binding Sites', 'Biological', 'Biological Assay', 'Biological Neural Networks', 'Biology', 'Biotechnology', 'Code', 'Computational Technique', 'DNA Library', 'Data', 'Data Set', 'Disease', 'Elements', 'Engineering', 'Expression Library', 'Gene Expression', 'Genes', 'Genetic Programming', 'Genetic Transcription', 'Genetic Translation', 'Genetic Variation', 'Genome', 'Genomics', 'Human', 'Human Engineering', 'Human Genetics', 'Human Genome', 'Image', 'In Vitro', 'Learning', 'Libraries', 'Machine Learning', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Neural Network Simulation', 'Performance', 'Polyribosomes', 'Production', 'Property', 'Proteins', 'RNA', 'RNA Splicing', 'RNA Stability', 'RNA-Binding Proteins', 'Randomized', 'Regulator Genes', 'Regulatory Element', 'Research Project Grants', 'Resolution', 'Ribosomes', 'Role', 'Site', 'Source', 'Structure', 'Techniques', 'Testing', 'Therapeutic', 'Thiouridine', 'Time', 'Training', 'Transcript', 'Translating', 'Translations', 'Untranslated Regions', 'Validation', 'Variant', 'Vision', 'Work', 'base', 'comparative', 'computer science', 'design', 'experimental study', 'genetic variant', 'mRNA Stability', 'member', 'novel', 'polysome profiling', 'practical application', 'predictive modeling', 'protein expression', 'ribosome profiling', 'screening', 'stable cell line', 'synthetic construct', 'voice recognition']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2018,444578,-0.02429665413195442
"A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics The leading and trailing untranslated regions (UTRs) of an mRNA, along with the coding sequence (CDS), control protein production by modulating translation and mRNA stability. However, although we have identified a vast number of regulatory features in these regions, we are still far from being able to predict, for example, whether and how a sequence variant affects the levels of protein being made. Here, we propose to combine high-throughput experimental characterization of protein expression in synthetic libraries with machine learning to create predictive models of translation and mRNA stability, addressing an urgent need. Recent progress in machine vision, voice recognition and other fields of computer science has been driven by the availability of enormous data sets on which to train models. Machine learning approaches have also had remarkable impact in biology, but biological data sets often are comparatively small, limiting the quality of models that can be learned. For example, there are only around 20,000 genes in the human genome, a restrictively small set of examples for training a predictive model that captures the full extent of the genomes regulatory code. In this proposal, we aim to overcome this data size limitation by training predictive models of protein expression on data from millions of synthetic constructs -- a data set several orders of magnitude larger than the number of genes in the genome. Specifically, we will create libraries of in vitro transcribed mRNA with targeted variation in the UTRs and CDS and will assay protein expression of each library member by performing high-throughput polysome profiling, ribosome profiling, and mRNA stability assays. We will then use neural network approaches to learn predictive models of the relationship between mRNA sequence and levels of protein production. We will apply our models to three applications of practical importance: first, we expect to uncover novel biology, for example identifying regulatory sequence elements and interactions between them. Second, we will validate our models through the de novo design and experimental testing of sequences that result in higher levels or protein production than any of the millions of randomly generated members of the original library or than the endogenous UTR sequences currently used in biotechnology. Such stable and highly translating mRNA constructs would be of particular value for the field or mRNA therapeutics. Third, we will predict the functional consequences of genetic variation in UTRs on protein production and we will validate these predictions experimentally. We are far from understanding which genetic variants compromise gene regulatory function in ways that may contribute to disease, making such a comprehensive and quantitative analysis of variants valuable. This research project aims to use machine learning to build predictive models of translation and mRNA stability. Models are trained on data obtained by measuring protein production for millions of synthetic RNA constructs. Models will then be applied for understanding the consequences of genetic variation in humans and for the design of mRNA therapeutics.",A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics,9894822,R01HG009892,"['3&apos', ' Untranslated Regions', '5&apos', ' Untranslated Regions', 'Address', 'Affect', 'Alternative Splicing', 'Binding Sites', 'Biological', 'Biological Assay', 'Biology', 'Biotechnology', 'Code', 'Computational Technique', 'DNA Library', 'Data', 'Data Set', 'Disease', 'Elements', 'Engineering', 'Expression Library', 'Gene Expression', 'Genes', 'Genetic Programming', 'Genetic Transcription', 'Genetic Translation', 'Genetic Variation', 'Genome', 'Genomics', 'Human', 'Human Engineering', 'Human Genetics', 'Human Genome', 'Image', 'In Vitro', 'Learning', 'Libraries', 'Machine Learning', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Neural Network Simulation', 'Performance', 'Polyribosomes', 'Production', 'Property', 'Proteins', 'RNA', 'RNA Splicing', 'RNA Stability', 'RNA-Binding Proteins', 'Randomized', 'Regulator Genes', 'Regulatory Element', 'Research Project Grants', 'Resolution', 'Ribosomes', 'Role', 'Site', 'Source', 'Structure', 'Techniques', 'Testing', 'Therapeutic', 'Thiouridine', 'Time', 'Training', 'Transcript', 'Translating', 'Translations', 'Untranslated Regions', 'Validation', 'Variant', 'Work', 'base', 'comparative', 'computer science', 'convolutional neural network', 'design', 'experimental study', 'genetic variant', 'mRNA Stability', 'machine vision', 'member', 'neural network', 'novel', 'polysome profiling', 'practical application', 'predictive modeling', 'protein expression', 'ribosome profiling', 'screening', 'stable cell line', 'statistical learning', 'synthetic construct', 'voice recognition']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2020,473065,-0.02429665413195442
"A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics The leading and trailing untranslated regions (UTRs) of an mRNA, along with the coding sequence (CDS), control protein production by modulating translation and mRNA stability. However, although we have identified a vast number of regulatory features in these regions, we are still far from being able to predict, for example, whether and how a sequence variant affects the levels of protein being made. Here, we propose to combine high-throughput experimental characterization of protein expression in synthetic libraries with machine learning to create predictive models of translation and mRNA stability, addressing an urgent need. Recent progress in machine vision, voice recognition and other fields of computer science has been driven by the availability of enormous data sets on which to train models. Machine learning approaches have also had remarkable impact in biology, but biological data sets often are comparatively small, limiting the quality of models that can be learned. For example, there are only around 20,000 genes in the human genome, a restrictively small set of examples for training a predictive model that captures the full extent of the genomes regulatory code. In this proposal, we aim to overcome this data size limitation by training predictive models of protein expression on data from millions of synthetic constructs -- a data set several orders of magnitude larger than the number of genes in the genome. Specifically, we will create libraries of in vitro transcribed mRNA with targeted variation in the UTRs and CDS and will assay protein expression of each library member by performing high-throughput polysome profiling, ribosome profiling, and mRNA stability assays. We will then use neural network approaches to learn predictive models of the relationship between mRNA sequence and levels of protein production. We will apply our models to three applications of practical importance: first, we expect to uncover novel biology, for example identifying regulatory sequence elements and interactions between them. Second, we will validate our models through the de novo design and experimental testing of sequences that result in higher levels or protein production than any of the millions of randomly generated members of the original library or than the endogenous UTR sequences currently used in biotechnology. Such stable and highly translating mRNA constructs would be of particular value for the field or mRNA therapeutics. Third, we will predict the functional consequences of genetic variation in UTRs on protein production and we will validate these predictions experimentally. We are far from understanding which genetic variants compromise gene regulatory function in ways that may contribute to disease, making such a comprehensive and quantitative analysis of variants valuable. This research project aims to use machine learning to build predictive models of translation and mRNA stability. Models are trained on data obtained by measuring protein production for millions of synthetic RNA constructs. Models will then be applied for understanding the consequences of genetic variation in humans and for the design of mRNA therapeutics.",A predictive model of mRNA stability and translation for variant interpretation and mRNA therapeutics,9712954,R01HG009892,"['3&apos', ' Untranslated Regions', '5&apos', ' Untranslated Regions', 'Address', 'Affect', 'Alternative Splicing', 'Binding Sites', 'Biological', 'Biological Assay', 'Biology', 'Biotechnology', 'Code', 'Computational Technique', 'DNA Library', 'Data', 'Data Set', 'Disease', 'Elements', 'Engineering', 'Expression Library', 'Gene Expression', 'Genes', 'Genetic Programming', 'Genetic Transcription', 'Genetic Translation', 'Genetic Variation', 'Genome', 'Genomics', 'Human', 'Human Engineering', 'Human Genetics', 'Human Genome', 'Image', 'In Vitro', 'Learning', 'Libraries', 'Machine Learning', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Neural Network Simulation', 'Performance', 'Polyribosomes', 'Production', 'Property', 'Proteins', 'RNA', 'RNA Splicing', 'RNA Stability', 'RNA-Binding Proteins', 'Randomized', 'Regulator Genes', 'Regulatory Element', 'Research Project Grants', 'Resolution', 'Ribosomes', 'Role', 'Site', 'Source', 'Structure', 'Techniques', 'Testing', 'Therapeutic', 'Thiouridine', 'Time', 'Training', 'Transcript', 'Translating', 'Translations', 'Untranslated Regions', 'Validation', 'Variant', 'Work', 'base', 'comparative', 'computer science', 'convolutional neural network', 'design', 'experimental study', 'genetic variant', 'mRNA Stability', 'machine vision', 'member', 'neural network', 'novel', 'polysome profiling', 'practical application', 'predictive modeling', 'protein expression', 'ribosome profiling', 'screening', 'stable cell line', 'synthetic construct', 'voice recognition']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2019,459955,-0.02429665413195442
"Visualization, modeling and validation of chromatin interaction data The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Several recent high- throughput technologies based on Chromatin Conformation Capture (3C) have emerged (such as 4C, 5C, Hi-C and ChIA-PET) and given us an unprecedented opportunity to study the higher-order genome organization. Among them, Hi-C technology is of particular interest due to its unbiased genome-wide coverage that can measure chromatin interaction intensities between any two given genomic loci. However, Hi-C data analysis and interpretation are still in the early stages. One of the main challenges is how to efficiently visualize chromatin interaction data, so that the scientific community to visualize and use it for their own research. In addition, due to the complex experimental procedure and high sequencing cost, Hi-C has only been performed in a limited number of cell/tissue types. Finally, the underlying mechanism of chromatin interactions remains largely unclear. Therefore, the PI will propose the following aims: Aim 1. Build an interactive and customizable 3D genome browser. We will build an interactive and customizable 3D browser, which allows users to navigate Hi-C data and other high-throughput chromatin organization data, including ChIA-PET and Capture Hi-C. We have built a prototype of the 3D genome browser (www.3dgenome.org). Our browser will allow users to conveniently browse chromatin interaction data with other data types (such as ChIP-Seq and RNA-Seq) from the genomic region in the same window simultaneously. Our system will also empower the users to create their own session and query their own Hi-C and other epigenomic data. Aim 2. Impute chromatin interaction using other genomic/epigenomic information. We will predict Hi-C interaction frequencies using other available genomic and epigenomic data in the same cell type, such as ChIP-Seq data for histone modifications and transcription factors. We will build our prediction model and then systematically impute Hi-C interaction matrices for all 127 cell types whose epigenomes are available thanks to recent effort by the ENCODE and Roadmap Epigenome projects. Aim 3. Perform validation experiments for computational method in aim 1 and 2. We will perform 20 3C experiments in hESC and GM cell lines, coupled with genome engineering by CRISPR/Cas9, to evaluate Hi-C prediction method in aim 2. The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Although several recent high-throughput technologies including Hi-C have emerged and given us an unprecedented opportunity to study 3D chromatin interaction in high resolution, its analysis and interpretation are still in the early stages. Here we propose to develop a suite of statistical modeling and computational methods to model and validate chromatin interaction using other genomic/epigenomics data, and build an interactive and customizable 3D genome browser.","Visualization, modeling and validation of chromatin interaction data",9840492,R01HG009906,"['3-Dimensional', 'Address', 'CRISPR/Cas technology', 'Cell Line', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Chromatin Remodeling Factor', 'Chromosome Territory', 'Communities', 'Complex', 'Computer Models', 'Computing Methodologies', 'Country', 'Coupled', 'Data', 'Data Analyses', 'Distal', 'Elements', 'Environment', 'Event', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genome engineering', 'Genomic Segment', 'Genomics', 'Intuition', 'Knock-out', 'Learning', 'Link', 'Machine Learning', 'Measures', 'Mediating', 'Methods', 'Modeling', 'Molecular', 'Procedures', 'Regulator Genes', 'Regulatory Element', 'Research', 'Resolution', 'Statistical Models', 'Structure', 'System', 'Techniques', 'Technology', 'Tissues', 'Validation', 'Visit', 'Visualization', 'base', 'cell type', 'chromosome conformation capture', 'convolutional neural network', 'cost', 'epigenome', 'epigenomics', 'experimental study', 'genome annotation', 'genome browser', 'genome-wide', 'genomic locus', 'high throughput technology', 'histone modification', 'human embryonic stem cell', 'interest', 'mammalian genome', 'performance tests', 'predictive modeling', 'prototype', 'random forest', 'repository', 'transcription factor', 'transcriptome sequencing', 'web site']",NHGRI,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2020,395000,0.09797015205210417
"Visualization, modeling and validation of chromatin interaction data The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Several recent high- throughput technologies based on Chromatin Conformation Capture (3C) have emerged (such as 4C, 5C, Hi-C and ChIA-PET) and given us an unprecedented opportunity to study the higher-order genome organization. Among them, Hi-C technology is of particular interest due to its unbiased genome-wide coverage that can measure chromatin interaction intensities between any two given genomic loci. However, Hi-C data analysis and interpretation are still in the early stages. One of the main challenges is how to efficiently visualize chromatin interaction data, so that the scientific community to visualize and use it for their own research. In addition, due to the complex experimental procedure and high sequencing cost, Hi-C has only been performed in a limited number of cell/tissue types. Finally, the underlying mechanism of chromatin interactions remains largely unclear. Therefore, the PI will propose the following aims: Aim 1. Build an interactive and customizable 3D genome browser. We will build an interactive and customizable 3D browser, which allows users to navigate Hi-C data and other high-throughput chromatin organization data, including ChIA-PET and Capture Hi-C. We have built a prototype of the 3D genome browser (www.3dgenome.org). Our browser will allow users to conveniently browse chromatin interaction data with other data types (such as ChIP-Seq and RNA-Seq) from the genomic region in the same window simultaneously. Our system will also empower the users to create their own session and query their own Hi-C and other epigenomic data. Aim 2. Impute chromatin interaction using other genomic/epigenomic information. We will predict Hi-C interaction frequencies using other available genomic and epigenomic data in the same cell type, such as ChIP-Seq data for histone modifications and transcription factors. We will build our prediction model and then systematically impute Hi-C interaction matrices for all 127 cell types whose epigenomes are available thanks to recent effort by the ENCODE and Roadmap Epigenome projects. Aim 3. Perform validation experiments for computational method in aim 1 and 2. We will perform 20 3C experiments in hESC and GM cell lines, coupled with genome engineering by CRISPR/Cas9, to evaluate Hi-C prediction method in aim 2. The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Although several recent high-throughput technologies including Hi-C have emerged and given us an unprecedented opportunity to study 3D chromatin interaction in high resolution, its analysis and interpretation are still in the early stages. Here we propose to develop a suite of statistical modeling and computational methods to model and validate chromatin interaction using other genomic/epigenomics data, and build an interactive and customizable 3D genome browser.","Visualization, modeling and validation of chromatin interaction data",9967363,R01HG009906,"['3-Dimensional', 'Address', 'CRISPR/Cas technology', 'Cell Line', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Chromatin Remodeling Factor', 'Chromosome Territory', 'Communities', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'Country', 'Coupled', 'Data', 'Data Analyses', 'Dimensions', 'Distal', 'Elements', 'Environment', 'Event', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genome engineering', 'Genomic Segment', 'Genomics', 'Imagery', 'Intuition', 'Knock-out', 'Learning', 'Link', 'Machine Learning', 'Measures', 'Mediating', 'Methods', 'Modeling', 'Molecular', 'Procedures', 'Regulator Genes', 'Regulatory Element', 'Research', 'Resolution', 'Statistical Models', 'Structure', 'System', 'Techniques', 'Technology', 'Tissues', 'Validation', 'Visit', 'base', 'cell type', 'chromosome conformation capture', 'convolutional neural network', 'cost', 'epigenome', 'epigenomics', 'experimental study', 'genome annotation', 'genome browser', 'genome-wide', 'high throughput technology', 'histone modification', 'human embryonic stem cell', 'interest', 'mammalian genome', 'performance tests', 'predictive modeling', 'prototype', 'random forest', 'repository', 'transcription factor', 'transcriptome sequencing', 'web site']",NHGRI,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2019,102272,0.09797015205210417
"Visualization, modeling and validation of chromatin interaction data The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Several recent high- throughput technologies based on Chromatin Conformation Capture (3C) have emerged (such as 4C, 5C, Hi-C and ChIA-PET) and given us an unprecedented opportunity to study the higher-order genome organization. Among them, Hi-C technology is of particular interest due to its unbiased genome-wide coverage that can measure chromatin interaction intensities between any two given genomic loci. However, Hi-C data analysis and interpretation are still in the early stages. One of the main challenges is how to efficiently visualize chromatin interaction data, so that the scientific community to visualize and use it for their own research. In addition, due to the complex experimental procedure and high sequencing cost, Hi-C has only been performed in a limited number of cell/tissue types. Finally, the underlying mechanism of chromatin interactions remains largely unclear. Therefore, the PI will propose the following aims: Aim 1. Build an interactive and customizable 3D genome browser. We will build an interactive and customizable 3D browser, which allows users to navigate Hi-C data and other high-throughput chromatin organization data, including ChIA-PET and Capture Hi-C. We have built a prototype of the 3D genome browser (www.3dgenome.org). Our browser will allow users to conveniently browse chromatin interaction data with other data types (such as ChIP-Seq and RNA-Seq) from the genomic region in the same window simultaneously. Our system will also empower the users to create their own session and query their own Hi-C and other epigenomic data. Aim 2. Impute chromatin interaction using other genomic/epigenomic information. We will predict Hi-C interaction frequencies using other available genomic and epigenomic data in the same cell type, such as ChIP-Seq data for histone modifications and transcription factors. We will build our prediction model and then systematically impute Hi-C interaction matrices for all 127 cell types whose epigenomes are available thanks to recent effort by the ENCODE and Roadmap Epigenome projects. Aim 3. Perform validation experiments for computational method in aim 1 and 2. We will perform 20 3C experiments in hESC and GM cell lines, coupled with genome engineering by CRISPR/Cas9, to evaluate Hi-C prediction method in aim 2. The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Although several recent high-throughput technologies including Hi-C have emerged and given us an unprecedented opportunity to study 3D chromatin interaction in high resolution, its analysis and interpretation are still in the early stages. Here we propose to develop a suite of statistical modeling and computational methods to model and validate chromatin interaction using other genomic/epigenomics data, and build an interactive and customizable 3D genome browser.","Visualization, modeling and validation of chromatin interaction data",9623355,R01HG009906,"['3-Dimensional', 'Address', 'CRISPR/Cas technology', 'Cell Line', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Chromatin Remodeling Factor', 'Chromosome Territory', 'Communities', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'Country', 'Coupled', 'Data', 'Data Analyses', 'Dimensions', 'Distal', 'Elements', 'Environment', 'Event', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genome engineering', 'Genomic Segment', 'Genomics', 'Imagery', 'Intuition', 'Knock-out', 'Learning', 'Link', 'Machine Learning', 'Measures', 'Mediating', 'Methods', 'Modeling', 'Molecular', 'Procedures', 'Regulator Genes', 'Regulatory Element', 'Research', 'Resolution', 'Statistical Models', 'Structure', 'System', 'Techniques', 'Technology', 'Tissues', 'Validation', 'Visit', 'base', 'cell type', 'chromosome conformation capture', 'convolutional neural network', 'cost', 'epigenome', 'epigenomics', 'experimental study', 'genome annotation', 'genome browser', 'genome-wide', 'high throughput technology', 'histone modification', 'human embryonic stem cell', 'interest', 'mammalian genome', 'performance tests', 'predictive modeling', 'prototype', 'random forest', 'repository', 'transcription factor', 'transcriptome sequencing', 'web site']",NHGRI,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,R01,2019,284020,0.09797015205210417
"Visualization, modeling and validation of chromatin interaction data The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Several recent high- throughput technologies based on Chromatin Conformation Capture (3C) have emerged (such as 4C, 5C, Hi-C and ChIA-PET) and given us an unprecedented opportunity to study the higher-order genome organization. Among them, Hi-C technology is of particular interest due to its unbiased genome-wide coverage that can measure chromatin interaction intensities between any two given genomic loci. However, Hi-C data analysis and interpretation are still in the early stages. One of the main challenges is how to efficiently visualize chromatin interaction data, so that the scientific community to visualize and use it for their own research. In addition, due to the complex experimental procedure and high sequencing cost, Hi-C has only been performed in a limited number of cell/tissue types. Finally, the underlying mechanism of chromatin interactions remains largely unclear. Therefore, the PI will propose the following aims: Aim 1. Build an interactive and customizable 3D genome browser. We will build an interactive and customizable 3D browser, which allows users to navigate Hi-C data and other high-throughput chromatin organization data, including ChIA-PET and Capture Hi-C. We have built a prototype of the 3D genome browser (www.3dgenome.org). Our browser will allow users to conveniently browse chromatin interaction data with other data types (such as ChIP-Seq and RNA-Seq) from the genomic region in the same window simultaneously. Our system will also empower the users to create their own session and query their own Hi-C and other epigenomic data. Aim 2. Impute chromatin interaction using other genomic/epigenomic information. We will predict Hi-C interaction frequencies using other available genomic and epigenomic data in the same cell type, such as ChIP-Seq data for histone modifications and transcription factors. We will build our prediction model and then systematically impute Hi-C interaction matrices for all 127 cell types whose epigenomes are available thanks to recent effort by the ENCODE and Roadmap Epigenome projects. Aim 3. Perform validation experiments for computational method in aim 1 and 2. We will perform 20 3C experiments in hESC and GM cell lines, coupled with genome engineering by CRISPR/Cas9, to evaluate Hi-C prediction method in aim 2. The three dimensional (3D) organization of mammalian genomes is tightly linked to gene regulation, as it can reveal the physical interactions between distal regulatory elements and their target genes. Although several recent high-throughput technologies including Hi-C have emerged and given us an unprecedented opportunity to study 3D chromatin interaction in high resolution, its analysis and interpretation are still in the early stages. Here we propose to develop a suite of statistical modeling and computational methods to model and validate chromatin interaction using other genomic/epigenomics data, and build an interactive and customizable 3D genome browser.","Visualization, modeling and validation of chromatin interaction data",9425925,R01HG009906,"['Address', 'Biological Neural Networks', 'CRISPR/Cas technology', 'Cell Count', 'Cell Line', 'Cell physiology', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Chromatin Remodeling Factor', 'Chromosome Territory', 'Communities', 'Complex', 'Computer Simulation', 'Computing Methodologies', 'Country', 'Coupled', 'Data', 'Data Analyses', 'Dimensions', 'Distal', 'Elements', 'Environment', 'Event', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Genome engineering', 'Genomic Segment', 'Genomics', 'Imagery', 'Intuition', 'Knock-out', 'Learning', 'Link', 'Machine Learning', 'Measures', 'Mediating', 'Methods', 'Modeling', 'Molecular', 'Procedures', 'Regulator Genes', 'Regulatory Element', 'Research', 'Resolution', 'Statistical Models', 'Structure', 'System', 'Techniques', 'Technology', 'Tissues', 'Validation', 'Visit', 'base', 'cell type', 'chromosome conformation capture', 'cost', 'epigenome', 'epigenomics', 'experimental study', 'forest', 'genome annotation', 'genome browser', 'genome-wide', 'high throughput technology', 'histone modification', 'human embryonic stem cell', 'interest', 'mammalian genome', 'performance tests', 'predictive modeling', 'prototype', 'repository', 'transcription factor', 'transcriptome sequencing', 'web site']",NHGRI,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,R01,2018,383250,0.09797015205210417
"Learning the rules of enhancer activity to understand non-coding genetic variation in autoimmune disease Project Summary/Abstract Genome-wide association studies have given us many clues about the mutations that cause common genetic diseases, including autoimmune diseases like lupus and rheumatoid arthritis. However, many of the mutations implicated in disease lie outside of the genes themselves and instead lie in the regions controlling expression of the genes, and so probably contribute to disease by producing the wrong amount of the gene in the wrong tissue or at the wrong time. Mutations in regulatory regions are thought to cause disease by altering the binding of regulatory proteins to the DNA, changing the DNA sequence from one that the protein can bind to one that it cannot (or vice versa). However, the ways in which these regulatory proteins control gene expression remains incompletely understood and so it is presently difficult to understand which regulatory protein binds differently to a mutated regulatory region, or how that change in binding affects expression of the regulated genes. In fact, we still do not even know where the regulatory regions are in the tissues we think are dysfunctional in disease. This project aims to better understand how these mutations contribute to autoimmune disease by first increasing our understanding of how regulatory proteins and regulatory regions work to control when and where genes are expressed, and then applying this knowledge to understand genetic disease. First, regulatory regions will be identified in immune cells and their effects on gene expression measured so that mutations that are likely to contribute to disease (those in regulatory regions) can be identified. The relationship between regulatory proteins, regulatory sequence, and gene expression will be learned by creating millions of synthetic regulatory regions and measuring their effect on gene expression, providing many examples of binding sites for each regulatory protein from which to learn. Finally, our new understanding of gene regulation will be applied to determine which genetic mutations change regulatory protein binding and cause disease. This will help us better understand the underlying causes of disease so that new treatments can be developed that target the mutations within each person. The candidate's long term career goals are to better understand how gene regulation works in humans so that we can better understand how the sequence of the genome controls the expression of our genes. The candidate currently works at the Broad Institute, a leading institute in human genetics and genomics with the resources and personnel required of this project. In order to continue to develop as a scientist, the candidate will gain more experience teaching, publish and present his existing findings, gain the necessary skills to work with human cells, and secure a faculty position and funding so that he can continue to make a positive impact on our knowledge of the genome. Project Narrative Certain genetic diseases are thought to be caused by mutations in the DNA that alter the expression of nearby genes. This project will help us to understand how DNA sequence regulates the expression of genes, and aims to apply this knowledge to predict how and why mutations change gene expression and contribute to disease. By better understanding the fundamental causes of disease, we can better design therapeutic interventions.",Learning the rules of enhancer activity to understand non-coding genetic variation in autoimmune disease,9695242,K99HG009920,"['ATAC-seq', 'Affect', 'Alleles', 'Autoimmune Diseases', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biochemical', 'Biochemistry', 'Biological Assay', 'Cell Line', 'Cell Separation', 'Cell physiology', 'Cells', 'Chromatin', 'Communities', 'Complex', 'Computer Simulation', 'DNA', 'DNA Sequence', 'DNA Sequence Alteration', 'Data', 'Data Set', 'Development', 'Diagnosis', 'Disease', 'Educational process of instructing', 'Enhancers', 'Faculty', 'Funding', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Diseases', 'Genetic Polymorphism', 'Genetic Variation', 'Genome', 'Goals', 'Growth', 'Haplotypes', 'Health', 'Human', 'Human Activities', 'Human Cell Line', 'Human Genetics', 'Human Genome', 'Human Resources', 'Immune', 'Institutes', 'Knowledge', 'Learning', 'Libraries', 'Link', 'Logic', 'Lupus', 'Machine Learning', 'Maps', 'Measurement', 'Measures', 'Methodology', 'Modeling', 'Mutate', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Persons', 'Phase', 'Plasmids', 'Positioning Attribute', 'Predisposition', 'Protein Region', 'Proteins', 'Publishing', 'Regulation', 'Reporter', 'Research', 'Resolution', 'Resources', 'Rheumatoid Arthritis', 'Scientist', 'Secure', 'Specificity', 'System', 'Testing', 'Therapeutic Intervention', 'Time', 'Tissues', 'Training', 'Untranslated RNA', 'Work', 'Yeasts', 'biochemical model', 'career', 'cell type', 'design', 'disorder risk', 'experience', 'genetic predictors', 'genetic regulatory protein', 'genome wide association study', 'genome-wide', 'human genomics', 'improved', 'in vivo', 'personalized medicine', 'promoter', 'rare variant', 'skills', 'transcription factor']",NHGRI,"BROAD INSTITUTE, INC.",K99,2019,90935,-0.011102747036276997
"Learning the rules of enhancer activity to understand non-coding genetic variation in autoimmune disease Project Summary/Abstract Genome-wide association studies have given us many clues about the mutations that cause common genetic diseases, including autoimmune diseases like lupus and rheumatoid arthritis. However, many of the mutations implicated in disease lie outside of the genes themselves and instead lie in the regions controlling expression of the genes, and so probably contribute to disease by producing the wrong amount of the gene in the wrong tissue or at the wrong time. Mutations in regulatory regions are thought to cause disease by altering the binding of regulatory proteins to the DNA, changing the DNA sequence from one that the protein can bind to one that it cannot (or vice versa). However, the ways in which these regulatory proteins control gene expression remains incompletely understood and so it is presently difficult to understand which regulatory protein binds differently to a mutated regulatory region, or how that change in binding affects expression of the regulated genes. In fact, we still do not even know where the regulatory regions are in the tissues we think are dysfunctional in disease. This project aims to better understand how these mutations contribute to autoimmune disease by first increasing our understanding of how regulatory proteins and regulatory regions work to control when and where genes are expressed, and then applying this knowledge to understand genetic disease. First, regulatory regions will be identified in immune cells and their effects on gene expression measured so that mutations that are likely to contribute to disease (those in regulatory regions) can be identified. The relationship between regulatory proteins, regulatory sequence, and gene expression will be learned by creating millions of synthetic regulatory regions and measuring their effect on gene expression, providing many examples of binding sites for each regulatory protein from which to learn. Finally, our new understanding of gene regulation will be applied to determine which genetic mutations change regulatory protein binding and cause disease. This will help us better understand the underlying causes of disease so that new treatments can be developed that target the mutations within each person. The candidate's long term career goals are to better understand how gene regulation works in humans so that we can better understand how the sequence of the genome controls the expression of our genes. The candidate currently works at the Broad Institute, a leading institute in human genetics and genomics with the resources and personnel required of this project. In order to continue to develop as a scientist, the candidate will gain more experience teaching, publish and present his existing findings, gain the necessary skills to work with human cells, and secure a faculty position and funding so that he can continue to make a positive impact on our knowledge of the genome. Project Narrative Certain genetic diseases are thought to be caused by mutations in the DNA that alter the expression of nearby genes. This project will help us to understand how DNA sequence regulates the expression of genes, and aims to apply this knowledge to predict how and why mutations change gene expression and contribute to disease. By better understanding the fundamental causes of disease, we can better design therapeutic interventions.",Learning the rules of enhancer activity to understand non-coding genetic variation in autoimmune disease,9431485,K99HG009920,"['ATAC-seq', 'Affect', 'Alleles', 'Autoimmune Diseases', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biochemical', 'Biochemistry', 'Biological Assay', 'Cell Line', 'Cell Separation', 'Cell physiology', 'Cells', 'Chromatin', 'Communities', 'Complex', 'Computer Simulation', 'DNA', 'DNA Sequence', 'DNA Sequence Alteration', 'Data', 'Data Set', 'Development', 'Diagnosis', 'Disease', 'Educational process of instructing', 'Enhancers', 'Faculty', 'Funding', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Diseases', 'Genetic Polymorphism', 'Genetic Variation', 'Genome', 'Goals', 'Growth', 'Haplotypes', 'Health', 'Human', 'Human Activities', 'Human Cell Line', 'Human Genetics', 'Human Genome', 'Human Resources', 'Immune', 'Institutes', 'Knowledge', 'Learning', 'Libraries', 'Link', 'Logic', 'Machine Learning', 'Maps', 'Measurement', 'Measures', 'Methodology', 'Modeling', 'Mutate', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Persons', 'Phase', 'Plasmids', 'Positioning Attribute', 'Predisposition', 'Protein Region', 'Proteins', 'Publishing', 'Regulation', 'Reporter', 'Research', 'Resolution', 'Resources', 'Rheumatoid Arthritis', 'Scientist', 'Secure', 'Specificity', 'System', 'Testing', 'Therapeutic Intervention', 'Time', 'Tissues', 'Training', 'Untranslated RNA', 'Work', 'Yeasts', 'biochemical model', 'career', 'cell type', 'design', 'disorder risk', 'experience', 'genetic predictors', 'genetic regulatory protein', 'genome wide association study', 'genome-wide', 'human genomics', 'improved', 'in vivo', 'lupus-like', 'personalized medicine', 'promoter', 'rare variant', 'skills', 'transcription factor']",NHGRI,"BROAD INSTITUTE, INC.",K99,2018,120204,-0.011102747036276997
"Computational approaches for comparative regulatory genomics to decipher long-range gene regulation Project Abstract/Summary The three-dimensional organization of the genome is a major player in long-range gene regulation, where regulatory elements such as enhancers affect the expression of a gene hundreds of kilobases away. Changes in three-dimensional organization are associated with tissue-specific gene expression and have been implicated in several human diseases including cancer, diabetes and obesity. Advances in chromosome conformation capture (3C) technologies have expanded our repertoire of long-range interactions between enhancers and promoters in model cell lines and have shown that such interactions are established through a complex interplay of chromatin state, transcription factor binding and three-dimensional proximity of genomic regions. However, our current understanding of the dynamics of long-range gene regulation is limited, both across different cell types as well as across different species. This is because of the absence of such datasets in most species and cell types, lack of systematic methods to predict and interpret these interactions, and due to limited approaches to compare both the regions and their interactions across different cell types and especially across species. The overarching goals of this proposal are to develop novel computational methods to jointly identify candidate regulatory elements in multiple species and predict their long- range interactions in new cell types and species where high-throughput 3C datasets are not available or difficult to obtain. In Aim 1, we will develop a phylogenetically aware method of jointly identifying regulatory elements such as enhancers in multiple species. Aim 2 will develop multi-task and transfer learning approaches to predict interactions in new species and cell types by integrating available high-throughput 3C datasets from multiple cell types and 3C platforms. In Aim 3, we will collect a novel multi-species chromatin mark dataset in species-specific endothelial cells to enable a systematic study of long-range gene regulation dynamics. We will apply our computational approaches developed in Aims 1 and 2 on this multi-species epigenomic dataset to identify different regulatory elements and predict long-range interactions in multiple species. We will develop rigorous computational measures to evaluate the quality of predictions from our novel methods and the improvements compared to existing methods based on published 3C datasets. We will further experimentally validate predicted interactions using Capture-HiC in multiple species and using CRISPR/Cas9 experiments. We will examine individual and groups of interactions to identify species-specific, and clade- specific interactions and interpret the corresponding genes in the context of known pathways and curated gene sets associated with cardiovascular diseases. Our methods will be widely applicable to dissect long-range gene regulation in complex phenotypes including diseases. Software tools, resources, original data and experimental protocols developed by this project will be made publicly available. Project Narrative Long-range gene regulatory interactions are emerging as important determinants of tissue-specific gene expression and are often disrupted in different diseases including cancer. Such interactions occur between distally located regulatory sequence elements and genes hundreds of kilobases away. Currently our understanding of long-range gene regulation is limited to a few cell types and model organisms. Computational methods to identify regulatory elements and systematically link them to target genes in diverse cell types and mammalian species can significantly improve our understanding of the impact of long-range gene regulation in human diseases, help interpret regulatory variation in non-coding parts of the genome and assist in the development of better biomarkers.",Computational approaches for comparative regulatory genomics to decipher long-range gene regulation,9996761,R01HG010045,"['3-Dimensional', 'Address', 'Affect', 'Animal Model', 'Awareness', 'Basic Science', 'Binding', 'Biological', 'Biological Markers', 'CRISPR/Cas technology', 'Cardiovascular Diseases', 'Cell Line', 'Cell model', 'Cells', 'Chromatin', 'Comparative Study', 'Complex', 'Computing Methodologies', 'Data', 'Data Set', 'Development', 'Diabetes Mellitus', 'Dimensions', 'Disease', 'Distal', 'Elements', 'Endothelial Cells', 'Enhancers', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'Graph', 'Human', 'Ice', 'Individual', 'Joints', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Methods', 'Modeling', 'Obesity', 'Pathway interactions', 'Performance', 'Phenotype', 'Phylogenetic Analysis', 'Play', 'Process', 'Protocols documentation', 'Psychological Transfer', 'Publishing', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Resources', 'Role', 'Signal Transduction', 'Software Tools', 'Statistical Models', 'Technology', 'Testing', 'Tissue-Specific Gene Expression', 'Training', 'Translational Research', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'chromosome conformation capture', 'comparative', 'cost', 'epigenome', 'epigenomics', 'experimental study', 'follow-up', 'genomic locus', 'histone modification', 'human disease', 'improved', 'learning classifier', 'markov model', 'multi-task learning', 'multiple datasets', 'multitask', 'novel', 'promoter', 'tool', 'trait', 'transcription factor']",NHGRI,UNIVERSITY OF WISCONSIN-MADISON,R01,2020,352626,0.1420523117409452
"Computational approaches for comparative regulatory genomics to decipher long-range gene regulation Project Abstract/Summary The three-dimensional organization of the genome is a major player in long-range gene regulation, where regulatory elements such as enhancers affect the expression of a gene hundreds of kilobases away. Changes in three-dimensional organization are associated with tissue-specific gene expression and have been implicated in several human diseases including cancer, diabetes and obesity. Advances in chromosome conformation capture (3C) technologies have expanded our repertoire of long-range interactions between enhancers and promoters in model cell lines and have shown that such interactions are established through a complex interplay of chromatin state, transcription factor binding and three-dimensional proximity of genomic regions. However, our current understanding of the dynamics of long-range gene regulation is limited, both across different cell types as well as across different species. This is because of the absence of such datasets in most species and cell types, lack of systematic methods to predict and interpret these interactions, and due to limited approaches to compare both the regions and their interactions across different cell types and especially across species. The overarching goals of this proposal are to develop novel computational methods to jointly identify candidate regulatory elements in multiple species and predict their long- range interactions in new cell types and species where high-throughput 3C datasets are not available or difficult to obtain. In Aim 1, we will develop a phylogenetically aware method of jointly identifying regulatory elements such as enhancers in multiple species. Aim 2 will develop multi-task and transfer learning approaches to predict interactions in new species and cell types by integrating available high-throughput 3C datasets from multiple cell types and 3C platforms. In Aim 3, we will collect a novel multi-species chromatin mark dataset in species-specific endothelial cells to enable a systematic study of long-range gene regulation dynamics. We will apply our computational approaches developed in Aims 1 and 2 on this multi-species epigenomic dataset to identify different regulatory elements and predict long-range interactions in multiple species. We will develop rigorous computational measures to evaluate the quality of predictions from our novel methods and the improvements compared to existing methods based on published 3C datasets. We will further experimentally validate predicted interactions using Capture-HiC in multiple species and using CRISPR/Cas9 experiments. We will examine individual and groups of interactions to identify species-specific, and clade- specific interactions and interpret the corresponding genes in the context of known pathways and curated gene sets associated with cardiovascular diseases. Our methods will be widely applicable to dissect long-range gene regulation in complex phenotypes including diseases. Software tools, resources, original data and experimental protocols developed by this project will be made publicly available. Project Narrative Long-range gene regulatory interactions are emerging as important determinants of tissue-specific gene expression and are often disrupted in different diseases including cancer. Such interactions occur between distally located regulatory sequence elements and genes hundreds of kilobases away. Currently our understanding of long-range gene regulation is limited to a few cell types and model organisms. Computational methods to identify regulatory elements and systematically link them to target genes in diverse cell types and mammalian species can significantly improve our understanding of the impact of long-range gene regulation in human diseases, help interpret regulatory variation in non-coding parts of the genome and assist in the development of better biomarkers.",Computational approaches for comparative regulatory genomics to decipher long-range gene regulation,9786812,R01HG010045,"['3-Dimensional', 'Address', 'Affect', 'Animal Model', 'Awareness', 'Basic Science', 'Binding', 'Biological', 'Biological Markers', 'CRISPR/Cas technology', 'Cardiovascular Diseases', 'Cell Line', 'Cell model', 'Cells', 'Chromatin', 'Comparative Study', 'Complex', 'Computing Methodologies', 'Data', 'Data Set', 'Development', 'Diabetes Mellitus', 'Dimensions', 'Disease', 'Distal', 'Elements', 'Endothelial Cells', 'Enhancers', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'Graph', 'Human', 'Ice', 'Individual', 'Joints', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Methods', 'Modeling', 'Obesity', 'Pathway interactions', 'Performance', 'Phenotype', 'Phylogenetic Analysis', 'Play', 'Process', 'Protocols documentation', 'Psychological Transfer', 'Publishing', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Resources', 'Role', 'Signal Transduction', 'Software Tools', 'Statistical Models', 'Technology', 'Testing', 'Tissue-Specific Gene Expression', 'Training', 'Translational Research', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'chromosome conformation capture', 'comparative', 'cost', 'epigenome', 'epigenomics', 'experimental study', 'follow-up', 'histone modification', 'human disease', 'improved', 'markov model', 'multi-task learning', 'multitask', 'novel', 'promoter', 'tool', 'trait', 'transcription factor']",NHGRI,UNIVERSITY OF WISCONSIN-MADISON,R01,2019,352626,0.1420523117409452
"Computational approaches for comparative regulatory genomics to decipher long-range gene regulation Project Abstract/Summary The three-dimensional organization of the genome is a major player in long-range gene regulation, where regulatory elements such as enhancers affect the expression of a gene hundreds of kilobases away. Changes in three-dimensional organization are associated with tissue-specific gene expression and have been implicated in several human diseases including cancer, diabetes and obesity. Advances in chromosome conformation capture (3C) technologies have expanded our repertoire of long-range interactions between enhancers and promoters in model cell lines and have shown that such interactions are established through a complex interplay of chromatin state, transcription factor binding and three-dimensional proximity of genomic regions. However, our current understanding of the dynamics of long-range gene regulation is limited, both across different cell types as well as across different species. This is because of the absence of such datasets in most species and cell types, lack of systematic methods to predict and interpret these interactions, and due to limited approaches to compare both the regions and their interactions across different cell types and especially across species. The overarching goals of this proposal are to develop novel computational methods to jointly identify candidate regulatory elements in multiple species and predict their long- range interactions in new cell types and species where high-throughput 3C datasets are not available or difficult to obtain. In Aim 1, we will develop a phylogenetically aware method of jointly identifying regulatory elements such as enhancers in multiple species. Aim 2 will develop multi-task and transfer learning approaches to predict interactions in new species and cell types by integrating available high-throughput 3C datasets from multiple cell types and 3C platforms. In Aim 3, we will collect a novel multi-species chromatin mark dataset in species-specific endothelial cells to enable a systematic study of long-range gene regulation dynamics. We will apply our computational approaches developed in Aims 1 and 2 on this multi-species epigenomic dataset to identify different regulatory elements and predict long-range interactions in multiple species. We will develop rigorous computational measures to evaluate the quality of predictions from our novel methods and the improvements compared to existing methods based on published 3C datasets. We will further experimentally validate predicted interactions using Capture-HiC in multiple species and using CRISPR/Cas9 experiments. We will examine individual and groups of interactions to identify species-specific, and clade- specific interactions and interpret the corresponding genes in the context of known pathways and curated gene sets associated with cardiovascular diseases. Our methods will be widely applicable to dissect long-range gene regulation in complex phenotypes including diseases. Software tools, resources, original data and experimental protocols developed by this project will be made publicly available. Project Narrative Long-range gene regulatory interactions are emerging as important determinants of tissue-specific gene expression and are often disrupted in different diseases including cancer. Such interactions occur between distally located regulatory sequence elements and genes hundreds of kilobases away. Currently our understanding of long-range gene regulation is limited to a few cell types and model organisms. Computational methods to identify regulatory elements and systematically link them to target genes in diverse cell types and mammalian species can significantly improve our understanding of the impact of long-range gene regulation in human diseases, help interpret regulatory variation in non-coding parts of the genome and assist in the development of better biomarkers.",Computational approaches for comparative regulatory genomics to decipher long-range gene regulation,9500095,R01HG010045,"['Address', 'Affect', 'Animal Model', 'Awareness', 'Basic Science', 'Binding', 'Biological', 'Biological Markers', 'CRISPR/Cas technology', 'Cardiovascular Diseases', 'Cell Count', 'Cell Line', 'Cell model', 'Chromatin', 'Comparative Study', 'Complex', 'Computing Methodologies', 'Data', 'Data Set', 'Development', 'Diabetes Mellitus', 'Dimensions', 'Disease', 'Distal', 'Elements', 'Endothelial Cells', 'Enhancers', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Genomic Segment', 'Genomics', 'Goals', 'Graph', 'Human', 'Ice', 'Individual', 'Joints', 'Learning', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Methods', 'Modeling', 'Obesity', 'Pathway interactions', 'Performance', 'Phenotype', 'Phylogenetic Analysis', 'Play', 'Process', 'Protocols documentation', 'Psychological Transfer', 'Publishing', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Resources', 'Role', 'Signal Transduction', 'Software Tools', 'Statistical Models', 'Technology', 'Testing', 'Tissue-Specific Gene Expression', 'Training', 'Translational Research', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'chromosome conformation capture', 'comparative', 'cost', 'epigenome', 'epigenomics', 'experimental study', 'follow-up', 'histone modification', 'human disease', 'improved', 'markov model', 'multitask', 'novel', 'promoter', 'tool', 'trait', 'transcription factor']",NHGRI,UNIVERSITY OF WISCONSIN-MADISON,R01,2018,411292,0.1420523117409452
"Gene expression and regulation in C. elegans with single cell resolution Abstract The nematode C. elegans is unique among model organisms in having a defined lineage and known connections for all its 302 neurons. The genome sequence was completed more than 20 years ago, but knowing which genes in the genome are used in exactly which cells and what transcription factors are controlling that expression remains a major challenge. We have successfully applied single cell- (sc-)RNA-seq methods to one larval stage and three embryonic stages to measure the RNA content of individual cells across the whole animal. We also have preliminary data that indicates that we can assay chromatin accessibility at the single cell level using the assay for transposase accessible chromatin (ATAC-seq). We now propose to collect both sc-RNA-seq and ATAC-seq data at multiple stages to determine the gene expression patterns of each cell in the worm and the active regulatory sequence throughout the entire life cycle of C. elegans. In turn we will use the combined data sets along with chromatin- immunoprecipitation- (ChIP-) seq data to impute what transcription factors are controlling expression of each gene in the genome in every cell and what regulatory sequences these transcription factors recognize. The results will provide a valuable resource to scientists studying the worm and addresses a major outstanding question in the molecular biology of development. In addition, these data sets, from an animal with a ground truth should serve as a platform for methods development in the single cell field. Narrative The nematode C. elegans is a simple animal that as an adult has just 959 somatic cells that arise from a known and constant lineage. We propose to use single cell methods to measure in every cell the expression of each gene and the active regulatory regions throughout the life cycle. Using these data and others, we will impute how these regulatory regions and the transcription factors that bind to them control gene expression in each cell.",Gene expression and regulation in C. elegans with single cell resolution,9969245,R01HG010478,"['Address', 'Adult', 'Anatomy', 'Animal Model', 'Animals', 'Behavior', 'Binding', 'Biological Assay', 'Caenorhabditis elegans', 'Catalogs', 'Cell Lineage', 'Cell Nucleus', 'Cells', 'Cellular Assay', 'ChIP-seq', 'Chromatin', 'Communities', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Dissociation', 'Embryo', 'Embryonic Development', 'Event', 'Expression Profiling', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Human', 'Individual', 'Larva', 'Life Cycle Stages', 'Literature', 'Machine Learning', 'Measures', 'Methods', 'Modeling', 'Molecular Biology', 'Nematoda', 'Nervous system structure', 'Neurons', 'Nucleic Acid Regulatory Sequences', 'Organism', 'Pattern', 'Population', 'Publications', 'RNA', 'Resolution', 'Resources', 'Sampling', 'Scientist', 'Site', 'Somatic Cell', 'Structure', 'Synapses', 'Tissues', 'Transposase', 'base', 'cell type', 'chromatin immunoprecipitation', 'cost effectiveness', 'exhaustion', 'experimental study', 'improved', 'male', 'method development', 'muscular system', 'relating to nervous system', 'single-cell RNA sequencing', 'transcription factor', 'young adult']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2020,510309,0.08832551700982762
"Gene expression and regulation in C. elegans with single cell resolution Abstract The nematode C. elegans is unique among model organisms in having a defined lineage and known connections for all its 302 neurons. The genome sequence was completed more than 20 years ago, but knowing which genes in the genome are used in exactly which cells and what transcription factors are controlling that expression remains a major challenge. We have successfully applied single cell- (sc-)RNA-seq methods to one larval stage and three embryonic stages to measure the RNA content of individual cells across the whole animal. We also have preliminary data that indicates that we can assay chromatin accessibility at the single cell level using the assay for transposase accessible chromatin (ATAC-seq). We now propose to collect both sc-RNA-seq and ATAC-seq data at multiple stages to determine the gene expression patterns of each cell in the worm and the active regulatory sequence throughout the entire life cycle of C. elegans. In turn we will use the combined data sets along with chromatin- immunoprecipitation- (ChIP-) seq data to impute what transcription factors are controlling expression of each gene in the genome in every cell and what regulatory sequences these transcription factors recognize. The results will provide a valuable resource to scientists studying the worm and addresses a major outstanding question in the molecular biology of development. In addition, these data sets, from an animal with a ground truth should serve as a platform for methods development in the single cell field. Narrative The nematode C. elegans is a simple animal that as an adult has just 959 somatic cells that arise from a known and constant lineage. We propose to use single cell methods to measure in every cell the expression of each gene and the active regulatory regions throughout the life cycle. Using these data and others, we will impute how these regulatory regions and the transcription factors that bind to them control gene expression in each cell.",Gene expression and regulation in C. elegans with single cell resolution,9711034,R01HG010478,"['Address', 'Adult', 'Anatomy', 'Animal Model', 'Animals', 'Behavior', 'Binding', 'Biological Assay', 'Caenorhabditis elegans', 'Catalogs', 'Cell Lineage', 'Cell Nucleus', 'Cells', 'Cellular Assay', 'ChIP-seq', 'Chromatin', 'Communities', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Dissociation', 'Embryo', 'Embryonic Development', 'Event', 'Expression Profiling', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Human', 'Individual', 'Larva', 'Life Cycle Stages', 'Literature', 'Machine Learning', 'Measures', 'Methods', 'Modeling', 'Molecular Biology', 'Nematoda', 'Nervous system structure', 'Neurons', 'Nucleic Acid Regulatory Sequences', 'Organism', 'Pattern', 'Population', 'Publications', 'RNA', 'Resolution', 'Resources', 'Sampling', 'Scientist', 'Site', 'Somatic Cell', 'Structure', 'Synapses', 'Tissues', 'Transposase', 'base', 'cell type', 'chromatin immunoprecipitation', 'cost effectiveness', 'exhaustion', 'experimental study', 'improved', 'male', 'method development', 'muscular system', 'relating to nervous system', 'single-cell RNA sequencing', 'transcription factor', 'young adult']",NHGRI,UNIVERSITY OF WASHINGTON,R01,2019,510309,0.08832551700982762
"Computational tools for regulome mapping using single-cell genomic data Project Summary Understanding how genes' activities are controlled is crucial for elucidating the basic operating rules of biology and molecular mechanisms of diseases. Recent innovations in single-cell genomic technologies have opened the door to analyzing a variety of functional genomic features in individual cells. These technologies enable scientists to systematically discover unknown cell subpopulations in complex tissue and disease samples, and allow them to reconstruct a sample's gene regulatory landscape at an unprecedented cellular resolution. Despite these promising developments, many challenges still exist and must be overcome before one can fully decode gene regulation at the single-cell resolution. In particular, current technologies lack the ability to accurately measure the activity of each individual cis-regulatory element (CRE) in a single cell. They also cannot measure all functional genomic data types in the same cell. Moreover, the prevalent technical biases and noises in single-cell genomic data make computational analysis non-trivial. With rapid growth of data, lack of computational tools for data analysis has become a rate-limiting factor for effective applications of single-cell genomic technologies.  The objective of this proposal is to develop computational and statistical methods and software tools for mapping and analyzing gene regulatory landscape using single-cell genomic data. Our Aim 1 addresses the challenge of accurately measuring CRE activities in single cells using single-cell regulome data. Regulome, dened as the activities of all cis-regulatory elements in a genome, contains crucial information for understanding gene regulation. The state-of-the-art technologies for mapping regulome in a single cell produce sparse data that cannot accurately measure activities of individual CREs. We will develop a new computational framework to allow more accurate analysis of individual CREs' activities in single cells using sparse data. Our Aim 2 addresses the challenge of collecting multiple functional genomic data types in the same cell. We will develop a method that uses single-cell RNA sequencing (scRNA-seq), the most widely used single-cell functional genomic technology, to predict cells' regulatory landscape. Since most scRNA-seq datasets do not have accompanying single-cell data for other -omics data types, our method will also signicantly expand the utility and increase the value of scRNA- seq experiments. Our Aim 3 addresses the challenge of integrating different data types generated by different single-cell genomic technologies from different cells. We will develop a method to align single-cell RNA-seq and single-cell regulome data to generate an integrated map of transcriptome and regulome.  Upon completion of this proposal, we will deliver our methods through open-source software tools. These tools will be widely useful for analyzing and integrating single-cell regulome and transcriptome data. By addressing several major challenges in single-cell genomics, our new methods and tools will help unleash the full potential of single-cell genomic technologies for studying gene regulation. As such, they can have a major impact on advancing our understanding of both basic biology and human diseases. Project Narrative Understanding how genes' activities are controlled at single-cell resolution is crucial for studying human diseases. This proposal will develop a coordinated set of computational and statistical methods and software tools for mapping and analyzing gene regulatory programs using single-cell genomic data. These methods and tools will allow scientists to more accurately and comprehensively reconstruct gene regulatory landscape of individual cells in complex tissue and disease samples, and they can have a major impact on advancing our understanding of both basic biology and human diseases.",Computational tools for regulome mapping using single-cell genomic data,10001077,R01HG010889,"['Address', 'Atlases', 'Behavior', 'Biological', 'Biology', 'Biomedical Research', 'Brain', 'Cells', 'Cellular Assay', 'Chromatin', 'Complex', 'Computer Analysis', 'Computing Methodologies', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Disease', 'Emerging Technologies', 'Foundations', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Human', 'Immune system', 'Individual', 'Knowledge', 'Malignant Neoplasms', 'Maps', 'Measures', 'Methods', 'Modality', 'Molecular', 'Multiomic Data', 'Noise', 'Organ', 'Phase', 'Population', 'Regulator Genes', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Sampling', 'Scientist', 'Software Tools', 'Statistical Methods', 'Stem Cell Development', 'System', 'Technology', 'Therapeutic', 'Tissues', 'Training', 'Transposase', 'base', 'computer framework', 'computerized tools', 'epigenome', 'experimental study', 'functional genomics', 'genomic data', 'histone modification', 'human disease', 'innovation', 'multiple data types', 'multiple omics', 'novel strategies', 'open source', 'predictive modeling', 'programs', 'rapid growth', 'single cell analysis', 'single cell technology', 'single-cell RNA sequencing', 'supervised learning', 'tool', 'transcriptome', 'transcriptome sequencing', 'user-friendly']",NHGRI,JOHNS HOPKINS UNIVERSITY,R01,2020,409375,0.07478235155329402
"Computational tools for regulome mapping using single-cell genomic data Project Summary Understanding how genes' activities are controlled is crucial for elucidating the basic operating rules of biology and molecular mechanisms of diseases. Recent innovations in single-cell genomic technologies have opened the door to analyzing a variety of functional genomic features in individual cells. These technologies enable scientists to systematically discover unknown cell subpopulations in complex tissue and disease samples, and allow them to reconstruct a sample's gene regulatory landscape at an unprecedented cellular resolution. Despite these promising developments, many challenges still exist and must be overcome before one can fully decode gene regulation at the single-cell resolution. In particular, current technologies lack the ability to accurately measure the activity of each individual cis-regulatory element (CRE) in a single cell. They also cannot measure all functional genomic data types in the same cell. Moreover, the prevalent technical biases and noises in single-cell genomic data make computational analysis non-trivial. With rapid growth of data, lack of computational tools for data analysis has become a rate-limiting factor for effective applications of single-cell genomic technologies.  The objective of this proposal is to develop computational and statistical methods and software tools for mapping and analyzing gene regulatory landscape using single-cell genomic data. Our Aim 1 addresses the challenge of accurately measuring CRE activities in single cells using single-cell regulome data. Regulome, dened as the activities of all cis-regulatory elements in a genome, contains crucial information for understanding gene regulation. The state-of-the-art technologies for mapping regulome in a single cell produce sparse data that cannot accurately measure activities of individual CREs. We will develop a new computational framework to allow more accurate analysis of individual CREs' activities in single cells using sparse data. Our Aim 2 addresses the challenge of collecting multiple functional genomic data types in the same cell. We will develop a method that uses single-cell RNA sequencing (scRNA-seq), the most widely used single-cell functional genomic technology, to predict cells' regulatory landscape. Since most scRNA-seq datasets do not have accompanying single-cell data for other -omics data types, our method will also signicantly expand the utility and increase the value of scRNA- seq experiments. Our Aim 3 addresses the challenge of integrating different data types generated by different single-cell genomic technologies from different cells. We will develop a method to align single-cell RNA-seq and single-cell regulome data to generate an integrated map of transcriptome and regulome.  Upon completion of this proposal, we will deliver our methods through open-source software tools. These tools will be widely useful for analyzing and integrating single-cell regulome and transcriptome data. By addressing several major challenges in single-cell genomics, our new methods and tools will help unleash the full potential of single-cell genomic technologies for studying gene regulation. As such, they can have a major impact on advancing our understanding of both basic biology and human diseases. Project Narrative Understanding how genes' activities are controlled at single-cell resolution is crucial for studying human diseases. This proposal will develop a coordinated set of computational and statistical methods and software tools for mapping and analyzing gene regulatory programs using single-cell genomic data. These methods and tools will allow scientists to more accurately and comprehensively reconstruct gene regulatory landscape of individual cells in complex tissue and disease samples, and they can have a major impact on advancing our understanding of both basic biology and human diseases.",Computational tools for regulome mapping using single-cell genomic data,9649896,R01HG010889,"['Address', 'Atlases', 'Behavior', 'Biological', 'Biology', 'Biomedical Research', 'Brain', 'Cells', 'Cellular Assay', 'Chromatin', 'Complex', 'Computer Analysis', 'Computing Methodologies', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Disease', 'Emerging Technologies', 'Foundations', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Human', 'Immune system', 'Individual', 'Knowledge', 'Malignant Neoplasms', 'Maps', 'Measures', 'Methods', 'Modality', 'Molecular', 'Multiomic Data', 'Noise', 'Organ', 'Phase', 'Population', 'Regulator Genes', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Sampling', 'Scientist', 'Software Tools', 'Statistical Methods', 'Stem Cell Development', 'System', 'Technology', 'Therapeutic', 'Tissues', 'Training', 'Transposase', 'base', 'computer framework', 'computerized tools', 'epigenome', 'experimental study', 'functional genomics', 'genomic data', 'histone modification', 'human disease', 'innovation', 'multiple omics', 'novel strategies', 'open source', 'predictive modeling', 'programs', 'rapid growth', 'single cell analysis', 'single cell technology', 'single-cell RNA sequencing', 'supervised learning', 'tool', 'transcriptome', 'transcriptome sequencing', 'user-friendly']",NHGRI,JOHNS HOPKINS UNIVERSITY,R01,2019,409375,0.07478235155329402
"Joint analysis of 3D chromatin organization and 1D epigenome Abstract After the completion of the Human Genome Project, thousands of experiments from ENCODE and Roadmap Epigenomics projects have successfully proled regulatory elements and epigenetic landscape along the genome. More recently, over 2,000 chromatin organization datasets have been generated from 4D Nucleome (4DN) Project, and they provide complementary information about how these genomic and epigenomic elements are spatially organized in a nucleus. Joint analysis of 3D chromatin organization with previously proled 1D epigenome in different cell types will be a key step to understand the mechanisms underlying transcriptional regulation over long genomic distances. However, there are two challenges. First, there is a resolution mismatch between chromatin organization data (e.g. Hi-C contacts) which are usually measured at 10k base pair resolution, and epigenome-based chromatin state features (e.g. ChIP-seq peaks) whose signals are usually at tens to hundreds of base pairs. Second, existing computational approaches for analyzing epigenome, such as annotating genome and understanding regulatory elements, all treat the DNA sequence as one-dimensional data, leaving the important 3D structural information unutilized. We aim to develop the most cutting-edge deep learning approaches for understanding the relationship between chromatin state features and chromatin organization, performing 3D and 4D genome annotation, and identifying spatially collaborative transcription factors, respectively. After the completion of the proposed work, we expect to have: (1) an accurate and interpretable computational model to predict chromatin contact maps at nucleosome resolution for a wide range of cell lines, (2) 3D and 4D genome annotations over dynamic chromatin organization, regulatory elements and epigenomic features, and (3) a computational method for identifying spatially collaborative transcription factors which can help us understand the orchestration of noncoding genetic variants. These results will provide fundamental understanding of disease-relevant genetic variation in the light of the spatial organization of these genomic and epigenomic elements and their functional implications. Project Narrative The goal of this project is to develop novel computational methods to jointly analyze 3D chromatin organization data and 1D epigenomic features, and reveal the interplay among regulatory elements, epigenomic features, and dynamic chromatin organization. These new methods will help us understand the mechanisms of the genetic variants identied in genome-wide association studies, and understand the genetic basis of many human diseases.",Joint analysis of 3D chromatin organization and 1D epigenome,10046394,R35HG011279,"['3-Dimensional', 'Base Pairing', 'Cell Line', 'Cell Nucleus', 'ChIP-seq', 'Chromatin', 'Computer Models', 'Computing Methodologies', 'DNA Sequence', 'Data', 'Data Set', 'Dimensions', 'Disease', 'Elements', 'Epigenetic Process', 'Genetic', 'Genetic Variation', 'Genome', 'Genomics', 'Goals', 'Human Genome Project', 'Joints', 'Maps', 'Measures', 'Methods', 'Nucleosomes', 'Regulatory Element', 'Resolution', 'Signal Transduction', 'Three-dimensional analysis', 'Transcriptional Regulation', 'Untranslated RNA', 'Work', 'base', 'cell type', 'deep learning', 'epigenome', 'epigenomics', 'experimental study', 'genetic variant', 'genome annotation', 'genome wide association study', 'human disease', 'novel', 'three dimensional structure', 'transcription factor']",NHGRI,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R35,2020,432839,0.0676157692765272
"Informatics Platform for Mammalian Gene Regulation at Isoform-level DESCRIPTION (provided by applicant): In recent years, the notion of ""one gene makes one protein that functions in one signaling pathway"" in mammalian cells has been shown to be overly simplistic. Recent evidence suggests that more than 50% of the human genes produce multiple protein isoforms, through alternative splicing and alternative usage of transcription initiation and/or termination. Notably, the disruption of many of these genes is implicated in cancer and several neuropsychiatric disorders. For majority of human genes the resulting multiple protein isoforms are functionally different and can participate in different signaling pathways. However, nearly after a decade since the completion of the human genome draft sequence, we still assume ""gene"" as the basic functional unit in a cell. We argue that the isoform-level gene products - ""transcript variants"" and ""protein isoforms"" are the basic functional units in a mammalian cell, and accordingly, the informatics resources for managing and analyzing gene regulation data in mammalian cells should adopt ""gene isoform centric"" rather than ""gene centric"" approaches. We propose to build an informatics platform for understanding gene regulation at isoform-level by developing statistically rigorous bioinformatics resources for processing Next-Generation Sequencing (NGS) data. Recently, computational approaches that combine seemingly disparate experimental data have been successful in developing concise gene regulation models and transcriptional modules. We plan to extend these methodologies to perform integrative analysis of multiple high-throughput data sets currently generated across different laboratories, including ours at Wistar, into computational models to predict different transcriptional isoforms of mammalian genes and protein-DNA interactions at isoform level. We will apply innovative statistical modeling approaches that combine state-of-the-art meta-classification algorithms, such as Nave Bayes Tree, Bagging and LogitBoost, with Random Forest feature selection to classify different types of target promoters with good classification accuracy and reduced instability, in order to predict gene promoters and infer the protein-DNA interactions from ChIP-seq data. The computational models and the derived information will be integrated into a novel database, which will serve as an in silico platform for transcriptional regulation studies. This will be completed by pursuing the following aims, (1) Develop statistically rigorous novel algorithms and bioinformatics pipelines to identify the orthologous promoters, corresponding transcript variants and protein isoforms that are conserved between human and mouse, (2) develop novel algorithms and informatics pipelines for integrative analysis of NGS datasets to estimate the activity and expression of both known and novel promoters and their transcript variants, in various tissues, developmental stages, and disease conditions, and (3) develop a web-accessible database for integrating the information generated. The novel bioinformatics methods developed by this project will help in silico discovery and research for accelerating the linkage of phenotypic and genomic information, at gene-isoform level. Public health relevance statement:  The disruption of numerous human genes and their isoforms driven by alternative splicing and alternative transcription is implicated in cancer and several neuropsychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder and autism. The development of bioinformatics methods and user-friendly  software in this study will provide useful tools to better understand gene regulatory mechanisms in mammalian cells, and more importantly, how dis-regulation of these mechanisms leads to a variety of diseases.",Informatics Platform for Mammalian Gene Regulation at Isoform-level,8843951,R01LM011297,"['Adopted', 'Algorithms', 'Alternative Splicing', 'Arts', 'Autistic Disorder', 'Binding Sites', 'Bioinformatics', 'Bipolar Disorder', 'Cells', 'ChIP-seq', 'Classification', 'Complex', 'Computational algorithm', 'Computer Simulation', 'Computer software', 'DNA', 'DNA Polymerase II', 'DNA-Protein Interaction', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Embryonic Development', 'Fertility', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Generations', 'Genes', 'Genetic Transcription', 'Genome', 'Genomics', 'Goals', 'Homologous Gene', 'Human', 'Human Genome', 'Informatics', 'Laboratories', 'Life', 'Malignant Neoplasms', 'Mammalian Cell', 'Methodology', 'Methods', 'Modeling', 'Molecular', 'Mus', 'Nature', 'Oncogenic', 'Parkinson Disease', 'Pathway interactions', 'Pattern Recognition', 'Process', 'Protein Isoforms', 'Protein Kinase', 'Proteins', 'Regulation', 'Regulator Genes', 'Research', 'Research Personnel', 'Resource Informatics', 'Resources', 'Schizophrenia', 'Secure', 'Signal Pathway', 'Solutions', 'Staging', 'Statistical Models', 'TP53 gene', 'TP73 gene', 'Technology', 'Tissues', 'Transcript', 'Transcription Initiation', 'Transcription factor genes', 'Transcriptional Regulation', 'Trees', 'Tumor Suppressor Genes', 'Tumor Suppressor Proteins', 'Variant', 'Work', 'base', 'cancer initiation', 'cost', 'epigenomics', 'forest', 'genome-wide analysis', 'improved', 'innovation', 'neuropsychiatry', 'next generation sequencing', 'novel', 'prevent', 'promoter', 'protein function', 'public health relevance', 'tool', 'transcription factor', 'transcriptome sequencing', 'tumor progression', 'user friendly software', 'user-friendly', 'web-accessible']",NLM,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2015,337196,0.011708855669311048
"Informatics platform for mammalian gene regulation at isoform-level     DESCRIPTION (provided by applicant): In recent years, the notion of ""one gene makes one protein that functions in one signaling pathway"" in mammalian cells has been shown to be overly simplistic. Recent evidence suggests that more than 50% of the human genes produce multiple protein isoforms, through alternative splicing and alternative usage of transcription initiation and/or termination. Notably, the disruption of many of these genes is implicated in cancer and several neuropsychiatric disorders. For majority of human genes the resulting multiple protein isoforms are functionally different and can participate in different signaling pathways. However, nearly after a decade since the completion of the human genome draft sequence, we still assume ""gene"" as the basic functional unit in a cell. We argue that the isoform-level gene products - ""transcript variants"" and ""protein isoforms"" are the basic functional units in a mammalian cell, and accordingly, the informatics resources for managing and analyzing gene regulation data in mammalian cells should adopt ""gene isoform centric"" rather than ""gene centric"" approaches. We propose to build an informatics platform for understanding gene regulation at isoform-level by developing statistically rigorous bioinformatics resources for processing Next-Generation Sequencing (NGS) data. Recently, computational approaches that combine seemingly disparate experimental data have been successful in developing concise gene regulation models and transcriptional modules. We plan to extend these methodologies to perform integrative analysis of multiple high-throughput data sets currently generated across different laboratories, including ours at Wistar, into computational models to predict different transcriptional isoforms of mammalian genes and protein-DNA interactions at isoform level. We will apply innovative statistical modeling approaches that combine state-of-the-art meta-classification algorithms, such as Nave Bayes Tree, Bagging and LogitBoost, with Random Forest feature selection to classify different types of target promoters with good classification accuracy and reduced instability, in order to predict gene promoters and infer the protein-DNA interactions from ChIP-seq data. The computational models and the derived information will be integrated into a novel database, which will serve as an in silico platform for transcriptional regulation studies. This will be completed by pursuing the following aims, (1) Develop statistically rigorous novel algorithms and bioinformatics pipelines to identify the orthologous promoters, corresponding transcript variants and protein isoforms that are conserved between human and mouse, (2) develop novel algorithms and informatics pipelines for integrative analysis of NGS datasets to estimate the activity and expression of both known and novel promoters and their transcript variants, in various tissues, developmental stages, and disease conditions, and (3) develop a web-accessible database for integrating the information generated. The novel bioinformatics methods developed by this project will help in silico discovery and research for accelerating the linkage of phenotypic and genomic information, at gene-isoform level.             Public health relevance statement:  The disruption of numerous human genes and their isoforms driven by alternative splicing and alternative transcription is implicated in cancer and several neuropsychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder and autism. The development of bioinformatics methods and user-friendly  software in this study will provide useful tools to better understand gene regulatory mechanisms in mammalian cells, and more importantly, how dis-regulation of these mechanisms leads to a variety of diseases.",Informatics platform for mammalian gene regulation at isoform-level,8658144,R01LM011297,"['Adopted', 'Algorithms', 'Alternative Splicing', 'Arts', 'Autistic Disorder', 'Binding Sites', 'Bioinformatics', 'Bipolar Disorder', 'Cells', 'ChIP-seq', 'Classification', 'Complex', 'Computational algorithm', 'Computer Simulation', 'Computer software', 'DNA', 'DNA Polymerase II', 'DNA-Protein Interaction', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Embryonic Development', 'Fertility', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Generations', 'Genes', 'Genetic Transcription', 'Genome', 'Genomics', 'Goals', 'Homologous Gene', 'Human', 'Human Genome', 'Informatics', 'Laboratories', 'Life', 'Malignant Neoplasms', 'Mammalian Cell', 'Methodology', 'Methods', 'Modeling', 'Molecular', 'Mus', 'Nature', 'Oncogenic', 'Parkinson Disease', 'Pathway interactions', 'Pattern Recognition', 'Process', 'Protein Isoforms', 'Protein Kinase', 'Proteins', 'Regulation', 'Regulator Genes', 'Research', 'Research Personnel', 'Resource Informatics', 'Resources', 'Schizophrenia', 'Secure', 'Signal Pathway', 'Solutions', 'Staging', 'Statistical Models', 'TP53 gene', 'TP73 gene', 'Technology', 'Tissues', 'Transcript', 'Transcription Initiation', 'Transcription factor genes', 'Transcriptional Regulation', 'Trees', 'Tumor Suppressor Genes', 'Tumor Suppressor Proteins', 'Variant', 'Work', 'base', 'cancer initiation', 'cost', 'epigenomics', 'forest', 'genome wide association study', 'improved', 'innovation', 'neuropsychiatry', 'next generation sequencing', 'novel', 'prevent', 'promoter', 'protein function', 'public health relevance', 'tool', 'transcription factor', 'transcriptome sequencing', 'tumor progression', 'user friendly software', 'user-friendly', 'web-accessible']",NLM,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2014,337196,0.011708855669311048
"Informatics platform for mammalian gene regulation at isoform-level     DESCRIPTION (provided by applicant): In recent years, the notion of ""one gene makes one protein that functions in one signaling pathway"" in mammalian cells has been shown to be overly simplistic. Recent evidence suggests that more than 50% of the human genes produce multiple protein isoforms, through alternative splicing and alternative usage of transcription initiation and/or termination. Notably, the disruption of many of these genes is implicated in cancer and several neuropsychiatric disorders. For majority of human genes the resulting multiple protein isoforms are functionally different and can participate in different signaling pathways. However, nearly after a decade since the completion of the human genome draft sequence, we still assume ""gene"" as the basic functional unit in a cell. We argue that the isoform-level gene products - ""transcript variants"" and ""protein isoforms"" are the basic functional units in a mammalian cell, and accordingly, the informatics resources for managing and analyzing gene regulation data in mammalian cells should adopt ""gene isoform centric"" rather than ""gene centric"" approaches. We propose to build an informatics platform for understanding gene regulation at isoform-level by developing statistically rigorous bioinformatics resources for processing Next-Generation Sequencing (NGS) data. Recently, computational approaches that combine seemingly disparate experimental data have been successful in developing concise gene regulation models and transcriptional modules. We plan to extend these methodologies to perform integrative analysis of multiple high-throughput data sets currently generated across different laboratories, including ours at Wistar, into computational models to predict different transcriptional isoforms of mammalian genes and protein-DNA interactions at isoform level. We will apply innovative statistical modeling approaches that combine state-of-the-art meta-classification algorithms, such as Nave Bayes Tree, Bagging and LogitBoost, with Random Forest feature selection to classify different types of target promoters with good classification accuracy and reduced instability, in order to predict gene promoters and infer the protein-DNA interactions from ChIP-seq data. The computational models and the derived information will be integrated into a novel database, which will serve as an in silico platform for transcriptional regulation studies. This will be completed by pursuing the following aims, (1) Develop statistically rigorous novel algorithms and bioinformatics pipelines to identify the orthologous promoters, corresponding transcript variants and protein isoforms that are conserved between human and mouse, (2) develop novel algorithms and informatics pipelines for integrative analysis of NGS datasets to estimate the activity and expression of both known and novel promoters and their transcript variants, in various tissues, developmental stages, and disease conditions, and (3) develop a web-accessible database for integrating the information generated. The novel bioinformatics methods developed by this project will help in silico discovery and research for accelerating the linkage of phenotypic and genomic information, at gene-isoform level.             Public health relevance statement:  The disruption of numerous human genes and their isoforms driven by alternative splicing and alternative transcription is implicated in cancer and several neuropsychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder and autism. The development of bioinformatics methods and user-friendly  software in this study will provide useful tools to better understand gene regulatory mechanisms in mammalian cells, and more importantly, how dis-regulation of these mechanisms leads to a variety of diseases.",Informatics platform for mammalian gene regulation at isoform-level,8436859,R01LM011297,"['Adopted', 'Algorithms', 'Alternative Splicing', 'Arts', 'Autistic Disorder', 'Binding Sites', 'Bioinformatics', 'Bipolar Disorder', 'Cells', 'ChIP-seq', 'Classification', 'Complex', 'Computational algorithm', 'Computer Simulation', 'Computer software', 'DNA', 'DNA Polymerase II', 'DNA-Protein Interaction', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Embryonic Development', 'Fertility', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Generations', 'Genes', 'Genetic Transcription', 'Genome', 'Genomics', 'Goals', 'Homologous Gene', 'Human', 'Human Genome', 'Informatics', 'Laboratories', 'Life', 'Malignant Neoplasms', 'Mammalian Cell', 'Methodology', 'Methods', 'Modeling', 'Molecular', 'Mus', 'Nature', 'Oncogenic', 'Parkinson Disease', 'Pathway interactions', 'Pattern Recognition', 'Process', 'Protein Isoforms', 'Protein Kinase', 'Proteins', 'Regulation', 'Regulator Genes', 'Research', 'Research Personnel', 'Resource Informatics', 'Resources', 'Schizophrenia', 'Secure', 'Signal Pathway', 'Solutions', 'Staging', 'Statistical Models', 'TP53 gene', 'TP73 gene', 'Technology', 'Tissues', 'Transcript', 'Transcription Initiation', 'Transcription factor genes', 'Transcriptional Regulation', 'Trees', 'Tumor Suppressor Genes', 'Tumor Suppressor Proteins', 'Variant', 'Work', 'base', 'cancer initiation', 'cost', 'epigenomics', 'forest', 'genome wide association study', 'improved', 'innovation', 'neuropsychiatry', 'next generation sequencing', 'novel', 'prevent', 'promoter', 'protein function', 'public health relevance', 'tool', 'transcription factor', 'transcriptome sequencing', 'tumor progression', 'user friendly software', 'user-friendly', 'web-accessible']",NLM,WISTAR INSTITUTE,R01,2013,234950,0.011708855669311048
"Informatics platform for mammalian gene regulation at isoform-level DESCRIPTION (provided by applicant): In recent years, the notion of ""one gene makes one protein that functions in one signaling pathway"" in mammalian cells has been shown to be overly simplistic. Recent evidence suggests that more than 50% of the human genes produce multiple protein isoforms, through alternative splicing and alternative usage of transcription initiation and/or termination. Notably, the disruption of many of these genes is implicated in cancer and several neuropsychiatric disorders. For majority of human genes the resulting multiple protein isoforms are functionally different and can participate in different signaling pathways. However, nearly after a decade since the completion of the human genome draft sequence, we still assume ""gene"" as the basic functional unit in a cell. We argue that the isoform-level gene products - ""transcript variants"" and ""protein isoforms"" are the basic functional units in a mammalian cell, and accordingly, the informatics resources for managing and analyzing gene regulation data in mammalian cells should adopt ""gene isoform centric"" rather than ""gene centric"" approaches. We propose to build an informatics platform for understanding gene regulation at isoform-level by developing statically rigorous bioinformatics resources for processing Next-Generation Sequencing (NGS) data. Recently, computational approaches that combine seemingly disparate experimental data have been successful in developing concise gene regulation models and transcriptional modules. We plan to extend these methodologies to perform integrative analysis of multiple high-throughput data sets currently generated across different laboratories, including ours at Wistar, into computational models to predict different transcriptional isoforms of mammalian genes and protein-DNA interactions at isoform level. We will apply innovative statistical modeling approaches that combine state-of-the-art meta-classification algorithms, such as Nave Bayes Tree, Bagging and LogitBoost, with Random Forest feature selection to classify different types of target promoters with good classification accuracy and reduced instability, in order to predict gene promoters and infer the protein-DNA interactions from ChIP-seq data. The computational models and the derived information will be integrated into a novel database, which will serve as an in silico platform for transcriptional regulation studies. This will be completed by pursuing the following aims, (1) develop computational pipelines to identify the orthologous promoters, corresponding transcript variants and protein isoforms that are conserved between human and mouse, (2) develop efficient algorithms and informatics pipelines for integrative analysis of NGS datasets to predict the activity and expression of both known and novel promoters and their transcript variants, in various tissues, developmental stages, and disease conditions, and (3) develop a web-accessible database for integrating the information generated. The development of these methods and user-friendly software will provide useful tools to better understand gene regulatory mechanisms in mammalian cells, and more importantly, how dis-regulation of these mechanisms leads to a variety of diseases. Public health relevance statement: The disruption of numerous human genes and their isoforms driven by alternative splicing and alternative transcription is implicated in cancer and several neuropsychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder and autism. The development of bioinformatics methods and user-friendly software in this study will provide useful tools to better understand gene regulatory mechanisms in mammalian cells, and more importantly, how dis-regulation of these mechanisms leads to a variety of diseases.",Informatics platform for mammalian gene regulation at isoform-level,8823012,R01LM011297,[' '],NLM,NORTHWESTERN UNIVERSITY AT CHICAGO,R01,2013,152050,0.028812722182821222
"Causal Effect Estimation of Regulatory Molecules Project Summary/Abstract Transcription factors and microRNAs are essential regulatory molecules (RM) that control messenger RNAs (mRNA) and are known to be dysregulated in human diseases. Each RM may affect multiple pathways of the cell which is both a blessing and a curse. If a therapy targets the proper RM, it can attack the disease from multiple fronts and increase efficacy. On the other hand, targeted therapy may result in serious adverse effects due to our limited knowledge of the downstream causal effect of RM manipulation. Although the local bindings between single RMs and their targets have been studied computationally and experimentally, the intensity of functional consequences of such bindings on the transcriptome is unclear. Here, I propose statistical machine learning techniques and causal inference methods to predict the observed variability of gene expression using only regulatory molecules and estimate their downstream causal effect on the entire transcriptome. To achieve this goal, I start in Aim 1 by building a multi-response predictive model to predict the whole transcriptome using only RMs. This goal is challenging because the dimension of the response vector is more than the number of samples and I will use techniques from high-dimensional statistics to address this issue. In Aim 2, I will go beyond predictive modeling by estimating the causal effect of RMs on the transcriptome using invariant causal prediction. I will leverage the rapidly growing literature which connects causal inference to invariant prediction accuracy across heterogeneous data sources to infer the causal effect of RMs on mRNA. Having developed both predictive and causal models of RMs contribution to gene regulation, in Aim 3 during the R00 phase, I will focus on the most recent advances in double/debiased machine learning which allows the use of scalable machine learning methods for reliable estimation of causal effect of RMs on transcription. My proposed research will bring the most advanced statistical machine learning and causal inference techniques to genomics research and help design more effective targeted therapies by providing insights into the global role of RMs in gene expression regulation. During the training phase of the award, with the support of my outstanding mentoring team and scientific advisory committee, I will gain expertise in molecular biology and genomics while perfecting my knowledge of causal inference and machine learning. The Ohio State University Comprehensive Cancer Center  James Hospital and the Mathematical Biosciences Institute will provide me with the ideal interdisciplinary environment to bridge data science and genomics and will help me achieve my career development goals and transition to a tenure-track faculty position. Project Narrative Targeting regulatory elements has the advantage of concurrently attacking multiple damaged pathways, with the possible pitfall of toxicity due to adverse unintended effects. Understanding the functional global impact of therapy on the entire transcriptome will guide us in designing drugs with higher efficacy and lower toxicity. I propose to leverage advanced causal inference and machine learning methods to elucidate the functional role of regulatory molecules across tissue types.",Causal Effect Estimation of Regulatory Molecules,10040882,K99HG011367,"['Address', 'Adverse effects', 'Advisory Committees', 'Affect', 'Autoimmunity', 'Award', 'Base Pairing', 'Binding', 'Binding Sites', 'Biological', 'Biological Sciences', 'Cardiovascular Diseases', 'Cells', 'ChIP-seq', 'Collaborations', 'Communities', 'Complex', 'Comprehensive Cancer Center', 'Computational Biology', 'DNA', 'Data', 'Data Science', 'Data Sources', 'Diabetes Mellitus', 'Differential Equation', 'Dimensions', 'Disease', 'Drug Design', 'Economics', 'Faculty', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genomics', 'Genotype', 'Genotype-Tissue Expression Project', 'Goals', 'Hospitals', 'Institutes', 'Knowledge', 'Light', 'Linear Models', 'Literature', 'Machine Learning', 'Malignant Neoplasms', 'Mathematics', 'Measures', 'Mentors', 'Messenger RNA', 'Methods', 'MicroRNAs', 'Modeling', 'Modernization', 'Molecular Biology', 'Natural experiment', 'Ohio', 'Outcome', 'Output', 'Pathway interactions', 'Performance', 'Pharmaceutical Preparations', 'Phase', 'Phenotype', 'Positioning Attribute', 'RNA Binding', 'Regulator Genes', 'Regulatory Element', 'Research', 'Role', 'Sample Size', 'Sampling', 'Site', 'Somatic Mutation', 'Source', 'Techniques', 'The Cancer Genome Atlas', 'Tissues', 'Toxic effect', 'Training', 'Transfection', 'Translations', 'Universities', 'base', 'cancer cell', 'career development', 'causal model', 'collaborative environment', 'computer studies', 'computerized tools', 'deep neural network', 'design', 'experimental study', 'feature selection', 'heterogenous data', 'high dimensionality', 'human disease', 'improved', 'insight', 'machine learning method', 'physical model', 'predicting response', 'predictive modeling', 'response', 'statistical and machine learning', 'statistics', 'targeted treatment', 'tenure track', 'tool', 'transcription factor', 'transcriptome', 'tumor', 'vector']",NHGRI,OHIO STATE UNIVERSITY,K99,2020,99439,0.021083268733353314
"In Silico Analysis of Ocular Genes and Proteins    DESCRIPTION (provided by applicant): Advances in computation and high-throughput methods of biomedical data collection have created tremendous opportunities to advance our understanding of visual physiology. We will test the hypothesis that genes and their protein products expressed in ocular tissues can be analyzed in silico using statistical and machine learning techniques and create knowledge regarding ocular gene regulation, structure and function. In particular, these studies will produce testable predictions that may be validated by bench experiments. A primary goal will be to characterize the regulatory elements that govern gene expression in ocular cells. In addition, these tools will be used to characterize ocular protein structure, particularly structure/function relationships and to make predictions about secondary and tertiary structure. Finally, in silico methods will be used to analyze the gene/protein networks that carry out cellular functions such as metabolism, signal transduction and regulation of gone expression. The following specific questions will be addressed in this research:      1) Can computational and statistical methods be used to identify DNA sequences that regulate   ocular gene expression? Can these sequences be used to identify new, uncharacterized   genes in the human genome?      2) Can these methods be used to predict protein structural features in both health and disease   states?      3) Can gene/protein functional networks be elucidated in silico by the use of advanced   analytical and modeling techniques?      This proposal describes a four year training program that aims to develop the independent research abilities of the PI, and to prepare for a career as an individual investigator in computational biology and translational medicine.         n/a",In Silico Analysis of Ocular Genes and Proteins,7082121,K08EY014665,"['DNA binding protein', 'biological signal transduction', 'computational biology', 'eye', 'functional /structural genomics', 'gene expression', 'genetic library', 'genetic regulation', 'genetic regulatory element', 'glycoproteins', 'mathematical model', 'metabolism', 'molecular biology information system', 'nucleic acid sequence', 'protein structure function', 'serial analysis of gene expression', 'silicon compounds', 'statistics /biometry', 'trabecular meshwork', 'vision']",NEI,DUKE UNIVERSITY,K08,2006,42432,0.089443019588629
"In Silico Analysis of Ocular Genes and Proteins    DESCRIPTION (provided by applicant): Advances in computation and high-throughput methods of biomedical data collection have created tremendous opportunities to advance our understanding of visual physiology. We will test the hypothesis that genes and their protein products expressed in ocular tissues can be analyzed in silico using statistical and machine learning techniques and create knowledge regarding ocular gene regulation, structure and function. In particular, these studies will produce testable predictions that may be validated by bench experiments. A primary goal will be to characterize the regulatory elements that govern gene expression in ocular cells. In addition, these tools will be used to characterize ocular protein structure, particularly structure/function relationships and to make predictions about secondary and tertiary structure. Finally, in silico methods will be used to analyze the gene/protein networks that carry out cellular functions such as metabolism, signal transduction and regulation of gone expression. The following specific questions will be addressed in this research:      1) Can computational and statistical methods be used to identify DNA sequences that regulate   ocular gene expression? Can these sequences be used to identify new, uncharacterized   genes in the human genome?      2) Can these methods be used to predict protein structural features in both health and disease   states?      3) Can gene/protein functional networks be elucidated in silico by the use of advanced   analytical and modeling techniques?      This proposal describes a four year training program that aims to develop the independent research abilities of the PI, and to prepare for a career as an individual investigator in computational biology and translational medicine.         n/a",In Silico Analysis of Ocular Genes and Proteins,6919176,K08EY014665,"['DNA binding protein', 'biological signal transduction', 'computational biology', 'eye', 'functional /structural genomics', 'gene expression', 'genetic library', 'genetic regulation', 'genetic regulatory element', 'glycoproteins', 'mathematical model', 'metabolism', 'molecular biology information system', 'nucleic acid sequence', 'protein structure function', 'serial analysis of gene expression', 'silicon compounds', 'statistics /biometry', 'trabecular meshwork', 'vision']",NEI,DUKE UNIVERSITY,K08,2005,176458,0.089443019588629
"In Silico Analysis of Ocular Genes and Proteins    DESCRIPTION (provided by applicant): Advances in computation and high-throughput methods of biomedical data collection have created tremendous opportunities to advance our understanding of visual physiology. We will test the hypothesis that genes and their protein products expressed in ocular tissues can be analyzed in silico using statistical and machine learning techniques and create knowledge regarding ocular gene regulation, structure and function. In particular, these studies will produce testable predictions that may be validated by bench experiments. A primary goal will be to characterize the regulatory elements that govern gene expression in ocular cells. In addition, these tools will be used to characterize ocular protein structure, particularly structure/function relationships and to make predictions about secondary and tertiary structure. Finally, in silico methods will be used to analyze the gene/protein networks that carry out cellular functions such as metabolism, signal transduction and regulation of gone expression. The following specific questions will be addressed in this research:      1) Can computational and statistical methods be used to identify DNA sequences that regulate   ocular gene expression? Can these sequences be used to identify new, uncharacterized   genes in the human genome?      2) Can these methods be used to predict protein structural features in both health and disease   states?      3) Can gene/protein functional networks be elucidated in silico by the use of advanced   analytical and modeling techniques?      This proposal describes a four year training program that aims to develop the independent research abilities of the PI, and to prepare for a career as an individual investigator in computational biology and translational medicine.         n/a",In Silico Analysis of Ocular Genes and Proteins,6785475,K08EY014665,"['DNA binding protein', 'biological signal transduction', 'computational biology', 'eye', 'functional /structural genomics', 'gene expression', 'genetic library', 'genetic regulation', 'genetic regulatory element', 'glycoproteins', 'mathematical model', 'metabolism', 'molecular biology information system', 'nucleic acid sequence', 'protein structure function', 'serial analysis of gene expression', 'silicon compounds', 'statistics /biometry', 'trabecular meshwork', 'vision']",NEI,DUKE UNIVERSITY,K08,2004,171317,0.089443019588629
"In Silico Analysis of Ocular Genes and Proteins    DESCRIPTION (provided by applicant): Advances in computation and high-throughput methods of biomedical data collection have created tremendous opportunities to advance our understanding of visual physiology. We will test the hypothesis that genes and their protein products expressed in ocular tissues can be analyzed in silico using statistical and machine learning techniques and create knowledge regarding ocular gene regulation, structure and function. In particular, these studies will produce testable predictions that may be validated by bench experiments. A primary goal will be to characterize the regulatory elements that govern gene expression in ocular cells. In addition, these tools will be used to characterize ocular protein structure, particularly structure/function relationships and to make predictions about secondary and tertiary structure. Finally, in silico methods will be used to analyze the gene/protein networks that carry out cellular functions such as metabolism, signal transduction and regulation of gone expression. The following specific questions will be addressed in this research:      1) Can computational and statistical methods be used to identify DNA sequences that regulate   ocular gene expression? Can these sequences be used to identify new, uncharacterized   genes in the human genome?      2) Can these methods be used to predict protein structural features in both health and disease   states?      3) Can gene/protein functional networks be elucidated in silico by the use of advanced   analytical and modeling techniques?      This proposal describes a four year training program that aims to develop the independent research abilities of the PI, and to prepare for a career as an individual investigator in computational biology and translational medicine.         n/a",In Silico Analysis of Ocular Genes and Proteins,6605943,K08EY014665,"['DNA binding protein', ' biological signal transduction', ' eye', ' functional /structural genomics', ' gene expression', ' genetic library', ' genetic regulation', ' genetic regulatory element', ' glycoproteins', ' mathematical model', ' metabolism', ' molecular biology information system', ' nucleic acid sequence', ' protein structure function', ' serial analysis of gene expression', ' silicon compounds', ' statistics /biometry', ' trabecular meshwork', ' vision']",NEI,DUKE UNIVERSITY,K08,2003,166328,0.089443019588629
"Dissecting the transcriptional network governing differentiation of periderm Orofacial clefting is a common disease that causes significant morbidity for the affected individual and a major burden to families and society. The etiology of orofacial clefting is complex, but genetic factors contribute significant risk. To date, scores of genes have been identified where rare variants cause rare syndromic forms of orofacial clefting, and DNA variants at 24 loci have been associated with the common non-syndromic form of orofacial clefting. Despite these efforts, less than half of the heritable risk has been identified. In addition, the pathogenic variant has yet to be determined at most of the 24 associated loci. New approaches are needed to identify these genetic risk factors. Since most of the associated loci are located between genes, it is hypothesized that the pathogenic allele is in a regulatory element. Thus, the new approaches should not only help find new candidate genes but they should also find the elements that regulate the expression of those genes. In this proposal, we will use a triumvirate approach to find new candidate genes, the DNA elements that regulate their expression and the transcription factors that bind to those regulatory elements. In total, analysis of these three datasets will yield a gene regulatory network for a target tissue. The target tissue for this proposal is periderm. Periderm is the most superficial layer of squamous epithelial cells that covers the entire embryo, including the oral cavity. Recent studies from human and animal models identified 19 genes that are essential for periderm development, and of these, 10 have DNA variation that causes or increases risk for orofacial clefting. Despite its significant role in palate development, little is known about periderm at the molecular level. The immediate goals of this proposal are to i) determine the gene regulatory network for periderm and ii) apply that new knowledge to identify alleles within the 24 associated loci that perturb the gene regulatory network for periderm. The longterm goals of this proposal are to identify genetic pathways that are essential for periderm differentiation and to identify the actual pathogenic DNA variants that perturb these pathways. This new knowledge will help determine recurrence risk and provide opportunities to develop new rational therapies. In particular, since periderm only exists in the embryo and since it is the most superficial layer of the embryo, it is an ideal target for in utero therapies, when and where orofacial clefting actually occurs. We have two parallel specific aims. In Aim 1 we will determine the gene regulatory network for periderm differentiation in zebrafish by systematically perturbing the system. In Aim 2, we will use a parallel approach to determine the gene regulatory network for mouse periderm. It is essential to use both animal models because while studies of zebrafish periderm led to the identification of genes required for development of the lip and palate, the periderm between these two clades has a different embryonic origin and it is possible aspects of the gene regulatory network are different. Our project thus exploits the power and tractability of the zebrafish, and the human-like origin of periderm in the mouse. Orofacial is a common disease with a major impact on the affected individual, their family and society. Here, we will determine the gene regulatory network for periderm, an embryonic tissue that is critical for development of the palate. Our new knowledge will identify candidate genes and help identify pathogenic variants located in regulatory elements which will improve risk assessment and provide new targets for rational therapies.",Dissecting the transcriptional network governing differentiation of periderm,9783225,R56DE023575,"['ATAC-seq', 'Affect', 'Algorithms', 'Alleles', 'Animal Model', 'Architecture', 'Area', 'Binding', 'Binding Sites', 'Bioinformatics', 'Biological Assay', 'Candidate Disease Gene', 'Cell Separation', 'Cells', 'ChIP-seq', 'Chromatin', 'Code', 'Complement', 'Complex', 'DNA', 'Data Set', 'Development', 'Differentiated Gene', 'Disease', 'Dominant-Negative Mutation', 'Elements', 'Embryo', 'Embryonic Development', 'Enhancers', 'Epidermis', 'Epithelial Cells', 'Etiology', 'Expression Profiling', 'Family', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Transcription', 'Goals', 'Heritability', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Genome', 'In Vitro', 'Individual', 'Knowledge', 'Lip structure', 'Machine Learning', 'Molecular', 'Morbidity - disease rate', 'Mus', 'Oral', 'Oral cavity', 'Outcome', 'Palate', 'Pathogenesis', 'Pathogenicity', 'Pathologic', 'Pathway interactions', 'Patients', 'Periderm', 'Population', 'Positioning Attribute', 'Public Domains', 'RNA analysis', 'Recurrence', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Research', 'Risk', 'Risk Assessment', 'Role', 'Series', 'Societies', 'Sorting - Cell Movement', 'Structural Congenital Anomalies', 'System', 'Systems Biology', 'Testing', 'Time', 'Tissues', 'Training', 'Transgenic Organisms', 'Transposase', 'Untranslated RNA', 'Variant', 'Zebrafish', 'clinically significant', 'differential expression', 'embryo tissue', 'exome', 'exome sequencing', 'genetic risk factor', 'genome sequencing', 'human model', 'improved', 'in vivo', 'loss of function', 'member', 'network models', 'novel', 'novel strategies', 'oral cavity epithelium', 'orofacial', 'orofacial cleft', 'paralogous gene', 'prenatal therapy', 'promoter', 'rare condition', 'rare variant', 'risk variant', 'transcription factor', 'transcriptome sequencing', 'vector', 'whole genome']",NIDCR,UNIVERSITY OF IOWA,R56,2018,339622,0.06888980447644416
"CHARTING THE EPIGENOMIC LANDSCAPE OF HUMAN TRANSPOSABLE ELEMENTS DESCRIPTION (provided by applicant): We propose to develop novel computational methods to identify regulatory elements in repetitive regions of the genomes using publicly available data from Roadmap Epigenomics and ENCODE. Half of the human genome is derived from transposable elements (TEs). These highly repetitive elements were recently shown to harbor transcription factor (TF) binding sites and epigenetic regulatory signals. TEs have shaped gene regulatory networks during evolution and are dysregulated in many diseases. However, the extent to which TEs contribute to regulatory networks, and how TE sequences evolved from parasitic DNA to functional elements, remains unclear. In this proposal, we introduce a computational framework to identify TE-derived cell type-specific enhancers and to estimate the evolutionary impact of TEs to cell type-specific gene regulation. In Specific Aim 1 we plan to develop an epigenomics-based approach to detect TE-derived enhancers and their target genes. Extending our recent success in developing machine learning methods to integrate DNA methylation data, we will bring to bear computational models that allow us to predict TE-derived enhancers. If successful, not only will we produce the largest catalog of TE-derived cell type-specific enhancers, but also have created a robust framework for detecting the contributions of TEs to gene regulation in any cell type or tissue. In Specific Aim 2 we will develop a TE epigenetic association assay. By taking advantage of the multi-copy nature of TE sequences, we will identify TE sequence variations or features that associate with specific epigenetic and/or TF binding pattern. We will reconstruct sequences of the evolutionary intermediates of candidate TEs and estimate their epigenetic and/or TF binding pattern. We will address questions including whether particular classes of TEs gained TF-binding sites and then spread quickly, or whether TEs first spread and later gained TF binding sites. If successful, we will develop an understanding of what sequence features drive the functional potential of TEs, and the modes of evolution followed by different TEs during regulatory network evolution. Such an understanding will dramatically improve our picture of regulatory network evolution by including the effects of TEs, a major class of fast evolving regulatory sequences that have been largely ignored in functional genomics studies. In Specific Aim 3 we will create a public resource based on our newly invented Repeat Element Browser to allow investigators to display, analyze, compare, and integrate Roadmap/ENCODE data and their own data on TEs. The methods developed in this proposal will have a high impact on the utility of data produced by consortia such as ENCODE, Roadmap Epigenomics, and TCGA, which currently discard most TE derived sequences. Such improvement will in turn accelerate research into understanding the impact of TEs on normal gene regulation and in human diseases. PUBLIC HEALTH RELEVANCE: Transposable elements (TEs) are a special class of DNA sequences which copy themselves and ""hop"" to many different locations in the genome. TEs are often referred to as ""junk"" DNA or ""parasitic"" DNA, but they are more and more implicated in genome evolution, gene regulation and diseases. These elements comprise a huge fraction of the DNA in mammalian genomes, including 50% of the human genome. Because of their repetitive nature they are generally discarded in most genomics studies. We recently showed that these elements often carry regulatory sequences that are co-opted by host genomes to perform normal gene regulation. Here we propose to study the extent to which TEs contribute to normal gene regulation throughout the genome and how mis-regulation of TE derived sequences contributes to disease.",CHARTING THE EPIGENOMIC LANDSCAPE OF HUMAN TRANSPOSABLE ELEMENTS,8928618,R01ES024992,"['Address', 'Attention', 'Back', 'Binding', 'Binding Sites', 'Biological Assay', 'Cataloging', 'Catalogs', 'Chromatin', 'Code', 'Communities', 'Computer Simulation', 'Computing Methodologies', 'DNA', 'DNA Methylation', 'DNA Sequence', 'DNA Transposable Elements', 'Data', 'Data Display', 'Databases', 'Deposition', 'Development', 'Disease', 'Distal', 'Elements', 'Enhancers', 'Epigenetic Process', 'Evolution', 'Exhibits', 'Family', 'Funding', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Processes', 'Genome', 'Genomics', 'Health', 'Housing', 'Human', 'Human Genome', 'Individual', 'Junk DNA', 'Location', 'Machine Learning', 'Maps', 'Methods', 'Methylation', 'Modeling', 'Nature', 'Parasites', 'Pattern', 'Phylogenetic Analysis', 'Play', 'Reading', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Repetitive Sequence', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resources', 'Rodent', 'Role', 'Series', 'Shapes', 'Signal Transduction', 'The Cancer Genome Atlas', 'Tissues', 'Trees', 'Untranslated RNA', 'Ursidae Family', 'Variant', 'base', 'cell type', 'computer framework', 'computerized tools', 'epigenome', 'epigenomics', 'functional genomics', 'gene function', 'genome-wide', 'human disease', 'improved', 'innovation', 'mammalian genome', 'next generation sequencing', 'novel', 'programs', 'success', 'tool', 'transcription factor']",NIEHS,WASHINGTON UNIVERSITY,R01,2015,152500,0.1005221070541773
"CHARTING THE EPIGENOMIC LANDSCAPE OF HUMAN TRANSPOSABLE ELEMENTS     DESCRIPTION (provided by applicant): We propose to develop novel computational methods to identify regulatory elements in repetitive regions of the genomes using publicly available data from Roadmap Epigenomics and ENCODE. Half of the human genome is derived from transposable elements (TEs). These highly repetitive elements were recently shown to harbor transcription factor (TF) binding sites and epigenetic regulatory signals. TEs have shaped gene regulatory networks during evolution and are dysregulated in many diseases. However, the extent to which TEs contribute to regulatory networks, and how TE sequences evolved from parasitic DNA to functional elements, remains unclear. In this proposal, we introduce a computational framework to identify TE-derived cell type-specific enhancers and to estimate the evolutionary impact of TEs to cell type-specific gene regulation. In Specific Aim 1 we plan to develop an epigenomics-based approach to detect TE-derived enhancers and their target genes. Extending our recent success in developing machine learning methods to integrate DNA methylation data, we will bring to bear computational models that allow us to predict TE-derived enhancers. If successful, not only will we produce the largest catalog of TE-derived cell type-specific enhancers, but also have created a robust framework for detecting the contributions of TEs to gene regulation in any cell type or tissue. In Specific Aim 2 we will develop a TE epigenetic association assay. By taking advantage of the multi-copy nature of TE sequences, we will identify TE sequence variations or features that associate with specific epigenetic and/or TF binding pattern. We will reconstruct sequences of the evolutionary intermediates of candidate TEs and estimate their epigenetic and/or TF binding pattern. We will address questions including whether particular classes of TEs gained TF-binding sites and then spread quickly, or whether TEs first spread and later gained TF binding sites. If successful, we will develop an understanding of what sequence features drive the functional potential of TEs, and the modes of evolution followed by different TEs during regulatory network evolution. Such an understanding will dramatically improve our picture of regulatory network evolution by including the effects of TEs, a major class of fast evolving regulatory sequences that have been largely ignored in functional genomics studies. In Specific Aim 3 we will create a public resource based on our newly invented Repeat Element Browser to allow investigators to display, analyze, compare, and integrate Roadmap/ENCODE data and their own data on TEs. The methods developed in this proposal will have a high impact on the utility of data produced by consortia such as ENCODE, Roadmap Epigenomics, and TCGA, which currently discard most TE derived sequences. Such improvement will in turn accelerate research into understanding the impact of TEs on normal gene regulation and in human diseases.         PUBLIC HEALTH RELEVANCE: Transposable elements (TEs) are a special class of DNA sequences which copy themselves and ""hop"" to many different locations in the genome. TEs are often referred to as ""junk"" DNA or ""parasitic"" DNA, but they are more and more implicated in genome evolution, gene regulation and diseases. These elements comprise a huge fraction of the DNA in mammalian genomes, including 50% of the human genome. Because of their repetitive nature they are generally discarded in most genomics studies. We recently showed that these elements often carry regulatory sequences that are co-opted by host genomes to perform normal gene regulation. Here we propose to study the extent to which TEs contribute to normal gene regulation throughout the genome and how mis-regulation of TE derived sequences contributes to disease.            ",CHARTING THE EPIGENOMIC LANDSCAPE OF HUMAN TRANSPOSABLE ELEMENTS,8815597,R01ES024992,"['Address', 'Attention', 'Back', 'Binding', 'Binding Sites', 'Biological Assay', 'Cataloging', 'Catalogs', 'Chromatin', 'Code', 'Communities', 'Computer Simulation', 'Computing Methodologies', 'DNA', 'DNA Methylation', 'DNA Sequence', 'DNA Transposable Elements', 'Data', 'Data Display', 'Databases', 'Deposition', 'Development', 'Disease', 'Distal', 'Elements', 'Enhancers', 'Epigenetic Process', 'Evolution', 'Exhibits', 'Family', 'Functional RNA', 'Funding', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Processes', 'Genome', 'Genomics', 'Health', 'Housing', 'Human', 'Human Genome', 'Individual', 'Junk DNA', 'Location', 'Machine Learning', 'Maps', 'Methods', 'Methylation', 'Modeling', 'Nature', 'Parasites', 'Pattern', 'Phylogenetic Analysis', 'Play', 'Reading', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Repetitive Sequence', 'Research', 'Research Infrastructure', 'Research Personnel', 'Resources', 'Rodent', 'Role', 'Series', 'Shapes', 'Signal Transduction', 'The Cancer Genome Atlas', 'Tissues', 'Trees', 'Ursidae Family', 'Variant', 'base', 'cell type', 'computer framework', 'computerized tools', 'epigenome', 'epigenomics', 'functional genomics', 'gene function', 'genome-wide', 'human disease', 'improved', 'innovation', 'mammalian genome', 'next generation sequencing', 'novel', 'programs', 'public health relevance', 'success', 'tool', 'transcription factor']",NIEHS,WASHINGTON UNIVERSITY,R01,2014,189100,0.1005221070541773
"Computational methods for modeling lineage-specific gene regulation DESCRIPTION (provided by applicant): Complex sensory and signaling pathways ultimately converge on the DNA in the form of complexes of interacting regulatory RNAs and proteins that bind specific gene-proximal and distal regulatory elements to active and repress genes resulting in the establishment and maintenance of cell-type specific transcriptional responses. These regulatory elements have static and dynamic components - the former encoded in the genomic sequence itself as combinations of transcription factor binding site sequence motifs and the latter a consequence of locus and cell-type specific chromatin accessibility and epigenomic modifications as well as the dynamic linking of distal regulatory elements to target genes. In addition, transcriptional and post-transcriptional feedback and control of the levels of regulatory proteins and RNAs also play a key role in dynamic cell-type specific gene regulation. One of the central challenges in modern genomics is to learn these rules by which the genome and epigenome encode regulatory information. How does a single genome sequence encode the information for exquisitely precise, and yet highly distinctive programs of gene regulation for different cell types, and at different time points? What are the key sequence determinants, and grammatical rules that determine the function of any given DNA sequence under any particular set of conditions? In this project we seek to use public data from The Roadmap Epigenomics project and The ENCODE project to make progress on these questions. We propose to build methods for interpreting shared and distinctive regulatory features, including especially transcription factor binding, across related cell types. In parallel, we will implement novel methods for identifying high-resolution, context-specific dynamic regulatory elements, decipher their underlying regulatory sequence grammars and learn predictive, integrative models of transcriptional regulation to decipher the effects of heterogeneous regulatory components on lineage-specific gene expression dynamics and provide regulatory annotations for large collections of curated and disease-associated gene sets. PUBLIC HEALTH RELEVANCE: The purpose of this project is to develop powerful statistical methods to study cell-type specific gene regulation, and apply these to publicly available data from The Roadmap Epigenomics Project, The ENCODE Project and several publicly available gene expression compendia. We propose new methods for joint inference of regulatory elements across diverse cell types, deciphering lineage-specific regulatory sequence grammars encoded in these elements and learning integrative transcriptional regulation programs. Our models will serve as a resource to provide comprehensive context-specific regulatory annotations for disease-associated gene sets and co-expression modules.",Computational methods for modeling lineage-specific gene regulation,9351660,R01ES025009,"['Beryllium', 'Binding', 'Binding Sites', 'Cell Line', 'Chromatin', 'Collection', 'Communities', 'Complex', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Data', 'Data Analyses', 'Development', 'Disease', 'Distal', 'Elements', 'Feedback', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Genomics', 'Goals', 'Health', 'Imagery', 'Indium', 'Joints', 'Knowledge', 'Lead', 'Learning', 'Link', 'Machine Learning', 'Maintenance', 'Methods', 'Modeling', 'Modification', 'Play', 'Process', 'RNA-Binding Proteins', 'Regulatory Element', 'Regulatory Pathway', 'Research Personnel', 'Resolution', 'Resources', 'Sensory', 'Signal Pathway', 'Statistical Methods', 'Techniques', 'Time', 'Tissues', 'Transcriptional Regulation', 'cell type', 'combinatorial', 'epigenome', 'epigenomics', 'experience', 'functional genomics', 'genetic regulatory protein', 'genome sequencing', 'genomic data', 'insight', 'novel', 'programs', 'response', 'tool', 'transcription factor']",NIEHS,STANFORD UNIVERSITY,R01,2016,150000,0.18555995628908553
"Computational methods for modeling lineage-specific gene regulation DESCRIPTION (provided by applicant): Complex sensory and signaling pathways ultimately converge on the DNA in the form of complexes of interacting regulatory RNAs and proteins that bind specific gene-proximal and distal regulatory elements to active and repress genes resulting in the establishment and maintenance of cell-type specific transcriptional responses. These regulatory elements have static and dynamic components - the former encoded in the genomic sequence itself as combinations of transcription factor binding site sequence motifs and the latter a consequence of locus and cell-type specific chromatin accessibility and epigenomic modifications as well as the dynamic linking of distal regulatory elements to target genes. In addition, transcriptional and post-transcriptional feedback and control of the levels of regulatory proteins and RNAs also play a key role in dynamic cell-type specific gene regulation. One of the central challenges in modern genomics is to learn these rules by which the genome and epigenome encode regulatory information. How does a single genome sequence encode the information for exquisitely precise, and yet highly distinctive programs of gene regulation for different cell types, and at different time points? What are the key sequence determinants, and grammatical rules that determine the function of any given DNA sequence under any particular set of conditions? In this project we seek to use public data from The Roadmap Epigenomics project and The ENCODE project to make progress on these questions. We propose to build methods for interpreting shared and distinctive regulatory features, including especially transcription factor binding, across related cell types. In parallel, we will implement novel methods for identifying high-resolution, context-specific dynamic regulatory elements, decipher their underlying regulatory sequence grammars and learn predictive, integrative models of transcriptional regulation to decipher the effects of heterogeneous regulatory components on lineage-specific gene expression dynamics and provide regulatory annotations for large collections of curated and disease-associated gene sets. PUBLIC HEALTH RELEVANCE: The purpose of this project is to develop powerful statistical methods to study cell-type specific gene regulation, and apply these to publicly available data from The Roadmap Epigenomics Project, The ENCODE Project and several publicly available gene expression compendia. We propose new methods for joint inference of regulatory elements across diverse cell types, deciphering lineage-specific regulatory sequence grammars encoded in these elements and learning integrative transcriptional regulation programs. Our models will serve as a resource to provide comprehensive context-specific regulatory annotations for disease-associated gene sets and co-expression modules.",Computational methods for modeling lineage-specific gene regulation,8921203,R01ES025009,"['Beryllium', 'Binding', 'Binding Sites', 'Cell Line', 'Chromatin', 'Collection', 'Communities', 'Complex', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Data', 'Data Analyses', 'Development', 'Disease', 'Distal', 'Elements', 'Feedback', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Genomics', 'Goals', 'Health', 'Imagery', 'Indium', 'Joints', 'Knowledge', 'Lead', 'Learning', 'Link', 'Machine Learning', 'Maintenance', 'Methods', 'Modeling', 'Modification', 'Play', 'Process', 'RNA-Binding Proteins', 'Regulatory Element', 'Regulatory Pathway', 'Research Personnel', 'Resolution', 'Resources', 'Sensory', 'Signal Pathway', 'Statistical Methods', 'Techniques', 'Time', 'Tissues', 'Transcriptional Regulation', 'cell type', 'combinatorial', 'epigenome', 'epigenomics', 'experience', 'functional genomics', 'genetic regulatory protein', 'genome sequencing', 'insight', 'novel', 'programs', 'response', 'tool', 'transcription factor']",NIEHS,STANFORD UNIVERSITY,R01,2015,318763,0.18555995628908553
"Computational methods for modeling lineage-specific gene regulation     DESCRIPTION (provided by applicant): Complex sensory and signaling pathways ultimately converge on the DNA in the form of complexes of interacting regulatory RNAs and proteins that bind specific gene-proximal and distal regulatory elements to active and repress genes resulting in the establishment and maintenance of cell-type specific transcriptional responses. These regulatory elements have static and dynamic components - the former encoded in the genomic sequence itself as combinations of transcription factor binding site sequence motifs and the latter a consequence of locus and cell-type specific chromatin accessibility and epigenomic modifications as well as the dynamic linking of distal regulatory elements to target genes. In addition, transcriptional and post-transcriptional feedback and control of the levels of regulatory proteins and RNAs also play a key role in dynamic cell-type specific gene regulation. One of the central challenges in modern genomics is to learn these rules by which the genome and epigenome encode regulatory information. How does a single genome sequence encode the information for exquisitely precise, and yet highly distinctive programs of gene regulation for different cell types, and at different time points? What are the key sequence determinants, and grammatical rules that determine the function of any given DNA sequence under any particular set of conditions? In this project we seek to use public data from The Roadmap Epigenomics project and The ENCODE project to make progress on these questions. We propose to build methods for interpreting shared and distinctive regulatory features, including especially transcription factor binding, across related cell types. In parallel, we will implement novel methods for identifying high-resolution, context-specific dynamic regulatory elements, decipher their underlying regulatory sequence grammars and learn predictive, integrative models of transcriptional regulation to decipher the effects of heterogeneous regulatory components on lineage-specific gene expression dynamics and provide regulatory annotations for large collections of curated and disease-associated gene sets.         PUBLIC HEALTH RELEVANCE: The purpose of this project is to develop powerful statistical methods to study cell-type specific gene regulation, and apply these to publicly available data from The Roadmap Epigenomics Project, The ENCODE Project and several publicly available gene expression compendia. We propose new methods for joint inference of regulatory elements across diverse cell types, deciphering lineage-specific regulatory sequence grammars encoded in these elements and learning integrative transcriptional regulation programs. Our models will serve as a resource to provide comprehensive context-specific regulatory annotations for disease-associated gene sets and co-expression modules.            ",Computational methods for modeling lineage-specific gene regulation,8815902,R01ES025009,"['Beryllium', 'Binding', 'Binding Sites', 'Cell Line', 'Chromatin', 'Collection', 'Communities', 'Complex', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Data', 'Data Analyses', 'Development', 'Disease', 'Distal', 'Elements', 'Feedback', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Genomics', 'Goals', 'Imagery', 'Indium', 'Joints', 'Knowledge', 'Lead', 'Learning', 'Link', 'Machine Learning', 'Maintenance', 'Methods', 'Modeling', 'Modification', 'Play', 'Process', 'RNA-Binding Proteins', 'Regulatory Element', 'Regulatory Pathway', 'Research Personnel', 'Resolution', 'Resources', 'Sensory', 'Signal Pathway', 'Statistical Methods', 'Techniques', 'Time', 'Tissues', 'Transcriptional Regulation', 'cell type', 'combinatorial', 'epigenome', 'epigenomics', 'experience', 'functional genomics', 'genetic regulatory protein', 'genome sequencing', 'insight', 'novel', 'programs', 'public health relevance', 'response', 'tool', 'transcription factor']",NIEHS,STANFORD UNIVERSITY,R01,2014,318763,0.18555995628908553
"Integrated multi-omics analyses of early mammalian craniofacial development Abstract Craniofacial abnormalities are some of the most commonly occurring human birth defects worldwide, with up to 200,000 children born every year with some type of craniofacial defect. These defects can occur as part of complex syndromes that involve multiple tissues and organs. The syndromic forms of these disorders have been successfully linked to nearly 500 genes including TWIST1 for craniosynostosis and IRF6 for orofacial clefting. However more frequently no other part of the body is directly involved (50% of craniosynostoses, 70% of orofacial clefts). Genome wide association studies indicate heritability for such defects, however the vast majority of associations fall outside of genes suggesting defective gene regulation is a major contributor to incidence of such defects. Gene regulatory elements can be located throughout the genome and typically have tissue-specific activity, making them difficult to identify and predict what gene they control. The overall objective of this application is to integrate epigenomic and transcriptomic data sets from early human and mouse craniofacial development from our lab as well as FaceBase to comprehensively predict regulatory element-gene interactions. Our hypothesis posits that conserved regulatory networks between human and mouse are enriched for disease relevant biology. In Aim 1 we propose to systematically identify chromatin states in human from 4.5 to 8 weeks of gestation and in mouse from embryonic days 9.5 to 15.5. In Aim 2 we propose to identify genes that are coordinately regulated in both species across these developmental windows. Finally, in Aim 3 we propose to integrate these two disparate network types to identify regulatory element-gene pairings. We will experimentally validate predicted interactions in a culture model of cranial neural crest cells using proximity-ligation coupled with immunoprecipitation. Our proposed studies will generate the most comprehensive epigenomic and transcriptomic networks in a developing human tissue and for the first time identify the conserved regulatory architecture for building the mammalian orofacial complex. Defects in embryonic patterning resulting in clefts of orofacial tissue are common birth defects affecting more than 1 in 1000 live births. The genetic causes of these defects have been difficult to determine, but all current evidence suggests defective gene regulation during embryonic development underlies these birth defects. This project seeks to identify regulatory networks that control gene expression during craniofacial development and are conserved between human and mouse.",Integrated multi-omics analyses of early mammalian craniofacial development,9891599,R03DE028588,"['Address', 'Affect', 'Architecture', 'Biological', 'Biology', 'Body part', 'Cephalic', 'Characteristics', 'Child', 'Chromatin', 'Chromatin Interaction Analysis by Paired-End Tag Sequencing', 'Code', 'Complex', 'Congenital Abnormality', 'Coupled', 'Craniofacial Abnormalities', 'Craniosynostosis', 'Data', 'Data Set', 'Defect', 'Development', 'Disease', 'Embryo', 'Embryonic Development', 'Enhancers', 'Exons', 'Expression Profiling', 'Face', 'FaceBase', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genome', 'Heritability', 'Human', 'Immunoprecipitation', 'Incidence', 'Individual', 'Laboratories', 'Ligation', 'Link', 'Live Birth', 'Machine Learning', 'Measures', 'Modeling', 'Mus', 'Mutation', 'Network-based', 'Neural Crest Cell', 'Nucleic Acid Regulatory Sequences', 'Organ', 'Organism', 'Pathway Analysis', 'Pathway interactions', 'Pattern', 'Play', 'Pregnancy', 'Process', 'Proteins', 'RNA', 'Regulator Genes', 'Regulatory Element', 'Role', 'Sampling', 'Series', 'Signal Transduction', 'Specificity', 'Syndrome', 'TWIST1 gene', 'Testing', 'Time', 'Tissue Sample', 'Tissues', 'Work', 'base', 'comparative', 'computational pipelines', 'craniofacial', 'craniofacial development', 'differential expression', 'embryo tissue', 'epigenome', 'epigenomics', 'exome sequencing', 'falls', 'gene interaction', 'genetic information', 'genome wide association study', 'human tissue', 'multiple omics', 'orofacial', 'orofacial cleft', 'programs', 'promoter', 'transcriptome', 'transcriptomics', 'virtual', 'whole genome']",NIDCR,UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,R03,2020,164000,0.060012241726867484
"A database for high-resolution chromatin contact maps and human genetic variants Abstract After the completion of the Human Genome Project, several landmarking consortia have accumulated large amounts of genomic data towards understanding the functions of human genome. The ENCODE project has annotated genome-wide regulatory elements. The Roadmap Epigenomic project has characterized tissue-specic variation in epigenetic state. The NIH Common Fund GTEx project has delineated tissue-specic gene expression and transcription regulation. The NIH Common Fund 4D Nucleome (4DN) project has revealed dynamic 3D chromatin organization in many cell and tissue types. Each of the aforementioned consortia has generated thousands or even tens of thousands of datasets, and provided different insights regarding human genome at an unprecedent scale and depth. However, the datasets generated from these consortia are isolated in terms of cell types and tissue types covered, how the data are stored, and the resolution of the genomic data. These gaps bring realistic data analysis challenges to biomedical researchers when they use these public datasets jointly in their research  they need to go through different data portals with heterogeneous processing pipelines, different data formats, and unmatched resolutions. We aim to develop the most cutting-edge deep learning approaches to impute high-resolution chromatin contact maps, and integrate the high-resolution chromatin contact maps with transcriptional data available from GTEx project and epigenomic data from ENCODE/Roadmap. We plan to share the integrated data on a public web server with a multi-panel interactive visualization genome browser. The integrated data will provide an important resource for understanding of tissue-specic genetic variation in the light of the spatial organization of these genomic and epigenomic elements and their functional implications. Project Narrative The goal of this project is to develop novel computational methods to integrate 4DN datasets with GTEx datasets and ENCODE/Roadmap datasets. The integrated datasets will be critical resource to unveil the mechanisms of the genetic variants identied in genome-wide association studies. The new knowledge gained here could help us understand the genetic basis of many human diseases.",A database for high-resolution chromatin contact maps and human genetic variants,10109293,R03OD030599,"['3-Dimensional', 'Address', 'Area', 'Base Pairing', 'Cells', 'Chromatin', 'Chromatin Structure', 'Communities', 'Computing Methodologies', 'DNA', 'Data', 'Data Analyses', 'Data Science', 'Data Set', 'Data Sources', 'Databases', 'Elements', 'Epigenetic Process', 'Funding', 'Gene Expression Regulation', 'Genetic', 'Genetic Transcription', 'Genetic Variation', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Goals', 'Human Genetics', 'Human Genome', 'Human Genome Project', 'Internet', 'Knowledge', 'Maps', 'Molecular', 'Nucleosomes', 'Regulatory Element', 'Reproducibility', 'Research', 'Research Personnel', 'Resolution', 'Resources', 'Technology', 'Tissue-Specific Gene Expression', 'Tissues', 'Transcriptional Regulation', 'United States National Institutes of Health', 'Variant', 'Visualization', 'Work', 'cell type', 'data format', 'data integration', 'data portal', 'data resource', 'data visualization', 'deep learning', 'epigenomics', 'expectation', 'genetic variant', 'genome annotation', 'genome browser', 'genome sciences', 'genome wide association study', 'genome-wide', 'genomic data', 'human disease', 'insight', 'interest', 'next generation sequencing', 'novel', 'open data', 'web server']",OD,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R03,2020,265495,-0.0005110678110459072
"Transcriptional co-regulators in epidermis    DESCRIPTION (provided by applicant): The stratified mammalian epidermis develops from somatic ectoderm by the progressive addition and differentiation of superficial epidermal layers (1). After the initial morphogenesis, the epidermis is maintained by homeostatic mechanisms whereby keratinocytes move from the proliferating basal cell layer towards the surface as they undergo a series of differentiation steps, ultimately undergoing cell death. One role of keratinocyte differentiation is the formation of an effective permeability barrier, which depends on the regulated expression of a large battery of genes encoding components of the cornified and granular layers (2). Under funding by the parent grant, we are using molecular biology to investigate the role of a single transcription factor, the Grainyhead-like transcription factor Get1/Grhl3 (3-5), in epidermal differentiation. In contrast, in this revision application, we propose a systems biology approach to computationally generate transcriptional regulatory network for the process of epidermal differentiation. Thus, this application leads to a new direction and differs from the parent grant in two important ways: First, it expands the scope of the study to transcriptional regulatory networks in epidermal development in general, and second, it incorporates the methods of systems biology; thus the application is consistent with one of the key emphasis areas of this RFA (Developmental Biology - Systems biology). The specific goals are to: 1) Generate global gene expression data over the time course of epidermal keratinocyte differentiation; and 2) Use the time course gene expression data from 1, other genome-wide expression data, DNA motif information, functional annotation, and literature mining to infer transcriptional networks in epidermal differentiation. The goal of this project is also to build a new interdisciplinary team between the Andersen laboratory, whose primary expertise is in molecular/developmental biology, and Alex Ihler, a new assistant professor whose primary expertise is in graphical models, Bayesian inference methods, machine learning, and data mining. The contributions of the Ihler group -- the mathematical modeling required to define the networks -- will allow approaches and advances in our understanding of epidermal differentiation that would not be attainable without this collaboration.               Defective epidermal differentiation and disrupted barrier formation are salient features of several skin diseases, including childhood eczema and psoriasis. With the definition of networks important for these processes, we expect to discover new diagnostic approaches and treatment targets.",Transcriptional co-regulators in epidermis,7776854,R01AR044882,"['Area', 'Basal Cell', 'Cell Death', 'Childhood', 'Collaborations', 'DNA', 'Data', 'Development', 'Developmental Biology', 'Ectoderm', 'Eczema', 'Epidermis', 'Funding', 'Gene Expression', 'Genes', 'Goals', 'Laboratories', 'Machine Learning', 'Methods', 'Modeling', 'Molecular', 'Molecular Biology', 'Morphogenesis', 'Permeability', 'Process', 'Proliferating', 'Psoriasis', 'Role', 'Series', 'Stratum Granulosum', 'Surface', 'Systems Biology', 'Time', 'data mining', 'genome-wide', 'keratinocyte', 'keratinocyte differentiation', 'mathematical model', 'novel diagnostics', 'parent grant', 'professor', 'skin disorder', 'text searching', 'time use', 'transcription factor']",NIAMS,UNIVERSITY OF CALIFORNIA-IRVINE,R01,2009,146526,0.028443205392166146
"Structural analysis of G protein regulatory mechanisms    DESCRIPTION (provided by applicant):  The proposed research will elucidate molecular mechanisms by which G proteins regulate effectors and are themselves regulated. Because G proteins are central to regulation of multiple cellular pathways, a clear understanding of their molecular function is ultimately critical for recognition of many disease processes and their treatment. Aim 1 will define the dynamic components of G alpha-i1 that are coupled to GTP hydrolysis and conformational changes and that result in the termination of its signaling activity. Proline or Glycine mutations shall be introduced to constrain or relax backbone conformation at permissive sites throughout the molecule. Rates of nucleotide dissociation, conformational change and GTP hydrolysis shall be measured, and crystal structures determined of mutants with altered properties. Molecular dynamics calculations will be used to find correlations between changes in function and structure and alterations in essential dynamic components. Aim 2 will address the mechanism by which p115Rho GEF is stimulated by G alpha-13, leading to the activation of the small G protein Rho, which induces stress fiber formation required for cell motility. The crystal structure of p115Rho GEF shall be determined, together with those of its complexes with G alpha-13/i chimeras and RhoA, singly and in combination. To accomplish this goal, well-expressed chimeric proteins containing structural elements of G alpha-i1 and G alpha-13 will be used, in their GDP-magnesium fluoroaluminate form, together with negative-dominant mutants of RhoA to stabilize the desired complexes. The third aim explores a newly discovered G protein-coupled receptor independent pathway in which G alpha-i controls asymmetric cell division, and Ric-8 serves as the GEF for Galpha-i1. Complexes of G alpha-i1 with Ric-8, or subdomains of Ric-8 identified by sequence analysis and proteolytic mapping of Ric-8, shall be formed in the absence of nucleotide. These, together with Ric-8 alone will be crystallized and structures of Ric-8 and its complexes with G alpha-i1 determined.         n/a",Structural analysis of G protein regulatory mechanisms,7271217,R01DK046371,"['Address', 'Area', 'Binding', 'Caenorhabditis elegans', 'Cell division', 'Cell physiology', 'Chimera organism', 'Chimeric Proteins', 'Complex', 'Coupled', 'Crystallization', 'Crystallography', 'Data', 'Disease', 'Dissociation', 'Dominant-Negative Mutation', 'Elements', 'Escherichia coli', 'Exhibits', 'Funding', 'G-Protein-Coupled Receptors', 'GTP Binding', 'GTP-Binding Protein alpha Subunits, Gs', 'GTP-Binding Proteins', 'Glutathione S-Transferase', 'Glycine', 'Goals', 'Grant', 'Guanine Nucleotide Exchange Factors', 'Guanine Nucleotides', 'Guanosine Triphosphate', 'Guanosine Triphosphate Phosphohydrolases', 'Heterotrimeric GTP-Binding Proteins', 'Human G(i) Alpha Proteins', 'Hydrolysis', 'Investigation', 'Libraries', 'Localized', 'Magnesium', 'Maps', 'Measures', 'Molecular', 'Molecular Conformation', 'Monoclonal Antibodies', 'Monomeric GTP-Binding Proteins', 'Mutation', 'Nucleotides', 'PH Domain', 'Pathway interactions', 'Personal Satisfaction', 'Pliability', 'Principal Component Analysis', 'Process', 'Proline', 'Property', 'Protein Dynamics', 'Protein Overexpression', 'Proteins', 'Rate', 'Regulation', 'Research', 'Research Personnel', 'Rotation', 'Sequence Analysis', 'Set protein', 'Signal Transduction', 'Simulate', 'Site', 'Stress Fibers', 'Structure', 'Vertebral column', 'Work', 'cell motility', 'design', 'desire', 'fluoroaluminum', 'inorganic phosphate', 'molecular dynamics', 'mutant', 'novel', 'programs', 'research study', 'rho', 'rho guanine nucleotide exchange factor p115', 'three dimensional structure']",NIDDK,UNIVERSITY OF MONTANA,R01,2007,244069,-0.005182459077369612
"Chromosome Movement in Prometaphase    DESCRIPTION (provided by applicant): The long term objectives of this project are to understand the mechanisms that regulate chromosome movement and cell cycle control in mitosis. Balanced chromosome segregation in mitosis occurs through complex spatial and temporal regulation of enzyme activities, particularly kinases, phosphatases and enzymes of the ubiquitin cascade. Mitosis also involves highly dynamic and structural reorganization of nuclear and cytoplasmic organelles. Of particular interest in this project are the molecular mechanics of chromosome attachment to and movement on the microtubules of the mitotic spindle. The other main focus is cell cycle control of enzyme activities and their consequences for regulating mitotic progression and the mitotic spindle checkpoint. The mitotic spindle checkpoint is essential in ensuring the normal distribution of chromosomes. It is often defective in cancer cells and it plays a key role in the response of cells to therapeutic anti-cancer drugs such as paclitaxel. The current proposal consists of three aims. Two of the aims are focused on characterization of an entirely novel protein called Kinetochore Protein 1 (Kinp1). Preliminary data indicate that Kinp1 plays an essential role in normal microtubule-kinetochore attachment and/or in regulation of the mitotic spindle checkpoint. The other aim is focused on the general role of nuclear envelope integrity in controlling early events in mitosis. Accomplishing the goals proposed will add significantly to our understanding of cell cycle control of cell division in normal cells and contribute toward understanding how these controls become aberrant in chromosomal imbalances that contribute to human disease such as birth defects and cancer. PUBLIC HEALTH RELEVANCE: This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.           Project Narrative This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.",Chromosome Movement in Prometaphase,8321518,R01GM050412,"['Algorithms', 'Anaphase', 'Antibodies', 'Antineoplastic Agents', 'Area', 'Binding Proteins', 'Cell Cycle', 'Cell Cycle Regulation', 'Cell Extracts', 'Cell Nucleus', 'Cell division', 'Cells', 'Chromosome Segregation', 'Chromosomes', 'Code', 'Complex', 'Congenital Abnormality', 'Cyclins', 'Cytoplasm', 'Cytoplasmic Organelle', 'Data', 'Disease', 'Ensure', 'Enzymes', 'Equilibrium', 'Event', 'Funding', 'Genes', 'Goals', 'Health', 'Human Genome', 'Intervention', 'Investigation', 'Kinetochores', 'Life', 'Malignant Neoplasms', 'Mass Spectrum Analysis', 'Mediating', 'Meta-Analysis', 'Metaphase', 'Microtubules', 'Mitosis', 'Mitotic', 'Mitotic spindle', 'Mitotic/Spindle Checkpoint', 'Movement', 'Mutate', 'Names', 'Normal Cell', 'Normal Statistical Distribution', 'Nuclear', 'Nuclear Envelope', 'Open Reading Frames', 'Paclitaxel', 'Pathway interactions', 'Phenotype', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Play', 'Post-Translational Protein Processing', 'Process', 'Prometaphase', 'Prophase', 'Proteins', 'Publishing', 'Regulation', 'Research Personnel', 'Role', 'Signal Pathway', 'Signal Transduction', 'Small Interfering RNA', 'Testing', 'Therapeutic', 'Time', 'Troglodytinae', 'Ubiquitin', 'aurora-A kinase', 'cancer cell', 'cancer therapy', 'chromosome movement', 'enzyme activity', 'human disease', 'improved', 'interest', 'molecular mechanics', 'novel', 'overexpression', 'response', 'segregation', 'text searching']",NIGMS,OKLAHOMA MEDICAL RESEARCH FOUNDATION,R01,2012,399391,0.045710804629871336
"Chromosome Movement in Prometaphase    DESCRIPTION (provided by applicant): The long term objectives of this project are to understand the mechanisms that regulate chromosome movement and cell cycle control in mitosis. Balanced chromosome segregation in mitosis occurs through complex spatial and temporal regulation of enzyme activities, particularly kinases, phosphatases and enzymes of the ubiquitin cascade. Mitosis also involves highly dynamic and structural reorganization of nuclear and cytoplasmic organelles. Of particular interest in this project are the molecular mechanics of chromosome attachment to and movement on the microtubules of the mitotic spindle. The other main focus is cell cycle control of enzyme activities and their consequences for regulating mitotic progression and the mitotic spindle checkpoint. The mitotic spindle checkpoint is essential in ensuring the normal distribution of chromosomes. It is often defective in cancer cells and it plays a key role in the response of cells to therapeutic anti-cancer drugs such as paclitaxel. The current proposal consists of three aims. Two of the aims are focused on characterization of an entirely novel protein called Kinetochore Protein 1 (Kinp1). Preliminary data indicate that Kinp1 plays an essential role in normal microtubule-kinetochore attachment and/or in regulation of the mitotic spindle checkpoint. The other aim is focused on the general role of nuclear envelope integrity in controlling early events in mitosis. Accomplishing the goals proposed will add significantly to our understanding of cell cycle control of cell division in normal cells and contribute toward understanding how these controls become aberrant in chromosomal imbalances that contribute to human disease such as birth defects and cancer. PUBLIC HEALTH RELEVANCE: This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.           Project Narrative This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.",Chromosome Movement in Prometaphase,8133362,R01GM050412,"['Algorithms', 'Anaphase', 'Antibodies', 'Antineoplastic Agents', 'Area', 'Binding Proteins', 'Cell Cycle', 'Cell Cycle Regulation', 'Cell Extracts', 'Cell Nucleus', 'Cell division', 'Cells', 'Chromosome Segregation', 'Chromosomes', 'Code', 'Complex', 'Congenital Abnormality', 'Cyclins', 'Cytoplasm', 'Cytoplasmic Organelle', 'Data', 'Disease', 'Ensure', 'Enzymes', 'Equilibrium', 'Event', 'Funding', 'Genes', 'Goals', 'Health', 'Human Genome', 'Intervention', 'Investigation', 'Kinetochores', 'Life', 'Malignant Neoplasms', 'Mass Spectrum Analysis', 'Mediating', 'Meta-Analysis', 'Metaphase', 'Microtubules', 'Mitosis', 'Mitotic', 'Mitotic spindle', 'Mitotic/Spindle Checkpoint', 'Movement', 'Mutate', 'Names', 'Normal Cell', 'Normal Statistical Distribution', 'Nuclear', 'Nuclear Envelope', 'Open Reading Frames', 'Paclitaxel', 'Pathway interactions', 'Phenotype', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Play', 'Post-Translational Protein Processing', 'Process', 'Prometaphase', 'Prophase', 'Proteins', 'Publishing', 'Regulation', 'Research Personnel', 'Role', 'Signal Pathway', 'Signal Transduction', 'Small Interfering RNA', 'Testing', 'Therapeutic', 'Time', 'Troglodytinae', 'Ubiquitin', 'aurora-A kinase', 'cancer cell', 'cancer therapy', 'chromosome movement', 'enzyme activity', 'human disease', 'improved', 'interest', 'molecular mechanics', 'novel', 'overexpression', 'response', 'segregation', 'text searching']",NIGMS,OKLAHOMA MEDICAL RESEARCH FOUNDATION,R01,2011,399391,0.045710804629871336
"Chromosome Movement in Prometaphase    DESCRIPTION (provided by applicant): The long term objectives of this project are to understand the mechanisms that regulate chromosome movement and cell cycle control in mitosis. Balanced chromosome segregation in mitosis occurs through complex spatial and temporal regulation of enzyme activities, particularly kinases, phosphatases and enzymes of the ubiquitin cascade. Mitosis also involves highly dynamic and structural reorganization of nuclear and cytoplasmic organelles. Of particular interest in this project are the molecular mechanics of chromosome attachment to and movement on the microtubules of the mitotic spindle. The other main focus is cell cycle control of enzyme activities and their consequences for regulating mitotic progression and the mitotic spindle checkpoint. The mitotic spindle checkpoint is essential in ensuring the normal distribution of chromosomes. It is often defective in cancer cells and it plays a key role in the response of cells to therapeutic anti-cancer drugs such as paclitaxel. The current proposal consists of three aims. Two of the aims are focused on characterization of an entirely novel protein called Kinetochore Protein 1 (Kinp1). Preliminary data indicate that Kinp1 plays an essential role in normal microtubule-kinetochore attachment and/or in regulation of the mitotic spindle checkpoint. The other aim is focused on the general role of nuclear envelope integrity in controlling early events in mitosis. Accomplishing the goals proposed will add significantly to our understanding of cell cycle control of cell division in normal cells and contribute toward understanding how these controls become aberrant in chromosomal imbalances that contribute to human disease such as birth defects and cancer. PUBLIC HEALTH RELEVANCE: This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.           Project Narrative This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.",Chromosome Movement in Prometaphase,7926951,R01GM050412,"['Algorithms', 'Anaphase', 'Antibodies', 'Antineoplastic Agents', 'Area', 'Binding Proteins', 'Cell Cycle', 'Cell Cycle Regulation', 'Cell Extracts', 'Cell Nucleus', 'Cell division', 'Cells', 'Chromosome Segregation', 'Chromosomes', 'Code', 'Complex', 'Congenital Abnormality', 'Cyclins', 'Cytoplasm', 'Cytoplasmic Organelle', 'Data', 'Disease', 'Ensure', 'Enzymes', 'Equilibrium', 'Event', 'Funding', 'Genes', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Kinetochores', 'Life', 'Malignant Neoplasms', 'Mass Spectrum Analysis', 'Mediating', 'Meta-Analysis', 'Metaphase', 'Microtubules', 'Mitosis', 'Mitotic', 'Mitotic spindle', 'Mitotic/Spindle Checkpoint', 'Movement', 'Mutate', 'Names', 'Normal Cell', 'Normal Statistical Distribution', 'Nuclear', 'Nuclear Envelope', 'Open Reading Frames', 'Paclitaxel', 'Pathway interactions', 'Phenotype', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Play', 'Post-Translational Protein Processing', 'Process', 'Prometaphase', 'Prophase', 'Proteins', 'Publishing', 'Regulation', 'Research', 'Research Personnel', 'Role', 'Signal Pathway', 'Signal Transduction', 'Small Interfering RNA', 'Testing', 'Therapeutic', 'Time', 'Troglodytinae', 'Ubiquitin', 'aurora-A kinase', 'cancer cell', 'cancer therapy', 'chromosome movement', 'enzyme activity', 'human disease', 'improved', 'interest', 'molecular mechanics', 'novel', 'overexpression', 'public health relevance', 'response', 'segregation', 'text searching']",NIGMS,OKLAHOMA MEDICAL RESEARCH FOUNDATION,R01,2010,403425,0.045710804629871336
"Chromosome Movement in Prometaphase    DESCRIPTION (provided by applicant): The long term objectives of this project are to understand the mechanisms that regulate chromosome movement and cell cycle control in mitosis. Balanced chromosome segregation in mitosis occurs through complex spatial and temporal regulation of enzyme activities, particularly kinases, phosphatases and enzymes of the ubiquitin cascade. Mitosis also involves highly dynamic and structural reorganization of nuclear and cytoplasmic organelles. Of particular interest in this project are the molecular mechanics of chromosome attachment to and movement on the microtubules of the mitotic spindle. The other main focus is cell cycle control of enzyme activities and their consequences for regulating mitotic progression and the mitotic spindle checkpoint. The mitotic spindle checkpoint is essential in ensuring the normal distribution of chromosomes. It is often defective in cancer cells and it plays a key role in the response of cells to therapeutic anti-cancer drugs such as paclitaxel. The current proposal consists of three aims. Two of the aims are focused on characterization of an entirely novel protein called Kinetochore Protein 1 (Kinp1). Preliminary data indicate that Kinp1 plays an essential role in normal microtubule-kinetochore attachment and/or in regulation of the mitotic spindle checkpoint. The other aim is focused on the general role of nuclear envelope integrity in controlling early events in mitosis. Accomplishing the goals proposed will add significantly to our understanding of cell cycle control of cell division in normal cells and contribute toward understanding how these controls become aberrant in chromosomal imbalances that contribute to human disease such as birth defects and cancer. PUBLIC HEALTH RELEVANCE: This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.           Project Narrative This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.",Chromosome Movement in Prometaphase,7999990,R01GM050412,"['Algorithms', 'Anaphase', 'Antibodies', 'Antineoplastic Agents', 'Area', 'Binding Proteins', 'Cell Cycle', 'Cell Cycle Regulation', 'Cell Extracts', 'Cell Nucleus', 'Cell division', 'Cells', 'Chromosome Segregation', 'Chromosomes', 'Code', 'Complex', 'Congenital Abnormality', 'Cyclins', 'Cytoplasm', 'Cytoplasmic Organelle', 'Data', 'Disease', 'Ensure', 'Enzymes', 'Equilibrium', 'Event', 'Funding', 'Genes', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Kinetochores', 'Life', 'Malignant Neoplasms', 'Mass Spectrum Analysis', 'Mediating', 'Meta-Analysis', 'Metaphase', 'Microtubules', 'Mitosis', 'Mitotic', 'Mitotic spindle', 'Mitotic/Spindle Checkpoint', 'Movement', 'Mutate', 'Names', 'Normal Cell', 'Normal Statistical Distribution', 'Nuclear', 'Nuclear Envelope', 'Open Reading Frames', 'Paclitaxel', 'Pathway interactions', 'Phenotype', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Play', 'Post-Translational Protein Processing', 'Process', 'Prometaphase', 'Prophase', 'Proteins', 'Publishing', 'Regulation', 'Research', 'Research Personnel', 'Role', 'Signal Pathway', 'Signal Transduction', 'Small Interfering RNA', 'Testing', 'Therapeutic', 'Time', 'Troglodytinae', 'Ubiquitin', 'aurora-A kinase', 'cancer cell', 'cancer therapy', 'chromosome movement', 'enzyme activity', 'human disease', 'improved', 'interest', 'molecular mechanics', 'novel', 'overexpression', 'public health relevance', 'response', 'segregation', 'text searching']",NIGMS,OKLAHOMA MEDICAL RESEARCH FOUNDATION,R01,2010,91683,0.045710804629871336
"Chromosome Movement in Prometaphase    DESCRIPTION (provided by applicant): The long term objectives of this project are to understand the mechanisms that regulate chromosome movement and cell cycle control in mitosis. Balanced chromosome segregation in mitosis occurs through complex spatial and temporal regulation of enzyme activities, particularly kinases, phosphatases and enzymes of the ubiquitin cascade. Mitosis also involves highly dynamic and structural reorganization of nuclear and cytoplasmic organelles. Of particular interest in this project are the molecular mechanics of chromosome attachment to and movement on the microtubules of the mitotic spindle. The other main focus is cell cycle control of enzyme activities and their consequences for regulating mitotic progression and the mitotic spindle checkpoint. The mitotic spindle checkpoint is essential in ensuring the normal distribution of chromosomes. It is often defective in cancer cells and it plays a key role in the response of cells to therapeutic anti-cancer drugs such as paclitaxel. The current proposal consists of three aims. Two of the aims are focused on characterization of an entirely novel protein called Kinetochore Protein 1 (Kinp1). Preliminary data indicate that Kinp1 plays an essential role in normal microtubule-kinetochore attachment and/or in regulation of the mitotic spindle checkpoint. The other aim is focused on the general role of nuclear envelope integrity in controlling early events in mitosis. Accomplishing the goals proposed will add significantly to our understanding of cell cycle control of cell division in normal cells and contribute toward understanding how these controls become aberrant in chromosomal imbalances that contribute to human disease such as birth defects and cancer. PUBLIC HEALTH RELEVANCE: This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.           Project Narrative This project seeks to define novel aspects of the regulation of cell division in normal and cancer cells. Many of the control mechanisms in cancer cells are abnormal in cancer and these differences provide opportunities to target cancer cells specifically with new therapies. This project will also help us to understand how many current cancer therapies target cells and thus how these therapies can be improved. The results from this study will also enlighten the mechanisms that contribute to chromosome imbalances that are the cause of many birth defects.",Chromosome Movement in Prometaphase,7730735,R01GM050412,"['Algorithms', 'Anaphase', 'Antibodies', 'Antineoplastic Agents', 'Area', 'Binding Proteins', 'Cell Cycle', 'Cell Cycle Regulation', 'Cell Extracts', 'Cell Nucleus', 'Cell division', 'Cells', 'Chromosome Segregation', 'Chromosomes', 'Code', 'Complex', 'Congenital Abnormality', 'Cyclins', 'Cytoplasm', 'Cytoplasmic Organelle', 'Data', 'Disease', 'Ensure', 'Enzymes', 'Equilibrium', 'Event', 'Funding', 'Genes', 'Goals', 'Human Genome', 'Intervention', 'Investigation', 'Kinetochores', 'Life', 'Malignant Neoplasms', 'Mass Spectrum Analysis', 'Mediating', 'Meta-Analysis', 'Metaphase', 'Microtubules', 'Mitosis', 'Mitotic', 'Mitotic spindle', 'Mitotic/Spindle Checkpoint', 'Movement', 'Mutate', 'Names', 'Normal Cell', 'Normal Statistical Distribution', 'Nuclear', 'Nuclear Envelope', 'Open Reading Frames', 'Paclitaxel', 'Pathway interactions', 'Phenotype', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Play', 'Post-Translational Protein Processing', 'Process', 'Prometaphase', 'Prophase', 'Proteins', 'Publishing', 'Regulation', 'Research', 'Research Personnel', 'Role', 'Signal Pathway', 'Signal Transduction', 'Small Interfering RNA', 'Testing', 'Therapeutic', 'Time', 'Troglodytinae', 'Ubiquitin', 'aurora-A kinase', 'cancer cell', 'cancer therapy', 'chromosome movement', 'enzyme activity', 'human disease', 'improved', 'interest', 'molecular mechanics', 'novel', 'overexpression', 'public health relevance', 'response', 'segregation', 'text searching']",NIGMS,OKLAHOMA MEDICAL RESEARCH FOUNDATION,R01,2009,407500,0.045710804629871336
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases    DESCRIPTION (provided by applicant): The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on 4 problems: 1. The mechanism of the reduction of dioxygen to water by wild-type and mutant bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coli, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus, will be investigated using a photoactivatable dye, thiouredopyrenetrisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy will be used to determine the spectra of the intermediates. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 3. We will synthesize chemical analogs of the active site of cytochrome oxidase, including the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using steady-state and time-resolved UV-Vis spectroscopy, FTIR and EPR, which will provide insight into the role of the cross-link in cytochrome oxidase function. 4. Nitric oxide (NO) has emerged as an important biological regulatory agent. A new direction in our research is to understand how NO interacts with heme-copper oxidases. The photodissociation dynamics of ruthenium nitrosyl complexes and the reaction of the photoproduced NO with heme-copper oxidases and their turnover intermediates will be investigated using time-resolved multichannel optical absorption spectroscopy. These studies will circumvent rate limitation imposed by stopped-flow techniques and provide information regarding NO regulation of cytochrome oxidase activity.         n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,8059123,R01GM053788,"['Active Sites', 'Apoptosis', 'Biological', 'Cattle', 'Cell Respiration', 'Chemicals', 'Complex', 'Cysteine', 'Dioxygen', 'Dyes', 'Electron Transport', 'Electrons', 'Escherichia coli', 'Future', 'Heart', 'Heme', 'Histidine', 'Hydrogen', 'Individual', 'Inflammation', 'Kinetics', 'Label', 'Ligands', 'Link', 'Methods', 'Modeling', 'Muscle relaxation phase', 'Mutate', 'Nitric Oxide', 'Optics', 'Oxidants', 'Oxidases', 'Pathologic Processes', 'Pathway interactions', 'Phenols', 'Physiological', 'Play', 'Process', 'Protons', 'Reaction', 'Regulation', 'Research', 'Rhodobacter sphaeroides', 'Roentgen Rays', 'Role', 'Ruthenium', 'Site', 'Site-Directed Mutagenesis', 'Smooth Muscle', 'Spectroscopy, Fourier Transform Infrared', 'Spectrum Analysis', 'Thermus thermophilus', 'Time', 'Tyrosine', 'Water', 'Work', 'absorption', 'analog', 'circular magnetic dichroism', 'copper oxidase', 'crosslink', 'cytochrome c oxidase', 'electronic structure', 'in vivo', 'inhibitor/antagonist', 'insight', 'mutant', 'nanosecond', 'prolylglutamic acid', 'research study', 'stop flow technique', 'thiouredopyrenetrisulfonate', 'time use', 'valyltyrosine']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2010,133138,0.013540637495145821
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases    DESCRIPTION (provided by applicant): The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on 4 problems: 1. The mechanism of the reduction of dioxygen to water by wild-type and mutant bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coli, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus, will be investigated using a photoactivatable dye, thiouredopyrenetrisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy will be used to determine the spectra of the intermediates. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 3. We will synthesize chemical analogs of the active site of cytochrome oxidase, including the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using steady-state and time-resolved UV-Vis spectroscopy, FTIR and EPR, which will provide insight into the role of the cross-link in cytochrome oxidase function. 4. Nitric oxide (NO) has emerged as an important biological regulatory agent. A new direction in our research is to understand how NO interacts with heme-copper oxidases. The photodissociation dynamics of ruthenium nitrosyl complexes and the reaction of the photoproduced NO with heme-copper oxidases and their turnover intermediates will be investigated using time-resolved multichannel optical absorption spectroscopy. These studies will circumvent rate limitation imposed by stopped-flow techniques and provide information regarding NO regulation of cytochrome oxidase activity.         n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,7450838,R01GM053788,"['Active Sites', 'Apoptosis', 'Biological', 'Bos taurus', 'Cattle', 'Cell Respiration', 'Chemicals', 'Complex', 'Cysteine', 'Dioxygen', 'Dyes', 'Electron Transport', 'Electronics', 'Electrons', 'Escherichia coli', 'Future', 'Heart', 'Heme', 'Histidine', 'Hydrogen', 'Individual', 'Inflammation', 'Kinetics', 'Label', 'Ligands', 'Link', 'Methods', 'Modeling', 'Muscle relaxation phase', 'Mutate', 'Nitric Oxide', 'Numbers', 'Object Attachment', 'Optics', 'Oxidants', 'Oxidases', 'Pathologic Processes', 'Pathway interactions', 'Phenols', 'Physiological', 'Play', 'Process', 'Protons', 'Rate', 'Reaction', 'Regulation', 'Research', 'Rhodobacter sphaeroides', 'Roentgen Rays', 'Role', 'Ruthenium', 'Site', 'Site-Directed Mutagenesis', 'Spectroscopy, Fourier Transform Infrared', 'Spectrum Analysis', 'Structure', 'Thermus thermophilus', 'Time', 'Tyrosine', 'Water', 'Work', 'absorption', 'analog', 'circular magnetic dichroism', 'copper oxidase', 'crosslink', 'cytochrome c oxidase', 'in vivo', 'inhibitor/antagonist', 'insight', 'mutant', 'nanosecond', 'prolylglutamic acid', 'research study', 'stop flow technique', 'thiouredopyrenetrisulfonate', 'time use', 'valyltyrosine']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2008,268754,0.013540637495145821
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases    DESCRIPTION (provided by applicant): The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on 4 problems: 1. The mechanism of the reduction of dioxygen to water by wild-type and mutant bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coli, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus, will be investigated using a photoactivatable dye, thiouredopyrenetrisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy will be used to determine the spectra of the intermediates. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 3. We will synthesize chemical analogs of the active site of cytochrome oxidase, including the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using steady-state and time-resolved UV-Vis spectroscopy, FTIR and EPR, which will provide insight into the role of the cross-link in cytochrome oxidase function. 4. Nitric oxide (NO) has emerged as an important biological regulatory agent. A new direction in our research is to understand how NO interacts with heme-copper oxidases. The photodissociation dynamics of ruthenium nitrosyl complexes and the reaction of the photoproduced NO with heme-copper oxidases and their turnover intermediates will be investigated using time-resolved multichannel optical absorption spectroscopy. These studies will circumvent rate limitation imposed by stopped-flow techniques and provide information regarding NO regulation of cytochrome oxidase activity.         n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,7250853,R01GM053788,"['Active Sites', 'Apoptosis', 'Biological', 'Bos taurus', 'Cattle', 'Cell Respiration', 'Chemicals', 'Complex', 'Cysteine', 'Dioxygen', 'Dyes', 'Electron Transport', 'Electronics', 'Electrons', 'Escherichia coli', 'Future', 'Heart', 'Heme', 'Histidine', 'Hydrogen', 'Individual', 'Inflammation', 'Kinetics', 'Label', 'Ligands', 'Link', 'Methods', 'Modeling', 'Muscle relaxation phase', 'Mutate', 'Nitric Oxide', 'Numbers', 'Object Attachment', 'Optics', 'Oxidants', 'Oxidases', 'Pathologic Processes', 'Pathway interactions', 'Phenols', 'Physiological', 'Play', 'Process', 'Protons', 'Rate', 'Reaction', 'Regulation', 'Research', 'Rhodobacter sphaeroides', 'Roentgen Rays', 'Role', 'Ruthenium', 'Site', 'Site-Directed Mutagenesis', 'Spectroscopy, Fourier Transform Infrared', 'Spectrum Analysis', 'Structure', 'Thermus thermophilus', 'Time', 'Tyrosine', 'Water', 'Work', 'absorption', 'analog', 'circular magnetic dichroism', 'copper oxidase', 'crosslink', 'cytochrome c oxidase', 'in vivo', 'inhibitor/antagonist', 'insight', 'mutant', 'nanosecond', 'prolylglutamic acid', 'research study', 'stop flow technique', 'thiouredopyrenetrisulfonate', 'time use', 'valyltyrosine']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2007,265033,0.013540637495145821
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases    DESCRIPTION (provided by applicant): The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on 4 problems: 1. The mechanism of the reduction of dioxygen to water by wild-type and mutant bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coli, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus, will be investigated using a photoactivatable dye, thiouredopyrenetrisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy will be used to determine the spectra of the intermediates. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 3. We will synthesize chemical analogs of the active site of cytochrome oxidase, including the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using steady-state and time-resolved UV-Vis spectroscopy, FTIR and EPR, which will provide insight into the role of the cross-link in cytochrome oxidase function. 4. Nitric oxide (NO) has emerged as an important biological regulatory agent. A new direction in our research is to understand how NO interacts with heme-copper oxidases. The photodissociation dynamics of ruthenium nitrosyl complexes and the reaction of the photoproduced NO with heme-copper oxidases and their turnover intermediates will be investigated using time-resolved multichannel optical absorption spectroscopy. These studies will circumvent rate limitation imposed by stopped-flow techniques and provide information regarding NO regulation of cytochrome oxidase activity.         n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,7090725,R01GM053788,"['Escherichia coli', 'bacterial proteins', 'circular magnetic dichroism', 'crosslink', 'cytochrome oxidase', 'electron spin resonance spectroscopy', 'electron transport', 'enzyme activity', 'enzyme mechanism', 'nitric oxide', 'oxidation reduction reaction', 'oxygen', 'peptide analog', 'peptide chemical synthesis', 'photoactivation', 'site directed mutagenesis', 'water']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2006,271208,0.013540637495145821
"Mechanism of Dioxygen Reduction by Heme-Copper Oxidases    DESCRIPTION (provided by applicant): The primary objective of this research is to elucidate the mechanism of electron and proton transfer during the reduction of dioxygen to water by heme-copper oxidases. Our specific aims will focus on 4 problems: 1. The mechanism of the reduction of dioxygen to water by wild-type and mutant bacterial heme-copper oxidases will be studied by the CO flow-flash method. Time-resolved multichannel optical absorption spectroscopy, in conjunction with singular value decomposition (SVD) and global exponential fitting analysis, will be used to follow the kinetics of electron and proton transfer and to deduce the UV-Vis spectra of the transient intermediates. These studies should provide new insight into the mechanism of the dioxygen reduction reaction by heme-copper oxidases. 2. The intramolecular electron transfer in the bacterial oxidases, bo3 from E. coli, aa3 from Rhodobacter sphaeroides and ba3 from Thermus thermophilus, will be investigated using a photoactivatable dye, thiouredopyrenetrisulfonate (TUPS), covalently linked to single reactive cysteine residues on the oxidases. Time-resolved optical absorption spectroscopy will be used to determine the spectra of the intermediates. By varying the distance between the labeled cysteine and the initial electron acceptor and by introducing breaks into presumed electron transfer pathways by site-directed mutagenesis, detailed information regarding intramolecular electron transfer pathways in heme-copper oxidases will be obtained. 3. We will synthesize chemical analogs of the active site of cytochrome oxidase, including the cyclic pentapeptide (His-Pro-Glu-Val-Tyr) with and without Cu-ligands incorporated. The analogs will be studied using steady-state and time-resolved UV-Vis spectroscopy, FTIR and EPR, which will provide insight into the role of the cross-link in cytochrome oxidase function. 4. Nitric oxide (NO) has emerged as an important biological regulatory agent. A new direction in our research is to understand how NO interacts with heme-copper oxidases. The photodissociation dynamics of ruthenium nitrosyl complexes and the reaction of the photoproduced NO with heme-copper oxidases and their turnover intermediates will be investigated using time-resolved multichannel optical absorption spectroscopy. These studies will circumvent rate limitation imposed by stopped-flow techniques and provide information regarding NO regulation of cytochrome oxidase activity.         n/a",Mechanism of Dioxygen Reduction by Heme-Copper Oxidases,6983544,R01GM053788,"['Escherichia coli', 'bacterial proteins', 'circular magnetic dichroism', 'crosslink', 'cytochrome oxidase', 'electron spin resonance spectroscopy', 'electron transport', 'enzyme activity', 'enzyme mechanism', 'nitric oxide', 'oxidation reduction reaction', 'oxygen', 'peptide analog', 'peptide chemical synthesis', 'photoactivation', 'site directed mutagenesis', 'water']",NIGMS,UNIVERSITY OF CALIFORNIA SANTA CRUZ,R01,2005,275537,0.013540637495145821
"Development of a Neuronal Regulatory Lexicon DESCRIPTION (provided by applicant): This proposal builds upon our successes in the first funding cycle, and technological advances in in the wider scientific community. We will expand our understanding of the biology and sequence-based encryption of transcriptional regulatory instructions in clinically pertinent neuronal populations, focusing on tyrosine hydroxylase (Th)-expressing ventral midbrain neurons that are compromised in Parkinson's disease and certain behavioral and neuropsychiatric disorders. In recent years, we have made great strides in characterizing regulatory control at specific neurogenic loci by generating, validating and publicly depositing huge catalogs of neuronal enhancers. We have developed and implemented computational strategies that catalog key motif combinations that identify neuronal enhancers, and developed sequence- based vocabularies (classifiers) for neuroanatomical domains (forebrain, midbrain, hindbrain) among other more homogenous isolated cell populations. By integrating our experiences in functional and computational genomics we have been able to indict several disease-associated variants in pertinent biological processes. We are also beginning to develop the capacity to impute the functional impact of non-coding variation from primary sequence alone.  Efforts to understand the architecture of human complex disease through Genome Wide Association Studies have drawn increased attention to potential roles played by regulatory variation. Thus, understanding the connections between regulatory variants and disease risk is very important. We propose detailed characterization of cell-type appropriate genome-wide regulatory sequence catalogs, isolating labeled dopaminergic neurons ex vivo at multiple time points (Aim 1). We will functionally validate the catalogs and define the sequence motifs that specify their function, developing computational classifiers to identify human DA enhancers, and assaying the functional impact of disease-associated variants therein (Aim 2). We will determine the relationship between distal-acting regulatory sequences and their cognate genes using cutting edge chromatin conformation capture (3C)-based strategies to reveal enhancers- promoter interactions. Then we will determine the consequences of deleting selected enhancers using contemporary genome editing strategies (Aim 3). This proposal takes crucial next steps towards a neuronal regulatory lexicon that can inform our observation of disease-associated variation in non-coding, putative regulatory sequence space. PUBLIC HEALTH RELEVANCE:  We wish to better understand how the regulatory instructions are encoded in DNA sequence, telling critical genes when and where to be switched on/off. We will focus on neurons that are lost in disorders like Parkinson's disease, prioritizing the study o genes implicated in related disorders. Our work will provide new insight into the identity, composition and biological requirement for these gene switches, informing our understanding of mutations that contribute to common genetic disorders.",Development of a Neuronal Regulatory Lexicon,9511921,R01NS062972,"['Affect', 'Alleles', 'Architecture', 'Attention', 'Base Sequence', 'Behavior Disorders', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Process', 'Biology', 'Catalogs', 'Cells', 'ChIP-seq', 'Chromatin', 'Chromatin Conformation Capture and Sequencing', 'Clinical', 'Communities', 'Complex', 'Congenital Megacolon', 'DNA Sequence', 'Data', 'Deposition', 'Development', 'Disease', 'Dissection', 'Distal', 'Dopamine', 'Embryonic Development', 'Enhancers', 'Functional disorder', 'Funding', 'Gene Expression Profile', 'Gene Targeting', 'Genes', 'Genetic Diseases', 'Genetic Transcription', 'Genomics', 'Human', 'Human Genome', 'Instruction', 'Label', 'Light', 'Machine Learning', 'Midbrain structure', 'Mitotic', 'Mus', 'Mutate', 'Mutation', 'Neurons', 'Nucleotides', 'Ontology', 'Orthologous Gene', 'Output', 'Parkinson Disease', 'Phenotype', 'Play', 'Population', 'Prosencephalon', 'Role', 'Satiation', 'Specific qualifier value', 'Switch Genes', 'Syndrome', 'Time', 'Training', 'Transcriptional Regulation', 'Transgenic Mice', 'Transgenic Organisms', 'Tyrosine 3-Monooxygenase', 'Untranslated RNA', 'Variant', 'Vocabulary', 'Work', 'Zebrafish', 'addiction', 'base', 'cancer risk', 'cell type', 'chromosome conformation capture', 'disorder risk', 'dopaminergic neuron', 'encryption', 'experience', 'genetic architecture', 'genome editing', 'genome wide association study', 'genome-wide', 'hindbrain', 'human disease', 'insight', 'mutant', 'neuropsychiatric disorder', 'promoter', 'public health relevance', 'success', 'transcription factor', 'transcriptome sequencing']",NINDS,JOHNS HOPKINS UNIVERSITY,R01,2018,461240,0.09135420720971758
"Development of a Neuronal Regulatory Lexicon DESCRIPTION (provided by applicant): This proposal builds upon our successes in the first funding cycle, and technological advances in in the wider scientific community. We will expand our understanding of the biology and sequence-based encryption of transcriptional regulatory instructions in clinically pertinent neuronal populations, focusing on tyrosine hydroxylase (Th)-expressing ventral midbrain neurons that are compromised in Parkinson's disease and certain behavioral and neuropsychiatric disorders. In recent years, we have made great strides in characterizing regulatory control at specific neurogenic loci by generating, validating and publicly depositing huge catalogs of neuronal enhancers. We have developed and implemented computational strategies that catalog key motif combinations that identify neuronal enhancers, and developed sequence- based vocabularies (classifiers) for neuroanatomical domains (forebrain, midbrain, hindbrain) among other more homogenous isolated cell populations. By integrating our experiences in functional and computational genomics we have been able to indict several disease-associated variants in pertinent biological processes. We are also beginning to develop the capacity to impute the functional impact of non-coding variation from primary sequence alone.  Efforts to understand the architecture of human complex disease through Genome Wide Association Studies have drawn increased attention to potential roles played by regulatory variation. Thus, understanding the connections between regulatory variants and disease risk is very important. We propose detailed characterization of cell-type appropriate genome-wide regulatory sequence catalogs, isolating labeled dopaminergic neurons ex vivo at multiple time points (Aim 1). We will functionally validate the catalogs and define the sequence motifs that specify their function, developing computational classifiers to identify human DA enhancers, and assaying the functional impact of disease-associated variants therein (Aim 2). We will determine the relationship between distal-acting regulatory sequences and their cognate genes using cutting edge chromatin conformation capture (3C)-based strategies to reveal enhancers- promoter interactions. Then we will determine the consequences of deleting selected enhancers using contemporary genome editing strategies (Aim 3). This proposal takes crucial next steps towards a neuronal regulatory lexicon that can inform our observation of disease-associated variation in non-coding, putative regulatory sequence space. PUBLIC HEALTH RELEVANCE:  We wish to better understand how the regulatory instructions are encoded in DNA sequence, telling critical genes when and where to be switched on/off. We will focus on neurons that are lost in disorders like Parkinson's disease, prioritizing the study o genes implicated in related disorders. Our work will provide new insight into the identity, composition and biological requirement for these gene switches, informing our understanding of mutations that contribute to common genetic disorders.",Development of a Neuronal Regulatory Lexicon,9291510,R01NS062972,"['Affect', 'Alleles', 'Architecture', 'Attention', 'Base Sequence', 'Behavior Disorders', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Process', 'Biology', 'Catalogs', 'Cells', 'ChIP-seq', 'Chromatin', 'Clinical', 'Communities', 'Complex', 'Congenital Megacolon', 'DNA Sequence', 'Data', 'Deposition', 'Development', 'Disease', 'Dissection', 'Distal', 'Dopamine', 'Embryonic Development', 'Enhancers', 'Functional disorder', 'Funding', 'Gene Expression Profile', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genomics', 'Hereditary Disease', 'Human', 'Human Genome', 'Instruction', 'Label', 'Light', 'Machine Learning', 'Midbrain structure', 'Mitotic', 'Molecular Conformation', 'Mus', 'Mutate', 'Mutation', 'Neurons', 'Nucleotides', 'Ontology', 'Orthologous Gene', 'Output', 'Parkinson Disease', 'Phenotype', 'Play', 'Population', 'Prosencephalon', 'Role', 'Satiation', 'Specific qualifier value', 'Switch Genes', 'Time', 'Training', 'Transcriptional Regulation', 'Transgenic Mice', 'Transgenic Organisms', 'Tyrosine 3-Monooxygenase', 'Untranslated RNA', 'Variant', 'Vocabulary', 'Work', 'Zebrafish', 'addiction', 'base', 'cancer risk', 'cell type', 'chromosome conformation capture', 'disorder risk', 'dopaminergic neuron', 'encryption', 'experience', 'genome editing', 'genome wide association study', 'genome-wide', 'hindbrain', 'human disease', 'insight', 'mutant', 'neuropsychiatric disorder', 'promoter', 'public health relevance', 'success', 'transcription factor', 'transcriptome sequencing']",NINDS,JOHNS HOPKINS UNIVERSITY,R01,2017,461190,0.09135420720971758
"Development of a Neuronal Regulatory Lexicon DESCRIPTION (provided by applicant): This proposal builds upon our successes in the first funding cycle, and technological advances in in the wider scientific community. We will expand our understanding of the biology and sequence-based encryption of transcriptional regulatory instructions in clinically pertinent neuronal populations, focusing on tyrosine hydroxylase (Th)-expressing ventral midbrain neurons that are compromised in Parkinson's disease and certain behavioral and neuropsychiatric disorders. In recent years, we have made great strides in characterizing regulatory control at specific neurogenic loci by generating, validating and publicly depositing huge catalogs of neuronal enhancers. We have developed and implemented computational strategies that catalog key motif combinations that identify neuronal enhancers, and developed sequence- based vocabularies (classifiers) for neuroanatomical domains (forebrain, midbrain, hindbrain) among other more homogenous isolated cell populations. By integrating our experiences in functional and computational genomics we have been able to indict several disease-associated variants in pertinent biological processes. We are also beginning to develop the capacity to impute the functional impact of non-coding variation from primary sequence alone.  Efforts to understand the architecture of human complex disease through Genome Wide Association Studies have drawn increased attention to potential roles played by regulatory variation. Thus, understanding the connections between regulatory variants and disease risk is very important. We propose detailed characterization of cell-type appropriate genome-wide regulatory sequence catalogs, isolating labeled dopaminergic neurons ex vivo at multiple time points (Aim 1). We will functionally validate the catalogs and define the sequence motifs that specify their function, developing computational classifiers to identify human DA enhancers, and assaying the functional impact of disease-associated variants therein (Aim 2). We will determine the relationship between distal-acting regulatory sequences and their cognate genes using cutting edge chromatin conformation capture (3C)-based strategies to reveal enhancers- promoter interactions. Then we will determine the consequences of deleting selected enhancers using contemporary genome editing strategies (Aim 3). This proposal takes crucial next steps towards a neuronal regulatory lexicon that can inform our observation of disease-associated variation in non-coding, putative regulatory sequence space. PUBLIC HEALTH RELEVANCE:  We wish to better understand how the regulatory instructions are encoded in DNA sequence, telling critical genes when and where to be switched on/off. We will focus on neurons that are lost in disorders like Parkinson's disease, prioritizing the study o genes implicated in related disorders. Our work will provide new insight into the identity, composition and biological requirement for these gene switches, informing our understanding of mutations that contribute to common genetic disorders.",Development of a Neuronal Regulatory Lexicon,9084287,R01NS062972,"['Affect', 'Alleles', 'Architecture', 'Attention', 'Base Sequence', 'Behavior Disorders', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Process', 'Biology', 'Cataloging', 'Catalogs', 'Cells', 'ChIP-seq', 'Chromatin', 'Communities', 'Complex', 'Congenital Megacolon', 'DNA Sequence', 'Data', 'Deposition', 'Development', 'Disease', 'Dissection', 'Distal', 'Dopamine', 'Embryonic Development', 'Enhancers', 'Functional disorder', 'Funding', 'Gene Expression Profile', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genomics', 'Health', 'Hereditary Disease', 'Human', 'Human Genome', 'Instruction', 'Label', 'Learning', 'Light', 'Machine Learning', 'Midbrain structure', 'Mitotic', 'Molecular Conformation', 'Mus', 'Mutate', 'Mutation', 'Neurons', 'Nucleotides', 'Ontology', 'Orthologous Gene', 'Output', 'Parkinson Disease', 'Phenotype', 'Play', 'Population', 'Prosencephalon', 'Role', 'Satiation', 'Specific qualifier value', 'Switch Genes', 'Syndrome', 'Time', 'Training', 'Transcriptional Regulation', 'Transgenic Mice', 'Transgenic Organisms', 'Tyrosine 3-Monooxygenase', 'Untranslated RNA', 'Variant', 'Vocabulary', 'Work', 'Zebrafish', 'addiction', 'base', 'cancer risk', 'cell type', 'chromosome conformation capture', 'disorder risk', 'dopaminergic neuron', 'encryption', 'experience', 'genome editing', 'genome wide association study', 'genome-wide', 'hindbrain', 'human disease', 'insight', 'mutant', 'neuropsychiatric disorder', 'promoter', 'success', 'transcription factor', 'transcriptome sequencing']",NINDS,JOHNS HOPKINS UNIVERSITY,R01,2016,461141,0.09135420720971758
"Development of a Neuronal Regulatory Lexicon DESCRIPTION (provided by applicant): This proposal builds upon our successes in the first funding cycle, and technological advances in in the wider scientific community. We will expand our understanding of the biology and sequence-based encryption of transcriptional regulatory instructions in clinically pertinent neuronal populations, focusing on tyrosine hydroxylase (Th)-expressing ventral midbrain neurons that are compromised in Parkinson's disease and certain behavioral and neuropsychiatric disorders. In recent years, we have made great strides in characterizing regulatory control at specific neurogenic loci by generating, validating and publicly depositing huge catalogs of neuronal enhancers. We have developed and implemented computational strategies that catalog key motif combinations that identify neuronal enhancers, and developed sequence- based vocabularies (classifiers) for neuroanatomical domains (forebrain, midbrain, hindbrain) among other more homogenous isolated cell populations. By integrating our experiences in functional and computational genomics we have been able to indict several disease-associated variants in pertinent biological processes. We are also beginning to develop the capacity to impute the functional impact of non-coding variation from primary sequence alone.  Efforts to understand the architecture of human complex disease through Genome Wide Association Studies have drawn increased attention to potential roles played by regulatory variation. Thus, understanding the connections between regulatory variants and disease risk is very important. We propose detailed characterization of cell-type appropriate genome-wide regulatory sequence catalogs, isolating labeled dopaminergic neurons ex vivo at multiple time points (Aim 1). We will functionally validate the catalogs and define the sequence motifs that specify their function, developing computational classifiers to identify human DA enhancers, and assaying the functional impact of disease-associated variants therein (Aim 2). We will determine the relationship between distal-acting regulatory sequences and their cognate genes using cutting edge chromatin conformation capture (3C)-based strategies to reveal enhancers- promoter interactions. Then we will determine the consequences of deleting selected enhancers using contemporary genome editing strategies (Aim 3). This proposal takes crucial next steps towards a neuronal regulatory lexicon that can inform our observation of disease-associated variation in non-coding, putative regulatory sequence space. PUBLIC HEALTH RELEVANCE:  We wish to better understand how the regulatory instructions are encoded in DNA sequence, telling critical genes when and where to be switched on/off. We will focus on neurons that are lost in disorders like Parkinson's disease, prioritizing the study o genes implicated in related disorders. Our work will provide new insight into the identity, composition and biological requirement for these gene switches, informing our understanding of mutations that contribute to common genetic disorders.",Development of a Neuronal Regulatory Lexicon,8928251,R01NS062972,"['Affect', 'Alleles', 'Architecture', 'Attention', 'Base Sequence', 'Behavioral', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Process', 'Biology', 'Cataloging', 'Catalogs', 'Cells', 'ChIP-seq', 'Chromatin', 'Communities', 'Complex', 'Congenital Megacolon', 'DNA Sequence', 'Data', 'Deposition', 'Development', 'Disease', 'Dissection', 'Distal', 'Dopamine', 'Embryonic Development', 'Enhancers', 'Functional disorder', 'Funding', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genomics', 'Health', 'Hereditary Disease', 'Human', 'Human Genome', 'Instruction', 'Label', 'Learning', 'Light', 'Machine Learning', 'Midbrain structure', 'Mitotic', 'Molecular Conformation', 'Mus', 'Mutate', 'Mutation', 'Neurons', 'Nucleotides', 'Ontology', 'Orthologous Gene', 'Output', 'Parkinson Disease', 'Phenotype', 'Play', 'Population', 'Prosencephalon', 'Role', 'Satiation', 'Specific qualifier value', 'Switch Genes', 'Syndrome', 'Time', 'Training', 'Transcriptional Regulation', 'Transgenic Mice', 'Transgenic Organisms', 'Tyrosine 3-Monooxygenase', 'Untranslated RNA', 'Variant', 'Vocabulary', 'Work', 'Zebrafish', 'addiction', 'base', 'cancer risk', 'cell type', 'disorder risk', 'dopaminergic neuron', 'encryption', 'experience', 'genome editing', 'genome wide association study', 'genome-wide', 'hindbrain', 'human disease', 'insight', 'mutant', 'neuropsychiatry', 'promoter', 'success', 'transcription factor', 'transcriptome sequencing']",NINDS,JOHNS HOPKINS UNIVERSITY,R01,2015,461094,0.09135420720971758
"Development of a Neuronal Regulatory Lexicon     DESCRIPTION (provided by applicant): This proposal builds upon our successes in the first funding cycle, and technological advances in in the wider scientific community. We will expand our understanding of the biology and sequence-based encryption of transcriptional regulatory instructions in clinically pertinent neuronal populations, focusing on tyrosine hydroxylase (Th)-expressing ventral midbrain neurons that are compromised in Parkinson's disease and certain behavioral and neuropsychiatric disorders. In recent years, we have made great strides in characterizing regulatory control at specific neurogenic loci by generating, validating and publicly depositing huge catalogs of neuronal enhancers. We have developed and implemented computational strategies that catalog key motif combinations that identify neuronal enhancers, and developed sequence- based vocabularies (classifiers) for neuroanatomical domains (forebrain, midbrain, hindbrain) among other more homogenous isolated cell populations. By integrating our experiences in functional and computational genomics we have been able to indict several disease-associated variants in pertinent biological processes. We are also beginning to develop the capacity to impute the functional impact of non-coding variation from primary sequence alone.  Efforts to understand the architecture of human complex disease through Genome Wide Association Studies have drawn increased attention to potential roles played by regulatory variation. Thus, understanding the connections between regulatory variants and disease risk is very important. We propose detailed characterization of cell-type appropriate genome-wide regulatory sequence catalogs, isolating labeled dopaminergic neurons ex vivo at multiple time points (Aim 1). We will functionally validate the catalogs and define the sequence motifs that specify their function, developing computational classifiers to identify human DA enhancers, and assaying the functional impact of disease-associated variants therein (Aim 2). We will determine the relationship between distal-acting regulatory sequences and their cognate genes using cutting edge chromatin conformation capture (3C)-based strategies to reveal enhancers- promoter interactions. Then we will determine the consequences of deleting selected enhancers using contemporary genome editing strategies (Aim 3). This proposal takes crucial next steps towards a neuronal regulatory lexicon that can inform our observation of disease-associated variation in non-coding, putative regulatory sequence space.         PUBLIC HEALTH RELEVANCE:  We wish to better understand how the regulatory instructions are encoded in DNA sequence, telling critical genes when and where to be switched on/off. We will focus on neurons that are lost in disorders like Parkinson's disease, prioritizing the study o genes implicated in related disorders. Our work will provide new insight into the identity, composition and biological requirement for these gene switches, informing our understanding of mutations that contribute to common genetic disorders.                                ",Development of a Neuronal Regulatory Lexicon,8811553,R01NS062972,"['Affect', 'Alleles', 'Architecture', 'Attention', 'Base Sequence', 'Behavioral', 'Binding Sites', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Process', 'Biology', 'Cataloging', 'Catalogs', 'Cells', 'ChIP-seq', 'Chromatin', 'Communities', 'Complex', 'Congenital Megacolon', 'DNA Sequence', 'Data', 'Deposition', 'Development', 'Disease', 'Dissection', 'Distal', 'Dopamine', 'Embryonic Development', 'Enhancers', 'Functional RNA', 'Functional disorder', 'Funding', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Hereditary Disease', 'Human', 'Human Genome', 'Instruction', 'Label', 'Learning', 'Light', 'Machine Learning', 'Midbrain structure', 'Mitotic', 'Molecular Conformation', 'Mus', 'Mutate', 'Mutation', 'Neurons', 'Nucleotides', 'Ontology', 'Orthologous Gene', 'Output', 'Parkinson Disease', 'Phenotype', 'Play', 'Population', 'Prosencephalon', 'Role', 'Satiation', 'Specific qualifier value', 'Switch Genes', 'Syndrome', 'Time', 'Training', 'Transcriptional Regulation', 'Transgenic Mice', 'Transgenic Organisms', 'Tyrosine 3-Monooxygenase', 'Variant', 'Vocabulary', 'Work', 'Zebrafish', 'addiction', 'base', 'cancer risk', 'cell type', 'disorder risk', 'dopaminergic neuron', 'encryption', 'experience', 'genome wide association study', 'genome-wide', 'hindbrain', 'human disease', 'insight', 'mutant', 'neuropsychiatry', 'promoter', 'public health relevance', 'success', 'transcription factor', 'transcriptome sequencing']",NINDS,JOHNS HOPKINS UNIVERSITY,R01,2014,467946,0.09135420720971758
"Whole transcriptome analysis for neurobiology    DESCRIPTION (provided by applicant): Development of an organ as complex as the brain depends on an intricate interplay of thousands of signaling proteins, orchestrated by an interacting web of regulatory factors. Recent ENCODE data reveal that the large tracts of so-called 'junk' DNA in introns and between genes is, in fact, actively transcribed. The functions of these non-coding transcripts, which number in the millions, are virtually unknown, although one small sib-class - the microRNAs - is receiving close attention as regulatory RNAs. One process that may be controlled by the non-coding transcripts is alternate exon use - a mechanism that adds significantly to the diversity of cellular proteins (particularly in the CNS), the regulation of which is little understood at this time. Recent advances that generate whole-transcriptome data have provided the means to systematically explore both these factors. However, the bioinformatic challenges are substantial, and the lack of comprehensive, well designed, and easily used software to manage, visualize, analyze and interpret the data will likely be the limiting factor in this field of research. We propose to develop a bioinformatics toolkit specifically to integrate whole-transcriptome data from two different technologies, the Affymetrix All Exon microarray which 1.4 million distinct transcript measurements, and RNASeq, which provides for 'digital' expression analysis of the whole transcriptome. The toolkit will also integrate epigenomic data that will be essential in the understanding of regulation of transcription. The design and development of the software will be guided by prominent scientists engaged in the study of the brain, and will be applied to sample datasets derived from neurological tissues, to ensure that the program incorporates functions and annotations relevant to this field.        While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatics software tools. The utility of the next generation of arrays and sequencing technologies- which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.         ",Whole transcriptome analysis for neurobiology,8515535,R44NS063540,"['Analysis of Variance', 'Atlases', 'Attention', 'Base Sequence', 'Bioinformatics', 'Biological', 'Biological Neural Networks', 'Brain', 'Cell physiology', 'Clinical', 'Clinical Research', 'Complex', 'Computer software', 'CpG Islands', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Discipline', 'Disease', 'Elements', 'Ensure', 'Evaluation', 'Exons', 'Factor Analysis', 'Functional RNA', 'Gene Expression Profile', 'Genes', 'Genome', 'Genomics', 'Glioblastoma', 'Human', 'Imagery', 'Individual', 'Informatics', 'Internet', 'Introns', 'Junk DNA', 'Link', 'Location', 'Measurement', 'Measures', 'Methods', 'Methylation', 'MicroRNAs', 'Modeling', 'Names', 'Nervous system structure', 'Neurobiology', 'Neuroblastoma', 'Neurologic', 'Non-linear Models', 'Organ', 'Pattern', 'Phase', 'Principal Component Analysis', 'Process', 'Proteins', 'RNA', 'RNA Editing', 'RNA Splicing', 'Regression Analysis', 'Regulation', 'Research', 'Sampling', 'Schizophrenia', 'Scientist', 'Signaling Protein', 'Site', 'Software Tools', 'Technology', 'Time', 'Tissues', 'Trans-Splicing', 'Transcript', 'Transcriptional Regulation', 'Variant', 'base', 'biological research', 'data management', 'data reduction', 'design', 'digital', 'empowered', 'epigenomics', 'histone modification', 'new technology', 'next generation', 'programs', 'relating to nervous system', 'screening', 'software development', 'tool', 'transcription factor']",NINDS,EPICENTER SOFTWARE,R44,2013,433513,0.056938831105290216
"Whole transcriptome analysis for neurobiology    DESCRIPTION (provided by applicant): Development of an organ as complex as the brain depends on an intricate interplay of thousands of signaling proteins, orchestrated by an interacting web of regulatory factors. Recent ENCODE data reveal that the large tracts of so-called 'junk' DNA in introns and between genes is, in fact, actively transcribed. The functions of these non-coding transcripts, which number in the millions, are virtually unknown, although one small sib-class - the microRNAs - is receiving close attention as regulatory RNAs. One process that may be controlled by the non-coding transcripts is alternate exon use - a mechanism that adds significantly to the diversity of cellular proteins (particularly in the CNS), the regulation of which is little understood at this time. Recent advances that generate whole-transcriptome data have provided the means to systematically explore both these factors. However, the bioinformatic challenges are substantial, and the lack of comprehensive, well designed, and easily used software to manage, visualize, analyze and interpret the data will likely be the limiting factor in this field of research. We propose to develop a bioinformatics toolkit specifically to integrate whole-transcriptome data from two different technologies, the Affymetrix All Exon microarray which 1.4 million distinct transcript measurements, and RNASeq, which provides for 'digital' expression analysis of the whole transcriptome. The toolkit will also integrate epigenomic data that will be essential in the understanding of regulation of transcription. The design and development of the software will be guided by prominent scientists engaged in the study of the brain, and will be applied to sample datasets derived from neurological tissues, to ensure that the program incorporates functions and annotations relevant to this field.        While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatics software tools. The utility of the next generation of arrays and sequencing technologies- which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.         ",Whole transcriptome analysis for neurobiology,8269839,R44NS063540,"['Analysis of Variance', 'Atlases', 'Attention', 'Base Sequence', 'Bioinformatics', 'Biological', 'Biological Neural Networks', 'Brain', 'Cell physiology', 'Clinical', 'Clinical Research', 'Complex', 'Computer software', 'CpG Islands', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Discipline', 'Disease', 'Elements', 'Ensure', 'Evaluation', 'Exons', 'Factor Analysis', 'Functional RNA', 'Gene Expression Profile', 'Genes', 'Genome', 'Genomics', 'Glioblastoma', 'Human', 'Imagery', 'Individual', 'Informatics', 'Internet', 'Introns', 'Junk DNA', 'Link', 'Location', 'Measurement', 'Measures', 'Methods', 'Methylation', 'MicroRNAs', 'Modeling', 'Names', 'Nervous system structure', 'Neurobiology', 'Neuroblastoma', 'Neurologic', 'Non-linear Models', 'Organ', 'Pattern', 'Phase', 'Principal Component Analysis', 'Process', 'Proteins', 'RNA', 'RNA Editing', 'RNA Splicing', 'Regression Analysis', 'Regulation', 'Research', 'Sampling', 'Schizophrenia', 'Scientist', 'Screening procedure', 'Signaling Protein', 'Site', 'Software Tools', 'Technology', 'Time', 'Tissues', 'Trans-Splicing', 'Transcript', 'Transcriptional Regulation', 'Variant', 'base', 'biological research', 'data management', 'data reduction', 'design', 'digital', 'empowered', 'epigenomics', 'histone modification', 'new technology', 'next generation', 'programs', 'relating to nervous system', 'software development', 'tool', 'transcription factor']",NINDS,EPICENTER SOFTWARE,R44,2012,436189,0.056938831105290216
"Whole transcriptome analysis for neurobiology    DESCRIPTION (provided by applicant): Development of an organ as complex as the brain depends on an intricate interplay of thousands of signaling proteins, orchestrated by an interacting web of regulatory factors. Recent ENCODE data reveal that the large tracts of so-called 'junk' DNA in introns and between genes is, in fact, actively transcribed. The functions of these non-coding transcripts, which number in the millions, are virtually unknown, although one small sib-class - the microRNAs - is receiving close attention as regulatory RNAs. One process that may be controlled by the non-coding transcripts is alternate exon use - a mechanism that adds significantly to the diversity of cellular proteins (particularly in the CNS), the regulation of which is little understood at this time. Recent advances that generate whole-transcriptome data have provided the means to systematically explore both these factors. However, the bioinformatic challenges are substantial, and the lack of comprehensive, well designed, and easily used software to manage, visualize, analyze and interpret the data will likely be the limiting factor in this field of research. We propose to develop a bioinformatics toolkit specifically to integrate whole-transcriptome data from two different technologies, the Affymetrix All Exon microarray which 1.4 million distinct transcript measurements, and RNASeq, which provides for 'digital' expression analysis of the whole transcriptome. The toolkit will also integrate epigenomic data that will be essential in the understanding of regulation of transcription. The design and development of the software will be guided by prominent scientists engaged in the study of the brain, and will be applied to sample datasets derived from neurological tissues, to ensure that the program incorporates functions and annotations relevant to this field.        While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatics software tools. The utility of the next generation of arrays and sequencing technologies- which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.         ",Whole transcriptome analysis for neurobiology,8516306,R44NS063540,"['Analysis of Variance', 'Atlases', 'Attention', 'Base Sequence', 'Bioinformatics', 'Biological', 'Biological Neural Networks', 'Brain', 'Cell physiology', 'Clinical', 'Clinical Research', 'Complex', 'Computer software', 'CpG Islands', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Discipline', 'Disease', 'Elements', 'Ensure', 'Evaluation', 'Exons', 'Factor Analysis', 'Functional RNA', 'Gene Expression Profile', 'Genes', 'Genome', 'Genomics', 'Glioblastoma', 'Human', 'Imagery', 'Individual', 'Informatics', 'Internet', 'Introns', 'Junk DNA', 'Link', 'Location', 'Measurement', 'Measures', 'Methods', 'Methylation', 'MicroRNAs', 'Modeling', 'Names', 'Nervous system structure', 'Neurobiology', 'Neuroblastoma', 'Neurologic', 'Non-linear Models', 'Organ', 'Pattern', 'Phase', 'Principal Component Analysis', 'Process', 'Proteins', 'RNA', 'RNA Editing', 'RNA Splicing', 'Regression Analysis', 'Regulation', 'Research', 'Sampling', 'Schizophrenia', 'Scientist', 'Screening procedure', 'Signaling Protein', 'Site', 'Software Tools', 'Technology', 'Time', 'Tissues', 'Trans-Splicing', 'Transcript', 'Transcriptional Regulation', 'Variant', 'base', 'biological research', 'data management', 'data reduction', 'design', 'digital', 'empowered', 'epigenomics', 'histone modification', 'new technology', 'next generation', 'programs', 'relating to nervous system', 'software development', 'tool', 'transcription factor']",NINDS,EPICENTER SOFTWARE,R44,2012,155953,0.056938831105290216
"Whole transcriptome analysis for neurobiology    DESCRIPTION (provided by applicant): Development of an organ as complex as the brain depends on an intricate interplay of thousands of signaling proteins, orchestrated by an interacting web of regulatory factors. Recent ENCODE data reveal that the large tracts of so-called 'junk' DNA in introns and between genes is, in fact, actively transcribed. The functions of these non-coding transcripts, which number in the millions, are virtually unknown, although one small sib-class - the microRNAs - is receiving close attention as regulatory RNAs. One process that may be controlled by the non-coding transcripts is alternate exon use - a mechanism that adds significantly to the diversity of cellular proteins (particularly in the CNS), the regulation of which is little understood at this time. Recent advances that generate whole-transcriptome data have provided the means to systematically explore both these factors. However, the bioinformatic challenges are substantial, and the lack of comprehensive, well designed, and easily used software to manage, visualize, analyze and interpret the data will likely be the limiting factor in this field of research. We propose to develop a bioinformatics toolkit specifically to integrate whole-transcriptome data from two different technologies, the Affymetrix All Exon microarray which 1.4 million distinct transcript measurements, and RNASeq, which provides for 'digital' expression analysis of the whole transcriptome. The toolkit will also integrate epigenomic data that will be essential in the understanding of regulation of transcription. The design and development of the software will be guided by prominent scientists engaged in the study of the brain, and will be applied to sample datasets derived from neurological tissues, to ensure that the program incorporates functions and annotations relevant to this field.      PUBLIC HEALTH RELEVANCE: While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatics software tools. The utility of the next generation of arrays and sequencing technologies- which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.           While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatics software tools. The utility of the next generation of arrays and sequencing technologies- which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.         ",Whole transcriptome analysis for neurobiology,8125756,R44NS063540,"['Analysis of Variance', 'Atlases', 'Attention', 'Base Sequence', 'Bioinformatics', 'Biological', 'Biological Neural Networks', 'Brain', 'Cell physiology', 'Clinical', 'Clinical Research', 'Complex', 'Computer software', 'CpG Islands', 'DNA Methylation', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Discipline', 'Disease', 'Elements', 'Ensure', 'Evaluation', 'Exons', 'Factor Analysis', 'Functional RNA', 'Gene Expression Profile', 'Genes', 'Genome', 'Genomics', 'Glioblastoma', 'Human', 'Imagery', 'Individual', 'Informatics', 'Internet', 'Introns', 'Junk DNA', 'Link', 'Location', 'Measurement', 'Measures', 'Methods', 'Methylation', 'MicroRNAs', 'Modeling', 'Names', 'Nervous system structure', 'Neurobiology', 'Neuroblastoma', 'Neurologic', 'Non-linear Models', 'Organ', 'Pattern', 'Phase', 'Principal Component Analysis', 'Process', 'Proteins', 'RNA', 'RNA Editing', 'RNA Splicing', 'Regression Analysis', 'Regulation', 'Research', 'Sampling', 'Schizophrenia', 'Scientist', 'Screening procedure', 'Signaling Protein', 'Site', 'Software Tools', 'Technology', 'Time', 'Tissues', 'Trans-Splicing', 'Transcript', 'Transcriptional Regulation', 'Variant', 'base', 'biological research', 'data management', 'data reduction', 'design', 'digital', 'empowered', 'epigenomics', 'histone modification', 'new technology', 'next generation', 'programs', 'relating to nervous system', 'software development', 'tool', 'transcription factor']",NINDS,EPICENTER SOFTWARE,R44,2011,477134,0.047701036516292254
"Toolkit for Whole Transcriptome Analysis of Neural Tissues    DESCRIPTION (provided by applicant): Development of an organ as complex as the brain must depend on an intricate interplay of thousands of signaling proteins, orchestrated by an interacting web of regulatory factors. Recent ENCODE data reveal that the large tracts of so-called `junk' DNA in introns and between genes is, in fact, actively transcribed. The functions of these non-coding transcripts, which number in the millions, are virtually unknown, although one very small sib-class - the microRNAs - is receiving close attention as regulatory RNAs. One process that may be controlled by the non-coding transcripts is alternate exon use - a mechanism that adds significantly to the diversity of cellular proteins (particularly in the CNS), the regulation of which is little understood at this time. Recent technological advances that generate whole-transcriptome data have provided the means to systematically explore both these factors - the role non-coding transcripts, and the occurrence and control of splice variation. However, the bioinformatic challenges posed by these technologies are substantial, and the lack of comprehensive, well designed, and easily used software to manage, visualize, analyze and interpret these data will likely be the limiting factor in this field of research. We propose to develop a bioinformatics toolkit specifically to mine whole-transcriptome data from two fundamentally different technologies, the Affymetrix All Exon microarray which provides measures of over 1.4 million distinct transcripts, and the Solexa ultra high throughput sequencer, which provides for `digital' expression analysis of the whole transcriptome. The design and development of the software will be guided by prominent scientists engaged in the study of the brain, and will be applied to sample data set derived from neurological tissue, to ensure that the progra incorporates functions and annotations relevant to this field. PUBLIC HEALTH RELEVANCE: While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatic software tools. The utility of the next generation of arrays - which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.           Narrative While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatic software tools. The utility of the next generation of arrays - which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.",Toolkit for Whole Transcriptome Analysis of Neural Tissues,7694376,R43NS063540,"['Analysis of Variance', 'Atlases', 'Attention', 'Base Sequence', 'Bioinformatics', 'Biological', 'Biological Neural Networks', 'Brain', 'Cell physiology', 'Clinical', 'Clinical Research', 'Complex', 'Computer software', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Discipline', 'Disease', 'Elements', 'Ensure', 'Evaluation', 'Exons', 'Factor Analysis', 'Functional RNA', 'Gene Expression Profile', 'Genes', 'Genome', 'Genomics', 'Glioblastoma', 'Graph', 'Imagery', 'Individual', 'Informatics', 'Internet', 'Introns', 'Junk DNA', 'Link', 'Measures', 'Messenger RNA', 'Methods', 'MicroRNAs', 'Mining', 'Modeling', 'Neuroblastoma', 'Neurologic', 'Non-linear Models', 'Organ', 'Pattern', 'Phase', 'Principal Component Analysis', 'Process', 'Proteins', 'RNA Splicing', 'Regression Analysis', 'Regulation', 'Research', 'Role', 'Sampling', 'Schizophrenia', 'Scientist', 'Screening procedure', 'Signaling Protein', 'Site', 'Small Business Innovation Research Grant', 'Software Tools', 'Source', 'Technology', 'Time', 'Tissues', 'Transcript', 'Variant', 'base', 'comparison group', 'computer based statistical methods', 'data management', 'depression', 'design', 'digital', 'empowered', 'new technology', 'next generation', 'public health relevance', 'relating to nervous system', 'software development', 'tool']",NINDS,EPICENTER SOFTWARE,R43,2009,296447,0.041115184592412285
"Toolkit for Whole Transcriptome Analysis of Neural Tissues    DESCRIPTION (provided by applicant): Development of an organ as complex as the brain must depend on an intricate interplay of thousands of signaling proteins, orchestrated by an interacting web of regulatory factors. Recent ENCODE data reveal that the large tracts of so-called `junk' DNA in introns and between genes is, in fact, actively transcribed. The functions of these non-coding transcripts, which number in the millions, are virtually unknown, although one very small sib-class - the microRNAs - is receiving close attention as regulatory RNAs. One process that may be controlled by the non-coding transcripts is alternate exon use - a mechanism that adds significantly to the diversity of cellular proteins (particularly in the CNS), the regulation of which is little understood at this time. Recent technological advances that generate whole-transcriptome data have provided the means to systematically explore both these factors - the role non-coding transcripts, and the occurrence and control of splice variation. However, the bioinformatic challenges posed by these technologies are substantial, and the lack of comprehensive, well designed, and easily used software to manage, visualize, analyze and interpret these data will likely be the limiting factor in this field of research. We propose to develop a bioinformatics toolkit specifically to mine whole-transcriptome data from two fundamentally different technologies, the Affymetrix All Exon microarray which provides measures of over 1.4 million distinct transcripts, and the Solexa ultra high throughput sequencer, which provides for `digital' expression analysis of the whole transcriptome. The design and development of the software will be guided by prominent scientists engaged in the study of the brain, and will be applied to sample data set derived from neurological tissue, to ensure that the progra incorporates functions and annotations relevant to this field. PUBLIC HEALTH RELEVANCE: While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatic software tools. The utility of the next generation of arrays - which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.           Narrative While the large-scale array technologies have provided an unprecedented capability to model cellular processes in the brain, both in normal functioning and disease states, this capability is utterly dependent on the availability of complex data management, computational, statistical and informatic software tools. The utility of the next generation of arrays - which focus on critical regulation and control functions of the cell - will be stymied by an initial lack of suitable bioinformatic tools. This proposal initiates an accelerated development of an integrated software package intended to empower biologists in the application and analysis of these powerful new technologies, with broadly reaching impact at all levels of biological and clinical research, and across every discipline.",Toolkit for Whole Transcriptome Analysis of Neural Tissues,7611045,R43NS063540,"['Analysis of Variance', 'Atlases', 'Attention', 'Base Sequence', 'Bioinformatics', 'Biological', 'Biological Neural Networks', 'Brain', 'Cell physiology', 'Class', 'Clinical', 'Clinical Research', 'Complex', 'Computer software', 'DNA', 'Data', 'Data Analyses', 'Data Set', 'Databases', 'Development', 'Discipline', 'Disease', 'Disease regression', 'Elements', 'Ensure', 'Evaluation', 'Exons', 'Factor Analysis', 'Functional RNA', 'Gene Expression Profile', 'Genes', 'Genome', 'Genomics', 'Glioblastoma', 'Graph', 'Imagery', 'Individual', 'Informatics', 'Internet', 'Introns', 'Link', 'Measures', 'Mental Depression', 'Messenger RNA', 'Methods', 'MicroRNAs', 'Mining', 'Modeling', 'Neuroblastoma', 'Neurologic', 'Non-linear Models', 'Numbers', 'Organ', 'Pattern', 'Phase', 'Principal Component Analysis', 'Process', 'Proteins', 'Public Health', 'RNA Splicing', 'Regression Analysis', 'Regulation', 'Research', 'Role', 'Sampling', 'Schizophrenia', 'Scientist', 'Screening procedure', 'Signaling Protein', 'Site', 'Small Business Funding Mechanisms', 'Small Business Innovation Research Grant', 'Software Tools', 'Source', 'Technology', 'Time', 'Tissues', 'Transcript', 'Variant', 'base', 'comparison group', 'computer based statistical methods', 'data management', 'design', 'new technology', 'next generation', 'relating to nervous system', 'software development', 'tool']",NINDS,EPICENTER SOFTWARE,R43,2008,145388,0.041115184592412285
"Global Predictions and Tests of Erythroid Regulation    DESCRIPTION (provided by applicant): Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation is known to cause many genetic diseases, including some inherited anemias, and it is thought to be a major contributor to complex phenotypes such as susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies aim for a deeper molecular understanding of global aspects of gene regulation in an important biological process, the maturation of erythroid precursor cells to become red blood cells. Building on our progress using patterns in sequence alignments to predict cis-regulatory modules for erythroid genes and deciphering functional correlations of their evolutionary history, we propose to acquire genome-wide information on biochemical features associated with regulation to reach a more complete understanding of gene regulation in erythroid cells. Specifically, we propose to use high throughput biochemical assays such as chromatin immunoprecipitation followed by hybridization to microarrays and deep re-sequencing to acquire data on genomic DNA sequences (Aim 1) occupied in vivo by critical tissue-specific transcription factors, (Aim 2) bound by histones with modifications associated with gene activation or repression, (Aim 3) in chromatin with an altered structure, and (Aim 4) transcribed in a mouse erythroid cell model that undergoes maturation upon restoration of the critical transcription factor GATA-1. Then we will (Aim 5) apply existing software and develop new data-processing algorithms to determine peaks of signals that are likely to represent the locations of the features targeted in aims 1-4. Aim 6 will mine the peak-calling results, along with raw data, multiple sequence alignments and other information to investigate their covariation structure and integrate them to predict cis-regulatory modules, classify the modules by function, identify motifs associated with specific protein occupancy, and deduce the phylogenetic depth of preservation of critical motifs in the regulatory modules. Aim 7 will experimentally test biological hypotheses that arise from the analyses in Aims 6 and 7, determining the extent to which we can validate the locations of protein occupancy and transcripts, the predictions of both positive and negative cis-regulatory modules by gain-of-function cell transfection assays, and the role of motifs implicated in occupancy by directed mutagenesis and in vivo binding assays. We will test whether the motif- constraint hypothesis for protein-occupied DNA segments involved in enhancement applies to transcription factors in addition to GATA-1, and we will conduct additional experiments probing deeper biological issues. This research will provide not only global insights into mechanisms and effects of gene regulation during erythroid maturation, but the techniques and analytical tools developed here can be applied to better understand the development and differentiation of any tissue.       PUBLIC HEALTH RELEVANCE: Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.         ",Global Predictions and Tests of Erythroid Regulation,8423806,R01DK065806,"['Affinity', 'Algorithms', 'Anemia', 'Binding', 'Binding Sites', 'Biochemical', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Models', 'Biological Preservation', 'Biological Process', 'Biological Testing', 'Cell model', 'Cells', 'Characteristics', 'Chromatin', 'Code', 'Complement', 'Complex', 'Computer software', 'Critical Pathways', 'DNA', 'DNA Resequencing', 'DNA Sequence', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Developmental Biology', 'Disease', 'Distal', 'Enhancers', 'Erythrocytes', 'Erythroid', 'Erythroid Cells', 'Erythroid Progenitor Cells', 'Erythropoiesis', 'Evolution', 'Gene Activation', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Health', 'Hereditary Disease', 'Histones', 'Inherited', 'Investigation', 'Location', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Mining', 'Modeling', 'Modification', 'Molecular', 'Mus', 'Mutagenesis', 'Nucleosomes', 'Organism', 'Pattern', 'Phenotype', 'Phylogenetic Analysis', 'Predisposition', 'Process', 'Property', 'Proteins', 'Recording of previous events', 'Regulation', 'Reporter Genes', 'Research', 'Resolution', 'Reverse Transcriptase Polymerase Chain Reaction', 'Role', 'Sensitivity and Specificity', 'Sequence Alignment', 'Signal Transduction', 'Site', 'Stream', 'Structure', 'Techniques', 'Technology', 'Testing', 'Therapeutic Intervention', 'Tissues', 'Transcript', 'Transfection', 'analytical tool', 'chromatin immunoprecipitation', 'computerized data processing', 'data acquisition', 'data mining', 'density', 'gain of function', 'gene repression', 'genome-wide', 'histone modification', 'human GATA1 protein', 'improved', 'in vivo', 'insight', 'novel', 'promoter', 'public health relevance', 'research study', 'restoration', 'software development', 'success', 'tool', 'transcription factor']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2013,555662,0.09488566082312493
"Global Predictions and Tests of Erythroid Regulation    DESCRIPTION (provided by applicant): Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation is known to cause many genetic diseases, including some inherited anemias, and it is thought to be a major contributor to complex phenotypes such as susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies aim for a deeper molecular understanding of global aspects of gene regulation in an important biological process, the maturation of erythroid precursor cells to become red blood cells. Building on our progress using patterns in sequence alignments to predict cis-regulatory modules for erythroid genes and deciphering functional correlations of their evolutionary history, we propose to acquire genome-wide information on biochemical features associated with regulation to reach a more complete understanding of gene regulation in erythroid cells. Specifically, we propose to use high throughput biochemical assays such as chromatin immunoprecipitation followed by hybridization to microarrays and deep re-sequencing to acquire data on genomic DNA sequences (Aim 1) occupied in vivo by critical tissue-specific transcription factors, (Aim 2) bound by histones with modifications associated with gene activation or repression, (Aim 3) in chromatin with an altered structure, and (Aim 4) transcribed in a mouse erythroid cell model that undergoes maturation upon restoration of the critical transcription factor GATA-1. Then we will (Aim 5) apply existing software and develop new data-processing algorithms to determine peaks of signals that are likely to represent the locations of the features targeted in aims 1-4. Aim 6 will mine the peak-calling results, along with raw data, multiple sequence alignments and other information to investigate their covariation structure and integrate them to predict cis-regulatory modules, classify the modules by function, identify motifs associated with specific protein occupancy, and deduce the phylogenetic depth of preservation of critical motifs in the regulatory modules. Aim 7 will experimentally test biological hypotheses that arise from the analyses in Aims 6 and 7, determining the extent to which we can validate the locations of protein occupancy and transcripts, the predictions of both positive and negative cis-regulatory modules by gain-of-function cell transfection assays, and the role of motifs implicated in occupancy by directed mutagenesis and in vivo binding assays. We will test whether the motif- constraint hypothesis for protein-occupied DNA segments involved in enhancement applies to transcription factors in addition to GATA-1, and we will conduct additional experiments probing deeper biological issues. This research will provide not only global insights into mechanisms and effects of gene regulation during erythroid maturation, but the techniques and analytical tools developed here can be applied to better understand the development and differentiation of any tissue.      PUBLIC HEALTH RELEVANCE: Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.           Project Narrative ""Global Predictions and Tests of Erythroid Regulation"" R01 DK065806 Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.",Global Predictions and Tests of Erythroid Regulation,8214629,R01DK065806,"['Affinity', 'Algorithms', 'Anemia', 'Binding', 'Binding Sites', 'Biochemical', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Models', 'Biological Preservation', 'Biological Process', 'Biological Testing', 'Cell model', 'Cells', 'Characteristics', 'Chromatin', 'Code', 'Complement', 'Complex', 'Computer software', 'Critical Pathways', 'DNA', 'DNA Resequencing', 'DNA Sequence', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Developmental Biology', 'Disease', 'Distal', 'Enhancers', 'Erythrocytes', 'Erythroid', 'Erythroid Cells', 'Erythroid Progenitor Cells', 'Erythropoiesis', 'Evolution', 'Gene Activation', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Health', 'Hereditary Disease', 'Histones', 'Inherited', 'Investigation', 'Location', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Mining', 'Modeling', 'Modification', 'Molecular', 'Mus', 'Mutagenesis', 'Nucleosomes', 'Organism', 'Pattern', 'Phenotype', 'Phylogenetic Analysis', 'Predisposition', 'Process', 'Property', 'Proteins', 'Recording of previous events', 'Regulation', 'Reporter Genes', 'Research', 'Resolution', 'Reverse Transcriptase Polymerase Chain Reaction', 'Role', 'Sensitivity and Specificity', 'Sequence Alignment', 'Signal Transduction', 'Site', 'Stream', 'Structure', 'Techniques', 'Technology', 'Testing', 'Therapeutic Intervention', 'Tissues', 'Transcript', 'Transfection', 'analytical tool', 'chromatin immunoprecipitation', 'computerized data processing', 'data acquisition', 'data mining', 'density', 'gain of function', 'gene repression', 'genome-wide', 'histone modification', 'human GATA1 protein', 'improved', 'in vivo', 'insight', 'novel', 'promoter', 'public health relevance', 'research study', 'restoration', 'software development', 'success', 'tool', 'transcription factor']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2012,575817,0.09750769875600365
"Global Predictions and Tests of Erythroid Regulation    DESCRIPTION (provided by applicant): Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation is known to cause many genetic diseases, including some inherited anemias, and it is thought to be a major contributor to complex phenotypes such as susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies aim for a deeper molecular understanding of global aspects of gene regulation in an important biological process, the maturation of erythroid precursor cells to become red blood cells. Building on our progress using patterns in sequence alignments to predict cis-regulatory modules for erythroid genes and deciphering functional correlations of their evolutionary history, we propose to acquire genome-wide information on biochemical features associated with regulation to reach a more complete understanding of gene regulation in erythroid cells. Specifically, we propose to use high throughput biochemical assays such as chromatin immunoprecipitation followed by hybridization to microarrays and deep re-sequencing to acquire data on genomic DNA sequences (Aim 1) occupied in vivo by critical tissue-specific transcription factors, (Aim 2) bound by histones with modifications associated with gene activation or repression, (Aim 3) in chromatin with an altered structure, and (Aim 4) transcribed in a mouse erythroid cell model that undergoes maturation upon restoration of the critical transcription factor GATA-1. Then we will (Aim 5) apply existing software and develop new data-processing algorithms to determine peaks of signals that are likely to represent the locations of the features targeted in aims 1-4. Aim 6 will mine the peak-calling results, along with raw data, multiple sequence alignments and other information to investigate their covariation structure and integrate them to predict cis-regulatory modules, classify the modules by function, identify motifs associated with specific protein occupancy, and deduce the phylogenetic depth of preservation of critical motifs in the regulatory modules. Aim 7 will experimentally test biological hypotheses that arise from the analyses in Aims 6 and 7, determining the extent to which we can validate the locations of protein occupancy and transcripts, the predictions of both positive and negative cis-regulatory modules by gain-of-function cell transfection assays, and the role of motifs implicated in occupancy by directed mutagenesis and in vivo binding assays. We will test whether the motif- constraint hypothesis for protein-occupied DNA segments involved in enhancement applies to transcription factors in addition to GATA-1, and we will conduct additional experiments probing deeper biological issues. This research will provide not only global insights into mechanisms and effects of gene regulation during erythroid maturation, but the techniques and analytical tools developed here can be applied to better understand the development and differentiation of any tissue.      PUBLIC HEALTH RELEVANCE: Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.           Project Narrative ""Global Predictions and Tests of Erythroid Regulation"" R01 DK065806 Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.",Global Predictions and Tests of Erythroid Regulation,8046378,R01DK065806,"['Affinity', 'Algorithms', 'Anemia', 'Binding', 'Binding Sites', 'Biochemical', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Models', 'Biological Preservation', 'Biological Process', 'Biological Testing', 'Cell model', 'Cells', 'Characteristics', 'Chromatin', 'Code', 'Complement', 'Complex', 'Computer software', 'Critical Pathways', 'DNA', 'DNA Resequencing', 'DNA Sequence', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Developmental Biology', 'Disease', 'Distal', 'Enhancers', 'Erythrocytes', 'Erythroid', 'Erythroid Cells', 'Erythroid Progenitor Cells', 'Erythropoiesis', 'Evolution', 'Gene Activation', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Health', 'Hereditary Disease', 'Histones', 'Inherited', 'Investigation', 'Location', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Mining', 'Modeling', 'Modification', 'Molecular', 'Mus', 'Mutagenesis', 'Nucleosomes', 'Organism', 'Pattern', 'Phenotype', 'Phylogenetic Analysis', 'Predisposition', 'Process', 'Property', 'Proteins', 'Recording of previous events', 'Regulation', 'Reporter Genes', 'Research', 'Resolution', 'Reverse Transcriptase Polymerase Chain Reaction', 'Role', 'Sensitivity and Specificity', 'Sequence Alignment', 'Signal Transduction', 'Site', 'Stream', 'Structure', 'Techniques', 'Technology', 'Testing', 'Therapeutic Intervention', 'Tissues', 'Transcript', 'Transfection', 'analytical tool', 'chromatin immunoprecipitation', 'computerized data processing', 'data acquisition', 'data mining', 'density', 'gain of function', 'gene repression', 'genome-wide', 'histone modification', 'human GATA1 protein', 'improved', 'in vivo', 'insight', 'novel', 'promoter', 'public health relevance', 'research study', 'restoration', 'software development', 'success', 'tool', 'transcription factor']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2011,575817,0.09750769875600365
"Global Predictions and Tests of Erythroid Regulation    DESCRIPTION (provided by applicant): Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation is known to cause many genetic diseases, including some inherited anemias, and it is thought to be a major contributor to complex phenotypes such as susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies aim for a deeper molecular understanding of global aspects of gene regulation in an important biological process, the maturation of erythroid precursor cells to become red blood cells. Building on our progress using patterns in sequence alignments to predict cis-regulatory modules for erythroid genes and deciphering functional correlations of their evolutionary history, we propose to acquire genome-wide information on biochemical features associated with regulation to reach a more complete understanding of gene regulation in erythroid cells. Specifically, we propose to use high throughput biochemical assays such as chromatin immunoprecipitation followed by hybridization to microarrays and deep re-sequencing to acquire data on genomic DNA sequences (Aim 1) occupied in vivo by critical tissue-specific transcription factors, (Aim 2) bound by histones with modifications associated with gene activation or repression, (Aim 3) in chromatin with an altered structure, and (Aim 4) transcribed in a mouse erythroid cell model that undergoes maturation upon restoration of the critical transcription factor GATA-1. Then we will (Aim 5) apply existing software and develop new data-processing algorithms to determine peaks of signals that are likely to represent the locations of the features targeted in aims 1-4. Aim 6 will mine the peak-calling results, along with raw data, multiple sequence alignments and other information to investigate their covariation structure and integrate them to predict cis-regulatory modules, classify the modules by function, identify motifs associated with specific protein occupancy, and deduce the phylogenetic depth of preservation of critical motifs in the regulatory modules. Aim 7 will experimentally test biological hypotheses that arise from the analyses in Aims 6 and 7, determining the extent to which we can validate the locations of protein occupancy and transcripts, the predictions of both positive and negative cis-regulatory modules by gain-of-function cell transfection assays, and the role of motifs implicated in occupancy by directed mutagenesis and in vivo binding assays. We will test whether the motif- constraint hypothesis for protein-occupied DNA segments involved in enhancement applies to transcription factors in addition to GATA-1, and we will conduct additional experiments probing deeper biological issues. This research will provide not only global insights into mechanisms and effects of gene regulation during erythroid maturation, but the techniques and analytical tools developed here can be applied to better understand the development and differentiation of any tissue.      PUBLIC HEALTH RELEVANCE: Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.           Project Narrative ""Global Predictions and Tests of Erythroid Regulation"" R01 DK065806 Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.",Global Predictions and Tests of Erythroid Regulation,7848337,R01DK065806,"['Affinity', 'Algorithms', 'Anemia', 'Binding', 'Binding Sites', 'Biochemical', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Models', 'Biological Preservation', 'Biological Process', 'Biological Testing', 'Cell model', 'Cells', 'Characteristics', 'Chromatin', 'Code', 'Complement', 'Complex', 'Computer software', 'Critical Pathways', 'DNA', 'DNA Resequencing', 'DNA Sequence', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Developmental Biology', 'Disease', 'Distal', 'Enhancers', 'Erythrocytes', 'Erythroid', 'Erythroid Cells', 'Erythroid Progenitor Cells', 'Erythropoiesis', 'Evolution', 'Gene Activation', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Health', 'Hereditary Disease', 'Histones', 'Inherited', 'Investigation', 'Location', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Mining', 'Modeling', 'Modification', 'Molecular', 'Mus', 'Mutagenesis', 'Nucleosomes', 'Organism', 'Pattern', 'Phenotype', 'Phylogenetic Analysis', 'Predisposition', 'Process', 'Property', 'Proteins', 'Recording of previous events', 'Regulation', 'Reporter Genes', 'Repression', 'Research', 'Resolution', 'Reverse Transcriptase Polymerase Chain Reaction', 'Role', 'Sensitivity and Specificity', 'Sequence Alignment', 'Signal Transduction', 'Site', 'Solid', 'Stream', 'Structure', 'Techniques', 'Technology', 'Testing', 'Therapeutic Intervention', 'Tissues', 'Transcript', 'Transfection', 'analytical tool', 'chromatin immunoprecipitation', 'computerized data processing', 'data acquisition', 'data mining', 'density', 'gain of function', 'genome-wide', 'histone modification', 'human GATA1 protein', 'improved', 'in vivo', 'insight', 'novel', 'promoter', 'public health relevance', 'research study', 'restoration', 'software development', 'success', 'tool', 'transcription factor']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2010,685235,0.09750769875600365
"Global Predictions and Tests of Erythroid Regulation    DESCRIPTION (provided by applicant): Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation is known to cause many genetic diseases, including some inherited anemias, and it is thought to be a major contributor to complex phenotypes such as susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies aim for a deeper molecular understanding of global aspects of gene regulation in an important biological process, the maturation of erythroid precursor cells to become red blood cells. Building on our progress using patterns in sequence alignments to predict cis-regulatory modules for erythroid genes and deciphering functional correlations of their evolutionary history, we propose to acquire genome-wide information on biochemical features associated with regulation to reach a more complete understanding of gene regulation in erythroid cells. Specifically, we propose to use high throughput biochemical assays such as chromatin immunoprecipitation followed by hybridization to microarrays and deep re-sequencing to acquire data on genomic DNA sequences (Aim 1) occupied in vivo by critical tissue-specific transcription factors, (Aim 2) bound by histones with modifications associated with gene activation or repression, (Aim 3) in chromatin with an altered structure, and (Aim 4) transcribed in a mouse erythroid cell model that undergoes maturation upon restoration of the critical transcription factor GATA-1. Then we will (Aim 5) apply existing software and develop new data-processing algorithms to determine peaks of signals that are likely to represent the locations of the features targeted in aims 1-4. Aim 6 will mine the peak-calling results, along with raw data, multiple sequence alignments and other information to investigate their covariation structure and integrate them to predict cis-regulatory modules, classify the modules by function, identify motifs associated with specific protein occupancy, and deduce the phylogenetic depth of preservation of critical motifs in the regulatory modules. Aim 7 will experimentally test biological hypotheses that arise from the analyses in Aims 6 and 7, determining the extent to which we can validate the locations of protein occupancy and transcripts, the predictions of both positive and negative cis-regulatory modules by gain-of-function cell transfection assays, and the role of motifs implicated in occupancy by directed mutagenesis and in vivo binding assays. We will test whether the motif- constraint hypothesis for protein-occupied DNA segments involved in enhancement applies to transcription factors in addition to GATA-1, and we will conduct additional experiments probing deeper biological issues. This research will provide not only global insights into mechanisms and effects of gene regulation during erythroid maturation, but the techniques and analytical tools developed here can be applied to better understand the development and differentiation of any tissue.      PUBLIC HEALTH RELEVANCE: Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.           Project Narrative ""Global Predictions and Tests of Erythroid Regulation"" R01 DK065806 Proper regulation of gene expression is essential to the normal development and health of organisms, whereas aberrant gene regulation can cause genetic diseases, and it appears to be a major contributor to susceptibility to common diseases. Understanding the molecular mechanisms of gene regulation may provide novel candidates for therapeutic interventions. Our studies collecting genome-wide data on many biochemical features associated with gene regulation, mining the data deeply to predict functional DNA sequences, and experimentally testing those bioinformatic predictions will provide global insights into mechanisms and effects of gene regulation during erythroid maturation and provide techniques and analytical tools to better understand the development and differentiation of any tissue.",Global Predictions and Tests of Erythroid Regulation,7654891,R01DK065806,"['Affinity', 'Algorithms', 'Anemia', 'Binding', 'Binding Sites', 'Biochemical', 'Bioinformatics', 'Biological', 'Biological Assay', 'Biological Models', 'Biological Preservation', 'Biological Process', 'Biological Testing', 'Cell model', 'Cells', 'Characteristics', 'Chromatin', 'Code', 'Complement', 'Complex', 'Computer software', 'Critical Pathways', 'DNA', 'DNA Resequencing', 'DNA Sequence', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Developmental Biology', 'Disease', 'Distal', 'Enhancers', 'Erythrocytes', 'Erythroid', 'Erythroid Cells', 'Erythroid Progenitor Cells', 'Erythropoiesis', 'Evolution', 'Gene Activation', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Health', 'Hereditary Disease', 'Histones', 'Inherited', 'Investigation', 'Location', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Mining', 'Modeling', 'Modification', 'Molecular', 'Mus', 'Mutagenesis', 'Nucleosomes', 'Organism', 'Pattern', 'Phenotype', 'Phylogenetic Analysis', 'Predisposition', 'Process', 'Property', 'Proteins', 'Recording of previous events', 'Regulation', 'Reporter Genes', 'Repression', 'Research', 'Resolution', 'Reverse Transcriptase Polymerase Chain Reaction', 'Role', 'Sensitivity and Specificity', 'Sequence Alignment', 'Signal Transduction', 'Site', 'Solid', 'Stream', 'Structure', 'Techniques', 'Technology', 'Testing', 'Therapeutic Intervention', 'Tissues', 'Transcript', 'Transfection', 'analytical tool', 'chromatin immunoprecipitation', 'computerized data processing', 'data acquisition', 'data mining', 'density', 'gain of function', 'genome-wide', 'histone modification', 'human GATA1 protein', 'improved', 'in vivo', 'insight', 'novel', 'promoter', 'public health relevance', 'research study', 'restoration', 'software development', 'success', 'tool', 'transcription factor']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2009,706720,0.09750769875600365
"Genomic Reconstruction of Yeast Transcription Networks DESCRIPTION (provided by applicant): Organisms devote a significant fraction of their genomes to encoding regulatory information which specifies when and where different genes should be turned on or off. Such information is essential for understanding development, tissue specificity, and cellular response to the environment and has great importance for understanding the molecular basis of disease. The one dimensional regulatory programs encoded in DNA are executed by transcription factors which respond to different conditions and regulate gene expression combinatorially, leading to complex regulatory networks. The goal of the proposed research is to develop theoretical models and computational algorithms to decipher the regulatory programs and to reconstruct the transcription networks in the model organism Saccharomyces cerevisiae. The following are the specific aims: 1) to systematically map the DNA recognition sites and target genes of transcription factors in the genome, 2) to identify environmental and genetic perturbations under which each transcription factor is activated or deactivated, 3) to systematically analyze combinatorial regulation by multiple transcription factors, 4) collaborate with two experimental labs to address specific problems of transcriptional regulation and combinatorial control, and 5) to build databases and online tools for the biological community to analyze gene expression data and transcriptional regulation. We will develop methods integrating information from the genome sequences for several yeast species and genome-wide functional data, and we will combine bioinformatics analysis with mechanistic models of gene regulation. n/a",Genomic Reconstruction of Yeast Transcription Networks,7031547,R01GM070808,"['Saccharomyces cerevisiae', 'artificial intelligence', 'binding sites', 'chemical binding', 'chromatin immunoprecipitation', 'combinatorial chemistry', 'fungal genetics', 'genetic mapping', 'genetic models', 'genetic regulation', 'genetic transcription', 'mathematical model', 'microarray technology', 'model design /development', 'molecular biology information system', 'transcription factor']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,2006,261699,0.1468519010625848
"Genomic Reconstruction of Yeast Transcription Networks DESCRIPTION (provided by applicant): Organisms devote a significant fraction of their genomes to encoding regulatory information which specifies when and where different genes should be turned on or off. Such information is essential for understanding development, tissue specificity, and cellular response to the environment and has great importance for understanding the molecular basis of disease. The one dimensional regulatory programs encoded in DNA are executed by transcription factors which respond to different conditions and regulate gene expression combinatorially, leading to complex regulatory networks. The goal of the proposed research is to develop theoretical models and computational algorithms to decipher the regulatory programs and to reconstruct the transcription networks in the model organism Saccharomyces cerevisiae. The following are the specific aims: 1) to systematically map the DNA recognition sites and target genes of transcription factors in the genome, 2) to identify environmental and genetic perturbations under which each transcription factor is activated or deactivated, 3) to systematically analyze combinatorial regulation by multiple transcription factors, 4) collaborate with two experimental labs to address specific problems of transcriptional regulation and combinatorial control, and 5) to build databases and online tools for the biological community to analyze gene expression data and transcriptional regulation. We will develop methods integrating information from the genome sequences for several yeast species and genome-wide functional data, and we will combine bioinformatics analysis with mechanistic models of gene regulation. n/a",Genomic Reconstruction of Yeast Transcription Networks,6877057,R01GM070808,"['Saccharomyces cerevisiae', 'artificial intelligence', 'binding sites', 'chemical binding', 'chromatin immunoprecipitation', 'combinatorial chemistry', 'fungal genetics', 'genetic mapping', 'genetic models', 'genetic regulation', 'genetic transcription', 'mathematical model', 'microarray technology', 'model design /development', 'molecular biology information system', 'transcription factor']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,2005,268134,0.1468519010625848
"Genomic Reconstruction of Yeast Transcription Networks DESCRIPTION (provided by applicant): Organisms devote a significant fraction of their genomes to encoding regulatory information which specifies when and where different genes should be turned on or off. Such information is essential for understanding development, tissue specificity, and cellular response to the environment and has great importance for understanding the molecular basis of disease. The one dimensional regulatory programs encoded in DNA are executed by transcription factors which respond to different conditions and regulate gene expression combinatorially, leading to complex regulatory networks. The goal of the proposed research is to develop theoretical models and computational algorithms to decipher the regulatory programs and to reconstruct the transcription networks in the model organism Saccharomyces cerevisiae. The following are the specific aims: 1) to systematically map the DNA recognition sites and target genes of transcription factors in the genome, 2) to identify environmental and genetic perturbations under which each transcription factor is activated or deactivated, 3) to systematically analyze combinatorial regulation by multiple transcription factors, 4) collaborate with two experimental labs to address specific problems of transcriptional regulation and combinatorial control, and 5) to build databases and online tools for the biological community to analyze gene expression data and transcriptional regulation. We will develop methods integrating information from the genome sequences for several yeast species and genome-wide functional data, and we will combine bioinformatics analysis with mechanistic models of gene regulation. n/a",Genomic Reconstruction of Yeast Transcription Networks,6754662,R01GM070808,"['Saccharomyces cerevisiae', 'artificial intelligence', 'binding sites', 'chemical binding', 'chromatin immunoprecipitation', 'combinatorial chemistry', 'fungal genetics', 'genetic mapping', 'genetic models', 'genetic regulation', 'genetic transcription', 'mathematical model', 'microarray technology', 'model design /development', 'molecular biology information system', 'transcription factor']",NIGMS,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,R01,2004,268267,0.1468519010625848
"Gene Regulation E. coli Database Integrated Modeling    DESCRIPTION (provided by applicant):  The Center for Genomic Sciences of the National Autonomous University of Mexico (UNAM) in Cuernavaca and a group of collaborators propose to further develop and enrich the RegulonDB database. RegulonDB contains the largest electronically-available regulatory network of any living organism, that of Escherichia coli K-12. In the project we will expand the design, implement computational and conceptual models, and generate annotations derived from original literature of the different components of the regulatory network. We will experimentally map promoters and transcription units under different conditions. This project expands a previous grant supporting RegulonDB. High quality manual curation is to be enriched beyond transcription initiation to include signal-transduction connecting sensing with regulation, as well as with natural language text processing tools. We propose to continue an exhaustive experimental mapping of all possible transcription initiation sites in the genome and to perform an exhaustive experimental identification of transcription units in different conditions. The core of RegulonDB (literature-based network and the graphic and browsing tools) will be linked and made accessible, as optional user selections, with high-throughput available experiments (microarrays and ChIP- chip) both as raw and pre-analyzed data, as well as with collections of computational predictions of all network elements (transcription factors, promoters, binding sites, operons, regulatory interactions). This will be based on track representations and compliant with international consortia normalized pathway exchange formats. The openness of RegulonDB data and internal structure will expand considerably, enhancing as well its availability to tools for analysis and representation. PUBLIC HEALTH RELEVANCE:  RegulonDB is a gold standard both in its conceptual and computational design, as well as in the amount and quality of data gathered on the largest and best characterized regulatory network of a single organism. The improvements and expansion of RegulonDB may accelerate research in other bacterial models, including pathogens. RegulonDB has served as a benchmark for a variety of computational predictive tools for components of the network. Furthermore, E.coli is at the forefront in systems biology as a proof-of-concept biological model to develop new methodologies in bioinformatics, representation and simulation, to overcome challenges in order to model and understand the functioning of a whole cell.          n/a",Gene Regulation E. coli Database Integrated Modeling,8127813,R01GM071962,"['Affect', 'Area', 'Bacteria', 'Bacterial Model', 'Benchmarking', 'Binding Sites', 'Bioinformatics', 'Biological Models', 'Biotechnology', 'Boston', 'Cells', 'Classification', 'Collaborations', 'Collection', 'Complex', 'Computer Simulation', 'Data', 'Data Analyses', 'Data Quality', 'Data Set', 'Databases', 'Elements', 'Escherichia coli', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genome Mappings', 'Genomics', 'Gold', 'Grant', 'Growth', 'Health', 'Institutes', 'International', 'Knowledge', 'Life', 'Link', 'Literature', 'Manuals', 'Maps', 'Metabolism', 'Methodology', 'Methods', 'Mexico', 'Modeling', 'Natural Language Processing', 'Network-based', 'Ontology', 'Operon', 'Organism', 'Outcome', 'Pathway interactions', 'Physiology', 'Process', 'Publications', 'Regulation', 'Regulon', 'Research', 'Science', 'Sigma Factor', 'Signal Transduction', 'Small RNA', 'Structure', 'System', 'Systems Biology', 'Text', 'Transcription Initiation', 'Transcription Initiation Site', 'Transduction Gene', 'Universities', 'Work', 'base', 'biological research', 'data exchange', 'design', 'improved', 'interest', 'mutant', 'natural language', 'novel', 'pathogen', 'promoter', 'protein protein interaction', 'reconstruction', 'relational database', 'research study', 'sensor', 'simulation', 'text searching', 'tool', 'transcription factor', 'web services']",NIGMS,CENTER FOR GENOMIC SCIENCES,R01,2011,382052,0.07215206663639542
"Gene Regulation E. coli Database Integrated Modeling    DESCRIPTION (provided by applicant):  The Center for Genomic Sciences of the National Autonomous University of Mexico (UNAM) in Cuernavaca and a group of collaborators propose to further develop and enrich the RegulonDB database. RegulonDB contains the largest electronically-available regulatory network of any living organism, that of Escherichia coli K-12. In the project we will expand the design, implement computational and conceptual models, and generate annotations derived from original literature of the different components of the regulatory network. We will experimentally map promoters and transcription units under different conditions. This project expands a previous grant supporting RegulonDB. High quality manual curation is to be enriched beyond transcription initiation to include signal-transduction connecting sensing with regulation, as well as with natural language text processing tools. We propose to continue an exhaustive experimental mapping of all possible transcription initiation sites in the genome and to perform an exhaustive experimental identification of transcription units in different conditions. The core of RegulonDB (literature-based network and the graphic and browsing tools) will be linked and made accessible, as optional user selections, with high-throughput available experiments (microarrays and ChIP- chip) both as raw and pre-analyzed data, as well as with collections of computational predictions of all network elements (transcription factors, promoters, binding sites, operons, regulatory interactions). This will be based on track representations and compliant with international consortia normalized pathway exchange formats. The openness of RegulonDB data and internal structure will expand considerably, enhancing as well its availability to tools for analysis and representation. PUBLIC HEALTH RELEVANCE:  RegulonDB is a gold standard both in its conceptual and computational design, as well as in the amount and quality of data gathered on the largest and best characterized regulatory network of a single organism. The improvements and expansion of RegulonDB may accelerate research in other bacterial models, including pathogens. RegulonDB has served as a benchmark for a variety of computational predictive tools for components of the network. Furthermore, E.coli is at the forefront in systems biology as a proof-of-concept biological model to develop new methodologies in bioinformatics, representation and simulation, to overcome challenges in order to model and understand the functioning of a whole cell.          n/a",Gene Regulation E. coli Database Integrated Modeling,7924775,R01GM071962,"['Affect', 'Area', 'Bacteria', 'Bacterial Model', 'Benchmarking', 'Binding Sites', 'Bioinformatics', 'Biological Models', 'Biotechnology', 'Boston', 'Cells', 'Classification', 'Collaborations', 'Collection', 'Complex', 'Computer Simulation', 'Data', 'Data Analyses', 'Data Quality', 'Data Set', 'Databases', 'Elements', 'Escherichia coli', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genome Mappings', 'Genomics', 'Gold', 'Grant', 'Growth', 'Institutes', 'International', 'Internet', 'Knowledge', 'Life', 'Link', 'Literature', 'Manuals', 'Maps', 'Metabolism', 'Methodology', 'Methods', 'Mexico', 'Modeling', 'Natural Language Processing', 'Network-based', 'Ontology', 'Operon', 'Organism', 'Outcome', 'Pathway interactions', 'Physiology', 'Process', 'Publications', 'Regulation', 'Regulon', 'Research', 'Science', 'Services', 'Sigma Factor', 'Signal Transduction', 'Small RNA', 'Structure', 'System', 'Systems Biology', 'Text', 'Transcription Initiation', 'Transcription Initiation Site', 'Transduction Gene', 'Universities', 'Work', 'base', 'biological research', 'data exchange', 'design', 'improved', 'interest', 'mutant', 'natural language', 'novel', 'pathogen', 'promoter', 'protein protein interaction', 'public health relevance', 'reconstruction', 'relational database', 'research study', 'sensor', 'simulation', 'text searching', 'tool', 'transcription factor']",NIGMS,CENTER FOR GENOMIC SCIENCES,R01,2010,389654,0.07215206663639542
"Gene Regulation E. coli Database Integrated Modeling    DESCRIPTION (provided by applicant):  The Center for Genomic Sciences of the National Autonomous University of Mexico (UNAM) in Cuernavaca and a group of collaborators propose to further develop and enrich the RegulonDB database. RegulonDB contains the largest electronically-available regulatory network of any living organism, that of Escherichia coli K-12. In the project we will expand the design, implement computational and conceptual models, and generate annotations derived from original literature of the different components of the regulatory network. We will experimentally map promoters and transcription units under different conditions. This project expands a previous grant supporting RegulonDB. High quality manual curation is to be enriched beyond transcription initiation to include signal-transduction connecting sensing with regulation, as well as with natural language text processing tools. We propose to continue an exhaustive experimental mapping of all possible transcription initiation sites in the genome and to perform an exhaustive experimental identification of transcription units in different conditions. The core of RegulonDB (literature-based network and the graphic and browsing tools) will be linked and made accessible, as optional user selections, with high-throughput available experiments (microarrays and ChIP- chip) both as raw and pre-analyzed data, as well as with collections of computational predictions of all network elements (transcription factors, promoters, binding sites, operons, regulatory interactions). This will be based on track representations and compliant with international consortia normalized pathway exchange formats. The openness of RegulonDB data and internal structure will expand considerably, enhancing as well its availability to tools for analysis and representation. PUBLIC HEALTH RELEVANCE:  RegulonDB is a gold standard both in its conceptual and computational design, as well as in the amount and quality of data gathered on the largest and best characterized regulatory network of a single organism. The improvements and expansion of RegulonDB may accelerate research in other bacterial models, including pathogens. RegulonDB has served as a benchmark for a variety of computational predictive tools for components of the network. Furthermore, E.coli is at the forefront in systems biology as a proof-of-concept biological model to develop new methodologies in bioinformatics, representation and simulation, to overcome challenges in order to model and understand the functioning of a whole cell.          n/a",Gene Regulation E. coli Database Integrated Modeling,7683918,R01GM071962,"['Affect', 'Area', 'Bacteria', 'Bacterial Model', 'Benchmarking', 'Binding Sites', 'Bioinformatics', 'Biological Models', 'Biotechnology', 'Boston', 'Cells', 'Classification', 'Collaborations', 'Collection', 'Complex', 'Computer Simulation', 'Data', 'Data Analyses', 'Data Quality', 'Data Set', 'Databases', 'Elements', 'Escherichia coli', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genome Mappings', 'Genomics', 'Gold', 'Grant', 'Growth', 'Institutes', 'International', 'Internet', 'Knowledge', 'Life', 'Link', 'Literature', 'Manuals', 'Maps', 'Metabolism', 'Methodology', 'Methods', 'Mexico', 'Modeling', 'Natural Language Processing', 'Network-based', 'Ontology', 'Operon', 'Organism', 'Outcome', 'Pathway interactions', 'Physiology', 'Process', 'Publications', 'Regulation', 'Regulon', 'Research', 'Science', 'Services', 'Sigma Factor', 'Signal Transduction', 'Small RNA', 'Structure', 'System', 'Systems Biology', 'Text', 'Transcription Initiation', 'Transcription Initiation Site', 'Transduction Gene', 'Universities', 'Work', 'base', 'biological research', 'data exchange', 'design', 'improved', 'interest', 'mutant', 'natural language', 'novel', 'pathogen', 'promoter', 'protein protein interaction', 'public health relevance', 'reconstruction', 'research study', 'sensor', 'simulation', 'text searching', 'tool', 'transcription factor']",NIGMS,CENTER FOR GENOMIC SCIENCES,R01,2009,400507,0.07215206663639542
"Gene Regulation E. coli Database Integrated Modeling    DESCRIPTION (provided by applicant):  The Center for Genomic Sciences of the National Autonomous University of Mexico (UNAM) in Cuernavaca and a group of collaborators propose to further develop and enrich the RegulonDB database. RegulonDB contains the largest electronically-available regulatory network of any living organism, that of Escherichia coli K-12. In the project we will expand the design, implement computational and conceptual models, and generate annotations derived from original literature of the different components of the regulatory network. We will experimentally map promoters and transcription units under different conditions. This project expands a previous grant supporting RegulonDB. High quality manual curation is to be enriched beyond transcription initiation to include signal-transduction connecting sensing with regulation, as well as with natural language text processing tools. We propose to continue an exhaustive experimental mapping of all possible transcription initiation sites in the genome and to perform an exhaustive experimental identification of transcription units in different conditions. The core of RegulonDB (literature-based network and the graphic and browsing tools) will be linked and made accessible, as optional user selections, with high-throughput available experiments (microarrays and ChIP- chip) both as raw and pre-analyzed data, as well as with collections of computational predictions of all network elements (transcription factors, promoters, binding sites, operons, regulatory interactions). This will be based on track representations and compliant with international consortia normalized pathway exchange formats. The openness of RegulonDB data and internal structure will expand considerably, enhancing as well its availability to tools for analysis and representation. PUBLIC HEALTH RELEVANCE:  RegulonDB is a gold standard both in its conceptual and computational design, as well as in the amount and quality of data gathered on the largest and best characterized regulatory network of a single organism. The improvements and expansion of RegulonDB may accelerate research in other bacterial models, including pathogens. RegulonDB has served as a benchmark for a variety of computational predictive tools for components of the network. Furthermore, E.coli is at the forefront in systems biology as a proof-of-concept biological model to develop new methodologies in bioinformatics, representation and simulation, to overcome challenges in order to model and understand the functioning of a whole cell.          n/a",Gene Regulation E. coli Database Integrated Modeling,7526482,R01GM071962,"['Affect', 'Area', 'Bacteria', 'Bacterial Model', 'Benchmarking', 'Binding Sites', 'Bioinformatics', 'Biological Models', 'Biotechnology', 'Boston', 'Cells', 'Classification', 'Collaborations', 'Collection', 'Complex', 'Computer Simulation', 'Condition', 'Data', 'Data Analyses', 'Data Quality', 'Data Set', 'Databases', 'Elements', 'Escherichia coli', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genome Mappings', 'Genomics', 'Gold', 'Grant', 'Growth', 'Institutes', 'International', 'Internet', 'Knowledge', 'Language', 'Life', 'Link', 'Literature', 'Manuals', 'Maps', 'Metabolism', 'Methodology', 'Methods', 'Mexico', 'Modeling', 'Natural Language Processing', 'Network-based', 'Numbers', 'Ontology', 'Operon', 'Organism', 'Outcome', 'Pathway interactions', 'Physiology', 'Process', 'Public Health', 'Publications', 'Regulation', 'Regulon', 'Research', 'Science', 'Services', 'Sigma Factor', 'Signal Transduction', 'Small RNA', 'Standards of Weights and Measures', 'Statistically Significant', 'Structure', 'System', 'Systems Biology', 'Text', 'Transcription Initiation', 'Transcription Initiation Site', 'Transduction Gene', 'Universities', 'Work', 'base', 'biological research', 'concept', 'design', 'improved', 'interest', 'mutant', 'novel', 'pathogen', 'promoter', 'protein protein interaction', 'reconstruction', 'research study', 'sensor', 'simulation', 'text searching', 'tool', 'transcription factor']",NIGMS,CENTER FOR GENOMIC SCIENCES,R01,2008,408032,0.07215206663639542
"Interrogation of systems level mechanisms controlling DNA repair processes    DESCRIPTION (provided by applicant): A comprehensive model of a complete biological system will enable prediction of phenotypic outcomes in face of novel genetic and environmental perturbations. Such predictive power for cellular systems, such as DMA repair, will have tremendous impacts on early detection and diagnosis of genetic disorders and, ultimately in designing preventive and/or curative treatments. However, the full understanding of eukaryotic DMA repair systems presents a daunting challenge due to their enormous complexity, especially given that systems approaches are not yet sufficiently mature to mathematically model such complex processes. At a molecular level, eukaryotic genetic information processing is mirrored in a simplified manner by their evolutionary ancestors, the archaea. In Halobacterium NRC-1 we have a simple yet powerful model system of -2400 genes in which the underlying generalized principles of a systems approach can be delineated. This halophilic archaeon routinely mitigates damage from high salinity, UV radiation and desiccation-rehydration cycles. We will use this model system to address the hypothesis that the decision making process governing cell fate after exposure to DMA damaging events such as UV irradiation is mediated by robust gene regulatory networks that simultaneously process information on spectral characteristics of the impinging radiation, the nature and extent of DMA damage and the potential preparative role of cellular entrainment to diurnal cycles. This hypothesis is motivated by two main observations: a. in systems analysis of UV response, although extraordinarily resistant, not all expected repair genes in this microbe responded to irradiation or damage; b. many of these damage-unresponsive repair genes did, however, respond to day-night entrainment. At a fundamental level this suggested that the resident state of the cell at time of irradiation may influence the type of response elicited. A systems approach is ideally suited to delinate the networks underlying this decision making process. Specifically, we will measure dynamic global changes (degree of damage, mRNA /protein levels, protein-protein and protein-DNA interactions) in wild type and mutant strains (defective in sensors, signal transducers, regulators and repair proteins) subjected to combinatorial changes in incident radiation, type of damage inflicted and resident state of the cell at the time of radiation. Through an integrated analysis of these diverse systems level data we will statistically learn perturbation-induced rewiring of a gene regulatory network that processes environmental perturbations (input) into phenotype (output), i.e. a predictive model for regulatory mechanisms for repair. This basic model will serve as a template for designing systems approaches to model higher complexities of eukaryotic repair processes.           n/a",Interrogation of systems level mechanisms controlling DNA repair processes,7896417,R01GM077398,"['Address', 'Algorithms', 'Animal Model', 'Archaea', 'Architecture', 'Behavior', 'Biological', 'Biological Assay', 'Biological Models', 'Biology', 'Candidate Disease Gene', 'Cell Cycle Progression', 'Cell Size', 'Cell Survival', 'Cell physiology', 'Cells', 'Characteristics', 'Chromosomes, Human, Pair 4', 'Circadian Rhythms', 'Complex', 'Coupled', 'DNA', 'DNA Damage', 'DNA Repair', 'DNA Repair Gene', 'DNA Repair Pathway', 'DNA biosynthesis', 'DNA lesion', 'DNA repair protein', 'DNA-Protein Interaction', 'Data', 'Decision Making', 'Desiccation', 'Disease', 'Early Diagnosis', 'Elements', 'Engineering', 'Environment', 'Epitopes', 'Equilibrium', 'Event', 'Exogenous Factors', 'Exposure to', 'Face', 'Gene Proteins', 'Genes', 'Genetic', 'Genetic Information Processing Pathway', 'Genetic Transcription', 'Genome', 'Global Change', 'Halobacterium', 'Heart', 'Hour', 'Human', 'Lead', 'Learning', 'Life', 'Light', 'Machine Learning', 'Maps', 'Measures', 'Mediating', 'Messenger RNA', 'Metabolism', 'Microbe', 'Modeling', 'Molecular', 'Mutation', 'Nature', 'Nucleotide Excision Repair', 'Organism', 'Outcome', 'Output', 'Oxidative Stress', 'Pathway interactions', 'Phenotype', 'Physiological Processes', 'Physiology', 'Preventive', 'Process', 'Protein Dynamics', 'Proteins', 'Radiation', 'Readiness', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Rehydrations', 'Resistance', 'Resources', 'Role', 'Signal Transduction', 'Skin Cancer', 'Source', 'Specific qualifier value', 'System', 'Systems Analysis', 'Systems Biology', 'Technology', 'Tertiary Protein Structure', 'Time', 'Transcript', 'Transducers', 'Translations', 'UV response', 'Ultraviolet Rays', 'biological research', 'biological systems', 'cell type', 'combinatorial', 'coping', 'cryptochrome', 'design', 'gene repair', 'genetic disorder diagnosis', 'halobacteria', 'information processing', 'interest', 'irradiation', 'knockout gene', 'mathematical model', 'mutant', 'novel', 'operation', 'predictive modeling', 'repaired', 'response', 'segregation', 'sensor', 'technology development', 'trait', 'ultraviolet damage', 'ultraviolet irradiation']",NIGMS,INSTITUTE FOR SYSTEMS BIOLOGY,R01,2010,332561,0.030418830233945073
"Interrogation of systems level mechanisms controlling DNA repair processes    DESCRIPTION (provided by applicant): A comprehensive model of a complete biological system will enable prediction of phenotypic outcomes in face of novel genetic and environmental perturbations. Such predictive power for cellular systems, such as DMA repair, will have tremendous impacts on early detection and diagnosis of genetic disorders and, ultimately in designing preventive and/or curative treatments. However, the full understanding of eukaryotic DMA repair systems presents a daunting challenge due to their enormous complexity, especially given that systems approaches are not yet sufficiently mature to mathematically model such complex processes. At a molecular level, eukaryotic genetic information processing is mirrored in a simplified manner by their evolutionary ancestors, the archaea. In Halobacterium NRC-1 we have a simple yet powerful model system of -2400 genes in which the underlying generalized principles of a systems approach can be delineated. This halophilic archaeon routinely mitigates damage from high salinity, UV radiation and desiccation-rehydration cycles. We will use this model system to address the hypothesis that the decision making process governing cell fate after exposure to DMA damaging events such as UV irradiation is mediated by robust gene regulatory networks that simultaneously process information on spectral characteristics of the impinging radiation, the nature and extent of DMA damage and the potential preparative role of cellular entrainment to diurnal cycles. This hypothesis is motivated by two main observations: a. in systems analysis of UV response, although extraordinarily resistant, not all expected repair genes in this microbe responded to irradiation or damage; b. many of these damage-unresponsive repair genes did, however, respond to day-night entrainment. At a fundamental level this suggested that the resident state of the cell at time of irradiation may influence the type of response elicited. A systems approach is ideally suited to delinate the networks underlying this decision making process. Specifically, we will measure dynamic global changes (degree of damage, mRNA /protein levels, protein-protein and protein-DNA interactions) in wild type and mutant strains (defective in sensors, signal transducers, regulators and repair proteins) subjected to combinatorial changes in incident radiation, type of damage inflicted and resident state of the cell at the time of radiation. Through an integrated analysis of these diverse systems level data we will statistically learn perturbation-induced rewiring of a gene regulatory network that processes environmental perturbations (input) into phenotype (output), i.e. a predictive model for regulatory mechanisms for repair. This basic model will serve as a template for designing systems approaches to model higher complexities of eukaryotic repair processes.           n/a",Interrogation of systems level mechanisms controlling DNA repair processes,7646234,R01GM077398,"['Address', 'Algorithms', 'Animal Model', 'Archaea', 'Architecture', 'Behavior', 'Biological', 'Biological Assay', 'Biological Models', 'Biology', 'Candidate Disease Gene', 'Cell Cycle Progression', 'Cell Size', 'Cell Survival', 'Cell physiology', 'Cells', 'Characteristics', 'Chromosomes, Human, Pair 4', 'Circadian Rhythms', 'Complex', 'Coupled', 'DNA', 'DNA Damage', 'DNA Repair', 'DNA Repair Gene', 'DNA Repair Pathway', 'DNA biosynthesis', 'DNA lesion', 'DNA repair protein', 'DNA-Protein Interaction', 'Data', 'Decision Making', 'Desiccation', 'Disease', 'Early Diagnosis', 'Elements', 'Engineering', 'Environment', 'Epitopes', 'Equilibrium', 'Event', 'Exogenous Factors', 'Exposure to', 'Face', 'Gene Proteins', 'Genes', 'Genetic', 'Genetic Information Processing Pathway', 'Genetic Transcription', 'Genome', 'Global Change', 'Halobacterium', 'Heart', 'Hour', 'Human', 'Lead', 'Learning', 'Life', 'Light', 'Machine Learning', 'Maps', 'Measures', 'Mediating', 'Messenger RNA', 'Metabolism', 'Microbe', 'Modeling', 'Molecular', 'Mutation', 'Nature', 'Nucleotide Excision Repair', 'Operative Surgical Procedures', 'Organism', 'Outcome', 'Output', 'Oxidative Stress', 'Pathway interactions', 'Phenotype', 'Physiological Processes', 'Physiology', 'Preventive', 'Process', 'Protein Dynamics', 'Proteins', 'Radiation', 'Readiness', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Rehydrations', 'Resistance', 'Resources', 'Role', 'Signal Transduction', 'Skin Cancer', 'Source', 'Specific qualifier value', 'System', 'Systems Analysis', 'Systems Biology', 'Technology', 'Tertiary Protein Structure', 'Time', 'Transcript', 'Transducers', 'Translations', 'UV response', 'Ultraviolet Rays', 'biological research', 'biological systems', 'cell type', 'combinatorial', 'coping', 'cryptochrome', 'design', 'gene repair', 'genetic disorder diagnosis', 'halobacteria', 'information processing', 'interest', 'irradiation', 'knockout gene', 'mathematical model', 'mutant', 'novel', 'predictive modeling', 'repaired', 'response', 'segregation', 'sensor', 'technology development', 'trait', 'ultraviolet damage', 'ultraviolet irradiation']",NIGMS,INSTITUTE FOR SYSTEMS BIOLOGY,R01,2009,335920,0.030418830233945073
"Interrogation of systems level mechanisms controlling DNA repair processes    DESCRIPTION (provided by applicant): A comprehensive model of a complete biological system will enable prediction of phenotypic outcomes in face of novel genetic and environmental perturbations. Such predictive power for cellular systems, such as DMA repair, will have tremendous impacts on early detection and diagnosis of genetic disorders and, ultimately in designing preventive and/or curative treatments. However, the full understanding of eukaryotic DMA repair systems presents a daunting challenge due to their enormous complexity, especially given that systems approaches are not yet sufficiently mature to mathematically model such complex processes. At a molecular level, eukaryotic genetic information processing is mirrored in a simplified manner by their evolutionary ancestors, the archaea. In Halobacterium NRC-1 we have a simple yet powerful model system of -2400 genes in which the underlying generalized principles of a systems approach can be delineated. This halophilic archaeon routinely mitigates damage from high salinity, UV radiation and desiccation-rehydration cycles. We will use this model system to address the hypothesis that the decision making process governing cell fate after exposure to DMA damaging events such as UV irradiation is mediated by robust gene regulatory networks that simultaneously process information on spectral characteristics of the impinging radiation, the nature and extent of DMA damage and the potential preparative role of cellular entrainment to diurnal cycles. This hypothesis is motivated by two main observations: a. in systems analysis of UV response, although extraordinarily resistant, not all expected repair genes in this microbe responded to irradiation or damage; b. many of these damage-unresponsive repair genes did, however, respond to day-night entrainment. At a fundamental level this suggested that the resident state of the cell at time of irradiation may influence the type of response elicited. A systems approach is ideally suited to delinate the networks underlying this decision making process. Specifically, we will measure dynamic global changes (degree of damage, mRNA /protein levels, protein-protein and protein-DNA interactions) in wild type and mutant strains (defective in sensors, signal transducers, regulators and repair proteins) subjected to combinatorial changes in incident radiation, type of damage inflicted and resident state of the cell at the time of radiation. Through an integrated analysis of these diverse systems level data we will statistically learn perturbation-induced rewiring of a gene regulatory network that processes environmental perturbations (input) into phenotype (output), i.e. a predictive model for regulatory mechanisms for repair. This basic model will serve as a template for designing systems approaches to model higher complexities of eukaryotic repair processes.           n/a",Interrogation of systems level mechanisms controlling DNA repair processes,7473118,R01GM077398,"['Address', 'Algorithms', 'Animal Model', 'Archaea', 'Architecture', 'Behavior', 'Biological', 'Biological Assay', 'Biological Models', 'Biology', 'Candidate Disease Gene', 'Cell Cycle Progression', 'Cell Size', 'Cell Survival', 'Cell physiology', 'Cells', 'Characteristics', 'Chromosomes, Human, Pair 4', 'Circadian Rhythms', 'Complex', 'Computer information processing', 'Condition', 'Coupled', 'DNA', 'DNA Damage', 'DNA Repair', 'DNA Repair Gene', 'DNA Repair Pathway', 'DNA biosynthesis', 'DNA lesion', 'DNA repair protein', 'DNA-Protein Interaction', 'Data', 'Decision Making', 'Desiccation', 'Disease', 'Early Diagnosis', 'Elements', 'Engineering', 'Environment', 'Epitopes', 'Equilibrium', 'Event', 'Exogenous Factors', 'Exposure to', 'Face', 'Gene Proteins', 'Genes', 'Genetic', 'Genetic Information Processing Pathway', 'Genetic Transcription', 'Genome', 'Global Change', 'Halobacterium', 'Heart', 'Hour', 'Human', 'Lead', 'Learning', 'Life', 'Light', 'Machine Learning', 'Maps', 'Measures', 'Mediating', 'Messenger RNA', 'Metabolism', 'Microbe', 'Modeling', 'Molecular', 'Mutation', 'Nature', 'Nucleotide Excision Repair', 'Numbers', 'Operative Surgical Procedures', 'Organism', 'Outcome', 'Output', 'Oxidative Stress', 'Pathway interactions', 'Phenotype', 'Physiological Processes', 'Physiology', 'Preventive', 'Process', 'Protein Dynamics', 'Proteins', 'Radiation', 'Readiness', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Rehydrations', 'Resistance', 'Resources', 'Role', 'Signal Transduction', 'Skin Cancer', 'Source', 'Specific qualifier value', 'System', 'Systems Analysis', 'Systems Biology', 'Technology', 'Tertiary Protein Structure', 'Time', 'Transcript', 'Transducers', 'Translations', 'UV response', 'Ultraviolet Rays', 'biological research', 'cell type', 'combinatorial', 'coping', 'cryptochrome', 'day', 'design', 'gene repair', 'genetic disorder diagnosis', 'halobacteria', 'interest', 'irradiation', 'knockout gene', 'mathematical model', 'mutant', 'novel', 'predictive modeling', 'repaired', 'response', 'segregation', 'sensor', 'technology development', 'trait', 'ultraviolet damage', 'ultraviolet irradiation']",NIGMS,INSTITUTE FOR SYSTEMS BIOLOGY,R01,2008,335920,0.030418830233945073
"Interrogation of systems level mechanisms controlling DNA repair processes    DESCRIPTION (provided by applicant): A comprehensive model of a complete biological system will enable prediction of phenotypic outcomes in face of novel genetic and environmental perturbations. Such predictive power for cellular systems, such as DMA repair, will have tremendous impacts on early detection and diagnosis of genetic disorders and, ultimately in designing preventive and/or curative treatments. However, the full understanding of eukaryotic DMA repair systems presents a daunting challenge due to their enormous complexity, especially given that systems approaches are not yet sufficiently mature to mathematically model such complex processes. At a molecular level, eukaryotic genetic information processing is mirrored in a simplified manner by their evolutionary ancestors, the archaea. In Halobacterium NRC-1 we have a simple yet powerful model system of -2400 genes in which the underlying generalized principles of a systems approach can be delineated. This halophilic archaeon routinely mitigates damage from high salinity, UV radiation and desiccation-rehydration cycles. We will use this model system to address the hypothesis that the decision making process governing cell fate after exposure to DMA damaging events such as UV irradiation is mediated by robust gene regulatory networks that simultaneously process information on spectral characteristics of the impinging radiation, the nature and extent of DMA damage and the potential preparative role of cellular entrainment to diurnal cycles. This hypothesis is motivated by two main observations: a. in systems analysis of UV response, although extraordinarily resistant, not all expected repair genes in this microbe responded to irradiation or damage; b. many of these damage-unresponsive repair genes did, however, respond to day-night entrainment. At a fundamental level this suggested that the resident state of the cell at time of irradiation may influence the type of response elicited. A systems approach is ideally suited to delinate the networks underlying this decision making process. Specifically, we will measure dynamic global changes (degree of damage, mRNA /protein levels, protein-protein and protein-DNA interactions) in wild type and mutant strains (defective in sensors, signal transducers, regulators and repair proteins) subjected to combinatorial changes in incident radiation, type of damage inflicted and resident state of the cell at the time of radiation. Through an integrated analysis of these diverse systems level data we will statistically learn perturbation-induced rewiring of a gene regulatory network that processes environmental perturbations (input) into phenotype (output), i.e. a predictive model for regulatory mechanisms for repair. This basic model will serve as a template for designing systems approaches to model higher complexities of eukaryotic repair processes.           n/a",Interrogation of systems level mechanisms controlling DNA repair processes,7317856,R01GM077398,"['Address', 'Algorithms', 'Animal Model', 'Archaea', 'Architecture', 'Behavior', 'Biological', 'Biological Assay', 'Biological Models', 'Biology', 'Candidate Disease Gene', 'Cell Cycle Progression', 'Cell Size', 'Cell Survival', 'Cell physiology', 'Cells', 'Characteristics', 'Chromosomes, Human, Pair 4', 'Circadian Rhythms', 'Complex', 'Computer information processing', 'Condition', 'Coupled', 'DNA', 'DNA Damage', 'DNA Repair', 'DNA Repair Gene', 'DNA Repair Pathway', 'DNA biosynthesis', 'DNA lesion', 'DNA repair protein', 'DNA-Protein Interaction', 'Data', 'Decision Making', 'Desiccation', 'Disease', 'Early Diagnosis', 'Elements', 'Engineering', 'Environment', 'Epitopes', 'Equilibrium', 'Event', 'Exogenous Factors', 'Exposure to', 'Face', 'Gene Proteins', 'Genes', 'Genetic', 'Genetic Information Processing Pathway', 'Genetic Transcription', 'Genome', 'Global Change', 'Halobacterium', 'Heart', 'Hour', 'Human', 'Lead', 'Learning', 'Life', 'Light', 'Machine Learning', 'Maps', 'Measures', 'Mediating', 'Messenger RNA', 'Metabolism', 'Microbe', 'Modeling', 'Molecular', 'Mutation', 'Nature', 'Nucleotide Excision Repair', 'Numbers', 'Operative Surgical Procedures', 'Organism', 'Outcome', 'Output', 'Oxidative Stress', 'Pathway interactions', 'Phenotype', 'Physiological Processes', 'Physiology', 'Preventive', 'Process', 'Protein Dynamics', 'Proteins', 'Radiation', 'Readiness', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Rehydrations', 'Resistance', 'Resources', 'Role', 'Signal Transduction', 'Skin Cancer', 'Source', 'Specific qualifier value', 'System', 'Systems Analysis', 'Systems Biology', 'Technology', 'Tertiary Protein Structure', 'Time', 'Transcript', 'Transducers', 'Translations', 'UV response', 'Ultraviolet Rays', 'biological research', 'cell type', 'combinatorial', 'coping', 'cryptochrome', 'day', 'design', 'gene repair', 'genetic disorder diagnosis', 'halobacteria', 'interest', 'irradiation', 'knockout gene', 'mathematical model', 'mutant', 'novel', 'predictive modeling', 'repaired', 'response', 'segregation', 'sensor', 'technology development', 'trait', 'ultraviolet damage', 'ultraviolet irradiation']",NIGMS,INSTITUTE FOR SYSTEMS BIOLOGY,R01,2007,335920,0.030418830233945073
"Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks    DESCRIPTION (provided by applicant): Improved understanding of disease mechanisms and drug target identification requires better understanding of how diseases alter cellular processes from the healthy state. Our group has developed an integrative pathway search algorithm that reconstructs networks of active pathways from gene expression and phenotypic profiles. Preliminary studies illustrate that this framework is able to reconstruct networks that include those pathways that should be altered, and how they should be altered, to obtain a desired phenotype. Nevertheless, the current framework may not fully capture transients, such as cycles and feedback loops. Furthermore, cells continuously reprogram gene regulatory networks as they sense changes in their environment. To understand how cells are regulated in response to environmental alterations, time series (i.e., dynamic) data are required. Correspondingly, a dynamic model is required to uncover the mechanisms from time series data. We hypothesize that incorporating domain knowledge and metabolic data into a dynamic model would enhance the accuracy of the genes chosen and in turn improve the prediction of the reconstructed networks. Unlike previous studies that have focused on using the gene ontology information, we propose to incorporate domain knowledge retrieved from the free text. This is significant because a large portion of the genes do not have gene ontological keywords. Additionally, it is often difficult to assess the accuracy of the network structures that have been inferred from experimental data because the underlying ""true"" regulatory network is unknown or unavailable a priori. Therefore, one needs to have a known network structure that can be used to optimize and evaluate the modeling frameworks. Once so optimized, the static and dynamic models will be applied to an experimental cell culture system, which has a perturbed (transfected or silenced) gene, and assessed as to how well each model predicts the resulting, measured phenotypic responses. The cost-effectiveness of the cell culture, in contrast to in vivo animal studies, allows us to establish, with experimental data, which model produces predictions of greater confidence. Having established which model is more predictive, we will apply that model to rats that are maintained on high fat diets, so as to identify the pathways that could be altered to reduce triglyceride storage (steatosis) and inflammation in the livers of these rats. The findings could have implications for identifying potential therapies for steatosis and, perhaps, even non-alcoholic steatohepatitis (NASH). The objectives will be achieved through the following aims: 1) Develop a novel approach that incorporates domain knowledge retrieved from the free text as well as gene expression data to predict cellular or phenotypic responses. 2) Develop an optimized dynamic Bayesian Network to infer gene regulatory networks from time series data. 3) Experimentally validate the model predictions for the cell culture system. 4) Characterize the livers from rats fed high fat vs. normal diets.           n/a",Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks,7755390,R01GM079688,"['Algorithms', 'Animals', 'Cell Culture System', 'Cell Culture Techniques', 'Cell physiology', 'Cells', 'Computer Simulation', 'Data', 'Diet', 'Disease', 'Drug Delivery Systems', 'Environment', 'Fatty acid glycerol esters', 'Feedback', 'Gene Expression', 'Gene Silencing', 'Genes', 'Inflammation', 'Knowledge', 'Liver', 'Measures', 'Metabolic', 'Modeling', 'Ontology', 'Pathway interactions', 'Phenotype', 'RNA Interference', 'Rattus', 'Regulator Genes', 'Series', 'Structure', 'Text', 'Time', 'Transfection', 'Triglycerides', 'computer based statistical methods', 'cost effectiveness', 'feeding', 'improved', 'in vivo', 'nonalcoholic steatohepatitis', 'novel strategies', 'reconstruction', 'research study', 'response', 'text searching']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2010,248003,-0.00688318581837753
"Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks    DESCRIPTION (provided by applicant): Improved understanding of disease mechanisms and drug target identification requires better understanding of how diseases alter cellular processes from the healthy state. Our group has developed an integrative pathway search algorithm that reconstructs networks of active pathways from gene expression and phenotypic profiles. Preliminary studies illustrate that this framework is able to reconstruct networks that include those pathways that should be altered, and how they should be altered, to obtain a desired phenotype. Nevertheless, the current framework may not fully capture transients, such as cycles and feedback loops. Furthermore, cells continuously reprogram gene regulatory networks as they sense changes in their environment. To understand how cells are regulated in response to environmental alterations, time series (i.e., dynamic) data are required. Correspondingly, a dynamic model is required to uncover the mechanisms from time series data. We hypothesize that incorporating domain knowledge and metabolic data into a dynamic model would enhance the accuracy of the genes chosen and in turn improve the prediction of the reconstructed networks. Unlike previous studies that have focused on using the gene ontology information, we propose to incorporate domain knowledge retrieved from the free text. This is significant because a large portion of the genes do not have gene ontological keywords. Additionally, it is often difficult to assess the accuracy of the network structures that have been inferred from experimental data because the underlying ""true"" regulatory network is unknown or unavailable a priori. Therefore, one needs to have a known network structure that can be used to optimize and evaluate the modeling frameworks. Once so optimized, the static and dynamic models will be applied to an experimental cell culture system, which has a perturbed (transfected or silenced) gene, and assessed as to how well each model predicts the resulting, measured phenotypic responses. The cost-effectiveness of the cell culture, in contrast to in vivo animal studies, allows us to establish, with experimental data, which model produces predictions of greater confidence. Having established which model is more predictive, we will apply that model to rats that are maintained on high fat diets, so as to identify the pathways that could be altered to reduce triglyceride storage (steatosis) and inflammation in the livers of these rats. The findings could have implications for identifying potential therapies for steatosis and, perhaps, even non-alcoholic steatohepatitis (NASH). The objectives will be achieved through the following aims: 1) Develop a novel approach that incorporates domain knowledge retrieved from the free text as well as gene expression data to predict cellular or phenotypic responses. 2) Develop an optimized dynamic Bayesian Network to infer gene regulatory networks from time series data. 3) Experimentally validate the model predictions for the cell culture system. 4) Characterize the livers from rats fed high fat vs. normal diets.           n/a",Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks,7570074,R01GM079688,"['Algorithms', 'Animals', 'Cell Culture System', 'Cell Culture Techniques', 'Cell physiology', 'Cells', 'Computer Simulation', 'Data', 'Diet', 'Disease', 'Drug Delivery Systems', 'Environment', 'Fatty acid glycerol esters', 'Feedback', 'Gene Expression', 'Gene Silencing', 'Genes', 'Inflammation', 'Knowledge', 'Liver', 'Measures', 'Metabolic', 'Modeling', 'Ontology', 'Pathway interactions', 'Phenotype', 'RNA Interference', 'Rattus', 'Regulator Genes', 'Series', 'Structure', 'Text', 'Time', 'Transfection', 'Triglycerides', 'computer based statistical methods', 'cost effectiveness', 'feeding', 'improved', 'in vivo', 'nonalcoholic steatohepatitis', 'novel strategies', 'reconstruction', 'research study', 'response', 'text searching']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2009,250508,-0.00688318581837753
"Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks    DESCRIPTION (provided by applicant): Improved understanding of disease mechanisms and drug target identification requires better understanding of how diseases alter cellular processes from the healthy state. Our group has developed an integrative pathway search algorithm that reconstructs networks of active pathways from gene expression and phenotypic profiles. Preliminary studies illustrate that this framework is able to reconstruct networks that include those pathways that should be altered, and how they should be altered, to obtain a desired phenotype. Nevertheless, the current framework may not fully capture transients, such as cycles and feedback loops. Furthermore, cells continuously reprogram gene regulatory networks as they sense changes in their environment. To understand how cells are regulated in response to environmental alterations, time series (i.e., dynamic) data are required. Correspondingly, a dynamic model is required to uncover the mechanisms from time series data. We hypothesize that incorporating domain knowledge and metabolic data into a dynamic model would enhance the accuracy of the genes chosen and in turn improve the prediction of the reconstructed networks. Unlike previous studies that have focused on using the gene ontology information, we propose to incorporate domain knowledge retrieved from the free text. This is significant because a large portion of the genes do not have gene ontological keywords. Additionally, it is often difficult to assess the accuracy of the network structures that have been inferred from experimental data because the underlying ""true"" regulatory network is unknown or unavailable a priori. Therefore, one needs to have a known network structure that can be used to optimize and evaluate the modeling frameworks. Once so optimized, the static and dynamic models will be applied to an experimental cell culture system, which has a perturbed (transfected or silenced) gene, and assessed as to how well each model predicts the resulting, measured phenotypic responses. The cost-effectiveness of the cell culture, in contrast to in vivo animal studies, allows us to establish, with experimental data, which model produces predictions of greater confidence. Having established which model is more predictive, we will apply that model to rats that are maintained on high fat diets, so as to identify the pathways that could be altered to reduce triglyceride storage (steatosis) and inflammation in the livers of these rats. The findings could have implications for identifying potential therapies for steatosis and, perhaps, even non-alcoholic steatohepatitis (NASH). The objectives will be achieved through the following aims: 1) Develop a novel approach that incorporates domain knowledge retrieved from the free text as well as gene expression data to predict cellular or phenotypic responses. 2) Develop an optimized dynamic Bayesian Network to infer gene regulatory networks from time series data. 3) Experimentally validate the model predictions for the cell culture system. 4) Characterize the livers from rats fed high fat vs. normal diets.           n/a",Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks,7918729,R01GM079688,"['Algorithms', 'Animals', 'Cell Culture System', 'Cell Culture Techniques', 'Cell physiology', 'Cells', 'Computer Simulation', 'Data', 'Diet', 'Disease', 'Drug Delivery Systems', 'Environment', 'Fatty acid glycerol esters', 'Feedback', 'Gene Expression', 'Gene Silencing', 'Genes', 'Inflammation', 'Knowledge', 'Liver', 'Measures', 'Metabolic', 'Modeling', 'Ontology', 'Pathway interactions', 'Phenotype', 'RNA Interference', 'Rattus', 'Regulator Genes', 'Series', 'Structure', 'Text', 'Time', 'Transfection', 'Triglycerides', 'computer based statistical methods', 'cost effectiveness', 'feeding', 'improved', 'in vivo', 'nonalcoholic steatohepatitis', 'novel strategies', 'reconstruction', 'research study', 'response', 'text searching']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2009,189920,-0.00688318581837753
"Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks    DESCRIPTION (provided by applicant): Improved understanding of disease mechanisms and drug target identification requires better understanding of how diseases alter cellular processes from the healthy state. Our group has developed an integrative pathway search algorithm that reconstructs networks of active pathways from gene expression and phenotypic profiles. Preliminary studies illustrate that this framework is able to reconstruct networks that include those pathways that should be altered, and how they should be altered, to obtain a desired phenotype. Nevertheless, the current framework may not fully capture transients, such as cycles and feedback loops. Furthermore, cells continuously reprogram gene regulatory networks as they sense changes in their environment. To understand how cells are regulated in response to environmental alterations, time series (i.e., dynamic) data are required. Correspondingly, a dynamic model is required to uncover the mechanisms from time series data. We hypothesize that incorporating domain knowledge and metabolic data into a dynamic model would enhance the accuracy of the genes chosen and in turn improve the prediction of the reconstructed networks. Unlike previous studies that have focused on using the gene ontology information, we propose to incorporate domain knowledge retrieved from the free text. This is significant because a large portion of the genes do not have gene ontological keywords. Additionally, it is often difficult to assess the accuracy of the network structures that have been inferred from experimental data because the underlying ""true"" regulatory network is unknown or unavailable a priori. Therefore, one needs to have a known network structure that can be used to optimize and evaluate the modeling frameworks. Once so optimized, the static and dynamic models will be applied to an experimental cell culture system, which has a perturbed (transfected or silenced) gene, and assessed as to how well each model predicts the resulting, measured phenotypic responses. The cost-effectiveness of the cell culture, in contrast to in vivo animal studies, allows us to establish, with experimental data, which model produces predictions of greater confidence. Having established which model is more predictive, we will apply that model to rats that are maintained on high fat diets, so as to identify the pathways that could be altered to reduce triglyceride storage (steatosis) and inflammation in the livers of these rats. The findings could have implications for identifying potential therapies for steatosis and, perhaps, even non-alcoholic steatohepatitis (NASH). The objectives will be achieved through the following aims: 1) Develop a novel approach that incorporates domain knowledge retrieved from the free text as well as gene expression data to predict cellular or phenotypic responses. 2) Develop an optimized dynamic Bayesian Network to infer gene regulatory networks from time series data. 3) Experimentally validate the model predictions for the cell culture system. 4) Characterize the livers from rats fed high fat vs. normal diets.           n/a",Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks,7348388,R01GM079688,"['Algorithms', 'Animals', 'Cell Culture System', 'Cell physiology', 'Cells', 'Computer Simulation', 'Condition', 'Cultured Cells', 'Data', 'Diet', 'Disease', 'Drug Delivery Systems', 'Environment', 'Fatty acid glycerol esters', 'Feedback', 'Gene Expression', 'Gene Silencing', 'Genes', 'Inflammation', 'Knowledge', 'Liver', 'Measures', 'Metabolic', 'Modeling', 'Numbers', 'Ontology', 'Pathway interactions', 'Phenotype', 'RNA Interference', 'Rattus', 'Regulator Genes', 'Series', 'Structure', 'Text', 'Time', 'Transfection', 'Triglycerides', 'computer based statistical methods', 'cost effectiveness', 'desire', 'feeding', 'improved', 'in vivo', 'nonalcoholic steatohepatitis', 'novel strategies', 'reconstruction', 'research study', 'response', 'text searching']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2008,250508,-0.00688318581837753
"Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks    DESCRIPTION (provided by applicant): Improved understanding of disease mechanisms and drug target identification requires better understanding of how diseases alter cellular processes from the healthy state. Our group has developed an integrative pathway search algorithm that reconstructs networks of active pathways from gene expression and phenotypic profiles. Preliminary studies illustrate that this framework is able to reconstruct networks that include those pathways that should be altered, and how they should be altered, to obtain a desired phenotype. Nevertheless, the current framework may not fully capture transients, such as cycles and feedback loops. Furthermore, cells continuously reprogram gene regulatory networks as they sense changes in their environment. To understand how cells are regulated in response to environmental alterations, time series (i.e., dynamic) data are required. Correspondingly, a dynamic model is required to uncover the mechanisms from time series data. We hypothesize that incorporating domain knowledge and metabolic data into a dynamic model would enhance the accuracy of the genes chosen and in turn improve the prediction of the reconstructed networks. Unlike previous studies that have focused on using the gene ontology information, we propose to incorporate domain knowledge retrieved from the free text. This is significant because a large portion of the genes do not have gene ontological keywords. Additionally, it is often difficult to assess the accuracy of the network structures that have been inferred from experimental data because the underlying ""true"" regulatory network is unknown or unavailable a priori. Therefore, one needs to have a known network structure that can be used to optimize and evaluate the modeling frameworks. Once so optimized, the static and dynamic models will be applied to an experimental cell culture system, which has a perturbed (transfected or silenced) gene, and assessed as to how well each model predicts the resulting, measured phenotypic responses. The cost-effectiveness of the cell culture, in contrast to in vivo animal studies, allows us to establish, with experimental data, which model produces predictions of greater confidence. Having established which model is more predictive, we will apply that model to rats that are maintained on high fat diets, so as to identify the pathways that could be altered to reduce triglyceride storage (steatosis) and inflammation in the livers of these rats. The findings could have implications for identifying potential therapies for steatosis and, perhaps, even non-alcoholic steatohepatitis (NASH). The objectives will be achieved through the following aims: 1) Develop a novel approach that incorporates domain knowledge retrieved from the free text as well as gene expression data to predict cellular or phenotypic responses. 2) Develop an optimized dynamic Bayesian Network to infer gene regulatory networks from time series data. 3) Experimentally validate the model predictions for the cell culture system. 4) Characterize the livers from rats fed high fat vs. normal diets.           n/a",Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks,8518163,R01GM079688,"['Algorithms', 'Animals', 'Cell Culture System', 'Cell Culture Techniques', 'Cell physiology', 'Cells', 'Computer Simulation', 'Data', 'Diet', 'Disease', 'Drug Delivery Systems', 'Environment', 'Fatty acid glycerol esters', 'Feedback', 'Gene Expression', 'Gene Silencing', 'Genes', 'Inflammation', 'Knowledge', 'Liver', 'Measures', 'Metabolic', 'Modeling', 'Ontology', 'Pathway interactions', 'Phenotype', 'RNA Interference', 'Rattus', 'Regulator Genes', 'Series', 'Structure', 'Text', 'Time', 'Transfection', 'Triglycerides', 'computer based statistical methods', 'cost effectiveness', 'feeding', 'improved', 'in vivo', 'nonalcoholic steatohepatitis', 'novel strategies', 'reconstruction', 'research study', 'response', 'text searching']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2012,48122,-0.00688318581837753
"Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks    DESCRIPTION (provided by applicant): Improved understanding of disease mechanisms and drug target identification requires better understanding of how diseases alter cellular processes from the healthy state. Our group has developed an integrative pathway search algorithm that reconstructs networks of active pathways from gene expression and phenotypic profiles. Preliminary studies illustrate that this framework is able to reconstruct networks that include those pathways that should be altered, and how they should be altered, to obtain a desired phenotype. Nevertheless, the current framework may not fully capture transients, such as cycles and feedback loops. Furthermore, cells continuously reprogram gene regulatory networks as they sense changes in their environment. To understand how cells are regulated in response to environmental alterations, time series (i.e., dynamic) data are required. Correspondingly, a dynamic model is required to uncover the mechanisms from time series data. We hypothesize that incorporating domain knowledge and metabolic data into a dynamic model would enhance the accuracy of the genes chosen and in turn improve the prediction of the reconstructed networks. Unlike previous studies that have focused on using the gene ontology information, we propose to incorporate domain knowledge retrieved from the free text. This is significant because a large portion of the genes do not have gene ontological keywords. Additionally, it is often difficult to assess the accuracy of the network structures that have been inferred from experimental data because the underlying ""true"" regulatory network is unknown or unavailable a priori. Therefore, one needs to have a known network structure that can be used to optimize and evaluate the modeling frameworks. Once so optimized, the static and dynamic models will be applied to an experimental cell culture system, which has a perturbed (transfected or silenced) gene, and assessed as to how well each model predicts the resulting, measured phenotypic responses. The cost-effectiveness of the cell culture, in contrast to in vivo animal studies, allows us to establish, with experimental data, which model produces predictions of greater confidence. Having established which model is more predictive, we will apply that model to rats that are maintained on high fat diets, so as to identify the pathways that could be altered to reduce triglyceride storage (steatosis) and inflammation in the livers of these rats. The findings could have implications for identifying potential therapies for steatosis and, perhaps, even non-alcoholic steatohepatitis (NASH). The objectives will be achieved through the following aims: 1) Develop a novel approach that incorporates domain knowledge retrieved from the free text as well as gene expression data to predict cellular or phenotypic responses. 2) Develop an optimized dynamic Bayesian Network to infer gene regulatory networks from time series data. 3) Experimentally validate the model predictions for the cell culture system. 4) Characterize the livers from rats fed high fat vs. normal diets.           n/a",Develop a Dynamic Model that Incoporates Text-mining to Reconstruct Networks,7193903,R01GM079688,"['Address', 'Algorithms', 'Animals', 'Biological Process', 'Cell Culture System', 'Cell physiology', 'Cells', 'Computer Simulation', 'Condition', 'Cultured Cells', 'Data', 'Diet', 'Disease', 'Drug Delivery Systems', 'Environment', 'Fatty acid glycerol esters', 'Feedback', 'Gene Expression', 'Gene Silencing', 'Genes', 'Genomics', 'Goals', 'Hepatic', 'Inflammation', 'Intracellular Accumulation of Lipids', 'Knowledge', 'Liver', 'Measures', 'Metabolic', 'Modeling', 'Numbers', 'Ontology', 'Pathway interactions', 'Personal Satisfaction', 'Phenotype', 'Process', 'RNA Interference', 'Rattus', 'Regulator Genes', 'Series', 'Structure', 'Text', 'Time', 'Toxic effect', 'Transfection', 'Triglycerides', 'computer based statistical methods', 'cost effectiveness', 'desire', 'drug discovery', 'feeding', 'improved', 'in vivo', 'knowledge base', 'nonalcoholic steatohepatitis', 'novel strategies', 'reconstruction', 'research study', 'response', 'text searching']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2007,257990,-0.00688318581837753
"Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells    DESCRIPTION (provided by applicant): Eukaryotic cell motility is essential for many physiological processes such as embryonic development, tissue renewal, and the function of the immune system. Dictyostelium discoideum has proven to be an excellent model for the chemotactic migration of amoeboid cells such as leukocytes. Amoeboid migration is the result of the sequential repetition of pseudopod protrusions and retractions and is driven by the generation of traction forces. The strength and spatiotemporal organization of traction forces is determined by the coordinated interactions of actin-directed motors, F-actin regulation, actin crosslinking, motor protein-mediated contractility, and cell adhesions. However, precise knowledge of the biophysical coordination of these processes has been limited by the lack of quantitative information and analysis. We and others have observed that a considerable portion of the changes in cell shape occurring during amoeboid migration are due to periodic repetitive events, which enables the use of conditional statistics methods to analyze the network of biochemical processes involved in cell motility.  The primary goal of this research is to determine in a statistically-robust, quantitative manner the biochemical basis for the spatiotemporal distribution of traction forces and the duration of each phase of the motility cycle by studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the different stages of the motility cycle. We hypothesize that Myosin II is essential not only to the contractility phase of the motility cycle but also to the pseudopod protrusion phase. The generation of the traction forces depends not only on the contractile action of Myosin II, but also in its actin crosslinking effect. Based on preliminary results, we further hypothesize that the spatiotemporal distribution of traction forces and the average distance a cell travels per cycle depend on actin polymerization.  To test the above hypotheses, we propose three Specific Aims. Specific Aim 1 is to apply our new 3D force cytometry method to measure the three components of the forces exerted by the cells on the substrate. The second and third aims are aimed at studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the motility by undertaking systematic comparison of wild type cells and mutant strains with actin crosslinking or motor protein contractility defects (Specific Aim 2), and F-actin regulation defects (Specific Aim 3). Our method consists of simultaneously measuring the spatial and temporal changes in the distribution of fluorescently tagged signaling (or cytoskeletal) proteins and the 3D traction forces that mediate each stage of the cell motility cycle, while also recording the changes in cell shape. We will apply conditional statistics and Principal Component Analysis (PCA) to connect specific biochemical processes to each of the physical events in the motility cycle. Our studies will provide the necessary building blocks to begin constructing the complex network of biochemical processes controlling cell migration.      PUBLIC HEALTH RELEVANCE: Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.           PROJECT NARRATIVE Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.",Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells,8539020,R01GM084227,"['Actins', 'Address', 'Adhesions', 'Affect', 'Biochemical', 'Biochemical Process', 'Biomechanics', 'Biophysical Process', 'Cell Adhesion', 'Cell Shape', 'Cells', 'Chemotaxis', 'Cicatrix', 'Complex', 'Cytochalasin B', 'Cytometry', 'Cytoskeletal Modeling', 'Cytoskeletal Proteins', 'Defect', 'Dictyostelium discoideum', 'Dimensions', 'Disease', 'Embryonic Development', 'Eukaryotic Cell', 'Event', 'F-Actin', 'Frequencies', 'Future', 'Generations', 'Goals', 'Guanosine Triphosphate', 'Immune system', 'Individual', 'Inflammation', 'Knowledge', 'Lateral', 'Length', 'Leukocytes', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Measures', 'Mechanics', 'Mediating', 'Mental Retardation', 'Methods', 'Modeling', 'Molecular', 'Molecular Motors', 'Motor', 'Motor Activity', 'Mutation', 'Myosin Type II', 'Osteoporosis', 'Phase', 'Physiological Processes', 'Play', 'Principal Component Analysis', 'Process', 'Production', 'Proteins', 'Regulation', 'Reporter', 'Research', 'Role', 'Shapes', 'Signal Pathway', 'Signal Transduction', 'Site', 'Staging', 'Stress', 'Testing', 'Therapeutic', 'Time', 'Tissues', 'Traction', 'Travel', 'base', 'cell growth regulation', 'cell motility', 'cell type', 'crosslink', 'genetic regulatory protein', 'migration', 'mutant', 'neglect', 'physical property', 'polymerization', 'public health relevance', 'research study', 'spatiotemporal', 'statistics']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2013,286966,0.028058075119874126
"Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells    DESCRIPTION (provided by applicant): Eukaryotic cell motility is essential for many physiological processes such as embryonic development, tissue renewal, and the function of the immune system. Dictyostelium discoideum has proven to be an excellent model for the chemotactic migration of amoeboid cells such as leukocytes. Amoeboid migration is the result of the sequential repetition of pseudopod protrusions and retractions and is driven by the generation of traction forces. The strength and spatiotemporal organization of traction forces is determined by the coordinated interactions of actin-directed motors, F-actin regulation, actin crosslinking, motor protein-mediated contractility, and cell adhesions. However, precise knowledge of the biophysical coordination of these processes has been limited by the lack of quantitative information and analysis. We and others have observed that a considerable portion of the changes in cell shape occurring during amoeboid migration are due to periodic repetitive events, which enables the use of conditional statistics methods to analyze the network of biochemical processes involved in cell motility.  The primary goal of this research is to determine in a statistically-robust, quantitative manner the biochemical basis for the spatiotemporal distribution of traction forces and the duration of each phase of the motility cycle by studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the different stages of the motility cycle. We hypothesize that Myosin II is essential not only to the contractility phase of the motility cycle but also to the pseudopod protrusion phase. The generation of the traction forces depends not only on the contractile action of Myosin II, but also in its actin crosslinking effect. Based on preliminary results, we further hypothesize that the spatiotemporal distribution of traction forces and the average distance a cell travels per cycle depend on actin polymerization.  To test the above hypotheses, we propose three Specific Aims. Specific Aim 1 is to apply our new 3D force cytometry method to measure the three components of the forces exerted by the cells on the substrate. The second and third aims are aimed at studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the motility by undertaking systematic comparison of wild type cells and mutant strains with actin crosslinking or motor protein contractility defects (Specific Aim 2), and F-actin regulation defects (Specific Aim 3). Our method consists of simultaneously measuring the spatial and temporal changes in the distribution of fluorescently tagged signaling (or cytoskeletal) proteins and the 3D traction forces that mediate each stage of the cell motility cycle, while also recording the changes in cell shape. We will apply conditional statistics and Principal Component Analysis (PCA) to connect specific biochemical processes to each of the physical events in the motility cycle. Our studies will provide the necessary building blocks to begin constructing the complex network of biochemical processes controlling cell migration.      PUBLIC HEALTH RELEVANCE: Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.           PROJECT NARRATIVE Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.",Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells,8325551,R01GM084227,"['Actins', 'Address', 'Adhesions', 'Affect', 'Biochemical', 'Biochemical Process', 'Biomechanics', 'Biophysical Process', 'Cell Adhesion', 'Cell Shape', 'Cells', 'Chemotaxis', 'Cicatrix', 'Complex', 'Cytochalasin B', 'Cytometry', 'Cytoskeletal Modeling', 'Cytoskeletal Proteins', 'Defect', 'Dictyostelium discoideum', 'Dimensions', 'Disease', 'Embryonic Development', 'Eukaryotic Cell', 'Event', 'F-Actin', 'Frequencies', 'Future', 'Generations', 'Goals', 'Guanosine Triphosphate', 'Immune system', 'Individual', 'Inflammation', 'Knowledge', 'Lateral', 'Length', 'Leukocytes', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Measures', 'Mechanics', 'Mediating', 'Mental Retardation', 'Methods', 'Modeling', 'Molecular', 'Molecular Motors', 'Motor', 'Motor Activity', 'Mutation', 'Myosin Type II', 'Osteoporosis', 'Phase', 'Physiological Processes', 'Play', 'Principal Component Analysis', 'Process', 'Production', 'Proteins', 'Regulation', 'Reporter', 'Research', 'Role', 'Shapes', 'Signal Pathway', 'Signal Transduction', 'Site', 'Staging', 'Stress', 'Testing', 'Therapeutic', 'Time', 'Tissues', 'Traction', 'Travel', 'base', 'cell growth regulation', 'cell motility', 'cell type', 'crosslink', 'genetic regulatory protein', 'migration', 'mutant', 'neglect', 'physical property', 'polymerization', 'public health relevance', 'research study', 'spatiotemporal', 'statistics']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2012,297998,0.028058075119874126
"Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells    DESCRIPTION (provided by applicant): Eukaryotic cell motility is essential for many physiological processes such as embryonic development, tissue renewal, and the function of the immune system. Dictyostelium discoideum has proven to be an excellent model for the chemotactic migration of amoeboid cells such as leukocytes. Amoeboid migration is the result of the sequential repetition of pseudopod protrusions and retractions and is driven by the generation of traction forces. The strength and spatiotemporal organization of traction forces is determined by the coordinated interactions of actin-directed motors, F-actin regulation, actin crosslinking, motor protein-mediated contractility, and cell adhesions. However, precise knowledge of the biophysical coordination of these processes has been limited by the lack of quantitative information and analysis. We and others have observed that a considerable portion of the changes in cell shape occurring during amoeboid migration are due to periodic repetitive events, which enables the use of conditional statistics methods to analyze the network of biochemical processes involved in cell motility.  The primary goal of this research is to determine in a statistically-robust, quantitative manner the biochemical basis for the spatiotemporal distribution of traction forces and the duration of each phase of the motility cycle by studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the different stages of the motility cycle. We hypothesize that Myosin II is essential not only to the contractility phase of the motility cycle but also to the pseudopod protrusion phase. The generation of the traction forces depends not only on the contractile action of Myosin II, but also in its actin crosslinking effect. Based on preliminary results, we further hypothesize that the spatiotemporal distribution of traction forces and the average distance a cell travels per cycle depend on actin polymerization.  To test the above hypotheses, we propose three Specific Aims. Specific Aim 1 is to apply our new 3D force cytometry method to measure the three components of the forces exerted by the cells on the substrate. The second and third aims are aimed at studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the motility by undertaking systematic comparison of wild type cells and mutant strains with actin crosslinking or motor protein contractility defects (Specific Aim 2), and F-actin regulation defects (Specific Aim 3). Our method consists of simultaneously measuring the spatial and temporal changes in the distribution of fluorescently tagged signaling (or cytoskeletal) proteins and the 3D traction forces that mediate each stage of the cell motility cycle, while also recording the changes in cell shape. We will apply conditional statistics and Principal Component Analysis (PCA) to connect specific biochemical processes to each of the physical events in the motility cycle. Our studies will provide the necessary building blocks to begin constructing the complex network of biochemical processes controlling cell migration.      PUBLIC HEALTH RELEVANCE: Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.           PROJECT NARRATIVE Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.",Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells,8141956,R01GM084227,"['Actins', 'Address', 'Adhesions', 'Affect', 'Biochemical', 'Biochemical Process', 'Biomechanics', 'Biophysical Process', 'Cell Adhesion', 'Cell Shape', 'Cells', 'Chemotaxis', 'Cicatrix', 'Complex', 'Cytochalasin B', 'Cytometry', 'Cytoskeletal Modeling', 'Cytoskeletal Proteins', 'Defect', 'Dictyostelium discoideum', 'Dimensions', 'Disease', 'Embryonic Development', 'Eukaryotic Cell', 'Event', 'F-Actin', 'Frequencies', 'Future', 'Generations', 'Goals', 'Guanosine Triphosphate', 'Immune system', 'Individual', 'Inflammation', 'Knowledge', 'Lateral', 'Length', 'Leukocytes', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Measures', 'Mechanics', 'Mediating', 'Mental Retardation', 'Methods', 'Modeling', 'Molecular', 'Molecular Motors', 'Motor', 'Motor Activity', 'Mutation', 'Myosin Type II', 'Osteoporosis', 'Phase', 'Physiological Processes', 'Play', 'Principal Component Analysis', 'Process', 'Production', 'Proteins', 'Regulation', 'Reporter', 'Research', 'Role', 'Shapes', 'Signal Pathway', 'Signal Transduction', 'Site', 'Staging', 'Stress', 'Testing', 'Therapeutic', 'Time', 'Tissues', 'Traction', 'Travel', 'base', 'cell growth regulation', 'cell motility', 'cell type', 'crosslink', 'genetic regulatory protein', 'migration', 'mutant', 'neglect', 'physical property', 'polymerization', 'public health relevance', 'research study', 'spatiotemporal', 'statistics']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2011,297818,0.028058075119874126
"Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells    DESCRIPTION (provided by applicant): Eukaryotic cell motility is essential for many physiological processes such as embryonic development, tissue renewal, and the function of the immune system. Dictyostelium discoideum has proven to be an excellent model for the chemotactic migration of amoeboid cells such as leukocytes. Amoeboid migration is the result of the sequential repetition of pseudopod protrusions and retractions and is driven by the generation of traction forces. The strength and spatiotemporal organization of traction forces is determined by the coordinated interactions of actin-directed motors, F-actin regulation, actin crosslinking, motor protein-mediated contractility, and cell adhesions. However, precise knowledge of the biophysical coordination of these processes has been limited by the lack of quantitative information and analysis. We and others have observed that a considerable portion of the changes in cell shape occurring during amoeboid migration are due to periodic repetitive events, which enables the use of conditional statistics methods to analyze the network of biochemical processes involved in cell motility.  The primary goal of this research is to determine in a statistically-robust, quantitative manner the biochemical basis for the spatiotemporal distribution of traction forces and the duration of each phase of the motility cycle by studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the different stages of the motility cycle. We hypothesize that Myosin II is essential not only to the contractility phase of the motility cycle but also to the pseudopod protrusion phase. The generation of the traction forces depends not only on the contractile action of Myosin II, but also in its actin crosslinking effect. Based on preliminary results, we further hypothesize that the spatiotemporal distribution of traction forces and the average distance a cell travels per cycle depend on actin polymerization.  To test the above hypotheses, we propose three Specific Aims. Specific Aim 1 is to apply our new 3D force cytometry method to measure the three components of the forces exerted by the cells on the substrate. The second and third aims are aimed at studying the role of candidate cytoskeletal and regulatory molecules with known or suspected involvement in the motility by undertaking systematic comparison of wild type cells and mutant strains with actin crosslinking or motor protein contractility defects (Specific Aim 2), and F-actin regulation defects (Specific Aim 3). Our method consists of simultaneously measuring the spatial and temporal changes in the distribution of fluorescently tagged signaling (or cytoskeletal) proteins and the 3D traction forces that mediate each stage of the cell motility cycle, while also recording the changes in cell shape. We will apply conditional statistics and Principal Component Analysis (PCA) to connect specific biochemical processes to each of the physical events in the motility cycle. Our studies will provide the necessary building blocks to begin constructing the complex network of biochemical processes controlling cell migration.      PUBLIC HEALTH RELEVANCE: Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.           PROJECT NARRATIVE Motility of eukaryotic cells is essential for many physiological processes such as embryonic development, and tissue renewal, as well as for the function of the immune system. Incorrect regulation of motility plays an important part in many diseases (cancer, destructive inflammation, osteoporosis, mental retardation, etc.), and therefore, future therapeutic approaches will benefit from a precise quantitative understanding of the biophysical processes controlling cell motility. The aim of this study is to establish the mechanisms whereby each individual stage of the motility cycle is related to specific biochemical signaling events, and to elucidate the effects that the regulation of these signaling pathways has on cell motility, with the ultimate goal of developing a level of understanding of the biomechanical processes sufficient to predict and control cell motility.",Quantitative Analysis of Chemotactic Motility Cycle of Ameboid Cells,7917518,R01GM084227,"['Actins', 'Address', 'Adhesions', 'Affect', 'Biochemical', 'Biochemical Process', 'Biomechanics', 'Biophysical Process', 'Cell Adhesion', 'Cell Shape', 'Cells', 'Chemotaxis', 'Cicatrix', 'Complex', 'Cytochalasin B', 'Cytometry', 'Cytoskeletal Modeling', 'Cytoskeletal Proteins', 'Defect', 'Dictyostelium discoideum', 'Dimensions', 'Disease', 'Embryonic Development', 'Eukaryotic Cell', 'Event', 'F-Actin', 'Frequencies', 'Future', 'Generations', 'Goals', 'Immune system', 'Individual', 'Inflammation', 'Knowledge', 'Lateral', 'Length', 'Leukocytes', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Measures', 'Mechanics', 'Mediating', 'Mental Retardation', 'Methods', 'Modeling', 'Molecular', 'Molecular Motors', 'Motor', 'Motor Activity', 'Mutation', 'Myosin Type II', 'Osteoporosis', 'Phase', 'Physiological Processes', 'Play', 'Principal Component Analysis', 'Process', 'Production', 'Proteins', 'Regulation', 'Reporter', 'Research', 'Role', 'Shapes', 'Signal Pathway', 'Signal Transduction', 'Site', 'Staging', 'Stress', 'Testing', 'Therapeutic', 'Time', 'Tissues', 'Traction', 'Travel', 'base', 'cell growth regulation', 'cell motility', 'cell type', 'crosslink', 'genetic regulatory protein', 'migration', 'mutant', 'neglect', 'physical property', 'polymerization', 'public health relevance', 'research study', 'spatiotemporal', 'statistics']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2010,293369,0.028058075119874126
"Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach Project Summary/Abstract We have recently developed a genetic screening approach, termed E-MAP (Epistatic MiniArray Technology Profiling), that can quantify the strength of systematically generated pair-wise genetic interactions. The method identifies negative double mutant interactions, where combination of mutations causes defects leads to enhancement of growth defects or lethality. Such interactions often specify membership of parallel biochemical pathways. Additionally, E-MAP also identifies positive interactions, where combination of mutants show mutual suppression or lack any additive defects, which are enriched among physically interacting gene products. Using gene deletions of non-essential genes and hypomorphic alleles of essential genes, we have recently generated E-MAPs in S. cerevisiae that have focused on 1) the early secretory pathway and 2) chromosome biology, which includes transcriptional regulation, chromatin remodeling and DNA repair. We now propose the second generation of E-MAP analysis, allowing us to address the next level of complexity, via examination of point mutants of multifunctional and essential genes. Specifically, we will genetically dissect two essential, multisubunit, multifunctional complexes at the heart of gene expression and chromatin structure: RNA polymerase II (RNAPII) and the nucleosome. This approach will allow us to A) map the structural features of these complexes onto their functional roles, and B) characterize the functional relationships between RNAPII and the nucleosome and the wider gene expression apparatus. In Aim #1, we will use the chromosome biology E-MAP to genetically examine a set of approximately 450 histone H3 and H4 mutants including A) complete alanine (or serine)-scans, B) comprehensive substitution of modifiable residues, and C) semi- systematic deletions of the N-terminal tails. The work, which is being done collaboratively with NIH Roadmap TCNP (Technology Center for Networks and Pathways) of Lysine Modification (PI Jef Boeke), will help reveal how histone-histone and histone-DNA contacts and histone modifications influence the steps of transcription and chromatin regulation. In Aim #2, we will screen approximately 100 distinct and diverse point mutants of several essential RNAPII subunits isolated in collaboration with Craig Kaplan and Roger Kornberg. In Aim #3, we will subject these data to hierarchical clustering and our recently developed metrics (S- and COP-scoring systems) to help identify functional relationships using the E-MAP data. We will also employ newly developed algorithms that identify functionally related sets of genes (or modules) from large-scale interaction datasets and allows for multi-functional genes to be members of more than one module. We anticipate that a systematic genetic approach described here will provide a more holistic view of chromatin function and transcriptional regulation in eukaryotic cells. Project Narrative/Relevance to Public Health The interplay between the gene expression machinery and the compaction of genetic material into chromatin is now recognized as highly dynamic and complex. These processes must be tightly controlled for normal cellular physiology and to prevent disease states such as cancer. We will use a systems approach to genetically dissect the structural and functional relationships between the highly conserved components of these pathways in the budding yeast, S. cerevisiae, in order to more easily understand and eventually manipulate the vast complexity of human cells. n/a",Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach,8258763,R01GM084448,"['Address', 'Alanine', 'Algorithms', 'Alleles', 'Arginine', 'Aspartic Acid', 'Biochemical Pathway', 'Biological', 'Biology', 'Cell Nucleus', 'Cell physiology', 'Cells', 'Chromatin', 'Chromatin Structure', 'Chromosomes', 'Chromosomes, Human, Pair 2', 'Collaborations', 'Complement', 'Complex', 'Computer Analysis', 'DNA', 'DNA Repair', 'Data', 'Data Set', 'Defect', 'Disease', 'Essential Genes', 'Eukaryotic Cell', 'Galactose', 'Gene Deletion', 'Gene Expression', 'Gene Order', 'Generations', 'Genes', 'Genetic', 'Genetic Epistasis', 'Genetic Materials', 'Genetic Screening', 'Genetic Transcription', 'Glutamic Acid', 'Goals', 'Growth', 'Heart', 'Histone H3', 'Histone H4', 'Histones', 'Human', 'Individual', 'Length', 'Lysine', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Measurement', 'Messenger RNA', 'Methods', 'Metric', 'Modification', 'Mutation', 'Mycophenolic Acid', 'N-terminal', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phenotype', 'Physiological', 'Play', 'Positioning Attribute', 'Process', 'Proteins', 'Public Health', 'Quantitative Genetics', 'RNA Polymerase II', 'Regulation', 'Reporting', 'Resolution', 'Role', 'Saccharomyces cerevisiae', 'Saccharomycetales', 'Scanning', 'Serine', 'Specific qualifier value', 'Structure-Activity Relationship', 'System', 'Tail', 'Technology', 'Threonine', 'Transcriptional Regulation', 'Tyrosine', 'United States National Institutes of Health', 'Work', 'abstracting', 'chromatin modification', 'chromatin remodeling', 'computerized tools', 'gene function', 'genetic analysis', 'genetic profiling', 'histone modification', 'in vivo', 'insight', 'member', 'mutant', 'prevent', 'protein function']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2012,438425,-0.014342040056915946
"Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach    DESCRIPTION (provided by applicant): We have recently developed a genetic screening approach, termed E-MAP (Epistatic MiniArray Technology Profiling), that can quantify the strength of systematically generated pair-wise genetic interactions. The method identifies negative double mutant interactions, where combination of mutations causes defects leads to enhancement of growth defects or lethality. Such interactions often specify membership of parallel biochemical pathways. Additionally, E-MAP also identifies positive interactions, where combination of mutants show mutual suppression or lack any additive defects, which are enriched among physically interacting gene products. Using gene deletions of non-essential genes and hypomorphic alleles of essential genes, we have recently generated E-MAPs in S. cerevisiae that have focused on 1) the early secretory pathway and 2) chromosome biology, which includes transcriptional regulation, chromatin remodeling and DNA repair. We now propose the second generation of E-MAP analysis, allowing us to address the next level of complexity, via examination of point mutants of multifunctional and essential genes. Specifically, we will genetically dissect two essential, multisubunit, multifunctional complexes at the heart of gene expression and chromatin structure: RNA polymerase II (RNAPII) and the nucleosome. This approach will allow us to A) map the structural features of these complexes onto their functional roles, and B) characterize the functional relationships between RNAPII and the nucleosome and the wider gene expression apparatus. In Aim #1, we will use the chromosome biology E-MAP to genetically examine a set of approximately 450 histone H3 and H4 mutants including A) complete alanine (or serine)-scans, B) comprehensive substitution of modifiable residues, and C) semisystematic deletions of the N-terminal tails. The work, which is being done collaboratively with NIH Roadmap TCNP (Technology Center for Networks and Pathways) of Lysine Modification (PI Jef Boeke), will help reveal how histone-histone and histone-DNA contacts and histone modifications influence the steps of transcription and chromatin regulation. In Aim #2, we will screen approximately 100 distinct and diverse point mutants of several essential RNAPII subunits isolated in collaboration with Craig Kaplan and Roger Kornberg. In Aim #3, we will subject these data to hierarchical clustering and our recently developed metrics (S- and COP-scoring systems) to help identify functional relationships using the E-MAP data. We will also employ newly developed algorithms that identify functionally related sets of genes (or modules) from large-scale interaction datasets and allows for multi-functional genes to be members of more than one module. We anticipate that a systematic genetic approach described here will provide a more holistic view of chromatin function and transcriptional regulation in eukaryotic cells.          n/a",Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach,8063104,R01GM084448,"['Address', 'Alanine', 'Algorithms', 'Alleles', 'Arginine', 'Aspartic Acid', 'Biochemical Pathway', 'Biological', 'Biology', 'Cell Nucleus', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Chromosomes', 'Chromosomes, Human, Pair 2', 'Collaborations', 'Complement', 'Complex', 'Computer Analysis', 'DNA', 'DNA Repair', 'Data', 'Data Set', 'Defect', 'Disease', 'Essential Genes', 'Eukaryotic Cell', 'Galactose', 'Gene Deletion', 'Gene Expression', 'Gene Order', 'Generations', 'Genes', 'Genetic', 'Genetic Epistasis', 'Genetic Screening', 'Genetic Transcription', 'Glutamic Acid', 'Goals', 'Growth', 'Heart', 'Histone H3', 'Histone H4', 'Histones', 'Individual', 'Length', 'Lysine', 'Machine Learning', 'Maps', 'Measurement', 'Messenger RNA', 'Methods', 'Metric', 'Modification', 'Mutation', 'Mycophenolic Acid', 'N-terminal', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phenotype', 'Physiological', 'Play', 'Positioning Attribute', 'Proteins', 'Quantitative Genetics', 'RNA Polymerase II', 'Regulation', 'Reporting', 'Resolution', 'Role', 'Saccharomyces cerevisiae', 'Saccharomycetales', 'Scanning', 'Serine', 'Specific qualifier value', 'Structure-Activity Relationship', 'System', 'Tail', 'Technology', 'Threonine', 'Transcriptional Regulation', 'Tyrosine', 'United States National Institutes of Health', 'Work', 'chromatin modification', 'chromatin remodeling', 'computerized tools', 'gene function', 'genetic analysis', 'genetic profiling', 'histone modification', 'in vivo', 'insight', 'member', 'mutant', 'protein function']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2011,460136,-0.024424427467657113
"Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach    DESCRIPTION (provided by applicant): We have recently developed a genetic screening approach, termed E-MAP (Epistatic MiniArray Technology Profiling), that can quantify the strength of systematically generated pair-wise genetic interactions. The method identifies negative double mutant interactions, where combination of mutations causes defects leads to enhancement of growth defects or lethality. Such interactions often specify membership of parallel biochemical pathways. Additionally, E-MAP also identifies positive interactions, where combination of mutants show mutual suppression or lack any additive defects, which are enriched among physically interacting gene products. Using gene deletions of non-essential genes and hypomorphic alleles of essential genes, we have recently generated E-MAPs in S. cerevisiae that have focused on 1) the early secretory pathway and 2) chromosome biology, which includes transcriptional regulation, chromatin remodeling and DNA repair. We now propose the second generation of E-MAP analysis, allowing us to address the next level of complexity, via examination of point mutants of multifunctional and essential genes. Specifically, we will genetically dissect two essential, multisubunit, multifunctional complexes at the heart of gene expression and chromatin structure: RNA polymerase II (RNAPII) and the nucleosome. This approach will allow us to A) map the structural features of these complexes onto their functional roles, and B) characterize the functional relationships between RNAPII and the nucleosome and the wider gene expression apparatus. In Aim #1, we will use the chromosome biology E-MAP to genetically examine a set of approximately 450 histone H3 and H4 mutants including A) complete alanine (or serine)-scans, B) comprehensive substitution of modifiable residues, and C) semisystematic deletions of the N-terminal tails. The work, which is being done collaboratively with NIH Roadmap TCNP (Technology Center for Networks and Pathways) of Lysine Modification (PI Jef Boeke), will help reveal how histone-histone and histone-DNA contacts and histone modifications influence the steps of transcription and chromatin regulation. In Aim #2, we will screen approximately 100 distinct and diverse point mutants of several essential RNAPII subunits isolated in collaboration with Craig Kaplan and Roger Kornberg. In Aim #3, we will subject these data to hierarchical clustering and our recently developed metrics (S- and COP-scoring systems) to help identify functional relationships using the E-MAP data. We will also employ newly developed algorithms that identify functionally related sets of genes (or modules) from large-scale interaction datasets and allows for multi-functional genes to be members of more than one module. We anticipate that a systematic genetic approach described here will provide a more holistic view of chromatin function and transcriptional regulation in eukaryotic cells.          n/a",Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach,7810583,R01GM084448,"['Address', 'Alanine', 'Algorithms', 'Alleles', 'Arginine', 'Aspartic Acid', 'Biochemical Pathway', 'Biological', 'Biology', 'Cell Nucleus', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Chromosomes', 'Chromosomes, Human, Pair 2', 'Collaborations', 'Complement', 'Complex', 'Computer Analysis', 'DNA', 'DNA Repair', 'Data', 'Data Set', 'Defect', 'Disease', 'Essential Genes', 'Eukaryotic Cell', 'Galactose', 'Gene Deletion', 'Gene Expression', 'Gene Order', 'Generations', 'Genes', 'Genetic', 'Genetic Epistasis', 'Genetic Screening', 'Genetic Transcription', 'Glutamic Acid', 'Goals', 'Growth', 'Heart', 'Histone H3', 'Histones', 'Individual', 'Length', 'Lysine', 'Machine Learning', 'Maps', 'Measurement', 'Messenger RNA', 'Methods', 'Metric', 'Modification', 'Mutation', 'Mycophenolic Acid', 'N-terminal', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phenotype', 'Physiological', 'Play', 'Positioning Attribute', 'Proteins', 'Quantitative Genetics', 'RNA Polymerase II', 'Regulation', 'Reporting', 'Resolution', 'Role', 'Saccharomyces cerevisiae', 'Saccharomycetales', 'Scanning', 'Serine', 'Specific qualifier value', 'Structure-Activity Relationship', 'System', 'Tail', 'Technology', 'Threonine', 'Transcriptional Regulation', 'Tyrosine', 'United States National Institutes of Health', 'Work', 'chromatin remodeling', 'computerized tools', 'gene function', 'genetic analysis', 'genetic profiling', 'histone modification', 'in vivo', 'insight', 'member', 'mutant', 'protein function']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2010,467448,-0.024424427467657113
"Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach    DESCRIPTION (provided by applicant): We have recently developed a genetic screening approach, termed E-MAP (Epistatic MiniArray Technology Profiling), that can quantify the strength of systematically generated pair-wise genetic interactions. The method identifies negative double mutant interactions, where combination of mutations causes defects leads to enhancement of growth defects or lethality. Such interactions often specify membership of parallel biochemical pathways. Additionally, E-MAP also identifies positive interactions, where combination of mutants show mutual suppression or lack any additive defects, which are enriched among physically interacting gene products. Using gene deletions of non-essential genes and hypomorphic alleles of essential genes, we have recently generated E-MAPs in S. cerevisiae that have focused on 1) the early secretory pathway and 2) chromosome biology, which includes transcriptional regulation, chromatin remodeling and DNA repair. We now propose the second generation of E-MAP analysis, allowing us to address the next level of complexity, via examination of point mutants of multifunctional and essential genes. Specifically, we will genetically dissect two essential, multisubunit, multifunctional complexes at the heart of gene expression and chromatin structure: RNA polymerase II (RNAPII) and the nucleosome. This approach will allow us to A) map the structural features of these complexes onto their functional roles, and B) characterize the functional relationships between RNAPII and the nucleosome and the wider gene expression apparatus. In Aim #1, we will use the chromosome biology E-MAP to genetically examine a set of approximately 450 histone H3 and H4 mutants including A) complete alanine (or serine)-scans, B) comprehensive substitution of modifiable residues, and C) semisystematic deletions of the N-terminal tails. The work, which is being done collaboratively with NIH Roadmap TCNP (Technology Center for Networks and Pathways) of Lysine Modification (PI Jef Boeke), will help reveal how histone-histone and histone-DNA contacts and histone modifications influence the steps of transcription and chromatin regulation. In Aim #2, we will screen approximately 100 distinct and diverse point mutants of several essential RNAPII subunits isolated in collaboration with Craig Kaplan and Roger Kornberg. In Aim #3, we will subject these data to hierarchical clustering and our recently developed metrics (S- and COP-scoring systems) to help identify functional relationships using the E-MAP data. We will also employ newly developed algorithms that identify functionally related sets of genes (or modules) from large-scale interaction datasets and allows for multi-functional genes to be members of more than one module. We anticipate that a systematic genetic approach described here will provide a more holistic view of chromatin function and transcriptional regulation in eukaryotic cells.          n/a",Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach,7629191,R01GM084448,"['Address', 'Alanine', 'Algorithms', 'Alleles', 'Arginine', 'Aspartic Acid', 'Biochemical Pathway', 'Biological', 'Biology', 'Cell Nucleus', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Chromosomes', 'Chromosomes, Human, Pair 2', 'Classification', 'Collaborations', 'Complement', 'Complex', 'Computer Analysis', 'DNA', 'DNA Repair', 'Data', 'Data Set', 'Defect', 'Disease', 'Essential Genes', 'Eukaryotic Cell', 'Galactose', 'Gene Deletion', 'Gene Expression', 'Gene Order', 'Generations', 'Genes', 'Genetic', 'Genetic Epistasis', 'Genetic Screening', 'Genetic Transcription', 'Glutamic Acid', 'Goals', 'Growth', 'Heart', 'Histone H3', 'Histones', 'Individual', 'Length', 'Lysine', 'Machine Learning', 'Maps', 'Measurement', 'Messenger RNA', 'Methods', 'Metric', 'Modification', 'Mutation', 'Mycophenolic Acid', 'N-terminal', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phenotype', 'Physiological', 'Play', 'Positioning Attribute', 'Proteins', 'Quantitative Genetics', 'RNA Polymerase II', 'Regulation', 'Reporting', 'Resolution', 'Role', 'Saccharomyces cerevisiae', 'Saccharomycetales', 'Scanning', 'Serine', 'Specific qualifier value', 'Structure-Activity Relationship', 'System', 'Tail', 'Technology', 'Threonine', 'Transcriptional Regulation', 'Tyrosine', 'United States National Institutes of Health', 'Work', 'chromatin remodeling', 'computerized tools', 'gene function', 'genetic analysis', 'genetic profiling', 'histone modification', 'in vivo', 'insight', 'member', 'mutant', 'protein function']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2009,448088,-0.024424427467657113
"Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach    DESCRIPTION (provided by applicant): We have recently developed a genetic screening approach, termed E-MAP (Epistatic MiniArray Technology Profiling), that can quantify the strength of systematically generated pair-wise genetic interactions. The method identifies negative double mutant interactions, where combination of mutations causes defects leads to enhancement of growth defects or lethality. Such interactions often specify membership of parallel biochemical pathways. Additionally, E-MAP also identifies positive interactions, where combination of mutants show mutual suppression or lack any additive defects, which are enriched among physically interacting gene products. Using gene deletions of non-essential genes and hypomorphic alleles of essential genes, we have recently generated E-MAPs in S. cerevisiae that have focused on 1) the early secretory pathway and 2) chromosome biology, which includes transcriptional regulation, chromatin remodeling and DNA repair. We now propose the second generation of E-MAP analysis, allowing us to address the next level of complexity, via examination of point mutants of multifunctional and essential genes. Specifically, we will genetically dissect two essential, multisubunit, multifunctional complexes at the heart of gene expression and chromatin structure: RNA polymerase II (RNAPII) and the nucleosome. This approach will allow us to A) map the structural features of these complexes onto their functional roles, and B) characterize the functional relationships between RNAPII and the nucleosome and the wider gene expression apparatus. In Aim #1, we will use the chromosome biology E-MAP to genetically examine a set of approximately 450 histone H3 and H4 mutants including A) complete alanine (or serine)-scans, B) comprehensive substitution of modifiable residues, and C) semisystematic deletions of the N-terminal tails. The work, which is being done collaboratively with NIH Roadmap TCNP (Technology Center for Networks and Pathways) of Lysine Modification (PI Jef Boeke), will help reveal how histone-histone and histone-DNA contacts and histone modifications influence the steps of transcription and chromatin regulation. In Aim #2, we will screen approximately 100 distinct and diverse point mutants of several essential RNAPII subunits isolated in collaboration with Craig Kaplan and Roger Kornberg. In Aim #3, we will subject these data to hierarchical clustering and our recently developed metrics (S- and COP-scoring systems) to help identify functional relationships using the E-MAP data. We will also employ newly developed algorithms that identify functionally related sets of genes (or modules) from large-scale interaction datasets and allows for multi-functional genes to be members of more than one module. We anticipate that a systematic genetic approach described here will provide a more holistic view of chromatin function and transcriptional regulation in eukaryotic cells.          n/a",Genetic Analysis of the Nucleosome and RNA Polymerase II: A Systems Approach,7445536,R01GM084448,"['Address', 'Alanine', 'Algorithms', 'Alleles', 'Arginine', 'Aspartic Acid', 'Biochemical Pathway', 'Biological', 'Biology', 'Cell Nucleus', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Chromosomes', 'Chromosomes, Human, Pair 2', 'Classification', 'Collaborations', 'Complement', 'Complex', 'Computer Analysis', 'DNA', 'DNA Repair', 'Data', 'Data Set', 'Defect', 'Disease', 'Essential Genes', 'Eukaryotic Cell', 'Galactose', 'Gene Deletion', 'Gene Expression', 'Gene Order', 'Generations', 'Genes', 'Genetic', 'Genetic Epistasis', 'Genetic Screening', 'Genetic Transcription', 'Glutamic Acid', 'Goals', 'Growth', 'Heart', 'Histone H3', 'Histones', 'Individual', 'Length', 'Lysine', 'Machine Learning', 'Maps', 'Measurement', 'Messenger RNA', 'Methods', 'Metric', 'Modification', 'Mutation', 'Mycophenolic Acid', 'N-terminal', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phenotype', 'Physiological', 'Play', 'Positioning Attribute', 'Proteins', 'Quantitative Genetics', 'RNA Polymerase II', 'Regulation', 'Reporting', 'Resolution', 'Role', 'Saccharomyces cerevisiae', 'Saccharomycetales', 'Scanning', 'Score', 'Serine', 'Specific qualifier value', 'Structure-Activity Relationship', 'System', 'Tail', 'Technology', 'Threonine', 'Transcriptional Regulation', 'Tyrosine', 'United States National Institutes of Health', 'Work', 'chromatin remodeling', 'computerized tools', 'gene function', 'genetic analysis', 'genetic profiling', 'in vivo', 'insight', 'member', 'mutant', 'protein function']",NIGMS,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R01,2008,467804,-0.024424427467657113
"Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages     DESCRIPTION (provided by applicant): The gene regulatory networks underlying early human cardiovascular (CV) development is poorly understood, in large part due to the dearth of molecular and genetic information specifying the diversity of cardiovascular progenitor cell-types (CVPCs). Human pluripotent stem cell (hPSC)-derived CV cells provide a model for human cardiogenesis and afford us the opportunity to reveal the various CV cell types generated during heart development and to also functionally discover and validate CV developmental gene regulatory networks. In this proposal, we will employ single cell transcriptome (RNA-seq) analysis to dissect the heterogeneity of early CV progenitor populations that give rise to the spectrum of distinct CV cell types and their intermediates. By identifying these potentially rare and novel progenitor cell types as well as studying their lineage choice decisions at the single cell level, the cellular and molecular networks underlying these progenitor cells and their differentiated CV cell types that control their differentiation can be revealed. To achieve our goal, a synergistic and complementary collaboration between the Yeo and Chi labs will aim to (1) investigate the diversity and organization of CV cellular subtypes during cardiogenesis in vitro, (2) develop novel algorithms that enable the extraction of gene regulatory programs that specify CV lineage sub-networks and (3) investigate the functional significance of identified CV cell subtypes. If successful, we will reveal pathways and cell-types that will advance our basic and translational framework for treating congenital heart disease. PUBLIC HEALTH RELEVANCE: This proposal seeks to develop network-based algorithms to perform single-cell transcriptome analysis during derivation of cardiovascular progenitor cells from engineered human pluripotent stem cells to extract previously unknown subpopulations of cardiovascular cell-types and gene regulatory networks underlying cardiovascular lineage specification. These basic and translational studies will provide novel insights into human heart development as well as innovative strategies for developing future treatments for congenital heart disease, which accounts for a third of all major congenital anomalies.",Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages,9867524,R01HD085902,"['Accounting', 'Adult', 'Algorithms', 'Animal Model', 'Behavior', 'Biological Assay', 'Cardiovascular system', 'Cell Differentiation process', 'Cell Lineage', 'Cells', 'Chromatin', 'Collaborations', 'Communities', 'Computer Analysis', 'Data Set', 'Derivation procedure', 'Development', 'Developmental Gene', 'Event', 'Family', 'Fluorescent in Situ Hybridization', 'Future', 'Genes', 'Genetic Transcription', 'Genetic study', 'Goals', 'Heart', 'Heterogeneity', 'Human', 'In Situ', 'In Situ Hybridization', 'In Vitro', 'Maintenance', 'Mediating', 'Modeling', 'Molecular', 'Molecular Genetics', 'Mutation', 'Network-based', 'Newborn Infant', 'Pathway interactions', 'Patients', 'Phenotype', 'Physicians', 'Population', 'Population Heterogeneity', 'Principal Component Analysis', 'Process', 'Protein Isoforms', 'Regulator Genes', 'Regulatory Pathway', 'Reporter', 'Research', 'Signal Pathway', 'Societies', 'Specific qualifier value', 'Technology', 'Testing', 'Tissues', 'Validation', 'base', 'cardiogenesis', 'cell type', 'congenital anomaly', 'congenital heart disorder', 'differential expression', 'engineered stem cells', 'genetic information', 'human pluripotent stem cell', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'patient population', 'progenitor', 'programs', 'public health relevance', 'reconstruction', 'single cell analysis', 'stem cells', 'transcriptome', 'transcriptome sequencing', 'translational study']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2020,601222,0.021291903555579264
"Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages     DESCRIPTION (provided by applicant): The gene regulatory networks underlying early human cardiovascular (CV) development is poorly understood, in large part due to the dearth of molecular and genetic information specifying the diversity of cardiovascular progenitor cell-types (CVPCs). Human pluripotent stem cell (hPSC)-derived CV cells provide a model for human cardiogenesis and afford us the opportunity to reveal the various CV cell types generated during heart development and to also functionally discover and validate CV developmental gene regulatory networks. In this proposal, we will employ single cell transcriptome (RNA-seq) analysis to dissect the heterogeneity of early CV progenitor populations that give rise to the spectrum of distinct CV cell types and their intermediates. By identifying these potentially rare and novel progenitor cell types as well as studying their lineage choice decisions at the single cell level, the cellular and molecular networks underlying these progenitor cells and their differentiated CV cell types that control their differentiation can be revealed. To achieve our goal, a synergistic and complementary collaboration between the Yeo and Chi labs will aim to (1) investigate the diversity and organization of CV cellular subtypes during cardiogenesis in vitro, (2) develop novel algorithms that enable the extraction of gene regulatory programs that specify CV lineage sub-networks and (3) investigate the functional significance of identified CV cell subtypes. If successful, we will reveal pathways and cell-types that will advance our basic and translational framework for treating congenital heart disease. PUBLIC HEALTH RELEVANCE: This proposal seeks to develop network-based algorithms to perform single-cell transcriptome analysis during derivation of cardiovascular progenitor cells from engineered human pluripotent stem cells to extract previously unknown subpopulations of cardiovascular cell-types and gene regulatory networks underlying cardiovascular lineage specification. These basic and translational studies will provide novel insights into human heart development as well as innovative strategies for developing future treatments for congenital heart disease, which accounts for a third of all major congenital anomalies.",Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages,9650612,R01HD085902,"['Accounting', 'Adult', 'Algorithms', 'Animal Model', 'Behavior', 'Biological Assay', 'Cardiovascular system', 'Cell Differentiation process', 'Cell Lineage', 'Cells', 'Chromatin', 'Collaborations', 'Communities', 'Computer Analysis', 'Data Set', 'Derivation procedure', 'Development', 'Developmental Gene', 'Event', 'Family', 'Fluorescent in Situ Hybridization', 'Future', 'Genes', 'Genetic Transcription', 'Genetic study', 'Goals', 'Heart', 'Heterogeneity', 'Human', 'Human Engineering', 'In Situ', 'In Situ Hybridization', 'In Vitro', 'Maintenance', 'Mediating', 'Modeling', 'Molecular', 'Molecular Genetics', 'Mutation', 'Network-based', 'Newborn Infant', 'Pathway interactions', 'Patients', 'Phenotype', 'Physicians', 'Population', 'Population Heterogeneity', 'Principal Component Analysis', 'Process', 'Protein Isoforms', 'Regulator Genes', 'Regulatory Pathway', 'Reporter', 'Research', 'Signal Pathway', 'Societies', 'Specific qualifier value', 'Stem cells', 'Technology', 'Testing', 'Tissues', 'Validation', 'base', 'cardiogenesis', 'cell type', 'congenital anomaly', 'congenital heart disorder', 'differential expression', 'genetic information', 'human model', 'human pluripotent stem cell', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'patient population', 'progenitor', 'programs', 'public health relevance', 'reconstruction', 'single cell analysis', 'transcriptome', 'transcriptome sequencing', 'translational study']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2019,613227,0.021291903555579264
"Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages     DESCRIPTION (provided by applicant): The gene regulatory networks underlying early human cardiovascular (CV) development is poorly understood, in large part due to the dearth of molecular and genetic information specifying the diversity of cardiovascular progenitor cell-types (CVPCs). Human pluripotent stem cell (hPSC)-derived CV cells provide a model for human cardiogenesis and afford us the opportunity to reveal the various CV cell types generated during heart development and to also functionally discover and validate CV developmental gene regulatory networks. In this proposal, we will employ single cell transcriptome (RNA-seq) analysis to dissect the heterogeneity of early CV progenitor populations that give rise to the spectrum of distinct CV cell types and their intermediates. By identifying these potentially rare and novel progenitor cell types as well as studying their lineage choice decisions at the single cell level, the cellular and molecular networks underlying these progenitor cells and their differentiated CV cell types that control their differentiation can be revealed. To achieve our goal, a synergistic and complementary collaboration between the Yeo and Chi labs will aim to (1) investigate the diversity and organization of CV cellular subtypes during cardiogenesis in vitro, (2) develop novel algorithms that enable the extraction of gene regulatory programs that specify CV lineage sub-networks and (3) investigate the functional significance of identified CV cell subtypes. If successful, we will reveal pathways and cell-types that will advance our basic and translational framework for treating congenital heart disease. PUBLIC HEALTH RELEVANCE: This proposal seeks to develop network-based algorithms to perform single-cell transcriptome analysis during derivation of cardiovascular progenitor cells from engineered human pluripotent stem cells to extract previously unknown subpopulations of cardiovascular cell-types and gene regulatory networks underlying cardiovascular lineage specification. These basic and translational studies will provide novel insights into human heart development as well as innovative strategies for developing future treatments for congenital heart disease, which accounts for a third of all major congenital anomalies.",Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages,9441025,R01HD085902,"['Accounting', 'Adult', 'Algorithms', 'Animal Model', 'Behavior', 'Biological Assay', 'Cardiovascular system', 'Cell Differentiation process', 'Cell Lineage', 'Cells', 'Chromatin', 'Collaborations', 'Communities', 'Computer Analysis', 'Data Set', 'Derivation procedure', 'Development', 'Developmental Gene', 'Event', 'Family', 'Fluorescent in Situ Hybridization', 'Future', 'Genes', 'Genetic Transcription', 'Genetic study', 'Goals', 'Heart', 'Heterogeneity', 'Human', 'Human Engineering', 'In Situ', 'In Situ Hybridization', 'In Vitro', 'Maintenance', 'Mediating', 'Modeling', 'Molecular', 'Molecular Genetics', 'Mutation', 'Network-based', 'Newborn Infant', 'Pathway interactions', 'Patients', 'Phenotype', 'Physicians', 'Population', 'Population Heterogeneity', 'Principal Component Analysis', 'Process', 'Protein Isoforms', 'Regulator Genes', 'Regulatory Pathway', 'Reporter', 'Research', 'Signal Pathway', 'Societies', 'Specific qualifier value', 'Stem cells', 'Technology', 'Testing', 'Tissues', 'Validation', 'base', 'cardiogenesis', 'cell type', 'congenital anomaly', 'congenital heart disorder', 'differential expression', 'genetic information', 'human model', 'human pluripotent stem cell', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'patient population', 'progenitor', 'programs', 'public health relevance', 'reconstruction', 'single cell analysis', 'transcriptome', 'transcriptome sequencing', 'translational study']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2018,625871,0.021291903555579264
"Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages     DESCRIPTION (provided by applicant): The gene regulatory networks underlying early human cardiovascular (CV) development is poorly understood, in large part due to the dearth of molecular and genetic information specifying the diversity of cardiovascular progenitor cell-types (CVPCs). Human pluripotent stem cell (hPSC)-derived CV cells provide a model for human cardiogenesis and afford us the opportunity to reveal the various CV cell types generated during heart development and to also functionally discover and validate CV developmental gene regulatory networks. In this proposal, we will employ single cell transcriptome (RNA-seq) analysis to dissect the heterogeneity of early CV progenitor populations that give rise to the spectrum of distinct CV cell types and their intermediates. By identifying these potentially rare and novel progenitor cell types as well as studying their lineage choice decisions at the single cell level, the cellular and molecular networks underlying these progenitor cells and their differentiated CV cell types that control their differentiation can be revealed. To achieve our goal, a synergistic and complementary collaboration between the Yeo and Chi labs will aim to (1) investigate the diversity and organization of CV cellular subtypes during cardiogenesis in vitro, (2) develop novel algorithms that enable the extraction of gene regulatory programs that specify CV lineage sub-networks and (3) investigate the functional significance of identified CV cell subtypes. If successful, we will reveal pathways and cell-types that will advance our basic and translational framework for treating congenital heart disease. PUBLIC HEALTH RELEVANCE: This proposal seeks to develop network-based algorithms to perform single-cell transcriptome analysis during derivation of cardiovascular progenitor cells from engineered human pluripotent stem cells to extract previously unknown subpopulations of cardiovascular cell-types and gene regulatory networks underlying cardiovascular lineage specification. These basic and translational studies will provide novel insights into human heart development as well as innovative strategies for developing future treatments for congenital heart disease, which accounts for a third of all major congenital anomalies.  ",Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages,9223716,R01HD085902,"['Accounting', 'Adult', 'Algorithms', 'Animal Model', 'Behavior', 'Biological Assay', 'Cardiovascular system', 'Cell Differentiation process', 'Cell Lineage', 'Cells', 'Chromatin', 'Collaborations', 'Communities', 'Computer Analysis', 'Data Set', 'Derivation procedure', 'Development', 'Developmental Gene', 'Event', 'Family', 'Fluorescent in Situ Hybridization', 'Future', 'Genes', 'Genetic Transcription', 'Genetic study', 'Goals', 'Heart', 'Heterogeneity', 'Human', 'Human Engineering', 'In Situ', 'In Vitro', 'Maintenance', 'Mediating', 'Modeling', 'Molecular', 'Molecular Genetics', 'Mutation', 'Network-based', 'Newborn Infant', 'Pathway interactions', 'Patients', 'Phenotype', 'Physicians', 'Population', 'Population Heterogeneity', 'Principal Component Analysis', 'Process', 'Protein Isoforms', 'Regulator Genes', 'Regulatory Pathway', 'Reporter', 'Research', 'Signal Pathway', 'Societies', 'Specific qualifier value', 'Stem cells', 'Technology', 'Testing', 'Tissues', 'Validation', 'base', 'cardiogenesis', 'cell type', 'congenital anomaly', 'congenital heart disorder', 'differential expression', 'genetic information', 'human pluripotent stem cell', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'patient population', 'progenitor', 'programs', 'public health relevance', 'reconstruction', 'single cell analysis', 'transcriptome', 'transcriptome sequencing', 'translational study']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2017,632755,0.021291903555579264
"Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages     DESCRIPTION (provided by applicant): The gene regulatory networks underlying early human cardiovascular (CV) development is poorly understood, in large part due to the dearth of molecular and genetic information specifying the diversity of cardiovascular progenitor cell-types (CVPCs). Human pluripotent stem cell (hPSC)-derived CV cells provide a model for human cardiogenesis and afford us the opportunity to reveal the various CV cell types generated during heart development and to also functionally discover and validate CV developmental gene regulatory networks. In this proposal, we will employ single cell transcriptome (RNA-seq) analysis to dissect the heterogeneity of early CV progenitor populations that give rise to the spectrum of distinct CV cell types and their intermediates. By identifying these potentially rare and novel progenitor cell types as well as studying their lineage choice decisions at the single cell level, the cellular and molecular networks underlying these progenitor cells and their differentiated CV cell types that control their differentiation can be revealed. To achieve our goal, a synergistic and complementary collaboration between the Yeo and Chi labs will aim to (1) investigate the diversity and organization of CV cellular subtypes during cardiogenesis in vitro, (2) develop novel algorithms that enable the extraction of gene regulatory programs that specify CV lineage sub-networks and (3) investigate the functional significance of identified CV cell subtypes. If successful, we will reveal pathways and cell-types that will advance our basic and translational framework for treating congenital heart disease.   PUBLIC HEALTH RELEVANCE: This proposal seeks to develop network-based algorithms to perform single-cell transcriptome analysis during derivation of cardiovascular progenitor cells from engineered human pluripotent stem cells to extract previously unknown subpopulations of cardiovascular cell-types and gene regulatory networks underlying cardiovascular lineage specification. These basic and translational studies will provide novel insights into human heart development as well as innovative strategies for developing future treatments for congenital heart disease, which accounts for a third of all major congenital anomalies.  ",Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages,8996084,R01HD085902,"['Accounting', 'Adult', 'Algorithms', 'Animal Model', 'Behavior', 'Biological Assay', 'Cardiovascular system', 'Cell Differentiation process', 'Cell Lineage', 'Cells', 'Chromatin', 'Collaborations', 'Communities', 'Computer Analysis', 'Data Set', 'Derivation procedure', 'Development', 'Developmental Gene', 'Event', 'Family', 'Fluorescent in Situ Hybridization', 'Future', 'Genes', 'Genetic study', 'Goals', 'Health', 'Heart', 'Heterogeneity', 'Histocompatibility Testing', 'Human', 'In Situ', 'In Vitro', 'Maintenance', 'Maps', 'Mediating', 'Modeling', 'Molecular', 'Molecular Genetics', 'Mutation', 'Network-based', 'Newborn Infant', 'Pathway interactions', 'Patients', 'Phenotype', 'Physicians', 'Pluripotent Stem Cells', 'Population', 'Population Heterogeneity', 'Principal Component Analysis', 'Process', 'Protein Isoforms', 'Regulator Genes', 'Regulatory Pathway', 'Reporter', 'Research', 'Signal Pathway', 'Societies', 'Specific qualifier value', 'Staging', 'Stem cells', 'Technology', 'Testing', 'Validation', 'base', 'cardiogenesis', 'cell type', 'cellular engineering', 'congenital anomaly', 'congenital heart disorder', 'differential expression', 'genetic information', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'patient population', 'progenitor', 'programs', 'reconstruction', 'single cell analysis', 'transcriptome', 'transcriptome sequencing', 'translational study']",NICHD,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2016,621688,0.021291903555579264
"COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS    DESCRIPTION (provided by applicant):  MicroRNAs (miRNAs) are involved in many diverse biological processes and a single miRNA can modulate the expression of hundreds of gene targets. Identification of miRNA targets is a critical first step for miRNA functional studies. Unfortunately, none of the existing computational tools are sufficient for the accurate prediction of miRNA targets. The major goal of this study is to significantly improve our ability to predict miRNA gene targets by developing and validating a new computational target prediction model. Our preliminary data indicate that machine learning techniques are effective in building improved target prediction models using expression profiling data. Based on these studies, we propose the hypothesis that the application of novel computational methods on large expression profiling datasets will lead to a robust bioinformatics model for miRNA target prediction. Under Specific Aim 1, we will build this model by first performing microarray profiling analyses to identify a large number of miRNA-down regulated genes. The expression profiling data generated from our study will then be used as training data to identify general sequence features that are important to miRNA target prediction. These features will be systematically analyzed in various computational frameworks to build a robust target prediction model, which will later be validated with independent experimental data. Under Specific Aim 2, this new model will be used to develop an online miRNA database for target prediction for all known miRNAs in humans and animals. In addition to bioinformatics target prediction data, the new database will also host data integrated from many heterogeneous sources. Thus, our new database will serve as an integrated web portal to retrieve relevant miRNA functional data with a focus on miRNA target gene regulation. Finally, under Specific Aim 3, we will evaluate the usefulness of the new computational model and database by initiating the development of new miRNA-based therapeutic strategies for disease control. As a specific example, we will test predicted oncogene modulation by natural and artificial miRNAs as a potential new strategy for cancer control. The successful completion of this project will significantly advance our ability to understand the gene regulation by miRNAs in a variety of normal physiological processes and disease states.      PUBLIC HEALTH RELEVANCE: MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.           RELEVANCE MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.",COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS,7897045,R01GM089784,"['Algorithms', 'Animals', 'Bioinformatics', 'Biological', 'Biological Process', 'Cancer Control', 'Categories', 'Cells', 'Cellular Assay', 'Communities', 'Computer Simulation', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Goals', 'Human', 'Internet', 'Knowledge', 'Lead', 'Learning', 'Machine Learning', 'MicroRNAs', 'Modeling', 'Molecular Profiling', 'Nature', 'Oncogenes', 'Oncogenic', 'Pathway interactions', 'Performance', 'Physiological Processes', 'Process', 'Publishing', 'Regulation', 'Source', 'Techniques', 'Testing', 'Therapeutic', 'Time', 'Training', 'base', 'computer framework', 'computerized tools', 'design', 'disorder control', 'improved', 'novel', 'overexpression', 'performance tests', 'public health relevance', 'tumor', 'wiki']",NIGMS,WASHINGTON UNIVERSITY,R01,2010,273600,0.06694589543372209
"COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS    DESCRIPTION (provided by applicant):  MicroRNAs (miRNAs) are involved in many diverse biological processes and a single miRNA can modulate the expression of hundreds of gene targets. Identification of miRNA targets is a critical first step for miRNA functional studies. Unfortunately, none of the existing computational tools are sufficient for the accurate prediction of miRNA targets. The major goal of this study is to significantly improve our ability to predict miRNA gene targets by developing and validating a new computational target prediction model. Our preliminary data indicate that machine learning techniques are effective in building improved target prediction models using expression profiling data. Based on these studies, we propose the hypothesis that the application of novel computational methods on large expression profiling datasets will lead to a robust bioinformatics model for miRNA target prediction. Under Specific Aim 1, we will build this model by first performing microarray profiling analyses to identify a large number of miRNA-down regulated genes. The expression profiling data generated from our study will then be used as training data to identify general sequence features that are important to miRNA target prediction. These features will be systematically analyzed in various computational frameworks to build a robust target prediction model, which will later be validated with independent experimental data. Under Specific Aim 2, this new model will be used to develop an online miRNA database for target prediction for all known miRNAs in humans and animals. In addition to bioinformatics target prediction data, the new database will also host data integrated from many heterogeneous sources. Thus, our new database will serve as an integrated web portal to retrieve relevant miRNA functional data with a focus on miRNA target gene regulation. Finally, under Specific Aim 3, we will evaluate the usefulness of the new computational model and database by initiating the development of new miRNA-based therapeutic strategies for disease control. As a specific example, we will test predicted oncogene modulation by natural and artificial miRNAs as a potential new strategy for cancer control. The successful completion of this project will significantly advance our ability to understand the gene regulation by miRNAs in a variety of normal physiological processes and disease states.       PUBLIC HEALTH RELEVANCE: MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.         ",COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS,8650899,R01GM089784,"['Algorithms', 'Animals', 'Bioinformatics', 'Biological', 'Biological Process', 'Cancer Control', 'Categories', 'Cells', 'Cellular Assay', 'Communities', 'Computer Simulation', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Goals', 'Human', 'Internet', 'Knowledge', 'Lead', 'Learning', 'Machine Learning', 'MicroRNAs', 'Modeling', 'Molecular Profiling', 'Nature', 'Oncogenes', 'Oncogenic', 'Pathway interactions', 'Performance', 'Physiological Processes', 'Process', 'Publishing', 'Regulation', 'Source', 'Techniques', 'Testing', 'Therapeutic', 'Time', 'Training', 'base', 'computer framework', 'computerized tools', 'design', 'disorder control', 'improved', 'novel', 'overexpression', 'performance tests', 'public health relevance', 'tumor', 'wiki']",NIGMS,WASHINGTON UNIVERSITY,R01,2014,300960,0.07078847073871142
"COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS    DESCRIPTION (provided by applicant):  MicroRNAs (miRNAs) are involved in many diverse biological processes and a single miRNA can modulate the expression of hundreds of gene targets. Identification of miRNA targets is a critical first step for miRNA functional studies. Unfortunately, none of the existing computational tools are sufficient for the accurate prediction of miRNA targets. The major goal of this study is to significantly improve our ability to predict miRNA gene targets by developing and validating a new computational target prediction model. Our preliminary data indicate that machine learning techniques are effective in building improved target prediction models using expression profiling data. Based on these studies, we propose the hypothesis that the application of novel computational methods on large expression profiling datasets will lead to a robust bioinformatics model for miRNA target prediction. Under Specific Aim 1, we will build this model by first performing microarray profiling analyses to identify a large number of miRNA-down regulated genes. The expression profiling data generated from our study will then be used as training data to identify general sequence features that are important to miRNA target prediction. These features will be systematically analyzed in various computational frameworks to build a robust target prediction model, which will later be validated with independent experimental data. Under Specific Aim 2, this new model will be used to develop an online miRNA database for target prediction for all known miRNAs in humans and animals. In addition to bioinformatics target prediction data, the new database will also host data integrated from many heterogeneous sources. Thus, our new database will serve as an integrated web portal to retrieve relevant miRNA functional data with a focus on miRNA target gene regulation. Finally, under Specific Aim 3, we will evaluate the usefulness of the new computational model and database by initiating the development of new miRNA-based therapeutic strategies for disease control. As a specific example, we will test predicted oncogene modulation by natural and artificial miRNAs as a potential new strategy for cancer control. The successful completion of this project will significantly advance our ability to understand the gene regulation by miRNAs in a variety of normal physiological processes and disease states.       PUBLIC HEALTH RELEVANCE: MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.         ",COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS,8454454,R01GM089784,"['Algorithms', 'Animals', 'Bioinformatics', 'Biological', 'Biological Process', 'Cancer Control', 'Categories', 'Cells', 'Cellular Assay', 'Communities', 'Computer Simulation', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Goals', 'Human', 'Internet', 'Knowledge', 'Lead', 'Learning', 'Machine Learning', 'MicroRNAs', 'Modeling', 'Molecular Profiling', 'Nature', 'Oncogenes', 'Oncogenic', 'Pathway interactions', 'Performance', 'Physiological Processes', 'Process', 'Publishing', 'Regulation', 'Source', 'Techniques', 'Testing', 'Therapeutic', 'Time', 'Training', 'base', 'computer framework', 'computerized tools', 'design', 'disorder control', 'improved', 'novel', 'overexpression', 'performance tests', 'public health relevance', 'tumor', 'wiki']",NIGMS,WASHINGTON UNIVERSITY,R01,2013,290426,0.07078847073871142
"COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS    DESCRIPTION (provided by applicant):  MicroRNAs (miRNAs) are involved in many diverse biological processes and a single miRNA can modulate the expression of hundreds of gene targets. Identification of miRNA targets is a critical first step for miRNA functional studies. Unfortunately, none of the existing computational tools are sufficient for the accurate prediction of miRNA targets. The major goal of this study is to significantly improve our ability to predict miRNA gene targets by developing and validating a new computational target prediction model. Our preliminary data indicate that machine learning techniques are effective in building improved target prediction models using expression profiling data. Based on these studies, we propose the hypothesis that the application of novel computational methods on large expression profiling datasets will lead to a robust bioinformatics model for miRNA target prediction. Under Specific Aim 1, we will build this model by first performing microarray profiling analyses to identify a large number of miRNA-down regulated genes. The expression profiling data generated from our study will then be used as training data to identify general sequence features that are important to miRNA target prediction. These features will be systematically analyzed in various computational frameworks to build a robust target prediction model, which will later be validated with independent experimental data. Under Specific Aim 2, this new model will be used to develop an online miRNA database for target prediction for all known miRNAs in humans and animals. In addition to bioinformatics target prediction data, the new database will also host data integrated from many heterogeneous sources. Thus, our new database will serve as an integrated web portal to retrieve relevant miRNA functional data with a focus on miRNA target gene regulation. Finally, under Specific Aim 3, we will evaluate the usefulness of the new computational model and database by initiating the development of new miRNA-based therapeutic strategies for disease control. As a specific example, we will test predicted oncogene modulation by natural and artificial miRNAs as a potential new strategy for cancer control. The successful completion of this project will significantly advance our ability to understand the gene regulation by miRNAs in a variety of normal physiological processes and disease states.      PUBLIC HEALTH RELEVANCE: MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.           RELEVANCE MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.",COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS,8244418,R01GM089784,"['Algorithms', 'Animals', 'Bioinformatics', 'Biological', 'Biological Process', 'Cancer Control', 'Categories', 'Cells', 'Cellular Assay', 'Communities', 'Computer Simulation', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Goals', 'Human', 'Internet', 'Knowledge', 'Lead', 'Learning', 'Machine Learning', 'MicroRNAs', 'Modeling', 'Molecular Profiling', 'Nature', 'Oncogenes', 'Oncogenic', 'Pathway interactions', 'Performance', 'Physiological Processes', 'Process', 'Publishing', 'Regulation', 'Source', 'Techniques', 'Testing', 'Therapeutic', 'Time', 'Training', 'base', 'computer framework', 'computerized tools', 'design', 'disorder control', 'improved', 'novel', 'overexpression', 'performance tests', 'public health relevance', 'tumor', 'wiki']",NIGMS,WASHINGTON UNIVERSITY,R01,2012,300960,0.06694589543372209
"COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS    DESCRIPTION (provided by applicant):  MicroRNAs (miRNAs) are involved in many diverse biological processes and a single miRNA can modulate the expression of hundreds of gene targets. Identification of miRNA targets is a critical first step for miRNA functional studies. Unfortunately, none of the existing computational tools are sufficient for the accurate prediction of miRNA targets. The major goal of this study is to significantly improve our ability to predict miRNA gene targets by developing and validating a new computational target prediction model. Our preliminary data indicate that machine learning techniques are effective in building improved target prediction models using expression profiling data. Based on these studies, we propose the hypothesis that the application of novel computational methods on large expression profiling datasets will lead to a robust bioinformatics model for miRNA target prediction. Under Specific Aim 1, we will build this model by first performing microarray profiling analyses to identify a large number of miRNA-down regulated genes. The expression profiling data generated from our study will then be used as training data to identify general sequence features that are important to miRNA target prediction. These features will be systematically analyzed in various computational frameworks to build a robust target prediction model, which will later be validated with independent experimental data. Under Specific Aim 2, this new model will be used to develop an online miRNA database for target prediction for all known miRNAs in humans and animals. In addition to bioinformatics target prediction data, the new database will also host data integrated from many heterogeneous sources. Thus, our new database will serve as an integrated web portal to retrieve relevant miRNA functional data with a focus on miRNA target gene regulation. Finally, under Specific Aim 3, we will evaluate the usefulness of the new computational model and database by initiating the development of new miRNA-based therapeutic strategies for disease control. As a specific example, we will test predicted oncogene modulation by natural and artificial miRNAs as a potential new strategy for cancer control. The successful completion of this project will significantly advance our ability to understand the gene regulation by miRNAs in a variety of normal physiological processes and disease states.      PUBLIC HEALTH RELEVANCE: MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.           RELEVANCE MicroRNAs are involved in many diverse biological processes and a single microRNA can modulate the expression of hundreds of gene targets. The major goal of this study is to significantly improve our ability to predict microRNA gene targets by developing and testing a new computational microRNA target prediction model. The successful completion of this project will significantly advance our ability to understand the gene regulation by microRNAs in a variety of normal physiological processes and disease states.",COMBINED COMPUTATIONAL AND EXPERIMENTAL ANALYSES OF GENE REGULATION BY MICRORNAS,8051646,R01GM089784,"['Algorithms', 'Animals', 'Bioinformatics', 'Biological', 'Biological Process', 'Cancer Control', 'Categories', 'Cells', 'Cellular Assay', 'Communities', 'Computer Simulation', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Goals', 'Human', 'Internet', 'Knowledge', 'Lead', 'Learning', 'Machine Learning', 'MicroRNAs', 'Modeling', 'Molecular Profiling', 'Nature', 'Oncogenes', 'Oncogenic', 'Pathway interactions', 'Performance', 'Physiological Processes', 'Process', 'Publishing', 'Regulation', 'Source', 'Techniques', 'Testing', 'Therapeutic', 'Time', 'Training', 'base', 'computer framework', 'computerized tools', 'design', 'disorder control', 'improved', 'novel', 'overexpression', 'performance tests', 'public health relevance', 'tumor', 'wiki']",NIGMS,WASHINGTON UNIVERSITY,R01,2011,300960,0.06694589543372209
"Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition PROJECTSUMMARY Our goal in this proposal is to identify biological networks involved in synchronizing placental growth and maturity.Toaccomplishthisgoal,wehaveestablishedacollaborativeeffortbetweentheCenterforPrevention of Preterm Birth at Cincinnati Childrens Hospital Medical Center (CCHMC) and the Institute for Systems Biology(ISB)inSeattletoconductasystemslevelanalysisofomicsdata.Perturbedgrowthandmaturitycan lead to placental insufficiency, which underlies a significant proportion of adverse pregnancy outcomes, such aspretermbirth.Apaucityofknowledgeregardingnormalplacentaldevelopmentandmaturitygreatlyhinders any study of placental insufficiency. Placental growth and development occurs throughout gestation and reachesmaturityatterm.Therefore,itiscriticaltoidentifythenetworksinvolvedandtoassessthemoverthe lengthofgestation.Ourcentralhypothesisisthatkeybiologicalnetworksvitaltoplacentalgrowthand maturity can be identified through the intersection of transcriptomic, proteomic, and metabolomics data from term and preterm placentae. Furthermore, utilizing longitudinal proteomics and metabolomics data, we can determine how those pathways change over gestation and differ between normal and preterm placentae.Wewilltestthishypothesisthroughthefollowingaims: Aim 1: Identification of key gene and metabolite signatures involved in placental development by analyzing longitudinal omics data. Using publically available transcriptomic data, we will generate a molecularprofileofexpressedgenesinplacentaldevelopmentthroughoutgestation.Wewillalsodetermine the placental secretome and identify biomarker signatures that appear in maternal urine that reflect placental maturation. Aim 2: Identification of molecular pathways associated with placental maturity. We will utilize network topologyalgorithmstoidentifychangesinmolecularpathwaysinpretermandtermplacentae.Thesedatawill be combined with publically available data to identify molecular pathways and genes within those pathways thatdifferbetweentermandpretermplacentaetoprovideinsightintoplacentalmaturity. Aim3:Generationofaplacenta-specifictranscriptionalnetworkforidentifyingregulatorymechanisms involved in placental maturity. We will construct genome-scale, tissue specific models of placental transcriptional regulatory networks using our newly-developed Transcriptional Regulatory Network Analysis (TRENA) approach, which leverages a wealth of information from the NIHs ENCODE project. We will characterize which transcriptional regulators are most likely responsible for perturbed gene expression, their signalingpathwaysanddownstreamtargets.Previouslyunknownorunderstudiednetworksorgenesidentified targetedforfurtheranalysesinplacentalgrowthandmaturityandfutureprospectiveclinicalstudies.   PROJECTNARRATIVE  Thenormaldevelopmentoftheplacentalisessentialforoptimalpregnancyoutcomes,andunderstandingnormal and pathological placental development will allow new opportunities to prevent major public health concerns suchaspretermbirth,preeclampsia,andintrauterinegrowthrestriction.Thisworkwillseektodevelopnew,non- invasive strategies to monitor human placental maturation, reflecting normal development, against which deviationscanbedeterminedearlierinpregnancyformoreeffectiveinterventions. ","Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition",9302935,R01HD091527,"['Accounting', 'Algorithms', 'Archives', 'Biochemical Pathway', 'Biological', 'Biological Assay', 'Biological Markers', 'Birth', 'Blood', 'Clinical Research', 'Data', 'Databases', 'Development', 'Ethics', 'Fetal Growth', 'Fetal Growth Retardation', 'First Pregnancy Trimester', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Generations', 'Genes', 'Genetic Transcription', 'Goals', 'Growth', 'Growth and Development function', 'Human', 'Institutes', 'Knowledge', 'Lead', 'Length', 'Machine Learning', 'Medical', 'Medical center', 'Methodology', 'Modeling', 'Molecular', 'Molecular Profiling', 'Monitor', 'Pathologic', 'Pathway Analysis', 'Pathway interactions', 'Pediatric Hospitals', 'Peptides', 'Peripheral', 'Placenta', 'Placental Biology', 'Placental Insufficiency', 'Placentation', 'Pre-Eclampsia', 'Pregnancy', 'Pregnancy Outcome', 'Premature Birth', 'Prevention', 'Proteins', 'Proteomics', 'Public Health', 'Role', 'Sampling', 'Signal Pathway', 'Source', 'System', 'Systems Biology', 'Testing', 'Tissues', 'United States National Institutes of Health', 'Urine', 'Work', 'adverse pregnancy outcome', 'biomarker panel', 'database design', 'effective intervention', 'fetal', 'genome-wide', 'infant death', 'insight', 'longitudinal analysis', 'maternal serum', 'metabolomics', 'premature', 'prevent', 'prospective', 'transcription factor', 'transcriptomics']",NICHD,CINCINNATI CHILDRENS HOSP MED CTR,R01,2017,668125,0.05568413858965685
"Harnessing ""omics"": A Systems Biology approach to discovery of biologicalpathways in placental development and parturition PROJECTSUMMARY Our goal in this proposal is to identify biological networks involved in synchronizing placental growth and maturity.Toaccomplishthisgoal,wehaveestablishedacollaborativeeffortbetweentheCenterforPrevention of Preterm Birth at Cincinnati Childrens Hospital Medical Center (CCHMC) and the Institute for Systems Biology(ISB)inSeattletoconductasystemslevelanalysisofomicsdata.Perturbedgrowthandmaturitycan lead to placental insufficiency, which underlies a significant proportion of adverse pregnancy outcomes, such aspretermbirth.Apaucityofknowledgeregardingnormalplacentaldevelopmentandmaturitygreatlyhinders any study of placental insufficiency. Placental growth and development occurs throughout gestation and reachesmaturityatterm.Therefore,itiscriticaltoidentifythenetworksinvolvedandtoassessthemoverthe lengthofgestation.Ourcentralhypothesisisthatkeybiologicalnetworksvitaltoplacentalgrowthand maturity can be identified through the intersection of transcriptomic, proteomic, and metabolomics data from term and preterm placentae. Furthermore, utilizing longitudinal proteomics and metabolomics data, we can determine how those pathways change over gestation and differ between normal and preterm placentae.Wewilltestthishypothesisthroughthefollowingaims: Aim 1: Identification of key gene and metabolite signatures involved in placental development by analyzing longitudinal omics data. Using publically available transcriptomic data, we will generate a molecularprofileofexpressedgenesinplacentaldevelopmentthroughoutgestation.Wewillalsodetermine the placental secretome and identify biomarker signatures that appear in maternal urine that reflect placental maturation. Aim 2: Identification of molecular pathways associated with placental maturity. We will utilize network topologyalgorithmstoidentifychangesinmolecularpathwaysinpretermandtermplacentae.Thesedatawill be combined with publically available data to identify molecular pathways and genes within those pathways thatdifferbetweentermandpretermplacentaetoprovideinsightintoplacentalmaturity. Aim3:Generationofaplacenta-specifictranscriptionalnetworkforidentifyingregulatorymechanisms involved in placental maturity. We will construct genome-scale, tissue specific models of placental transcriptional regulatory networks using our newly-developed Transcriptional Regulatory Network Analysis (TRENA) approach, which leverages a wealth of information from the NIHs ENCODE project. We will characterize which transcriptional regulators are most likely responsible for perturbed gene expression, their signalingpathwaysanddownstreamtargets.Previouslyunknownorunderstudiednetworksorgenesidentified targetedforfurtheranalysesinplacentalgrowthandmaturityandfutureprospectiveclinicalstudies.   PROJECTNARRATIVE  Thenormaldevelopmentoftheplacentalisessentialforoptimalpregnancyoutcomes,andunderstandingnormal and pathological placental development will allow new opportunities to prevent major public health concerns suchaspretermbirth,preeclampsia,andintrauterinegrowthrestriction.Thisworkwillseektodevelopnew,non- invasive strategies to monitor human placental maturation, reflecting normal development, against which deviationscanbedeterminedearlierinpregnancyformoreeffectiveinterventions. ","Harnessing ""omics"": A Systems Biology approach to discovery of biologicalpathways in placental development and parturition",10243626,R01HD091527,"['Accounting', 'Algorithms', 'Archives', 'Biochemical Pathway', 'Biological', 'Biological Assay', 'Biological Markers', 'Birth', 'Blood', 'Clinical Research', 'Data', 'Databases', 'Development', 'Ethics', 'Fetal Growth', 'Fetal Growth Retardation', 'First Pregnancy Trimester', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic Transcription', 'Goals', 'Growth', 'Growth and Development function', 'Human', 'Institutes', 'Knowledge', 'Lead', 'Length', 'Medical', 'Medical center', 'Methodology', 'Modeling', 'Molecular', 'Molecular Profiling', 'Monitor', 'Pathologic', 'Pathway Analysis', 'Pathway interactions', 'Pediatric Hospitals', 'Peptides', 'Peripheral', 'Placenta', 'Placental Biology', 'Placental Insufficiency', 'Placentation', 'Pre-Eclampsia', 'Pregnancy', 'Pregnancy Outcome', 'Premature Birth', 'Prevention', 'Proteins', 'Proteomics', 'Public Health', 'Role', 'Sampling', 'Signal Pathway', 'Source', 'System', 'Systems Biology', 'Testing', 'Tissues', 'United States National Institutes of Health', 'Urine', 'Work', 'adverse pregnancy outcome', 'biomarker panel', 'database design', 'effective intervention', 'fetal', 'genome-wide', 'infant death', 'insight', 'longitudinal analysis', 'machine learning algorithm', 'maternal serum', 'metabolomics', 'premature', 'prevent', 'prospective', 'transcription factor', 'transcriptomics']",NICHD,UNIVERSITY OF FLORIDA,R01,2020,357022,0.05568413858965685
"Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition PROJECTSUMMARY Our goal in this proposal is to identify biological networks involved in synchronizing placental growth and maturity.Toaccomplishthisgoal,wehaveestablishedacollaborativeeffortbetweentheCenterforPrevention of Preterm Birth at Cincinnati Childrens Hospital Medical Center (CCHMC) and the Institute for Systems Biology(ISB)inSeattletoconductasystemslevelanalysisofomicsdata.Perturbedgrowthandmaturitycan lead to placental insufficiency, which underlies a significant proportion of adverse pregnancy outcomes, such aspretermbirth.Apaucityofknowledgeregardingnormalplacentaldevelopmentandmaturitygreatlyhinders any study of placental insufficiency. Placental growth and development occurs throughout gestation and reachesmaturityatterm.Therefore,itiscriticaltoidentifythenetworksinvolvedandtoassessthemoverthe lengthofgestation.Ourcentralhypothesisisthatkeybiologicalnetworksvitaltoplacentalgrowthand maturity can be identified through the intersection of transcriptomic, proteomic, and metabolomics data from term and preterm placentae. Furthermore, utilizing longitudinal proteomics and metabolomics data, we can determine how those pathways change over gestation and differ between normal and preterm placentae.Wewilltestthishypothesisthroughthefollowingaims: Aim 1: Identification of key gene and metabolite signatures involved in placental development by analyzing longitudinal omics data. Using publically available transcriptomic data, we will generate a molecularprofileofexpressedgenesinplacentaldevelopmentthroughoutgestation.Wewillalsodetermine the placental secretome and identify biomarker signatures that appear in maternal urine that reflect placental maturation. Aim 2: Identification of molecular pathways associated with placental maturity. We will utilize network topologyalgorithmstoidentifychangesinmolecularpathwaysinpretermandtermplacentae.Thesedatawill be combined with publically available data to identify molecular pathways and genes within those pathways thatdifferbetweentermandpretermplacentaetoprovideinsightintoplacentalmaturity. Aim3:Generationofaplacenta-specifictranscriptionalnetworkforidentifyingregulatorymechanisms involved in placental maturity. We will construct genome-scale, tissue specific models of placental transcriptional regulatory networks using our newly-developed Transcriptional Regulatory Network Analysis (TRENA) approach, which leverages a wealth of information from the NIHs ENCODE project. We will characterize which transcriptional regulators are most likely responsible for perturbed gene expression, their signalingpathwaysanddownstreamtargets.Previouslyunknownorunderstudiednetworksorgenesidentified targetedforfurtheranalysesinplacentalgrowthandmaturityandfutureprospectiveclinicalstudies.   PROJECTNARRATIVE  Thenormaldevelopmentoftheplacentalisessentialforoptimalpregnancyoutcomes,andunderstandingnormal and pathological placental development will allow new opportunities to prevent major public health concerns suchaspretermbirth,preeclampsia,andintrauterinegrowthrestriction.Thisworkwillseektodevelopnew,non- invasive strategies to monitor human placental maturation, reflecting normal development, against which deviationscanbedeterminedearlierinpregnancyformoreeffectiveinterventions. ","Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition",9855015,R01HD091527,"['Accounting', 'Algorithms', 'Archives', 'Biochemical Pathway', 'Biological', 'Biological Assay', 'Biological Markers', 'Birth', 'Blood', 'Clinical Research', 'Data', 'Databases', 'Development', 'Ethics', 'Fetal Growth', 'Fetal Growth Retardation', 'First Pregnancy Trimester', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic Transcription', 'Goals', 'Growth', 'Growth and Development function', 'Human', 'Institutes', 'Knowledge', 'Lead', 'Length', 'Medical', 'Medical center', 'Methodology', 'Modeling', 'Molecular', 'Molecular Profiling', 'Monitor', 'Pathologic', 'Pathway Analysis', 'Pathway interactions', 'Pediatric Hospitals', 'Peptides', 'Peripheral', 'Placenta', 'Placental Biology', 'Placental Insufficiency', 'Placentation', 'Pre-Eclampsia', 'Pregnancy', 'Pregnancy Outcome', 'Premature Birth', 'Prevention', 'Proteins', 'Proteomics', 'Public Health', 'Role', 'Sampling', 'Signal Pathway', 'Source', 'System', 'Systems Biology', 'Testing', 'Tissues', 'United States National Institutes of Health', 'Urine', 'Work', 'adverse pregnancy outcome', 'biomarker panel', 'database design', 'effective intervention', 'fetal', 'genome-wide', 'infant death', 'insight', 'longitudinal analysis', 'machine learning algorithm', 'maternal serum', 'metabolomics', 'premature', 'prevent', 'prospective', 'transcription factor', 'transcriptomics']",NICHD,CINCINNATI CHILDRENS HOSP MED CTR,R01,2020,149117,0.05568413858965685
"Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition PROJECTSUMMARY Our goal in this proposal is to identify biological networks involved in synchronizing placental growth and maturity.Toaccomplishthisgoal,wehaveestablishedacollaborativeeffortbetweentheCenterforPrevention of Preterm Birth at Cincinnati Childrens Hospital Medical Center (CCHMC) and the Institute for Systems Biology(ISB)inSeattletoconductasystemslevelanalysisofomicsdata.Perturbedgrowthandmaturitycan lead to placental insufficiency, which underlies a significant proportion of adverse pregnancy outcomes, such aspretermbirth.Apaucityofknowledgeregardingnormalplacentaldevelopmentandmaturitygreatlyhinders any study of placental insufficiency. Placental growth and development occurs throughout gestation and reachesmaturityatterm.Therefore,itiscriticaltoidentifythenetworksinvolvedandtoassessthemoverthe lengthofgestation.Ourcentralhypothesisisthatkeybiologicalnetworksvitaltoplacentalgrowthand maturity can be identified through the intersection of transcriptomic, proteomic, and metabolomics data from term and preterm placentae. Furthermore, utilizing longitudinal proteomics and metabolomics data, we can determine how those pathways change over gestation and differ between normal and preterm placentae.Wewilltestthishypothesisthroughthefollowingaims: Aim 1: Identification of key gene and metabolite signatures involved in placental development by analyzing longitudinal omics data. Using publically available transcriptomic data, we will generate a molecularprofileofexpressedgenesinplacentaldevelopmentthroughoutgestation.Wewillalsodetermine the placental secretome and identify biomarker signatures that appear in maternal urine that reflect placental maturation. Aim 2: Identification of molecular pathways associated with placental maturity. We will utilize network topologyalgorithmstoidentifychangesinmolecularpathwaysinpretermandtermplacentae.Thesedatawill be combined with publically available data to identify molecular pathways and genes within those pathways thatdifferbetweentermandpretermplacentaetoprovideinsightintoplacentalmaturity. Aim3:Generationofaplacenta-specifictranscriptionalnetworkforidentifyingregulatorymechanisms involved in placental maturity. We will construct genome-scale, tissue specific models of placental transcriptional regulatory networks using our newly-developed Transcriptional Regulatory Network Analysis (TRENA) approach, which leverages a wealth of information from the NIHs ENCODE project. We will characterize which transcriptional regulators are most likely responsible for perturbed gene expression, their signalingpathwaysanddownstreamtargets.Previouslyunknownorunderstudiednetworksorgenesidentified targetedforfurtheranalysesinplacentalgrowthandmaturityandfutureprospectiveclinicalstudies.   PROJECTNARRATIVE  Thenormaldevelopmentoftheplacentalisessentialforoptimalpregnancyoutcomes,andunderstandingnormal and pathological placental development will allow new opportunities to prevent major public health concerns suchaspretermbirth,preeclampsia,andintrauterinegrowthrestriction.Thisworkwillseektodevelopnew,non- invasive strategies to monitor human placental maturation, reflecting normal development, against which deviationscanbedeterminedearlierinpregnancyformoreeffectiveinterventions. ","Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition",9650596,R01HD091527,"['Accounting', 'Algorithms', 'Archives', 'Biochemical Pathway', 'Biological', 'Biological Assay', 'Biological Markers', 'Birth', 'Blood', 'Clinical Research', 'Data', 'Databases', 'Development', 'Ethics', 'Fetal Growth', 'Fetal Growth Retardation', 'First Pregnancy Trimester', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic Transcription', 'Goals', 'Growth', 'Growth and Development function', 'Human', 'Institutes', 'Knowledge', 'Lead', 'Length', 'Medical', 'Medical center', 'Methodology', 'Modeling', 'Molecular', 'Molecular Profiling', 'Monitor', 'Pathologic', 'Pathway Analysis', 'Pathway interactions', 'Pediatric Hospitals', 'Peptides', 'Peripheral', 'Placenta', 'Placental Biology', 'Placental Insufficiency', 'Placentation', 'Pre-Eclampsia', 'Pregnancy', 'Pregnancy Outcome', 'Premature Birth', 'Prevention', 'Proteins', 'Proteomics', 'Public Health', 'Role', 'Sampling', 'Signal Pathway', 'Source', 'System', 'Systems Biology', 'Testing', 'Tissues', 'United States National Institutes of Health', 'Urine', 'Work', 'adverse pregnancy outcome', 'biomarker panel', 'database design', 'effective intervention', 'fetal', 'genome-wide', 'infant death', 'insight', 'longitudinal analysis', 'machine learning algorithm', 'maternal serum', 'metabolomics', 'premature', 'prevent', 'prospective', 'transcription factor', 'transcriptomics']",NICHD,CINCINNATI CHILDRENS HOSP MED CTR,R01,2019,472976,0.05568413858965685
"Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition PROJECTSUMMARY Our goal in this proposal is to identify biological networks involved in synchronizing placental growth and maturity.Toaccomplishthisgoal,wehaveestablishedacollaborativeeffortbetweentheCenterforPrevention of Preterm Birth at Cincinnati Childrens Hospital Medical Center (CCHMC) and the Institute for Systems Biology(ISB)inSeattletoconductasystemslevelanalysisofomicsdata.Perturbedgrowthandmaturitycan lead to placental insufficiency, which underlies a significant proportion of adverse pregnancy outcomes, such aspretermbirth.Apaucityofknowledgeregardingnormalplacentaldevelopmentandmaturitygreatlyhinders any study of placental insufficiency. Placental growth and development occurs throughout gestation and reachesmaturityatterm.Therefore,itiscriticaltoidentifythenetworksinvolvedandtoassessthemoverthe lengthofgestation.Ourcentralhypothesisisthatkeybiologicalnetworksvitaltoplacentalgrowthand maturity can be identified through the intersection of transcriptomic, proteomic, and metabolomics data from term and preterm placentae. Furthermore, utilizing longitudinal proteomics and metabolomics data, we can determine how those pathways change over gestation and differ between normal and preterm placentae.Wewilltestthishypothesisthroughthefollowingaims: Aim 1: Identification of key gene and metabolite signatures involved in placental development by analyzing longitudinal omics data. Using publically available transcriptomic data, we will generate a molecularprofileofexpressedgenesinplacentaldevelopmentthroughoutgestation.Wewillalsodetermine the placental secretome and identify biomarker signatures that appear in maternal urine that reflect placental maturation. Aim 2: Identification of molecular pathways associated with placental maturity. We will utilize network topologyalgorithmstoidentifychangesinmolecularpathwaysinpretermandtermplacentae.Thesedatawill be combined with publically available data to identify molecular pathways and genes within those pathways thatdifferbetweentermandpretermplacentaetoprovideinsightintoplacentalmaturity. Aim3:Generationofaplacenta-specifictranscriptionalnetworkforidentifyingregulatorymechanisms involved in placental maturity. We will construct genome-scale, tissue specific models of placental transcriptional regulatory networks using our newly-developed Transcriptional Regulatory Network Analysis (TRENA) approach, which leverages a wealth of information from the NIHs ENCODE project. We will characterize which transcriptional regulators are most likely responsible for perturbed gene expression, their signalingpathwaysanddownstreamtargets.Previouslyunknownorunderstudiednetworksorgenesidentified targetedforfurtheranalysesinplacentalgrowthandmaturityandfutureprospectiveclinicalstudies.   PROJECTNARRATIVE  Thenormaldevelopmentoftheplacentalisessentialforoptimalpregnancyoutcomes,andunderstandingnormal and pathological placental development will allow new opportunities to prevent major public health concerns suchaspretermbirth,preeclampsia,andintrauterinegrowthrestriction.Thisworkwillseektodevelopnew,non- invasive strategies to monitor human placental maturation, reflecting normal development, against which deviationscanbedeterminedearlierinpregnancyformoreeffectiveinterventions. ","Harnessing ""omics"": A Systems Biology approach to discovery of biological pathways in placental development and parturition",9452089,R01HD091527,"['Accounting', 'Algorithms', 'Archives', 'Biochemical Pathway', 'Biological', 'Biological Assay', 'Biological Markers', 'Birth', 'Blood', 'Clinical Research', 'Data', 'Databases', 'Development', 'Ethics', 'Fetal Growth', 'Fetal Growth Retardation', 'First Pregnancy Trimester', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Generations', 'Genes', 'Genetic Transcription', 'Goals', 'Growth', 'Growth and Development function', 'Human', 'Institutes', 'Knowledge', 'Lead', 'Length', 'Machine Learning', 'Medical', 'Medical center', 'Methodology', 'Modeling', 'Molecular', 'Molecular Profiling', 'Monitor', 'Pathologic', 'Pathway Analysis', 'Pathway interactions', 'Pediatric Hospitals', 'Peptides', 'Peripheral', 'Placenta', 'Placental Biology', 'Placental Insufficiency', 'Placentation', 'Pre-Eclampsia', 'Pregnancy', 'Pregnancy Outcome', 'Premature Birth', 'Prevention', 'Proteins', 'Proteomics', 'Public Health', 'Role', 'Sampling', 'Signal Pathway', 'Source', 'System', 'Systems Biology', 'Testing', 'Tissues', 'United States National Institutes of Health', 'Urine', 'Work', 'adverse pregnancy outcome', 'biomarker panel', 'database design', 'effective intervention', 'fetal', 'genome-wide', 'infant death', 'insight', 'longitudinal analysis', 'maternal serum', 'metabolomics', 'premature', 'prevent', 'prospective', 'transcription factor', 'transcriptomics']",NICHD,CINCINNATI CHILDRENS HOSP MED CTR,R01,2018,591415,0.05568413858965685
"PROMOTERS     DESCRIPTION (provided by applicant): The long-term goal of this project is to understand the combinatorial rules that govern the interactions between transcription factor binding sites (TFBS). Through these rules, combinations of TFBS specify an enormous diversity of gene expression patterns. Normal growth and development depends on the tight control of TFBS over levels of gene expression in both time and space, and aberrant regulation of gene expression underlies many genetic diseases. Although much progress has been made identifying TFBS, and the transcription factors (TFs) that bind to them, much less is known about how TFBS interact with each other to generate specific patterns of gene expression. In particular we lack an understanding of how specificity is achieved in large genomes where the cell must distinguish between ""true"" cis-regulatory elements and thousands of similar, but non-functional sequences. The proposal addresses this problem through experiments designed to unravel the mechanisms that govern cis-regulatory element specificity. Large libraries of simplified synthetic promoters will be constructed and assayed for expression, TF occupancy, and chromatin state. The data from these libraries will be analyzed with a thermodynamic model that describes the physical interactions between TFBS, TFs, RNA polymerase, and other elements that determine cis- regulatory activity. The models we produce from synthetic promoters will be explicitly tested on genomic promoters. The three aims of the proposal are organized around three different sources of information that determine specificity. In Aim1 we test the hypothesis that functional TFBS are specified by their interactions with other nearby TFBS. In Aim2 we explore the extent to which local sequence features besides TFBS help specify functional cis-regulatory elements. Finally, in Aim3 we will test the extent to which the chromosomal position and chromatin state of cis-regulatory elements influence the interactions between TFBS that govern their activity. The successful completion of the aims of this proposal will result in a quantitative and molecular understanding of the rules underlying combinatorial cis-regulation. Such an understanding is necessary to empower biomedical applications, such as stem cell engineering, that are based on manipulating gene expression patterns. The results produced from this proposal will also help guide the annotation of the large regions of non-coding DNA in the genome that specify gene expression patterns. Finally, a clear understanding of TFBS interactions will help the identification and interpretation of disease causing genetic variants that affect cis-regulation. PUBLIC HEALTH RELEVANCE: In addition to serving as a ""parts list"" of genes, the genome also encodes information that controls precisely where, when, and to what levels genes are produced (expressed). Strict control of gene expression is critical for normal growth and development, and aberrant gene expression underlies many genetic diseases, including cancer. Successful completion of the experiments in this proposal will illuminate the processes through which information in the genome controls precise patterns of gene expression, and will help us interpret disease causing genetic variants that alter normal patterns of gene expression.",PROMOTERS,9490337,R01GM092910,"['Address', 'Affect', 'Binding', 'Binding Sites', 'Biological Assay', 'Cells', 'Chromatin', 'Chromatin Structure', 'Chromosome Positioning', 'Collection', 'DNA', 'DNA Sequence', 'DNA-Directed RNA Polymerase', 'Data', 'Disease', 'Elements', 'Explosion', 'Funding', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic Diseases', 'Genetic Transcription', 'Genome', 'Genomic DNA', 'Genomics', 'Goals', 'Grant', 'Growth and Development function', 'Learning', 'Libraries', 'Machine Learning', 'Malignant Neoplasms', 'Mammalian Cell', 'Measures', 'Modeling', 'Modification', 'Molecular', 'Process', 'Regulation', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Site', 'Source', 'Specific qualifier value', 'Specificity', 'Stem cells', 'System', 'Techniques', 'Test Result', 'Testing', 'Thermodynamics', 'Time', 'To specify', 'Training', 'Transcriptional Regulation', 'Untranslated RNA', 'Variant', 'base', 'cellular engineering', 'chromatin modification', 'chromosomal location', 'combinatorial', 'design', 'experimental study', 'genetic variant', 'genome editing', 'insight', 'predictive modeling', 'promoter', 'public health relevance', 'synthetic genomics', 'transcription factor']",NIGMS,WASHINGTON UNIVERSITY,R01,2018,397299,0.05800712815652209
"PROMOTERS     DESCRIPTION (provided by applicant): The long-term goal of this project is to understand the combinatorial rules that govern the interactions between transcription factor binding sites (TFBS). Through these rules, combinations of TFBS specify an enormous diversity of gene expression patterns. Normal growth and development depends on the tight control of TFBS over levels of gene expression in both time and space, and aberrant regulation of gene expression underlies many genetic diseases. Although much progress has been made identifying TFBS, and the transcription factors (TFs) that bind to them, much less is known about how TFBS interact with each other to generate specific patterns of gene expression. In particular we lack an understanding of how specificity is achieved in large genomes where the cell must distinguish between ""true"" cis-regulatory elements and thousands of similar, but non-functional sequences. The proposal addresses this problem through experiments designed to unravel the mechanisms that govern cis-regulatory element specificity. Large libraries of simplified synthetic promoters will be constructed and assayed for expression, TF occupancy, and chromatin state. The data from these libraries will be analyzed with a thermodynamic model that describes the physical interactions between TFBS, TFs, RNA polymerase, and other elements that determine cis- regulatory activity. The models we produce from synthetic promoters will be explicitly tested on genomic promoters. The three aims of the proposal are organized around three different sources of information that determine specificity. In Aim1 we test the hypothesis that functional TFBS are specified by their interactions with other nearby TFBS. In Aim2 we explore the extent to which local sequence features besides TFBS help specify functional cis-regulatory elements. Finally, in Aim3 we will test the extent to which the chromosomal position and chromatin state of cis-regulatory elements influence the interactions between TFBS that govern their activity. The successful completion of the aims of this proposal will result in a quantitative and molecular understanding of the rules underlying combinatorial cis-regulation. Such an understanding is necessary to empower biomedical applications, such as stem cell engineering, that are based on manipulating gene expression patterns. The results produced from this proposal will also help guide the annotation of the large regions of non-coding DNA in the genome that specify gene expression patterns. Finally, a clear understanding of TFBS interactions will help the identification and interpretation of disease causing genetic variants that affect cis-regulation. PUBLIC HEALTH RELEVANCE: In addition to serving as a ""parts list"" of genes, the genome also encodes information that controls precisely where, when, and to what levels genes are produced (expressed). Strict control of gene expression is critical for normal growth and development, and aberrant gene expression underlies many genetic diseases, including cancer. Successful completion of the experiments in this proposal will illuminate the processes through which information in the genome controls precise patterns of gene expression, and will help us interpret disease causing genetic variants that alter normal patterns of gene expression.",PROMOTERS,9280975,R01GM092910,"['Address', 'Affect', 'Binding', 'Binding Sites', 'Biological Assay', 'Cells', 'Chromatin', 'Chromatin Structure', 'Chromosome Positioning', 'Collection', 'DNA', 'DNA Sequence', 'DNA-Directed RNA Polymerase', 'Data', 'Disease', 'Elements', 'Explosion', 'Funding', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic DNA', 'Genomics', 'Goals', 'Grant', 'Growth and Development function', 'Hereditary Disease', 'Learning', 'Libraries', 'Machine Learning', 'Malignant Neoplasms', 'Mammalian Cell', 'Measures', 'Modeling', 'Modification', 'Molecular', 'Process', 'Regulation', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Site', 'Source', 'Specific qualifier value', 'Specificity', 'Stem cells', 'System', 'Techniques', 'Test Result', 'Testing', 'Thermodynamics', 'Time', 'To specify', 'Training', 'Transcriptional Regulation', 'Untranslated RNA', 'Variant', 'base', 'cellular engineering', 'chromatin modification', 'chromosomal location', 'combinatorial', 'design', 'experimental study', 'genetic variant', 'genome editing', 'insight', 'predictive modeling', 'promoter', 'public health relevance', 'synthetic genomics', 'transcription factor']",NIGMS,WASHINGTON UNIVERSITY,R01,2017,397299,0.05800712815652209
"ANALYSIS OF COMBINATORIAL CIS-REGULATION IN SYNTHETIC AND GENOMIC PROMOTER     DESCRIPTION (provided by applicant): The long-term goal of this project is to understand the combinatorial rules that govern the interactions between transcription factor binding sites (TFBS). Through these rules, combinations of TFBS specify an enormous diversity of gene expression patterns. Normal growth and development depends on the tight control of TFBS over levels of gene expression in both time and space, and aberrant regulation of gene expression underlies many genetic diseases. Although much progress has been made identifying TFBS, and the transcription factors (TFs) that bind to them, much less is known about how TFBS interact with each other to generate specific patterns of gene expression. In particular we lack an understanding of how specificity is achieved in large genomes where the cell must distinguish between ""true"" cis-regulatory elements and thousands of similar, but non-functional sequences. The proposal addresses this problem through experiments designed to unravel the mechanisms that govern cis-regulatory element specificity. Large libraries of simplified synthetic promoters will be constructed and assayed for expression, TF occupancy, and chromatin state. The data from these libraries will be analyzed with a thermodynamic model that describes the physical interactions between TFBS, TFs, RNA polymerase, and other elements that determine cis- regulatory activity. The models we produce from synthetic promoters will be explicitly tested on genomic promoters. The three aims of the proposal are organized around three different sources of information that determine specificity. In Aim1 we test the hypothesis that functional TFBS are specified by their interactions with other nearby TFBS. In Aim2 we explore the extent to which local sequence features besides TFBS help specify functional cis-regulatory elements. Finally, in Aim3 we will test the extent to which the chromosomal position and chromatin state of cis-regulatory elements influence the interactions between TFBS that govern their activity. The successful completion of the aims of this proposal will result in a quantitative and molecular understanding of the rules underlying combinatorial cis-regulation. Such an understanding is necessary to empower biomedical applications, such as stem cell engineering, that are based on manipulating gene expression patterns. The results produced from this proposal will also help guide the annotation of the large regions of non-coding DNA in the genome that specify gene expression patterns. Finally, a clear understanding of TFBS interactions will help the identification and interpretation of disease causing genetic variants that affect cis-regulation.         PUBLIC HEALTH RELEVANCE: In addition to serving as a ""parts list"" of genes, the genome also encodes information that controls precisely where, when, and to what levels genes are produced (expressed). Strict control of gene expression is critical for normal growth and development, and aberrant gene expression underlies many genetic diseases, including cancer. Successful completion of the experiments in this proposal will illuminate the processes through which information in the genome controls precise patterns of gene expression, and will help us interpret disease causing genetic variants that alter normal patterns of gene expression.            ",ANALYSIS OF COMBINATORIAL CIS-REGULATION IN SYNTHETIC AND GENOMIC PROMOTER,8888066,R01GM092910,"['Address', 'Affect', 'Binding', 'Binding Sites', 'Biological Assay', 'Cells', 'Chromatin', 'Chromatin Structure', 'Chromosome Positioning', 'Collection', 'DNA', 'DNA Sequence', 'DNA-Directed RNA Polymerase', 'Data', 'Disease', 'Elements', 'Explosion', 'Funding', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomic DNA', 'Genomics', 'Goals', 'Grant', 'Growth and Development function', 'Hereditary Disease', 'Learning', 'Libraries', 'Machine Learning', 'Malignant Neoplasms', 'Mammalian Cell', 'Measures', 'Modeling', 'Modification', 'Molecular', 'Positioning Attribute', 'Process', 'Regulation', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Site', 'Source', 'Specific qualifier value', 'Specificity', 'Stem cells', 'System', 'Techniques', 'Test Result', 'Testing', 'Thermodynamics', 'Time', 'To specify', 'Training', 'Untranslated RNA', 'Variant', 'base', 'cellular engineering', 'chromatin modification', 'combinatorial', 'design', 'empowered', 'genetic variant', 'genome editing', 'insight', 'promoter', 'public health relevance', 'research study', 'transcription factor']",NIGMS,WASHINGTON UNIVERSITY,R01,2015,397299,0.05800712815652209
"PROMOTERS     DESCRIPTION (provided by applicant): The long-term goal of this project is to understand the combinatorial rules that govern the interactions between transcription factor binding sites (TFBS). Through these rules, combinations of TFBS specify an enormous diversity of gene expression patterns. Normal growth and development depends on the tight control of TFBS over levels of gene expression in both time and space, and aberrant regulation of gene expression underlies many genetic diseases. Although much progress has been made identifying TFBS, and the transcription factors (TFs) that bind to them, much less is known about how TFBS interact with each other to generate specific patterns of gene expression. In particular we lack an understanding of how specificity is achieved in large genomes where the cell must distinguish between ""true"" cis-regulatory elements and thousands of similar, but non-functional sequences. The proposal addresses this problem through experiments designed to unravel the mechanisms that govern cis-regulatory element specificity. Large libraries of simplified synthetic promoters will be constructed and assayed for expression, TF occupancy, and chromatin state. The data from these libraries will be analyzed with a thermodynamic model that describes the physical interactions between TFBS, TFs, RNA polymerase, and other elements that determine cis- regulatory activity. The models we produce from synthetic promoters will be explicitly tested on genomic promoters. The three aims of the proposal are organized around three different sources of information that determine specificity. In Aim1 we test the hypothesis that functional TFBS are specified by their interactions with other nearby TFBS. In Aim2 we explore the extent to which local sequence features besides TFBS help specify functional cis-regulatory elements. Finally, in Aim3 we will test the extent to which the chromosomal position and chromatin state of cis-regulatory elements influence the interactions between TFBS that govern their activity. The successful completion of the aims of this proposal will result in a quantitative and molecular understanding of the rules underlying combinatorial cis-regulation. Such an understanding is necessary to empower biomedical applications, such as stem cell engineering, that are based on manipulating gene expression patterns. The results produced from this proposal will also help guide the annotation of the large regions of non-coding DNA in the genome that specify gene expression patterns. Finally, a clear understanding of TFBS interactions will help the identification and interpretation of disease causing genetic variants that affect cis-regulation. PUBLIC HEALTH RELEVANCE: In addition to serving as a ""parts list"" of genes, the genome also encodes information that controls precisely where, when, and to what levels genes are produced (expressed). Strict control of gene expression is critical for normal growth and development, and aberrant gene expression underlies many genetic diseases, including cancer. Successful completion of the experiments in this proposal will illuminate the processes through which information in the genome controls precise patterns of gene expression, and will help us interpret disease causing genetic variants that alter normal patterns of gene expression.",PROMOTERS,9066171,R01GM092910,"['Address', 'Affect', 'Binding', 'Binding Sites', 'Biological Assay', 'Cells', 'Chromatin', 'Chromatin Structure', 'Chromosome Positioning', 'Collection', 'DNA', 'DNA Sequence', 'DNA-Directed RNA Polymerase', 'Data', 'Disease', 'Elements', 'Explosion', 'Funding', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomic DNA', 'Genomics', 'Goals', 'Grant', 'Growth and Development function', 'Health', 'Hereditary Disease', 'Learning', 'Libraries', 'Machine Learning', 'Malignant Neoplasms', 'Mammalian Cell', 'Measures', 'Modeling', 'Modification', 'Molecular', 'Process', 'Regulation', 'Regulatory Element', 'Reporter', 'Reporter Genes', 'Site', 'Source', 'Specific qualifier value', 'Specificity', 'Stem cells', 'System', 'Techniques', 'Test Result', 'Testing', 'Thermodynamics', 'Time', 'To specify', 'Training', 'Untranslated RNA', 'Variant', 'base', 'cellular engineering', 'chromatin modification', 'chromosomal location', 'combinatorial', 'design', 'empowered', 'genetic variant', 'genome editing', 'insight', 'promoter', 'research study', 'synthetic genomics', 'transcription factor']",NIGMS,WASHINGTON UNIVERSITY,R01,2016,397299,0.05800712815652209
"Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin DESCRIPTION (provided by applicant): A major challenge in systems biology is to quantitatively understand and model the dynamic topological and functional properties of cellular networks, such as the spatial-temporally specific and context-dependent rewiring of transcriptional regulatory circuitry and signal transduction pathways that control cell behavior. Current efforts to study biological networks have primarily focused on creating a descriptive analysis of macroscopic properties. Such simple analyses offer limited insights into the remarkably complex functional and structural organization of a biological system, especially in a dynamic context. Furthermore, most existing techniques for reconstructing molecular networks based on high-throughput data ignore the dynamic aspect of the network topology and represent it as an invariant graph. To our knowledge the network itself is rarely considered as an object that is changing and evolving. In this proposal, we aim to develop principled machine learning algorithms that reverse engineer the temporally and spatially varying interactions between biological molecules from longitudinal or spatial experimental data. Our approaches will take into account biological prior information such as transcriptional factor binding targets, gene knockout experiments, gene ontology, and PPI. Contrary to traditional co-expression studies, our methods unfold the rewiring networks underlying the entire span of the biological process. This will make it possible to discover and trace transient molecular interactions, modules, and pathways during the progression of the process. We will also develop a Bayesian formalism to model and infer the ""dynamic network tomography"" - the meta-states that determine each molecule's function and relationship to other molecules, thereby driving the evolution of the network topology, possibly in response to internal perturbations or environmental changes. Using these new tools, we will carry out a case study on time series gene expression data from organotypic models of breast cancer progression/reversal to gain insight into the mechanisms that drive the temporal rewiring of gene networks during this process. Finally we will also deliver a software platform offering the tools developed in this project to the public. So far, there has not been work done to consider temporally and spatially varying biological interactions under a unified framework. Our proposed work represents an initial foray into this important problem. Our proposed work represents a significant step forward over the current methodology. We envisage a new paradigm that facilitates: 1) Statistical inference and learning of gene networks that are evolving over space and time, possibly in response to various stimuli and possibly mediating genome-environmental interactions. 2) Thorough exploration of the underlying functional underpinnings that drive the network rewiring, dynamic trajectory, and trend of functional evolution. 3) Uncovering transient events taking place in the dynamic systems, building predictive understanding of the mechanisms of gene regulation, network formation, and evolution. 4) Fast and accurate computational algorithms, with stronger statistical guarantee and greater scalability and robustness in large-scale dynamic network analysis. 5) A full spectrum of convenient software packages and user interfaces for dynamic network analysis, available to the public. PUBLIC HEALTH RELEVANCE: We propose a systematic attempt on methodological development for the largely unexplored but practically important problem of time- and space-varying (rather than static) gene network learning, and Bayesian inference of the latent dynamic multi-functionality of genes/proteins in the context of such evolving networks. We intend to apply our method to the study of the dynamic genome-microenvironmental interactions during breast cancer progression and reversal. Since any complex biological processes such as development and disease pathogenesis involve intricate and transient regulatory events and signal transduction, it is unreasonable to assume that the underlying network of gene interaction is invariant throughout the process. But modern experimental and computational methodology is not able to identify such time/space specific network due to technical difficulty, therefore our proposed new methods for inferring evolving network, and the functional underpinnings behind network rewiring are not only needed, but also necessary; but it is beyond the grasp of convention methods and requires the methodological innovations we propose. Unraveling and characterizing such dynamic activities and trajectories of biological networks can provide a more comprehensive genetic and molecular view of complex biological processes and diseases, which may lead to better understanding of the mechanisms driving genome-microenvironmental interactions, and identification of key elements in the network responsible for the functional integrity of the network and the system; in addition, such an approach will allow us to formulate hypotheses regarding the roles of these genes with respect to cell differentiation and disease pathogenesis, and to develop improved diagnostic biomarkers and treatment scheme.",Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin,7865088,R01GM093156,"['3-Dimensional', 'Accounting', 'Address', 'Adopted', 'Algorithms', 'Architecture', 'Automobile Driving', 'Back', 'Behavior', 'Belief', 'Binding', 'Biochemical', 'Biological', 'Biological Markers', 'Biological Process', 'Case Study', 'Cell Cycle', 'Cell Differentiation process', 'Cell Line', 'Cell physiology', 'Characteristics', 'Clinical', 'Collaborations', 'Collection', 'Complex', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Data', 'Data Set', 'Databases', 'Dependency', 'Development', 'Developmental Process', 'Diagnosis', 'Diagnostic', 'Diagnostic Neoplasm Staging', 'Disease', 'Disease Progression', 'Documentation', 'Drosophila genus', 'Drug Delivery Systems', 'Embryo', 'Engineering', 'Event', 'Evolution', 'Exhibits', 'Foundations', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Gene Targeting', 'Genes', 'Genetic', 'Genome', 'Graph', 'Hand', 'Heel', 'Human', 'Imagery', 'Immune response', 'Indium', 'Individual', 'Internet', 'Investigation', 'Knowledge', 'Laboratories', 'Lead', 'Learning', 'Length', 'Light', 'Literature', 'Location', 'Machine Learning', 'Measurement', 'Measures', 'Mediating', 'Medical', 'Methodology', 'Methods', 'Mining', 'Modality', 'Modeling', 'Molecular', 'Molecular Genetics', 'Molecular Profiling', 'Nature', 'Network-based', 'Ontology', 'Organism', 'Pathogenesis', 'Pathologic Processes', 'Pathway Analysis', 'Pathway interactions', 'Pattern', 'Performance', 'Pharmaceutical Preparations', 'Physiological Processes', 'Play', 'Problem Formulations', 'Process', 'Property', 'Proteins', 'Publications', 'Publishing', 'RNA Interference', 'Regulation', 'Regulator Genes', 'Regulatory Pathway', 'Reporting', 'Research', 'Role', 'Saccharomyces cerevisiae', 'Sampling', 'Scheme', 'Science', 'Seminal', 'Series', 'Signal Transduction', 'Signal Transduction Pathway', 'Simulate', 'Software Tools', 'Solutions', 'Source', 'Staging', 'Stimulus', 'Structure', 'System', 'Systems Biology', 'Techniques', 'Technology', 'Terminology', 'Testing', 'Time', 'Time Study', 'Tissues', 'Trees', 'Ursidae Family', 'Validation', 'Variant', 'Visual', 'Work', 'base', 'biological systems', 'cell behavior', 'combinatorial', 'computer based statistical methods', 'cost', 'design', 'driving force', 'environmental change', 'fitness', 'gene function', 'gene interaction', 'grasp', 'heuristics', 'improved', 'in vivo', 'innovation', 'insight', 'interest', 'knockout gene', 'malignant breast neoplasm', 'mathematical model', 'novel', 'peer', 'prevent', 'programs', 'promoter', 'protein protein interaction', 'public health relevance', 'research study', 'response', 'scale up', 'software systems', 'sound', 'success', 'tomography', 'tool', 'trait', 'trend', 'tumor progression', 'user friendly software', 'yeast two hybrid system']",NIGMS,CARNEGIE-MELLON UNIVERSITY,R01,2010,460864,-0.03392927090317145
"Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin DESCRIPTION (provided by applicant): A major challenge in systems biology is to quantitatively understand and model the dynamic topological and functional properties of cellular networks, such as the spatial-temporally specific and context-dependent rewiring of transcriptional regulatory circuitry and signal transduction pathways that control cell behavior. Current efforts to study biological networks have primarily focused on creating a descriptive analysis of macroscopic properties. Such simple analyses offer limited insights into the remarkably complex functional and structural organization of a biological system, especially in a dynamic context. Furthermore, most existing techniques for reconstructing molecular networks based on high-throughput data ignore the dynamic aspect of the network topology and represent it as an invariant graph. To our knowledge the network itself is rarely considered as an object that is changing and evolving. In this proposal, we aim to develop principled machine learning algorithms that reverse engineer the temporally and spatially varying interactions between biological molecules from longitudinal or spatial experimental data. Our approaches will take into account biological prior information such as transcriptional factor binding targets, gene knockout experiments, gene ontology, and PPI. Contrary to traditional co-expression studies, our methods unfold the rewiring networks underlying the entire span of the biological process. This will make it possible to discover and trace transient molecular interactions, modules, and pathways during the progression of the process. We will also develop a Bayesian formalism to model and infer the ""dynamic network tomography"" - the meta-states that determine each molecule's function and relationship to other molecules, thereby driving the evolution of the network topology, possibly in response to internal perturbations or environmental changes. Using these new tools, we will carry out a case study on time series gene expression data from organotypic models of breast cancer progression/reversal to gain insight into the mechanisms that drive the temporal rewiring of gene networks during this process. Finally we will also deliver a software platform offering the tools developed in this project to the public. So far, there has not been work done to consider temporally and spatially varying biological interactions under a unified framework. Our proposed work represents an initial foray into this important problem. Our proposed work represents a significant step forward over the current methodology. We envisage a new paradigm that facilitates: 1) Statistical inference and learning of gene networks that are evolving over space and time, possibly in response to various stimuli and possibly mediating genome-environmental interactions. 2) Thorough exploration of the underlying functional underpinnings that drive the network rewiring, dynamic trajectory, and trend of functional evolution. 3) Uncovering transient events taking place in the dynamic systems, building predictive understanding of the mechanisms of gene regulation, network formation, and evolution. 4) Fast and accurate computational algorithms, with stronger statistical guarantee and greater scalability and robustness in large-scale dynamic network analysis. 5) A full spectrum of convenient software packages and user interfaces for dynamic network analysis, available to the public. Project Narrative  We propose a systematic attempt on methodological development for the largely unexplored but practically  important problem of time- and space-varying (rather than static) gene network learning, and Bayesian  inference of the latent dynamic multi-functionality of genes/proteins in the context of such evolving networks.  We intend to apply our method to the study of the dynamic genome-microenvironmental interactions during  breast cancer progression and reversal. Since any complex biological processes such as development and  disease pathogenesis involve intricate and transient regulatory events and signal transduction, it is  unreasonable to assume that the underlying network of gene interaction is invariant throughout the process.  But modern experimental and computational methodology is not able to identify such time/space specific  network due to technical difficulty, therefore our proposed new methods for inferring evolving network, and the  functional underpinnings behind network rewiring are not only needed, but also necessary; but it is beyond the  grasp of convention methods and requires the methodological innovations we propose. Unraveling and  characterizing such dynamic activities and trajectories of biological networks can provide a more  comprehensive genetic and molecular view of complex biological processes and diseases, which may lead to  better understanding of the mechanisms driving genome-microenvironmental interactions, and identification of  key elements in the network responsible for the functional integrity of the network and the system; in addition,  such an approach will allow us to formulate hypotheses regarding the roles of these genes with respect to cell  differentiation and disease pathogenesis, and to develop improved diagnostic biomarkers and treatment  scheme.  PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page",Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin,8727043,R01GM093156,"['Accounting', 'Algorithmic Software', 'Algorithms', 'Automobile Driving', 'Bayesian Analysis', 'Binding', 'Biochemical', 'Biological', 'Biological Markers', 'Biological Process', 'Breast', 'Case Study', 'Cell Cycle', 'Cell Differentiation process', 'Cell physiology', 'ChIP-seq', 'Complex', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Data', 'Development', 'Diagnostic', 'Disease', 'Engineering', 'Event', 'Evolution', 'Exhibits', 'Foundations', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Gene Targeting', 'Genes', 'Genetic', 'Genome', 'Graph', 'Immune response', 'Indium', 'Investigation', 'Lead', 'Learning', 'Length', 'Location', 'Machine Learning', 'Mediating', 'Messenger RNA', 'Methodology', 'Methods', 'Mining', 'Modeling', 'Molecular', 'Molecular Genetics', 'Nature', 'Network-based', 'Ontology', 'Organism', 'Pathogenesis', 'Pathway Analysis', 'Pathway interactions', 'Physiological Processes', 'Play', 'Process', 'Property', 'Proteins', 'Regulator Genes', 'Research', 'Role', 'Saccharomyces cerevisiae', 'Sampling', 'Scheme', 'Science', 'Seminal', 'Series', 'Signal Transduction', 'Signal Transduction Pathway', 'Stimulus', 'Structure', 'System', 'Systems Biology', 'Techniques', 'Terminology', 'Testing', 'Time', 'Tissues', 'Work', 'base', 'biological systems', 'cell behavior', 'driving force', 'environmental change', 'gene interaction', 'grasp', 'improved', 'innovation', 'insight', 'interest', 'knockout gene', 'malignant breast neoplasm', 'prevent', 'research study', 'response', 'sound', 'tomography', 'tool', 'trend', 'tumor progression', 'yeast two hybrid system']",NIGMS,CARNEGIE-MELLON UNIVERSITY,R01,2014,434355,-0.03392927090317145
"Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin DESCRIPTION (provided by applicant): A major challenge in systems biology is to quantitatively understand and model the dynamic topological and functional properties of cellular networks, such as the spatial-temporally specific and context-dependent rewiring of transcriptional regulatory circuitry and signal transduction pathways that control cell behavior. Current efforts to study biological networks have primarily focused on creating a descriptive analysis of macroscopic properties. Such simple analyses offer limited insights into the remarkably complex functional and structural organization of a biological system, especially in a dynamic context. Furthermore, most existing techniques for reconstructing molecular networks based on high-throughput data ignore the dynamic aspect of the network topology and represent it as an invariant graph. To our knowledge the network itself is rarely considered as an object that is changing and evolving. In this proposal, we aim to develop principled machine learning algorithms that reverse engineer the temporally and spatially varying interactions between biological molecules from longitudinal or spatial experimental data. Our approaches will take into account biological prior information such as transcriptional factor binding targets, gene knockout experiments, gene ontology, and PPI. Contrary to traditional co-expression studies, our methods unfold the rewiring networks underlying the entire span of the biological process. This will make it possible to discover and trace transient molecular interactions, modules, and pathways during the progression of the process. We will also develop a Bayesian formalism to model and infer the ""dynamic network tomography"" - the meta-states that determine each molecule's function and relationship to other molecules, thereby driving the evolution of the network topology, possibly in response to internal perturbations or environmental changes. Using these new tools, we will carry out a case study on time series gene expression data from organotypic models of breast cancer progression/reversal to gain insight into the mechanisms that drive the temporal rewiring of gene networks during this process. Finally we will also deliver a software platform offering the tools developed in this project to the public. So far, there has not been work done to consider temporally and spatially varying biological interactions under a unified framework. Our proposed work represents an initial foray into this important problem. Our proposed work represents a significant step forward over the current methodology. We envisage a new paradigm that facilitates: 1) Statistical inference and learning of gene networks that are evolving over space and time, possibly in response to various stimuli and possibly mediating genome-environmental interactions. 2) Thorough exploration of the underlying functional underpinnings that drive the network rewiring, dynamic trajectory, and trend of functional evolution. 3) Uncovering transient events taking place in the dynamic systems, building predictive understanding of the mechanisms of gene regulation, network formation, and evolution. 4) Fast and accurate computational algorithms, with stronger statistical guarantee and greater scalability and robustness in large-scale dynamic network analysis. 5) A full spectrum of convenient software packages and user interfaces for dynamic network analysis, available to the public. Project Narrative  We propose a systematic attempt on methodological development for the largely unexplored but practically  important problem of time- and space-varying (rather than static) gene network learning, and Bayesian  inference of the latent dynamic multi-functionality of genes/proteins in the context of such evolving networks.  We intend to apply our method to the study of the dynamic genome-microenvironmental interactions during  breast cancer progression and reversal. Since any complex biological processes such as development and  disease pathogenesis involve intricate and transient regulatory events and signal transduction, it is  unreasonable to assume that the underlying network of gene interaction is invariant throughout the process.  But modern experimental and computational methodology is not able to identify such time/space specific  network due to technical difficulty, therefore our proposed new methods for inferring evolving network, and the  functional underpinnings behind network rewiring are not only needed, but also necessary; but it is beyond the  grasp of convention methods and requires the methodological innovations we propose. Unraveling and  characterizing such dynamic activities and trajectories of biological networks can provide a more  comprehensive genetic and molecular view of complex biological processes and diseases, which may lead to  better understanding of the mechanisms driving genome-microenvironmental interactions, and identification of  key elements in the network responsible for the functional integrity of the network and the system; in addition,  such an approach will allow us to formulate hypotheses regarding the roles of these genes with respect to cell  differentiation and disease pathogenesis, and to develop improved diagnostic biomarkers and treatment  scheme.  PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page",Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin,8531961,R01GM093156,"['Accounting', 'Algorithms', 'Automobile Driving', 'Binding', 'Biochemical', 'Biological', 'Biological Markers', 'Biological Process', 'Breast', 'Case Study', 'Cell Cycle', 'Cell Differentiation process', 'Cell physiology', 'ChIP-seq', 'Complex', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Data', 'Development', 'Diagnostic', 'Disease', 'Engineering', 'Event', 'Evolution', 'Exhibits', 'Foundations', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Gene Targeting', 'Genes', 'Genetic', 'Genome', 'Graph', 'Immune response', 'Indium', 'Investigation', 'Lead', 'Learning', 'Length', 'Location', 'Machine Learning', 'Mediating', 'Messenger RNA', 'Methodology', 'Methods', 'Mining', 'Modeling', 'Molecular', 'Molecular Genetics', 'Nature', 'Network-based', 'Ontology', 'Organism', 'Pathogenesis', 'Pathway Analysis', 'Pathway interactions', 'Physiological Processes', 'Play', 'Process', 'Property', 'Proteins', 'Regulator Genes', 'Research', 'Role', 'Saccharomyces cerevisiae', 'Sampling', 'Scheme', 'Science', 'Seminal', 'Series', 'Signal Transduction', 'Signal Transduction Pathway', 'Stimulus', 'Structure', 'System', 'Systems Biology', 'Techniques', 'Terminology', 'Testing', 'Time', 'Tissues', 'Work', 'base', 'biological systems', 'cell behavior', 'driving force', 'environmental change', 'gene interaction', 'grasp', 'improved', 'innovation', 'insight', 'interest', 'knockout gene', 'malignant breast neoplasm', 'prevent', 'research study', 'response', 'sound', 'tomography', 'tool', 'trend', 'tumor progression', 'yeast two hybrid system']",NIGMS,CARNEGIE-MELLON UNIVERSITY,R01,2013,422340,-0.03392927090317145
"Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin DESCRIPTION (provided by applicant): A major challenge in systems biology is to quantitatively understand and model the dynamic topological and functional properties of cellular networks, such as the spatial-temporally specific and context-dependent rewiring of transcriptional regulatory circuitry and signal transduction pathways that control cell behavior. Current efforts to study biological networks have primarily focused on creating a descriptive analysis of macroscopic properties. Such simple analyses offer limited insights into the remarkably complex functional and structural organization of a biological system, especially in a dynamic context. Furthermore, most existing techniques for reconstructing molecular networks based on high-throughput data ignore the dynamic aspect of the network topology and represent it as an invariant graph. To our knowledge the network itself is rarely considered as an object that is changing and evolving. In this proposal, we aim to develop principled machine learning algorithms that reverse engineer the temporally and spatially varying interactions between biological molecules from longitudinal or spatial experimental data. Our approaches will take into account biological prior information such as transcriptional factor binding targets, gene knockout experiments, gene ontology, and PPI. Contrary to traditional co-expression studies, our methods unfold the rewiring networks underlying the entire span of the biological process. This will make it possible to discover and trace transient molecular interactions, modules, and pathways during the progression of the process. We will also develop a Bayesian formalism to model and infer the ""dynamic network tomography"" - the meta-states that determine each molecule's function and relationship to other molecules, thereby driving the evolution of the network topology, possibly in response to internal perturbations or environmental changes. Using these new tools, we will carry out a case study on time series gene expression data from organotypic models of breast cancer progression/reversal to gain insight into the mechanisms that drive the temporal rewiring of gene networks during this process. Finally we will also deliver a software platform offering the tools developed in this project to the public. So far, there has not been work done to consider temporally and spatially varying biological interactions under a unified framework. Our proposed work represents an initial foray into this important problem. Our proposed work represents a significant step forward over the current methodology. We envisage a new paradigm that facilitates: 1) Statistical inference and learning of gene networks that are evolving over space and time, possibly in response to various stimuli and possibly mediating genome-environmental interactions. 2) Thorough exploration of the underlying functional underpinnings that drive the network rewiring, dynamic trajectory, and trend of functional evolution. 3) Uncovering transient events taking place in the dynamic systems, building predictive understanding of the mechanisms of gene regulation, network formation, and evolution. 4) Fast and accurate computational algorithms, with stronger statistical guarantee and greater scalability and robustness in large-scale dynamic network analysis. 5) A full spectrum of convenient software packages and user interfaces for dynamic network analysis, available to the public. Project Narrative  We propose a systematic attempt on methodological development for the largely unexplored but practically  important problem of time- and space-varying (rather than static) gene network learning, and Bayesian  inference of the latent dynamic multi-functionality of genes/proteins in the context of such evolving networks.  We intend to apply our method to the study of the dynamic genome-microenvironmental interactions during  breast cancer progression and reversal. Since any complex biological processes such as development and  disease pathogenesis involve intricate and transient regulatory events and signal transduction, it is  unreasonable to assume that the underlying network of gene interaction is invariant throughout the process.  But modern experimental and computational methodology is not able to identify such time/space specific  network due to technical difficulty, therefore our proposed new methods for inferring evolving network, and the  functional underpinnings behind network rewiring are not only needed, but also necessary; but it is beyond the  grasp of convention methods and requires the methodological innovations we propose. Unraveling and  characterizing such dynamic activities and trajectories of biological networks can provide a more  comprehensive genetic and molecular view of complex biological processes and diseases, which may lead to  better understanding of the mechanisms driving genome-microenvironmental interactions, and identification of  key elements in the network responsible for the functional integrity of the network and the system; in addition,  such an approach will allow us to formulate hypotheses regarding the roles of these genes with respect to cell  differentiation and disease pathogenesis, and to develop improved diagnostic biomarkers and treatment  scheme.  PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page",Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin,8294774,R01GM093156,"['Accounting', 'Algorithms', 'Automobile Driving', 'Binding', 'Biochemical', 'Biological', 'Biological Markers', 'Biological Process', 'Breast', 'Case Study', 'Cell Cycle', 'Cell Differentiation process', 'Cell physiology', 'ChIP-seq', 'Complex', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Data', 'Development', 'Diagnostic', 'Disease', 'Engineering', 'Event', 'Evolution', 'Exhibits', 'Foundations', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Gene Targeting', 'Genes', 'Genetic', 'Genome', 'Graph', 'Immune response', 'Indium', 'Investigation', 'Lead', 'Learning', 'Length', 'Location', 'Machine Learning', 'Mediating', 'Messenger RNA', 'Methodology', 'Methods', 'Mining', 'Modeling', 'Molecular', 'Molecular Genetics', 'Nature', 'Network-based', 'Ontology', 'Organism', 'Pathogenesis', 'Pathway Analysis', 'Pathway interactions', 'Physiological Processes', 'Play', 'Process', 'Property', 'Proteins', 'Regulator Genes', 'Research', 'Role', 'Saccharomyces cerevisiae', 'Sampling', 'Scheme', 'Science', 'Seminal', 'Series', 'Signal Transduction', 'Signal Transduction Pathway', 'Stimulus', 'Structure', 'System', 'Systems Biology', 'Techniques', 'Terminology', 'Testing', 'Time', 'Tissues', 'Work', 'base', 'biological systems', 'cell behavior', 'driving force', 'environmental change', 'gene interaction', 'grasp', 'improved', 'innovation', 'insight', 'interest', 'knockout gene', 'malignant breast neoplasm', 'prevent', 'research study', 'response', 'sound', 'tomography', 'tool', 'trend', 'tumor progression', 'yeast two hybrid system']",NIGMS,CARNEGIE-MELLON UNIVERSITY,R01,2012,442016,-0.03392927090317145
"Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin DESCRIPTION (provided by applicant): A major challenge in systems biology is to quantitatively understand and model the dynamic topological and functional properties of cellular networks, such as the spatial-temporally specific and context-dependent rewiring of transcriptional regulatory circuitry and signal transduction pathways that control cell behavior. Current efforts to study biological networks have primarily focused on creating a descriptive analysis of macroscopic properties. Such simple analyses offer limited insights into the remarkably complex functional and structural organization of a biological system, especially in a dynamic context. Furthermore, most existing techniques for reconstructing molecular networks based on high-throughput data ignore the dynamic aspect of the network topology and represent it as an invariant graph. To our knowledge the network itself is rarely considered as an object that is changing and evolving. In this proposal, we aim to develop principled machine learning algorithms that reverse engineer the temporally and spatially varying interactions between biological molecules from longitudinal or spatial experimental data. Our approaches will take into account biological prior information such as transcriptional factor binding targets, gene knockout experiments, gene ontology, and PPI. Contrary to traditional co-expression studies, our methods unfold the rewiring networks underlying the entire span of the biological process. This will make it possible to discover and trace transient molecular interactions, modules, and pathways during the progression of the process. We will also develop a Bayesian formalism to model and infer the ""dynamic network tomography"" - the meta-states that determine each molecule's function and relationship to other molecules, thereby driving the evolution of the network topology, possibly in response to internal perturbations or environmental changes. Using these new tools, we will carry out a case study on time series gene expression data from organotypic models of breast cancer progression/reversal to gain insight into the mechanisms that drive the temporal rewiring of gene networks during this process. Finally we will also deliver a software platform offering the tools developed in this project to the public. So far, there has not been work done to consider temporally and spatially varying biological interactions under a unified framework. Our proposed work represents an initial foray into this important problem. Our proposed work represents a significant step forward over the current methodology. We envisage a new paradigm that facilitates: 1) Statistical inference and learning of gene networks that are evolving over space and time, possibly in response to various stimuli and possibly mediating genome-environmental interactions. 2) Thorough exploration of the underlying functional underpinnings that drive the network rewiring, dynamic trajectory, and trend of functional evolution. 3) Uncovering transient events taking place in the dynamic systems, building predictive understanding of the mechanisms of gene regulation, network formation, and evolution. 4) Fast and accurate computational algorithms, with stronger statistical guarantee and greater scalability and robustness in large-scale dynamic network analysis. 5) A full spectrum of convenient software packages and user interfaces for dynamic network analysis, available to the public. Project Narrative  We propose a systematic attempt on methodological development for the largely unexplored but practically  important problem of time- and space-varying (rather than static) gene network learning, and Bayesian  inference of the latent dynamic multi-functionality of genes/proteins in the context of such evolving networks.  We intend to apply our method to the study of the dynamic genome-microenvironmental interactions during  breast cancer progression and reversal. Since any complex biological processes such as development and  disease pathogenesis involve intricate and transient regulatory events and signal transduction, it is  unreasonable to assume that the underlying network of gene interaction is invariant throughout the process.  But modern experimental and computational methodology is not able to identify such time/space specific  network due to technical difficulty, therefore our proposed new methods for inferring evolving network, and the  functional underpinnings behind network rewiring are not only needed, but also necessary; but it is beyond the  grasp of convention methods and requires the methodological innovations we propose. Unraveling and  characterizing such dynamic activities and trajectories of biological networks can provide a more  comprehensive genetic and molecular view of complex biological processes and diseases, which may lead to  better understanding of the mechanisms driving genome-microenvironmental interactions, and identification of  key elements in the network responsible for the functional integrity of the network and the system; in addition,  such an approach will allow us to formulate hypotheses regarding the roles of these genes with respect to cell  differentiation and disease pathogenesis, and to develop improved diagnostic biomarkers and treatment  scheme.  PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page",Time/Space-Varying Networks of Molecular Interactions: A New Paradigm for Studyin,8079755,R01GM093156,"['Accounting', 'Algorithms', 'Automobile Driving', 'Binding', 'Biochemical', 'Biological', 'Biological Markers', 'Biological Process', 'Breast', 'Case Study', 'Cell Cycle', 'Cell Differentiation process', 'Cell physiology', 'Complex', 'Computational algorithm', 'Computer software', 'Computing Methodologies', 'Data', 'Development', 'Diagnostic', 'Disease', 'Engineering', 'Event', 'Evolution', 'Exhibits', 'Foundations', 'Gene Expression', 'Gene Expression Regulation', 'Gene Proteins', 'Gene Targeting', 'Genes', 'Genetic', 'Genome', 'Graph', 'Immune response', 'Indium', 'Investigation', 'Lead', 'Learning', 'Length', 'Location', 'Machine Learning', 'Mediating', 'Messenger RNA', 'Methodology', 'Methods', 'Mining', 'Modeling', 'Molecular', 'Molecular Genetics', 'Nature', 'Network-based', 'Ontology', 'Organism', 'Pathogenesis', 'Pathway Analysis', 'Pathway interactions', 'Physiological Processes', 'Play', 'Process', 'Property', 'Proteins', 'Regulator Genes', 'Research', 'Role', 'Saccharomyces cerevisiae', 'Sampling', 'Scheme', 'Science', 'Seminal', 'Series', 'Signal Transduction', 'Signal Transduction Pathway', 'Stimulus', 'Structure', 'System', 'Systems Biology', 'Techniques', 'Terminology', 'Testing', 'Time', 'Tissues', 'Work', 'base', 'biological systems', 'cell behavior', 'driving force', 'environmental change', 'gene interaction', 'grasp', 'improved', 'innovation', 'insight', 'interest', 'knockout gene', 'malignant breast neoplasm', 'prevent', 'research study', 'response', 'sound', 'tomography', 'tool', 'trend', 'tumor progression', 'yeast two hybrid system']",NIGMS,CARNEGIE-MELLON UNIVERSITY,R01,2011,444631,-0.03392927090317145
"Arabidopsis N-regulatory network dynamics: Integrating metabolome & transcriptome The primary goal of the proposed research is to use a systems biology approach to collectively analyze and integrate time-dependent data from the transcriptome, metabolome, and fluxome components of the N- regulatory network controlling N-assimilation in Arabidopsis. This integrative approach will allow us to dynamically model the flow of N-signal propagation through the N-regulatory network on a systems-wide level and identify the transcriptional cascade involved in this regulation. This goal will be achieved through four aims: 1. Creation of high-resolution dynamic transcriptome datasets to generate a time-dependent nitrogen regulatory network, by performing microarray analysis on Arabidopsis roots and shoots treated with nitrate over a time course. 2. Quantification of metabolite levels and metabolic flux in the N-assimilatory network in response to N-signal, using stable isotope labeled N15 over a time course. 3. Integration of transcriptome, metabolome, and fluxome data to create a time-dependent dynamic network model for the control of N- uptake/assimilation, using a series of analytical techniques including lag correlation, linear regression, and machine learning (state space analysis). 4. Functional validation of regulatory network predictions by testing model generated hypotheses with T-DNA mutants and inducible expression systems. The overriding hypothesis being tested is that inorganic-N signals (nitrate) activate motifs involved in regulating nitrate uptake, reduction and assimilation into organic-N (Glu/Gln), used for biosynthetic reactions. The organic-N products (Glu/Gln) in turn activate motifs controlling Asn synthesized for N-storage, and repress ones controlling N- uptake/assimilation. The proposed research will allow me to identify the regulatory genes responding to these inorganic and organic N-signals that regulate genes in the N-uptake and assimilation pathways by integrating genome wide transcriptomic data with metabolomic data. The synthesis of these aims should allow for modeling, predicting and testing how perturbations of the ""system"" may be used to enhance N-use efficiency, which impacts energy-use (fertilizers/biofuels), nitrate contamination of the environment and human nutrition. Project Narrative  The long-term goal of the systems approach described in this proposal is to model and predictively manipulate gene regulatory networks affecting uptake/assimilation of inorganic nitrogen into amino acids to improve nitrogen-use-efficiency. This would decrease energy consumption, reduce ground water contamination by nitrates (Health and Environment) and improve seed yield, with implications for human health (Nutrition) and biofuels (Energy). Moreover, the systems biology approach and the tools that will be developed in this project can be applied to any species for which genome data is available, which will enable researchers to model and manipulate a broad spectrum of regulatory circuits in biology with potential medical and pharmaceutical applications.",Arabidopsis N-regulatory network dynamics: Integrating metabolome & transcriptome,8309335,F32GM095273,"['Affect', 'Amino Acids', 'Arabidopsis', 'Assimilations', 'Bioinformatics', 'Biology', 'Computer Simulation', 'Consumption', 'Data', 'Data Set', 'Development', 'Environment', 'Enzymes', 'Fertilizers', 'Gene Expression', 'Gene Expression Profile', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Glutamine', 'Goals', 'Health', 'Human', 'Imagery', 'Informatics', 'Kinetics', 'Light', 'Linear Regressions', 'Machine Learning', 'Measurement', 'Measures', 'Medical', 'Messenger RNA', 'Metabolic', 'Metabolic Pathway', 'Methods', 'Microarray Analysis', 'Modeling', 'Nitrates', 'Nitrogen', 'Output', 'Pathway interactions', 'Pharmacologic Substance', 'Plant Roots', 'Positioning Attribute', 'Reaction', 'Regulation', 'Regulator Genes', 'Research', 'Research Personnel', 'Resolution', 'Seeds', 'Series', 'Signal Transduction', 'Stable Isotope Labeling', 'System', 'Systems Biology', 'T-DNA', 'TF gene', 'Techniques', 'Testing', 'Time', 'Validation', 'Visual', 'Water Pollution', 'base', 'genome-wide', 'ground water', 'improved', 'metabolomics', 'molecular phenotype', 'mutant', 'network models', 'nutrition', 'response', 'tool', 'transcriptomics', 'uptake', 'validation studies']",NIGMS,NEW YORK UNIVERSITY,F32,2012,53942,0.12786230843306506
"Arabidopsis N-regulatory network dynamics: Integrating metabolome & transcriptome    DESCRIPTION (provided by applicant): The primary goal of the proposed research is to use a systems biology approach to collectively analyze and integrate time-dependent data from the transcriptome, metabolome, and fluxome components of the N- regulatory network controlling N-assimilation in Arabidopsis. This integrative approach will allow us to dynamically model the flow of N-signal propagation through the N-regulatory network on a systems-wide level and identify the transcriptional cascade involved in this regulation. This goal will be achieved through four aims: 1. Creation of high-resolution dynamic transcriptome datasets to generate a time-dependent nitrogen regulatory network, by performing microarray analysis on Arabidopsis roots and shoots treated with nitrate over a time course. 2. Quantification of metabolite levels and metabolic flux in the N-assimilatory network in response to N-signal, using stable isotope labeled N15 over a time course. 3. Integration of transcriptome, metabolome, and fluxome data to create a time-dependent dynamic network model for the control of N- uptake/assimilation, using a series of analytical techniques including lag correlation, linear regression, and machine learning (state space analysis). 4. Functional validation of regulatory network predictions by testing model generated hypotheses with T-DNA mutants and inducible expression systems. The overriding hypothesis being tested is that inorganic-N signals (nitrate) activate motifs involved in regulating nitrate uptake, reduction and assimilation into organic-N (Glu/Gln), used for biosynthetic reactions. The organic-N products (Glu/Gln) in turn activate motifs controlling Asn synthesized for N-storage, and repress ones controlling N- uptake/assimilation. The proposed research will allow me to identify the regulatory genes responding to these inorganic and organic N-signals that regulate genes in the N-uptake and assimilation pathways by integrating genome wide transcriptomic data with metabolomic data. The synthesis of these aims should allow for modeling, predicting and testing how perturbations of the ""system"" may be used to enhance N-use efficiency, which impacts energy-use (fertilizers/biofuels), nitrate contamination of the environment and human nutrition.      PUBLIC HEALTH RELEVANCE: The long-term goal of the systems approach described in this proposal is to model and predictively manipulate gene regulatory networks affecting uptake/assimilation of inorganic nitrogen into amino acids to improve nitrogen-use-efficiency. This would decrease energy consumption, reduce ground water contamination by nitrates (Health and Environment) and improve seed yield, with implications for human health (Nutrition) and biofuels (Energy). Moreover, the systems biology approach and the tools that will be developed in this project can be applied to any species for which genome data is available, which will enable researchers to model and manipulate a broad spectrum of regulatory circuits in biology with potential medical and pharmaceutical applications.          Project Narrative  The long-term goal of the systems approach described in this proposal is to model and  predictively manipulate gene regulatory networks affecting uptake/assimilation of inorganic nitrogen into amino acids to improve nitrogen-use-efficiency. This would decrease energy consumption, reduce ground water contamination by nitrates (Health and Environment) and improve seed yield, with implications for human health (Nutrition) and biofuels (Energy).  Moreover, the systems biology approach and the tools that will be developed in this project can  be applied to any species for which genome data is available, which will enable researchers to model and manipulate a broad spectrum of regulatory circuits in biology with potential medical and pharmaceutical applications.",Arabidopsis N-regulatory network dynamics: Integrating metabolome & transcriptome,8137676,F32GM095273,"['Affect', 'Amino Acids', 'Arabidopsis', 'Assimilations', 'Bioinformatics', 'Biology', 'Computer Simulation', 'Consumption', 'Data', 'Data Set', 'Development', 'Environment', 'Enzymes', 'Fertilizers', 'Gene Expression', 'Gene Expression Profile', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Glutamine', 'Goals', 'Health', 'Human', 'Imagery', 'Informatics', 'Kinetics', 'Light', 'Linear Regressions', 'Machine Learning', 'Measurement', 'Measures', 'Medical', 'Messenger RNA', 'Metabolic', 'Metabolic Pathway', 'Methods', 'Microarray Analysis', 'Modeling', 'Nitrates', 'Nitrogen', 'Output', 'Pathway interactions', 'Pharmacologic Substance', 'Plant Roots', 'Positioning Attribute', 'Reaction', 'Regulation', 'Regulator Genes', 'Research', 'Research Personnel', 'Resolution', 'Seeds', 'Series', 'Signal Transduction', 'Stable Isotope Labeling', 'System', 'Systems Biology', 'T-DNA', 'TF gene', 'Techniques', 'Testing', 'Time', 'Validation', 'Visual', 'Water Pollution', 'base', 'genome-wide', 'ground water', 'improved', 'metabolomics', 'molecular phenotype', 'mutant', 'network models', 'nutrition', 'public health relevance', 'response', 'tool', 'transcriptomics', 'uptake', 'validation studies']",NIGMS,NEW YORK UNIVERSITY,F32,2011,51326,0.13827182124060786
"Arabidopsis N-regulatory network dynamics: Integrating metabolome & transcriptome    DESCRIPTION (provided by applicant): The primary goal of the proposed research is to use a systems biology approach to collectively analyze and integrate time-dependent data from the transcriptome, metabolome, and fluxome components of the N- regulatory network controlling N-assimilation in Arabidopsis. This integrative approach will allow us to dynamically model the flow of N-signal propagation through the N-regulatory network on a systems-wide level and identify the transcriptional cascade involved in this regulation. This goal will be achieved through four aims: 1. Creation of high-resolution dynamic transcriptome datasets to generate a time-dependent nitrogen regulatory network, by performing microarray analysis on Arabidopsis roots and shoots treated with nitrate over a time course. 2. Quantification of metabolite levels and metabolic flux in the N-assimilatory network in response to N-signal, using stable isotope labeled N15 over a time course. 3. Integration of transcriptome, metabolome, and fluxome data to create a time-dependent dynamic network model for the control of N- uptake/assimilation, using a series of analytical techniques including lag correlation, linear regression, and machine learning (state space analysis). 4. Functional validation of regulatory network predictions by testing model generated hypotheses with T-DNA mutants and inducible expression systems. The overriding hypothesis being tested is that inorganic-N signals (nitrate) activate motifs involved in regulating nitrate uptake, reduction and assimilation into organic-N (Glu/Gln), used for biosynthetic reactions. The organic-N products (Glu/Gln) in turn activate motifs controlling Asn synthesized for N-storage, and repress ones controlling N- uptake/assimilation. The proposed research will allow me to identify the regulatory genes responding to these inorganic and organic N-signals that regulate genes in the N-uptake and assimilation pathways by integrating genome wide transcriptomic data with metabolomic data. The synthesis of these aims should allow for modeling, predicting and testing how perturbations of the ""system"" may be used to enhance N-use efficiency, which impacts energy-use (fertilizers/biofuels), nitrate contamination of the environment and human nutrition.      PUBLIC HEALTH RELEVANCE: The long-term goal of the systems approach described in this proposal is to model and predictively manipulate gene regulatory networks affecting uptake/assimilation of inorganic nitrogen into amino acids to improve nitrogen-use-efficiency. This would decrease energy consumption, reduce ground water contamination by nitrates (Health and Environment) and improve seed yield, with implications for human health (Nutrition) and biofuels (Energy). Moreover, the systems biology approach and the tools that will be developed in this project can be applied to any species for which genome data is available, which will enable researchers to model and manipulate a broad spectrum of regulatory circuits in biology with potential medical and pharmaceutical applications.           Project Narrative The long-term goal of the systems approach described in this proposal is to model and predictively manipulate gene regulatory networks affecting uptake/assimilation of inorganic nitrogen into amino acids to improve nitrogen-use-efficiency. This would decrease energy consumption, reduce ground water contamination by nitrates (Health and Environment) and improve seed yield, with implications for human health (Nutrition) and biofuels (Energy). Moreover, the systems biology approach and the tools that will be developed in this project can be applied to any species for which genome data is available, which will enable researchers to model and manipulate a broad spectrum of regulatory circuits in biology with potential medical and pharmaceutical applications.",Arabidopsis N-regulatory network dynamics: Integrating metabolome & transcriptome,8003591,F32GM095273,"['Affect', 'Amino Acids', 'Arabidopsis', 'Assimilations', 'Biology', 'Consumption', 'Data', 'Data Set', 'Environment', 'Fertilizers', 'Gene Expression Profile', 'Genes', 'Genome', 'Glutamine', 'Goals', 'Health', 'Human', 'Linear Regressions', 'Machine Learning', 'Medical', 'Metabolic', 'Microarray Analysis', 'Modeling', 'Nitrates', 'Nitrogen', 'Pathway interactions', 'Pharmacologic Substance', 'Plant Roots', 'Reaction', 'Regulation', 'Regulator Genes', 'Research', 'Research Personnel', 'Resolution', 'Seeds', 'Series', 'Signal Transduction', 'Stable Isotope Labeling', 'System', 'Systems Biology', 'T-DNA', 'Techniques', 'Testing', 'Time', 'Validation', 'Water Pollution', 'genome-wide', 'ground water', 'improved', 'metabolomics', 'mutant', 'network models', 'nutrition', 'public health relevance', 'response', 'tool', 'transcriptomics', 'uptake']",NIGMS,NEW YORK UNIVERSITY,F32,2010,47606,0.13827182124060786
"Analysis of force developed by a AAA ATPase    DESCRIPTION (provided by applicant):  The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. This project will focus on studying the activity of these machines at the single molecule level. The model protein will be ClpX - it is the part of the proteosome, a key effect of protein degradation that unfolds the proteins to prepare them for degradation. . Cellular proteins differ widely in their liability, from half-lives of minutes to days. Regulated degradation, by allowing rapid changes in the levels of cellular proteins, helps control signal transduction pathways, the cell- cycle, transcription, apoptosis, antigen processing, biological clock control, differentiation and surface receptor desensitization. The questions to be addressed are: How is work partitioned between alternative outcomes? What is the maximum work that can be performed by the system? What factors limit its efficiency in performing work? These questions have health implications: human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies. Thus, understanding the regulation of the half-life of proteins should provide critical insights into cell physiology and pathology. The mishandling of aberrant proteins incurs penalties throughout biology: the survival of bacteria subjected to stress depends on the effective performance of systems which deal with misfolded and structurally aberrant proteins- to either fold them properly or destroy them. The specific questions to be addressed are: How hard can the device pull to cause unfolding? How many pulls are needed to commit irreversibly? What is the limit of pulling power, and the statistical distribution of pulling power? Answers to these questions will begin to reveal not just what these machines do but the decision tree that describes how outcomes are controlled and when machine capacity may be exceeded. We want to know not just how the machine works, but how its decision tree yields alternative outcomes.        The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. The model will be a protein involved in degrading other proteins. Human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies.            ",Analysis of force developed by a AAA ATPase,8729491,R01GM097974,"['ATP Hydrolysis', 'ATP phosphohydrolase', 'Address', 'Affect', 'Amino Acids', 'Apoptosis', 'Bacteria', 'Binding', 'Biogenesis', 'Biological Clocks', 'Biology', 'Cell Cycle', 'Cell division', 'Cell physiology', 'Clinical Treatment', 'Clinical Trials', 'Commit', 'Decision Trees', 'Devices', 'Digestion', 'Failure', 'Family', 'Gene Expression Regulation', 'Generations', 'Genetic Transcription', 'Goals', 'Half-Life', 'Hand', 'Health', 'Human', 'Individual', 'Length', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Methods', 'Mitochondria', 'Modeling', 'Molecular Machines', 'Movement', 'Multiple Myeloma', 'Multivesicular Body', 'Mutate', 'Nervous System Trauma', 'Outcome', 'Pathology', 'Performance', 'Property', 'Proteasome Inhibitor', 'Proteins', 'Proteolysis', 'Recurrence', 'Regulation', 'Role', 'Side', 'Signal Transduction Pathway', 'Site', 'Statistical Distributions', 'Stress', 'Surface', 'System', 'Techniques', 'Testing', 'Therapeutic Intervention', 'Time', 'Transport Protein Gene', 'War', 'Work', 'antigen processing', 'desensitization', 'human disease', 'insight', 'member', 'multicatalytic endopeptidase complex', 'polypeptide', 'protein degradation', 'receptor', 'single molecule']",NIGMS,ROCKEFELLER UNIVERSITY,R01,2014,308086,-0.01630397335855108
"Analysis of force developed by a AAA ATPase    DESCRIPTION (provided by applicant):  The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. This project will focus on studying the activity of these machines at the single molecule level. The model protein will be ClpX - it is the part of the proteosome, a key effect of protein degradation that unfolds the proteins to prepare them for degradation. . Cellular proteins differ widely in their liability, from half-lives of minutes to days. Regulated degradation, by allowing rapid changes in the levels of cellular proteins, helps control signal transduction pathways, the cell- cycle, transcription, apoptosis, antigen processing, biological clock control, differentiation and surface receptor desensitization. The questions to be addressed are: How is work partitioned between alternative outcomes? What is the maximum work that can be performed by the system? What factors limit its efficiency in performing work? These questions have health implications: human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies. Thus, understanding the regulation of the half-life of proteins should provide critical insights into cell physiology and pathology. The mishandling of aberrant proteins incurs penalties throughout biology: the survival of bacteria subjected to stress depends on the effective performance of systems which deal with misfolded and structurally aberrant proteins- to either fold them properly or destroy them. The specific questions to be addressed are: How hard can the device pull to cause unfolding? How many pulls are needed to commit irreversibly? What is the limit of pulling power, and the statistical distribution of pulling power? Answers to these questions will begin to reveal not just what these machines do but the decision tree that describes how outcomes are controlled and when machine capacity may be exceeded. We want to know not just how the machine works, but how its decision tree yields alternative outcomes.        The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. The model will be a protein involved in degrading other proteins. Human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies.            ",Analysis of force developed by a AAA ATPase,8536863,R01GM097974,"['ATP Hydrolysis', 'ATP phosphohydrolase', 'Address', 'Affect', 'Amino Acids', 'Apoptosis', 'Bacteria', 'Binding', 'Biogenesis', 'Biological Clocks', 'Biology', 'Cell Cycle', 'Cell division', 'Cell physiology', 'Clinical Treatment', 'Clinical Trials', 'Commit', 'Decision Trees', 'Devices', 'Digestion', 'Failure', 'Family', 'Gene Expression Regulation', 'Generations', 'Genetic Transcription', 'Goals', 'Half-Life', 'Hand', 'Health', 'Human', 'Individual', 'Length', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Methods', 'Mitochondria', 'Modeling', 'Molecular Machines', 'Movement', 'Multiple Myeloma', 'Multivesicular Body', 'Mutate', 'Nervous System Trauma', 'Outcome', 'Pathology', 'Performance', 'Property', 'Proteasome Inhibitor', 'Proteins', 'Proteolysis', 'Recurrence', 'Regulation', 'Role', 'Side', 'Signal Transduction Pathway', 'Site', 'Statistical Distributions', 'Stress', 'Surface', 'System', 'Techniques', 'Testing', 'Therapeutic Intervention', 'Time', 'Transport Protein Gene', 'War', 'Work', 'antigen processing', 'desensitization', 'human disease', 'insight', 'member', 'multicatalytic endopeptidase complex', 'polypeptide', 'protein degradation', 'receptor', 'single molecule']",NIGMS,ROCKEFELLER UNIVERSITY,R01,2013,297303,-0.01630397335855108
"Analysis of force developed by a AAA ATPase    DESCRIPTION (provided by applicant):  The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. This project will focus on studying the activity of these machines at the single molecule level. The model protein will be ClpX - it is the part of the proteosome, a key effect of protein degradation that unfolds the proteins to prepare them for degradation. . Cellular proteins differ widely in their liability, from half-lives of minutes to days. Regulated degradation, by allowing rapid changes in the levels of cellular proteins, helps control signal transduction pathways, the cell- cycle, transcription, apoptosis, antigen processing, biological clock control, differentiation and surface receptor desensitization. The questions to be addressed are: How is work partitioned between alternative outcomes? What is the maximum work that can be performed by the system? What factors limit its efficiency in performing work? These questions have health implications: human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies. Thus, understanding the regulation of the half-life of proteins should provide critical insights into cell physiology and pathology. The mishandling of aberrant proteins incurs penalties throughout biology: the survival of bacteria subjected to stress depends on the effective performance of systems which deal with misfolded and structurally aberrant proteins- to either fold them properly or destroy them. The specific questions to be addressed are: How hard can the device pull to cause unfolding? How many pulls are needed to commit irreversibly? What is the limit of pulling power, and the statistical distribution of pulling power? Answers to these questions will begin to reveal not just what these machines do but the decision tree that describes how outcomes are controlled and when machine capacity may be exceeded. We want to know not just how the machine works, but how its decision tree yields alternative outcomes.        The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. The model will be a protein involved in degrading other proteins. Human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies.            ",Analysis of force developed by a AAA ATPase,8334589,R01GM097974,"['ATP Hydrolysis', 'ATP phosphohydrolase', 'Address', 'Affect', 'Amino Acids', 'Apoptosis', 'Bacteria', 'Binding', 'Biogenesis', 'Biological Clocks', 'Biology', 'Cell Cycle', 'Cell division', 'Cell physiology', 'Clinical Treatment', 'Clinical Trials', 'Commit', 'Decision Trees', 'Devices', 'Digestion', 'Failure', 'Family', 'Gene Expression Regulation', 'Generations', 'Genetic Transcription', 'Goals', 'Half-Life', 'Hand', 'Health', 'Human', 'Individual', 'Length', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Methods', 'Mitochondria', 'Modeling', 'Molecular Machines', 'Movement', 'Multiple Myeloma', 'Multivesicular Body', 'Mutate', 'Nervous System Trauma', 'Outcome', 'Pathology', 'Performance', 'Property', 'Proteasome Inhibitor', 'Proteins', 'Proteolysis', 'Recurrence', 'Regulation', 'Role', 'Side', 'Signal Transduction Pathway', 'Site', 'Statistical Distributions', 'Stress', 'Surface', 'System', 'Techniques', 'Testing', 'Therapeutic Intervention', 'Time', 'Transport Protein Gene', 'War', 'Work', 'antigen processing', 'desensitization', 'human disease', 'insight', 'member', 'multicatalytic endopeptidase complex', 'polypeptide', 'protein degradation', 'receptor', 'single molecule']",NIGMS,ROCKEFELLER UNIVERSITY,R01,2012,308086,-0.01630397335855108
"Analysis of force developed by a AAA ATPase    DESCRIPTION (provided by applicant):  The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. This project will focus on studying the activity of these machines at the single molecule level. The model protein will be ClpX - it is the part of the proteosome, a key effect of protein degradation that unfolds the proteins to prepare them for degradation. . Cellular proteins differ widely in their liability, from half-lives of minutes to days. Regulated degradation, by allowing rapid changes in the levels of cellular proteins, helps control signal transduction pathways, the cell- cycle, transcription, apoptosis, antigen processing, biological clock control, differentiation and surface receptor desensitization. The questions to be addressed are: How is work partitioned between alternative outcomes? What is the maximum work that can be performed by the system? What factors limit its efficiency in performing work? These questions have health implications: human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies. Thus, understanding the regulation of the half-life of proteins should provide critical insights into cell physiology and pathology. The mishandling of aberrant proteins incurs penalties throughout biology: the survival of bacteria subjected to stress depends on the effective performance of systems which deal with misfolded and structurally aberrant proteins- to either fold them properly or destroy them. The specific questions to be addressed are: How hard can the device pull to cause unfolding? How many pulls are needed to commit irreversibly? What is the limit of pulling power, and the statistical distribution of pulling power? Answers to these questions will begin to reveal not just what these machines do but the decision tree that describes how outcomes are controlled and when machine capacity may be exceeded. We want to know not just how the machine works, but how its decision tree yields alternative outcomes.      PUBLIC HEALTH RELEVANCE: The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. The model will be a protein involved in degrading other proteins. Human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies.              The AAA ATPases family includes molecules whose roles include, but are far from limited to, biogenesis of mitochondria and multivesicular bodies, proteins in involved in gene regulation and protein transport. The model will be a protein involved in degrading other proteins. Human pathological conditions are associated with failures of the degradation system and its regulation offers the potential for therapeutic intervention. Furthermore, an inhibitor of proteasome catalytic activity is in use for treatment of recurrent multiple myeloma, and proteasome inhibitors are in clinical trial for treatment of a broad spectrum of human malignancies.            ",Analysis of force developed by a AAA ATPase,8206159,R01GM097974,"['ATP Hydrolysis', 'ATP phosphohydrolase', 'Address', 'Affect', 'Amino Acids', 'Apoptosis', 'Bacteria', 'Binding', 'Biogenesis', 'Biological Clocks', 'Biology', 'Cell Cycle', 'Cell division', 'Cell physiology', 'Clinical Treatment', 'Clinical Trials', 'Commit', 'Decision Trees', 'Devices', 'Digestion', 'Failure', 'Family', 'Gene Expression Regulation', 'Generations', 'Genetic Transcription', 'Goals', 'Half-Life', 'Hand', 'Health', 'Human', 'Individual', 'Length', 'Malignant Neoplasms', 'Measurement', 'Measures', 'Methods', 'Mitochondria', 'Modeling', 'Molecular Machines', 'Movement', 'Multiple Myeloma', 'Multivesicular Body', 'Mutate', 'Nervous System Trauma', 'Outcome', 'Pathology', 'Performance', 'Property', 'Proteasome Inhibitor', 'Proteins', 'Proteolysis', 'Recurrence', 'Regulation', 'Role', 'Side', 'Signal Transduction Pathway', 'Site', 'Statistical Distributions', 'Stress', 'Surface', 'System', 'Techniques', 'Testing', 'Therapeutic Intervention', 'Time', 'Transport Protein Gene', 'War', 'Work', 'antigen processing', 'desensitization', 'human disease', 'insight', 'member', 'multicatalytic endopeptidase complex', 'polypeptide', 'protein degradation', 'receptor', 'single molecule']",NIGMS,ROCKEFELLER UNIVERSITY,R01,2011,321304,-0.012237630896513387
"Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers     DESCRIPTION (provided by applicant): Genome-wide mRNA profiling provides a snapshot of the global state of mammalian cells under different experimental conditions such as diseased vs. normal or drug vs. mock treatment cellular states. However, since measurements are in the form of quantitative changes in mRNA levels, such experimental data does not provide direct understanding of the regulatory upstream molecular mechanisms responsible for the observed changes. Identifying potential cell signaling regulatory mechanisms responsible for changes in gene expression under different experimental conditions or in different tissues has been the focus of many computational systems biology efforts. Most popular approaches include gene ontology or pathway enrichment analyses, as well as reverse engineering of networks from mRNA expression data. However, these methods often assume that differentially expressed genes give rise to pathways and functional modules which is not always true in higher eukaryotes. Here we propose an alternative rational approach, called Expression2Kinases, to identify and rank transcription factors, chromatin modifiers, protein complexes, and protein kinases that are likely responsible for observed changes in gene expression. By combining data from ChIP-seq and ChIP-chip experiments, protein-protein interactions reported in publicly available databases, and kinase-protein phosphorylation reactions collected from the literature, we can identify and rank upstream regulators based on genome-wide changes in gene expression. The idea is to infer the transcription-factors and chromatin regulators responsible for changes in gene-expression; then use protein-protein interactions to ""connect"" the identified factors to build transcriptional complexes involving the factors; then use kinase-protein phosphorylation reactions to identify and rank candidate protein kinases that most likely regulate the formation of the identified transcriptional complexes. We plan to validate this method with phosphoproteomics data, data from drug perturbations followed by genome-wide gene expression, RNAi screens, as well as through literature-based text-mining approaches. The project will produce several high quality datasets, web-based software, new algorithms, and robust lists of transcription-factors, histone modifiers, and kinase rankings likely responsible fo mammalian cell regulation. The approach will be experimentally tested in several collaborative projects mainly exploring regulation of differentiating stem and iPS cells. The databases, software tools and algorithms developed for this project will advance drug target discovery and help in unraveling drug mechanisms of action.          The project presents a new rational pipeline to identify and rank upstream regulators that are responsible for observed changes in gene expression collected at the genome-wide scale from mammalian cells as well as method to predict how combinations of FDA approved drugs could be used to affect changes in gene expression. The approach has the potential to rapidly advance drug target discovery, suggest drug repositioning strategies, and help in unraveling drug mechanisms of action, and will be mainly applied to study stem cell differentiation and iPS reprogramming through experimental collaborations.            ",Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers,8513369,R01GM098316,"['Affect', 'Algorithms', 'Cells', 'ChIP-on-chip', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Complex', 'Computer Simulation', 'Computer software', 'Data', 'Data Set', 'Databases', 'Dermal', 'Development', 'Disease', 'Drug Combinations', 'Drug Targeting', 'Engineering', 'Ensure', 'Erythrocytes', 'Eukaryota', 'FDA approved', 'Gene Chips', 'Gene Expression', 'Gene Expression Profile', 'Genes', 'Goals', 'Hair follicle structure', 'Hepatocyte', 'Histones', 'Human', 'Link', 'Literature', 'Mammalian Cell', 'Measurement', 'Messenger RNA', 'Methods', 'Modeling', 'Molecular', 'Molecular Profiling', 'Mus', 'Online Systems', 'Ontology', 'Pathway interactions', 'Pharmaceutical Preparations', 'Phosphorylation', 'Phosphotransferases', 'Positioning Attribute', 'Protein Kinase', 'Protein Microchips', 'Proteins', 'RNA Interference', 'Reaction', 'Regulation', 'Reporting', 'Series', 'Signal Transduction', 'Site', 'Software Tools', 'Somatic Cell', 'Source', 'Staging', 'Stem cells', 'Systems Biology', 'Testing', 'Time', 'Tissues', 'Validation', 'Weight', 'base', 'candidate identification', 'chromatin modification', 'drug mechanism', 'drug testing', 'embryonic stem cell', 'gain of function', 'genome-wide', 'histone modification', 'induced pluripotent stem cell', 'loss of function', 'mRNA Expression', 'network models', 'pluripotency', 'protein complex', 'protein protein interaction', 'research study', 'stem', 'stem cell differentiation', 'stem cell fate specification', 'text searching', 'tongue papilla', 'tool', 'transcription factor', 'transcriptome sequencing']",NIGMS,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2013,315382,0.11716237989578679
"Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers     DESCRIPTION (provided by applicant): Genome-wide mRNA profiling provides a snapshot of the global state of mammalian cells under different experimental conditions such as diseased vs. normal or drug vs. mock treatment cellular states. However, since measurements are in the form of quantitative changes in mRNA levels, such experimental data does not provide direct understanding of the regulatory upstream molecular mechanisms responsible for the observed changes. Identifying potential cell signaling regulatory mechanisms responsible for changes in gene expression under different experimental conditions or in different tissues has been the focus of many computational systems biology efforts. Most popular approaches include gene ontology or pathway enrichment analyses, as well as reverse engineering of networks from mRNA expression data. However, these methods often assume that differentially expressed genes give rise to pathways and functional modules which is not always true in higher eukaryotes. Here we propose an alternative rational approach, called Expression2Kinases, to identify and rank transcription factors, chromatin modifiers, protein complexes, and protein kinases that are likely responsible for observed changes in gene expression. By combining data from ChIP-seq and ChIP-chip experiments, protein-protein interactions reported in publicly available databases, and kinase-protein phosphorylation reactions collected from the literature, we can identify and rank upstream regulators based on genome-wide changes in gene expression. The idea is to infer the transcription-factors and chromatin regulators responsible for changes in gene-expression; then use protein-protein interactions to ""connect"" the identified factors to build transcriptional complexes involving the factors; then use kinase-protein phosphorylation reactions to identify and rank candidate protein kinases that most likely regulate the formation of the identified transcriptional complexes. We plan to validate this method with phosphoproteomics data, data from drug perturbations followed by genome-wide gene expression, RNAi screens, as well as through literature-based text-mining approaches. The project will produce several high quality datasets, web-based software, new algorithms, and robust lists of transcription-factors, histone modifiers, and kinase rankings likely responsible fo mammalian cell regulation. The approach will be experimentally tested in several collaborative projects mainly exploring regulation of differentiating stem and iPS cells. The databases, software tools and algorithms developed for this project will advance drug target discovery and help in unraveling drug mechanisms of action.        PUBLIC HEALTH RELEVANCE: The project presents a new rational pipeline to identify and rank upstream regulators that are responsible for observed changes in gene expression collected at the genome-wide scale from mammalian cells as well as method to predict how combinations of FDA approved drugs could be used to affect changes in gene expression. The approach has the potential to rapidly advance drug target discovery, suggest drug repositioning strategies, and help in unraveling drug mechanisms of action, and will be mainly applied to study stem cell differentiation and iPS reprogramming through experimental collaborations.              The project presents a new rational pipeline to identify and rank upstream regulators that are responsible for observed changes in gene expression collected at the genome-wide scale from mammalian cells as well as method to predict how combinations of FDA approved drugs could be used to affect changes in gene expression. The approach has the potential to rapidly advance drug target discovery, suggest drug repositioning strategies, and help in unraveling drug mechanisms of action, and will be mainly applied to study stem cell differentiation and iPS reprogramming through experimental collaborations.            ",Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers,8295704,R01GM098316,"['Affect', 'Algorithms', 'Cells', 'ChIP-on-chip', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Complex', 'Computer Simulation', 'Computer software', 'Data', 'Data Set', 'Databases', 'Dermal', 'Development', 'Disease', 'Drug Combinations', 'Drug Delivery Systems', 'Engineering', 'Ensure', 'Erythrocytes', 'Eukaryota', 'FDA approved', 'Gene Expression', 'Gene Expression Profile', 'Genes', 'Goals', 'Hair follicle structure', 'Hepatocyte', 'Histones', 'Human', 'Link', 'Literature', 'Mammalian Cell', 'Measurement', 'Messenger RNA', 'Methods', 'Modeling', 'Molecular', 'Molecular Profiling', 'Mus', 'Online Systems', 'Ontology', 'Pathway interactions', 'Pharmaceutical Preparations', 'Phosphorylation', 'Phosphotransferases', 'Positioning Attribute', 'Protein Kinase', 'Protein Microchips', 'Proteins', 'RNA', 'RNA Interference', 'Reaction', 'Regulation', 'Reporting', 'Series', 'Signal Transduction', 'Site', 'Software Tools', 'Somatic Cell', 'Source', 'Staging', 'Stem cells', 'Systems Biology', 'Testing', 'Time', 'Tissues', 'Validation', 'Weight', 'base', 'candidate identification', 'chromatin modification', 'drug mechanism', 'drug testing', 'embryonic stem cell', 'gain of function', 'genome-wide', 'histone modification', 'induced pluripotent stem cell', 'loss of function', 'mRNA Expression', 'network models', 'pluripotency', 'protein complex', 'protein protein interaction', 'research study', 'stem', 'stem cell differentiation', 'stem cell fate specification', 'text searching', 'tongue papilla', 'tool', 'transcription factor']",NIGMS,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2012,326820,0.10357658775863866
"Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers DESCRIPTION (provided by applicant): Genome-wide mRNA profiling provides a snapshot of the global state of mammalian cells under different experimental conditions such as diseased vs. normal or drug vs. mock treatment cellular states. However, since measurements are in the form of quantitative changes in mRNA levels, such experimental data does not provide direct understanding of the regulatory upstream molecular mechanisms responsible for the observed changes. Identifying potential cell signaling regulatory mechanisms responsible for changes in gene expression under different experimental conditions or in different tissues has been the focus of many computational systems biology efforts. Most popular approaches include gene ontology or pathway enrichment analyses, as well as reverse engineering of networks from mRNA expression data. However, these methods often assume that differentially expressed genes give rise to pathways and functional modules which is not always true in higher eukaryotes. Here we propose an alternative rational approach, called Expression2Kinases, to identify and rank transcription factors, chromatin modifiers, protein complexes, and protein kinases that are likely responsible for observed changes in gene expression. By combining data from ChIP-seq and ChIP-chip experiments, protein-protein interactions reported in publicly available databases, and kinase-protein phosphorylation reactions collected from the literature, we can identify and rank upstream regulators based on genome-wide changes in gene expression. The idea is to infer the transcription-factors and chromatin regulators responsible for changes in gene-expression; then use protein-protein interactions to ""connect"" the identified factors to build transcriptional complexes involving the factors; then use kinase-protein phosphorylation reactions to identify and rank candidate protein kinases that most likely regulate the formation of the identified transcriptional complexes. We plan to validate this method with phosphoproteomics data, data from drug perturbations followed by genome-wide gene expression, RNAi screens, as well as through literature-based text-mining approaches. The project will produce several high quality datasets, web-based software, new algorithms, and robust lists of transcription-factors, histone modifiers, and kinase rankings likely responsible fo mammalian cell regulation. The approach will be experimentally tested in several collaborative projects mainly exploring regulation of differentiating stem and iPS cells. The databases, software tools and algorithms developed for this project will advance drug target discovery and help in unraveling drug mechanisms of action. The project presents a new rational pipeline to identify and rank upstream regulators that are responsible for observed changes in gene expression collected at the genome-wide scale from mammalian cells as well as method to predict how combinations of FDA approved drugs could be used to affect changes in gene expression. The approach has the potential to rapidly advance drug target discovery, suggest drug repositioning strategies, and help in unraveling drug mechanisms of action, and will be mainly applied to study stem cell differentiation and iPS reprogramming through experimental collaborations.",Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers,8843008,R01GM098316,"['Affect', 'Algorithmic Software', 'Algorithms', 'Cells', 'ChIP-on-chip', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Complex', 'Computer Simulation', 'Computer software', 'Data', 'Data Set', 'Databases', 'Dermal', 'Development', 'Disease', 'Drug Combinations', 'Drug Targeting', 'Engineering', 'Ensure', 'Erythrocytes', 'Eukaryota', 'FDA approved', 'Gene Chips', 'Gene Expression', 'Gene Expression Profile', 'Genes', 'Goals', 'Hair follicle structure', 'Hepatocyte', 'Histones', 'Human', 'Link', 'Literature', 'Mammalian Cell', 'Measurement', 'Messenger RNA', 'Methods', 'Modeling', 'Molecular', 'Molecular Profiling', 'Mus', 'Online Systems', 'Ontology', 'Pathway interactions', 'Pharmaceutical Preparations', 'Phosphorylation', 'Phosphotransferases', 'Positioning Attribute', 'Protein Kinase', 'Protein Microchips', 'Proteins', 'RNA Interference', 'Reaction', 'Regulation', 'Reporting', 'Series', 'Signal Transduction', 'Site', 'Software Tools', 'Somatic Cell', 'Source', 'Staging', 'Stem cells', 'Systems Biology', 'Testing', 'Time', 'Tissues', 'Validation', 'Weight', 'base', 'candidate identification', 'chromatin modification', 'differential expression', 'drug mechanism', 'drug testing', 'embryonic stem cell', 'gain of function', 'genome-wide', 'histone modification', 'induced pluripotent stem cell', 'loss of function', 'mRNA Expression', 'network models', 'pluripotency', 'protein complex', 'protein protein interaction', 'research study', 'stem', 'stem cell differentiation', 'stem cell fate specification', 'text searching', 'tongue papilla', 'tool', 'transcription factor', 'transcriptome sequencing']",NIGMS,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2015,319806,0.11716237989578679
"Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers     DESCRIPTION (provided by applicant): Genome-wide mRNA profiling provides a snapshot of the global state of mammalian cells under different experimental conditions such as diseased vs. normal or drug vs. mock treatment cellular states. However, since measurements are in the form of quantitative changes in mRNA levels, such experimental data does not provide direct understanding of the regulatory upstream molecular mechanisms responsible for the observed changes. Identifying potential cell signaling regulatory mechanisms responsible for changes in gene expression under different experimental conditions or in different tissues has been the focus of many computational systems biology efforts. Most popular approaches include gene ontology or pathway enrichment analyses, as well as reverse engineering of networks from mRNA expression data. However, these methods often assume that differentially expressed genes give rise to pathways and functional modules which is not always true in higher eukaryotes. Here we propose an alternative rational approach, called Expression2Kinases, to identify and rank transcription factors, chromatin modifiers, protein complexes, and protein kinases that are likely responsible for observed changes in gene expression. By combining data from ChIP-seq and ChIP-chip experiments, protein-protein interactions reported in publicly available databases, and kinase-protein phosphorylation reactions collected from the literature, we can identify and rank upstream regulators based on genome-wide changes in gene expression. The idea is to infer the transcription-factors and chromatin regulators responsible for changes in gene-expression; then use protein-protein interactions to ""connect"" the identified factors to build transcriptional complexes involving the factors; then use kinase-protein phosphorylation reactions to identify and rank candidate protein kinases that most likely regulate the formation of the identified transcriptional complexes. We plan to validate this method with phosphoproteomics data, data from drug perturbations followed by genome-wide gene expression, RNAi screens, as well as through literature-based text-mining approaches. The project will produce several high quality datasets, web-based software, new algorithms, and robust lists of transcription-factors, histone modifiers, and kinase rankings likely responsible fo mammalian cell regulation. The approach will be experimentally tested in several collaborative projects mainly exploring regulation of differentiating stem and iPS cells. The databases, software tools and algorithms developed for this project will advance drug target discovery and help in unraveling drug mechanisms of action.          The project presents a new rational pipeline to identify and rank upstream regulators that are responsible for observed changes in gene expression collected at the genome-wide scale from mammalian cells as well as method to predict how combinations of FDA approved drugs could be used to affect changes in gene expression. The approach has the potential to rapidly advance drug target discovery, suggest drug repositioning strategies, and help in unraveling drug mechanisms of action, and will be mainly applied to study stem cell differentiation and iPS reprogramming through experimental collaborations.            ",Expression2Kinases: mRNA Profiling Linked to Multiple Upstream Regulatory Layers,8656365,R01GM098316,"['Affect', 'Algorithmic Software', 'Algorithms', 'Cells', 'ChIP-on-chip', 'ChIP-seq', 'Chromatin', 'Collaborations', 'Complex', 'Computer Simulation', 'Computer software', 'Data', 'Data Set', 'Databases', 'Dermal', 'Development', 'Disease', 'Drug Combinations', 'Drug Targeting', 'Engineering', 'Ensure', 'Erythrocytes', 'Eukaryota', 'FDA approved', 'Gene Chips', 'Gene Expression', 'Gene Expression Profile', 'Genes', 'Goals', 'Hair follicle structure', 'Hepatocyte', 'Histones', 'Human', 'Link', 'Literature', 'Mammalian Cell', 'Measurement', 'Messenger RNA', 'Methods', 'Modeling', 'Molecular', 'Molecular Profiling', 'Mus', 'Online Systems', 'Ontology', 'Pathway interactions', 'Pharmaceutical Preparations', 'Phosphorylation', 'Phosphotransferases', 'Positioning Attribute', 'Protein Kinase', 'Protein Microchips', 'Proteins', 'RNA Interference', 'Reaction', 'Regulation', 'Reporting', 'Series', 'Signal Transduction', 'Site', 'Software Tools', 'Somatic Cell', 'Source', 'Staging', 'Stem cells', 'Systems Biology', 'Testing', 'Time', 'Tissues', 'Validation', 'Weight', 'base', 'candidate identification', 'chromatin modification', 'drug mechanism', 'drug testing', 'embryonic stem cell', 'gain of function', 'genome-wide', 'histone modification', 'induced pluripotent stem cell', 'loss of function', 'mRNA Expression', 'network models', 'pluripotency', 'protein complex', 'protein protein interaction', 'research study', 'stem', 'stem cell differentiation', 'stem cell fate specification', 'text searching', 'tongue papilla', 'tool', 'transcription factor', 'transcriptome sequencing']",NIGMS,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2014,323152,0.11716237989578679
"An Integrative Approach to Construct a Regulatory Network Effected by TDZs     DESCRIPTION (provided by applicant): Obesity is a major risk factor for metabolic disorders. Obesit typically leads to accumulation of dysfunctional white adipose tissue (WAT), which further causes metabolic dysregulation with elevated circulation of fatty acids and increased secretion of proinflammatory adipokines. The discovery of fat burning brown adipose tissue (BAT) in humans has raised the exciting possibility of BAT may be targeted as a novel method to treat obesity and metablic diseases. Thiazolidinediones (TZDs) have a function to convert WAT into a ""brownlike"" state. Beside, TZDs have been used as a remedy for diabetes. But the clinical use of TZDs has been limited because of the safety concerns such as potential cardiovascular risks. Understanding the mechanism will identify efficacious but lower risk drug targets for the metabolic disorders. TZDs act by activatin PPAR? (peroxisome proliferator-activated receptor ?). However, our understanding about the targets f PPAR? and other cofactors is limited. To understand the role of TZDs and further study the browning effect, we propose to develop a novel algorithm to predict long-range promoter-enhancer interaction and construct a transcriptional network. To predict the long-range interactions, we will employ a machine learning algorithm that uses the enhancer RNA (eRNA) levels and gene transcription levels obtained from global run-on sequencing (GROseq) data. GROseq is a useful dataset to predict long-range interactions, as the eRNA levels highly correlate with the gene transcription level. Applyingthe obtained interactions to the known binding sites of TFs including PPAR?, GR, C/EBP, SMRT, and RXR, we will construct a comprehensive TF-gene network. The predicted interaction provides a useful environment to study gene regulation of TZDs. We will study how the distance, relative position, an the combination of multiple TF binding sites affect gene expression. We will also investigate the browning effects by TZDs by including BAT-specific TF binding data in the network. The transcriptioal rule of the BAT-specific binding information, in combination with other TFs, will be analyzed from he TF-gene network. As a whole, these studies use an innovative and creative approach to integrate various types of data to study gene regulation of TZDs. By reprocessing complex genomic datasets ino a comprehensive regulatory network, the proposed algorithm provides a unique view in analyzing the regulatory rules of the browning effect, which will greatly enhance our understanding about the gen regulation of TZDs and identify potential therapeutic targets for diabetes.          PUBLIC HEALTH RELEVANCE: A noble algorithm is developed to reprocess and integrate various types of data in a regulatory network to the study of the browning effect by thiazolidinedione (TZD). We will develop a novel algorithm to predict promoter-enhancer long-range interactions using the glbal run-on sequencing (GROseq) data and construct regulatory network using the known transcription factor binding sites. The analysis using the TF-gene networks will elucidate the transcriptional regulations of TZDs, which will identify efficacious but lower risk drug targets for the metabolic disorders.            ",An Integrative Approach to Construct a Regulatory Network Effected by TDZs,8640941,R21DK098769,"['2,4-thiazolidinedione', 'Adipose tissue', 'Affect', 'Algorithms', 'Antidiabetic Drugs', 'Binding', 'Binding Sites', 'Biological', 'Blood Circulation', 'Brown Fat', 'Burn injury', 'CCAAT-Enhancer-Binding Proteins', 'Calories', 'Chemicals', 'Classification', 'Clinical', 'Complex', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Diabetes Mellitus', 'Disease', 'Distal', 'Drug Targeting', 'Enhancers', 'Environment', 'Exposure to', 'Fatty Acids', 'Fatty acid glycerol esters', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Transcription', 'Genomics', 'Heating', 'Housing', 'Human', 'Machine Learning', 'Measures', 'Metabolic', 'Metabolic Diseases', 'Methodology', 'Methods', 'Modeling', 'Mus', 'Nature', 'Non-Insulin-Dependent Diabetes Mellitus', 'Nucleic Acid Regulatory Sequences', 'Obesity', 'Peroxisome Proliferator-Activated Receptors', 'Positioning Attribute', 'Prevention approach', 'Property', 'RNA', 'RXR', 'Regulation', 'Relative (related person)', 'Risk', 'Risk Factors', 'Role', 'Running', 'Safety', 'Therapeutic', 'Thiazolidinediones', 'Time', 'Transcription factor genes', 'Transcriptional Regulation', 'Variant', 'adipokines', 'base', 'cardiovascular risk factor', 'cofactor', 'design', 'epigenome', 'gene interaction', 'genome-wide', 'in vivo', 'innovation', 'insulin sensitivity', 'meetings', 'novel', 'novel strategies', 'promoter', 'public health relevance', 'receptor binding', 'response', 'therapeutic target', 'time use', 'transcription factor']",NIDDK,UNIVERSITY OF PENNSYLVANIA,R21,2014,200000,-0.02870189251321678
"An integrative approach to construct a regulatory network effected by TDZs     DESCRIPTION (provided by applicant): Obesity is a major risk factor for metabolic disorders. Obesit typically leads to accumulation of dysfunctional white adipose tissue (WAT), which further causes metabolic dysregulation with elevated circulation of fatty acids and increased secretion of proinflammatory adipokines. The discovery of fat burning brown adipose tissue (BAT) in humans has raised the exciting possibility of BAT may be targeted as a novel method to treat obesity and metablic diseases. Thiazolidinediones (TZDs) have a function to convert WAT into a ""brownlike"" state. Beside, TZDs have been used as a remedy for diabetes. But the clinical use of TZDs has been limited because of the safety concerns such as potential cardiovascular risks. Understanding the mechanism will identify efficacious but lower risk drug targets for the metabolic disorders. TZDs act by activatin PPAR? (peroxisome proliferator-activated receptor ?). However, our understanding about the targets f PPAR? and other cofactors is limited. To understand the role of TZDs and further study the browning effect, we propose to develop a novel algorithm to predict long-range promoter-enhancer interaction and construct a transcriptional network. To predict the long-range interactions, we will employ a machine learning algorithm that uses the enhancer RNA (eRNA) levels and gene transcription levels obtained from global run-on sequencing (GROseq) data. GROseq is a useful dataset to predict long-range interactions, as the eRNA levels highly correlate with the gene transcription level. Applyingthe obtained interactions to the known binding sites of TFs including PPAR?, GR, C/EBP, SMRT, and RXR, we will construct a comprehensive TF-gene network. The predicted interaction provides a useful environment to study gene regulation of TZDs. We will study how the distance, relative position, an the combination of multiple TF binding sites affect gene expression. We will also investigate the browning effects by TZDs by including BAT-specific TF binding data in the network. The transcriptioal rule of the BAT-specific binding information, in combination with other TFs, will be analyzed from he TF-gene network. As a whole, these studies use an innovative and creative approach to integrate various types of data to study gene regulation of TZDs. By reprocessing complex genomic datasets ino a comprehensive regulatory network, the proposed algorithm provides a unique view in analyzing the regulatory rules of the browning effect, which will greatly enhance our understanding about the gen regulation of TZDs and identify potential therapeutic targets for diabetes.          PUBLIC HEALTH RELEVANCE: A noble algorithm is developed to reprocess and integrate various types of data in a regulatory network to the study of the browning effect by thiazolidinedione (TZD). We will develop a novel algorithm to predict promoter-enhancer long-range interactions using the glbal run-on sequencing (GROseq) data and construct regulatory network using the known transcription factor binding sites. The analysis using the TF-gene networks will elucidate the transcriptional regulations of TZDs, which will identify efficacious but lower risk drug targets for the metabolic disorders.            ",An integrative approach to construct a regulatory network effected by TDZs,8491522,R21DK098769,"['2,4-thiazolidinedione', 'Adipose tissue', 'Affect', 'Algorithms', 'Antidiabetic Drugs', 'Binding', 'Binding Sites', 'Biological', 'Blood Circulation', 'Brown Fat', 'Burn injury', 'CCAAT-Enhancer-Binding Proteins', 'Calories', 'Chemicals', 'Classification', 'Clinical', 'Complex', 'Data', 'Data Analyses', 'Data Set', 'Development', 'Diabetes Mellitus', 'Disease', 'Distal', 'Drug Targeting', 'Enhancers', 'Environment', 'Exposure to', 'Fatty Acids', 'Fatty acid glycerol esters', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Transcription', 'Genomics', 'Heating', 'Housing', 'Human', 'Machine Learning', 'Measures', 'Metabolic', 'Metabolic Diseases', 'Methodology', 'Methods', 'Modeling', 'Mus', 'Nature', 'Non-Insulin-Dependent Diabetes Mellitus', 'Nucleic Acid Regulatory Sequences', 'Obesity', 'Peroxisome Proliferator-Activated Receptors', 'Positioning Attribute', 'Prevention approach', 'Property', 'RNA', 'RXR', 'Regulation', 'Relative (related person)', 'Risk', 'Risk Factors', 'Role', 'Running', 'Safety', 'Therapeutic', 'Thiazolidinediones', 'Time', 'Transcription factor genes', 'Transcriptional Regulation', 'Variant', 'adipokines', 'base', 'cardiovascular risk factor', 'cofactor', 'design', 'epigenome', 'gene interaction', 'genome-wide', 'in vivo', 'innovation', 'insulin sensitivity', 'meetings', 'novel', 'novel strategies', 'promoter', 'public health relevance', 'response', 'therapeutic target', 'time use', 'transcription factor']",NIDDK,UNIVERSITY OF PENNSYLVANIA,R21,2013,240000,-0.02870189251321678
"Determining lineage decisions and gene regulatory networks governing the generation of key progenitor cell types during early human brain development Abstract The long term goal of this proposal is to quantitatively understand how gene regulatory networks (GRNs) generate the diversity of cell types during the development of the human brain. The focus of this proposal is to determine how key progenitor cell types that are uniquely enriched in humans are generated. Such an understanding is essential for uncovering the mechanisms of human developmental diseases. There are three challenges to achieving this goal: 1. Ethical issues in working with developing human tissue, 2. Computational and experimental techniques to determine the sequence of progenitor cell states and state transitions that give rise to the diversity of cell types, 3. the difficultly in building quantitative models of the gene regulatory networks in the absence of data to determine the thousands of biochemical constants. The approach of the proposal is to build the necessary computational, mathematical and experimental framework to overcome these challenges. To recapitulate early human brain development, the proposal will employ an in vitro human embryonic stem cell differentiation system. To obtain snapshots of the underlying gene regulatory network, high throughput single cell sequencing will be employed to obtain transcriptional profiles of thousands of single cells during the course of development. The challenge of inferring the sequence of cell states and cell state transitions will be overcome through a novel statistical method to obtain a joint probability distribution of the cell states, sequence of transitions and a key set of genes whose dynamics reflect these states and transitions. The inferences will be tested by mapping to in vivo data and using viral lineage tracing. The origins of forebrain and outer radial glial cells (oRG) progenitors uniquely enriched in the developing human forebrain will thus be determined. The challenge of building predictive models will be overcome by using methods from theoretical physics and ensemble modeling from statistics to build models that make probabilistic predictions. By using the available data as constraints on the model, the framework will extract joint probability distributions of all the parameters of the model. These distribution functions will then be used to produce probabilistic predictions about the responses of the underlying GRNs to perturbations. High probability predictions will be tested experimentally by perturbing gene expression and signaling during early brain development and the model will be iteratively improved. The success of this proposal will result in the first quantitative model of the gene regulatory network controlling the generation of forebrain and the oRG progenitor cells. If achieved, this work therefore would represent a major insight into the molecular and cellular events that give rise to the disproportionately gyrated human brain. Narrative The project seeks to gain a quantitative understanding of the molecular networks within cells that control the generation of key progenitor cell types that arise during human brain development. To do so, it will develop modeling and computational tools as well as test these tools on human embryonic stem cell lines. In the longer term, a quantitative understanding of the circuits within cells that control development will allow us to uncover mechanisms underlying developmental disease.",Determining lineage decisions and gene regulatory networks governing the generation of key progenitor cell types during early human brain development,9968562,R01HD100036,"['Animal Model', 'Bar Codes', 'Biochemical', 'Biological Assay', 'Brain', 'CRISPR/Cas technology', 'Cell Line', 'Cells', 'Cellular Morphology', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Computer Analysis', 'Computing Methodologies', 'Congenital Abnormality', 'Data', 'Development', 'Disease model', 'Ethical Issues', 'Event', 'Expression Profiling', 'Forebrain Development', 'Foundations', 'Gene Expression', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Goals', 'Guide RNA', 'Human', 'In Vitro', 'Individual', 'Joints', 'LHX2 gene', 'Lentils - dietary', 'Libraries', 'Machine Learning', 'Maps', 'Mathematics', 'Methods', 'Midbrain structure', 'Mitotic', 'Modeling', 'Molecular', 'Neocortex', 'Neuroglia', 'Neurologic', 'Organism', 'Physics', 'Probability', 'Prosencephalon', 'RNA', 'Radial', 'Regulator Genes', 'Role', 'SOX11 gene', 'Signal Transduction', 'Statistical Methods', 'System', 'Techniques', 'Testing', 'Viral', 'WNT Signaling Pathway', 'Work', 'base', 'cell type', 'computerized tools', 'course development', 'developmental disease', 'glial cell development', 'human data', 'human embryonic stem cell', 'human embryonic stem cell line', 'human fetus tissue', 'human stem cells', 'human tissue', 'improved', 'in vivo', 'insight', 'molecular marker', 'neocortical', 'nerve stem cell', 'neurodevelopment', 'neuroregulation', 'novel', 'predictive modeling', 'progenitor', 'response', 'single cell sequencing', 'statistics', 'stem cell differentiation', 'stem cells', 'subventricular zone', 'success', 'time interval', 'tool', 'transcription factor']",NICHD,HARVARD UNIVERSITY,R01,2020,483538,0.10378012000823683
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9976999,R24DK106766,"['3-Dimensional', 'Address', 'Area', 'Back', 'Base Sequence', 'Basic Science', 'Binding Proteins', 'Biology', 'CISH gene', 'Catalogs', 'Categories', 'Cells', 'Chromatin', 'Chromosomes', 'Clinical Research', 'Collaborations', 'Communities', 'Custom', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Elements', 'Engineering', 'Epigenetic Process', 'Erythroid Cells', 'Evolution', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Genetic', 'Genetic Transcription', 'Genome', 'Health', 'Heart', 'Hematopoiesis', 'Hematopoietic', 'Hematopoietic stem cells', 'Human', 'Human Resources', 'Knock-out', 'Lead', 'Learning', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modification', 'Monitor', 'Monoclonal Antibody R24', 'Mus', 'National Institute of Diabetes and Digestive and Kidney Diseases', 'Online Systems', 'Output', 'Pathologic', 'Pattern', 'Positioning Attribute', 'Production', 'Proteins', 'Publications', 'Publishing', 'Recording of previous events', 'Regulator Genes', 'Research', 'Research Personnel', 'Resources', 'Science', 'System', 'Technology', 'Testing', 'Tissues', 'Training', 'Transcript', 'Translating', 'Vision', 'Work', 'annotation  system', 'blood formation', 'cell injury', 'cell type', 'chromosome conformation capture', 'clinically significant', 'data acquisition', 'epigenome', 'epigenomics', 'experimental study', 'falls', 'gene conservation', 'genome browser', 'genome editing', 'genome-wide', 'hematopoietic differentiation', 'improved', 'insight', 'interdisciplinary collaboration', 'loss of function', 'mouse model', 'novel', 'precision medicine', 'prototype', 'response', 'tool', 'transcriptome']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2020,1183458,0.002856651385268506
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9720892,R24DK106766,"['Address', 'Area', 'Back', 'Base Sequence', 'Basic Science', 'Binding Proteins', 'Biology', 'CISH gene', 'Catalogs', 'Categories', 'Cells', 'Chromatin', 'Chromosomes', 'Clinical Research', 'Collaborations', 'Communities', 'Custom', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Development', 'Dimensions', 'Disease', 'Elements', 'Engineering', 'Epigenetic Process', 'Erythroid Cells', 'Evolution', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Genetic', 'Genetic Transcription', 'Genome', 'Health', 'Heart', 'Hematopoiesis', 'Hematopoietic', 'Hematopoietic stem cells', 'Human', 'Human Resources', 'Knock-out', 'Lead', 'Learning', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modification', 'Monitor', 'Monoclonal Antibody R24', 'Mus', 'National Institute of Diabetes and Digestive and Kidney Diseases', 'Online Systems', 'Output', 'Pathologic', 'Pattern', 'Positioning Attribute', 'Production', 'Proteins', 'Publications', 'Publishing', 'Recording of previous events', 'Regulator Genes', 'Research', 'Research Personnel', 'Resources', 'Science', 'System', 'Technology', 'Testing', 'Tissues', 'Training', 'Transcript', 'Translating', 'Vision', 'Work', 'annotation  system', 'blood formation', 'cell injury', 'cell type', 'chromosome conformation capture', 'clinically significant', 'data acquisition', 'epigenome', 'epigenomics', 'experimental study', 'falls', 'gene conservation', 'genome browser', 'genome editing', 'genome-wide', 'hematopoietic differentiation', 'improved', 'insight', 'interdisciplinary collaboration', 'loss of function', 'mouse model', 'novel', 'precision medicine', 'prototype', 'response', 'tool', 'transcriptome']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2019,1202598,0.002856651385268506
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9524748,R24DK106766,"['Address', 'Area', 'Back', 'Base Sequence', 'Basic Science', 'Binding Proteins', 'Biology', 'Blood', 'Blood Cells', 'CISH gene', 'Catalogs', 'Categories', 'Cells', 'Chromatin', 'Chromosomes', 'Clinical Research', 'Collaborations', 'Communities', 'Custom', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Development', 'Dimensions', 'Disease', 'Elements', 'Engineering', 'Epigenetic Process', 'Erythroid Cells', 'Evolution', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genetic', 'Genetic Transcription', 'Genome', 'Health', 'Heart', 'Hematopoiesis', 'Hematopoietic', 'Hematopoietic stem cells', 'Human', 'Human Resources', 'Knock-out', 'Lead', 'Learning', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modification', 'Monitor', 'Monoclonal Antibody R24', 'Mus', 'National Institute of Diabetes and Digestive and Kidney Diseases', 'Online Systems', 'Output', 'Pathologic', 'Pattern', 'Positioning Attribute', 'Production', 'Proteins', 'Publications', 'Publishing', 'Recording of previous events', 'Regulator Genes', 'Research', 'Research Personnel', 'Resources', 'Science', 'System', 'Technology', 'Testing', 'Tissues', 'Training', 'Transcript', 'Translating', 'Vision', 'Work', 'annotation  system', 'cell injury', 'cell type', 'chromosome conformation capture', 'clinically significant', 'data acquisition', 'epigenome', 'epigenomics', 'experimental study', 'falls', 'gene conservation', 'genome browser', 'genome editing', 'genome-wide', 'improved', 'insight', 'interdisciplinary collaboration', 'loss of function', 'mouse model', 'novel', 'precision medicine', 'prototype', 'response', 'tool', 'transcriptome']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2018,1219282,0.002856651385268506
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9183143,R24DK106766,"['Accounting', 'Address', 'Area', 'Back', 'Base Sequence', 'Basic Science', 'Binding Proteins', 'Biology', 'Blood', 'Blood Cells', 'Cataloging', 'Catalogs', 'Categories', 'Cells', 'Chromatin', 'Chromosomes', 'Clinical Research', 'Collaborations', 'Communities', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Development', 'Disease', 'Elements', 'Engineering', 'Epigenetic Process', 'Erythroid Cells', 'Evolution', 'Experimental Models', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genetic', 'Genetic Transcription', 'Genome', 'Health', 'Heart', 'Hematopoiesis', 'Hematopoietic', 'Human', 'Human Resources', 'Knock-out', 'Lead', 'Learning', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modification', 'Monitor', 'Monoclonal Antibody R24', 'Mus', 'National Institute of Diabetes and Digestive and Kidney Diseases', 'Online Systems', 'Output', 'Pattern', 'Positioning Attribute', 'Production', 'Proteins', 'Publications', 'Publishing', 'Recording of previous events', 'Regulator Genes', 'Research', 'Research Personnel', 'Resources', 'Science', 'Staging', 'Stem cells', 'System', 'Technology', 'Testing', 'Tissues', 'Training', 'Transcript', 'Translating', 'Vision', 'Work', 'cell injury', 'cell type', 'chromosome conformation capture', 'clinically significant', 'data acquisition', 'epigenome', 'epigenomics', 'falls', 'feeding', 'gene conservation', 'genome browser', 'genome editing', 'genome-wide', 'improved', 'insight', 'interdisciplinary collaboration', 'loss of function', 'mouse model', 'novel', 'precision medicine', 'prototype', 'research study', 'response', 'stem', 'tool', 'transcriptome']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2016,1324873,0.002856651385268506
"VISION: ValIdated Systematic IntegratiON of epigenomic data Project Summary VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Technological advances enabling the production of large numbers of rich, genome-wide, sequence-based datasets have transformed biology. However, the volume of data is overwhelming for most investigators. Also, we do not know the mechanisms by which the vast majority of epigenetic features regulate normal differentiation or lead to aberrant function in disease. We have formed an interdisciplinary, collaborative team of investigators to address the problem of how to effectively utilize the enormous amount of epigenetic data both for basic research and precision medicine. At this point, acquisition of data is no longer the major barrier to understanding mechanisms of gene regulation during normal and pathological tissue development. The chief challenges are how to: (i) integrate epigenetic data in terms that are accessible and understandable to a broad community of researchers, (ii) build validated quantitative models explaining how the dynamics of gene expression relates to epigenetic features, and (iii) translate information effectively from mouse models to potential applications in human health. These needs are addressed by the proposed ValIdated Systematic IntegratiON (VISION) of epigenetic data to analyze mouse and human hematopoiesis, a tractable system with clear clinical significance and importance to NIDDK. By pursuing the following Specific Aims, the interdisciplinary collaboration will deliver comprehensive catalogs of cis regulatory modules (CRMs), extensive chromatin interaction maps and deduced regulatory domains, validated quantitative models for gene regulation, and a guide for investigators to translate insights from mouse models to human clinical studies. These deliverables will be provided to the community in readily accessible, web-based platforms including customized genome browsers, databases with facile query interfaces, and data-driven on-line tools. Specifically, the proposed work in Aim 1 will build comprehensive, integrative catalogs of hematopoietic CRMs and transcriptomes by compiling and determining informative epigenetic features and transcript levels in hematopoietic stem and progenitor cells and in mature cells. CRMs will be predicted using the novel IDEAS (Integrative and Discriminative Epigenome Annotation System) method. Work proposed in Aim 2 will build and validate quantitative models for gene regulation informed by chromatin interaction maps and epigenetic data. Compiling and determining chromosome interaction frequencies will predict likely target genes for CRMs. Gene regulatory models will be built that predict the contributions of CRMs and specific proteins to regulated expression; these models will be validated by extensive testing using genome-editing in ten reference loci. Finally, work in Aim 3 will produce a guide for investigators to translate insights from mouse models to human clinical studies. This effort will include categorizing orthologous mouse and human genes by conservation versus divergence of expression patterns, assigning CRMs to informative categories of epigenomic evolution, and testing the interspecies functional maps experimentally by genome-editing. Project Narrative VISION: ValIdated Systematic IntegratiON of hematopoietic epigenomes Blood cell formation is vitally important to human health because we must continually replace old and damaged cells, and because many diseases result from mis-regulation of gene expression during blood formation. Global measurements of proteins bound to DNA and their modifications help us find the genetic differences most likely to account for the aberrant gene expression at the heart of some diseases. Our formal modeling and experimental tests will open windows of insight to improve application of basic research in gene regulation to clinical studies.",VISION: ValIdated Systematic IntegratiON of epigenomic data,9316617,R24DK106766,"['Address', 'Area', 'Back', 'Base Sequence', 'Basic Science', 'Binding Proteins', 'Biology', 'Blood', 'Blood Cells', 'CISH gene', 'Catalogs', 'Categories', 'Cells', 'Chromatin', 'Chromosomes', 'Clinical Research', 'Collaborations', 'Communities', 'Custom', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Development', 'Dimensions', 'Disease', 'Elements', 'Engineering', 'Epigenetic Process', 'Erythroid Cells', 'Evolution', 'Frequencies', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genetic', 'Genetic Transcription', 'Genome', 'Health', 'Heart', 'Hematopoiesis', 'Hematopoietic', 'Hematopoietic stem cells', 'Human', 'Human Resources', 'Knock-out', 'Lead', 'Learning', 'Machine Learning', 'Maps', 'Measurement', 'Methods', 'Modeling', 'Modification', 'Monitor', 'Monoclonal Antibody R24', 'Mus', 'National Institute of Diabetes and Digestive and Kidney Diseases', 'Online Systems', 'Output', 'Pathologic', 'Pattern', 'Positioning Attribute', 'Production', 'Proteins', 'Publications', 'Publishing', 'Recording of previous events', 'Regulator Genes', 'Research', 'Research Personnel', 'Resources', 'Science', 'Stem cells', 'System', 'Technology', 'Testing', 'Tissues', 'Training', 'Transcript', 'Translating', 'Vision', 'Work', 'annotation  system', 'cell injury', 'cell type', 'chromosome conformation capture', 'clinically significant', 'data acquisition', 'epigenome', 'epigenomics', 'experimental study', 'falls', 'gene conservation', 'genome browser', 'genome editing', 'genome-wide', 'improved', 'insight', 'interdisciplinary collaboration', 'loss of function', 'mouse model', 'novel', 'precision medicine', 'prototype', 'response', 'tool', 'transcriptome']",NIDDK,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R24,2017,1232180,0.002856651385268506
"The spatial organization of the Plasmodium genome throughout its infectious cycle DESCRIPTION (provided by applicant): Malaria remains one of the most deadly infectious diseases in the developing world. The absence of a vaccine and the development of parasite resistance to commonly used antimalarial drugs underscore the urgent need for new therapeutic approaches. The goal of this project is to generate insights into the mechanisms whereby Plas- modium falciparum, the parasite responsible for the most virulent form of malaria, regulates its genes' expression throughout its life cycle.  Mechanisms controlling gene expression in the parasite are still poorly understood. Increasing evidence indicates that control of gene expression in Plasmodium occurs at multiple levels, via local protein-DNA binding events, patterns of histone modifications, local chromatin structure and nucleosome occupancy, and large-scale chromatin structure. A variety of existing genome-wide data sets, including the genomic DNA sequence as well as measurements of RNA expression levels and nucleosome occupancy, provide insight into many aspects of this regulatory machinery. However, a global picture of the structure of DNA in the nucleus of the parasite is not yet available.  This project will apply a recently developed technology to map in Plasmodium all intra- and inter-chromosomal interactions at kilobase resolution throughout the parasite life cycle. These data will be used to build a dynamic three-dimensional model of the Plasmodium genome in vivo. The project will also generate a series of maps of histone modifications genome-wide. Finally, these two new data sets, along with existing data sets, will be integrated using machine learning methods to produce a predictive model of gene expression across the Plasmodium eryrthrocytic cycle.  Rational drug design requires a detailed understanding of the molecular basis of disease. By providing fundamental insight into the regulatory mechanisms of the malaria parasite, this project will improve our ability to design new drugs and novel lines of defense against malaria. PUBLIC HEALTH RELEVANCE: To develop effective strategies for combating malaria, we must understand the biology of Plasmodium falciparum, the parasite that causes the most lethal form of the disease. This project will use a recently developed technique to discover the spatial organization of the Plasmodium genome during the parasite infectious cycle. The resulting data will be integrated with newly generated patterns of histone modifications and will be used in combination with published genome-wide data sets to develop a computational model that will yield insights into transcriptional regulation in the human malaria parasite.",The spatial organization of the Plasmodium genome throughout its infectious cycle,9067925,R01AI106775,"['Accounting', 'Agreement', 'Antibodies', 'Antimalarials', 'Architecture', 'Area', 'Biology', 'Cell Cycle', 'Cell Nucleus', 'ChIP-seq', 'Chromatin', 'Chromatin Structure', 'Chromosome Structures', 'Communicable Diseases', 'Computer Simulation', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'DNA Structure', 'DNA-Binding Proteins', 'Data', 'Data Set', 'Development', 'Disease', 'Drug Design', 'Drug Targeting', 'Epigenetic Process', 'Erythrocytes', 'Event', 'Exhibits', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic DNA', 'Genomics', 'Goals', 'Health', 'Human', 'Human Genome', 'Laboratories', 'Life Cycle Stages', 'Machine Learning', 'Malaria', 'Maps', 'Measurement', 'Messenger RNA', 'Metabolic stress', 'Methodology', 'Methods', 'Microscopy', 'Modeling', 'Molecular', 'Molecular Profiling', 'Nuclear', 'Nucleosomes', 'Organism', 'Parasite Control', 'Parasite resistance', 'Parasites', 'Pattern', 'Pharmaceutical Preparations', 'Phase', 'Plasmodium', 'Plasmodium falciparum', 'Play', 'Publishing', 'Research Personnel', 'Resolution', 'Role', 'Series', 'Staging', 'Structure', 'Techniques', 'Technology', 'Time', 'Time Series Analysis', 'Transcriptional Regulation', 'Vaccines', 'Variant', 'Virulence', 'Virulent', 'base', 'combat', 'computerized tools', 'design', 'genome-wide', 'histone modification', 'improved', 'in vivo', 'innovation', 'insight', 'learning strategy', 'novel', 'novel therapeutic intervention', 'novel therapeutics', 'predictive modeling', 'response', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'transcription factor', 'vaccine development']",NIAID,UNIVERSITY OF WASHINGTON,R01,2016,452972,0.03413627033774679
"The spatial organization of the Plasmodium genome throughout its infectious cycle DESCRIPTION (provided by applicant): Malaria remains one of the most deadly infectious diseases in the developing world. The absence of a vaccine and the development of parasite resistance to commonly used antimalarial drugs underscore the urgent need for new therapeutic approaches. The goal of this project is to generate insights into the mechanisms whereby Plas- modium falciparum, the parasite responsible for the most virulent form of malaria, regulates its genes' expression throughout its life cycle.  Mechanisms controlling gene expression in the parasite are still poorly understood. Increasing evidence indicates that control of gene expression in Plasmodium occurs at multiple levels, via local protein-DNA binding events, patterns of histone modifications, local chromatin structure and nucleosome occupancy, and large-scale chromatin structure. A variety of existing genome-wide data sets, including the genomic DNA sequence as well as measurements of RNA expression levels and nucleosome occupancy, provide insight into many aspects of this regulatory machinery. However, a global picture of the structure of DNA in the nucleus of the parasite is not yet available.  This project will apply a recently developed technology to map in Plasmodium all intra- and inter-chromosomal interactions at kilobase resolution throughout the parasite life cycle. These data will be used to build a dynamic three-dimensional model of the Plasmodium genome in vivo. The project will also generate a series of maps of histone modifications genome-wide. Finally, these two new data sets, along with existing data sets, will be integrated using machine learning methods to produce a predictive model of gene expression across the Plasmodium eryrthrocytic cycle.  Rational drug design requires a detailed understanding of the molecular basis of disease. By providing fundamental insight into the regulatory mechanisms of the malaria parasite, this project will improve our ability to design new drugs and novel lines of defense against malaria. PUBLIC HEALTH RELEVANCE: To develop effective strategies for combating malaria, we must understand the biology of Plasmodium falciparum, the parasite that causes the most lethal form of the disease. This project will use a recently developed technique to discover the spatial organization of the Plasmodium genome during the parasite infectious cycle. The resulting data will be integrated with newly generated patterns of histone modifications and will be used in combination with published genome-wide data sets to develop a computational model that will yield insights into transcriptional regulation in the human malaria parasite.",The spatial organization of the Plasmodium genome throughout its infectious cycle,8862371,R01AI106775,"['Accounting', 'Agreement', 'Antibodies', 'Antimalarials', 'Architecture', 'Area', 'Biology', 'Cell Cycle', 'Cell Nucleus', 'ChIP-seq', 'Chromatin', 'Chromatin Structure', 'Chromosome Structures', 'Communicable Diseases', 'Computer Simulation', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'DNA Structure', 'DNA-Binding Proteins', 'Data', 'Data Set', 'Development', 'Disease', 'Drug Design', 'Drug Targeting', 'Epigenetic Process', 'Erythrocytes', 'Event', 'Exhibits', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic DNA', 'Genomics', 'Goals', 'Health', 'Human', 'Human Genome', 'Laboratories', 'Life Cycle Stages', 'Machine Learning', 'Malaria', 'Maps', 'Measurement', 'Messenger RNA', 'Metabolic stress', 'Methodology', 'Methods', 'Microscopy', 'Modeling', 'Molecular', 'Molecular Profiling', 'Nuclear', 'Nucleosomes', 'Organism', 'Parasite Control', 'Parasite resistance', 'Parasites', 'Pattern', 'Pharmaceutical Preparations', 'Phase', 'Plasmodium', 'Plasmodium falciparum', 'Play', 'Publishing', 'Research Personnel', 'Resolution', 'Role', 'Series', 'Staging', 'Structure', 'Techniques', 'Technology', 'Time', 'Time Series Analysis', 'Transcriptional Regulation', 'Vaccines', 'Variant', 'Virulence', 'Virulent', 'base', 'combat', 'computerized tools', 'design', 'genome-wide', 'histone modification', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'novel therapeutic intervention', 'novel therapeutics', 'predictive modeling', 'response', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'transcription factor', 'vaccine development']",NIAID,UNIVERSITY OF WASHINGTON,R01,2015,451989,0.03413627033774679
"The spatial organization of the Plasmodium genome throughout its infectious cycle     DESCRIPTION (provided by applicant): Malaria remains one of the most deadly infectious diseases in the developing world. The absence of a vaccine and the development of parasite resistance to commonly used antimalarial drugs underscore the urgent need for new therapeutic approaches. The goal of this project is to generate insights into the mechanisms whereby Plas- modium falciparum, the parasite responsible for the most virulent form of malaria, regulates its genes' expression throughout its life cycle.  Mechanisms controlling gene expression in the parasite are still poorly understood. Increasing evidence indicates that control of gene expression in Plasmodium occurs at multiple levels, via local protein-DNA binding events, patterns of histone modifications, local chromatin structure and nucleosome occupancy, and large-scale chromatin structure. A variety of existing genome-wide data sets, including the genomic DNA sequence as well as measurements of RNA expression levels and nucleosome occupancy, provide insight into many aspects of this regulatory machinery. However, a global picture of the structure of DNA in the nucleus of the parasite is not yet available.  This project will apply a recently developed technology to map in Plasmodium all intra- and inter-chromosomal interactions at kilobase resolution throughout the parasite life cycle. These data will be used to build a dynamic three-dimensional model of the Plasmodium genome in vivo. The project will also generate a series of maps of histone modifications genome-wide. Finally, these two new data sets, along with existing data sets, will be integrated using machine learning methods to produce a predictive model of gene expression across the Plasmodium eryrthrocytic cycle.  Rational drug design requires a detailed understanding of the molecular basis of disease. By providing fundamental insight into the regulatory mechanisms of the malaria parasite, this project will improve our ability to design new drugs and novel lines of defense against malaria.         PUBLIC HEALTH RELEVANCE: To develop effective strategies for combating malaria, we must understand the biology of Plasmodium falciparum, the parasite that causes the most lethal form of the disease. This project will use a recently developed technique to discover the spatial organization of the Plasmodium genome during the parasite infectious cycle. The resulting data will be integrated with newly generated patterns of histone modifications and will be used in combination with published genome-wide data sets to develop a computational model that will yield insights into transcriptional regulation in the human malaria parasite.            ",The spatial organization of the Plasmodium genome throughout its infectious cycle,8675801,R01AI106775,"['Accounting', 'Agreement', 'Antibodies', 'Antimalarials', 'Architecture', 'Area', 'Biology', 'Cell Cycle', 'Cell Nucleus', 'ChIP-seq', 'Chromatin', 'Chromatin Structure', 'Chromosome Structures', 'Communicable Diseases', 'Computer Simulation', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'DNA Structure', 'DNA-Binding Proteins', 'Data', 'Data Set', 'Development', 'Disease', 'Drug Design', 'Drug Targeting', 'Epigenetic Process', 'Erythrocytes', 'Event', 'Exhibits', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic DNA', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Laboratories', 'Life Cycle Stages', 'Machine Learning', 'Malaria', 'Maps', 'Measurement', 'Messenger RNA', 'Metabolic stress', 'Methodology', 'Methods', 'Microscopy', 'Modeling', 'Molecular', 'Molecular Profiling', 'Nuclear', 'Nucleosomes', 'Organism', 'Parasite Control', 'Parasite resistance', 'Parasites', 'Pattern', 'Pharmaceutical Preparations', 'Phase', 'Plasmodium', 'Plasmodium falciparum', 'Play', 'Publishing', 'Research Personnel', 'Resolution', 'Role', 'Series', 'Staging', 'Structure', 'Techniques', 'Technology', 'Time', 'Time Series Analysis', 'Transcriptional Regulation', 'Vaccines', 'Variant', 'Virulence', 'Virulent', 'base', 'combat', 'computerized tools', 'design', 'genome-wide', 'histone modification', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'novel therapeutic intervention', 'novel therapeutics', 'predictive modeling', 'public health relevance', 'response', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'transcription factor', 'vaccine development']",NIAID,UNIVERSITY OF WASHINGTON,R01,2014,454989,0.03413627033774679
"The spatial organization of the Plasmodium genome throughout its infectious cycle     DESCRIPTION (provided by applicant): Malaria remains one of the most deadly infectious diseases in the developing world. The absence of a vaccine and the development of parasite resistance to commonly used antimalarial drugs underscore the urgent need for new therapeutic approaches. The goal of this project is to generate insights into the mechanisms whereby Plas- modium falciparum, the parasite responsible for the most virulent form of malaria, regulates its genes' expression throughout its life cycle.  Mechanisms controlling gene expression in the parasite are still poorly understood. Increasing evidence indicates that control of gene expression in Plasmodium occurs at multiple levels, via local protein-DNA binding events, patterns of histone modifications, local chromatin structure and nucleosome occupancy, and large-scale chromatin structure. A variety of existing genome-wide data sets, including the genomic DNA sequence as well as measurements of RNA expression levels and nucleosome occupancy, provide insight into many aspects of this regulatory machinery. However, a global picture of the structure of DNA in the nucleus of the parasite is not yet available.  This project will apply a recently developed technology to map in Plasmodium all intra- and inter-chromosomal interactions at kilobase resolution throughout the parasite life cycle. These data will be used to build a dynamic three-dimensional model of the Plasmodium genome in vivo. The project will also generate a series of maps of histone modifications genome-wide. Finally, these two new data sets, along with existing data sets, will be integrated using machine learning methods to produce a predictive model of gene expression across the Plasmodium eryrthrocytic cycle.  Rational drug design requires a detailed understanding of the molecular basis of disease. By providing fundamental insight into the regulatory mechanisms of the malaria parasite, this project will improve our ability to design new drugs and novel lines of defense against malaria.         PUBLIC HEALTH RELEVANCE: To develop effective strategies for combating malaria, we must understand the biology of Plasmodium falciparum, the parasite that causes the most lethal form of the disease. This project will use a recently developed technique to discover the spatial organization of the Plasmodium genome during the parasite infectious cycle. The resulting data will be integrated with newly generated patterns of histone modifications and will be used in combination with published genome-wide data sets to develop a computational model that will yield insights into transcriptional regulation in the human malaria parasite.            ",The spatial organization of the Plasmodium genome throughout its infectious cycle,8557512,R01AI106775,"['Accounting', 'Agreement', 'Antibodies', 'Antimalarials', 'Architecture', 'Area', 'Biology', 'Cell Cycle', 'Cell Nucleus', 'ChIP-seq', 'Chromatin', 'Chromatin Structure', 'Chromosome Structures', 'Communicable Diseases', 'Computer Simulation', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'DNA Structure', 'DNA-Binding Proteins', 'Data', 'Data Set', 'Development', 'Disease', 'Drug Design', 'Drug Targeting', 'Epigenetic Process', 'Erythrocytes', 'Event', 'Exhibits', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Genome', 'Genomics', 'Goals', 'Human', 'Human Genome', 'Laboratories', 'Life Cycle Stages', 'Machine Learning', 'Malaria', 'Maps', 'Measurement', 'Messenger RNA', 'Metabolic stress', 'Methodology', 'Methods', 'Microscopy', 'Modeling', 'Molecular', 'Molecular Profiling', 'Nuclear', 'Nucleosomes', 'Organism', 'Parasite Control', 'Parasite resistance', 'Parasites', 'Pattern', 'Pharmaceutical Preparations', 'Phase', 'Plasmodium', 'Plasmodium falciparum', 'Play', 'Publishing', 'Research Personnel', 'Resolution', 'Role', 'Series', 'Staging', 'Structure', 'Techniques', 'Technology', 'Time', 'Time Series Analysis', 'Transcriptional Regulation', 'Vaccines', 'Variant', 'Virulence', 'Virulent', 'base', 'combat', 'computerized tools', 'design', 'genome-wide', 'histone modification', 'improved', 'in vivo', 'innovation', 'insight', 'novel', 'novel therapeutic intervention', 'novel therapeutics', 'predictive modeling', 'public health relevance', 'response', 'three dimensional structure', 'three-dimensional modeling', 'tool', 'transcription factor', 'vaccine development']",NIAID,UNIVERSITY OF WASHINGTON,R01,2013,396836,0.03413627033774679
"Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD DESCRIPTION (provided by applicant): Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Abstract Virtually all multi-exon genes undergo alternative splicing (AS) to generate multiple protein isoforms (Wang et al., 2008). Alternative splicing is regulated by splicing factors (SF), such as the serine/arginine rich (SR) protein famil (Long and Caceres, 2009). All SR factors have alternative isoforms that contain in-frame premature termination codons (PTCs) that are recognized by the nonsense mediated mRNA decay (NMD) pathway and degraded (Ni et al., 2007; Lareau et al., 2007; Ishigaki et al., 2001). Generally, NMD is thought to play a protective role, by destroying truncated transcripts, but it also regulates gene expression through alternative splicing coupled with NMD. It has been shown that several SFs, including many SR proteins, affect splicing of their own pre-mRNA (Sureau et al., 2001; Sun et al., 2010). In this mode of negative feedback loop regulation, high levels of the SF cause its own pre-mRNA to be spliced into an unproductive isoform and degraded, resulting in lower protein levels (Sureau et al., 2001a). For example, SR proteins SRSF1, SRSR2, SRSF3, and SRSF7 are known to regulate their own expression by coupling alternative splicing and NMD (Sun et al., 2010; Sureau et al., 2001; nk et al., 2012b), also hnRNP L (Rossbach et al., 2009) and PTB (Spellman et al., 2005) are regulated in the same manner. There is anecdotal evidence that this mode of regulated unproductive splicing and translation (Green et al., 2003) is used in an inter-factor fashion, creating a splicing factor regulatory network (SF network). We hypothesize that the splicing regulation extends to all SR and other SFs. To date, there has been no systematic study of human splicing factors' gene regulation via NMD. A literature search allowed us to construct an SF network. This network is rich in protein-mRNA interactions, providing an intriguing hint that many SFs undergo alternative splicing coupled with NMD. Therefore we propose to conduct a comprehensive experimental survey to identify SFs that are regulated by alternative splicing coupled with NMD, to determine the effect of SF perturbation on other splicing factors, and to gain a functional insight on this regulation by looking at direct protein-mRNA binding sites. To identify SFs that are regulated by NMD, we will inhibit the NMD pathway in human cell lines via RNAi against essential NMD factors (Gatfield et al., 2003). Transcripts that undergo NMD will be up regulated in the NMD-inhibited environment and will be identified through the RNA-seq analysis. To determine the effect of SF perturbation on other splicing factors, we will overexpress and knockdown individual factors and will observe transcriptome perturbations using RNA-seq experiments and quantitative reverse transcriptase PCR (qRT-PCR) assay using splicing factors specific primers. To gain a functional insight on NMD regulation, we will look at direct protein-mRNA binding sites through UV cross-linking and immunoprecipitation (iCLIP) experiments of individual SFs followed by genome wide RNA-seq analysis with careful filtering for secondary effects. This experimental approach will allow us to determine the network of splicing factor regulation via alternative splicing coupled with NMD. PUBLIC HEALTH RELEVANCE: Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Project Narrative Splicing factors participate in transcriptome regulation; however, they themselves are regulated through a splicing factor network which couples alternative splicing with nonsense mediated mRNA decay (NMD). The aim of the project is to provide the extent and experimentally derived connections of this regulatory network. Since this project will survey NMD on a genomic scale, it will shed more light on the role of NMD in gene regulation and on changes in splicing, a phenomenon which has been shown to be prevalent in various types of cancer.",Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD,8898569,F31GM108462,"['Affect', 'Alternative Splicing', 'Arginine', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Coupled', 'Couples', 'Coupling', 'Data', 'Enhancers', 'Environment', 'Exclusion', 'Exons', 'Family', 'Feedback', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genomics', 'Goals', 'Health', 'Heterogeneous-Nuclear Ribonucleoprotein L', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Cell Line', 'Immunoprecipitation', 'Individual', 'Light', 'Mediating', 'Messenger RNA', 'Metabolism', 'Nonsense Codon', 'Normal Cell', 'Pathway interactions', 'Play', 'Prevalence', 'Protein Isoforms', 'Proteins', 'Quantitative Reverse Transcriptase PCR', 'RNA Interference', 'RNA Sequences', 'RNA Splicing', 'Regulation', 'Research', 'Role', 'Serine', 'Surveys', 'The Sun', 'Transcript', 'Translations', 'abstracting', 'cancer type', 'crosslink', 'crosslinking and immunoprecipitation sequencing', 'genome-wide', 'human ARMET protein', 'insight', 'mRNA Decay', 'mRNA Precursor', 'member', 'overexpression', 'research study', 'text searching', 'transcriptome sequencing']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2015,37549,0.08676168414404145
"Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD     DESCRIPTION (provided by applicant): Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Abstract Virtually all multi-exon genes undergo alternative splicing (AS) to generate multiple protein isoforms (Wang et al., 2008). Alternative splicing is regulated by splicing factors (SF), such as the serine/arginine rich (SR) protein famil (Long and Caceres, 2009). All SR factors have alternative isoforms that contain in-frame premature termination codons (PTCs) that are recognized by the nonsense mediated mRNA decay (NMD) pathway and degraded (Ni et al., 2007; Lareau et al., 2007; Ishigaki et al., 2001). Generally, NMD is thought to play a protective role, by destroying truncated transcripts, but it also regulates gene expression through alternative splicing coupled with NMD. It has been shown that several SFs, including many SR proteins, affect splicing of their own pre-mRNA (Sureau et al., 2001; Sun et al., 2010). In this mode of negative feedback loop regulation, high levels of the SF cause its own pre-mRNA to be spliced into an unproductive isoform and degraded, resulting in lower protein levels (Sureau et al., 2001a). For example, SR proteins SRSF1, SRSR2, SRSF3, and SRSF7 are known to regulate their own expression by coupling alternative splicing and NMD (Sun et al., 2010; Sureau et al., 2001; nk et al., 2012b), also hnRNP L (Rossbach et al., 2009) and PTB (Spellman et al., 2005) are regulated in the same manner. There is anecdotal evidence that this mode of regulated unproductive splicing and translation (Green et al., 2003) is used in an inter-factor fashion, creating a splicing factor regulatory network (SF network). We hypothesize that the splicing regulation extends to all SR and other SFs. To date, there has been no systematic study of human splicing factors' gene regulation via NMD. A literature search allowed us to construct an SF network. This network is rich in protein-mRNA interactions, providing an intriguing hint that many SFs undergo alternative splicing coupled with NMD. Therefore we propose to conduct a comprehensive experimental survey to identify SFs that are regulated by alternative splicing coupled with NMD, to determine the effect of SF perturbation on other splicing factors, and to gain a functional insight on this regulation by looking at direct protein-mRNA binding sites. To identify SFs that are regulated by NMD, we will inhibit the NMD pathway in human cell lines via RNAi against essential NMD factors (Gatfield et al., 2003). Transcripts that undergo NMD will be up regulated in the NMD-inhibited environment and will be identified through the RNA-seq analysis. To determine the effect of SF perturbation on other splicing factors, we will overexpress and knockdown individual factors and will observe transcriptome perturbations using RNA-seq experiments and quantitative reverse transcriptase PCR (qRT-PCR) assay using splicing factors specific primers. To gain a functional insight on NMD regulation, we will look at direct protein-mRNA binding sites through UV cross-linking and immunoprecipitation (iCLIP) experiments of individual SFs followed by genome wide RNA-seq analysis with careful filtering for secondary effects. This experimental approach will allow us to determine the network of splicing factor regulation via alternative splicing coupled with NMD.         PUBLIC HEALTH RELEVANCE: Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Project Narrative Splicing factors participate in transcriptome regulation; however, they themselves are regulated through a splicing factor network which couples alternative splicing with nonsense mediated mRNA decay (NMD). The aim of the project is to provide the extent and experimentally derived connections of this regulatory network. Since this project will survey NMD on a genomic scale, it will shed more light on the role of NMD in gene regulation and on changes in splicing, a phenomenon which has been shown to be prevalent in various types of cancer.            ",Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD,8786388,F31GM108462,"['Affect', 'Alternative Splicing', 'Arginine', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Coupled', 'Couples', 'Coupling', 'Data', 'Enhancers', 'Environment', 'Exclusion', 'Exons', 'Family', 'Feedback', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genomics', 'Goals', 'Heterogeneous-Nuclear Ribonucleoprotein L', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Cell Line', 'Immunoprecipitation', 'Individual', 'Light', 'Mediating', 'Messenger RNA', 'Metabolism', 'Nonsense Codon', 'Normal Cell', 'Pathway interactions', 'Play', 'Prevalence', 'Protein Isoforms', 'Proteins', 'Quantitative Reverse Transcriptase PCR', 'RNA Interference', 'RNA Sequences', 'RNA Splicing', 'Regulation', 'Research', 'Role', 'Serine', 'Surveys', 'The Sun', 'Transcript', 'Translations', 'abstracting', 'cancer type', 'crosslink', 'genome-wide', 'human ARMET protein', 'insight', 'mRNA Decay', 'mRNA Precursor', 'member', 'overexpression', 'public health relevance', 'research study', 'text searching', 'transcriptome sequencing']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2014,37105,0.08676168414404145
"Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD DESCRIPTION (provided by applicant): Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Abstract Virtually all multi-exon genes undergo alternative splicing (AS) to generate multiple protein isoforms (Wang et al., 2008). Alternative splicing is regulated by splicing factors (SF), such as the serine/arginine rich (SR) protein famil (Long and Caceres, 2009). All SR factors have alternative isoforms that contain in-frame premature termination codons (PTCs) that are recognized by the nonsense mediated mRNA decay (NMD) pathway and degraded (Ni et al., 2007; Lareau et al., 2007; Ishigaki et al., 2001). Generally, NMD is thought to play a protective role, by destroying truncated transcripts, but it also regulates gene expression through alternative splicing coupled with NMD. It has been shown that several SFs, including many SR proteins, affect splicing of their own pre-mRNA (Sureau et al., 2001; Sun et al., 2010). In this mode of negative feedback loop regulation, high levels of the SF cause its own pre-mRNA to be spliced into an unproductive isoform and degraded, resulting in lower protein levels (Sureau et al., 2001a). For example, SR proteins SRSF1, SRSR2, SRSF3, and SRSF7 are known to regulate their own expression by coupling alternative splicing and NMD (Sun et al., 2010; Sureau et al., 2001; nk et al., 2012b), also hnRNP L (Rossbach et al., 2009) and PTB (Spellman et al., 2005) are regulated in the same manner. There is anecdotal evidence that this mode of regulated unproductive splicing and translation (Green et al., 2003) is used in an inter-factor fashion, creating a splicing factor regulatory network (SF network). We hypothesize that the splicing regulation extends to all SR and other SFs. To date, there has been no systematic study of human splicing factors' gene regulation via NMD. A literature search allowed us to construct an SF network. This network is rich in protein-mRNA interactions, providing an intriguing hint that many SFs undergo alternative splicing coupled with NMD. Therefore we propose to conduct a comprehensive experimental survey to identify SFs that are regulated by alternative splicing coupled with NMD, to determine the effect of SF perturbation on other splicing factors, and to gain a functional insight on this regulation by looking at direct protein-mRNA binding sites. To identify SFs that are regulated by NMD, we will inhibit the NMD pathway in human cell lines via RNAi against essential NMD factors (Gatfield et al., 2003). Transcripts that undergo NMD will be up regulated in the NMD-inhibited environment and will be identified through the RNA-seq analysis. To determine the effect of SF perturbation on other splicing factors, we will overexpress and knockdown individual factors and will observe transcriptome perturbations using RNA-seq experiments and quantitative reverse transcriptase PCR (qRT-PCR) assay using splicing factors specific primers. To gain a functional insight on NMD regulation, we will look at direct protein-mRNA binding sites through UV cross-linking and immunoprecipitation (iCLIP) experiments of individual SFs followed by genome wide RNA-seq analysis with careful filtering for secondary effects. This experimental approach will allow us to determine the network of splicing factor regulation via alternative splicing coupled with NMD. PUBLIC HEALTH RELEVANCE: Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD Project Narrative Splicing factors participate in transcriptome regulation; however, they themselves are regulated through a splicing factor network which couples alternative splicing with nonsense mediated mRNA decay (NMD). The aim of the project is to provide the extent and experimentally derived connections of this regulatory network. Since this project will survey NMD on a genomic scale, it will shed more light on the role of NMD in gene regulation and on changes in splicing, a phenomenon which has been shown to be prevalent in various types of cancer.",Networks of Splice Factor Regulation by Unproductive Splicing Coupled With NMD,9091577,F31GM108462,"['Affect', 'Alternative Splicing', 'Arginine', 'Binding', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Coupled', 'Couples', 'Coupling', 'Data', 'Enhancers', 'Environment', 'Exclusion', 'Exons', 'Family', 'Feedback', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genomics', 'Goals', 'Health', 'Heterogeneous-Nuclear Ribonucleoprotein L', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Cell Line', 'Immunoprecipitation', 'Individual', 'Light', 'Mediating', 'Messenger RNA', 'Metabolism', 'Normal Cell', 'Pathway interactions', 'Play', 'Prevalence', 'Protein Isoforms', 'Proteins', 'Quantitative Reverse Transcriptase PCR', 'RNA Interference', 'RNA Sequences', 'RNA Splicing', 'Regulation', 'Research', 'Role', 'Serine', 'Surveys', 'Terminator Codon', 'The Sun', 'Transcript', 'Translations', 'abstracting', 'cancer type', 'crosslink', 'crosslinking and immunoprecipitation sequencing', 'genome-wide', 'insight', 'knock-down', 'mRNA Decay', 'mRNA Precursor', 'member', 'overexpression', 'premature', 'research study', 'text searching', 'transcriptome', 'transcriptome sequencing']",NIGMS,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2016,38005,0.08676168414404145
"Regulation and Functions of Human Histone Deacetylase 8    DESCRIPTION (provided by applicant): Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from conserved lysine residues in histones' amino terminal tails. They are found in all eukaryotic organisms and are believed to have a key role in the regulation of gene transcription. Importantly, recent studies suggest that HDACs are critically involved in cell cycle regulation, cell proliferation, differentiation, and the development of human cancer. The human class I HDACs, which possess homology to the yeast RPD3 protein, include HDAC1, HDAC2, HDAC3, and HDAC8. Although HDAC1, HDAC2, and HDAC3 have been extensively characterized, almost nothing is known about the functions, mechanisms of action, and regulation of HDAC8. In this proposal, the overall hypothesis is that, like other class I HDACs, HDAC8 plays an indispensable role in gene regulation. The long-term goal of this project is to obtain a greater mechanistic understanding of how HDAC8 regulates many cellular processes and how HDAC8 itself might be intricately regulated. Particular emphasis will be devoted to a detailed structure-function analysis of the HDAC8 protein and to the elucidation of how phosphorylation of HDAC8 by cAMP-dependent protein kinase A alters its activity. Additionally, genes that are regulated by HDAC8 will be rigorously identified. Given the importance of HDACs in health and disease, a thorough understanding of HDAC8 will not only increase our knowledge of chromatin structure and gene control, but will contribute directly to our overall understanding of normal and abnormal cellular processes.           n/a",Regulation and Functions of Human Histone Deacetylase 8,7395033,R01CA109699,"['Acetylation', 'Amino Acids', 'Biology', 'Cell Cycle Regulation', 'Cell Proliferation', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Class', 'Classification', 'Cloning', 'Complex', 'Cyclic AMP-Dependent Protein Kinases', 'DNA', 'Databases', 'Deacetylase', 'Deacetylation', 'Disease', 'Dissection', 'Enzymes', 'Eukaryota', 'Eukaryotic Cell', 'Evolution', 'Excision', 'Expressed Sequence Tags', 'Family', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Goals', 'HDAC1 gene', 'HDAC2 gene', 'HDAC3 gene', 'Health', 'Histone Deacetylase', 'Histone Deacetylation', 'Histones', 'Human', 'Human Development', 'Knowledge', 'Laboratories', 'Lysine', 'Malignant Neoplasms', 'Modeling', 'Modification', 'Molecular', 'Mus', 'Nucleosomes', 'Numbers', 'Organism', 'Paper', 'Phosphorylation', 'Phylogenetic Analysis', 'Play', 'Post-Translational Protein Processing', 'Protein Family', 'Proteins', 'Publishing', 'RPD3 protein', 'Recruitment Activity', 'Regulation', 'Reporting', 'Role', 'Stretching', 'Structure', 'Tail', 'Testing', 'Thinking', 'Trees', 'YY1 Transcription Factor', 'Yeasts', 'base', 'casein kinase II', 'histone deacetylase 3', 'interest', 'member', 'particle', 'protein reconstitution', 'text searching', 'yeast protein']",NCI,H. LEE MOFFITT CANCER CTR & RES INST,R01,2008,290399,0.088398469759711
"Regulation and Functions of Human Histone Deacetylase 8    DESCRIPTION (provided by applicant): Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from conserved lysine residues in histones' amino terminal tails. They are found in all eukaryotic organisms and are believed to have a key role in the regulation of gene transcription. Importantly, recent studies suggest that HDACs are critically involved in cell cycle regulation, cell proliferation, differentiation, and the development of human cancer. The human class I HDACs, which possess homology to the yeast RPD3 protein, include HDAC1, HDAC2, HDAC3, and HDAC8. Although HDAC1, HDAC2, and HDAC3 have been extensively characterized, almost nothing is known about the functions, mechanisms of action, and regulation of HDAC8. In this proposal, the overall hypothesis is that, like other class I HDACs, HDAC8 plays an indispensable role in gene regulation. The long-term goal of this project is to obtain a greater mechanistic understanding of how HDAC8 regulates many cellular processes and how HDAC8 itself might be intricately regulated. Particular emphasis will be devoted to a detailed structure-function analysis of the HDAC8 protein and to the elucidation of how phosphorylation of HDAC8 by cAMP-dependent protein kinase A alters its activity. Additionally, genes that are regulated by HDAC8 will be rigorously identified. Given the importance of HDACs in health and disease, a thorough understanding of HDAC8 will not only increase our knowledge of chromatin structure and gene control, but will contribute directly to our overall understanding of normal and abnormal cellular processes.           n/a",Regulation and Functions of Human Histone Deacetylase 8,7224869,R01CA109699,"['Acetylation', 'Amino Acids', 'Biology', 'Cell Cycle Regulation', 'Cell Proliferation', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Class', 'Classification', 'Cloning', 'Complex', 'Cyclic AMP-Dependent Protein Kinases', 'DNA', 'Databases', 'Deacetylase', 'Deacetylation', 'Disease', 'Dissection', 'Enzymes', 'Eukaryota', 'Eukaryotic Cell', 'Evolution', 'Excision', 'Expressed Sequence Tags', 'Family', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Transcription', 'Goals', 'HDAC1 gene', 'HDAC2 gene', 'HDAC3 gene', 'Health', 'Histone Deacetylase', 'Histone Deacetylation', 'Histones', 'Human', 'Human Development', 'Knowledge', 'Laboratories', 'Lysine', 'Malignant Neoplasms', 'Modeling', 'Modification', 'Molecular', 'Mus', 'Nucleosomes', 'Numbers', 'Organism', 'Paper', 'Phosphorylation', 'Phylogenetic Analysis', 'Play', 'Post-Translational Protein Processing', 'Protein Family', 'Proteins', 'Publishing', 'RPD3 protein', 'Recruitment Activity', 'Regulation', 'Reporting', 'Role', 'Stretching', 'Structure', 'Tail', 'Testing', 'Thinking', 'Trees', 'YY1 Transcription Factor', 'Yeasts', 'base', 'casein kinase II', 'histone deacetylase 3', 'interest', 'member', 'particle', 'protein reconstitution', 'text searching', 'yeast protein']",NCI,H. LEE MOFFITT CANCER CTR & RES INST,R01,2007,285151,0.088398469759711
"Comparative analysis and regulatory architecture of epigenomics datasets     DESCRIPTION (provided by applicant):  The NIH Roadmap Epigenomics and ENCODE projects have generated a collection of 3000+ epigenomics datasets, including histone modification, DNA methylation, gene expression, and DNaseI hypersensitivity profiled across 190 cell and tissue types. In order to maximize its impact on gene regulation, cellular differentiation, and human health, novel computational analyses are needed. To address this challenge, we will develop new methods for epigenomic analysis, building on our extensive experience interpreting epigenomic information, and our preliminary studies building chromatin states, activity clusters, and regulatory motif maps for the Roadmap Epigenomics and ENCODE datasets. In Aim 1, we will characterize epigenomic differences and changes during lineage differentiation by developing new tools for systematic comparison of groups of epigenomes that directly exploit the complexity of epigenomic datasets; we will also develop methods for clustering epigenomes into developmental lineages based on automatically-learned diverse epigenomic features that distinguish them; and methods that learn the unidirectional epigenomic changes that pluripotent cells undergo during lineage commitment to gain more insights into differentiation and automatically learn to classify lineages and differentiation trajectories. In Am 2, we will seek to characterize higher-order chromatin architecture and chromatin conformation to enable systematic interpretation of cis-regulatory modules: we will develop a novel statistical approach for enhancer-enhancer and enhancer-gene linking to reveal interacting regions and their target genes based on their coordinated activity patterns across cell and tissue types; we will train a supervised learning method for predicting both constitutive and tissue-specific chromatin conformation information based on chromatin state information, individual chromatin marks, genomic distance, activity, regulatory motif information, and DNA sequence; and we will use these higher-order interaction maps to predict gene expression levels based on the combined action of multiple regulatory regions and to define the cis-regulatory architecture of each gene in the human genome. The resulting resources will be invaluable for studies of gene regulation, by revealing the set of regulatory elements that are linked to each gene, and for the interpretation of genetic studies, by revealing the set of regulatory elements which jointly act to regulate each target gene and the potential target genes of non-coding variants associated with human disease. PUBLIC HEALTH RELEVANCE: The NIH ENCODE and Roadmap Epigenomics projects have generated a collection of 4000+ epigenomics datasets across 200+ cell and tissue types, which can be invaluable to the scientific community, but novel computational analyses are needed to maximize its impact on gene regulation, cellular differentiation, and human health. To address this need, we propose to systematically study epigenomic differences between cell types, lineages, and stages of differentiation, and to learn models predicting the higher-order chromatin structures across cell/tissue types, within each cell/tissue, and the chromatin architectures that they define. By systematically interpreting epigenomic annotations in the context of their cellular differentiation and their higher-order chromatin structures, the resultin resource will greatly increase their impact on human health by enabling disease studies to understand the mechanistic relationship between non-coding variants and their target genes, and the specific differentiation stages in which they act.",Comparative analysis and regulatory architecture of epigenomics datasets,9253408,R01GM113708,"['Address', 'Algorithms', 'Architecture', 'Cells', 'Chromatin', 'Chromosomes', 'Classification', 'Collection', 'Communities', 'Complex', 'Computer Analysis', 'Correlation Studies', 'DNA Methylation', 'DNA Sequence', 'Data Set', 'Development', 'Dimensions', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic study', 'Genomics', 'Graph', 'Health', 'Higher Order Chromatin Structure', 'Human', 'Human Genome', 'Hypersensitivity', 'Individual', 'Learning', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Methodology', 'Methods', 'Molecular Conformation', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phylogenetic Analysis', 'Quantitative Trait Loci', 'Regulatory Element', 'Resources', 'Somatic Mutation', 'Statistical Methods', 'Supervision', 'Tissues', 'Training', 'United States National Institutes of Health', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'comparative', 'comparison group', 'differential expression', 'epigenome', 'epigenomics', 'experience', 'experimental study', 'follow-up', 'genetic association', 'genome wide association study', 'histone modification', 'human disease', 'innovation', 'insight', 'learning strategy', 'novel', 'novel strategies', 'predictive modeling', 'public health relevance', 'rare variant', 'tool', 'ward']",NIGMS,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R01,2017,284959,0.13343310562611171
"Comparative analysis and regulatory architecture of epigenomics datasets     DESCRIPTION (provided by applicant):  The NIH Roadmap Epigenomics and ENCODE projects have generated a collection of 3000+ epigenomics datasets, including histone modification, DNA methylation, gene expression, and DNaseI hypersensitivity profiled across 190 cell and tissue types. In order to maximize its impact on gene regulation, cellular differentiation, and human health, novel computational analyses are needed. To address this challenge, we will develop new methods for epigenomic analysis, building on our extensive experience interpreting epigenomic information, and our preliminary studies building chromatin states, activity clusters, and regulatory motif maps for the Roadmap Epigenomics and ENCODE datasets. In Aim 1, we will characterize epigenomic differences and changes during lineage differentiation by developing new tools for systematic comparison of groups of epigenomes that directly exploit the complexity of epigenomic datasets; we will also develop methods for clustering epigenomes into developmental lineages based on automatically-learned diverse epigenomic features that distinguish them; and methods that learn the unidirectional epigenomic changes that pluripotent cells undergo during lineage commitment to gain more insights into differentiation and automatically learn to classify lineages and differentiation trajectories. In Am 2, we will seek to characterize higher-order chromatin architecture and chromatin conformation to enable systematic interpretation of cis-regulatory modules: we will develop a novel statistical approach for enhancer-enhancer and enhancer-gene linking to reveal interacting regions and their target genes based on their coordinated activity patterns across cell and tissue types; we will train a supervised learning method for predicting both constitutive and tissue-specific chromatin conformation information based on chromatin state information, individual chromatin marks, genomic distance, activity, regulatory motif information, and DNA sequence; and we will use these higher-order interaction maps to predict gene expression levels based on the combined action of multiple regulatory regions and to define the cis-regulatory architecture of each gene in the human genome. The resulting resources will be invaluable for studies of gene regulation, by revealing the set of regulatory elements that are linked to each gene, and for the interpretation of genetic studies, by revealing the set of regulatory elements which jointly act to regulate each target gene and the potential target genes of non-coding variants associated with human disease. PUBLIC HEALTH RELEVANCE: The NIH ENCODE and Roadmap Epigenomics projects have generated a collection of 4000+ epigenomics datasets across 200+ cell and tissue types, which can be invaluable to the scientific community, but novel computational analyses are needed to maximize its impact on gene regulation, cellular differentiation, and human health. To address this need, we propose to systematically study epigenomic differences between cell types, lineages, and stages of differentiation, and to learn models predicting the higher-order chromatin structures across cell/tissue types, within each cell/tissue, and the chromatin architectures that they define. By systematically interpreting epigenomic annotations in the context of their cellular differentiation and their higher-order chromatin structures, the resultin resource will greatly increase their impact on human health by enabling disease studies to understand the mechanistic relationship between non-coding variants and their target genes, and the specific differentiation stages in which they act.",Comparative analysis and regulatory architecture of epigenomics datasets,9038385,R01GM113708,"['Address', 'Algorithms', 'Architecture', 'Cells', 'Chromatin', 'Chromosomes', 'Classification', 'Collection', 'Communities', 'Complex', 'Computer Analysis', 'DNA Methylation', 'DNA Sequence', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic study', 'Genomics', 'Graph', 'Health', 'Higher Order Chromatin Structure', 'Histocompatibility Testing', 'Human', 'Human Genome', 'Hypersensitivity', 'Individual', 'Learning', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Methodology', 'Methods', 'Modeling', 'Molecular Conformation', 'Nucleic Acid Regulatory Sequences', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phylogenetic Analysis', 'Quantitative Trait Loci', 'Regulator Genes', 'Regulatory Element', 'Resources', 'Shapes', 'Somatic Mutation', 'Staging', 'Statistical Methods', 'Tissues', 'Training', 'United States National Institutes of Health', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'comparative', 'comparison group', 'differential expression', 'epigenome', 'epigenomics', 'experience', 'follow-up', 'genetic association', 'genome wide association study', 'histone modification', 'human disease', 'innovation', 'insight', 'learning strategy', 'novel', 'novel strategies', 'rare variant', 'research study', 'tool', 'ward']",NIGMS,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R01,2016,284106,0.13343310562611171
"Comparative analysis and regulatory architecture of epigenomics datasets     DESCRIPTION (provided by applicant):  The NIH Roadmap Epigenomics and ENCODE projects have generated a collection of 3000+ epigenomics datasets, including histone modification, DNA methylation, gene expression, and DNaseI hypersensitivity profiled across 190 cell and tissue types. In order to maximize its impact on gene regulation, cellular differentiation, and human health, novel computational analyses are needed. To address this challenge, we will develop new methods for epigenomic analysis, building on our extensive experience interpreting epigenomic information, and our preliminary studies building chromatin states, activity clusters, and regulatory motif maps for the Roadmap Epigenomics and ENCODE datasets. In Aim 1, we will characterize epigenomic differences and changes during lineage differentiation by developing new tools for systematic comparison of groups of epigenomes that directly exploit the complexity of epigenomic datasets; we will also develop methods for clustering epigenomes into developmental lineages based on automatically-learned diverse epigenomic features that distinguish them; and methods that learn the unidirectional epigenomic changes that pluripotent cells undergo during lineage commitment to gain more insights into differentiation and automatically learn to classify lineages and differentiation trajectories. In Am 2, we will seek to characterize higher-order chromatin architecture and chromatin conformation to enable systematic interpretation of cis-regulatory modules: we will develop a novel statistical approach for enhancer-enhancer and enhancer-gene linking to reveal interacting regions and their target genes based on their coordinated activity patterns across cell and tissue types; we will train a supervised learning method for predicting both constitutive and tissue-specific chromatin conformation information based on chromatin state information, individual chromatin marks, genomic distance, activity, regulatory motif information, and DNA sequence; and we will use these higher-order interaction maps to predict gene expression levels based on the combined action of multiple regulatory regions and to define the cis-regulatory architecture of each gene in the human genome. The resulting resources will be invaluable for studies of gene regulation, by revealing the set of regulatory elements that are linked to each gene, and for the interpretation of genetic studies, by revealing the set of regulatory elements which jointly act to regulate each target gene and the potential target genes of non-coding variants associated with human disease.         PUBLIC HEALTH RELEVANCE: The NIH ENCODE and Roadmap Epigenomics projects have generated a collection of 4000+ epigenomics datasets across 200+ cell and tissue types, which can be invaluable to the scientific community, but novel computational analyses are needed to maximize its impact on gene regulation, cellular differentiation, and human health. To address this need, we propose to systematically study epigenomic differences between cell types, lineages, and stages of differentiation, and to learn models predicting the higher-order chromatin structures across cell/tissue types, within each cell/tissue, and the chromatin architectures that they define. By systematically interpreting epigenomic annotations in the context of their cellular differentiation and their higher-order chromatin structures, the resultin resource will greatly increase their impact on human health by enabling disease studies to understand the mechanistic relationship between non-coding variants and their target genes, and the specific differentiation stages in which they act.                ",Comparative analysis and regulatory architecture of epigenomics datasets,8847548,R01GM113708,"['Address', 'Algorithms', 'Architecture', 'Cells', 'Chromatin', 'Chromosomes', 'Classification', 'Collection', 'Communities', 'Complex', 'DNA Methylation', 'DNA Sequence', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic study', 'Genomics', 'Graph', 'Health', 'Higher Order Chromatin Structure', 'Histocompatibility Testing', 'Human', 'Human Genome', 'Hypersensitivity', 'Individual', 'Learning', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Methodology', 'Methods', 'Modeling', 'Molecular Conformation', 'Nucleic Acid Regulatory Sequences', 'Nucleosomes', 'Pathway interactions', 'Pattern', 'Phylogenetic Analysis', 'Quantitative Trait Loci', 'Regulator Genes', 'Regulatory Element', 'Resources', 'Shapes', 'Somatic Mutation', 'Staging', 'Statistical Methods', 'Tissues', 'Training', 'United States National Institutes of Health', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'comparative', 'comparison group', 'differential expression', 'epigenome', 'epigenomics', 'experience', 'follow-up', 'genetic association', 'genome wide association study', 'histone modification', 'human disease', 'innovation', 'insight', 'novel', 'novel strategies', 'public health relevance', 'rare variant', 'research study', 'tool', 'ward']",NIGMS,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,R01,2015,283300,0.13343310562611171
"2/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders In this project, we will develop novel methods for finding brain-specific enhancers, build regulatory networks, deconvolve brain-region-specific regulation, and relate differential enhancer signals to variations in the human population. We will then apply these analytical methods to the psychENCODE data corpus, integrating these data with GTEx, ENCODE, and CommonMind data, annotating GWAS SNPs associated with psych disease, prioritizing the discovered regulatory elements for validation, and visualizing all psychENCODE data in an integrated fashion. We will then validate these predicted regulatory elements using large-scale genomic assays in neuroblastoma cells, iPSC cells, and neuronal precursor cells differentiated into neuronal lineages, and using a microfluidics platform capable of culturing neuronal cells and neuronal organoids. The results from these studies will further our understanding of the genetic regulatory basis for neuronal function in both normal and neuropsychiatric disease states. The data generated by the psychENCODE Consortium are a pre-eminent, centralized resource for studying the human brain. We will develop cutting-edge analytical methods and apply them to the psychENCODE data corpus to identify regulatory elements and then validate them using large-scale genomic assays in neuronal cells and organoids. Our results will further our understanding of the human brain in the healthy state and neuropsychiatric diseases.",2/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders,9924665,U01MH116489,"['3-Dimensional', 'Adolescence', 'Adult', 'Affect', 'Alleles', 'Base Sequence', 'Biological', 'Biological Assay', 'Brain', 'Brain region', 'Cell Differentiation process', 'Cell model', 'Cells', 'Cerebrum', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Human', 'Human Genome', 'Individual', 'Knock-out', 'Link', 'Machine Learning', 'Measures', 'Mental disorders', 'Metadata', 'Methodology', 'Methods', 'Microfluidic Microchips', 'Microfluidics', 'Modeling', 'Network-based', 'Neurons', 'Online Systems', 'Organoids', 'Output', 'Pattern Recognition', 'Population', 'Process', 'Prosencephalon', 'Protocols documentation', 'Quantitative Trait Loci', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Resources', 'Series', 'Signal Pathway', 'Signal Transduction', 'Specific qualifier value', 'Technology', 'Testing', 'Tissues', 'Validation', 'Variant', 'analytical method', 'base', 'cell type', 'early childhood', 'epigenomics', 'fetal', 'genetic variant', 'genome browser', 'genome wide association study', 'genome-wide', 'induced pluripotent stem cell', 'neuroblastoma cell', 'neuron development', 'neuropsychiatric disorder', 'novel', 'precursor cell', 'single cell sequencing', 'single-cell RNA sequencing', 'stem cell differentiation', 'transcriptome', 'transcriptome sequencing']",NIMH,UNIVERSITY OF CALIFORNIA LOS ANGELES,U01,2020,784830,0.09587120874510509
"2/2-Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders In this project, we will develop novel methods for finding brain-specific enhancers, build regulatory networks, deconvolve brain-region-specific regulation, and relate differential enhancer signals to variations in the human population. We will then apply these analytical methods to the psychENCODE data corpus, integrating these data with GTEx, ENCODE, and CommonMind data, annotating GWAS SNPs associated with psych disease, prioritizing the discovered regulatory elements for validation, and visualizing all psychENCODE data in an integrated fashion. We will then validate these predicted regulatory elements using large-scale genomic assays in neuroblastoma cells, iPSC cells, and neuronal precursor cells differentiated into neuronal lineages, and using a microfluidics platform capable of culturing neuronal cells and neuronal organoids. The results from these studies will further our understanding of the genetic regulatory basis for neuronal function in both normal and neuropsychiatric disease states. The data generated by the psychENCODE Consortium are a pre-eminent, centralized resource for studying the human brain. We will develop cutting-edge analytical methods and apply them to the psychENCODE data corpus to identify regulatory elements and then validate them using large-scale genomic assays in neuronal cells and organoids. Our results will further our understanding of the human brain in the healthy state and neuropsychiatric diseases.",2/2-Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders,9766386,U01MH116489,"['3-Dimensional', 'Adolescence', 'Adult', 'Affect', 'Alleles', 'Base Sequence', 'Biological', 'Biological Assay', 'Brain', 'Brain region', 'Cell Differentiation process', 'Cell model', 'Cells', 'Cerebrum', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Human', 'Human Genome', 'Individual', 'Knock-out', 'Link', 'Machine Learning', 'Measures', 'Mental disorders', 'Metadata', 'Methodology', 'Methods', 'Microfluidic Microchips', 'Microfluidics', 'Modeling', 'Network-based', 'Neurons', 'Online Systems', 'Organoids', 'Output', 'Pattern Recognition', 'Population', 'Process', 'Prosencephalon', 'Protocols documentation', 'Quantitative Trait Loci', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Resources', 'Series', 'Signal Pathway', 'Signal Transduction', 'Specific qualifier value', 'Technology', 'Testing', 'Tissues', 'Validation', 'Variant', 'analytical method', 'base', 'cell type', 'early childhood', 'epigenomics', 'fetal', 'genetic variant', 'genome browser', 'genome wide association study', 'genome-wide', 'induced pluripotent stem cell', 'neuroblastoma cell', 'neuron development', 'neuropsychiatric disorder', 'novel', 'precursor cell', 'single cell sequencing', 'single-cell RNA sequencing', 'stem cell differentiation', 'transcriptome', 'transcriptome sequencing']",NIMH,UNIVERSITY OF CHICAGO,U01,2019,531327,0.09587120874510509
"2/2-Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders In this project, we will develop novel methods for finding brain-specific enhancers, build regulatory networks, deconvolve brain-region-specific regulation, and relate differential enhancer signals to variations in the human population. We will then apply these analytical methods to the psychENCODE data corpus, integrating these data with GTEx, ENCODE, and CommonMind data, annotating GWAS SNPs associated with psych disease, prioritizing the discovered regulatory elements for validation, and visualizing all psychENCODE data in an integrated fashion. We will then validate these predicted regulatory elements using large-scale genomic assays in neuroblastoma cells, iPSC cells, and neuronal precursor cells differentiated into neuronal lineages, and using a microfluidics platform capable of culturing neuronal cells and neuronal organoids. The results from these studies will further our understanding of the genetic regulatory basis for neuronal function in both normal and neuropsychiatric disease states. The data generated by the psychENCODE Consortium are a pre-eminent, centralized resource for studying the human brain. We will develop cutting-edge analytical methods and apply them to the psychENCODE data corpus to identify regulatory elements and then validate them using large-scale genomic assays in neuronal cells and organoids. Our results will further our understanding of the human brain in the healthy state and neuropsychiatric diseases.",2/2-Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders,9525055,U01MH116489,"['Adolescence', 'Adult', 'Affect', 'Alleles', 'Base Sequence', 'Biological', 'Biological Assay', 'Brain', 'Brain region', 'Cell Differentiation process', 'Cell model', 'Cells', 'Cerebrum', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Human', 'Human Genome', 'Individual', 'Knock-out', 'Link', 'Machine Learning', 'Measures', 'Mental disorders', 'Metadata', 'Methodology', 'Methods', 'Microfluidic Microchips', 'Microfluidics', 'Modeling', 'Network-based', 'Neurons', 'Online Systems', 'Organoids', 'Output', 'Pattern Recognition', 'Population', 'Process', 'Prosencephalon', 'Protocols documentation', 'Quantitative Trait Loci', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Resources', 'Series', 'Signal Pathway', 'Signal Transduction', 'Specific qualifier value', 'Technology', 'Testing', 'Tissues', 'Validation', 'Variant', 'analytical method', 'base', 'cell type', 'early childhood', 'epigenomics', 'fetal', 'genetic variant', 'genome browser', 'genome wide association study', 'genome-wide', 'induced pluripotent stem cell', 'neuroblastoma cell', 'neuron development', 'neuropsychiatric disorder', 'novel', 'precursor cell', 'single cell sequencing', 'single-cell RNA sequencing', 'stem cell differentiation', 'transcriptome', 'transcriptome sequencing']",NIMH,UNIVERSITY OF CHICAGO,U01,2018,1006456,0.09587120874510509
"1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders Project Summary/Abstract In this project, we will develop novel methods for finding brain-specific enhancers, build regulatory networks, deconvolve brain-region-specific regulation, and relate differential enhancer signals to variations in the human population. We will then apply these analytical methods to the psychENCODE data corpus, integrating these data with GTEx, ENCODE, and CommonMind data, annotating GWAS SNPs associated with psych disease, prioritizing the discovered regulatory elements for validation, and visualizing all psychENCODE data in an integrated fashion. We will then validate these predicted regulatory elements using large-scale genomic assays in neuroblastoma cells, iPSC cells, and neuronal precursor cells differentiated into neuronal lineages, and using a microfluidics platform capable of culturing neuronal cells and neuronal organoids. The results from these studies will further our understanding of the genetic regulatory basis for neuronal function in both normal and neuropsychiatric disease states. Project Narrative The data generated by the psychENCODE Consortium are a pre-eminent, centralized resource for studying the human brain. We will develop cutting-edge analytical methods and apply them to the psychENCODE data corpus to identify regulatory elements and then validate them using large-scale genomic assays in neuronal cells and organoids. Our results will further our understanding of the human brain in the healthy state and neuropsychiatric diseases.",1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders,9896859,U01MH116492,"['3-Dimensional', 'Adolescence', 'Adult', 'Affect', 'Alleles', 'Base Sequence', 'Biological', 'Biological Assay', 'Brain', 'Brain region', 'Cell Differentiation process', 'Cell model', 'Cells', 'Cerebrum', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Human', 'Human Genome', 'Individual', 'Knock-out', 'Link', 'Machine Learning', 'Measures', 'Mental disorders', 'Metadata', 'Methodology', 'Methods', 'Microfluidic Microchips', 'Microfluidics', 'Modeling', 'Network-based', 'Neurons', 'Online Systems', 'Organoids', 'Output', 'Pattern Recognition', 'Population', 'Process', 'Prosencephalon', 'Protocols documentation', 'Quantitative Trait Loci', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Resources', 'Series', 'Signal Pathway', 'Signal Transduction', 'Specific qualifier value', 'Technology', 'Testing', 'Tissues', 'Validation', 'Variant', 'analytical method', 'base', 'cell type', 'early childhood', 'epigenomics', 'fetal', 'genetic variant', 'genome browser', 'genome wide association study', 'genome-wide', 'induced pluripotent stem cell', 'neuroblastoma cell', 'neuron development', 'neuropsychiatric disorder', 'novel', 'precursor cell', 'single cell sequencing', 'single-cell RNA sequencing', 'stem cell differentiation', 'transcriptome', 'transcriptome sequencing']",NIMH,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U01,2020,1132094,0.09587120874510509
"1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders Project Summary/Abstract In this project, we will develop novel methods for finding brain-specific enhancers, build regulatory networks, deconvolve brain-region-specific regulation, and relate differential enhancer signals to variations in the human population. We will then apply these analytical methods to the psychENCODE data corpus, integrating these data with GTEx, ENCODE, and CommonMind data, annotating GWAS SNPs associated with psych disease, prioritizing the discovered regulatory elements for validation, and visualizing all psychENCODE data in an integrated fashion. We will then validate these predicted regulatory elements using large-scale genomic assays in neuroblastoma cells, iPSC cells, and neuronal precursor cells differentiated into neuronal lineages, and using a microfluidics platform capable of culturing neuronal cells and neuronal organoids. The results from these studies will further our understanding of the genetic regulatory basis for neuronal function in both normal and neuropsychiatric disease states. Project Narrative The data generated by the psychENCODE Consortium are a pre-eminent, centralized resource for studying the human brain. We will develop cutting-edge analytical methods and apply them to the psychENCODE data corpus to identify regulatory elements and then validate them using large-scale genomic assays in neuronal cells and organoids. Our results will further our understanding of the human brain in the healthy state and neuropsychiatric diseases.",1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders,9741188,U01MH116492,"['3-Dimensional', 'Adolescence', 'Adult', 'Affect', 'Alleles', 'Base Sequence', 'Biological', 'Biological Assay', 'Brain', 'Brain region', 'Cell Differentiation process', 'Cell model', 'Cells', 'Cerebrum', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Human', 'Human Genome', 'Individual', 'Knock-out', 'Link', 'Machine Learning', 'Measures', 'Mental disorders', 'Metadata', 'Methodology', 'Methods', 'Microfluidic Microchips', 'Microfluidics', 'Modeling', 'Network-based', 'Neurons', 'Online Systems', 'Organoids', 'Output', 'Pattern Recognition', 'Population', 'Process', 'Prosencephalon', 'Protocols documentation', 'Quantitative Trait Loci', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Resources', 'Series', 'Signal Pathway', 'Signal Transduction', 'Specific qualifier value', 'Technology', 'Testing', 'Tissues', 'Validation', 'Variant', 'analytical method', 'base', 'cell type', 'early childhood', 'epigenomics', 'fetal', 'genetic variant', 'genome browser', 'genome wide association study', 'genome-wide', 'induced pluripotent stem cell', 'neuroblastoma cell', 'neuron development', 'neuropsychiatric disorder', 'novel', 'precursor cell', 'single cell sequencing', 'single-cell RNA sequencing', 'stem cell differentiation', 'transcriptome', 'transcriptome sequencing']",NIMH,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U01,2019,1142697,0.09587120874510509
"1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders Project Summary/Abstract In this project, we will develop novel methods for finding brain-specific enhancers, build regulatory networks, deconvolve brain-region-specific regulation, and relate differential enhancer signals to variations in the human population. We will then apply these analytical methods to the psychENCODE data corpus, integrating these data with GTEx, ENCODE, and CommonMind data, annotating GWAS SNPs associated with psych disease, prioritizing the discovered regulatory elements for validation, and visualizing all psychENCODE data in an integrated fashion. We will then validate these predicted regulatory elements using large-scale genomic assays in neuroblastoma cells, iPSC cells, and neuronal precursor cells differentiated into neuronal lineages, and using a microfluidics platform capable of culturing neuronal cells and neuronal organoids. The results from these studies will further our understanding of the genetic regulatory basis for neuronal function in both normal and neuropsychiatric disease states. Project Narrative The data generated by the psychENCODE Consortium are a pre-eminent, centralized resource for studying the human brain. We will develop cutting-edge analytical methods and apply them to the psychENCODE data corpus to identify regulatory elements and then validate them using large-scale genomic assays in neuronal cells and organoids. Our results will further our understanding of the human brain in the healthy state and neuropsychiatric diseases.",1/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders,9524870,U01MH116492,"['Adolescence', 'Adult', 'Affect', 'Alleles', 'Base Sequence', 'Biological', 'Biological Assay', 'Brain', 'Brain region', 'Cell Differentiation process', 'Cell model', 'Cells', 'Cerebrum', 'Chromatin', 'Clustered Regularly Interspaced Short Palindromic Repeats', 'Communities', 'Data', 'Data Analyses', 'Data Coordinating Center', 'Data Set', 'Development', 'Disease', 'Enhancers', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Polymorphism', 'Genomic Segment', 'Genomics', 'Genotype-Tissue Expression Project', 'Human', 'Human Genome', 'Individual', 'Knock-out', 'Link', 'Machine Learning', 'Measures', 'Mental disorders', 'Metadata', 'Methodology', 'Methods', 'Microfluidic Microchips', 'Microfluidics', 'Modeling', 'Network-based', 'Neurons', 'Online Systems', 'Organoids', 'Output', 'Pattern Recognition', 'Population', 'Process', 'Prosencephalon', 'Protocols documentation', 'Quantitative Trait Loci', 'Regulation', 'Regulatory Element', 'Reporter', 'Research', 'Resources', 'Series', 'Signal Pathway', 'Signal Transduction', 'Specific qualifier value', 'Technology', 'Testing', 'Tissues', 'Validation', 'Variant', 'analytical method', 'base', 'cell type', 'early childhood', 'epigenomics', 'fetal', 'genetic variant', 'genome browser', 'genome wide association study', 'genome-wide', 'induced pluripotent stem cell', 'neuroblastoma cell', 'neuron development', 'neuropsychiatric disorder', 'novel', 'precursor cell', 'single cell sequencing', 'single-cell RNA sequencing', 'stem cell differentiation', 'transcriptome', 'transcriptome sequencing']",NIMH,UNIV OF MASSACHUSETTS MED SCH WORCESTER,U01,2018,1180127,0.09587120874510509
"Neuroethical analysis of data sharing in the OpenNeuro project: Administrative supplement PROJECT SUMMARY/ABSTRACT Data sharing is essential to maximize the contributions of research subjects and the publics investment in scientific research, but human subjects research also requires strong protection of the privacy and confidentiality of research subjects. This supplement will support an expert in neuroethics to undertake a rigorous ethical and regulatory analysis of data sharing policies, focusing in particular on the threats by artificial intelligence and machine learning techniques to reidentify neuroimaging datasets that have been thought to be deidentified. This research will lay the foundation for a sound data sharing policy for the OpenNeuro project and a regulatory framework to provide for the adequate protection of neuroimaging data while maximizing the benefits of data sharing. Project Narrative Data sharing is essential to maximize the contributions of research subjects and the publics investment in scientific research, but human subjects research also requires strong protection of the privacy and confidentiality of research subjects. This supplement will support an expert in neuroethics to undertake a rigorous ethical and regulatory analysis of data sharing policies, focusing in particular on the threats by artificial intelligence and machine learning techniques to reidentify neuroimaging datasets that have been thought to be deidentified. This research will lay the foundation for a sound data sharing policy for the OpenNeuro project and a regulatory framework to provide for the adequate protection of neuroimaging data while maximizing the benefits of data sharing",Neuroethical analysis of data sharing in the OpenNeuro project: Administrative supplement,10149058,R24MH117179,"['Address', 'Administrative Supplement', 'Archives', 'Artificial Intelligence', 'Award', 'BRAIN initiative', 'Benefits and Risks', 'Consent Forms', 'Country', 'Data', 'Data Analyses', 'Data Security', 'Data Set', 'Ensure', 'Ethics', 'Foundations', 'Funding', 'Future', 'Goals', 'Guidelines', 'Health', 'Human', 'Human Subject Research', 'International', 'Investments', 'Laws', 'Legal', 'Light', 'Machine Learning', 'Magnetic Resonance Imaging', 'Neurosciences', 'Parents', 'Policies', 'Privacy', 'Process', 'Regulation', 'Research', 'Research Subjects', 'Risk', 'Security Measures', 'Series', 'Software Tools', 'Solid', 'Surveys', 'Techniques', 'United States', 'United States National Institutes of Health', 'data archive', 'data privacy', 'data sharing', 'design', 'human subject', 'human subject protection', 'machine learning algorithm', 'neuroethics', 'neuroimaging', 'novel', 'prevent', 'privacy protection', 'research study', 'sharing platform', 'sound', 'stem']",NIMH,STANFORD UNIVERSITY,R24,2020,126592,0.06415830133146411
"Computational Inference of Regulatory Network Dynamics on Cell Lineages Regulatory networks that control which genes are expressed when, are critical players in the maintenance and transitions of different cell states. In mammalian systems such networks are established by a complex interplay of thousands of regulatory proteins such as transcription factors, chromatin remodelers and signaling proteins, histone post-translational modifications and three-dimensional organization of the genome. Hence, the identification of genome-scale regulatory networks and their changes remains a computational and experimental challenge, especially for rare and novel cell types. Through recent efforts of consortia projects we now have rich datasets measuring multiple components of the regulation machinery in model cell lines. These data enable the creation of a more complete regulatory network for these cell lines. Can we use this information to identify networks in new cell types where measuring only a few components of the regulation machinery is possible (e.g. the transcriptome)? Can we leverage more complete regulatory networks to predict new cell types, and to predict the effect of network perturbations to cellular state? To tackle these questions, in this proposal we will develop innovative network reconstruction methods to identify regulatory networks in novel and rare cell types by leveraging their relationships to well-studied cell types, as well as to each other. Our methods will use the framework of non-stationary graphical models to represent cell type-specific regulatory networks and will use multi-task learning to incorporate shared information between cell types in a lineage. Methods in Aim 1 will infer modular gene regulatory networks for each cell type and additionally refine an existing incomplete or uncertain lineage structure. Methods in Aim 2 will identify cell type-specific directed dependencies among chromatin state and transcription factors and how they impact target gene expression through proximal and long-range regulation. Our methods will be applied to two cell-fate specification problems: cellular reprogramming and multi-cell lineage forward differentiation. In cellular reprogramming, regulators and subnetworks hindering reprogramming efficiency will be predicted and tested using genetic perturbation experiments. In forward differentiation, regulatory network changes that drive alternate lineages will be identified and tested. Successful completion of this project will provide two broadly applicable software tools that will enable researchers to (i) accurately identify regulatory networks and their changes between different cell states in complex cell lineages, (ii) examine interactions among multiple levels of regulation and their impact on cell type-specific gene expression, and (iii) efficiently identify the most upstream regulatory genes and subnetworks that change cellular states. Software tools from this project will be made available and will be broadly applicable to diverse types of dynamic biological processes in development and disease. Project Narrative Many human diseases are due to aberrant activity of genes in specific cell types. Transcriptional regulatory networks specify what genes must be expressed in which cell types and play a central role in the type and function of cells. Therefore, the ability to identify these networks in each cell type and the network changes that result in changes in cell type is important for a better understanding of human health and disease. Computational methods that can identify regulatory networks and their dynamics across related mammalian cell types offer a powerful approach to create better models of human disease and for regenerative medicine.",Computational Inference of Regulatory Network Dynamics on Cell Lineages,9517972,R01GM117339,"['Address', 'Algorithms', 'Binding', 'Biological Process', 'Cell Differentiation process', 'Cell Line', 'Cell Lineage', 'Cell model', 'Cell physiology', 'Cells', 'Chromatin', 'Complex', 'Computing Methodologies', 'Correlation Studies', 'DNA', 'Data', 'Data Set', 'Dependence', 'Development', 'Dimensions', 'Disease', 'Disease model', 'Distal', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Health', 'Histones', 'Human', 'Learning', 'Machine Learning', 'Maintenance', 'Mammalian Cell', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Output', 'Patients', 'Play', 'Post-Translational Protein Processing', 'Process', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resources', 'Role', 'Sample Size', 'Sampling', 'Signaling Protein', 'Software Tools', 'Specific qualifier value', 'Structure', 'Supervision', 'System', 'Testing', 'Training', 'Uncertainty', 'Update', 'Validation', 'cell fate specification', 'cell type', 'chromatin remodeling', 'computerized tools', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'genomic data', 'human disease', 'human model', 'innovation', 'learning network', 'learning strategy', 'multitask', 'novel', 'predictive modeling', 'predictive test', 'programs', 'promoter', 'reconstruction', 'tool', 'transcription factor', 'transcriptome']",NIGMS,UNIVERSITY OF WISCONSIN-MADISON,R01,2018,293249,0.17376462412044244
"Computational Inference of Regulatory Network Dynamics on Cell Lineages Regulatory networks that control which genes are expressed when, are critical players in the maintenance and transitions of different cell states. In mammalian systems such networks are established by a complex interplay of thousands of regulatory proteins such as transcription factors, chromatin remodelers and signaling proteins, histone post-translational modifications and three-dimensional organization of the genome. Hence, the identification of genome-scale regulatory networks and their changes remains a computational and experimental challenge, especially for rare and novel cell types. Through recent efforts of consortia projects we now have rich datasets measuring multiple components of the regulation machinery in model cell lines. These data enable the creation of a more complete regulatory network for these cell lines. Can we use this information to identify networks in new cell types where measuring only a few components of the regulation machinery is possible (e.g. the transcriptome)? Can we leverage more complete regulatory networks to predict new cell types, and to predict the effect of network perturbations to cellular state? To tackle these questions, in this proposal we will develop innovative network reconstruction methods to identify regulatory networks in novel and rare cell types by leveraging their relationships to well-studied cell types, as well as to each other. Our methods will use the framework of non-stationary graphical models to represent cell type-specific regulatory networks and will use multi-task learning to incorporate shared information between cell types in a lineage. Methods in Aim 1 will infer modular gene regulatory networks for each cell type and additionally refine an existing incomplete or uncertain lineage structure. Methods in Aim 2 will identify cell type-specific directed dependencies among chromatin state and transcription factors and how they impact target gene expression through proximal and long-range regulation. Our methods will be applied to two cell-fate specification problems: cellular reprogramming and multi-cell lineage forward differentiation. In cellular reprogramming, regulators and subnetworks hindering reprogramming efficiency will be predicted and tested using genetic perturbation experiments. In forward differentiation, regulatory network changes that drive alternate lineages will be identified and tested. Successful completion of this project will provide two broadly applicable software tools that will enable researchers to (i) accurately identify regulatory networks and their changes between different cell states in complex cell lineages, (ii) examine interactions among multiple levels of regulation and their impact on cell type-specific gene expression, and (iii) efficiently identify the most upstream regulatory genes and subnetworks that change cellular states. Software tools from this project will be made available and will be broadly applicable to diverse types of dynamic biological processes in development and disease. Project Narrative Many human diseases are due to aberrant activity of genes in specific cell types. Transcriptional regulatory networks specify what genes must be expressed in which cell types and play a central role in the type and function of cells. Therefore, the ability to identify these networks in each cell type and the network changes that result in changes in cell type is important for a better understanding of human health and disease. Computational methods that can identify regulatory networks and their dynamics across related mammalian cell types offer a powerful approach to create better models of human disease and for regenerative medicine.",Computational Inference of Regulatory Network Dynamics on Cell Lineages,9353838,R01GM117339,"['Address', 'Algorithms', 'Alpha Cell', 'Binding', 'Biological Process', 'Cell Differentiation process', 'Cell Line', 'Cell Lineage', 'Cell model', 'Cell physiology', 'Cells', 'Chromatin', 'Complex', 'Computing Methodologies', 'Correlation Studies', 'DNA', 'Data', 'Data Set', 'Dependency', 'Development', 'Dimensions', 'Disease', 'Disease model', 'Distal', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Health', 'Histones', 'Human', 'Learning', 'Machine Learning', 'Maintenance', 'Mammalian Cell', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Output', 'Patients', 'Play', 'Post-Translational Protein Processing', 'Process', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resources', 'Role', 'Sample Size', 'Sampling', 'Signaling Protein', 'Software Tools', 'Specific qualifier value', 'Structure', 'Supervision', 'System', 'Testing', 'Training', 'Uncertainty', 'Update', 'Validation', 'cell fate specification', 'cell type', 'computerized tools', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'genomic data', 'human disease', 'innovation', 'learning network', 'learning strategy', 'multitask', 'novel', 'programs', 'promoter', 'reconstruction', 'tool', 'transcription factor', 'transcriptome']",NIGMS,UNIVERSITY OF WISCONSIN-MADISON,R01,2017,303220,0.17376462412044244
"Computational Inference of Regulatory Network Dynamics on Cell Lineages Regulatory networks that control which genes are expressed when, are critical players in the maintenance and transitions of different cell states. In mammalian systems such networks are established by a complex interplay of thousands of regulatory proteins such as transcription factors, chromatin remodelers and signaling proteins, histone post-translational modifications and three-dimensional organization of the genome. Hence, the identification of genome-scale regulatory networks and their changes remains a computational and experimental challenge, especially for rare and novel cell types. Through recent efforts of consortia projects we now have rich datasets measuring multiple components of the regulation machinery in model cell lines. These data enable the creation of a more complete regulatory network for these cell lines. Can we use this information to identify networks in new cell types where measuring only a few components of the regulation machinery is possible (e.g. the transcriptome)? Can we leverage more complete regulatory networks to predict new cell types, and to predict the effect of network perturbations to cellular state? To tackle these questions, in this proposal we will develop innovative network reconstruction methods to identify regulatory networks in novel and rare cell types by leveraging their relationships to well-studied cell types, as well as to each other. Our methods will use the framework of non-stationary graphical models to represent cell type-specific regulatory networks and will use multi-task learning to incorporate shared information between cell types in a lineage. Methods in Aim 1 will infer modular gene regulatory networks for each cell type and additionally refine an existing incomplete or uncertain lineage structure. Methods in Aim 2 will identify cell type-specific directed dependencies among chromatin state and transcription factors and how they impact target gene expression through proximal and long-range regulation. Our methods will be applied to two cell-fate specification problems: cellular reprogramming and multi-cell lineage forward differentiation. In cellular reprogramming, regulators and subnetworks hindering reprogramming efficiency will be predicted and tested using genetic perturbation experiments. In forward differentiation, regulatory network changes that drive alternate lineages will be identified and tested. Successful completion of this project will provide two broadly applicable software tools that will enable researchers to (i) accurately identify regulatory networks and their changes between different cell states in complex cell lineages, (ii) examine interactions among multiple levels of regulation and their impact on cell type-specific gene expression, and (iii) efficiently identify the most upstream regulatory genes and subnetworks that change cellular states. Software tools from this project will be made available and will be broadly applicable to diverse types of dynamic biological processes in development and disease. Project Narrative Many human diseases are due to aberrant activity of genes in specific cell types. Transcriptional regulatory networks specify what genes must be expressed in which cell types and play a central role in the type and function of cells. Therefore, the ability to identify these networks in each cell type and the network changes that result in changes in cell type is important for a better understanding of human health and disease. Computational methods that can identify regulatory networks and their dynamics across related mammalian cell types offer a powerful approach to create better models of human disease and for regenerative medicine.",Computational Inference of Regulatory Network Dynamics on Cell Lineages,9177501,R01GM117339,"['Address', 'Algorithms', 'Binding', 'Biological Process', 'Cell Differentiation process', 'Cell Line', 'Cell Lineage', 'Cell physiology', 'Cells', 'Chromatin', 'Complex', 'Computing Methodologies', 'Correlation Studies', 'DNA', 'Data', 'Data Set', 'Dependency', 'Development', 'Disease', 'Disease model', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Health', 'Histones', 'Human', 'Learning', 'Machine Learning', 'Maintenance', 'Mammalian Cell', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Output', 'Patients', 'Play', 'Post-Translational Protein Processing', 'Process', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resources', 'Role', 'Sample Size', 'Sampling', 'Signaling Protein', 'Software Tools', 'Specific qualifier value', 'Staging', 'Structure', 'System', 'Testing', 'Training', 'Uncertainty', 'Update', 'Validation', 'Work', 'cell fate specification', 'cell type', 'computerized tools', 'epigenome', 'genetic regulatory protein', 'genome-wide', 'genomic data', 'human disease', 'innovation', 'learning strategy', 'multitask', 'novel', 'programs', 'promoter', 'reconstruction', 'research study', 'tool', 'transcription factor', 'transcriptome']",NIGMS,UNIVERSITY OF WISCONSIN-MADISON,R01,2016,288612,0.17376462412044244
"Computational Inference of Regulatory Network Dynamics on Cell Lineages Regulatory networks that control which genes are expressed when, are critical players in the maintenance and transitions of different cell states. In mammalian systems such networks are established by a complex interplay of thousands of regulatory proteins such as transcription factors, chromatin remodelers and signaling proteins, histone post-translational modifications and three-dimensional organization of the genome. Hence, the identification of genome-scale regulatory networks and their changes remains a computational and experimental challenge, especially for rare and novel cell types. Through recent efforts of consortia projects we now have rich datasets measuring multiple components of the regulation machinery in model cell lines. These data enable the creation of a more complete regulatory network for these cell lines. Can we use this information to identify networks in new cell types where measuring only a few components of the regulation machinery is possible (e.g. the transcriptome)? Can we leverage more complete regulatory networks to predict new cell types, and to predict the effect of network perturbations to cellular state? To tackle these questions, in this proposal we will develop innovative network reconstruction methods to identify regulatory networks in novel and rare cell types by leveraging their relationships to well-studied cell types, as well as to each other. Our methods will use the framework of non-stationary graphical models to represent cell type-specific regulatory networks and will use multi-task learning to incorporate shared information between cell types in a lineage. Methods in Aim 1 will infer modular gene regulatory networks for each cell type and additionally refine an existing incomplete or uncertain lineage structure. Methods in Aim 2 will identify cell type-specific directed dependencies among chromatin state and transcription factors and how they impact target gene expression through proximal and long-range regulation. Our methods will be applied to two cell-fate specification problems: cellular reprogramming and multi-cell lineage forward differentiation. In cellular reprogramming, regulators and subnetworks hindering reprogramming efficiency will be predicted and tested using genetic perturbation experiments. In forward differentiation, regulatory network changes that drive alternate lineages will be identified and tested. Successful completion of this project will provide two broadly applicable software tools that will enable researchers to (i) accurately identify regulatory networks and their changes between different cell states in complex cell lineages, (ii) examine interactions among multiple levels of regulation and their impact on cell type-specific gene expression, and (iii) efficiently identify the most upstream regulatory genes and subnetworks that change cellular states. Software tools from this project will be made available and will be broadly applicable to diverse types of dynamic biological processes in development and disease. Project Narrative Many human diseases are due to aberrant activity of genes in specific cell types. Transcriptional regulatory networks specify what genes must be expressed in which cell types and play a central role in the type and function of cells. Therefore, the ability to identify these networks in each cell type and the network changes that result in changes in cell type is important for a better understanding of human health and disease. Computational methods that can identify regulatory networks and their dynamics across related mammalian cell types offer a powerful approach to create better models of human disease and for regenerative medicine.",Computational Inference of Regulatory Network Dynamics on Cell Lineages,9979901,R01GM117339,"['3-Dimensional', 'Address', 'Algorithms', 'Binding', 'Biological Process', 'Cell Differentiation process', 'Cell Line', 'Cell Lineage', 'Cell model', 'Cell physiology', 'Cells', 'Chromatin', 'Complex', 'Computing Methodologies', 'Correlation Studies', 'DNA', 'Data', 'Data Set', 'Dependence', 'Development', 'Disease', 'Disease model', 'Distal', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Health', 'Histones', 'Human', 'Maintenance', 'Mammalian Cell', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Output', 'Patients', 'Play', 'Post-Translational Protein Processing', 'Process', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resources', 'Role', 'Sample Size', 'Sampling', 'Signaling Protein', 'Software Tools', 'Specific qualifier value', 'Structure', 'System', 'Testing', 'Training', 'Uncertainty', 'Update', 'Validation', 'cell fate specification', 'cell type', 'chromatin remodeling', 'computerized tools', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'genomic data', 'human disease', 'human model', 'innovation', 'learning network', 'learning strategy', 'machine learning method', 'multi-task learning', 'novel', 'predictive modeling', 'predictive test', 'programs', 'promoter', 'reconstruction', 'supervised learning', 'tool', 'transcription factor', 'transcriptome']",NIGMS,UNIVERSITY OF WISCONSIN-MADISON,R01,2020,303220,0.17376462412044244
"Computational Inference of Regulatory Network Dynamics on Cell Lineages Regulatory networks that control which genes are expressed when, are critical players in the maintenance and transitions of different cell states. In mammalian systems such networks are established by a complex interplay of thousands of regulatory proteins such as transcription factors, chromatin remodelers and signaling proteins, histone post-translational modifications and three-dimensional organization of the genome. Hence, the identification of genome-scale regulatory networks and their changes remains a computational and experimental challenge, especially for rare and novel cell types. Through recent efforts of consortia projects we now have rich datasets measuring multiple components of the regulation machinery in model cell lines. These data enable the creation of a more complete regulatory network for these cell lines. Can we use this information to identify networks in new cell types where measuring only a few components of the regulation machinery is possible (e.g. the transcriptome)? Can we leverage more complete regulatory networks to predict new cell types, and to predict the effect of network perturbations to cellular state? To tackle these questions, in this proposal we will develop innovative network reconstruction methods to identify regulatory networks in novel and rare cell types by leveraging their relationships to well-studied cell types, as well as to each other. Our methods will use the framework of non-stationary graphical models to represent cell type-specific regulatory networks and will use multi-task learning to incorporate shared information between cell types in a lineage. Methods in Aim 1 will infer modular gene regulatory networks for each cell type and additionally refine an existing incomplete or uncertain lineage structure. Methods in Aim 2 will identify cell type-specific directed dependencies among chromatin state and transcription factors and how they impact target gene expression through proximal and long-range regulation. Our methods will be applied to two cell-fate specification problems: cellular reprogramming and multi-cell lineage forward differentiation. In cellular reprogramming, regulators and subnetworks hindering reprogramming efficiency will be predicted and tested using genetic perturbation experiments. In forward differentiation, regulatory network changes that drive alternate lineages will be identified and tested. Successful completion of this project will provide two broadly applicable software tools that will enable researchers to (i) accurately identify regulatory networks and their changes between different cell states in complex cell lineages, (ii) examine interactions among multiple levels of regulation and their impact on cell type-specific gene expression, and (iii) efficiently identify the most upstream regulatory genes and subnetworks that change cellular states. Software tools from this project will be made available and will be broadly applicable to diverse types of dynamic biological processes in development and disease. Project Narrative Many human diseases are due to aberrant activity of genes in specific cell types. Transcriptional regulatory networks specify what genes must be expressed in which cell types and play a central role in the type and function of cells. Therefore, the ability to identify these networks in each cell type and the network changes that result in changes in cell type is important for a better understanding of human health and disease. Computational methods that can identify regulatory networks and their dynamics across related mammalian cell types offer a powerful approach to create better models of human disease and for regenerative medicine.",Computational Inference of Regulatory Network Dynamics on Cell Lineages,9729760,R01GM117339,"['Address', 'Algorithms', 'Binding', 'Biological Process', 'Cell Differentiation process', 'Cell Line', 'Cell Lineage', 'Cell model', 'Cell physiology', 'Cells', 'Chromatin', 'Complex', 'Computing Methodologies', 'Correlation Studies', 'DNA', 'Data', 'Data Set', 'Dependence', 'Development', 'Dimensions', 'Disease', 'Disease model', 'Distal', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Genome', 'Genomics', 'Health', 'Histones', 'Human', 'Maintenance', 'Mammalian Cell', 'Measures', 'Messenger RNA', 'Methods', 'Modeling', 'Output', 'Patients', 'Play', 'Post-Translational Protein Processing', 'Process', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Research Personnel', 'Resources', 'Role', 'Sample Size', 'Sampling', 'Signaling Protein', 'Software Tools', 'Specific qualifier value', 'Structure', 'System', 'Testing', 'Training', 'Uncertainty', 'Update', 'Validation', 'cell fate specification', 'cell type', 'chromatin remodeling', 'computerized tools', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'genomic data', 'human disease', 'human model', 'innovation', 'learning network', 'learning strategy', 'multi-task learning', 'novel', 'predictive modeling', 'predictive test', 'programs', 'promoter', 'reconstruction', 'supervised learning', 'tool', 'transcription factor', 'transcriptome']",NIGMS,UNIVERSITY OF WISCONSIN-MADISON,R01,2019,303220,0.17376462412044244
"Identifying Genetic Drivers of Expression Networks Causing Insulin Resistance Reduced insulin sensitivity or insulin resistance (IR) is a forerunner of Type 2 diabetes (T2D). Differences in the prevalence of IR among ethnic groups suggest its genetic etiology. However, recent studies implementing genetic association approaches were only nominally successful in defining the genetically-regulated molecular and cellular mechanisms of IR. Our physiologic and genomic studies suggest that (a) IR results from derangement in expression of thousands of genes in tissues involved in glucose homeostasis, and (b) genetic variants, such as single nucleotide polymorphisms (SNPs), determine the expression level of a subset of IR-associated genes. Thus, transcript levels are key molecular phenotypes associated with IR and are proximal to the action of genetic variants. A subset of genetically-regulated transcript subnetworks that operate within the large highly interconnected global expression networks in disease-relevant tissues can cause IR, but remain poorly understood. We hypothesize that, regulatory SNPs in expression quantitative trait loci (eQTLs) determine transcript levels of key driver genes, configure the expression subnetworks in adipose and muscle tissue, and are causal determinants for IR. The genetic architecture of eQTLs determines the heterogeneity in causal mechanisms of IR. Our preliminary data support the concept of causal genetic regulators of subnetworks in modulating insulin sensitivity. Challenging the current paradigms, our Aim 1 is to implement our cutting-edge Multiscale Network Modelling Approach to integrate measures of glucose homeostasis (SI and Matsuda index from FSIVGT and OGTT, respectively); adipose and muscle tissue transcript profiles; eSNP data from African American participants in the AAGMEx cohort (N=260); and genetic and epigenetic regulation data from knowledge bases to discover subnetworks and genetic drivers that are causally linked to IR. In Aim 2, we will validate insulin sensitivity-associated genetically-regulated subnetworks, and determine common and ethnically-predominant genetic regulatory mechanisms of IR, using multi-omics data from similarly phenotyped European ancestry individuals from the METSIM (N=770) and AREA (N=99) cohorts. These results will be compared with those from the AAGMEx cohort. Key driver genes of insulin sensitivity-associated genetically regulated adipose and muscle tissue subnetworks from Aims 1-2 will then be prioritized based on statistical ranking to validate their regulatory roles. In Aim 3, we will focus on understanding molecular and cellular mechanisms modulated by 10 selected putative key regulatory genes. Using in vitro genetic perturbation experiments in relevant human cell models we have already established, we will modulate the expression of these genes, identify target pathways, and examine IR-determining cellular mechanisms (e.g. metabolism, signal transduction, differentiation, inflammation, cell-cell interaction) regulated by these genes. Our study will be among the first to define the genetic regulatory networks of IR, a key step towards development of novel therapeutic options for prevention of IR and subsequent T2D. Deciphering the underlying molecular defects and genetic regulatory mechanisms of insulin sensitivity is an unmet need to develop novel and safe therapeutic options to prevent insulin resistance and progression to type 2 diabetes and other diseases of major public health importance. Building on our success in recruiting cohorts of metabolically well-characterized and molecularly profiled non-diabetic African and European Ancestry individuals, and creating a data resource that is suitably powered to conduct integrative multi-omics analysis, we will implement a novel computational approach to discover fat and muscle tissue gene regulatory networks and driver genes that are causally linked to insulin resistance. Leveraging expertise of our multidisciplinary research team in cell and molecular biological studies this project will define mechanistic roles for the computationally predicted key regulatory genes in determining insulin resistance and thus help inform new strategies to treat and even prevent the rapidly growing public-health challenge of type 2 diabetes, particularly among African Americans.",Identifying Genetic Drivers of Expression Networks Causing Insulin Resistance,9959404,R01DK118243,"['Adipose tissue', 'African', 'African American', 'Biological', 'Biological Assay', 'Cardiovascular system', 'Cell Communication', 'Cell Culture Techniques', 'Cell model', 'Cell physiology', 'Cells', 'Complex', 'Data', 'Defect', 'Development', 'Disease', 'Down-Regulation', 'Dyslipidemias', 'Ethnic group', 'European', 'Fatty acid glycerol esters', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Predisposition to Disease', 'Genetic Transcription', 'Genomics', 'Genotype', 'Glucose', 'Goals', 'Heterogeneity', 'Human', 'Hypertension', 'In Vitro', 'Individual', 'Inflammation', 'Insulin Resistance', 'Interdisciplinary Study', 'Laboratories', 'Link', 'Maps', 'Measures', 'Mediating', 'Metabolic', 'Metabolism', 'Modeling', 'Molecular', 'Molecular Profiling', 'Multiomic Data', 'Muscle', 'Network-based', 'Non-Insulin-Dependent Diabetes Mellitus', 'OGTT', 'Participant', 'Pathway interactions', 'Phenotype', 'Physiological', 'Prevalence', 'Prevention', 'Proteins', 'Public Health', 'Quantitative Trait Loci', 'Regulator Genes', 'Risk', 'Role', 'Signal Transduction', 'Single Nucleotide Polymorphism', 'Testing', 'Therapeutic', 'Tissues', 'Transcript', 'base', 'blood glucose regulation', 'causal model', 'causal variant', 'cohort', 'data resource', 'density', 'epigenetic regulation', 'experimental study', 'genetic architecture', 'genetic association', 'genetic variant', 'genome-wide', 'indexing', 'insulin sensitivity', 'knowledge base', 'metabolic phenotype', 'molecular phenotype', 'multidisciplinary', 'multiple omics', 'network models', 'non-diabetic', 'novel', 'novel therapeutics', 'overexpression', 'preservation', 'prevent', 'promoter', 'random forest', 'reconstruction', 'recruit', 'small hairpin RNA', 'success', 'transcriptome sequencing']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2020,378487,0.06210903694392959
"Identifying Genetic Drivers of Expression Networks Causing Insulin Resistance Reduced insulin sensitivity or insulin resistance (IR) is a forerunner of Type 2 diabetes (T2D). Differences in the prevalence of IR among ethnic groups suggest its genetic etiology. However, recent studies implementing genetic association approaches were only nominally successful in defining the genetically-regulated molecular and cellular mechanisms of IR. Our physiologic and genomic studies suggest that (a) IR results from derangement in expression of thousands of genes in tissues involved in glucose homeostasis, and (b) genetic variants, such as single nucleotide polymorphisms (SNPs), determine the expression level of a subset of IR-associated genes. Thus, transcript levels are key molecular phenotypes associated with IR and are proximal to the action of genetic variants. A subset of genetically-regulated transcript subnetworks that operate within the large highly interconnected global expression networks in disease-relevant tissues can cause IR, but remain poorly understood. We hypothesize that, regulatory SNPs in expression quantitative trait loci (eQTLs) determine transcript levels of key driver genes, configure the expression subnetworks in adipose and muscle tissue, and are causal determinants for IR. The genetic architecture of eQTLs determines the heterogeneity in causal mechanisms of IR. Our preliminary data support the concept of causal genetic regulators of subnetworks in modulating insulin sensitivity. Challenging the current paradigms, our Aim 1 is to implement our cutting-edge Multiscale Network Modelling Approach to integrate measures of glucose homeostasis (SI and Matsuda index from FSIVGT and OGTT, respectively); adipose and muscle tissue transcript profiles; eSNP data from African American participants in the AAGMEx cohort (N=260); and genetic and epigenetic regulation data from knowledge bases to discover subnetworks and genetic drivers that are causally linked to IR. In Aim 2, we will validate insulin sensitivity-associated genetically-regulated subnetworks, and determine common and ethnically-predominant genetic regulatory mechanisms of IR, using multi-omics data from similarly phenotyped European ancestry individuals from the METSIM (N=770) and AREA (N=99) cohorts. These results will be compared with those from the AAGMEx cohort. Key driver genes of insulin sensitivity-associated genetically regulated adipose and muscle tissue subnetworks from Aims 1-2 will then be prioritized based on statistical ranking to validate their regulatory roles. In Aim 3, we will focus on understanding molecular and cellular mechanisms modulated by 10 selected putative key regulatory genes. Using in vitro genetic perturbation experiments in relevant human cell models we have already established, we will modulate the expression of these genes, identify target pathways, and examine IR-determining cellular mechanisms (e.g. metabolism, signal transduction, differentiation, inflammation, cell-cell interaction) regulated by these genes. Our study will be among the first to define the genetic regulatory networks of IR, a key step towards development of novel therapeutic options for prevention of IR and subsequent T2D. Deciphering the underlying molecular defects and genetic regulatory mechanisms of insulin sensitivity is an unmet need to develop novel and safe therapeutic options to prevent insulin resistance and progression to type 2 diabetes and other diseases of major public health importance. Building on our success in recruiting cohorts of metabolically well-characterized and molecularly profiled non-diabetic African and European Ancestry individuals, and creating a data resource that is suitably powered to conduct integrative multi-omics analysis, we will implement a novel computational approach to discover fat and muscle tissue gene regulatory networks and driver genes that are causally linked to insulin resistance. Leveraging expertise of our multidisciplinary research team in cell and molecular biological studies this project will define mechanistic roles for the computationally predicted key regulatory genes in determining insulin resistance and thus help inform new strategies to treat and even prevent the rapidly growing public-health challenge of type 2 diabetes, particularly among African Americans.",Identifying Genetic Drivers of Expression Networks Causing Insulin Resistance,9728964,R01DK118243,"['Adipose tissue', 'African', 'African American', 'Biological', 'Biological Assay', 'Cardiovascular system', 'Cell Communication', 'Cell Culture Techniques', 'Cell model', 'Cell physiology', 'Cells', 'Complex', 'Data', 'Defect', 'Development', 'Disease', 'Down-Regulation', 'Dyslipidemias', 'Ethnic group', 'European', 'Fatty acid glycerol esters', 'Gene Expression', 'Genes', 'Genetic', 'Genetic Predisposition to Disease', 'Genetic Transcription', 'Genomics', 'Genotype', 'Glucose', 'Goals', 'Heterogeneity', 'Human', 'Hypertension', 'In Vitro', 'Individual', 'Inflammation', 'Insulin Resistance', 'Interdisciplinary Study', 'Laboratories', 'Link', 'Maps', 'Measures', 'Mediating', 'Metabolic', 'Metabolism', 'Modeling', 'Molecular', 'Molecular Profiling', 'Multiomic Data', 'Muscle', 'Network-based', 'Non-Insulin-Dependent Diabetes Mellitus', 'OGTT', 'Participant', 'Pathway interactions', 'Phenotype', 'Physiological', 'Prevalence', 'Prevention', 'Proteins', 'Public Health', 'Quantitative Trait Loci', 'Regulator Genes', 'Risk', 'Role', 'Signal Transduction', 'Single Nucleotide Polymorphism', 'Testing', 'Therapeutic', 'Tissues', 'Transcript', 'base', 'blood glucose regulation', 'causal model', 'causal variant', 'cohort', 'data resource', 'density', 'epigenetic regulation', 'experimental study', 'genetic architecture', 'genetic association', 'genetic variant', 'genome-wide', 'indexing', 'insulin sensitivity', 'knowledge base', 'metabolic phenotype', 'molecular phenotype', 'multidisciplinary', 'multiple omics', 'network models', 'non-diabetic', 'novel', 'novel therapeutics', 'overexpression', 'preservation', 'prevent', 'promoter', 'random forest', 'reconstruction', 'recruit', 'small hairpin RNA', 'success', 'transcriptome sequencing']",NIDDK,WAKE FOREST UNIVERSITY HEALTH SCIENCES,R01,2019,347047,0.06210903694392959
"Methods for analysis of regulatory variation in cellular differentiation One of the key challenges in human genomics currently is to dissect the impact of sequence variation on gene regulation. Characterizing the functional consequences of regulatory variation would lead to a greater understanding of evolutionary constraint on gene expression, improved interpretation of whole genome sequencing, and a more complete picture of the genetic architecture of complex disease. However, interpreting non-coding genetic variation remains difficult, particularly due to the complexity of gene regulation, which is highly specific to cell-type and environmental context. Understanding how disease-associated genetic variation impacts human tissues requires that we identify mechanisms behind cell-type-specific regulatory variation. In order to address these important goals, we propose to create a resource in which we can directly assay a range of regulatory phenotypes in multiple cell-types. We propose to establish a panel of induced pluripotent stem cells (iPSCs) from 70 individuals and collect genomic data from iPSCs and differentiated cells. This empirical effort will be complemented by formulating a novel statistical methodology to integrate data across different assays, cell-types, time points, and individuals; to robustly identify regulatory networks and genetic variants that affect gene regulation in each context. Together, these contributions will provide a basis for ongoing study of gene regulation and sequence variation in multiple disease-relevant cell types using a renewable model system and novel methods for robust analysis of these data. In Aim 1, we propose to develop the resource of 70 iPSC lines, where we will collect extensive molecular regulatory phenotypes at multiple time points throughout differentiation to three cell types (cardiomyocytes, neurons and hepatocytes). Measuring gene expression, chromatin accessibility, and methylation in each sample throughout differentiation, we will provide a detailed picture of the cascade of regulatory influences active in each cell type and during development. In Aim 2, we propose to develop a novel statistical framework for inferring universal and cell- type-specific regulatory factors from multi-dimensional data spanning cell-types, individuals, phenotypes, and time points. We specify a machine learning method based on Bayesian hierarchical transfer learning that provides dramatically increased power to detect shared effects while explicitly identifying context-specific regulatory changes. This approach will be adopted to infer regulatory networks, identify key regulatory sequence elements, and map QTLs in each phenotype and cell type. In Aim 3, we will utilize the empirical data and novel methods to infer regulatory relationships and mechanisms underlying genetic variants associated with gene expression in primary tissue and with disease. We will do this by performing a careful integration of external association studies. All samples, cell lines, data, computational tools, and analytical results will be made freely available to the community. We expect our project will greatly advance the understanding of gene regulation, the consequences of genetic variation in diverse cell-types, and the genetic basis of disease. Project narrative: Understanding the impact of individual genetic variation on diverse tissues and cell types in the human body is essential to dissecting the genetics of complex human diseases. Here, we gather data from multiple cell types derived from induced pluripotent stem cells, and develop a novel statistical framework for integrative analysis of data across individuals, cell types, and time points. Our approach provides a transformative approach for understanding gene regulation and the effects of genetic variation on individual health. ",Methods for analysis of regulatory variation in cellular differentiation,9774175,R01GM120167,"['Address', 'Adopted', 'Affect', 'Behavior', 'Biological Assay', 'Biological Models', 'Cardiac Myocytes', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Chromatin', 'Communities', 'Complement', 'Complex', 'Data', 'Data Analyses', 'Development', 'Disease', 'Ectoderm', 'Elements', 'Endoderm', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Germ Layers', 'Goals', 'Health', 'Hepatocyte', 'Hour', 'Human Genetics', 'Human body', 'Individual', 'Knowledge', 'Lead', 'Machine Learning', 'Maps', 'Measures', 'Mesoderm', 'Methodology', 'Methods', 'Methylation', 'Modeling', 'Molecular', 'Neurons', 'Outcome', 'Phenotype', 'Process', 'Psychological Transfer', 'Quantitative Trait Loci', 'Regulatory Element', 'Resources', 'Sampling', 'Specific qualifier value', 'Specificity', 'Statistical Methods', 'Supporting Cell', 'System', 'Time', 'Tissues', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'computerized tools', 'data resource', 'genetic architecture', 'genetic variant', 'genome sequencing', 'genomic data', 'histone modification', 'human disease', 'human genomics', 'human tissue', 'improved', 'induced pluripotent stem cell', 'learning network', 'learning strategy', 'multidimensional data', 'multimodality', 'novel', 'phenotypic data', 'pluripotency', 'programs', 'statistics', 'stem cell differentiation', 'trait', 'transcriptomics', 'whole genome']",NIGMS,JOHNS HOPKINS UNIVERSITY,R01,2019,520253,0.14110715733581078
"Methods for analysis of regulatory variation in cellular differentiation One of the key challenges in human genomics currently is to dissect the impact of sequence variation on gene regulation. Characterizing the functional consequences of regulatory variation would lead to a greater understanding of evolutionary constraint on gene expression, improved interpretation of whole genome sequencing, and a more complete picture of the genetic architecture of complex disease. However, interpreting non-coding genetic variation remains difficult, particularly due to the complexity of gene regulation, which is highly specific to cell-type and environmental context. Understanding how disease-associated genetic variation impacts human tissues requires that we identify mechanisms behind cell-type-specific regulatory variation. In order to address these important goals, we propose to create a resource in which we can directly assay a range of regulatory phenotypes in multiple cell-types. We propose to establish a panel of induced pluripotent stem cells (iPSCs) from 70 individuals and collect genomic data from iPSCs and differentiated cells. This empirical effort will be complemented by formulating a novel statistical methodology to integrate data across different assays, cell-types, time points, and individuals; to robustly identify regulatory networks and genetic variants that affect gene regulation in each context. Together, these contributions will provide a basis for ongoing study of gene regulation and sequence variation in multiple disease-relevant cell types using a renewable model system and novel methods for robust analysis of these data. In Aim 1, we propose to develop the resource of 70 iPSC lines, where we will collect extensive molecular regulatory phenotypes at multiple time points throughout differentiation to three cell types (cardiomyocytes, neurons and hepatocytes). Measuring gene expression, chromatin accessibility, and methylation in each sample throughout differentiation, we will provide a detailed picture of the cascade of regulatory influences active in each cell type and during development. In Aim 2, we propose to develop a novel statistical framework for inferring universal and cell- type-specific regulatory factors from multi-dimensional data spanning cell-types, individuals, phenotypes, and time points. We specify a machine learning method based on Bayesian hierarchical transfer learning that provides dramatically increased power to detect shared effects while explicitly identifying context-specific regulatory changes. This approach will be adopted to infer regulatory networks, identify key regulatory sequence elements, and map QTLs in each phenotype and cell type. In Aim 3, we will utilize the empirical data and novel methods to infer regulatory relationships and mechanisms underlying genetic variants associated with gene expression in primary tissue and with disease. We will do this by performing a careful integration of external association studies. All samples, cell lines, data, computational tools, and analytical results will be made freely available to the community. We expect our project will greatly advance the understanding of gene regulation, the consequences of genetic variation in diverse cell-types, and the genetic basis of disease. Project narrative: Understanding the impact of individual genetic variation on diverse tissues and cell types in the human body is essential to dissecting the genetics of complex human diseases. Here, we gather data from multiple cell types derived from induced pluripotent stem cells, and develop a novel statistical framework for integrative analysis of data across individuals, cell types, and time points. Our approach provides a transformative approach for understanding gene regulation and the effects of genetic variation on individual health. ",Methods for analysis of regulatory variation in cellular differentiation,9552890,R01GM120167,"['Address', 'Adopted', 'Affect', 'Behavior', 'Biological Assay', 'Biological Models', 'Cardiac Myocytes', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Chromatin', 'Communities', 'Complement', 'Complex', 'Data', 'Data Analyses', 'Development', 'Disease', 'Ectoderm', 'Elements', 'Endoderm', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Germ Layers', 'Goals', 'Health', 'Hepatocyte', 'Hour', 'Human Genetics', 'Human body', 'Individual', 'Knowledge', 'Lead', 'Machine Learning', 'Maps', 'Measures', 'Mesoderm', 'Methodology', 'Methods', 'Methylation', 'Modality', 'Modeling', 'Molecular', 'Neurons', 'Outcome', 'Phenotype', 'Process', 'Psychological Transfer', 'Quantitative Trait Loci', 'Regulatory Element', 'Resources', 'Sampling', 'Specific qualifier value', 'Specificity', 'Statistical Methods', 'Supporting Cell', 'System', 'Time', 'Tissues', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'computerized tools', 'data resource', 'genetic architecture', 'genetic variant', 'genome sequencing', 'genomic data', 'histone modification', 'human disease', 'human genomics', 'human tissue', 'improved', 'induced pluripotent stem cell', 'learning network', 'learning strategy', 'novel', 'phenotypic data', 'pluripotency', 'programs', 'statistics', 'stem cell differentiation', 'trait', 'transcriptomics', 'whole genome']",NIGMS,JOHNS HOPKINS UNIVERSITY,R01,2018,543228,0.14110715733581078
"Methods for analysis of regulatory variation in cellular differentiation One of the key challenges in human genomics currently is to dissect the impact of sequence variation on gene regulation. Characterizing the functional consequences of regulatory variation would lead to a greater understanding of evolutionary constraint on gene expression, improved interpretation of whole genome sequencing, and a more complete picture of the genetic architecture of complex disease. However, interpreting non-coding genetic variation remains difficult, particularly due to the complexity of gene regulation, which is highly specific to cell-type and environmental context. Understanding how disease-associated genetic variation impacts human tissues requires that we identify mechanisms behind cell-type-specific regulatory variation. In order to address these important goals, we propose to create a resource in which we can directly assay a range of regulatory phenotypes in multiple cell-types. We propose to establish a panel of induced pluripotent stem cells (iPSCs) from 70 individuals and collect genomic data from iPSCs and differentiated cells. This empirical effort will be complemented by formulating a novel statistical methodology to integrate data across different assays, cell-types, time points, and individuals; to robustly identify regulatory networks and genetic variants that affect gene regulation in each context. Together, these contributions will provide a basis for ongoing study of gene regulation and sequence variation in multiple disease-relevant cell types using a renewable model system and novel methods for robust analysis of these data. In Aim 1, we propose to develop the resource of 70 iPSC lines, where we will collect extensive molecular regulatory phenotypes at multiple time points throughout differentiation to three cell types (cardiomyocytes, neurons and hepatocytes). Measuring gene expression, chromatin accessibility, and methylation in each sample throughout differentiation, we will provide a detailed picture of the cascade of regulatory influences active in each cell type and during development. In Aim 2, we propose to develop a novel statistical framework for inferring universal and cell- type-specific regulatory factors from multi-dimensional data spanning cell-types, individuals, phenotypes, and time points. We specify a machine learning method based on Bayesian hierarchical transfer learning that provides dramatically increased power to detect shared effects while explicitly identifying context-specific regulatory changes. This approach will be adopted to infer regulatory networks, identify key regulatory sequence elements, and map QTLs in each phenotype and cell type. In Aim 3, we will utilize the empirical data and novel methods to infer regulatory relationships and mechanisms underlying genetic variants associated with gene expression in primary tissue and with disease. We will do this by performing a careful integration of external association studies. All samples, cell lines, data, computational tools, and analytical results will be made freely available to the community. We expect our project will greatly advance the understanding of gene regulation, the consequences of genetic variation in diverse cell-types, and the genetic basis of disease. Project narrative: Understanding the impact of individual genetic variation on diverse tissues and cell types in the human body is essential to dissecting the genetics of complex human diseases. Here, we gather data from multiple cell types derived from induced pluripotent stem cells, and develop a novel statistical framework for integrative analysis of data across individuals, cell types, and time points. Our approach provides a transformative approach for understanding gene regulation and the effects of genetic variation on individual health. ",Methods for analysis of regulatory variation in cellular differentiation,9356566,R01GM120167,"['Address', 'Adopted', 'Affect', 'Architecture', 'Behavior', 'Biological Assay', 'Biological Models', 'Cardiac Myocytes', 'Cell Differentiation process', 'Cell Line', 'Cells', 'Chromatin', 'Communities', 'Complement', 'Complex', 'Data', 'Data Analyses', 'Development', 'Disease', 'Ectoderm', 'Elements', 'Endoderm', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Germ Layers', 'Goals', 'Health', 'Hepatocyte', 'Hour', 'Human Genetics', 'Human body', 'Individual', 'Knowledge', 'Lead', 'Machine Learning', 'Maps', 'Measures', 'Mesoderm', 'Methodology', 'Methods', 'Methylation', 'Modality', 'Modeling', 'Molecular', 'Neurons', 'Outcome', 'Phenotype', 'Process', 'Psychological Transfer', 'Quantitative Trait Loci', 'Regulatory Element', 'Resources', 'Sampling', 'Specific qualifier value', 'Specificity', 'Statistical Methods', 'Supporting Cell', 'System', 'Time', 'Tissues', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'computerized tools', 'data resource', 'genetic variant', 'genome sequencing', 'genomic data', 'histone modification', 'human disease', 'human genomics', 'human tissue', 'improved', 'induced pluripotent stem cell', 'learning network', 'learning strategy', 'novel', 'phenotypic data', 'pluripotency', 'programs', 'statistics', 'trait', 'transcriptomics', 'whole genome']",NIGMS,JOHNS HOPKINS UNIVERSITY,R01,2017,463781,0.14110715733581078
"Methods for analysis of regulatory variation in cellular differentiation One of the key challenges in human genomics currently is to dissect the impact of sequence variation on gene regulation. Characterizing the functional consequences of regulatory variation would lead to a greater understanding of evolutionary constraint on gene expression, improved interpretation of whole genome sequencing, and a more complete picture of the genetic architecture of complex disease. However, interpreting non-coding genetic variation remains difficult, particularly due to the complexity of gene regulation, which is highly specific to cell-type and environmental context. Understanding how disease-associated genetic variation impacts human tissues requires that we identify mechanisms behind cell-type-specific regulatory variation. In order to address these important goals, we propose to create a resource in which we can directly assay a range of regulatory phenotypes in multiple cell-types. We propose to establish a panel of induced pluripotent stem cells (iPSCs) from 70 individuals and collect genomic data from iPSCs and differentiated cells. This empirical effort will be complemented by formulating a novel statistical methodology to integrate data across different assays, cell-types, time points, and individuals; to robustly identify regulatory networks and genetic variants that affect gene regulation in each context. Together, these contributions will provide a basis for ongoing study of gene regulation and sequence variation in multiple disease-relevant cell types using a renewable model system and novel methods for robust analysis of these data. In Aim 1, we propose to develop the resource of 70 iPSC lines, where we will collect extensive molecular regulatory phenotypes at multiple time points throughout differentiation to three cell types (cardiomyocytes, neurons and hepatocytes). Measuring gene expression, chromatin accessibility, and methylation in each sample throughout differentiation, we will provide a detailed picture of the cascade of regulatory influences active in each cell type and during development. In Aim 2, we propose to develop a novel statistical framework for inferring universal and cell- type-specific regulatory factors from multi-dimensional data spanning cell-types, individuals, phenotypes, and time points. We specify a machine learning method based on Bayesian hierarchical transfer learning that provides dramatically increased power to detect shared effects while explicitly identifying context-specific regulatory changes. This approach will be adopted to infer regulatory networks, identify key regulatory sequence elements, and map QTLs in each phenotype and cell type. In Aim 3, we will utilize the empirical data and novel methods to infer regulatory relationships and mechanisms underlying genetic variants associated with gene expression in primary tissue and with disease. We will do this by performing a careful integration of external association studies. All samples, cell lines, data, computational tools, and analytical results will be made freely available to the community. We expect our project will greatly advance the understanding of gene regulation, the consequences of genetic variation in diverse cell-types, and the genetic basis of disease. Project narrative: Understanding the impact of individual genetic variation on diverse tissues and cell types in the human body is essential to dissecting the genetics of complex human diseases. Here, we gather data from multiple cell types derived from induced pluripotent stem cells, and develop a novel statistical framework for integrative analysis of data across individuals, cell types, and time points. Our approach provides a transformative approach for understanding gene regulation and the effects of genetic variation on individual health. ",Methods for analysis of regulatory variation in cellular differentiation,9157021,R01GM120167,"['Address', 'Adopted', 'Affect', 'Architecture', 'Behavior', 'Biological Assay', 'Biological Models', 'Cardiac Myocytes', 'Cell Line', 'Cells', 'Chromatin', 'Communities', 'Complement', 'Complex', 'Data', 'Data Analyses', 'Development', 'Disease', 'Ectoderm', 'Elements', 'Endoderm', 'Epigenetic Process', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Variation', 'Genomics', 'Germ Layers', 'Goals', 'Health', 'Hepatocyte', 'Hour', 'Human Genetics', 'Human body', 'Individual', 'Knowledge', 'Lead', 'Machine Learning', 'Maps', 'Measures', 'Mesoderm', 'Methodology', 'Methods', 'Methylation', 'Modeling', 'Molecular', 'Neurons', 'Outcome', 'Phenotype', 'Process', 'Psychological Transfer', 'Quantitative Trait Loci', 'Regulatory Element', 'Resources', 'Sampling', 'Specific qualifier value', 'Specificity', 'Staging', 'Statistical Methods', 'Supporting Cell', 'System', 'Time', 'Tissues', 'Untranslated RNA', 'Variant', 'base', 'cell type', 'computerized tools', 'genetic variant', 'genome sequencing', 'genomic data', 'histone modification', 'human disease', 'human genomics', 'human tissue', 'improved', 'induced pluripotent stem cell', 'learning strategy', 'novel', 'pluripotency', 'programs', 'statistics', 'trait', 'transcriptomics', 'whole genome']",NIGMS,JOHNS HOPKINS UNIVERSITY,R01,2016,404036,0.14110715733581078
"Hit-and-Run transcription: The impact of transient interactions in dynamic gene regulatory networks that mediate rapid nutrient signaling Project Summary: This grant exploits TIME - the 4th and largely unexplored dimension of transcription - to capture transient interactions in gene regulatory networks (GRNs) that are important, but missed, in vivo. This is because genome- scale methods to capture transcription factor (TF) target interactions favor stable binding, and reporter gene studies which detect transient TF-target interactions in seconds, miss global responses needed for GRN models. We aim to fill the time-gap in our collective knowledge of dynamic GRNs by experimentally capturing transient TF-target interactions globally using a cell-based temporal TF perturbation assay (Aims 1 & 2), and evaluate their importance in forecasting gene expression at future time-points (Aim 3), a main goal of systems biology. We model temporal GRNs controlling nitrogen (N)-signaling in plants, but our approaches are broadly applicable. We exploit a cell-based assay for temporal TF perturbation, TARGET, which captures transient TF-target interactions genome-wide; i) by TF-mediated gene regulation even in the absence of detectable TF-binding, ii) within minutes of controlled TF nuclear entry, and iii) identifies highly transient TF-binding leading to sustained transcription by affinity-capture of de novo mRNAs. We discovered that i) a single TF can stably or transiently bind to, and induce or repress, distinct sets of targets depending on their cis-context, ii) that transient TF-targets captured only in cells control early N-responses in planta, for two master TFs in our GRNs (bZIP1 & NLP7). This genome-wide data supports a Hit-and-Run transcription model, where a TF Hit can initiate a stable transcriptional complex, including recruitment of TF partners, enabling transcription to continue after the initiating TF is no longer bound, the Run. This could allow a small number of TF molecules to rapidly affect a large number of target genes by acting catalytically. Our studies have been cited and influenced thinking of transient transcription mechanisms across yeast, stems cells, and were invoked to explain the new discovery of transient binding of Zelda/Bicoid to a reporter gene in Drosophila. Herein, we deploy experimental and computational innovations to test the pervasiveness and in vivo significance of a conceptual innovation - transient Hit-and- Run interactions in GRNs. Our experimental innovations include; i) Assays for Hit-and-Run activity across all 70 TF families in Arabidopsis, using a higher throughput version of the cell-based TARGET assay we recently published, ii) new methods to capture TF-target interactions using time-series biotin-ChIP and DamID, which leaves DNA methylation marks on transient TF-target interactions, supported by preliminary data (Aims 1 & 2). Our computational innovations include: i) ConnectTF, a platform to integrate TF-DNA binding and RNA-seq data and identify candidate Hit-and-Run TFs, and approaches to assess the in planta relevance of transient TF- target interactions in GRNs, such as ii) our newly published Network Walking method, and iii) OutPredict, a new time-based method to forecast gene expression at future time-points (Aim 3). Our experimental & computational approaches are broadly applicable and our results are relevant to environmental N-use affecting human health. PROJECT NARRATIVE This work illustrates a combined experimental and computational approach to discover gene regulatory networks in a pathway, process, or trait - applied across a range of problems in biology, agriculture and medicine. Our networks can suggest genes for targeted interventions to reduce nitrogen fertilizer use, yielding benefits for health, energy and the environment.",Hit-and-Run transcription: The impact of transient interactions in dynamic gene regulatory networks that mediate rapid nutrient signaling,9886986,R01GM121753,"['Affect', 'Affinity', 'Agriculture', 'Arabidopsis', 'Binding', 'Biological Assay', 'Biology', 'Biotin', 'Biotinylation', 'Cells', 'Complex', 'Computer software', 'DNA', 'DNA Binding', 'DNA Methylation', 'Data', 'Data Set', 'Databases', 'Dimensions', 'Drosophila genus', 'Environment', 'Eukaryota', 'Event', 'Family', 'Fertilizers', 'Fingerprint', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genetic Transcription', 'Goals', 'Grant', 'Health', 'Health Benefit', 'Human', 'Influentials', 'Internet', 'Intervention', 'Knowledge', 'Mediating', 'Medicine', 'Messenger RNA', 'Methods', 'Modeling', 'Nitrogen', 'Nuclear', 'Nutrient', 'Pathway interactions', 'Phenotype', 'Plants', 'Prevalence', 'Process', 'Protein Methyltransferases', 'Publishing', 'Regulation', 'Regulator Genes', 'Reporter Genes', 'Resolution', 'Role', 'Running', 'Sampling', 'Sensitivity and Specificity', 'Series', 'Signal Transduction', 'System', 'Systems Biology', 'Testing', 'Thinking', 'Time', 'Transcript', 'Validation', 'Walking', 'Work', 'Yeasts', 'base', 'embryonic stem cell', 'gene discovery', 'genome-wide', 'in vivo', 'innovation', 'network models', 'random forest', 'recruit', 'response', 'scale up', 'stem cells', 'time use', 'tool', 'trait', 'transcription factor', 'transcription factor S-II', 'transcriptome sequencing']",NIGMS,NEW YORK UNIVERSITY,R01,2020,429726,-0.0232062688437465
"Resolving single-cell brain regulatory elements with bulk data supervised models Gene regulation is an important determinant of the complex specialization of cells in the human brain, and nucleotide changes within regulatory elements contribute to risk for psychiatric disorders. We therefore hypothesize that these debilitating diseases are driven in part by genetic variants that alter gene expression and disturb the balance and function of cell types in brain tissue. Single-cell open chromatin assays are a promising approach to testing this hypothesis by mapping variants to regulatory elements specific to and shared across cell populations. There are two major barriers to this strategy, for which our project proposes modeling solutions. First, despite being the best assay currently, single-cell ATAC-sequencing (scATAC-seq) suffers from low resolution, meaning that an open chromatin region may be supported by zero or few reads in a given cell. This makes it hard to identify coherent cell populations. We propose a network model for semi-supervised clustering of cells in scATAC-seq that leverages information from higher-coverage bulk tissue experiments and single-cell RNA-sequencing (scRNA-seq), if available. The expected outcomes from applying this model to compendia of brain data from public repositories and our collaborators are (i) identification of open chromatin regions that differentiate cell types and states, and (ii) discovery of resolved cell populations whose open chromatin is enriched for psychiatric disorder associated genetic variants. These results alone may not be enough to develop a mechanistic understanding of how variants impact brain function. To address this second challenge, we will implement a computationally efficient, machine-learning framework for predicting the specific regulatory functions of single-cell open chromatin regions from our network model and other approaches. Gene regulatory enhancers are particularly amenable to this approach, because high-throughput mouse transgenics and massively parallel reporter assays have generated enough validated enhancers for supervised learning. Our framework will be easy to apply to other regulatory functions, such as insulating boundaries in chromatin capture data. By developing a compressed, yet flexible, featurization of massive bulk and single-cell data compendia, we will enable rapid iteration with computationally intensive prediction algorithms to be applied to single-cell open chromatin regions. Our approach will also incorporate transfer learning from data-rich (e.g., postmortem or mouse brains) to data-poor settings (e.g., human late-gestation brains). We expect predicted regulatory elements to be more enriched for psychiatric disorder genetic risk, to provide mechanistic insight regarding how variants cause disease, and to be useful molecular tools. Together our two proposed computational approaches will leverage the complementary strengths of bulk and single-cell data to resolve regulatory elements that drive the exquisite diversity of cells in developing and adult brains towards mapping the non-coding contribution of psychiatric disease. The human brain is a complex tissue comprised of diverse cell types with distinct gene regulation and function, making it difficult to mechanistically link genetic mutations to differences in brain health. This project will develop a network model and machine-learning framework that leverage single-cell and bulk genomics data to identify genome sequences that control gene expression in specific cell populations and states. We hypothesize that these cell type resolved regulatory elements will shed light on how sequence variants outside protein-coding genes increase risk for psychiatric disorders.",Resolving single-cell brain regulatory elements with bulk data supervised models,10007660,R01MH123178,"['3-Dimensional', 'Address', 'Adult', 'Algorithms', 'Anatomy', 'Atlases', 'Autopsy', 'Base Pairing', 'Binding Sites', 'Biological Assay', 'Biological Process', 'Brain', 'Cell Differentiation process', 'Cell physiology', 'Cells', 'Cellular Assay', 'Censuses', 'Chickens', 'Chromatin', 'Code', 'Collection', 'Complex', 'DNA Binding', 'DNA Sequence Alteration', 'Data', 'Diffusion', 'Disease', 'Drops', 'Elements', 'Enhancers', 'Epigenetic Process', 'Evaluation', 'Functional disorder', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic Risk', 'Genome', 'Genomics', 'Genotype-Tissue Expression Project', 'Goals', 'Graph', 'Human', 'Individual', 'Light', 'Link', 'Machine Learning', 'Maps', 'Measurement', 'Mental disorders', 'Methods', 'Modeling', 'Molecular', 'Mus', 'Mutation', 'Neuraxis', 'Nucleotides', 'Outcome', 'Pathway interactions', 'Pattern', 'Performance', 'Population', 'Pregnancy', 'Proteins', 'Psychological Transfer', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Resolution', 'Risk', 'Sampling', 'Signal Transduction', 'Source', 'Source Code', 'Specificity', 'Supervision', 'Technology', 'Testing', 'Theoretical model', 'Time', 'Tissue Sample', 'Tissues', 'Transgenic Mice', 'Untranslated RNA', 'Validation', 'Variant', 'Weight', 'XCL1 gene', 'autism spectrum disorder', 'base', 'brain cell', 'brain health', 'brain tissue', 'cell type', 'cohort', 'differential expression', 'disorder risk', 'egg', 'epigenomics', 'equilibration disorder', 'experimental study', 'flexibility', 'functional genomics', 'gene function', 'genetic variant', 'genome sequencing', 'genome-wide', 'genomic data', 'human data', 'improved', 'in vitro Assay', 'in vivo', 'insight', 'multiple data types', 'network models', 'open source', 'prediction algorithm', 'promoter', 'psychiatric genomics', 'public repository', 'single cell analysis', 'single-cell RNA sequencing', 'structured data', 'supervised learning', 'tool', 'web server', 'whole genome']",NIMH,J. DAVID GLADSTONE INSTITUTES,R01,2020,606575,0.05735751967759279
"Deep learning frameworks for regulatory genomics. PROJECT SUMMARY The deluge of genome sequencing and functional genomic data in multiple cellular contexts across healthy and diseased individuals provides a unique opportunity to decipher the regulatory and genetic architecture of diseases and traits. Novel computational methods are required that can address fundamental problems involving data representation, data integration, learning accurate predictive models from large-scale datasets and extraction of novel biological insights from complex models. We propose novel machine learning frameworks based on deep neural networks with new interpretation and hypothesis generation engines capable of integrating a wide variety of key genomic data types to learn predictive models of chromatin architecture and chromatin state; integrative models of transcription factor binding; determinants of macroscale three-dimensional genome architecture involving long-range chromatin contacts and the regulatory basis of functional non-coding, regulatory variants. Our methods are highly generalizable to several other related problems in regulatory genomics and lay the foundation for a paradigm shift in computational genomics. NARRATIVE We propose a novel class of machine learning methods based on deep neural networks to integrate diverse sources of functional genomics data and discover novel insights into the 1D microscale and 3D macroscale genetic and regulatory architecture of the human genome.",Deep learning frameworks for regulatory genomics.,9169521,DP2GM123485,"['Address', 'Architecture', 'Binding', 'Biological', 'Biological Neural Networks', 'Chromatin', 'Complex', 'Computing Methodologies', 'Data Reporting', 'Data Set', 'Disease', 'Foundations', 'Generations', 'Genetic', 'Genome', 'Genomics', 'Human Genome', 'Individual', 'Learning', 'Machine Learning', 'Methods', 'Modeling', 'Source', 'Untranslated RNA', 'Variant', 'base', 'data integration', 'functional genomics', 'genome sequencing', 'genomic data', 'insight', 'learning strategy', 'novel', 'predictive modeling', 'trait', 'transcription factor']",NIGMS,STANFORD UNIVERSITY,DP2,2016,2355000,0.09599505059154291
"A big data approach to explore epigenetic heterogeneity and interpret noncoding variants for psychiatric disorders PROJECT ABSTRACT  The incidence of diagnosed psychiatric disorders has been increasing for decades, leaving millions of afflicted individuals. Despite the high heritability, their underlying molecular mechanisms remain elusive. Most risk loci are located in noncoding genomic elements without direct effects on protein products. Comprehensive functional annotation and variant impact quantification are essential to provide new molecular insights and discover therapeutic targets.  Recent advances in novel sequencing technologies and community efforts to share genomic data provide unprecedented opportunities to understand how genetic variants contribute to psychiatric diseases. This application describes the development of integrative strategies and machine learning methods to combine novel assays (such as STARR-seq) with population-scale genomic profiles to elucidate the genetic regulatory grammar in the human prefrontal cortex (PFC) and to prioritize genetic variants in psychiatric disorders. Specifically, we will (1) dissect the cis- regulatory landscape of the PFC using population-scale epigenetics data, (2) construct multi- model gene regulatory networks by linking distal cis-regulatory elements to genes using chromatin co-variability analyses, (3) integrate genetic, epigenetic, and transcriptional data to identify key transcription factors and variants that contribute to psychiatric disorders. Distinct from existing efforts focusing on one genome, this proposed work presents a truly novel big-data approach for both modeling gene regulation and investigating disease-risk factors by incorporating heterogeneous multi-omics profiles from hundreds of individuals. The resultant comprehensive list of cis-regulatory elements will expand the number of known functional regions in the human brain by at least an order. We will release our methods and resources in the form of web services, distributed open-source software, and annotation databases, which will also benefit other investigators exploring the genetic underpinnings of neuropsychiatric disorders.  In addition to its scientific content, this application proposes a comprehensive training program for preparing an independent investigator in computational genomics and neurogenetics. This training will take place at Yale University (in the Dept. of Molecular Biophysics and Biochemistry) under the mentorship of Prof. Mark Gerstein (functional genomics), Prof. Nenad Sestan (neurogenetics), and Prof. Hongyu Zhao (statistical genetics and machine learning). A committee of experienced psychiatric disease experts and data scientists will also provide advice on both scientific research and career development. PROJECT NARRATIVE  The proposed study is to leverage advanced machine learning methods to discover cis- regulatory elements in the noncoding genome by incorporating novel functional characterization technologies (such as STARR-seq) with genetic, epigenetic, and transcriptomic data from psychiatric patients. In contrast to existing methods that rely on a single genome, this work assumes a dynamic regulatory program in each individual and explores the regulatory heterogeneity across hundreds of epigenomes, thereby significantly expanding our current knowledge of the noncoding genome and facilitating functional interpretation of genetic variants. Furthermore, it will also generate publicly available annotation resources and software packages for the scientific community, thereby significantly accelerating the pace of novel therapeutic target discovery for treating psychiatric disorders.",A big data approach to explore epigenetic heterogeneity and interpret noncoding variants for psychiatric disorders,10039384,K01MH123896,"['Affect', 'Award', 'Big Data', 'Binding', 'Biochemistry', 'Biological Assay', 'Biological Process', 'Biophysics', 'Brain', 'ChIP-seq', 'Chromatin', 'Communities', 'Computer software', 'Computing Methodologies', 'Data', 'Data Scientist', 'Databases', 'Dependence', 'Development', 'Dimensions', 'Disease', 'Distal', 'Elements', 'Enhancers', 'Entropy', 'Epigenetic Process', 'Event', 'Gaussian model', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Risk', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genomics', 'Heritability', 'Heterogeneity', 'Human', 'Incidence', 'Individual', 'Knowledge', 'Learning', 'Link', 'Machine Learning', 'Maps', 'Mental disorders', 'Mentorship', 'Methodology', 'Methods', 'Modeling', 'Molecular', 'Nucleic Acid Regulatory Sequences', 'Patients', 'Pattern', 'Phenotype', 'Population', 'Prefrontal Cortex', 'Proteins', 'Psychiatric Diagnosis', 'Regulator Genes', 'Regulatory Element', 'Reporter', 'Reporting', 'Research', 'Research Personnel', 'Resolution', 'Resources', 'Risk Factors', 'Sampling', 'Scanning', 'Scoring Method', 'Shapes', 'Signal Transduction', 'Technology', 'Training', 'Training Programs', 'Transcriptional Regulation', 'Universities', 'Untranslated RNA', 'Variant', 'Work', 'base', 'career development', 'cell type', 'deep learning', 'disorder risk', 'epigenome', 'experience', 'experimental study', 'functional genomics', 'genetic profiling', 'genetic variant', 'genome-wide', 'genomic data', 'genomic locus', 'genomic profiles', 'insight', 'machine learning method', 'multimodality', 'multiple omics', 'neurogenetics', 'neuropsychiatric disorder', 'new therapeutic target', 'novel', 'novel sequencing technology', 'open source', 'programs', 'promoter', 'recruit', 'research and development', 'risk variant', 'therapeutic target', 'transcription factor', 'transcriptomics', 'web services']",NIMH,UNIVERSITY OF CALIFORNIA-IRVINE,K01,2020,94262,-0.025517516087698533
"Application of MAGNet Tools to Gene Regulatory Networks in Cancer    DESCRIPTION (provided by applicant): Application of MAGNet Tools to Gene Regulatory Networks in Cancer Principal Investigator: Sander, Chris Project Summary / Abstract We propose to apply computational algorithms from the Columbia University National Center for Multiscale Analysis of Genomic and Cellular Networks (MAGNet) to study gene regulatory networks in human cancer. The project will be led by the Computational Biology Center at Memorial Sloan Kettering Cancer Center (MSKCC) and will build an intensive collaboration between computer scientists and clinical researchers. The aims of this project are to:  Make discoveries about gene regulation in soft tissue sarcoma and prostate cancer.  Strengthen the National Center's computational tools for the analysis of gene regulation and biological pathways, and  Develop better methods for predicting disease outcome in cancer patients. Specifically, advanced computational algorithms and software developed as part of this project will be used to predict gene regulators and their targets from mRNA and microRNA expression profiles. We propose to study three types of gene regulation in cancer samples: i) transcription of protein coding genes ii) transcription of microRNA genes and iii) translational regulation of protein coding genes by mature microRNAs. The predicted regulatory events will be compared with biological knowledge in pathway databases in order to discover novel regulatory events, detect biological processes characteristic of specific cancer subtypes and assess the accuracy of the prediction algorithms. Such detailed knowledge of gene regulation can improve the prediction of clinical outcomes and guide the choice of therapy for individual patients. Application of MAGNet Tools to Gene Regulatory Networks in Cancer Principal Investigator: Sander, Chris Project Narrative We propose to analyze molecular genetic data from cancer patients using advanced computational methods. The research supports the long-term goal of building genomic profiling tools for predicting disease outcome and response to therapy in individual cancer patients.          n/a",Application of MAGNet Tools to Gene Regulatory Networks in Cancer,7361773,R01CA124380,"['Ablation', 'Academic Medical Centers', 'Accounting', 'Activated B-Lymphocyte', 'Address', 'Adhesives', 'Affect', 'Affinity', 'Algorithms', 'Alzheimer&apos', 's Disease', 'Amino Acid Sequence', 'Androgens', 'Antibodies', 'Antigens', 'Applied Research', 'Area', 'Arts', 'Autistic Disorder', 'Automobile Driving', 'B-Cell Lymphomas', 'B-Cell Neoplasm', 'B-Lymphocytes', 'BCL6 gene', 'Basic Science', 'Behavior', 'Binding', 'Biochemical', 'Biochemistry', 'Bioinformatics', 'Biological', 'Biological Process', 'Biology', 'Biomedical Computing', 'Biophysics', 'Birds', 'Cadherins', 'Cancer Biology', 'Cancer Patient', 'Candidate Disease Gene', 'Cell Adhesion', 'Cell Aggregation', 'Cell physiology', 'Cell-Cell Adhesion', 'Cells', 'Characteristics', 'Chemicals', 'Chicago', 'Class', 'Classification', 'Clinical', 'Clinical Data', 'Code', 'Collaborations', 'Collection', 'Communities', 'Complex', 'Component of the National Institutes of Health', 'Computational Biology', 'Computational Science', 'Computational algorithm', 'Computer Analysis', 'Computer Simulation', 'Computer software', 'Computers', 'Computing Methodologies', 'Crystallography', 'DNA', 'DNA Sequence', 'Data', 'Data Set', 'Databases', 'Development', 'Diffusion', 'Disease', 'Disease Outcome', 'Disease regression', 'Doctor of Philosophy', 'Drug Interactions', 'Engineered Gene', 'Engineering', 'Equilibrium', 'Evaluation', 'Event', 'Experimental Genetics', 'Faculty', 'Family', 'Floor', 'Funding', 'Gene Cluster', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Determinism', 'Genetic Structures', 'Genetic Transcription', 'Genetic Variation', 'Genomics', 'Genotype', 'Goals', 'Graph', 'Homology Modeling', 'Human', 'Human Genetics', 'Imagery', 'Immune response', 'Individual', 'Information Theory', 'Institutes', 'Intervention', 'Investigation', 'Joints', 'Knowledge', 'Language', 'Learning', 'Link', 'Literature', 'Machine Learning', 'Malignant Neoplasms', 'Malignant neoplasm of prostate', 'Maps', 'Measures', 'Mediating', 'Medical Research', 'Memorial Sloan-Kettering Cancer Center', 'Messenger RNA', 'Metabolic', 'Methodology', 'Methods', 'MicroRNAs', 'Modality', 'Modeling', 'Molecular', 'Molecular Analysis', 'Molecular Genetics', 'Molecular Profiling', 'Molecular Structure', 'Natural Language Processing', 'New York', 'Numbers', 'Object Attachment', 'Oligonucleotides', 'Online Systems', 'Ontology', 'Other Resources', 'Outcome', 'Output', 'Pathogenesis', 'Pathway Analysis', 'Pathway interactions', 'Patients', 'Pattern', 'Peptide Sequence Determination', 'Phenotype', 'Phosphorylation', 'Physics', 'Physiological', 'Play', 'Population', 'Predisposition', 'Principal Investigator', 'Process', 'Property', 'Proteins', 'RNA', 'Range', 'Reaction', 'Recombinants', 'Regulator Genes', 'Reporting', 'Representations, Knowledge (Computer)', 'Research', 'Research Activity', 'Research Infrastructure', 'Research Personnel', 'Research Support', 'Resolution', 'Resources', 'Role', 'Sampling', 'Schools', 'Science', 'Scientist', 'Semantics', 'Sequence Analysis', 'Signal Transduction', 'Software Engineering', 'Software Tools', 'Solutions', 'Source', 'Specific qualifier value', 'Specificity', 'Staging', 'Standards of Weights and Measures', 'Statistical Methods', 'Structure', 'Structure of germinal center of lymph node', 'System', 'Systems Biology', 'Techniques', 'Technology', 'Testing', 'Tissues', 'Translational Regulation', 'Tumor-Derived', 'Universities', 'Validation', 'Visual', 'Work', 'abstracting', 'analytical ultracentrifugation', 'base', 'biomedical informatics', 'cancer cell', 'cancer genetics', 'cellular engineering', 'cluster computing', 'computer framework', 'computer science', 'computerized tools', 'concept', 'data mining', 'data modeling', 'data structure', 'design', 'dimer', 'experience', 'genetic variant', 'genome sequencing', 'improved', 'information organization', 'interfacial', 'interoperability', 'kindred', 'knowledge base', 'mRNA Expression', 'monomer', 'mutant', 'new technology', 'novel', 'outcome forecast', 'programs', 'protein function', 'protein protein interaction', 'protein structure function', 'repository', 'research study', 'response', 'sample collection', 'sarcoma', 'simulation', 'small molecule', 'software development', 'therapeutic target', 'tool', 'tumor']",NCI,SLOAN-KETTERING INST CAN RESEARCH,R01,2008,638491,0.16725490303773197
"Genome-wide structural organization of proteins within human gene regulatory complexes Project Summary/Abstract  The DNA sequence of the human genome informs us as to the composition of proteins that make up healthy cells, but also altered compositions that create diseased cells. How protein production is controlled through the regulation of the genes that encode them is of critical importance for healthy and diseased cells. Knowing precisely where gene regulatory proteins bind, and are organized throughout the genome, including their interactions with each other, informs us as to how genes are regulated and mis-regulated. Since there are potentially thousands of different kinds of regulatory proteins and thousands of different kinds of human cell types and environmental responses that are a product of various subsets of regulatory proteins, the entire universe of gene regulatory events is quite substantial and consequently, quite costly to identify. One of the main bottlenecks in analysis of genomic data is efficient and scalable visualization approaches. The PEGR open source platform will provide programmatic access to any number of human cell sequenced datasets, from any stage of NGS processing, with the pipeline analysis results available for high-throughput machine learning testing and development. This project will empower discovery through the automated analysis and visualization of results from both small- and large-scale datasets. This architecture will include the following features: 1) a secure, cloud-based, metadata management system that instills best practices of experimental rigor, reproducibility, and data sharing; 2) automated Galaxy-based epigenomic data processing pipelines that provide easy-to-use wizards for standardized processing of common epigenomic data types; and 3) an easily de-ployable, open source software package as a means to disseminate data, tools, and discoveries via cloud services. Project Narrative Proteins that bind to the human genome control the genes that govern human health. Precise identification of their positional organization informs us of how cells normally behave, and how they will respond to stress, disease, and therapies. This project aims to develop a novel integration of computation tools for analyzing high-resolution protein-DNA binding assays and characterizing spatial dependencies between genomic events.",Genome-wide structural organization of proteins within human gene regulatory complexes,10166093,R01GM125722,"['Architecture', 'Binding Proteins', 'Biological', 'Biological Assay', 'Cells', 'Cloud Service', 'Communities', 'Complex', 'Computer software', 'Custom', 'DNA Sequence', 'DNA sequencing', 'DNA-Binding Proteins', 'Data', 'Data Analyses', 'Data Set', 'Dependence', 'Development', 'Disease', 'Engineering', 'Environment', 'Event', 'Funding', 'Galaxy', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Government', 'Health', 'Human', 'Human Genome', 'Laboratories', 'Machine Learning', 'Management Information Systems', 'Metadata', 'Online Systems', 'Process', 'Production', 'Proteins', 'Reagent', 'Regulation', 'Regulator Genes', 'Reproducibility', 'Resolution', 'Resources', 'Sampling', 'Science', 'Secure', 'Services', 'Standardization', 'Stress', 'Supercomputing', 'System', 'Testing', 'Visualization', 'analysis pipeline', 'automated analysis', 'base', 'cell type', 'cloud based', 'computer infrastructure', 'computerized tools', 'cost', 'data analysis pipeline', 'data sharing', 'data tools', 'epigenomics', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'genomic data', 'large scale data', 'novel', 'open source', 'organizational structure', 'response']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2020,66712,0.10939530870723385
"Genome-wide structural organization of proteins within human gene regulatory complexes Project Summary/Abstract  The DNA sequence of the human genome informs us as to the composition of proteins that make up healthy cells, but also altered compositions that create diseased cells. How protein production is controlled through the regulation of the genes that encode them is of critical importance for healthy and diseased cells. Knowing precisely where gene regulatory proteins bind, and are organized throughout the genome, including their interactions with each other, informs us as to how genes are regulated and mis-regulated. Since there are potentially thousands of different kinds of regulatory proteins and thousands of different kinds of human cell types and environmental responses that are a product of various subsets of regulatory proteins, the entire universe of gene regulatory events is quite substantial and consequently, quite costly to identify. A subset of these events will likely be informative or diagnostic of diseases states. Therefore, an important goal is to define informative interactions using cost-enabling, high accuracy, and robust genome-wide assays. To this end, ChIP-exo was developed to map the genomic binding locations of gene regulatory proteins at near-single base pair resolution. This assay will be applied, in high throughput, to determine the genome-wide positional organization of factors within protein-DNA complexes, like enhanceosomes. By broadly mapping the various classes of proteins that constitute much of the regulated epigenome, general rules about enhancer and repressor complex organization will be deduced. Aim 1 involves collecting genome-wide ChIP-exo data in human cell lines for a wide variety of protein-DNA complexes. Aim 2 will develop and implement computational approaches towards pattern recognition and data distillation in ChIP-exo datasets. The results are expected to provide structural insights into macromolecular protein complex assembly on a genomic scale, and in various cell types and conditions. Project Narrative Proteins that bind throughout the human genome control the genes that govern human health. Precise identification of the positional organization of these proteins within complexes will inform us as to the mechanics of their action, and mis-action when diseased. This project will provide that high-resolution view.",Genome-wide structural organization of proteins within human gene regulatory complexes,9691556,R01GM125722,"['Antibodies', 'Base Pairing', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Chromatin Remodeling Factor', 'Collection', 'Complex', 'DNA', 'DNA Polymerase II', 'DNA Sequence', 'DNA-Binding Proteins', 'DNA-protein crosslink', 'Data', 'Data Collection', 'Data Set', 'Detection', 'Development', 'Diagnostic', 'Disease', 'Enhancers', 'Event', 'Formaldehyde', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Genomics', 'Goals', 'Grain', 'Health', 'HepG2', 'Human', 'Human Cell Line', 'Human Genome', 'Individual', 'K-562', 'Libraries', 'Location', 'Machine Learning', 'Maps', 'Mechanics', 'Modeling', 'Multiprotein Complexes', 'Natural Language Processing', 'Nucleosomes', 'Pattern', 'Pattern Recognition', 'Physiological', 'Process', 'Production', 'Proteins', 'Protocols documentation', 'Publishing', 'RNA', 'Regulator Genes', 'Resolution', 'Robotics', 'Running', 'Sampling', 'Site', 'System', 'Tissues', 'Transcript', 'Uncertainty', 'billboard', 'cell type', 'chromatin immunoprecipitation', 'cost', 'cost efficient', 'crosslink', 'deep sequencing', 'design', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'human embryonic stem cell', 'human model', 'in vivo', 'insight', 'promoter', 'protein complex', 'protein profiling', 'recruit', 'response', 'spatial relationship', 'syntax', 'transcription factor']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2018,61750,0.11498126119139535
"Genome-wide structural organization of proteins within human gene regulatory complexes The DNA sequence of the human genome informs us as to the composition of proteins that make up healthy cells, but also altered compositions that create diseased cells. How protein production is controlled through the regulation of the genes that encode them is of critical importance for healthy and diseased cells. Knowing precisely where gene regulatory proteins bind, and are organized throughout the genome, including their interactions with each other, informs us as to how genes are regulated and mis-regulated. Since there are potentially thousands of different kinds of regulatory proteins and thousands of different kinds of human cell types and environmental responses that are a product of various subsets of regulatory proteins, the entire universe of gene regulatory events is quite substantial and consequently, quite costly to identify. A subset of these events will likely be informative or diagnostic of diseases states. Therefore, an important goal is to define informative interactions using cost-enabling, high accuracy, and robust genome-wide assays. To this end, ChIP-exo was developed to map the genomic binding locations of gene regulatory proteins at near-single base pair resolution. This assay will be applied, in high throughput, to determine the genome-wide positional organization of factors within protein-DNA complexes, like enhanceosomes. By broadly mapping the various classes of proteins that constitute much of the regulated epigenome, general rules about enhancer and repressor complex organization will be deduced. Aim 1 involves collecting genome-wide ChIP-exo data in human cell lines for a wide variety of protein-DNA complexes. Aim 2 will develop and implement computational approaches towards pattern recognition and data distillation in ChIP-exo datasets. The results are expected to provide structural insights into macromolecular protein complex assembly on a genomic scale, and in various cell types and conditions. Proteins that bind throughout the human genome control the genes that govern human health. Precise identification of the positional organization of these proteins within complexes will inform us as to the mechanics of their action, and mis-action when diseased. This project will provide that high-resolution view.",Genome-wide structural organization of proteins within human gene regulatory complexes,9423525,R01GM125722,"['Antibodies', 'Base Pairing', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Chromatin Remodeling Factor', 'Collection', 'Complex', 'DNA', 'DNA Polymerase II', 'DNA Sequence', 'DNA-Binding Proteins', 'DNA-protein crosslink', 'Data', 'Data Collection', 'Data Set', 'Detection', 'Development', 'Diagnostic', 'Disease', 'Enhancers', 'Event', 'Formaldehyde', 'Gene Expression Regulation', 'Gene Targeting', 'Genes', 'Genome', 'Genomics', 'Goals', 'Grain', 'Health', 'HepG2', 'Human', 'Human Cell Line', 'Human Genome', 'Individual', 'K-562', 'Libraries', 'Location', 'Machine Learning', 'Maps', 'Mechanics', 'Modeling', 'Multiprotein Complexes', 'Natural Language Processing', 'Nucleosomes', 'Pattern', 'Pattern Recognition', 'Physiological', 'Process', 'Production', 'Proteins', 'Protocols documentation', 'Publishing', 'RNA', 'Regulator Genes', 'Resolution', 'Robotics', 'Running', 'Sampling', 'Site', 'System', 'Tissues', 'Transcript', 'Uncertainty', 'billboard', 'cell type', 'chromatin immunoprecipitation', 'cost', 'cost efficient', 'crosslink', 'deep sequencing', 'design', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'human embryonic stem cell', 'human model', 'in vivo', 'insight', 'promoter', 'protein complex', 'protein profiling', 'recruit', 'response', 'spatial relationship', 'syntax', 'transcription factor']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2018,320584,0.11498126119139535
"Genome-wide structural organization of proteins within human gene regulatory complexes The DNA sequence of the human genome informs us as to the composition of proteins that make up healthy cells, but also altered compositions that create diseased cells. How protein production is controlled through the regulation of the genes that encode them is of critical importance for healthy and diseased cells. Knowing precisely where gene regulatory proteins bind, and are organized throughout the genome, including their interactions with each other, informs us as to how genes are regulated and mis-regulated. Since there are potentially thousands of different kinds of regulatory proteins and thousands of different kinds of human cell types and environmental responses that are a product of various subsets of regulatory proteins, the entire universe of gene regulatory events is quite substantial and consequently, quite costly to identify. A subset of these events will likely be informative or diagnostic of diseases states. Therefore, an important goal is to define informative interactions using cost-enabling, high accuracy, and robust genome-wide assays. To this end, ChIP-exo was developed to map the genomic binding locations of gene regulatory proteins at near-single base pair resolution. This assay will be applied, in high throughput, to determine the genome-wide positional organization of factors within protein-DNA complexes, like enhanceosomes. By broadly mapping the various classes of proteins that constitute much of the regulated epigenome, general rules about enhancer and repressor complex organization will be deduced. Aim 1 involves collecting genome-wide ChIP-exo data in human cell lines for a wide variety of protein-DNA complexes. Aim 2 will develop and implement computational approaches towards pattern recognition and data distillation in ChIP-exo datasets. The results are expected to provide structural insights into macromolecular protein complex assembly on a genomic scale, and in various cell types and conditions. Proteins that bind throughout the human genome control the genes that govern human health. Precise identification of the positional organization of these proteins within complexes will inform us as to the mechanics of their action, and mis-action when diseased. This project will provide that high-resolution view.",Genome-wide structural organization of proteins within human gene regulatory complexes,9840489,R01GM125722,"['Antibodies', 'Bar Codes', 'Base Pairing', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Chromatin Remodeling Factor', 'Collection', 'Complex', 'DNA', 'DNA Polymerase II', 'DNA Sequence', 'DNA-Binding Proteins', 'DNA-protein crosslink', 'Data', 'Data Collection', 'Data Set', 'Detection', 'Development', 'Diagnostic', 'Disease', 'Enhancers', 'Event', 'Formaldehyde', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Grain', 'Health', 'HepG2', 'Human', 'Human Cell Line', 'Human Genome', 'Individual', 'K-562', 'Libraries', 'Location', 'Machine Learning', 'Maps', 'Mechanics', 'Modeling', 'Multiprotein Complexes', 'Natural Language Processing', 'Nucleosomes', 'Pattern', 'Pattern Recognition', 'Physiological', 'Process', 'Production', 'Proteins', 'Protocols documentation', 'Publishing', 'RNA', 'Regulator Genes', 'Repressor Proteins', 'Resolution', 'Robotics', 'Running', 'Sampling', 'Site', 'Structure', 'System', 'Tissues', 'Transcript', 'Uncertainty', 'billboard', 'cell type', 'chromatin immunoprecipitation', 'cost', 'cost efficient', 'crosslink', 'deep sequencing', 'design', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'human embryonic stem cell', 'human model', 'in vivo', 'insight', 'organizational structure', 'promoter', 'protein complex', 'protein profiling', 'recruit', 'response', 'spatial relationship', 'syntax', 'transcription factor']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2020,319962,0.11498126119139535
"Genome-wide structural organization of proteins within human gene regulatory complexes The DNA sequence of the human genome informs us as to the composition of proteins that make up healthy cells, but also altered compositions that create diseased cells. How protein production is controlled through the regulation of the genes that encode them is of critical importance for healthy and diseased cells. Knowing precisely where gene regulatory proteins bind, and are organized throughout the genome, including their interactions with each other, informs us as to how genes are regulated and mis-regulated. Since there are potentially thousands of different kinds of regulatory proteins and thousands of different kinds of human cell types and environmental responses that are a product of various subsets of regulatory proteins, the entire universe of gene regulatory events is quite substantial and consequently, quite costly to identify. A subset of these events will likely be informative or diagnostic of diseases states. Therefore, an important goal is to define informative interactions using cost-enabling, high accuracy, and robust genome-wide assays. To this end, ChIP-exo was developed to map the genomic binding locations of gene regulatory proteins at near-single base pair resolution. This assay will be applied, in high throughput, to determine the genome-wide positional organization of factors within protein-DNA complexes, like enhanceosomes. By broadly mapping the various classes of proteins that constitute much of the regulated epigenome, general rules about enhancer and repressor complex organization will be deduced. Aim 1 involves collecting genome-wide ChIP-exo data in human cell lines for a wide variety of protein-DNA complexes. Aim 2 will develop and implement computational approaches towards pattern recognition and data distillation in ChIP-exo datasets. The results are expected to provide structural insights into macromolecular protein complex assembly on a genomic scale, and in various cell types and conditions. Proteins that bind throughout the human genome control the genes that govern human health. Precise identification of the positional organization of these proteins within complexes will inform us as to the mechanics of their action, and mis-action when diseased. This project will provide that high-resolution view.",Genome-wide structural organization of proteins within human gene regulatory complexes,9626931,R01GM125722,"['Antibodies', 'Base Pairing', 'Binding', 'Binding Proteins', 'Binding Sites', 'Biological Assay', 'Cell Line', 'Cells', 'Chromatin', 'Chromatin Remodeling Factor', 'Collection', 'Complex', 'DNA', 'DNA Polymerase II', 'DNA Sequence', 'DNA-Binding Proteins', 'DNA-protein crosslink', 'Data', 'Data Collection', 'Data Set', 'Detection', 'Development', 'Diagnostic', 'Disease', 'Enhancers', 'Event', 'Formaldehyde', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genomics', 'Goals', 'Grain', 'Health', 'HepG2', 'Human', 'Human Cell Line', 'Human Genome', 'Individual', 'K-562', 'Libraries', 'Location', 'Machine Learning', 'Maps', 'Mechanics', 'Modeling', 'Multiprotein Complexes', 'Natural Language Processing', 'Nucleosomes', 'Pattern', 'Pattern Recognition', 'Physiological', 'Process', 'Production', 'Proteins', 'Protocols documentation', 'Publishing', 'RNA', 'Regulator Genes', 'Resolution', 'Robotics', 'Running', 'Sampling', 'Site', 'Structure', 'System', 'Tissues', 'Transcript', 'Uncertainty', 'billboard', 'cell type', 'chromatin immunoprecipitation', 'cost', 'cost efficient', 'crosslink', 'deep sequencing', 'design', 'epigenome', 'experimental study', 'genetic regulatory protein', 'genome-wide', 'human embryonic stem cell', 'human model', 'in vivo', 'insight', 'organizational structure', 'promoter', 'protein complex', 'protein profiling', 'recruit', 'response', 'spatial relationship', 'syntax', 'transcription factor']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2019,320279,0.11498126119139535
"Modeling gene expression in yeast using large degenerate libraries PROJECT SUMMARY Short sequence elements in DNA and RNA determine the levels and composition of mRNAs and proteins, making it critical that we can accurately model how any given sequence will affect transcription, splicing or translation. Such models of cis-regulation will fill in gaps in our knowledge of these core gene expression processes. Additionally, as large numbers of human genomes are sequenced, the ability to predict the effects of sequence variation on the ultimate levels of proteins will be integral to the interpretation of variation in regulatory sequences. Similarly, the construction of metabolic pathways with defined levels of expression and the engineering of synthetic gene networks require accurate knowledge of how regulatory sequences affect expression. This application seeks to use the yeast Saccharomyces cerevisiae as a test case for learning how any short regulatory sequence affects protein levels. A predictive model will be trained on a set of libraries two orders of magnitude more complex than have been characterized to date. Libraries will be generated of a growth reporter gene with a million random sequences of 50 nucleotides that comprise either a DNA element that regulates transcription or an RNA element that regulates splicing or translation. The libraries will be transformed into yeast, and the yeast will be placed under selection such that they grow according to the ability of each random sequence to contribute to protein expression. A convolution neural network approach will be used to learn the relationship between these fitness phenotypes and their associated genotypes. Although yeast is a single-celled eukaryote, it has been the source of most of the original findings on gene expression, and these findings form the basis for much of our knowledge of more complex eukaryotes. Furthermore, the short sequences in yeast that comprise the DNA- and RNA-binding sites of regulatory proteins tend to be comparable in size to those of other organisms. Yeast is used often in synthetic biology and metabolic engineering, and the work proposed here will result in novel tools for quantitatively controlling its gene expression. Initial results with a library of 5' untranslated regions (UTRs) indicate that we can construct a model to account for a large fraction of the observed variability in expression, and that the model extends to native sequence elements. The model allowed us to forward engineer 5' UTRs to have increased activity. Specific aims of this application are to assess the effects of random sequences targeted to upstream regulatory elements, core promoter elements, 5' UTRs, introns and 3' UTRs; to learn predictive and interpretable models using convolutional neural networks and to identify novel functional cis-regulatory elements; and to validate our models on native sequences and combinatorial libraries, and by engineering synthetic sequence elements with user-specified properties. In sum, the proposal seeks to construct a comprehensive and predictive model of regulatory sequencefunction relationships for a well-studied single- celled eukaryote, providing a basis for similar studies on other organisms. PROJECT NARRATIVE This research seeks to generate a model for how regulatory sequences present in the genome of a simple organism affect the expression of a protein. These studies will be important for ultimately understanding the consequences of genetic variation in humans and how this variation can lead to disease. The results will also improve the ability to engineer metabolic pathways to produce a protein, chemical, drug or other compound.",Modeling gene expression in yeast using large degenerate libraries,9422149,R01GM125809,"['3&apos', ' Untranslated Regions', '5&apos', ' Untranslated Regions', 'Affect', 'Alternative Splicing', 'Binding Sites', 'Biological', 'Biological Assay', 'Biological Neural Networks', 'Biology', 'Cells', 'Chemicals', 'Complex', 'Computer Simulation', 'DNA', 'DNA Binding', 'Data', 'Data Set', 'Disease', 'Elements', 'Engineering', 'Ensure', 'Eukaryota', 'Gene Expression', 'Gene Expression Process', 'Gene Library', 'Genes', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genome engineering', 'Genotype', 'Growth', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Introns', 'Investigation', 'Knowledge', 'Lead', 'Learning', 'Libraries', 'Messenger RNA', 'Metabolic Pathway', 'Modeling', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Organism', 'Pharmaceutical Preparations', 'Phenotype', 'Process', 'Property', 'Proteins', 'RNA', 'RNA Binding', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Reporter Genes', 'Research', 'Saccharomyces cerevisiae', 'Source', 'Specific qualifier value', 'Sum', 'Synthetic Genes', 'Testing', 'Training', 'Translating', 'Translations', 'Untranslated RNA', 'Untranslated Regions', 'Validation', 'Variant', 'Work', 'Yeasts', 'base', 'combinatorial', 'deep learning', 'design', 'fitness', 'genetic regulatory protein', 'human disease', 'improved', 'member', 'metabolic engineering', 'next generation sequencing', 'novel', 'novel sequencing technology', 'predictive modeling', 'promoter', 'protein expression', 'scale up', 'synthetic biology', 'tool']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2018,372737,0.0883510550293178
"Modeling gene expression in yeast using large degenerate libraries PROJECT SUMMARY Short sequence elements in DNA and RNA determine the levels and composition of mRNAs and proteins, making it critical that we can accurately model how any given sequence will affect transcription, splicing or translation. Such models of cis-regulation will fill in gaps in our knowledge of these core gene expression processes. Additionally, as large numbers of human genomes are sequenced, the ability to predict the effects of sequence variation on the ultimate levels of proteins will be integral to the interpretation of variation in regulatory sequences. Similarly, the construction of metabolic pathways with defined levels of expression and the engineering of synthetic gene networks require accurate knowledge of how regulatory sequences affect expression. This application seeks to use the yeast Saccharomyces cerevisiae as a test case for learning how any short regulatory sequence affects protein levels. A predictive model will be trained on a set of libraries two orders of magnitude more complex than have been characterized to date. Libraries will be generated of a growth reporter gene with a million random sequences of 50 nucleotides that comprise either a DNA element that regulates transcription or an RNA element that regulates splicing or translation. The libraries will be transformed into yeast, and the yeast will be placed under selection such that they grow according to the ability of each random sequence to contribute to protein expression. A convolution neural network approach will be used to learn the relationship between these fitness phenotypes and their associated genotypes. Although yeast is a single-celled eukaryote, it has been the source of most of the original findings on gene expression, and these findings form the basis for much of our knowledge of more complex eukaryotes. Furthermore, the short sequences in yeast that comprise the DNA- and RNA-binding sites of regulatory proteins tend to be comparable in size to those of other organisms. Yeast is used often in synthetic biology and metabolic engineering, and the work proposed here will result in novel tools for quantitatively controlling its gene expression. Initial results with a library of 5' untranslated regions (UTRs) indicate that we can construct a model to account for a large fraction of the observed variability in expression, and that the model extends to native sequence elements. The model allowed us to forward engineer 5' UTRs to have increased activity. Specific aims of this application are to assess the effects of random sequences targeted to upstream regulatory elements, core promoter elements, 5' UTRs, introns and 3' UTRs; to learn predictive and interpretable models using convolutional neural networks and to identify novel functional cis-regulatory elements; and to validate our models on native sequences and combinatorial libraries, and by engineering synthetic sequence elements with user-specified properties. In sum, the proposal seeks to construct a comprehensive and predictive model of regulatory sequencefunction relationships for a well-studied single- celled eukaryote, providing a basis for similar studies on other organisms. PROJECT NARRATIVE This research seeks to generate a model for how regulatory sequences present in the genome of a simple organism affect the expression of a protein. These studies will be important for ultimately understanding the consequences of genetic variation in humans and how this variation can lead to disease. The results will also improve the ability to engineer metabolic pathways to produce a protein, chemical, drug or other compound.",Modeling gene expression in yeast using large degenerate libraries,9929602,R01GM125809,"['3&apos', ' Untranslated Regions', '5&apos', ' Untranslated Regions', 'Affect', 'Alternative Splicing', 'Binding Sites', 'Biological', 'Biological Assay', 'Biology', 'Cells', 'Chemicals', 'Complex', 'Computer Models', 'DNA', 'DNA Binding', 'Data', 'Data Set', 'Disease', 'Elements', 'Engineering', 'Ensure', 'Eukaryota', 'Gene Expression', 'Gene Expression Process', 'Gene Library', 'Genes', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genome engineering', 'Genotype', 'Growth', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Introns', 'Investigation', 'Knowledge', 'Lead', 'Learning', 'Libraries', 'Messenger RNA', 'Metabolic Pathway', 'Modeling', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Organism', 'Pharmaceutical Preparations', 'Phenotype', 'Process', 'Property', 'Proteins', 'RNA', 'RNA Binding', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Reporter Genes', 'Research', 'Saccharomyces cerevisiae', 'Source', 'Specific qualifier value', 'Sum', 'Synthetic Genes', 'Testing', 'Training', 'Translating', 'Translations', 'Untranslated RNA', 'Untranslated Regions', 'Validation', 'Variant', 'Work', 'Yeasts', 'base', 'combinatorial', 'convolutional neural network', 'deep learning', 'design', 'fitness', 'genetic regulatory protein', 'human disease', 'improved', 'member', 'metabolic engineering', 'next generation sequencing', 'novel', 'novel sequencing technology', 'predictive modeling', 'promoter', 'protein expression', 'scale up', 'synthetic biology', 'tool']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2020,347304,0.0883510550293178
"Modeling gene expression in yeast using large degenerate libraries PROJECT SUMMARY Short sequence elements in DNA and RNA determine the levels and composition of mRNAs and proteins, making it critical that we can accurately model how any given sequence will affect transcription, splicing or translation. Such models of cis-regulation will fill in gaps in our knowledge of these core gene expression processes. Additionally, as large numbers of human genomes are sequenced, the ability to predict the effects of sequence variation on the ultimate levels of proteins will be integral to the interpretation of variation in regulatory sequences. Similarly, the construction of metabolic pathways with defined levels of expression and the engineering of synthetic gene networks require accurate knowledge of how regulatory sequences affect expression. This application seeks to use the yeast Saccharomyces cerevisiae as a test case for learning how any short regulatory sequence affects protein levels. A predictive model will be trained on a set of libraries two orders of magnitude more complex than have been characterized to date. Libraries will be generated of a growth reporter gene with a million random sequences of 50 nucleotides that comprise either a DNA element that regulates transcription or an RNA element that regulates splicing or translation. The libraries will be transformed into yeast, and the yeast will be placed under selection such that they grow according to the ability of each random sequence to contribute to protein expression. A convolution neural network approach will be used to learn the relationship between these fitness phenotypes and their associated genotypes. Although yeast is a single-celled eukaryote, it has been the source of most of the original findings on gene expression, and these findings form the basis for much of our knowledge of more complex eukaryotes. Furthermore, the short sequences in yeast that comprise the DNA- and RNA-binding sites of regulatory proteins tend to be comparable in size to those of other organisms. Yeast is used often in synthetic biology and metabolic engineering, and the work proposed here will result in novel tools for quantitatively controlling its gene expression. Initial results with a library of 5' untranslated regions (UTRs) indicate that we can construct a model to account for a large fraction of the observed variability in expression, and that the model extends to native sequence elements. The model allowed us to forward engineer 5' UTRs to have increased activity. Specific aims of this application are to assess the effects of random sequences targeted to upstream regulatory elements, core promoter elements, 5' UTRs, introns and 3' UTRs; to learn predictive and interpretable models using convolutional neural networks and to identify novel functional cis-regulatory elements; and to validate our models on native sequences and combinatorial libraries, and by engineering synthetic sequence elements with user-specified properties. In sum, the proposal seeks to construct a comprehensive and predictive model of regulatory sequencefunction relationships for a well-studied single- celled eukaryote, providing a basis for similar studies on other organisms. PROJECT NARRATIVE This research seeks to generate a model for how regulatory sequences present in the genome of a simple organism affect the expression of a protein. These studies will be important for ultimately understanding the consequences of genetic variation in humans and how this variation can lead to disease. The results will also improve the ability to engineer metabolic pathways to produce a protein, chemical, drug or other compound.",Modeling gene expression in yeast using large degenerate libraries,9747320,R01GM125809,"['3&apos', ' Untranslated Regions', '5&apos', ' Untranslated Regions', 'Affect', 'Alternative Splicing', 'Binding Sites', 'Biological', 'Biological Assay', 'Biology', 'Cells', 'Chemicals', 'Complex', 'Computer Simulation', 'DNA', 'DNA Binding', 'Data', 'Data Set', 'Disease', 'Elements', 'Engineering', 'Ensure', 'Eukaryota', 'Gene Expression', 'Gene Expression Process', 'Gene Library', 'Genes', 'Genetic Transcription', 'Genetic Variation', 'Genome', 'Genome engineering', 'Genotype', 'Growth', 'Human', 'Human Genetics', 'Human Genome', 'Individual', 'Introns', 'Investigation', 'Knowledge', 'Lead', 'Learning', 'Libraries', 'Messenger RNA', 'Metabolic Pathway', 'Modeling', 'Mutation', 'Nucleic Acid Regulatory Sequences', 'Nucleotides', 'Organism', 'Pharmaceutical Preparations', 'Phenotype', 'Process', 'Property', 'Proteins', 'RNA', 'RNA Binding', 'RNA Splicing', 'RNA-Binding Proteins', 'Regulation', 'Regulatory Element', 'Reporter Genes', 'Research', 'Saccharomyces cerevisiae', 'Source', 'Specific qualifier value', 'Sum', 'Synthetic Genes', 'Testing', 'Training', 'Translating', 'Translations', 'Untranslated RNA', 'Untranslated Regions', 'Validation', 'Variant', 'Work', 'Yeasts', 'base', 'combinatorial', 'convolutional neural network', 'deep learning', 'design', 'fitness', 'genetic regulatory protein', 'human disease', 'improved', 'member', 'metabolic engineering', 'next generation sequencing', 'novel', 'novel sequencing technology', 'predictive modeling', 'promoter', 'protein expression', 'scale up', 'synthetic biology', 'tool']",NIGMS,UNIVERSITY OF WASHINGTON,R01,2019,374550,0.0883510550293178
"New Computational Systems Biology Methods for Modeling Gene Regulatory Circuits PROJECTSUMMARY/ABSTRACT  Cellularstatetransitions(i.e.frompluripotenttocommitted,replicativetoquiescent,etc.)requirethe coordinatedregulationofthousandsofgenes.Therapeuticallyharnessingthesetransitionsholdsgreat promiseforhumanhealth;forinstance,autologousstemcelltherapyhasbeensuccessfullyusedin regenerativemedicineandcancertreatments,amongothers.Whilesomeofthekeyregulatoryswitchesare known,thefieldlacksasystems-levelunderstandingofthegenomiccircuitsthatcontrolthesetransitions, informationthatiscriticalforinformedclinicalintervention.Here,wewilldevelopanintegratedcomputational frameworktoidentifycoregeneregulatorycircuitsfromlargegenenetworksandpredicttheirdynamicsand regulatoryfunctionswithouttheneedofdetailednetworkkineticparameters.Advancesingenomicsprofiling technologyhaveenabledthemappingofgeneregulatorynetworks,thuswenowhavethecapacitytoidentify combinatorialinteractionsamonggenesandthemasterregulatorsofstatetransitions.Somesystemsbiology approacheshavesimulatedthedynamicsofageneregulatorycircuit,buttraditionalmethodssufferfromtwo keyissues.First,thereisnorationalruletochooseanappropriatesetofregulatorgenesinalargenetworkto model.Second,sinceitishardtodirectlymeasuremostnetworkkineticparametersfromexperiment, modelingresultsarebasedonasetofguessedparametersthatcanbelessthanoptimal,limitingthe applicationofmathematicalmodelingtolargesystemsandthepredictionpowerofsystemsbiology.To addresstheseissues,werecentlydevelopedalgorithmnamedrandomcircuitperturbation(RACIPE).RACIPE generatesanensembleofcircuitmodels,eachofwhichcorrespondstoadistinctsetofrandomkinetic parameters,anduniquelyidentifiesrobustfeatures,suchasclustersofstablegeneexpressionstates,by statisticalanalysis.WewillfurtherenhanceRACIPEalgorithmsforlargesystemsandnewdataanalysistools usingmachinelearning.Thisapproachwillconvertatraditionalnonlineardynamicsproblemintoadata analysisproblem,anessentialstepforextendingtheapplicationofgenecircuitmodelingtolargesystems.It alsoprovidesanovelstrategytointegratetop-downgenomicsapproacheswithbottom-upmathematical modeling.Thealgorithmswillbetestedandrefinedusingliterature-basedgenenetworks,publicgenomics data,anddatafromcollaboration,withafocusoncelldifferentiationindevelopmentalprocessesandstate transitionsinoncogenesis.Successoftheprojectwillresultinacomprehensivetoolkitthatwillunveilthegene regulatorymechanismofcellulardecision-makinginanycellofinterest.Thealgorithmicdevelopmentis  expectedtohaveabroadimpactonnotonlybasicresearchinsystemsbiologybutalsoshedlighton therapeuticinterventioningenomicmedicine.   RELEVANCETOPUBLICHEALTH Mosthumancomplexdiseasesaremultigenic,butourunderstandingoftheinteractionsbetweengenesin healthystatesandhowtheyaredisruptedindiseasestatesislacking.Computationalalgorithmswillbe designedtoconstructandmodelgeneregulatorycircuitsofhighercomplexitytofillanimportantgapinour understandingofthemaintenanceandtransitionsamongcellularstatesandtheirabnormalbehaviorin disease.Inthisproposal,wewilldevelopasuiteofsystems-biologytoolstoextendgenecircuitmodelingto largesystemsandintegrategenomicsdatarelevanttofundamentalcellbiology,cancer,andotherhuman diseases. ",New Computational Systems Biology Methods for Modeling Gene Regulatory Circuits,10246751,R35GM128717,"['Address', 'Algorithms', 'Autologous', 'Basic Science', 'Behavior', 'Cell Differentiation process', 'Cells', 'Cellular biology', 'Chromosome Mapping', 'Clinical', 'Collaborations', 'Complex', 'Computational algorithm', 'Data', 'Data Analyses', 'Decision Making', 'Developmental Process', 'Disease', 'Gene Expression', 'Genes', 'Genomic approach', 'Genomic medicine', 'Genomics', 'Health', 'Human', 'Intervention', 'Kinetics', 'Light', 'Literature', 'Machine Learning', 'Maintenance', 'Malignant Neoplasms', 'Measures', 'Methods', 'Modeling', 'Names', 'Nonlinear Dynamics', 'Public Health', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Statistical Data Interpretation', 'System', 'Systems Biology', 'Technology', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'algorithm development', 'base', 'cancer therapy', 'combinatorial', 'computer framework', 'design', 'experimental study', 'genomic data', 'genomic profiles', 'human disease', 'interest', 'mathematical model', 'novel strategies', 'stem cell therapy', 'success', 'tool', 'tumorigenesis']",NIGMS,NORTHEASTERN UNIVERSITY,R35,2020,392500,0.043117351852742826
"New Computational Systems Biology Methods for Modeling Gene Regulatory Circuits PROJECTSUMMARY/ABSTRACT  Cellularstatetransitions(i.e.frompluripotenttocommitted,replicativetoquiescent,etc.)requirethe coordinatedregulationofthousandsofgenes.Therapeuticallyharnessingthesetransitionsholdsgreat promiseforhumanhealth;forinstance,autologousstemcelltherapyhasbeensuccessfullyusedin regenerativemedicineandcancertreatments,amongothers.Whilesomeofthekeyregulatoryswitchesare known,thefieldlacksasystems-levelunderstandingofthegenomiccircuitsthatcontrolthesetransitions, informationthatiscriticalforinformedclinicalintervention.Here,wewilldevelopanintegratedcomputational frameworktoidentifycoregeneregulatorycircuitsfromlargegenenetworksandpredicttheirdynamicsand regulatoryfunctionswithouttheneedofdetailednetworkkineticparameters.Advancesingenomicsprofiling technologyhaveenabledthemappingofgeneregulatorynetworks,thuswenowhavethecapacitytoidentify combinatorialinteractionsamonggenesandthemasterregulatorsofstatetransitions.Somesystemsbiology approacheshavesimulatedthedynamicsofageneregulatorycircuit,buttraditionalmethodssufferfromtwo keyissues.First,thereisnorationalruletochooseanappropriatesetofregulatorgenesinalargenetworkto model.Second,sinceitishardtodirectlymeasuremostnetworkkineticparametersfromexperiment, modelingresultsarebasedonasetofguessedparametersthatcanbelessthanoptimal,limitingthe applicationofmathematicalmodelingtolargesystemsandthepredictionpowerofsystemsbiology.To addresstheseissues,werecentlydevelopedalgorithmnamedrandomcircuitperturbation(RACIPE).RACIPE generatesanensembleofcircuitmodels,eachofwhichcorrespondstoadistinctsetofrandomkinetic parameters,anduniquelyidentifiesrobustfeatures,suchasclustersofstablegeneexpressionstates,by statisticalanalysis.WewillfurtherenhanceRACIPEalgorithmsforlargesystemsandnewdataanalysistools usingmachinelearning.Thisapproachwillconvertatraditionalnonlineardynamicsproblemintoadata analysisproblem,anessentialstepforextendingtheapplicationofgenecircuitmodelingtolargesystems.It alsoprovidesanovelstrategytointegratetop-downgenomicsapproacheswithbottom-upmathematical modeling.Thealgorithmswillbetestedandrefinedusingliterature-basedgenenetworks,publicgenomics data,anddatafromcollaboration,withafocusoncelldifferentiationindevelopmentalprocessesandstate transitionsinoncogenesis.Successoftheprojectwillresultinacomprehensivetoolkitthatwillunveilthegene regulatorymechanismofcellulardecision-makinginanycellofinterest.Thealgorithmicdevelopmentis  expectedtohaveabroadimpactonnotonlybasicresearchinsystemsbiologybutalsoshedlighton therapeuticinterventioningenomicmedicine.   RELEVANCETOPUBLICHEALTH Mosthumancomplexdiseasesaremultigenic,butourunderstandingoftheinteractionsbetweengenesin healthystatesandhowtheyaredisruptedindiseasestatesislacking.Computationalalgorithmswillbe designedtoconstructandmodelgeneregulatorycircuitsofhighercomplexitytofillanimportantgapinour understandingofthemaintenanceandtransitionsamongcellularstatesandtheirabnormalbehaviorin disease.Inthisproposal,wewilldevelopasuiteofsystems-biologytoolstoextendgenecircuitmodelingto largesystemsandintegrategenomicsdatarelevanttofundamentalcellbiology,cancer,andotherhuman diseases. ",New Computational Systems Biology Methods for Modeling Gene Regulatory Circuits,9752643,R35GM128717,"['Address', 'Algorithms', 'Autologous', 'Basic Science', 'Behavior', 'Cell Differentiation process', 'Cells', 'Cellular biology', 'Chromosome Mapping', 'Clinical', 'Collaborations', 'Complex', 'Computational algorithm', 'Data', 'Data Analyses', 'Decision Making', 'Development', 'Developmental Process', 'Disease', 'Gene Expression', 'Genes', 'Genomic approach', 'Genomic medicine', 'Genomics', 'Health', 'Human', 'Intervention', 'Kinetics', 'Light', 'Literature', 'Machine Learning', 'Maintenance', 'Malignant Neoplasms', 'Measures', 'Methods', 'Modeling', 'Names', 'Nonlinear Dynamics', 'Public Health', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Statistical Data Interpretation', 'System', 'Systems Biology', 'Technology', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'base', 'cancer therapy', 'combinatorial', 'computer framework', 'design', 'experimental study', 'genomic data', 'genomic profiles', 'human disease', 'interest', 'mathematical model', 'novel strategies', 'stem cell therapy', 'success', 'tool', 'tumorigenesis']",NIGMS,JACKSON LABORATORY,R35,2019,437500,0.043117351852742826
"New Computational Systems Biology Methods for Modeling Gene Regulatory Circuits PROJECTSUMMARY/ABSTRACT  Cellularstatetransitions(i.e.frompluripotenttocommitted,replicativetoquiescent,etc.)requirethe coordinatedregulationofthousandsofgenes.Therapeuticallyharnessingthesetransitionsholdsgreat promiseforhumanhealth;forinstance,autologousstemcelltherapyhasbeensuccessfullyusedin regenerativemedicineandcancertreatments,amongothers.Whilesomeofthekeyregulatoryswitchesare known,thefieldlacksasystems-levelunderstandingofthegenomiccircuitsthatcontrolthesetransitions, informationthatiscriticalforinformedclinicalintervention.Here,wewilldevelopanintegratedcomputational frameworktoidentifycoregeneregulatorycircuitsfromlargegenenetworksandpredicttheirdynamicsand regulatoryfunctionswithouttheneedofdetailednetworkkineticparameters.Advancesingenomicsprofiling technologyhaveenabledthemappingofgeneregulatorynetworks,thuswenowhavethecapacitytoidentify combinatorialinteractionsamonggenesandthemasterregulatorsofstatetransitions.Somesystemsbiology approacheshavesimulatedthedynamicsofageneregulatorycircuit,buttraditionalmethodssufferfromtwo keyissues.First,thereisnorationalruletochooseanappropriatesetofregulatorgenesinalargenetworkto model.Second,sinceitishardtodirectlymeasuremostnetworkkineticparametersfromexperiment, modelingresultsarebasedonasetofguessedparametersthatcanbelessthanoptimal,limitingthe applicationofmathematicalmodelingtolargesystemsandthepredictionpowerofsystemsbiology.To addresstheseissues,werecentlydevelopedalgorithmnamedrandomcircuitperturbation(RACIPE).RACIPE generatesanensembleofcircuitmodels,eachofwhichcorrespondstoadistinctsetofrandomkinetic parameters,anduniquelyidentifiesrobustfeatures,suchasclustersofstablegeneexpressionstates,by statisticalanalysis.WewillfurtherenhanceRACIPEalgorithmsforlargesystemsandnewdataanalysistools usingmachinelearning.Thisapproachwillconvertatraditionalnonlineardynamicsproblemintoadata analysisproblem,anessentialstepforextendingtheapplicationofgenecircuitmodelingtolargesystems.It alsoprovidesanovelstrategytointegratetop-downgenomicsapproacheswithbottom-upmathematical modeling.Thealgorithmswillbetestedandrefinedusingliterature-basedgenenetworks,publicgenomics data,anddatafromcollaboration,withafocusoncelldifferentiationindevelopmentalprocessesandstate transitionsinoncogenesis.Successoftheprojectwillresultinacomprehensivetoolkitthatwillunveilthegene regulatorymechanismofcellulardecision-makinginanycellofinterest.Thealgorithmicdevelopmentis  expectedtohaveabroadimpactonnotonlybasicresearchinsystemsbiologybutalsoshedlighton therapeuticinterventioningenomicmedicine.   RELEVANCETOPUBLICHEALTH Mosthumancomplexdiseasesaremultigenic,butourunderstandingoftheinteractionsbetweengenesin healthystatesandhowtheyaredisruptedindiseasestatesislacking.Computationalalgorithmswillbe designedtoconstructandmodelgeneregulatorycircuitsofhighercomplexitytofillanimportantgapinour understandingofthemaintenanceandtransitionsamongcellularstatesandtheirabnormalbehaviorin disease.Inthisproposal,wewilldevelopasuiteofsystems-biologytoolstoextendgenecircuitmodelingto largesystemsandintegrategenomicsdatarelevanttofundamentalcellbiology,cancer,andotherhuman diseases. ",New Computational Systems Biology Methods for Modeling Gene Regulatory Circuits,9574761,R35GM128717,"['Address', 'Algorithms', 'Autologous', 'Basic Science', 'Behavior', 'Cell Differentiation process', 'Cells', 'Cellular biology', 'Chromosome Mapping', 'Clinical', 'Collaborations', 'Complex', 'Computational algorithm', 'Data', 'Data Analyses', 'Decision Making', 'Development', 'Developmental Process', 'Disease', 'Gene Expression', 'Genes', 'Genomic approach', 'Genomic medicine', 'Genomics', 'Health', 'Human', 'Intervention', 'Kinetics', 'Light', 'Literature', 'Machine Learning', 'Maintenance', 'Malignant Neoplasms', 'Measures', 'Methods', 'Modeling', 'Names', 'Nonlinear Dynamics', 'Public Health', 'Regenerative Medicine', 'Regulation', 'Regulator Genes', 'Statistical Data Interpretation', 'System', 'Systems Biology', 'Technology', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'base', 'cancer therapy', 'combinatorial', 'computer framework', 'design', 'experimental study', 'genomic data', 'genomic profiles', 'human disease', 'interest', 'mathematical model', 'novel strategies', 'stem cell therapy', 'success', 'tool', 'tumorigenesis']",NIGMS,JACKSON LABORATORY,R35,2018,437500,0.043117351852742826
"Discovery of diabetes-relevant  cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens ABSTRACT  Enhancers are essential regulatory elements that together with transcription factors (TFs) instruct cell- type specific transcriptional programs during development, tissue homeostasis and regeneration. Initiatives such as the ENCODE project, revealed tens of thousands putative enhancers based on linear proximity, using criteria like chromatin accessibility, TF binding, and histone modifications such as H3K27ac. However, a main challenge of uncovering functional enhancers and assigning them to target genes lies in the complexity of the 3D chromatin organization, which can influence enhancer specificity and activity. Using an advanced chromosome conformation capture assay, we recently captured the dynamic rewiring of 3D enhancer networks during mouse somatic cell reprogramming and discovered multi-connected enhancers that we named 3D enhancer hubs. Here we extend the 3D mapping approach to human primary islets, and compare islets from healthy and type 2 diabetes (T2D) donors to assemble a 4D atlas to capture the rewiring of 3D enhancer network in disease progression. At the same time, we plan to compare the enhancer network in adult islets to earlier stages of development by using human pluripotent stem cells (hPSCs) to generate early  cells and their developmental precursors. Utilizing these 4D genomic data, we will computationally nominate core -cell specific enhancers relevant to  cell development, function, and T2D, and then interrogate these putative enhancers through large-scale CRISPRi mediated perturbation screens using hPSC- cells. Enhancers identified from the screening effort will be further validated in an established human  cell line and primary human islet  cells. This proposal addresses a critical gap in the 4DN initiative, that is how to translate 3D genomics data into functional data with respect to gene expression in the context of human health. Successful completion of our aims will establish a paradigm for the discovery and interrogation of functional enhancers that instruct transcriptional programs specific to a cell type of interest, reveal unique insights into their mechanisms of action, and identify enhancers with relevance to human development and disease. For instance, uncovering functional enhancers could assist the identification of noncoding causal variants identified in genome-wide association studies. PROJECT NARRATIVE (RELEVANCE)  This project will take an integrative approach involving generating a 4D atlas of regulatory interactions during both development and disease progressions, computationally nominating diabetes-relevant  cell enhancers through integrative analysis and discovering functional enhancers through large-scale perturbation screens. Knowledge gained from the study will provide a conceptual framework for dissecting gene regulatory networks that instruct the  cell fate and function during development and in diabetic conditions.","Discovery of diabetes-relevant  cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens",10117708,U01DK128852,"['3-Dimensional', 'ATAC-seq', 'Address', 'Adult', 'Affect', 'Atlases', 'B-Cell Development', 'Beta Cell', 'Binding', 'Biological Assay', 'Biology', 'CRISPR interference', 'Cell Line', 'Cells', 'Chromatin', 'Clinical Data', 'Complex', 'Computational Biology', 'Computing Methodologies', 'Data', 'Development', 'Diabetes Mellitus', 'Disease', 'Disease Progression', 'Embryonic Development', 'Enhancers', 'Ensure', 'Gene Expression', 'Genes', 'Genetic Transcription', 'Genome', 'Genomic approach', 'Genomics', 'Goals', 'Health', 'Homeostasis', 'Human', 'Human Development', 'Human Genetics', 'Islet Cell', 'Islets of Langerhans', 'Knowledge', 'Link', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Mediating', 'Modeling', 'Mus', 'Mutation', 'Names', 'Natural regeneration', 'Non-Insulin-Dependent Diabetes Mellitus', 'Nucleic Acid Regulatory Sequences', 'Pathogenicity', 'Pathologic', 'Population', 'Publishing', 'Regulator Genes', 'Regulatory Element', 'Research Personnel', 'Resolution', 'Somatic Cell', 'Specificity', 'Time', 'Tissues', 'Translating', 'Untranslated RNA', 'Update', 'Validation', 'Variant', 'Work', 'base', 'causal variant', 'cell type', 'chromatin immunoprecipitation', 'chromosome conformation capture', 'clinical application', 'diabetes pathogenesis', 'diabetic', 'gene function', 'genome wide association study', 'genomic data', 'histone modification', 'human disease', 'human pluripotent stem cell', 'improved', 'innovation', 'insight', 'interest', 'islet', 'multidisciplinary', 'novel', 'precursor cell', 'programs', 'promoter', 'screening', 'tool', 'transcription factor']",NIDDK,SLOAN-KETTERING INST CAN RESEARCH,U01,2020,717356,0.058420251435013656
"Defining interaction quantitative trait loci (iQTLs) in the human genome Abstract My research aims to understand the role of three-dimensional (3D) chromatin structure in gene regulation. This involves studying associations among genotype, histone modifications, transcription factor binding, non-coding RNAs, chromatin interactions and gene expression. In order to transform this genome-wide information into new biological discoveries, my laboratory develops scalable and interpretable computational methods based on statistics, graph theory and machine learning. Our recent focus is to address an important gap in the current knowledge of the role of 3D chromatin structure in gene regulation. That is, we aim to define how genotypic variation affects 3D organization of gene promoters, and in turn, their expression. To achieve this at a genome- wide scale is an ambitious goal, because it requires having at a minimum, genotype, gene expression and chromatin interaction profiles in pure populations of specific cell types from a large number of donors. However, my laboratory is uniquely positioned to perform this research because: i) we are involved in a study at the La Jolla Institute (LJI-R24AI108564) that has already genotyped ~100 donors and expression-profiled more than 15 different pure populations of human immune cell types, and we have access to the same samples for chromatin interaction mapping, ii) in collaboration with other groups at LJI, we have already discovered a prototypical example of an interaction quantitative trait locus (iQTL) that alters and rewires interactions from the promoter of a specific gene that is associated with asthma susceptibility, iii) we have the necessary expertise and proven track record in experimental design and computational analyses of various chromatin conformation capture assays. Leveraging the resources available at LJI and our expertise in the field, we will build a unique research program around the novel concept of iQTLs. The emerging set of three main questions we propose to address within the next five years are: Q1) How do we define cell-type-specific iQTLs for common genetic variants? Q2) What is the extent of overlap between iQTLs and GWAS SNPs? Q3) Can we build predictive models for the cell-type specificity of chromatin interactions and iQTLs? Although we propose to define iQTLs only in two abundant, easily accessible, and highly disease-relevant immune cell types, the concept of iQTLs is equally important in other cell types implicated in diseases with a genetic component. Hence, the proof-of-concept developed by this work, without a doubt, will open up a new field in studying a previously uncharacterized role for disease-susceptibility variants, specifically non-coding SNPs, from genome-wide association studies (GWAS) in gene regulation. Narrative Recent discoveries that allow us to look beyond the one-dimensional sequence of DNA and understand the large-scale organization principals of its three-dimensional folding have been limited when it comes to characterizing the role of fine-scale genetic variations of the DNA code in controlling important cellular processes such as gene expression. This work will employ state-of-the-art molecular biology techniques and develop novel computational methods to define the role of such genetic variants in changing three-dimensional connections made by the promoters of genes in the human genome. This systematic and unbiased genome- wide study will have important implications in changing the way we study the disease relevance of genetic variation by revealing genotype dependence of long-range chromatin interactions between genes and their distal control switches at a scale that has not been achieved to date.",Defining interaction quantitative trait loci (iQTLs) in the human genome,9576241,R35GM128938,"['Address', 'Affect', 'Asthma', 'Binding', 'Biological', 'Biological Assay', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Code', 'Collaborations', 'Computer Analysis', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Dependence', 'Dimensions', 'Disease', 'Disease susceptibility', 'Distal', 'Experimental Designs', 'Expression Profiling', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Genes', 'Genetic', 'Genetic Variation', 'Genotype', 'Goals', 'Human', 'Human Genome', 'Immune', 'Institutes', 'Knowledge', 'Laboratories', 'Machine Learning', 'Molecular Biology Techniques', 'Population', 'Positioning Attribute', 'Predisposition', 'Quantitative Trait Loci', 'Research', 'Resources', 'Role', 'Sampling', 'Specificity', 'Susceptibility Gene', 'Uncertainty', 'Untranslated RNA', 'Variant', 'Work', 'base', 'cell type', 'chromosome conformation capture', 'genetic variant', 'genome wide association study', 'genome-wide', 'genome-wide analysis', 'graph theory', 'histone modification', 'novel', 'predictive modeling', 'programs', 'promoter', 'statistics', 'transcription factor']",NIGMS,LA JOLLA INSTITUTE FOR IMMUNOLOGY,R35,2018,449829,-0.015472443005767446
"Defining interaction quantitative trait loci (iQTLs) in the human genome Abstract My research aims to understand the role of three-dimensional (3D) chromatin structure in gene regulation. This involves studying associations among genotype, histone modifications, transcription factor binding, non-coding RNAs, chromatin interactions and gene expression. In order to transform this genome-wide information into new biological discoveries, my laboratory develops scalable and interpretable computational methods based on statistics, graph theory and machine learning. Our recent focus is to address an important gap in the current knowledge of the role of 3D chromatin structure in gene regulation. That is, we aim to define how genotypic variation affects 3D organization of gene promoters, and in turn, their expression. To achieve this at a genome- wide scale is an ambitious goal, because it requires having at a minimum, genotype, gene expression and chromatin interaction profiles in pure populations of specific cell types from a large number of donors. However, my laboratory is uniquely positioned to perform this research because: i) we are involved in a study at the La Jolla Institute (LJI-R24AI108564) that has already genotyped ~100 donors and expression-profiled more than 15 different pure populations of human immune cell types, and we have access to the same samples for chromatin interaction mapping, ii) in collaboration with other groups at LJI, we have already discovered a prototypical example of an interaction quantitative trait locus (iQTL) that alters and rewires interactions from the promoter of a specific gene that is associated with asthma susceptibility, iii) we have the necessary expertise and proven track record in experimental design and computational analyses of various chromatin conformation capture assays. Leveraging the resources available at LJI and our expertise in the field, we will build a unique research program around the novel concept of iQTLs. The emerging set of three main questions we propose to address within the next five years are: Q1) How do we define cell-type-specific iQTLs for common genetic variants? Q2) What is the extent of overlap between iQTLs and GWAS SNPs? Q3) Can we build predictive models for the cell-type specificity of chromatin interactions and iQTLs? Although we propose to define iQTLs only in two abundant, easily accessible, and highly disease-relevant immune cell types, the concept of iQTLs is equally important in other cell types implicated in diseases with a genetic component. Hence, the proof-of-concept developed by this work, without a doubt, will open up a new field in studying a previously uncharacterized role for disease-susceptibility variants, specifically non-coding SNPs, from genome-wide association studies (GWAS) in gene regulation. Narrative Recent discoveries that allow us to look beyond the one-dimensional sequence of DNA and understand the large-scale organization principals of its three-dimensional folding have been limited when it comes to characterizing the role of fine-scale genetic variations of the DNA code in controlling important cellular processes such as gene expression. This work will employ state-of-the-art molecular biology techniques and develop novel computational methods to define the role of such genetic variants in changing three-dimensional connections made by the promoters of genes in the human genome. This systematic and unbiased genome- wide study will have important implications in changing the way we study the disease relevance of genetic variation by revealing genotype dependence of long-range chromatin interactions between genes and their distal control switches at a scale that has not been achieved to date.",Defining interaction quantitative trait loci (iQTLs) in the human genome,9980439,R35GM128938,"['3-Dimensional', 'Address', 'Affect', 'Asthma', 'Binding', 'Biological', 'Biological Assay', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Code', 'Collaborations', 'Computer Analysis', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Dependence', 'Dimensions', 'Disease', 'Disease susceptibility', 'Distal', 'Experimental Designs', 'Expression Profiling', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Genes', 'Genetic', 'Genetic Variation', 'Genotype', 'Goals', 'Human', 'Human Genome', 'Immune', 'Institutes', 'Knowledge', 'Laboratories', 'Machine Learning', 'Molecular Biology Techniques', 'Population', 'Positioning Attribute', 'Predisposition', 'Quantitative Trait Loci', 'Research', 'Resources', 'Role', 'Sampling', 'Specificity', 'Susceptibility Gene', 'Uncertainty', 'Untranslated RNA', 'Variant', 'Work', 'base', 'cell type', 'chromosome conformation capture', 'genetic variant', 'genome wide association study', 'genome-wide', 'genome-wide analysis', 'graph theory', 'histone modification', 'novel', 'predictive modeling', 'programs', 'promoter', 'statistics', 'transcription factor']",NIGMS,LA JOLLA INSTITUTE FOR IMMUNOLOGY,R35,2020,449649,-0.015472443005767446
"Defining interaction quantitative trait loci (iQTLs) in the human genome Abstract My research aims to understand the role of three-dimensional (3D) chromatin structure in gene regulation. This involves studying associations among genotype, histone modifications, transcription factor binding, non-coding RNAs, chromatin interactions and gene expression. In order to transform this genome-wide information into new biological discoveries, my laboratory develops scalable and interpretable computational methods based on statistics, graph theory and machine learning. Our recent focus is to address an important gap in the current knowledge of the role of 3D chromatin structure in gene regulation. That is, we aim to define how genotypic variation affects 3D organization of gene promoters, and in turn, their expression. To achieve this at a genome- wide scale is an ambitious goal, because it requires having at a minimum, genotype, gene expression and chromatin interaction profiles in pure populations of specific cell types from a large number of donors. However, my laboratory is uniquely positioned to perform this research because: i) we are involved in a study at the La Jolla Institute (LJI-R24AI108564) that has already genotyped ~100 donors and expression-profiled more than 15 different pure populations of human immune cell types, and we have access to the same samples for chromatin interaction mapping, ii) in collaboration with other groups at LJI, we have already discovered a prototypical example of an interaction quantitative trait locus (iQTL) that alters and rewires interactions from the promoter of a specific gene that is associated with asthma susceptibility, iii) we have the necessary expertise and proven track record in experimental design and computational analyses of various chromatin conformation capture assays. Leveraging the resources available at LJI and our expertise in the field, we will build a unique research program around the novel concept of iQTLs. The emerging set of three main questions we propose to address within the next five years are: Q1) How do we define cell-type-specific iQTLs for common genetic variants? Q2) What is the extent of overlap between iQTLs and GWAS SNPs? Q3) Can we build predictive models for the cell-type specificity of chromatin interactions and iQTLs? Although we propose to define iQTLs only in two abundant, easily accessible, and highly disease-relevant immune cell types, the concept of iQTLs is equally important in other cell types implicated in diseases with a genetic component. Hence, the proof-of-concept developed by this work, without a doubt, will open up a new field in studying a previously uncharacterized role for disease-susceptibility variants, specifically non-coding SNPs, from genome-wide association studies (GWAS) in gene regulation. Narrative Recent discoveries that allow us to look beyond the one-dimensional sequence of DNA and understand the large-scale organization principals of its three-dimensional folding have been limited when it comes to characterizing the role of fine-scale genetic variations of the DNA code in controlling important cellular processes such as gene expression. This work will employ state-of-the-art molecular biology techniques and develop novel computational methods to define the role of such genetic variants in changing three-dimensional connections made by the promoters of genes in the human genome. This systematic and unbiased genome- wide study will have important implications in changing the way we study the disease relevance of genetic variation by revealing genotype dependence of long-range chromatin interactions between genes and their distal control switches at a scale that has not been achieved to date.",Defining interaction quantitative trait loci (iQTLs) in the human genome,9751340,R35GM128938,"['3-Dimensional', 'Address', 'Affect', 'Asthma', 'Binding', 'Biological', 'Biological Assay', 'Cell physiology', 'Chromatin', 'Chromatin Structure', 'Code', 'Collaborations', 'Computer Analysis', 'Computing Methodologies', 'DNA', 'DNA Sequence', 'Dependence', 'Dimensions', 'Disease', 'Disease susceptibility', 'Distal', 'Experimental Designs', 'Expression Profiling', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Genes', 'Genetic', 'Genetic Variation', 'Genotype', 'Goals', 'Human', 'Human Genome', 'Immune', 'Institutes', 'Knowledge', 'Laboratories', 'Machine Learning', 'Molecular Biology Techniques', 'Population', 'Positioning Attribute', 'Predisposition', 'Quantitative Trait Loci', 'Research', 'Resources', 'Role', 'Sampling', 'Specificity', 'Susceptibility Gene', 'Uncertainty', 'Untranslated RNA', 'Variant', 'Work', 'base', 'cell type', 'chromosome conformation capture', 'genetic variant', 'genome wide association study', 'genome-wide', 'genome-wide analysis', 'graph theory', 'histone modification', 'novel', 'predictive modeling', 'programs', 'promoter', 'statistics', 'transcription factor']",NIGMS,LA JOLLA INSTITUTE FOR IMMUNOLOGY,R35,2019,449829,-0.015472443005767446
"Computational Methods to Characterize Alternative Splicing from Massive Collections of RNA-seq Data SUMMARY Alternative splicing (AS) is a gene regulatory mechanism with important roles in human biology and disease. High throughput sequencing of RNA (RNA-seq) is making it possible to survey the expressed genes and their alternative splicing variations in a wide variety of cellular conditions. However, the short reads are challenging to analyze, demanding highly sophisticated computational methods that can extract meaningful AS information efficiently, accurately, and in a comprehensive way. While there has been great progress so far, current methods based on assembling the short reads into transcript annotations have reached a plateau. We propose two innovations that can help overcome the limits. The first is one-step simultaneous analyses of multiple samples in an RNA-seq collection, in contrast with the current two-step approach that analyzes each sample separately and then merges the results. The second is to create and interrogate assembly-free representations of AS. The project will design a suite of tools that will leverage the latent information in large collections of samples and from heterogeneous data types to build complete and accurate AS signatures of tissues and cell types, and to elucidate the regulatory circuitry of AS and its functional implications. Aim 1 will develop a high- performance multi-sample transcript assembly tool, combining subexon graph representations of genes and AS variations, statistical methods for improved feature detection, and search space reduction techniques for efficient sample processing. Aim 2 will build highly efficient and accurate feature selection tools to detect and characterize assembly-free AS variations (subexons and introns), simultaneously from collections of RNA-seq samples. It will combine novel regularized programs with complex models of intronic `noise' and other RNA-seq confounders, and enable analyses of differential splicing and to identify individual and group-specific variations. Lastly, Aim 3 will develop a system to comprehensively model the regulatory and functional circuitry of AS and the effects of mutations, starting from deep learning models of sequences and alignments and integrating expression, sequence, epigenetic and mutation data across tissues, cell types and conditions. We will rigorously test and evaluate all tools in simulations and on large public data sets, as well as on thyroid and head and neck cancer data provided by our collaborators, and we will experimentally validate random subsets of predictions with capillary electrophoresis and qRT-PCR. Collectively, the concepts, methods and tools will establish a new framework for analyzing RNA-seq data that can efficiently tackle the `big data' challenges, leading to more complete discovery and annotation of AS structure and function in human health and disease.  NARRATIVE Alternative splicing is a fundamental gene regulatory mechanism with important roles in human physiology and disease. Next generation RNA sequencing (RNA-seq) is making it possible to characterize alternative splicing in great detail, however, current bioinformatics analysis tools miss important variations. The project will design a suite of innovative tools that criss-cross information across multiple RNA-seq samples, and across heterogeneous sequence, epigenetic and expression data, to more comprehensively and more accurately determine the structure, function and regulation of alternative splicing in human biology and disease.",Computational Methods to Characterize Alternative Splicing from Massive Collections of RNA-seq Data,10021689,R01GM129085,"['Alternative Splicing', 'Big Data', 'Bioinformatics', 'Biological Models', 'Bypass', 'Capillary Electrophoresis', 'Charge', 'Collection', 'Complex', 'Computer software', 'Computing Methodologies', 'Data', 'Data Collection', 'Data Set', 'Disease', 'Drops', 'Elements', 'Environment', 'Epigenetic Process', 'Evaluation Studies', 'Event', 'Farming environment', 'Follicular thyroid carcinoma', 'Galaxy', 'Gene Expression', 'Genes', 'Genotype-Tissue Expression Project', 'Graph', 'Head and Neck Cancer', 'Health', 'Heterogeneity', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Biology', 'Individual', 'International', 'Introns', 'Learning Module', 'Length', 'Methods', 'Methylation', 'Modeling', 'Morphologic artifacts', 'Mutation', 'Noise', 'Pattern', 'Performance', 'Physiology', 'Protein Isoforms', 'Quantitative Reverse Transcriptase PCR', 'RNA', 'RNA Splicing', 'RNA analysis', 'Regulation', 'Regulator Genes', 'Reverse Transcriptase Polymerase Chain Reaction', 'Role', 'Sampling', 'Sequence Alignment', 'Signal Transduction', 'Spliced Genes', 'Statistical Methods', 'Structure', 'Surveys', 'System', 'Techniques', 'Testing', 'The Cancer Genome Atlas', 'Thyroid carcinoma', 'Tissues', 'Transcript', 'Variant', 'base', 'cell type', 'cohort', 'data reduction', 'deep learning', 'design', 'experimental study', 'feature detection', 'feature selection', 'heterogenous data', 'human disease', 'improved', 'innovation', 'next generation', 'next generation sequencing', 'novel', 'open source', 'programs', 'prototype', 'repository', 'sample collection', 'simulation', 'tool', 'transcriptome sequencing', 'user-friendly', 'virtual']",NIGMS,JOHNS HOPKINS UNIVERSITY,R01,2020,363164,0.023109634531954075
"Computational Methods to Characterize Alternative Splicing from Massive Collections of RNA-seq Data SUMMARY Alternative splicing (AS) is a gene regulatory mechanism with important roles in human biology and disease. High throughput sequencing of RNA (RNA-seq) is making it possible to survey the expressed genes and their alternative splicing variations in a wide variety of cellular conditions. However, the short reads are challenging to analyze, demanding highly sophisticated computational methods that can extract meaningful AS information efficiently, accurately, and in a comprehensive way. While there has been great progress so far, current methods based on assembling the short reads into transcript annotations have reached a plateau. We propose two innovations that can help overcome the limits. The first is one-step simultaneous analyses of multiple samples in an RNA-seq collection, in contrast with the current two-step approach that analyzes each sample separately and then merges the results. The second is to create and interrogate assembly-free representations of AS. The project will design a suite of tools that will leverage the latent information in large collections of samples and from heterogeneous data types to build complete and accurate AS signatures of tissues and cell types, and to elucidate the regulatory circuitry of AS and its functional implications. Aim 1 will develop a high- performance multi-sample transcript assembly tool, combining subexon graph representations of genes and AS variations, statistical methods for improved feature detection, and search space reduction techniques for efficient sample processing. Aim 2 will build highly efficient and accurate feature selection tools to detect and characterize assembly-free AS variations (subexons and introns), simultaneously from collections of RNA-seq samples. It will combine novel regularized programs with complex models of intronic `noise' and other RNA-seq confounders, and enable analyses of differential splicing and to identify individual and group-specific variations. Lastly, Aim 3 will develop a system to comprehensively model the regulatory and functional circuitry of AS and the effects of mutations, starting from deep learning models of sequences and alignments and integrating expression, sequence, epigenetic and mutation data across tissues, cell types and conditions. We will rigorously test and evaluate all tools in simulations and on large public data sets, as well as on thyroid and head and neck cancer data provided by our collaborators, and we will experimentally validate random subsets of predictions with capillary electrophoresis and qRT-PCR. Collectively, the concepts, methods and tools will establish a new framework for analyzing RNA-seq data that can efficiently tackle the `big data' challenges, leading to more complete discovery and annotation of AS structure and function in human health and disease.  NARRATIVE Alternative splicing is a fundamental gene regulatory mechanism with important roles in human physiology and disease. Next generation RNA sequencing (RNA-seq) is making it possible to characterize alternative splicing in great detail, however, current bioinformatics analysis tools miss important variations. The project will design a suite of innovative tools that criss-cross information across multiple RNA-seq samples, and across heterogeneous sequence, epigenetic and expression data, to more comprehensively and more accurately determine the structure, function and regulation of alternative splicing in human biology and disease.",Computational Methods to Characterize Alternative Splicing from Massive Collections of RNA-seq Data,9817658,R01GM129085,"['Alternative Splicing', 'Big Data', 'Bioinformatics', 'Biological Models', 'Bypass', 'Capillary Electrophoresis', 'Charge', 'Collection', 'Complex', 'Computer software', 'Computing Methodologies', 'Data', 'Data Collection', 'Data Set', 'Disease', 'Drops', 'Elements', 'Environment', 'Epigenetic Process', 'Evaluation Studies', 'Event', 'Farming environment', 'Follicular thyroid carcinoma', 'Galaxy', 'Gene Expression', 'Genes', 'Genotype-Tissue Expression Project', 'Graph', 'Head and Neck Cancer', 'Health', 'Heterogeneity', 'High-Throughput Nucleotide Sequencing', 'Human', 'Human Biology', 'Individual', 'International', 'Introns', 'Learning Module', 'Length', 'Methods', 'Methylation', 'Modeling', 'Morphologic artifacts', 'Mutation', 'Noise', 'One-Step dentin bonding system', 'Pattern', 'Performance', 'Physiology', 'Protein Isoforms', 'Quantitative Reverse Transcriptase PCR', 'RNA', 'RNA Splicing', 'RNA analysis', 'Regulation', 'Regulator Genes', 'Reverse Transcriptase Polymerase Chain Reaction', 'Role', 'Sampling', 'Sequence Alignment', 'Signal Transduction', 'Spliced Genes', 'Statistical Methods', 'Structure', 'Surveys', 'System', 'Techniques', 'Testing', 'The Cancer Genome Atlas', 'Thyroid carcinoma', 'Tissues', 'Transcript', 'Variant', 'base', 'cell type', 'cohort', 'data reduction', 'deep learning', 'design', 'experimental study', 'feature detection', 'human disease', 'improved', 'innovation', 'next generation', 'next generation sequencing', 'novel', 'open source', 'programs', 'prototype', 'repository', 'sample collection', 'simulation', 'tool', 'transcriptome sequencing', 'user-friendly', 'virtual']",NIGMS,JOHNS HOPKINS UNIVERSITY,R01,2019,363164,0.023109634531954075
"Statistical modeling of long-range chromatin interactions on gene regulation and underlying molecular Disease-associated genetic variants have been found to be enriched in regulatory genomic regions of gene expression. In order to gain detailed understanding of disease mechanisms, one central question is to systematically delineate how tissue-specific gene expression programs are regulated. Enhancers are a major family of regulatory elements with complex signatures and they are abundant in the human genome. Enhancer regulation of gene expression is highly tissue-specific, associated with combinatorial transcription factor binding, and involved with long-range three-dimensional chromatin interactions. It is therefore challenging to characterize the large-scale enhancer regulatory networks. The primary goal of this project is to develop a suite of probabilistic models and efficient machine learning algorithms to predict genome-wide enhancer regulatory networks in diverse panels of cellular contexts and the associated molecular mechanisms to establish long-range interactions, which will be leveraged to interpret disease-associated genetic variants. In Aim 1, novel integrative graphical models will be developed to predict long-range chromatin interactions linking tissue-specific enhancers to their distal target genes, along with combinatorial transcription factor binding patterns. In Aim 2, computational algorithms will be designed to interrogate how specific chromatin interactions are established, leading to mechanistic insights on chromatin formation. In Aim 3, statistical models will be developed to integrate enhancer-gene regulatory networks with genetics data to predict which non-coding variants may disrupt regulatory links and cause diseases, with improved statistical power and accuracy. This modeling framework will substantially expand the analytical ability on non-coding variants and human disease mechanisms. Computational predictions from the three aims will be experimentally tested in mouse models of breast cancer development. This project will lead to both innovative computational tools and systematic biological insights on long-range enhancer regulation and their functional roles in human diseases. The advanced statistical models and machine learning algorithms will provide efficient big-data integration tools for epigenetics, gene regulation and human genetics. Comprehensive predictions from this project represent valuable platforms to delineate genetic variants and disease mechanisms. Novel mechanistic insights of diseases at the regulatory and molecular level will facilitate improved diagnostic and therapeutic approaches for human diseases.",Statistical modeling of long-range chromatin interactions on gene regulation and underlying molecular,9932407,R01GM131398,"['3-Dimensional', 'Affect', 'Big Data', 'Binding', 'Biological', 'Breast Cancer Model', 'Chromatin', 'Chromatin Structure', 'Complex', 'Computational algorithm', 'Data', 'Development', 'Diagnostic', 'Disease', 'Distal', 'Drug Targeting', 'Elements', 'Enhancers', 'Epigenetic Process', 'Family', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genetic', 'Genetic Diseases', 'Genetic Predisposition to Disease', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Genotype', 'Goals', 'Human Genetics', 'Human Genome', 'Joints', 'Lead', 'Learning', 'Link', 'Mediating', 'Modeling', 'Molecular', 'Network-based', 'Pathway interactions', 'Pattern', 'Phenotype', 'Play', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Research', 'Resources', 'Role', 'Statistical Models', 'Structure', 'Testing', 'Therapeutic', 'Tissue-Specific Gene Expression', 'Tissues', 'Untranslated RNA', 'Validation', 'Variant', 'base', 'cell type', 'combinatorial', 'computerized tools', 'data integration', 'design', 'experimental study', 'functional genomics', 'genetic analysis', 'genetic information', 'genetic variant', 'genome-wide', 'genomic data', 'human disease', 'human tissue', 'improved', 'innovation', 'insight', 'machine learning algorithm', 'mouse model', 'novel', 'programs', 'protein protein interaction', 'tissue resource', 'tool', 'transcription factor', 'transcription factor USF']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2020,325001,0.0771846873146709
"Statistical modeling of long-range chromatin interactions on gene regulation and underlying molecular Disease-associated genetic variants have been found to be enriched in regulatory genomic regions of gene expression. In order to gain detailed understanding of disease mechanisms, one central question is to systematically delineate how tissue-specific gene expression programs are regulated. Enhancers are a major family of regulatory elements with complex signatures and they are abundant in the human genome. Enhancer regulation of gene expression is highly tissue-specific, associated with combinatorial transcription factor binding, and involved with long-range three-dimensional chromatin interactions. It is therefore challenging to characterize the large-scale enhancer regulatory networks. The primary goal of this project is to develop a suite of probabilistic models and efficient machine learning algorithms to predict genome-wide enhancer regulatory networks in diverse panels of cellular contexts and the associated molecular mechanisms to establish long-range interactions, which will be leveraged to interpret disease-associated genetic variants. In Aim 1, novel integrative graphical models will be developed to predict long-range chromatin interactions linking tissue-specific enhancers to their distal target genes, along with combinatorial transcription factor binding patterns. In Aim 2, computational algorithms will be designed to interrogate how specific chromatin interactions are established, leading to mechanistic insights on chromatin formation. In Aim 3, statistical models will be developed to integrate enhancer-gene regulatory networks with genetics data to predict which non-coding variants may disrupt regulatory links and cause diseases, with improved statistical power and accuracy. This modeling framework will substantially expand the analytical ability on non-coding variants and human disease mechanisms. Computational predictions from the three aims will be experimentally tested in mouse models of breast cancer development. This project will lead to both innovative computational tools and systematic biological insights on long-range enhancer regulation and their functional roles in human diseases. The advanced statistical models and machine learning algorithms will provide efficient big-data integration tools for epigenetics, gene regulation and human genetics. Comprehensive predictions from this project represent valuable platforms to delineate genetic variants and disease mechanisms. Novel mechanistic insights of diseases at the regulatory and molecular level will facilitate improved diagnostic and therapeutic approaches for human diseases.",Statistical modeling of long-range chromatin interactions on gene regulation and underlying molecular,9774269,R01GM131398,"['Affect', 'Big Data', 'Binding', 'Biological', 'Breast Cancer Model', 'Chromatin', 'Chromatin Structure', 'Complex', 'Computational algorithm', 'Data', 'Development', 'Diagnostic', 'Dimensions', 'Disease', 'Distal', 'Drug Targeting', 'Elements', 'Enhancers', 'Epigenetic Process', 'Family', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Genes', 'Genetic', 'Genetic Diseases', 'Genetic Predisposition to Disease', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Genotype', 'Goals', 'Human Genetics', 'Human Genome', 'Joints', 'Lead', 'Learning', 'Link', 'Mediating', 'Modeling', 'Molecular', 'Network-based', 'Pathway interactions', 'Pattern', 'Phenotype', 'Play', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Research', 'Resources', 'Role', 'Statistical Models', 'Structural Genes', 'Testing', 'Therapeutic', 'Tissue-Specific Gene Expression', 'Tissues', 'Untranslated RNA', 'Validation', 'Variant', 'base', 'cell type', 'combinatorial', 'computerized tools', 'data integration', 'design', 'experimental study', 'functional genomics', 'genetic analysis', 'genetic information', 'genetic variant', 'genome-wide', 'genomic data', 'human disease', 'human tissue', 'improved', 'innovation', 'insight', 'machine learning algorithm', 'mouse model', 'novel', 'programs', 'protein protein interaction', 'tissue resource', 'tool', 'transcription factor', 'transcription factor USF']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2019,325001,0.0771846873146709
"Statistical modeling of long-range chromatin interactions on gene regulation and underlying molecular Disease-associated genetic variants have been found to be enriched in regulatory genomic regions of gene expression. In order to gain detailed understanding of disease mechanisms, one central question is to systematically delineate how tissue-specific gene expression programs are regulated. Enhancers are a major family of regulatory elements with complex signatures and they are abundant in the human genome. Enhancer regulation of gene expression is highly tissue-specific, associated with combinatorial transcription factor binding, and involved with long-range three-dimensional chromatin interactions. It is therefore challenging to characterize the large-scale enhancer regulatory networks. The primary goal of this project is to develop a suite of probabilistic models and efficient machine learning algorithms to predict genome-wide enhancer regulatory networks in diverse panels of cellular contexts and the associated molecular mechanisms to establish long-range interactions, which will be leveraged to interpret disease-associated genetic variants. In Aim 1, novel integrative graphical models will be developed to predict long-range chromatin interactions linking tissue-specific enhancers to their distal target genes, along with combinatorial transcription factor binding patterns. In Aim 2, computational algorithms will be designed to interrogate how specific chromatin interactions are established, leading to mechanistic insights on chromatin formation. In Aim 3, statistical models will be developed to integrate enhancer-gene regulatory networks with genetics data to predict which non-coding variants may disrupt regulatory links and cause diseases, with improved statistical power and accuracy. This modeling framework will substantially expand the analytical ability on non-coding variants and human disease mechanisms. Computational predictions from the three aims will be experimentally tested in mouse models of breast cancer development. This project will lead to both innovative computational tools and systematic biological insights on long-range enhancer regulation and their functional roles in human diseases. The advanced statistical models and machine learning algorithms will provide efficient big-data integration tools for epigenetics, gene regulation and human genetics. Comprehensive predictions from this project represent valuable platforms to delineate genetic variants and disease mechanisms. Novel mechanistic insights of diseases at the regulatory and molecular level will facilitate improved diagnostic and therapeutic approaches for human diseases.",Statistical modeling of long-range chromatin interactions on gene regulation and underlying molecular,9672649,R01GM131398,"['Affect', 'Algorithms', 'Big Data', 'Binding', 'Biological', 'Breast Cancer Model', 'Chromatin', 'Chromatin Structure', 'Complex', 'Computational algorithm', 'Data', 'Data Set', 'Development', 'Diagnostic', 'Dimensions', 'Disease', 'Distal', 'Drug Targeting', 'Elements', 'Enhancers', 'Epigenetic Process', 'Family', 'Gene Expression', 'Gene Expression Regulation', 'Gene Structure', 'Gene Targeting', 'Genes', 'Genetic', 'Genetic Diseases', 'Genetic Predisposition to Disease', 'Genetic Transcription', 'Genome', 'Genomic Segment', 'Genomics', 'Genotype', 'Goals', 'Human Genetics', 'Human Genome', 'Joints', 'Lead', 'Learning', 'Link', 'Machine Learning', 'Mediating', 'Modeling', 'Molecular', 'Network-based', 'Pathway interactions', 'Pattern', 'Phenotype', 'Play', 'Regulation', 'Regulator Genes', 'Regulatory Element', 'Research', 'Resources', 'Role', 'Statistical Models', 'Testing', 'Therapeutic', 'Tissue-Specific Gene Expression', 'Tissues', 'Untranslated RNA', 'Validation', 'Variant', 'base', 'cell type', 'combinatorial', 'computerized tools', 'data integration', 'design', 'experimental study', 'functional genomics', 'genetic analysis', 'genetic information', 'genetic variant', 'genome-wide', 'human disease', 'human tissue', 'improved', 'innovation', 'insight', 'mouse model', 'novel', 'programs', 'protein protein interaction', 'tissue resource', 'tool', 'transcription factor', 'transcription factor USF']",NIGMS,MICHIGAN STATE UNIVERSITY,R01,2018,325001,0.0771846873146709
"Quantitative regulatory genomics: networks, cis-regulatory codes, and phenotypic variation How do changes in DNA sequence impact organismal properties? This is a central question of modern  biology, and insights into it can help us understand, among other things, why patients respond  differently to the same treatment, or why some species exhibit behavioral properties not seen in  other species. A major hurdle in solving this genotype-to-phenotype problem is our poor knowledge  of gene regulatory mechanisms underlying phenotypes and cellular processes, and how those  mechanisms are encoded in DNA. It also leads to severe difficulties in prioritizing  phenotype-linked non-coding variants (polymorphisms) for further investigation. Driven by these  challenges, my lab seeks to develop quantitative frameworks for describing and  discovering transcriptional regulatory mechanisms. We have made significant progress towards this  goal in two main directions: (1) We have developed detailed biophysical models of the  cis-regulatory encoding of gene expression. Using these models we have shown how the regulatory  function of transcription factor (TF) binding sites depends on their sequence and DNA shape, as  well as their trans-context, e.g., cellular concentrations of regulators, and  cis-context, e.g., proximity to other TF binding sites and chromatin states. (2) We have  devised statistical models to discover TF-gene interactions from transcriptomic data, as well as  other types of omics data if available. Working closely with biologists, we have applied these  models to understand phenotypes such as cytotoxic drug response in cell lines, behavioral response  to social encounters, and embryonic development. Building on the strong foundations of our  past work, I propose to establish a research program that studies transcriptional regulation  holistically at the cis- and trans- levels. Our new pursuits will include: (1) use of our  computational, sequence-level models to describe two data-rich mammalian regulatory programs, an  experimental collaboration to dissect the cis-regulatory logic of a key inflammation gene using  massively parallel reporter assays, and major advances in our modeling techniques; (2) new  machine learning methods for reconstructing networks of TF-gene interactions that explain  phenotypic differences, integration of cis- and trans-regulatory evidence from multi-omics  data, and collaborations to apply these methods in cancer pharmacogenomics and behavioral  neurogenomics; (3) a new probabilistic framework to combine traditional statistical scores of a  non-coding variant with quantitative predictions of its regulatory impact based on the  above-mentioned techniques. Explorations of new forms of synergy among these related goals of  network reconstruction, cis-regulatory sequence modeling and variant interpretation will be woven  throughout our research program. The proposed work will answer fundamental questions about molecular mechanisms underlying  phenotypic differences between individuals, such as why different patients respond differently to  the same drug. We will develop new computational methods for discovery of such mechanisms from a  variety of genomics data sets. We will work closely with experimental biologists and use our tools  to study important biological topics including cancer drug response, inflammation, and effect of  estrogen on breast cancer.","Quantitative regulatory genomics: networks, cis-regulatory codes, and phenotypic variation",9699641,R35GM131819,"['Antineoplastic Agents', 'Behavioral', 'Binding Sites', 'Biological', 'Biological Assay', 'Biology', 'Cell Line', 'Cell physiology', 'Chromatin', 'Code', 'Collaborations', 'Computing Methodologies', 'Cytotoxic agent', 'DNA', 'DNA Sequence', 'Data', 'Embryonic Development', 'Estrogens', 'Exhibits', 'Foundations', 'Gene Expression', 'Genes', 'Genetic Polymorphism', 'Genetic Transcription', 'Genomics', 'Genotype', 'Goals', 'Individual', 'Inflammation', 'Investigation', 'Knowledge', 'Link', 'Logic', 'Machine Learning', 'Malignant Neoplasms', 'Methods', 'Modeling', 'Modernization', 'Molecular', 'Multiomic Data', 'Patients', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Phenotype', 'Property', 'Regulator Genes', 'Reporter', 'Research', 'Shapes', 'Statistical Models', 'Techniques', 'Transcriptional Regulation', 'Untranslated RNA', 'Variant', 'Work', 'base', 'behavioral response', 'biophysical model', 'gene interaction', 'genomic data', 'insight', 'learning strategy', 'malignant breast neoplasm', 'neurogenomics', 'programs', 'reconstruction', 'response', 'social', 'synergism', 'tool', 'transcription factor', 'transcriptomics']",NIGMS,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,R35,2019,356979,0.07087849725181461
"Quantitative regulatory genomics: networks, cis-regulatory codes, and phenotypic variation How do changes in DNA sequence impact organismal properties? This is a central question of modern  biology, and insights into it can help us understand, among other things, why patients respond  differently to the same treatment, or why some species exhibit behavioral properties not seen in  other species. A major hurdle in solving this genotype-to-phenotype problem is our poor knowledge  of gene regulatory mechanisms underlying phenotypes and cellular processes, and how those  mechanisms are encoded in DNA. It also leads to severe difficulties in prioritizing  phenotype-linked non-coding variants (polymorphisms) for further investigation. Driven by these  challenges, my lab seeks to develop quantitative frameworks for describing and  discovering transcriptional regulatory mechanisms. We have made significant progress towards this  goal in two main directions: (1) We have developed detailed biophysical models of the  cis-regulatory encoding of gene expression. Using these models we have shown how the regulatory  function of transcription factor (TF) binding sites depends on their sequence and DNA shape, as  well as their trans-context, e.g., cellular concentrations of regulators, and  cis-context, e.g., proximity to other TF binding sites and chromatin states. (2) We have  devised statistical models to discover TF-gene interactions from transcriptomic data, as well as  other types of omics data if available. Working closely with biologists, we have applied these  models to understand phenotypes such as cytotoxic drug response in cell lines, behavioral response  to social encounters, and embryonic development. Building on the strong foundations of our  past work, I propose to establish a research program that studies transcriptional regulation  holistically at the cis- and trans- levels. Our new pursuits will include: (1) use of our  computational, sequence-level models to describe two data-rich mammalian regulatory programs, an  experimental collaboration to dissect the cis-regulatory logic of a key inflammation gene using  massively parallel reporter assays, and major advances in our modeling techniques; (2) new  machine learning methods for reconstructing networks of TF-gene interactions that explain  phenotypic differences, integration of cis- and trans-regulatory evidence from multi-omics  data, and collaborations to apply these methods in cancer pharmacogenomics and behavioral  neurogenomics; (3) a new probabilistic framework to combine traditional statistical scores of a  non-coding variant with quantitative predictions of its regulatory impact based on the  above-mentioned techniques. Explorations of new forms of synergy among these related goals of  network reconstruction, cis-regulatory sequence modeling and variant interpretation will be woven  throughout our research program. The proposed work will answer fundamental questions about molecular mechanisms underlying  phenotypic differences between individuals, such as why different patients respond differently to  the same drug. We will develop new computational methods for discovery of such mechanisms from a  variety of genomics data sets. We will work closely with experimental biologists and use our tools  to study important biological topics including cancer drug response, inflammation, and effect of  estrogen on breast cancer.","Quantitative regulatory genomics: networks, cis-regulatory codes, and phenotypic variation",10021007,R35GM131819,"['Antineoplastic Agents', 'Behavioral', 'Binding Sites', 'Biological', 'Biological Assay', 'Biology', 'Cell Line', 'Cell physiology', 'Chromatin', 'Code', 'Collaborations', 'Computing Methodologies', 'Cytotoxic agent', 'DNA', 'DNA Sequence', 'Data', 'Embryonic Development', 'Estrogens', 'Exhibits', 'Foundations', 'Gene Expression', 'Genes', 'Genetic Polymorphism', 'Genetic Transcription', 'Genomics', 'Genotype', 'Goals', 'Individual', 'Inflammation', 'Investigation', 'Knowledge', 'Link', 'Logic', 'Malignant Neoplasms', 'Methods', 'Modeling', 'Modernization', 'Molecular', 'Multiomic Data', 'Patients', 'Pharmaceutical Preparations', 'Pharmacogenomics', 'Phenotype', 'Property', 'Regulator Genes', 'Reporter', 'Research', 'Shapes', 'Statistical Models', 'Techniques', 'Transcriptional Regulation', 'Untranslated RNA', 'Variant', 'Work', 'base', 'behavioral response', 'biophysical model', 'gene interaction', 'genomic data', 'insight', 'machine learning method', 'malignant breast neoplasm', 'neurogenomics', 'programs', 'reconstruction', 'response', 'social', 'synergism', 'tool', 'transcription factor', 'transcriptomics']",NIGMS,UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN,R35,2020,356979,0.07087849725181461
"Computational modeling of spatial genome organization and gene regulation PROJECT SUMMARY/ABSTRACT The three-dimensional (3D) organization of the genome plays an essential role in genome stability, gene regulation, and many diseases, including cancer. The recent development of high-throughput chromatin conformation capture (Hi-C) and its variants provide an unprecedented opportunity to investigate higher-order chromatin organization. Despite the rapidly accumulating resources for investigating 3D genome organization, our understanding of the regulatory mechanisms and functions of the genome organization remain largely incomplete. Hi-C analyses and 3D genome research are still in their early stage and face several challenges. First, high-resolution chromatin contact maps require extremely deep sequencing and hence have been achieved only for a few cell lines. Second, it is computationally challenging to complement 3D genome structure with one-dimensional (1D) genomic and epigenomic features. Third, recent studies have just begun to infer associations between chromatin interactions and genetic variants and to identify potential target genes of those variants at the genome-wide scale. Given these challenges and my unique multi-disciplinary training, my long-term research goal is to develop innovative computational and statistical methods to uncover the interplay between 3D genome structure and function. Specically, in the next ve years, I will i) develop computational approaches to enhance the resolution of existing Hi-C data and investigate ne-scale 3D genome architecture as well as its spatiotemporal dynamics and ii) build scalable and interpretable machine learning models that leverage 1D epigenomic data to predict cell type-specic 3D chromatin interactions and gene expression and elucidate the function of 3D genome organization in gene regulation and human diseases. The completion of the proposed work will deepen our knowledge of 3D genome architecture as well as its functions in gene regulation and disease. PROJECT NARRATIVE The overarching mission of my research is to understand the interplay between genome architecture and gene regulation. Recent development of high-throughput chromatin conformation capture techniques has allowed us to look beyond the nucleotide sequence of DNA and investigate the principles of higher-order chromatin organization. I will develop innovative computational and statistical strategies to investigate 3D genome organization at an unprecedented scale, thereby elucidating the impacts of genome organization on gene regulation and disease.",Computational modeling of spatial genome organization and gene regulation,9999005,R35GM133678,"['3-Dimensional', 'Architecture', 'Base Sequence', 'Cell Line', 'Chromatin', 'Complement 3d', 'Computer Models', 'Computing Methodologies', 'DNA Sequence', 'Data', 'Development', 'Dimensions', 'Disease', 'Face', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genome Stability', 'Genomics', 'Goals', 'Knowledge', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Mission', 'Modeling', 'Play', 'Research', 'Resolution', 'Resources', 'Role', 'Statistical Methods', 'Structure', 'Techniques', 'Training', 'Variant', 'Work', 'cell type', 'chromosome conformation capture', 'deep sequencing', 'epigenomics', 'genetic variant', 'genome-wide', 'human disease', 'innovation', 'multidisciplinary', 'spatiotemporal']",NIGMS,UNIVERSITY OF CALIFORNIA RIVERSIDE,R35,2020,378309,0.03039056812220263
"Computational modeling of spatial genome organization and gene regulation PROJECT SUMMARY/ABSTRACT The three-dimensional (3D) organization of the genome plays an essential role in genome stability, gene regulation, and many diseases, including cancer. The recent development of high-throughput chromatin conformation capture (Hi-C) and its variants provide an unprecedented opportunity to investigate higher-order chromatin organization. Despite the rapidly accumulating resources for investigating 3D genome organization, our understanding of the regulatory mechanisms and functions of the genome organization remain largely incomplete. Hi-C analyses and 3D genome research are still in their early stage and face several challenges. First, high-resolution chromatin contact maps require extremely deep sequencing and hence have been achieved only for a few cell lines. Second, it is computationally challenging to complement 3D genome structure with one-dimensional (1D) genomic and epigenomic features. Third, recent studies have just begun to infer associations between chromatin interactions and genetic variants and to identify potential target genes of those variants at the genome-wide scale. Given these challenges and my unique multi-disciplinary training, my long-term research goal is to develop innovative computational and statistical methods to uncover the interplay between 3D genome structure and function. Specically, in the next ve years, I will i) develop computational approaches to enhance the resolution of existing Hi-C data and investigate ne-scale 3D genome architecture as well as its spatiotemporal dynamics and ii) build scalable and interpretable machine learning models that leverage 1D epigenomic data to predict cell type-specic 3D chromatin interactions and gene expression and elucidate the function of 3D genome organization in gene regulation and human diseases. The completion of the proposed work will deepen our knowledge of 3D genome architecture as well as its functions in gene regulation and disease. PROJECT NARRATIVE The overarching mission of my research is to understand the interplay between genome architecture and gene regulation. Recent development of high-throughput chromatin conformation capture techniques has allowed us to look beyond the nucleotide sequence of DNA and investigate the principles of higher-order chromatin organization. I will develop innovative computational and statistical strategies to investigate 3D genome organization at an unprecedented scale, thereby elucidating the impacts of genome organization on gene regulation and disease.",Computational modeling of spatial genome organization and gene regulation,9798957,R35GM133678,"['3-Dimensional', 'Architecture', 'Base Sequence', 'Cell Line', 'Chromatin', 'Complement 3d', 'Computer Simulation', 'Computing Methodologies', 'DNA Sequence', 'Data', 'Development', 'Dimensions', 'Disease', 'Face', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Genome Stability', 'Genomics', 'Goals', 'Knowledge', 'Machine Learning', 'Malignant Neoplasms', 'Maps', 'Mission', 'Modeling', 'Play', 'Research', 'Resolution', 'Resources', 'Role', 'Statistical Methods', 'Structure', 'Techniques', 'Training', 'Variant', 'Work', 'cell type', 'chromosome conformation capture', 'deep sequencing', 'epigenomics', 'genetic variant', 'genome-wide', 'human disease', 'innovation', 'multidisciplinary', 'spatiotemporal']",NIGMS,UNIVERSITY OF CALIFORNIA RIVERSIDE,R35,2019,369984,0.03039056812220263
"Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood Several million units of donor platelets are transfused annually in the US and Europe to treat patients undergoing radiation treatment, chemotherapy, or organ transplant surgery. Although transfusions of donor- derived platelets are an effective way to treat thrombocytopenic patients, numerous concerns have been raised due to the increase in demand, the five-day shelf-life, and the possibilities for contamination. Platelets are produced by megakaryocytes (MKs) in the bone marrow and are derived from hematopoietic stem and progenitor cells (HSPCs). The long-term objective of this proposal is to generate platelets ex vivo from HSPC- enriched umbilical cord blood that will allow us to address a vast public need. Recent studies have shown that the addition of histone deacetylase inhibitors (HDACi) can greatly affect expansion of progenitor cells, but can reduce MK differentiation efficiency. My central hypothesis is that epigenetic and transcriptional changes prime or desensitize HSPC to MK differentiation cues. To investigate the role of epigenetic signals during HSPC-to- MK transition, I propose to perform high-throughput ChIP and RNA-sequencing to discover differentially active regulatory elements between expanded (low potential) and fresh cord blood HSPCs. This highly interdisciplinary and collaborative proposal utilizes computational biology and machine-learning to identify differentially active regulatory elements, and associate genetic features with MK fate. To validate my findings and establish a causal relationship between histone modifications of certain regions and MK potential, I will generate a dCas9-fusion protein that can directly manipulate the epigenetic marker at a targeted site. My findings will establish the mechanism of action of chromatin-modifying agents such as HDACi, and the causal relationship between the epigenome and MK differentiation. My highly collaborative proposal with the Miller, Bagheri, and Mahmud lab will substantially enhance our understanding of hematopoietic differentiation toward manufacturing platelets. Project Narrative More than two million platelet units from donors are used to treat patients undergoing surgery or chemotherapy every year, but short shelf-life, increasing demand, and risk of contamination keep platelets in strained supply. In my proposed study, I will apply a panel of small molecules to expand and differentiate hematopoietic stem and progenitor cells from umbilical cord blood into platelet-producing cells. My work will identify the role of epigenetic modifications during the culture process, and elucidate new strategies to efficiently manufacture platelets from culture.",Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood,9345356,F31HL134331,"['Acetylation', 'Address', 'Affect', 'Algorithms', 'Apoptosis', 'Azacitidine', 'Biological', 'Blood Cells', 'Blood Platelets', 'Bone Marrow', 'CD34 gene', 'Cell Maintenance', 'Cells', 'ChIP-seq', 'Chemicals', 'Chimeric Proteins', 'Chromatin', 'Chromatin Structure', 'Classification', 'Computational Biology', 'Cues', 'Data', 'Data Set', 'Deacetylase', 'Deacetylation', 'Elements', 'Epigenetic Process', 'Equilibrium', 'Europe', 'GATA1 gene', 'GATA2 transcription factor', 'Gene Expression', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Genomic Segment', 'Growth', 'HDAC3 gene', 'HDAC6 gene', 'Hematopoietic', 'Hematopoietic stem cells', 'Histone Deacetylase Inhibitor', 'Histones', 'Influentials', 'Life', 'Machine Learning', 'Megakaryocytes', 'Methods', 'Methylation', 'Microtubules', 'Modification', 'Molecular Profiling', 'Nucleic Acid Regulatory Sequences', 'Operative Surgical Procedures', 'Organ Transplantation', 'Outcome', 'Patients', 'Pattern', 'Phenotype', 'Play', 'Population', 'Process', 'Radiation therapy', 'Reagent', 'Regulatory Element', 'Repression', 'Risk', 'Role', 'Signal Transduction', 'Signaling Protein', 'Site', 'Somatic Cell', 'Specificity', 'Stem cells', 'Supervision', 'Supplementation', 'System', 'Techniques', 'Thrombocytopenia', 'Training', 'Transfusion', 'Tryptophan', 'Umbilical Cord Blood', 'Valproic Acid', 'Work', 'alpha Tubulin', 'base', 'chemotherapy', 'desensitization', 'epigenetic marker', 'epigenome', 'epigenomics', 'forest', 'high dimensionality', 'high throughput screening', 'histone acetyltransferase', 'histone modification', 'improved', 'large scale production', 'novel', 'predictive modeling', 'progenitor', 'prognostic', 'sarcoma', 'small molecule', 'stem cell biology', 'stem cell differentiation', 'transcription factor', 'transcriptome sequencing']",NHLBI,NORTHWESTERN UNIVERSITY,F31,2017,38039,0.0174867056191127
"Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood Several million units of donor platelets are transfused annually in the US and Europe to treat patients undergoing radiation treatment, chemotherapy, or organ transplant surgery. Although transfusions of donor- derived platelets are an effective way to treat thrombocytopenic patients, numerous concerns have been raised due to the increase in demand, the five-day shelf-life, and the possibilities for contamination. Platelets are produced by megakaryocytes (MKs) in the bone marrow and are derived from hematopoietic stem and progenitor cells (HSPCs). The long-term objective of this proposal is to generate platelets ex vivo from HSPC- enriched umbilical cord blood that will allow us to address a vast public need. Recent studies have shown that the addition of histone deacetylase inhibitors (HDACi) can greatly affect expansion of progenitor cells, but can reduce MK differentiation efficiency. My central hypothesis is that epigenetic and transcriptional changes prime or desensitize HSPC to MK differentiation cues. To investigate the role of epigenetic signals during HSPC-to- MK transition, I propose to perform high-throughput ChIP and RNA-sequencing to discover differentially active regulatory elements between expanded (low potential) and fresh cord blood HSPCs. This highly interdisciplinary and collaborative proposal utilizes computational biology and machine-learning to identify differentially active regulatory elements, and associate genetic features with MK fate. To validate my findings and establish a causal relationship between histone modifications of certain regions and MK potential, I will generate a dCas9-fusion protein that can directly manipulate the epigenetic marker at a targeted site. My findings will establish the mechanism of action of chromatin-modifying agents such as HDACi, and the causal relationship between the epigenome and MK differentiation. My highly collaborative proposal with the Miller, Bagheri, and Mahmud lab will substantially enhance our understanding of hematopoietic differentiation toward manufacturing platelets. Project Narrative More than two million platelet units from donors are used to treat patients undergoing surgery or chemotherapy every year, but short shelf-life, increasing demand, and risk of contamination keep platelets in strained supply. In my proposed study, I will apply a panel of small molecules to expand and differentiate hematopoietic stem and progenitor cells from umbilical cord blood into platelet-producing cells. My work will identify the role of epigenetic modifications during the culture process, and elucidate new strategies to efficiently manufacture platelets from culture.",Integrative Epigenetic Analysis and Ex Vivo Generation of Megakaryocytes from Umbilical Cord Blood,9195237,F31HL134331,"['Acetylation', 'Address', 'Affect', 'Algorithms', 'Apoptosis', 'Azacitidine', 'Biological', 'Blood Cells', 'Blood Platelets', 'Bone Marrow', 'CD34 gene', 'Cell Maintenance', 'Cells', 'ChIP-seq', 'Chemicals', 'Chimeric Proteins', 'Chromatin', 'Chromatin Structure', 'Classification', 'Computational Biology', 'Cues', 'Data', 'Data Set', 'Deacetylation', 'Elements', 'Epigenetic Process', 'Equilibrium', 'Europe', 'GATA1 gene', 'GATA2 transcription factor', 'Gene Expression', 'Generations', 'Genes', 'Genetic', 'Genetic Transcription', 'Genomic Segment', 'Growth', 'HDAC3 gene', 'HDAC6 gene', 'Hematopoietic', 'Histone Deacetylase Inhibitor', 'Histones', 'Influentials', 'Life', 'Machine Learning', 'Megakaryocytes', 'Methods', 'Methylation', 'Microtubules', 'Modification', 'Molecular Profiling', 'Nucleic Acid Regulatory Sequences', 'Operative Surgical Procedures', 'Organ Transplantation', 'Outcome', 'Patients', 'Pattern', 'Phenotype', 'Play', 'Population', 'Process', 'Radiation therapy', 'Reagent', 'Regulatory Element', 'Repression', 'Risk', 'Role', 'Signal Transduction', 'Signaling Protein', 'Site', 'Somatic Cell', 'Specificity', 'Staging', 'Stem cells', 'Supplementation', 'System', 'Techniques', 'Thrombocytopenia', 'Training', 'Transfusion', 'Tryptophan', 'Umbilical Cord Blood', 'Valproic Acid', 'Work', 'alpha Tubulin', 'base', 'chemotherapy', 'epigenetic marker', 'epigenome', 'epigenomics', 'forest', 'high throughput screening', 'histone acetyltransferase', 'histone modification', 'improved', 'inhibitor/antagonist', 'large scale production', 'novel', 'predictive modeling', 'progenitor', 'prognostic', 'sarcoma', 'small molecule', 'stem', 'stem cell biology', 'stem cell differentiation', 'transcription factor', 'transcriptome sequencing']",NHLBI,NORTHWESTERN UNIVERSITY,F31,2016,37571,0.0174867056191127
"Predictive models of boundaries of topologically associated domains (TADs) Predictive Models of Boundaries of Topologically Associated Domains (TADs) in Human. The PI proposes a high-impact research project to develop novel predictive models to predict boundaries of topologically associated domains in a variety of human cell lines. The goal of this proposal is not just building these models, but to interpret them to decipher some biological meaning. Studies have recently indicated that genomes of different organisms are organized into domains called topologically associated domains (TADs), which consist of self-interacting chromatin regions. The boundaries of TADs have been linked to several diseases and gene regulation by modulating the overall genome organization. Accurate identification of these boundaries and interpretation of regulatory units in the boundaries are essential for development of effective therapy for diseases in future. Since existing experimental methods are costly and challenging, we will explore, evaluate, and compare predictive models for accurate prediction of TAD boundaries in different cell lines. We propose to test if sequence and chromatin features can be used in traditional feature based predictive models for TADs boundaries. This will be compared to deep learning models which have the capacity to learn important discriminative features from sequence information only. By interpreting these models, we will characterize the regulatory code of TAD boundaries by (a) characterizing a comprehensive list of motifs in TAD boundaries in 10 different human cell lines, (b) characterizing the association between different chromatin features and their predicting power of the boundaries, and (c) scoring, ranking and prioritizing likely causal noncoding variants that occur in TAD boundaries. Furthermore, this proposal will enhance the infrastructure of research and education at University of Houston-Downtown, introducing computational biology research experiences to underrepresented minority, first time in college and female undergraduate students, who would otherwise lack such opportunities. This will allow them to acquire a broad area of skills in data analytics, critical thinking, and research methods, which will encourage them to pursue a biomedical career and change their lives and communities. Understanding genome organization is essential for deciphering the complex mechanisms associated with gene regulation and development of effective therapies for diseases. To address current experimental challenges to quantify genome organization, we propose to develop novel artificial intelligence predictive methods to decipher genome organization in humans. These methods will also help link how genome organization modulates gene expression and how it can contribute to diseases.",Predictive models of boundaries of topologically associated domains (TADs),9965292,R15GM137254,"['Address', 'Affect', 'Architecture', 'Area', 'Artificial Intelligence', 'Binding', 'Binding Sites', 'Biological', 'Cell Line', 'Cell Nucleus', 'Cells', 'Chromatin', 'Code', 'Communities', 'Complex', 'Computational Biology', 'Consumption', 'Critical Thinking', 'DNA', 'DNA Methylation', 'DNA Sequence', 'DNA-Binding Proteins', 'Data', 'Data Analytics', 'Databases', 'Development', 'Disease', 'Drosophila genus', 'Education', 'Enhancers', 'Female', 'Future', 'Gene Expression', 'Gene Expression Regulation', 'Genes', 'Genome', 'Goals', 'Histones', 'Human', 'Human Cell Line', 'Insecta', 'Learning', 'Link', 'Mammals', 'Methods', 'Modeling', 'Organism', 'Pattern', 'Proteins', 'Reporting', 'Research', 'Research Infrastructure', 'Research Methodology', 'Research Personnel', 'Research Project Grants', 'Resolution', 'Role', 'Signal Transduction', 'Testing', 'Time', 'Tissues', 'Underrepresented Minority', 'Universities', 'Untranslated RNA', 'Variant', 'base', 'career', 'chromosome conformation capture', 'college', 'cost', 'deep learning', 'effective therapy', 'experience', 'experimental study', 'genome-wide', 'histone modification', 'human embryonic stem cell', 'long short term memory', 'mammalian genome', 'model building', 'novel', 'predictive modeling', 'promoter', 'skills', 'tool', 'transcription factor', 'undergraduate student']",NIGMS,UNIVERSITY OF HOUSTON-DOWNTOWN,R15,2020,399888,0.05163562915201998
"DEVELOP NOVEL DEEP LEARNING AND COMBINATORIAL OPTIMIZATION METHODS TO IDENTIFY KEY DISEASE REGULATORY ELEMENTS FOR SINGLE-CELL DATA Contact Principal Investigator / Project Leader: Yang, Mary Organization: University of Arkansas Little Rock Title: DEVELOP NOVEL DEEP LEARNING AND COMBINATORIAL OPTIMIZATION METHODS TO IDENTIFY KEY DISEASE REGULATORY ELEMENTS FOR SINGLE-CELL DATA Abstract Text: Description: Traditional bulk sequencing measures the average of cell population constituents, inevitably masking the intrinsic cell-to-cell heterogeneity. Single-cell technologies, on the other hand, enable a high-resolution measurement for each individual cell, providing new opportunities to capture cell population diversity and dissect the heterogeneity of complex diseases. Meanwhile, the high-sparsity and the relatively small number of sequencing reads pose new data analytic challenges. In this proposed project, we will develop innovative computational methods for single-cell RNA sequencing (scRNA-seq) data analysis and integration to identify key regulatory elements that underlie disease heterogeneity and drive disease development. The scRNA-seq data contains substantial proportion of zero expression counts due to low capture efficiency and stochastic gene expression. We will develop a novel data-driven deep learning model to recover the missing values. Our model utilizes a deep learning algorithm to capture complex and latent distributions of missing values without assuming an underlying distribution, thus, ensuring effective performance across various scRNA-seq generated by different protocols. scRNA-seq profiles enable characterization of unique transcriptome for each cell type. We hypothesize that disrupted expression patterns accompanying the disease development in different cell types are controlled by sequential alterations of the activity and connectivity in the regulatory networks. Hence, using scRNA-seq data, we will first infer cell lineage trajectories. Then, we will develop a novel deep neural network method to reconstruct cellular regulatory networks according to pseudo-time ordering of the cell types. With a new network alignment model, we will exploit the dynamic changes of regulations in the disease process, revealing key regulators and providing cell type-specific drug targets. The fulfillment of the proposed project will facilitate single-cell genomic and biomedical research efforts allowing for a much broader, cross-disciplinary understanding of the underlying mechanisms of complex diseases. The proposed project will be devised into capstone projects and will be primarily completed by undergraduate students under the PI's supervision with the assistance of a graduate student. The project will serve as a vehicle to equip undergraduate students with essential research skills and interdisciplinary knowledge, and to stimulate the students' ambition to pursue careers in the biomedical science. This project will create a multidisciplinary platform in a comprehensive university setting that encourages undergraduate students to engage in biomedical research.! Public Health Relevance Statement: This R15 project aims to provide novel deep learning and hybrid statistical methods to tackle challenges with a focus on single-cell genomic data to improve our understanding of disease evolution mechanisms and advance treatment strategies for the complex diseases. Our approaches enable the reconstruction of cell type-specific regulatory networks and infer dysregulated pathways in different cell types and the integration of the research efforts made on the bulk-level, hence, lead to further discoveries, accurate diagnosis and new cell type-specific therapies. With the processes of this R15 project, we will engage and continue to recruit undergraduate students from diverse backgrounds focusing on their research skills development and incorporate the scientific investigations for this project into their college education and provide broader careers.",DEVELOP NOVEL DEEP LEARNING AND COMBINATORIAL OPTIMIZATION METHODS TO IDENTIFY KEY DISEASE REGULATORY ELEMENTS FOR SINGLE-CELL DATA,9965550,R15GM137288,"['Accountability', 'Arkansas', 'Biological', 'Biological Process', 'Biomedical Research', 'Cell Differentiation process', 'Cell Lineage', 'Cells', 'Combinatorial Optimization', 'Complex', 'Computing Methodologies', 'Data', 'Data Analyses', 'Data Analytics', 'Data Set', 'Development', 'Disease', 'Drug Targeting', 'Education', 'Educational Models', 'Ensure', 'Evolution', 'Gene Expression', 'Gene Expression Profile', 'Gene Expression Regulation', 'Genes', 'Genetic Programming', 'Genetic Transcription', 'Genomics', 'Heterogeneity', 'Hybrids', 'Individual', 'Information Sciences', 'Investigation', 'Knowledge', 'Lead', 'Learning', 'Masks', 'Measurable', 'Measurement', 'Measures', 'Methods', 'Modeling', 'Noise', 'Outcome', 'Pathway interactions', 'Patients', 'Pattern', 'Performance', 'Pharmaceutical Preparations', 'Philosophy', 'Population', 'Population Heterogeneity', 'Principal Investigator', 'Process', 'Production', 'Protocols documentation', 'Regulation', 'Regulatory Element', 'Reporting', 'Research', 'Research Activity', 'Resolution', 'Resources', 'Schedule', 'Scholarship', 'Science', 'Signal Pathway', 'Signal Transduction', 'Statistical Methods', 'Students', 'Supervision', 'Technology', 'Text', 'Therapeutic', 'Time', 'Training', 'Transference', 'Universities', 'Work', 'Yang', 'accurate diagnosis', 'base', 'career', 'cell type', 'college', 'data integration', 'data modeling', 'deep learning', 'deep learning algorithm', 'deep neural network', 'differential expression', 'disease heterogeneity', 'education research', 'genomic data', 'graduate student', 'improved', 'innovation', 'insight', 'multidisciplinary', 'novel', 'pedagogy', 'precision medicine', 'public health relevance', 'reconstruction', 'recruit', 'single cell sequencing', 'single cell technology', 'single-cell RNA sequencing', 'skill acquisition', 'skills', 'success', 'transcriptome', 'treatment strategy', 'undergraduate student']",NIGMS,UNIVERSITY OF ARKANSAS AT LITTLE ROCK,R15,2020,443854,-0.017536116667695074
"Systems Biology of Shape and Size Regulation Abstract The molecular regulation of body shape and size during development and regeneration involves numerous pathways precisely integrated together with the biophysical properties of cellular and tissue dynamics, a complex process poorly understood at the level of whole animals. The overall goal of this project is to gain a mechanistic understanding of the genetic regulation and coordination of large-scale tissue growth by developing and applying a novel integrated systems biology approach. Combining in vivo experiments and their morphological formalization with machine learning of mathematical biophysical models, we will discern the molecular mechanisms that control growth, shape, and size regulation. We will leverage the robustness of the planarian worm to address the molecular and physical mechanisms regulating their extraordinary homeostatic and regenerative capacity to grow, degrow, and regenerate their whole-body shapes and organs from almost any amputation and across one order of magnitude in sizes. This work will develop novel computational systems biology methods and integrate them with whole-body gene expression imaging and surgical and genetic manipulations assays to elucidate the molecular regulators of body shape and size. Morphological, genetic, and surgical data will be formalized with novel mathematical ontologies, which will serve as input to new machine learning methods able to infer mechanistic gene regulatory networks. The regulatory networks will be quantitatively modeled with a novel mathematical continuous approach for whole-body biophysical simulation, including tissue growth, adhesion molecules, and gene regulation. This computational framework combining machine learning with biophysical modeling will be able to discover the mechanisms of growth and shape regulation from large formalized experimental datasets. Novel genetic interactions will be discovered by the machine learning methodology, which predictions in terms of morphological and gene expression outcomes resulting from genetic and surgical manipulations will be validated at the bench via RNAi and in situ hybridization assays. Integrating machine learning, biophysical mathematical modeling, ontological formalizations, and in vivo surgical and molecular assays represents a comprehensive systems biology approach for elucidating the regulation of shape and size. This work will provide a mechanistic understanding of the diverse genetic pathways that regulate tissue growth dynamics and how they interact precisely between them and with tissue biophysics to create and maintain whole-body scale targeted shapes and sizes. This work will pave the way for new applications and novel therapies in human developmental, regenerative, and cancer medicine. Project Narrative The genetic regulation of the shape and size of internal organs and whole body is crucial during development, regeneration, and homeostasis. This project will develop a novel integrated systems biology approach to elucidate mechanistically the molecular pathways and their coordination that control large-scale tissue growth dynamics in living organisms. These advancements will have a broad impact on our understanding of human development and regeneration towards novel therapeutic interventions for treating birth defects, traumatic injuries, and cancer.",Systems Biology of Shape and Size Regulation,10027400,R35GM137953,"['Address', 'Amputation', 'Animals', 'Biological Assay', 'Biophysics', 'Cell Adhesion Molecules', 'Complex', 'Congenital Abnormality', 'Data', 'Data Set', 'Development', 'Gene Expression', 'Gene Expression Regulation', 'Genetic', 'Goals', 'Growth', 'Homeostasis', 'Human', 'Human Development', 'Image', 'In Situ Hybridization', 'Machine Learning', 'Malignant Neoplasms', 'Mathematics', 'Medicine', 'Methodology', 'Methods', 'Modeling', 'Molecular', 'Morphology', 'Natural regeneration', 'Ontology', 'Operative Surgical Procedures', 'Organ', 'Organism', 'Outcome', 'Pathway interactions', 'Planarians', 'Process', 'RNA Interference', 'Regulation', 'Regulator Genes', 'Shapes', 'Systems Biology', 'Tissues', 'Traumatic injury', 'Work', 'biophysical model', 'biophysical properties', 'computer framework', 'experimental study', 'genetic manipulation', 'in vivo', 'machine learning method', 'mathematical learning', 'mathematical model', 'novel', 'novel therapeutic intervention', 'novel therapeutics', 'regenerative', 'simulation']",NIGMS,UNIVERSITY OF MARYLAND BALT CO CAMPUS,R35,2020,378160,0.03064441890377769
"Advanced algorithms to infer and analyze 3D genome structures Project Summary For the past decade, the population-cell Hi-C technique has significantly improved our ability to discover genome-wide DNA proximities. However, because population Hi-C is based on a pool of cells, it will not help us reveal each single cell's 3D genome structure or understand cell-to-cell variability in terms of 3D genome structure and gene regulation. It is also difficult to achieve a high resolution, such as 1 Kbp, with population Hi- C; therefore, when finding and analyzing the spatial interactions for the promoter or enhancer regions typically associated with biologically-important regulatory elements, population Hi-C data's resolution is too low to be useful. Moreover, while we know that the CTCF-cohesin complex plays a key role in the formation of genome 3D structures, the question is whether long non-coding RNAs (lncRNAs) are involved in the process since lncRNAs have been found to recruit proteins needed for chromatin remodeling, and our preliminary research has found that lncRNA LINC00346 directly interacts with CTCF. Finally, while members of the bioinformatics community, including the PI, have developed many algorithms to reconstruct 3D genome structures based on population Hi-C data, important questions still must be answered regarding how 3D genome structures are involved in gene regulation and whether there are relationships between 3D genome structures and genetic and epigenetic features. The PI proposes to conduct leading research to overcome these challenges and address these questions. During the next five years, the PI will develop algorithms to reconstruct the 3D whole- genome structures for single cells and analyze cell-to-cell variabilities in terms of 3D genome structure and gene regulation. The PI will develop a deep learning algorithm to enhance the resolution of population Hi-C data to that of Capture Hi-C data (1 Kbp) so that we can make good use of the large amount of Hi-C data accumulated in the past decade. An online database will be built to allow the community to access both population and single-cell 3D genome structures in an integrated way. The PI will work with a cancer biologist to discover any lncRNAs that function as a scaffold to fine-tune the CTCF-cohesin protein complex, as well as two neuron scientists to develop a more complete understanding of gene regulation while considering 3D genome and other genetic and epigenetic features. Given the PI's track record and productivity, having three computational goals and two collaborative goals is not only feasible but computationally and biologically rewarding. In five years, once the proposed studies are accomplished, the PI should have established a uniquely independent place in the field of 3D genome, maintaining leading positions in inferring single-cell 3D genome structures, enhancing Hi-C data resolution, and building 3D genome databases, while establishing similar positions in reconstructing high-resolution 3D genome structures, finding lncRNAs' roles in the formation of genome structures, and understanding how 3D genome structures are involved in gene regulation. Project Narrative The three-dimensional (3D) structure of genome is critically important for gene regulation; and the abnormal 3D genome structures are often associated with diseases such as cancer. This proposal aims to reconstruct and analyze the 3D genome structures of thousands of individual cells, study how 3D genome structures participate in gene regulation, determine whether long noncoding RNAs (lncRNAs) are involved in the formation of genome structures, and build an online knowledge base integrating 3D genome structures with other biological information.",Advanced algorithms to infer and analyze 3D genome structures,10027542,R35GM137974,"['3-Dimensional', 'Address', 'Algorithms', 'Bioinformatics', 'Biological', 'Cells', 'Communities', 'Complex', 'DNA', 'Data', 'Databases', 'Disease', 'Enhancers', 'Epigenetic Process', 'Gene Expression Regulation', 'Genetic', 'Genome', 'Goals', 'Individual', 'Malignant Neoplasms', 'Neurons', 'Other Genetics', 'Play', 'Population', 'Positioning Attribute', 'Process', 'Productivity', 'Proteins', 'Regulatory Element', 'Research', 'Resolution', 'Rewards', 'Role', 'Scientist', 'Structure', 'Techniques', 'Untranslated RNA', 'Work', 'base', 'chromatin remodeling', 'cohesin', 'deep learning algorithm', 'genome database', 'genome-wide', 'improved', 'knowledge base', 'member', 'promoter', 'protein complex', 'recruit', 'scaffold', 'three dimensional structure', 'whole genome']",NIGMS,UNIVERSITY OF MIAMI CORAL GABLES,R35,2020,354694,0.02298055026691445
"IKK:Biophysical basis of dynamic regulation  IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies (arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical and central role in many functions in physiology and pathology, but its potential as a drug target has not been realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease associated misregulation and stimulus-responsive regulation in healthy cells. In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response and temporal control determine the efficacy of cytokine traps.  7. Project Narrative The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to down stream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.",IKK:Biophysical basis of dynamic regulation,8463406,R01CA141722,"['Accounting', 'Adverse effects', 'Affect', 'Analytical Centrifugation', 'Architecture', 'Arthritis', 'Atherosclerosis', 'Binding', 'Binding Sites', 'Biochemical', 'Biochemical Reaction', 'Biochemistry', 'Biological Assay', 'Biophysics', 'Catalytic Domain', 'Cell Line', 'Cell Surface Receptors', 'Cells', 'Characteristics', 'Chronic', 'Chronic Disease', 'Complex', 'Computer Simulation', 'Coupled', 'Crystallography', 'Development', 'Disease', 'Dissociation', 'Dose', 'Drug Targeting', 'Effectiveness', 'Enzymes', 'Equation', 'Estimation Techniques', 'Family', 'Feedback', 'Genes', 'Genetic', 'Goals', 'Half-Life', 'Heat-Shock Proteins 90', 'Human Pathology', 'IkappaB kinase', 'Immune', 'Immune response', 'In Vitro', 'Inflammatory', 'Inflammatory Response', 'Interleukin-1', 'Intervention', 'Kinetics', 'Lesion', 'Libraries', 'Malignant Epithelial Cell', 'Malignant Neoplasms', 'Maps', 'Mass Spectrum Analysis', 'Measures', 'Mediating', 'Methodology', 'Modeling', 'Molecular', 'Molecular Chaperones', 'Monitor', 'Multienzyme Complexes', 'NF-kappa B', 'Natural regeneration', 'Neoplasm Metastasis', 'Nucleotides', 'Outcome', 'Pathogenesis', 'Pathology', 'Pathway interactions', 'Peptide Hydrolases', 'Pharmaceutical Preparations', 'Pharmacological Treatment', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Physiology', 'Play', 'Protein Dephosphorylation', 'Protein Kinase', 'Protein Phosphatase 2A Regulatory Subunit PR53', 'Proteins', 'Reaction', 'Receptor Cell', 'Receptor Down-Regulation', 'Recycling', 'Regulation', 'Reporting', 'Rest', 'Role', 'Scaffolding Protein', 'Signal Transduction', 'Signaling Protein', 'Specificity', 'Squamous cell carcinoma', 'Stimulus', 'Stream', 'Structure', 'Structure-Activity Relationship', 'Study models', 'TNF gene', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'Tumor Necrosis Factor Receptor', 'Work', 'autocrine', 'base', 'cancer cell', 'cancer type', 'cell type', 'crosslink', 'cytokine', 'design', 'high throughput screening', 'immune activation', 'in vivo', 'inhibitor/antagonist', 'mathematical model', 'mutant', 'novel', 'paracrine', 'reaction rate', 'receptor', 'reconstitution', 'research study', 'response', 'self assembly', 'simulation', 'small molecule', 'src-Family Kinases', 'text searching', 'transcription factor', 'ubiquitin ligase', 'upstream kinase']",NCI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2013,506483,0.0727057826926484
"IKK:Biophysical basis of dynamic regulation  IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies (arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical and central role in many functions in physiology and pathology, but its potential as a drug target has not been realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease associated misregulation and stimulus-responsive regulation in healthy cells. In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response and temporal control determine the efficacy of cytokine traps.  7. Project Narrative The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to down stream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.",IKK:Biophysical basis of dynamic regulation,8259780,R01CA141722,"['Accounting', 'Adverse effects', 'Affect', 'Analytical Centrifugation', 'Architecture', 'Arthritis', 'Atherosclerosis', 'Binding', 'Binding Sites', 'Biochemical', 'Biochemical Reaction', 'Biochemistry', 'Biological Assay', 'Biophysics', 'Catalytic Domain', 'Cell Line', 'Cell Surface Receptors', 'Cells', 'Characteristics', 'Chronic', 'Chronic Disease', 'Complex', 'Computer Simulation', 'Coupled', 'Crystallography', 'Development', 'Disease', 'Dissociation', 'Dose', 'Drug Delivery Systems', 'Effectiveness', 'Enzymes', 'Equation', 'Estimation Techniques', 'Family', 'Feedback', 'Genes', 'Genetic', 'Goals', 'Half-Life', 'Heat-Shock Proteins 90', 'Human Pathology', 'IkappaB kinase', 'Immune', 'Immune response', 'In Vitro', 'Inflammatory', 'Inflammatory Response', 'Interleukin-1', 'Intervention', 'Kinetics', 'Lesion', 'Libraries', 'Malignant Epithelial Cell', 'Malignant Neoplasms', 'Maps', 'Mass Spectrum Analysis', 'Measures', 'Mediating', 'Methodology', 'Modeling', 'Molecular', 'Molecular Chaperones', 'Monitor', 'Multienzyme Complexes', 'NF-kappa B', 'Natural regeneration', 'Neoplasm Metastasis', 'Nucleotides', 'Outcome', 'Pathogenesis', 'Pathology', 'Pathway interactions', 'Peptide Hydrolases', 'Pharmaceutical Preparations', 'Pharmacological Treatment', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Physiology', 'Play', 'Protein Dephosphorylation', 'Protein Kinase', 'Protein Phosphatase 2A Regulatory Subunit PR53', 'Proteins', 'Reaction', 'Receptor Cell', 'Receptor Down-Regulation', 'Recycling', 'Regulation', 'Reporting', 'Rest', 'Role', 'Scaffolding Protein', 'Signal Transduction', 'Signaling Protein', 'Specificity', 'Squamous cell carcinoma', 'Stimulus', 'Stream', 'Structure', 'Structure-Activity Relationship', 'Study models', 'TNF gene', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'Tumor Necrosis Factor Receptor', 'Work', 'autocrine', 'base', 'cancer cell', 'cancer type', 'cell type', 'crosslink', 'cytokine', 'design', 'high throughput screening', 'immune activation', 'in vivo', 'inhibitor/antagonist', 'mathematical model', 'mutant', 'novel', 'paracrine', 'reaction rate', 'receptor', 'reconstitution', 'research study', 'response', 'self assembly', 'simulation', 'small molecule', 'src-Family Kinases', 'text searching', 'transcription factor', 'ubiquitin ligase', 'upstream kinase']",NCI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2012,538810,0.0727057826926484
"IKK:Biophysical basis of dynamic regulation    DESCRIPTION (provided by applicant): IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies (arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical and central role in many functions in physiology and pathology, but its potential as a drug target has not been realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease associated misregulation and stimulus-responsive regulation in healthy cells. In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response and temporal control determine the efficacy of cytokine traps.       PUBLIC HEALTH RELEVANCE: The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to downstream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.           7. Project Narrative The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to down stream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.",IKK:Biophysical basis of dynamic regulation,8072633,R01CA141722,"['Accounting', 'Adverse effects', 'Affect', 'Analytical Centrifugation', 'Architecture', 'Arthritis', 'Atherosclerosis', 'Binding', 'Binding Sites', 'Biochemical', 'Biochemical Reaction', 'Biochemistry', 'Biological Assay', 'Biophysics', 'Catalytic Domain', 'Cell Line', 'Cell Surface Receptors', 'Cells', 'Characteristics', 'Chronic', 'Chronic Disease', 'Complex', 'Computer Simulation', 'Coupled', 'Crystallography', 'Development', 'Disease', 'Dissociation', 'Dose', 'Drug Delivery Systems', 'Effectiveness', 'Enzymes', 'Equation', 'Estimation Techniques', 'Family', 'Feedback', 'Genes', 'Genetic', 'Goals', 'Half-Life', 'Heat-Shock Proteins 90', 'Human Pathology', 'IkappaB kinase', 'Immune', 'Immune response', 'In Vitro', 'Inflammatory', 'Inflammatory Response', 'Interleukin-1', 'Intervention', 'Kinetics', 'Lesion', 'Libraries', 'Malignant Epithelial Cell', 'Malignant Neoplasms', 'Maps', 'Mass Spectrum Analysis', 'Measures', 'Mediating', 'Methodology', 'Modeling', 'Molecular', 'Molecular Chaperones', 'Monitor', 'Multienzyme Complexes', 'NF-kappa B', 'Natural regeneration', 'Neoplasm Metastasis', 'Nucleotides', 'Outcome', 'Pathogenesis', 'Pathology', 'Pathway interactions', 'Peptide Hydrolases', 'Pharmaceutical Preparations', 'Pharmacological Treatment', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Physiology', 'Play', 'Protein Dephosphorylation', 'Protein Kinase', 'Protein Phosphatase 2A Regulatory Subunit PR53', 'Proteins', 'Reaction', 'Receptor Cell', 'Receptor Down-Regulation', 'Recycling', 'Regulation', 'Reporting', 'Rest', 'Role', 'Scaffolding Protein', 'Signal Transduction', 'Signaling Protein', 'Specificity', 'Squamous cell carcinoma', 'Stimulus', 'Stream', 'Structure', 'Structure-Activity Relationship', 'Study models', 'TNF gene', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'Tumor Necrosis Factor Receptor', 'Work', 'autocrine', 'base', 'cancer cell', 'cancer type', 'cell type', 'crosslink', 'cytokine', 'design', 'high throughput screening', 'immune activation', 'in vivo', 'inhibitor/antagonist', 'mathematical model', 'mutant', 'novel', 'paracrine', 'public health relevance', 'reaction rate', 'receptor', 'reconstitution', 'research study', 'response', 'self assembly', 'simulation', 'small molecule', 'src-Family Kinases', 'text searching', 'transcription factor', 'ubiquitin ligase', 'upstream kinase']",NCI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2011,538810,0.09014386887476744
"IKK:Biophysical basis of dynamic regulation    DESCRIPTION (provided by applicant): IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies (arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical and central role in many functions in physiology and pathology, but its potential as a drug target has not been realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease associated misregulation and stimulus-responsive regulation in healthy cells. In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response and temporal control determine the efficacy of cytokine traps.       PUBLIC HEALTH RELEVANCE: The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to downstream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.           7. Project Narrative The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to down stream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.",IKK:Biophysical basis of dynamic regulation,7843488,R01CA141722,"['Accounting', 'Adverse effects', 'Affect', 'Analytical Centrifugation', 'Architecture', 'Arthritis', 'Atherosclerosis', 'Binding', 'Biochemical', 'Biochemical Reaction', 'Biochemistry', 'Biological Assay', 'Biophysics', 'Catalytic Domain', 'Cell Line', 'Cell Surface Receptors', 'Cells', 'Characteristics', 'Chronic', 'Chronic Disease', 'Complex', 'Computer Simulation', 'Coupled', 'Crystallography', 'Development', 'Disease', 'Dissociation', 'Dose', 'Drug Delivery Systems', 'Effectiveness', 'Enzymes', 'Equation', 'Estimation Techniques', 'Family', 'Feedback', 'Genes', 'Genetic', 'Goals', 'Half-Life', 'Heat-Shock Proteins 90', 'Human Pathology', 'IkappaB kinase', 'Immune', 'Immune response', 'In Vitro', 'Inflammatory', 'Inflammatory Response', 'Interleukin-1', 'Intervention', 'Kinetics', 'Lesion', 'Libraries', 'Malignant Epithelial Cell', 'Malignant Neoplasms', 'Maps', 'Mass Spectrum Analysis', 'Measures', 'Mediating', 'Metastatic Squamous Cell Carcinoma', 'Methodology', 'Modeling', 'Molecular', 'Molecular Chaperones', 'Monitor', 'Multienzyme Complexes', 'NF-kappa B', 'Natural regeneration', 'Neoplasm Metastasis', 'Nucleotides', 'Outcome', 'Pathogenesis', 'Pathology', 'Pathway interactions', 'Peptide Hydrolases', 'Pharmaceutical Preparations', 'Pharmacological Treatment', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Physiology', 'Play', 'Protein Dephosphorylation', 'Protein Kinase', 'Protein Phosphatase 2A Regulatory Subunit PR53', 'Proteins', 'Reaction', 'Receptor Cell', 'Receptor Down-Regulation', 'Recycling', 'Regulation', 'Reporting', 'Rest', 'Role', 'Scaffolding Protein', 'Signal Transduction', 'Signaling Protein', 'Specificity', 'Stimulus', 'Stream', 'Structure', 'Structure-Activity Relationship', 'TNF gene', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'Tumor Necrosis Factor Receptor', 'Work', 'autocrine', 'base', 'cancer cell', 'cancer type', 'cell type', 'crosslink', 'cytokine', 'design', 'high throughput screening', 'immune activation', 'in vivo', 'inhibitor/antagonist', 'mathematical model', 'mutant', 'novel', 'paracrine', 'public health relevance', 'reaction rate', 'receptor', 'reconstitution', 'research study', 'response', 'self assembly', 'simulation', 'small molecule', 'src-Family Kinases', 'text searching', 'transcription factor', 'ubiquitin ligase', 'upstream kinase']",NCI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2010,555473,0.09014386887476744
"IKK:Biophysical basis of dynamic regulation    DESCRIPTION (provided by applicant): IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies (arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical and central role in many functions in physiology and pathology, but its potential as a drug target has not been realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease associated misregulation and stimulus-responsive regulation in healthy cells. In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response and temporal control determine the efficacy of cytokine traps.       PUBLIC HEALTH RELEVANCE: The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to downstream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.           7. Project Narrative The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to down stream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.",IKK:Biophysical basis of dynamic regulation,7714251,R01CA141722,"['Accounting', 'Adverse effects', 'Affect', 'Analytical Centrifugation', 'Architecture', 'Arthritis', 'Atherosclerosis', 'Binding', 'Biochemical', 'Biochemical Reaction', 'Biochemistry', 'Biological Assay', 'Biophysics', 'Catalytic Domain', 'Cell Line', 'Cell Surface Receptors', 'Cells', 'Characteristics', 'Chronic', 'Chronic Disease', 'Complex', 'Computer Simulation', 'Coupled', 'Crystallography', 'Development', 'Disease', 'Dissociation', 'Dose', 'Drug Delivery Systems', 'Effectiveness', 'Enzymes', 'Equation', 'Estimation Techniques', 'Family', 'Feedback', 'Genes', 'Genetic', 'Goals', 'Half-Life', 'Heat-Shock Proteins 90', 'Human Pathology', 'IkappaB kinase', 'Immune', 'Immune response', 'In Vitro', 'Inflammatory', 'Inflammatory Response', 'Interleukin-1', 'Intervention', 'Kinetics', 'Lesion', 'Libraries', 'Malignant Epithelial Cell', 'Malignant Neoplasms', 'Maps', 'Mass Spectrum Analysis', 'Measures', 'Mediating', 'Metastatic Squamous Cell Carcinoma', 'Methodology', 'Modeling', 'Molecular', 'Molecular Chaperones', 'Monitor', 'Multienzyme Complexes', 'NF-kappa B', 'Natural regeneration', 'Neoplasm Metastasis', 'Nucleotides', 'Outcome', 'Pathogenesis', 'Pathology', 'Pathway interactions', 'Peptide Hydrolases', 'Pharmaceutical Preparations', 'Pharmacological Treatment', 'Phosphoric Monoester Hydrolases', 'Phosphorylation', 'Phosphorylation Site', 'Phosphotransferases', 'Physiological', 'Physiology', 'Play', 'Protein Dephosphorylation', 'Protein Kinase', 'Protein Phosphatase 2A Regulatory Subunit PR53', 'Proteins', 'Reaction', 'Receptor Cell', 'Receptor Down-Regulation', 'Recycling', 'Regulation', 'Reporting', 'Rest', 'Role', 'Scaffolding Protein', 'Signal Transduction', 'Signaling Protein', 'Specificity', 'Stimulus', 'Stream', 'Structure', 'Structure-Activity Relationship', 'TNF gene', 'Testing', 'Therapeutic', 'Therapeutic Intervention', 'Tumor Necrosis Factor Receptor', 'Work', 'autocrine', 'base', 'cancer cell', 'cancer type', 'cell type', 'crosslink', 'cytokine', 'design', 'high throughput screening', 'in vivo', 'inhibitor/antagonist', 'mathematical model', 'mutant', 'novel', 'paracrine', 'public health relevance', 'reaction rate', 'receptor', 'reconstitution', 'research study', 'response', 'self assembly', 'simulation', 'small molecule', 'src-Family Kinases', 'text searching', 'transcription factor', 'ubiquitin ligase', 'upstream kinase']",NCI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",R01,2009,544581,0.09014386887476744
"Identification of Transposable Element Insertions in the Kids First Data Project Summary Insertion of transposable elements (TEs, sometimes referred to as jumping genes) into the human genome can be pathogenic. Our aim in this project is to use sophisticated computational approaches to characterize TE insertions in the whole-genome sequencing data generated in the Gabriella Miller Kids First Pediatric Research Program and identify any insertional mutations that may disrupt gene function. The large scale of the Kids First program provides an unprecedented opportunity to investigate the role of TE insertions in childhood cancers and structural birth defects, as well as to create a resource of reference TE maps that will be important for all other TE studies. We will first modify our existing algorithm called xTEA for the trio design of the Kids First studies and increase the accuracy and efficiency of the algorithm. Then, we will apply it to the thousands of trios that have been profiled in the Kids First program, using a pipeline optimized for the cloud environment. The resulting set of TE insertions (especially L1, Alu, SVA, and HERV insertions) will be curated with all relevant features and be made into a database for the community. We will also apply machine learning methods to improve the calls once a sufficient amount of training data have been obtained. To investigate the potential pathogenicity of the mutation, we will first focus on insertions within genes, but we will also explore those in regulatory elements inferred from epigenetic profiling data. PROJECT NARRATIVE Transposable elements, or jumping genes, are genetic elements that can alter the DNA of an individual. We aim to utilize a computational method to identify such elements in the genome sequencing data generated in the Gabriella Miller Kids First Pediatric Research Program. Our analysis will identify transposable elements that may be causal for a disease phenotype.",Identification of Transposable Element Insertions in the Kids First Data,9957262,R03CA249364,"['Algorithms', 'Communities', 'Computer software', 'Computing Methodologies', 'DNA', 'DNA Insertion Elements', 'DNA Transposable Elements', 'Data', 'Data Set', 'Databases', 'Disease', 'Elements', 'Endogenous Retroviruses', 'Environment', 'Gene Frequency', 'Genes', 'Genetic Diseases', 'Genome', 'Genomics', 'Genotype', 'Human Genome', 'Individual', 'Inherited', 'Insertion Mutation', 'Jumping Genes', 'Length', 'Location', 'Machine Learning', 'Malignant Childhood Neoplasm', 'Malignant Neoplasms', 'Maps', 'Mendelian disorder', 'Methods', 'Modeling', 'Mutation', 'Neurons', 'Output', 'Parents', 'Paste substance', 'Pathogenicity', 'Pediatric Research', 'Play', 'Population', 'Regulatory Element', 'Reporting', 'Resources', 'Retrotransposon', 'Role', 'Sampling', 'Sensitivity and Specificity', 'Single Nucleotide Polymorphism', 'Site', 'Source', 'Speed', 'Structural Congenital Anomalies', 'Training', 'base', 'cloud based', 'cohort', 'design', 'disease phenotype', 'epigenetic profiling', 'gene function', 'genetic element', 'genome sequencing', 'improved', 'machine learning method', 'proband', 'programs', 'transcriptome sequencing', 'whole genome']",NCI,HARVARD MEDICAL SCHOOL,R03,2020,169041,-0.016306329123504774
